primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
109982197,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2021,Q1,Blindness,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
109982197,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2021,Q1,Diabetic coma,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
109982197,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
109982197,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
109982197,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 UNIT PER 12 GRAMS AS DIRECTED),,,,,,,,,,,,2021,Q1,Steroid diabetes,,2021,Q1,7,F,20050414.0,20210318.0,20150408,20210319,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20210319.0,,HP,US,US,2021,Q1,Adult
134266779,13426677,14,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Delirium,,2021,Q1,9,F,20170329.0,20210105.0,20170411,20210111,EXP,,JP-CELGENEUS-JPN-20170401659,CELGENE,,68.0,YR,,M,Y,,,20210111.0,,MD,JP,JP,2021,Q1,Elderly
134266779,13426677,14,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Hypercalcaemia,,2021,Q1,9,F,20170329.0,20210105.0,20170411,20210111,EXP,,JP-CELGENEUS-JPN-20170401659,CELGENE,,68.0,YR,,M,Y,,,20210111.0,,MD,JP,JP,2021,Q1,Elderly
143341604,14334160,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,90.0,IU,,QD,2021,Q1,Caesarean section,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,90.0,IU,,QD,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,90.0,IU,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,90.0,IU,,QD,2021,Q1,Infection,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,90.0,IU,,QD,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,90.0,IU,,QD,2021,Q1,Postpartum haemorrhage,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,90.0,IU,,QD,2021,Q1,Product use issue,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,72 IU (INTERNATIONAL UNIT) DAILY; THERAPY END DATE ASKU,,,,,,,,72.0,IU,,QD,2021,Q1,Caesarean section,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,72 IU (INTERNATIONAL UNIT) DAILY; THERAPY END DATE ASKU,,,,,,,,72.0,IU,,QD,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,72 IU (INTERNATIONAL UNIT) DAILY; THERAPY END DATE ASKU,,,,,,,,72.0,IU,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,72 IU (INTERNATIONAL UNIT) DAILY; THERAPY END DATE ASKU,,,,,,,,72.0,IU,,QD,2021,Q1,Infection,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,72 IU (INTERNATIONAL UNIT) DAILY; THERAPY END DATE ASKU,,,,,,,,72.0,IU,,QD,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,72 IU (INTERNATIONAL UNIT) DAILY; THERAPY END DATE ASKU,,,,,,,,72.0,IU,,QD,2021,Q1,Postpartum haemorrhage,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,72 IU (INTERNATIONAL UNIT) DAILY; THERAPY END DATE ASKU,,,,,,,,72.0,IU,,QD,2021,Q1,Product use issue,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,86.0,IU,,QD,2021,Q1,Caesarean section,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,86.0,IU,,QD,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,86.0,IU,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,86.0,IU,,QD,2021,Q1,Infection,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,86.0,IU,,QD,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,86.0,IU,,QD,2021,Q1,Postpartum haemorrhage,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
143341604,14334160,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 IU (INTERNATIONAL UNIT) DAILY; THERAPY START DATE ASKU, THERAPY END DATE ASKU",,,,,,,,86.0,IU,,QD,2021,Q1,Product use issue,,2021,Q1,4,F,20170420.0,20210113.0,20171228,20210121,EXP,,IE-TEVA-2017-IE-837116,TEVA,,35.0,YR,A,F,Y,91.0,KG,20210121.0,,MD,IE,IE,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Arthralgia,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Cataract,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Clostridium difficile colitis,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Coxsackie viral infection,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Dry eye,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Dysgeusia,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Headache,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Hyperhidrosis,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Hypoacusis,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Hypogammaglobulinaemia,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Influenza like illness,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Myalgia,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Neuropathy peripheral,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Pollakiuria,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Product administration error,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Pyrexia,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Rash morbilliform,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Stevens-Johnson syndrome,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Urinary incontinence,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Vision blurred,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Vitamin D abnormal,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
145681968,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q1,Weight decreased,,2021,Q1,8,F,2017.0,20210215.0,20180223,20210301,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210301.0,,MD,US,US,2021,Q1,Adult
151269673,15126967,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,3,F,20180319.0,20210127.0,20180710,20210203,EXP,IT-MINISAL02-483579,IT-SA-2018SA174461,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Adult
151269673,15126967,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20180319.0,20210127.0,20180710,20210203,EXP,IT-MINISAL02-483579,IT-SA-2018SA174461,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Adult
151455402,15145540,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 INTERNATIONAL UNIT, DAILY",20.0,IU,Y,,,,20563.0,10.0,IU,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180613.0,20210121.0,20180713,20210203,EXP,IT-MINISAL02-487762,IT-ELI_LILLY_AND_COMPANY-IT201807005199,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210203.0,,HP,IT,IT,2021,Q1,Elderly
151455402,15145540,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"10 INTERNATIONAL UNIT, DAILY",20.0,IU,Y,,,,20563.0,10.0,IU,,QD,2021,Q1,Hypotension,,2021,Q1,2,F,20180613.0,20210121.0,20180713,20210203,EXP,IT-MINISAL02-487762,IT-ELI_LILLY_AND_COMPANY-IT201807005199,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210203.0,,HP,IT,IT,2021,Q1,Elderly
151853497,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Anti factor VIII antibody positive,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Haematoma muscle,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Intestinal obstruction,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Therapy non-responder,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Underdose,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Anti factor VIII antibody positive,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Haematoma muscle,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Intestinal obstruction,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Therapy non-responder,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
151853497,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Underdose,,2021,Q1,7,F,20180220.0,20201202.0,20180723,20210118,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210118.0,,MD,IT,IT,2021,Q1,Elderly
152141052,15214105,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"VARIED DOSE OF 150 TO 160 UNITS , TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,2,F,2010.0,20210107.0,20180730,20210111,PER,,US-SA-2018SA195950,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210111.0,,CN,US,US,2021,Q1,Adult
152141052,15214105,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"VARIED DOSE OF 150 TO 160 UNITS , TID",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2021,Q1,Myocardial infarction,,2021,Q1,2,F,2010.0,20210107.0,20180730,20210111,PER,,US-SA-2018SA195950,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20210111.0,,CN,US,US,2021,Q1,Adult
153127892,15312789,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",3240.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Confusional state,,2021,Q1,2,F,20180611.0,20210127.0,20180823,20210211,EXP,IT-MINISAL02-492970,IT-SA-2018SA221855,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
153127892,15312789,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",3240.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180611.0,20210127.0,20180823,20210211,EXP,IT-MINISAL02-492970,IT-SA-2018SA221855,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
153217662,15321766,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD",1300.0,IU,,,,,,25.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Abdominal pain,,2021,Q1,2,F,20180201.0,20210127.0,20180827,20210203,EXP,IT-MINISAL02-492917,IT-SA-2018SA221090,SANOFI AVENTIS,,11.0,YR,C,F,Y,62.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Child
153217662,15321766,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD",1300.0,IU,,,,,,25.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Dawn phenomenon,,2021,Q1,2,F,20180201.0,20210127.0,20180827,20210203,EXP,IT-MINISAL02-492917,IT-SA-2018SA221090,SANOFI AVENTIS,,11.0,YR,C,F,Y,62.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Child
153217662,15321766,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 IU, QD",1300.0,IU,,,,,,25.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Weight decreased,,2021,Q1,2,F,20180201.0,20210127.0,20180827,20210203,EXP,IT-MINISAL02-492917,IT-SA-2018SA221090,SANOFI AVENTIS,,11.0,YR,C,F,Y,62.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Child
154190432,15419043,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"33 IU, QD",1221.0,IU,Y,,,,,33.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Headache,,2021,Q1,2,F,20180405.0,20210127.0,20180924,20210203,EXP,IT-MINISAL02-493367,IT-SA-2018SA256724,SANOFI AVENTIS,,14.0,YR,T,F,Y,59.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Youth
154190432,15419043,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"33 IU, QD",1221.0,IU,Y,,,,,33.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180405.0,20210127.0,20180924,20210203,EXP,IT-MINISAL02-493367,IT-SA-2018SA256724,SANOFI AVENTIS,,14.0,YR,T,F,Y,59.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Youth
154190432,15419043,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK(REDUCED DOSE ),1221.0,IU,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Headache,,2021,Q1,2,F,20180405.0,20210127.0,20180924,20210203,EXP,IT-MINISAL02-493367,IT-SA-2018SA256724,SANOFI AVENTIS,,14.0,YR,T,F,Y,59.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Youth
154190432,15419043,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK(REDUCED DOSE ),1221.0,IU,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180405.0,20210127.0,20180924,20210203,EXP,IT-MINISAL02-493367,IT-SA-2018SA256724,SANOFI AVENTIS,,14.0,YR,T,F,Y,59.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Youth
154194643,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,,QD,2021,Q1,Depressed level of consciousness,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
154194643,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,,QD,2021,Q1,Dizziness,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
154194643,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
154194643,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,,QD,2021,Q1,Malaise,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
154194643,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,,QD,2021,Q1,Neurological symptom,,2021,Q1,3,F,20180203.0,20210127.0,20180924,20210211,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Acute kidney injury,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Adrenomegaly,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Blood pressure increased,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Chest pain,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Colitis,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Device related infection,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Dyspnoea,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Heparin-induced thrombocytopenia,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Hyperglycaemia,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Hypertensive crisis,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Klebsiella infection,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Malignant neoplasm progression,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Meningitis,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Metastases to meninges,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Pulmonary oedema,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Retinal detachment,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Tachycardia,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
1549343218,15493432,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 UNIT, UNK",,,U,,,,,300.0,DF,INJECTION,,2021,Q1,Urosepsis,,2021,Q1,18,F,20180419.0,20210118.0,20181012,20210127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20210127.0,,HP,DE,DE,2021,Q1,Elderly
155799642,15579964,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, QD",3036.0,IU,,,,,,11.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Cold sweat,,2021,Q1,2,F,20181004.0,20210127.0,20181102,20210203,EXP,IT-MINISAL02-506089,IT-SAKK-2018SA299541AA,SANOFI AVENTIS,,13.0,YR,T,M,Y,55.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Child
155799642,15579964,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, QD",3036.0,IU,,,,,,11.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20181004.0,20210127.0,20181102,20210203,EXP,IT-MINISAL02-506089,IT-SAKK-2018SA299541AA,SANOFI AVENTIS,,13.0,YR,T,M,Y,55.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Child
155799642,15579964,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, QD",3036.0,IU,,,,,,11.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Vertigo,,2021,Q1,2,F,20181004.0,20210127.0,20181102,20210203,EXP,IT-MINISAL02-506089,IT-SAKK-2018SA299541AA,SANOFI AVENTIS,,13.0,YR,T,M,Y,55.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Child
155799642,15579964,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, QD",3036.0,IU,,,,,,11.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Vision blurred,,2021,Q1,2,F,20181004.0,20210127.0,20181102,20210203,EXP,IT-MINISAL02-506089,IT-SAKK-2018SA299541AA,SANOFI AVENTIS,,13.0,YR,T,M,Y,55.0,KG,20210203.0,,MD,IT,IT,2021,Q1,Child
156578453,15657845,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 IU, QD",5406.0,IU,Y,,,,,17.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Fall,,2021,Q1,3,F,20171114.0,20210127.0,20181126,20210211,EXP,IT-MINISAL02-477128,IT-SAKK-2018SA169229AA,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
156578453,15657845,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 IU, QD",5406.0,IU,Y,,,,,17.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20171114.0,20210127.0,20181126,20210211,EXP,IT-MINISAL02-477128,IT-SAKK-2018SA169229AA,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
156892662,15689266,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",3520.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Generalised tonic-clonic seizure,,2021,Q1,2,F,20180626.0,20210127.0,20181205,20210203,EXP,IT-MINISAL02-510999,IT-SAKK-2018SA324335AA,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Elderly
156892662,15689266,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QD",3520.0,IU,U,,,,,20.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180626.0,20210127.0,20181205,20210203,EXP,IT-MINISAL02-510999,IT-SAKK-2018SA324335AA,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Elderly
157106832,15710683,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,Y,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Confusional state,,2021,Q1,2,F,20180422.0,20210127.0,20181211,20210209,EXP,IT-MINISAL02-512458,IT-SAKK-2018SA327674AA,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20210209.0,,MD,IT,IT,2021,Q1,Elderly
157106832,15710683,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, QD",,,Y,,,,,1.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180422.0,20210127.0,20181211,20210209,EXP,IT-MINISAL02-512458,IT-SAKK-2018SA327674AA,SANOFI AVENTIS,,84.0,YR,E,M,Y,,,20210209.0,,MD,IT,IT,2021,Q1,Elderly
158256682,15825668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"52 IU, QD",1404.0,IU,U,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180127.0,20210127.0,20190115,20210203,EXP,IT-MINISAL02-519029,IT-SA-2019SA005559,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210203.0,,PH,IT,IT,2021,Q1,Elderly
158256682,15825668,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"52 IU, QD",1404.0,IU,U,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Sopor,,2021,Q1,2,F,20180127.0,20210127.0,20190115,20210203,EXP,IT-MINISAL02-519029,IT-SA-2019SA005559,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20210203.0,,PH,IT,IT,2021,Q1,Elderly
160715876,16071587,16,C,INSULIN LISPRO HUMAN,,2,,,,,,,,,,,,,,2021,Q1,Hepatic encephalopathy,Hepatic encephalopathy,2021,Q1,6,F,20181204.0,20210331.0,20190314,20210331,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-048932,EISAI,,68.0,YR,E,M,Y,124.6,KG,20210331.0,,MD,US,US,2021,Q1,Elderly
160715876,16071587,16,C,INSULIN LISPRO HUMAN,,2,,,,,,,,,,,,,,2021,Q1,Pulmonary embolism,,2021,Q1,6,F,20181204.0,20210331.0,20190314,20210331,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-048932,EISAI,,68.0,YR,E,M,Y,124.6,KG,20210331.0,,MD,US,US,2021,Q1,Elderly
161172075,16117207,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Drug hypersensitivity,,2021,Q1,5,F,20190317.0,20200817.0,20190326,20210224,PER,,US-ELI_LILLY_AND_COMPANY-US201903010619,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
161172075,16117207,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Incorrect dose administered,,2021,Q1,5,F,20190317.0,20200817.0,20190326,20210224,PER,,US-ELI_LILLY_AND_COMPANY-US201903010619,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
161172075,16117207,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,5,F,20190317.0,20200817.0,20190326,20210224,PER,,US-ELI_LILLY_AND_COMPANY-US201903010619,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
161172075,16117207,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Wrong patient received product,,2021,Q1,5,F,20190317.0,20200817.0,20190326,20210224,PER,,US-ELI_LILLY_AND_COMPANY-US201903010619,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
161917955,16191795,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?4 UNITS?NIGHTLY,,,,,,,,,,,QD,2021,Q1,Chemical burns of eye,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?4 UNITS?NIGHTLY,,,,,,,,,,,QD,2021,Q1,Eye infection staphylococcal,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?4 UNITS?NIGHTLY,,,,,,,,,,,QD,2021,Q1,Eye injury,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?4 UNITS?NIGHTLY,,,,,,,,,,,QD,2021,Q1,Eye irritation,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?4 UNITS?NIGHTLY,,,,,,,,,,,QD,2021,Q1,Product quality issue,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?4 UNITS?NIGHTLY,,,,,,,,,,,QD,2021,Q1,Suspected product tampering,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?4 UNITS?NIGHTLY,,,,,,,,,,,QD,2021,Q1,Ulcerative keratitis,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?4 UNITS?NIGHTLY,,,,,,,,,,,QD,2021,Q1,Visual impairment,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS,,,,,,,,,,,TID,2021,Q1,Chemical burns of eye,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS,,,,,,,,,,,TID,2021,Q1,Eye infection staphylococcal,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS,,,,,,,,,,,TID,2021,Q1,Eye injury,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS,,,,,,,,,,,TID,2021,Q1,Eye irritation,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS,,,,,,,,,,,TID,2021,Q1,Product quality issue,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS,,,,,,,,,,,TID,2021,Q1,Suspected product tampering,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS,,,,,,,,,,,TID,2021,Q1,Ulcerative keratitis,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161917955,16191795,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?5 UNITS,,,,,,,,,,,TID,2021,Q1,Visual impairment,,2021,Q1,5,F,,20210205.0,20190412,20210218,EXP,,US-BAUSCH-BL-2019-010859,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20210218.0,,LW,US,US,2021,Q1,Adult
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Disability,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Dysphonia,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Hypoaesthesia,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Incorrect product administration duration,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Malaise,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Nasopharyngitis,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Oropharyngeal pain,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,8,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,U,,,,,,INJECTION,,2021,Q1,Thrombosis,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Disability,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Dysphonia,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Hypoaesthesia,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Incorrect product administration duration,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Malaise,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Nasopharyngitis,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Oropharyngeal pain,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
161949623,16194962,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D182600E,,,,,INJECTION,,2021,Q1,Thrombosis,,2021,Q1,3,F,2017.0,20210114.0,20190415,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US201904006866,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
1619976611,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Cutaneous sarcoidosis,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
1619976611,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Epiglottic oedema,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
1619976611,16199766,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Sarcoidosis,,2021,Q1,11,F,20190404.0,20210120.0,20190415,20210126,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20210126.0,,HP,BR,BR,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Chronic kidney disease,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Chronic kidney disease-mineral and bone disorder,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Death,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,End stage renal disease,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Metabolic acidosis,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Nephrogenic anaemia,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Renal failure,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
162782132,16278213,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Renal tubular necrosis,,2021,Q1,2,F,20120416.0,20210222.0,20190506,20210301,EXP,,US-ASTRAZENECA-2019SE61408,ASTRAZENECA,,22884.0,DY,,M,Y,122.5,KG,20210301.0,,,US,US,2021,Q1,Elderly
163066532,16306653,20,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,2004.0,20210219.0,20190513,20210226,EXP,,US-ASTRAZENECA-2019SE65954,ASTRAZENECA,,35.0,YR,,M,Y,120.2,KG,20210226.0,,,US,US,2021,Q1,Adult
163066532,16306653,20,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Chronic kidney disease,,2021,Q1,2,F,2004.0,20210219.0,20190513,20210226,EXP,,US-ASTRAZENECA-2019SE65954,ASTRAZENECA,,35.0,YR,,M,Y,120.2,KG,20210226.0,,,US,US,2021,Q1,Adult
163066532,16306653,20,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,End stage renal disease,,2021,Q1,2,F,2004.0,20210219.0,20190513,20210226,EXP,,US-ASTRAZENECA-2019SE65954,ASTRAZENECA,,35.0,YR,,M,Y,120.2,KG,20210226.0,,,US,US,2021,Q1,Adult
163066532,16306653,20,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Nephrogenic anaemia,,2021,Q1,2,F,2004.0,20210219.0,20190513,20210226,EXP,,US-ASTRAZENECA-2019SE65954,ASTRAZENECA,,35.0,YR,,M,Y,120.2,KG,20210226.0,,,US,US,2021,Q1,Adult
163066532,16306653,20,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Renal failure,,2021,Q1,2,F,2004.0,20210219.0,20190513,20210226,EXP,,US-ASTRAZENECA-2019SE65954,ASTRAZENECA,,35.0,YR,,M,Y,120.2,KG,20210226.0,,,US,US,2021,Q1,Adult
163232843,16323284,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, QD",,,Y,,,,,5.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hyperhidrosis,,2021,Q1,3,F,20190503.0,20210127.0,20190517,20210208,EXP,IT-MINISAL02-547935,IT-SA-2019SA132469,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
163232843,16323284,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, QD",,,Y,,,,,5.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20190503.0,20210127.0,20190517,20210208,EXP,IT-MINISAL02-547935,IT-SA-2019SA132469,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
163232843,16323284,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, QD",,,Y,,,,,5.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hyporesponsive to stimuli,,2021,Q1,3,F,20190503.0,20210127.0,20190517,20210208,EXP,IT-MINISAL02-547935,IT-SA-2019SA132469,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
163232843,16323284,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 IU, QD",,,Y,,,,,5.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Overdose,,2021,Q1,3,F,20190503.0,20210127.0,20190517,20210208,EXP,IT-MINISAL02-547935,IT-SA-2019SA132469,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
167079115,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2021,Q1,Cytokine release syndrome,,2021,Q1,5,F,20190723.0,20210203.0,20190815,20210208,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20210208.0,,MD,US,US,2021,Q1,Elderly
167079115,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,5,F,20190723.0,20210203.0,20190815,20210208,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20210208.0,,MD,US,US,2021,Q1,Elderly
167079115,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,5,F,20190723.0,20210203.0,20190815,20210208,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20210208.0,,MD,US,US,2021,Q1,Elderly
167079115,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2021,Q1,Pyrexia,,2021,Q1,5,F,20190723.0,20210203.0,20190815,20210208,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20210208.0,,MD,US,US,2021,Q1,Elderly
167079115,16707911,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10,IU,TWICE DAILY",,,,,,,,,,,,2021,Q1,Sepsis,,2021,Q1,5,F,20190723.0,20210203.0,20190815,20210208,EXP,,US-GILEAD-2019-0420218,GILEAD,,69.0,YR,E,M,Y,104.0,KG,20210208.0,,MD,US,US,2021,Q1,Elderly
169324975,16932497,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Leukopenia,,2021,Q1,5,F,20190723.0,20210121.0,20191017,20210122,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20210122.0,,MD,PL,PL,2021,Q1,Adult
169324975,16932497,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,5,F,20190723.0,20210121.0,20191017,20210122,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20210122.0,,MD,PL,PL,2021,Q1,Adult
1696951024,16969510,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,12.0,DF,INJECTION,,2021,Q1,Heart injury,,2021,Q1,24,F,20191021.0,20210220.0,20191029,20210225,EXP,,CN-EISAI MEDICAL RESEARCH-EC-2019-064326,EISAI,,62.0,YR,A,M,Y,69.0,KG,20210225.0,,MD,CN,CN,2021,Q1,Adult
1698641211,16986412,56,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,11,F,20191026.0,20210325.0,20191101,20210327,EXP,,NVSC2019US019491,NOVARTIS,,59.0,YR,,F,Y,66.9,KG,20210327.0,,HP,US,US,2021,Q1,Adult
1698641211,16986412,57,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,11,F,20191026.0,20210325.0,20191101,20210327,EXP,,NVSC2019US019491,NOVARTIS,,59.0,YR,,F,Y,66.9,KG,20210327.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Abdominal pain,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Abdominal pain upper,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Asthenia,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Bile output abnormal,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Blood lactic acid increased,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,COVID-19,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Cough,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Gastritis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Gastrointestinal perforation,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Glycosuria,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Hepatic cirrhosis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Hepatic steatosis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Malaise,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Nausea,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Oesophageal candidiasis,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Pyrexia,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,Viral infection,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
170266994,17026699,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, TID",,,Y,,,,,16.0,IU,,TID,2021,Q1,White blood cell count increased,,2021,Q1,4,F,20190812.0,20210302.0,20191113,20210310,EXP,,NVSC2019US031797,NOVARTIS,,63.0,YR,,F,Y,62.13,KG,20210310.0,,HP,US,US,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Cholelithiasis,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Food intolerance,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Headache,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Malaise,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Photophobia,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pituitary enlargement,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Vision blurred,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
172933825,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,5,F,,20201229.0,20200121,20210108,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210108.0,,CN,CO,CO,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Anhedonia,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Ankle fracture,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Anxiety,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Bone density decreased,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Depression,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Economic problem,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Emotional distress,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Femur fracture,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Fibula fracture,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Gangrene,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Lumbar vertebral fracture,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Multiple fractures,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pain,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Tibia fracture,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
173679554,17367955,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Tooth loss,,2021,Q1,4,F,20110209.0,20210218.0,20200204,20210304,EXP,,US-GILEAD-2020-0449364,GILEAD,,56.0,YR,A,M,Y,104.3,KG,20210304.0,,LW,US,US,2021,Q1,Adult
175356353,17535635,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"64 IU, QD (20 + 22 + 22 IU/DAY)",,,,,,,,64.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Confusional state,,2021,Q1,3,F,20191114.0,20210127.0,20200313,20210211,EXP,IT-MINISAL02-596609,IT-SA-2020SA060237,SANOFI AVENTIS,,60.0,YR,A,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Adult
175356353,17535635,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"64 IU, QD (20 + 22 + 22 IU/DAY)",,,,,,,,64.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hyperglycaemia,,2021,Q1,3,F,20191114.0,20210127.0,20200313,20210211,EXP,IT-MINISAL02-596609,IT-SA-2020SA060237,SANOFI AVENTIS,,60.0,YR,A,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Adult
175356353,17535635,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"64 IU, QD (20 + 22 + 22 IU/DAY)",,,,,,,,64.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Intentional product misuse,,2021,Q1,3,F,20191114.0,20210127.0,20200313,20210211,EXP,IT-MINISAL02-596609,IT-SA-2020SA060237,SANOFI AVENTIS,,60.0,YR,A,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Adult
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Asthma,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Blood count abnormal,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Chest discomfort,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Cough,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Diaphragmatic disorder,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Discomfort,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Dyspnoea,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Hypoxia,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Left ventricular hypertrophy,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Obstructive airways disorder,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Oedema peripheral,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Oropharyngeal pain,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Pyrexia,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Weight increased,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
175884872,17588487,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,QD,2021,Q1,Wheezing,,2021,Q1,2,F,,20210301.0,20200327,20210308,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-015919",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210308.0,,CN,CA,CA,2021,Q1,Elderly
1766093410,17660934,73,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q1,COVID-19,,2021,Q1,10,F,20200327.0,20210114.0,20200413,20210209,EXP,,US-SA-2020SA089695,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20210209.0,,MD,US,US,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Anaemia,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Blood glucose fluctuation,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Blood potassium increased,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Blood sodium decreased,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Cardio-respiratory arrest,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Infection,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Inflammation,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Oropharyngeal pain,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Platelet count decreased,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177283282,17728328,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,10 UNITS BEFORE EACH MEAL,,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Secondary immunodeficiency,,2021,Q1,2,F,20200326.0,20210119.0,20200430,20210125,EXP,,CO-ASTELLAS-2020US014758,ASTELLAS,,67.0,YR,,M,Y,,,20210125.0,,CN,CO,CO,2021,Q1,Elderly
177684892,17768489,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, UNKNOWN",,,,, C938255F,,20563.0,10.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"10 U, UNKNOWN",,,,, C938255F,,20563.0,10.0,IU,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"12 U, UNKNOWN",,,,, C938255F,,20563.0,12.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"12 U, UNKNOWN",,,,, C938255F,,20563.0,12.0,IU,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"30 U, UNKNOWN",,,,, C938255F,,20563.0,30.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"30 U, UNKNOWN",,,,, C938255F,,20563.0,30.0,IU,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D058036A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D058036A,,20563.0,,,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
177684892,17768489,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,2,F,20200502.0,20210128.0,20200511,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202005001445,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
178420032,17842003,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,20110719.0,20210222.0,20200529,20210302,EXP,,US-ASTRAZENECA-2020SE69051,ASTRAZENECA,,19938.0,DY,,M,Y,122.5,KG,20210302.0,,,US,US,2021,Q1,Elderly
178420032,17842003,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Chronic kidney disease,,2021,Q1,2,F,20110719.0,20210222.0,20200529,20210302,EXP,,US-ASTRAZENECA-2020SE69051,ASTRAZENECA,,19938.0,DY,,M,Y,122.5,KG,20210302.0,,,US,US,2021,Q1,Elderly
178420032,17842003,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Electrolyte imbalance,,2021,Q1,2,F,20110719.0,20210222.0,20200529,20210302,EXP,,US-ASTRAZENECA-2020SE69051,ASTRAZENECA,,19938.0,DY,,M,Y,122.5,KG,20210302.0,,,US,US,2021,Q1,Elderly
178420032,17842003,44,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Renal failure,,2021,Q1,2,F,20110719.0,20210222.0,20200529,20210302,EXP,,US-ASTRAZENECA-2020SE69051,ASTRAZENECA,,19938.0,DY,,M,Y,122.5,KG,20210302.0,,,US,US,2021,Q1,Elderly
179266563,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2021,Q1,Anaemia,,2021,Q1,3,F,,20210308.0,20200623,20210318,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20210318.0,,PH,DE,DE,2021,Q1,Elderly
179266563,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2021,Q1,Electrolyte imbalance,,2021,Q1,3,F,,20210308.0,20200623,20210318,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20210318.0,,PH,DE,DE,2021,Q1,Elderly
179266563,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2021,Q1,Hyperkalaemia,,2021,Q1,3,F,,20210308.0,20200623,20210318,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20210318.0,,PH,DE,DE,2021,Q1,Elderly
179266563,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2021,Q1,Labelled drug-drug interaction medication error,,2021,Q1,3,F,,20210308.0,20200623,20210318,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20210318.0,,PH,DE,DE,2021,Q1,Elderly
179266563,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2021,Q1,Product monitoring error,,2021,Q1,3,F,,20210308.0,20200623,20210318,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20210318.0,,PH,DE,DE,2021,Q1,Elderly
179266563,17926656,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0",,,,, UNKNOWN,,,300.0,IU,,TID,2021,Q1,Renal impairment,,2021,Q1,3,F,,20210308.0,20200623,20210318,PER,,DE-DRREDDYS-GER/GER/20/0124238,DR REDDYS,,70.0,YR,E,M,Y,78.0,KG,20210318.0,,PH,DE,DE,2021,Q1,Elderly
179361865,17936186,23,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q1,Cardiac disorder,,2021,Q1,5,F,,20210119.0,20200624,20210330,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210330.0,,MD,US,US,2021,Q1,Adult
179361865,17936186,23,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q1,Colon cancer,,2021,Q1,5,F,,20210119.0,20200624,20210330,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210330.0,,MD,US,US,2021,Q1,Adult
179361865,17936186,23,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q1,Pulmonary oedema,,2021,Q1,5,F,,20210119.0,20200624,20210330,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210330.0,,MD,US,US,2021,Q1,Adult
179386183,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2021,Q1,Anaemia,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2021,Q1,Electrolyte imbalance,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2021,Q1,Hyperkalaemia,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2021,Q1,Labelled drug-drug interaction medication error,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2021,Q1,Product monitoring error,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179386183,17938618,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, 3 TIMES A DAY (8?8?8?0)",,,U,,,,,300.0,IU,,TID,2021,Q1,Renal impairment,,2021,Q1,3,F,,20210125.0,20200625,20210201,EXP,,DE-AUROBINDO-AUR-APL-2020-030160,AUROBINDO,,70.0,YR,,M,Y,78.0,KG,20210201.0,,HP,DE,DE,2021,Q1,Elderly
179407995,17940799,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Anaemia,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Electrolyte imbalance,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Hyperkalaemia,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Labelled drug-drug interaction medication error,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Product monitoring error,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179407995,17940799,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q1,Renal impairment,,2021,Q1,5,F,,20210128.0,20200625,20210204,EXP,,DE-SA-2020SA160936,SANOFI AVENTIS,,70.0,YR,E,M,Y,78.0,KG,20210204.0,,PH,DE,DE,2021,Q1,Elderly
179816903,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,3,F,,20210125.0,20200706,20210208,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20210208.0,,HP,NL,DE,2021,Q1,Elderly
179816903,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2021,Q1,Electrolyte imbalance,,2021,Q1,3,F,,20210125.0,20200706,20210208,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20210208.0,,HP,NL,DE,2021,Q1,Elderly
179816903,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2021,Q1,Hyperkalaemia,,2021,Q1,3,F,,20210125.0,20200706,20210208,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20210208.0,,HP,NL,DE,2021,Q1,Elderly
179816903,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2021,Q1,Labelled drug-drug interaction medication error,,2021,Q1,3,F,,20210125.0,20200706,20210208,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20210208.0,,HP,NL,DE,2021,Q1,Elderly
179816903,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2021,Q1,Product monitoring error,,2021,Q1,3,F,,20210125.0,20200706,20210208,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20210208.0,,HP,NL,DE,2021,Q1,Elderly
179816903,17981690,5,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 8?8?8?0 ()",,,U,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,3,F,,20210125.0,20200706,20210208,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-252126,RANBAXY,,70.0,YR,,M,Y,78.0,KG,20210208.0,,HP,NL,DE,2021,Q1,Elderly
179976468,17997646,54,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,54,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,54,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,57,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,57,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,57,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Cholecystitis acute,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Peripheral ischaemia,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
179976468,17997646,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Sepsis,,2021,Q1,8,F,20200603.0,20210222.0,20200708,20210302,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210302.0,,MD,US,US,2021,Q1,Adult
180401412,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180401412,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Dialysis,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180401412,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Disturbance in attention,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180401412,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Inability to afford medication,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
180401412,18040141,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Liver dialysis,,2021,Q1,2,F,,20210322.0,20200717,20210329,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210329.0,,CN,US,US,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Asthma,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Blood count abnormal,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Chest discomfort,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Cough,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Diaphragmatic disorder,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Discomfort,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Dyspnoea,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Hypoxia,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Left ventricular hypertrophy,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Obstructive airways disorder,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Oedema peripheral,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Oropharyngeal pain,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Pyrexia,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Weight increased,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181369893,18136989,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q1,Wheezing,,2021,Q1,3,F,,20210308.0,20200811,20210315,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210315.0,,CN,CA,CA,2021,Q1,Elderly
181433772,18143377,8,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"22 UNIT, TID",,,,,,,,,,,TID,2021,Q1,Drug resistance,,2021,Q1,2,F,,20210209.0,20200813,20210220,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20210220.0,,HP,US,US,2021,Q1,Elderly
181433772,18143377,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"10 UNIT, TID",,,,,,,,,,,TID,2021,Q1,Drug resistance,,2021,Q1,2,F,,20210209.0,20200813,20210220,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20210220.0,,HP,US,US,2021,Q1,Elderly
181433772,18143377,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"30 UNIT, TID",,,,,,,,,,,TID,2021,Q1,Drug resistance,,2021,Q1,2,F,,20210209.0,20200813,20210220,EXP,,US-LUPIN PHARMACEUTICALS INC.-2020-04472,LUPIN,,65.0,YR,,M,Y,,,20210220.0,,HP,US,US,2021,Q1,Elderly
181585857,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
181585857,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2021,Q1,Cardio-respiratory arrest,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
181585857,18158585,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEDTIME,,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
181585857,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEF MEALS,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
181585857,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEF MEALS,,,,,,,,,,,,2021,Q1,Cardio-respiratory arrest,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
181585857,18158585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,BEF MEALS,,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
181585857,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
181585857,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Cardio-respiratory arrest,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
181585857,18158585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,7,F,20200715.0,20210129.0,20200817,20210212,EXP,,US-ROCHE-2658622,ROCHE,,37.0,YR,,F,Y,78.0,KG,20210212.0,,MD,US,US,2021,Q1,Adult
182358399,18235839,44,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 IU,,,,,,,,1.0,IU,,,2021,Q1,Toxic epidermal necrolysis,,2021,Q1,9,F,20200809.0,20210112.0,20200905,20210122,EXP,,FR-SA-2020SA239827,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210122.0,,MD,FR,FR,2021,Q1,Elderly
182392142,18239214,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Interstitial lung disease,,2021,Q1,2,F,202004.0,20210111.0,20200907,20210113,EXP,,NVSC2020DE240576,NOVARTIS,,64.0,YR,,M,Y,,,20210113.0,,HP,DE,DE,2021,Q1,Adult
182585335,18258533,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,U,, ASKED BUT UNKNOWN,,,,,,,2021,Q1,Toxic epidermal necrolysis,,2021,Q1,5,F,20200809.0,20210223.0,20200911,20210310,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-260814,RANBAXY,,74.0,YR,,M,Y,,,20210310.0,,HP,NL,FR,2021,Q1,Elderly
182692099,18269209,47,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, UNK",,,,,,,,1.0,IU,,,2021,Q1,Toxic epidermal necrolysis,,2021,Q1,9,F,20200809.0,20210115.0,20200915,20210128,EXP,FR-ASPEN-GLO2020FR008258,FR-VALIDUS PHARMACEUTICALS LLC-FR-2020VAL000752,VALIDUS,,75.0,YR,,M,Y,,,20210128.0,,HP,FR,FR,2021,Q1,Elderly
183247172,18324717,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,, UNK,,,1.0,IU,UNKNOWN,,2021,Q1,Toxic epidermal necrolysis,,2021,Q1,2,F,20200809.0,20210224.0,20200929,20210302,EXP,,FR-FRESENIUS KABI-FK202008998,FRESENIUS KABI,,75.0,YR,,M,Y,,,20210302.0,,HP,NL,FR,2021,Q1,Elderly
183879223,18387922,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
183879223,18387922,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,3,F,2015.0,20210210.0,20201015,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202010003226,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Elderly
184547092,18454709,17,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,2,F,20201003.0,20210201.0,20201103,20210226,PER,,US-ELI_LILLY_AND_COMPANY-US202010002550,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210226.0,,CN,US,US,2021,Q1,Elderly
184547092,18454709,17,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20201003.0,20210201.0,20201103,20210226,PER,,US-ELI_LILLY_AND_COMPANY-US202010002550,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210226.0,,CN,US,US,2021,Q1,Elderly
184547092,18454709,17,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Dizziness,,2021,Q1,2,F,20201003.0,20210201.0,20201103,20210226,PER,,US-ELI_LILLY_AND_COMPANY-US202010002550,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210226.0,,CN,US,US,2021,Q1,Elderly
184547092,18454709,17,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Drug hypersensitivity,,2021,Q1,2,F,20201003.0,20210201.0,20201103,20210226,PER,,US-ELI_LILLY_AND_COMPANY-US202010002550,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210226.0,,CN,US,US,2021,Q1,Elderly
184547092,18454709,17,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Somnolence,,2021,Q1,2,F,20201003.0,20210201.0,20201103,20210226,PER,,US-ELI_LILLY_AND_COMPANY-US202010002550,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210226.0,,CN,US,US,2021,Q1,Elderly
184547092,18454709,17,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,2,F,20201003.0,20210201.0,20201103,20210226,PER,,US-ELI_LILLY_AND_COMPANY-US202010002550,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210226.0,,CN,US,US,2021,Q1,Elderly
184664598,18466459,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,QID,2021,Q1,Neurotoxicity,,2021,Q1,8,F,20201018.0,20210210.0,20201104,20210215,EXP,,US-ROCHE-2706721,ROCHE,,78.0,YR,,M,Y,100.0,KG,20210215.0,,MD,US,US,2021,Q1,Elderly
184664598,18466459,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,QID,2021,Q1,Septic shock,,2021,Q1,8,F,20201018.0,20210210.0,20201104,20210215,EXP,,US-ROCHE-2706721,ROCHE,,78.0,YR,,M,Y,100.0,KG,20210215.0,,MD,US,US,2021,Q1,Elderly
184821753,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q1,Cataract,,2021,Q1,3,F,20201019.0,20210310.0,20201110,20210312,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20210312.0,,MD,JP,JP,2021,Q1,Adult
184821753,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q1,Eczema asteatotic,,2021,Q1,3,F,20201019.0,20210310.0,20201110,20210312,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20210312.0,,MD,JP,JP,2021,Q1,Adult
184821753,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q1,Rash pruritic,,2021,Q1,3,F,20201019.0,20210310.0,20201110,20210312,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20210312.0,,MD,JP,JP,2021,Q1,Adult
184823974,18482397,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Diverticular perforation,,2021,Q1,4,F,20200814.0,20210125.0,20201109,20210201,EXP,,US-GILEAD-2020-0491789,GILEAD,,62.0,YR,A,M,Y,75.0,KG,20210201.0,,MD,US,US,2021,Q1,Adult
184823974,18482397,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q1,Diverticular perforation,,2021,Q1,4,F,20200814.0,20210125.0,20201109,20210201,EXP,,US-GILEAD-2020-0491789,GILEAD,,62.0,YR,A,M,Y,75.0,KG,20210201.0,,MD,US,US,2021,Q1,Adult
184836682,18483668,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q1,Enterobacter bacteraemia,,2021,Q1,2,F,20201023.0,20210118.0,20201109,20210122,EXP,,US-GILEAD-2020-0502183,GILEAD,,60.0,YR,A,M,Y,76.5,KG,20210122.0,,MD,US,US,2021,Q1,Adult
184836682,18483668,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,2,F,20201023.0,20210118.0,20201109,20210122,EXP,,US-GILEAD-2020-0502183,GILEAD,,60.0,YR,A,M,Y,76.5,KG,20210122.0,,MD,US,US,2021,Q1,Adult
184871002,18487100,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (AT BREAKFAST AND DINNER)",,,,, D214632C,,20563.0,,,INJECTION,,2021,Q1,Dementia,,2021,Q1,2,F,202005.0,20210105.0,20201110,20210114,EXP,,US-ELI_LILLY_AND_COMPANY-US202011000458,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
184871002,18487100,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (AT BREAKFAST AND DINNER)",,,,, D214632C,,20563.0,,,INJECTION,,2021,Q1,Illness,,2021,Q1,2,F,202005.0,20210105.0,20201110,20210114,EXP,,US-ELI_LILLY_AND_COMPANY-US202011000458,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20210114.0,,CN,US,US,2021,Q1,Elderly
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Anxiety,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Asthenia,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Cardiac arrest,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Cardiac disorder,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Cardiac operation,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Constipation,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Dizziness,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Drug dependence,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,End stage renal disease,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Fluid retention,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Immobile,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Insomnia,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Kidney transplant rejection,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Nausea,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Overdose,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Respiratory disorder,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184917662,18491766,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,U, UNK,,,,,,,2021,Q1,Vomiting,,2021,Q1,2,F,2018.0,20200624.0,20201111,20210131,EXP,,US-PURDUE-USA-2020-0173871,PURDUE,,53.0,YR,,F,Y,,,20210131.0,,CN,US,US,2021,Q1,Adult
184936633,18493663,17,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 INTERNATIONAL UNIT,,,U,U,,,,200.0,IU,,,2021,Q1,Blood cholesterol abnormal,,2021,Q1,3,F,201912.0,20210210.0,20201111,20210220,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20210220.0,,CN,CA,CA,2021,Q1,Adult
184936633,18493663,17,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 INTERNATIONAL UNIT,,,U,U,,,,200.0,IU,,,2021,Q1,Cystitis,,2021,Q1,3,F,201912.0,20210210.0,20201111,20210220,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20210220.0,,CN,CA,CA,2021,Q1,Adult
184936633,18493663,17,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 INTERNATIONAL UNIT,,,U,U,,,,200.0,IU,,,2021,Q1,Diabetes mellitus,,2021,Q1,3,F,201912.0,20210210.0,20201111,20210220,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20210220.0,,CN,CA,CA,2021,Q1,Adult
184936633,18493663,17,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,200 INTERNATIONAL UNIT,,,U,U,,,,200.0,IU,,,2021,Q1,Lung disorder,,2021,Q1,3,F,201912.0,20210210.0,20201111,20210220,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20210220.0,,CN,CA,CA,2021,Q1,Adult
185151962,18515196,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,2,F,20201102.0,20210126.0,20201118,20210203,EXP,,JP-009507513-2011JPN010507,MERCK,,71.0,YR,,M,Y,,,20210203.0,,PH,JP,JP,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,1,PS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,3,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,4,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,,,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,6,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,7,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,8,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,,,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,9,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,10,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,11,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,12,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,,,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,13,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,14,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,15,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,16,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,20?21 UNITS AT BREAKFAST,,,,, D137576E,,20563.0,21.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,17,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,18,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,19,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,20,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,6?8 UNITS AT LUNCH,,,,, D137576E,,20563.0,8.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,21,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,22,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,23,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blindness,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Hypoacusis,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Metastases to liver,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Renal disorder,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Somnolence,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185308683,18530868,24,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,10?12 UNITS AT DINNER,,,,, D137576E,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,3,F,20210111.0,20210111.0,20201121,20210122,EXP,,US-ELI_LILLY_AND_COMPANY-US202011009587,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20210122.0,,CN,US,US,2021,Q1,Elderly
185524002,18552400,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Malaise,,2021,Q1,2,F,,20201228.0,20201127,20210210,PER,,US-LUNDBECK-DKLU3022550,LUNDBECK,,56.0,YR,,F,Y,,,20210210.0,,CN,US,US,2021,Q1,Adult
185524002,18552400,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Product dose omission issue,,2021,Q1,2,F,,20201228.0,20201127,20210210,PER,,US-LUNDBECK-DKLU3022550,LUNDBECK,,56.0,YR,,F,Y,,,20210210.0,,CN,US,US,2021,Q1,Adult
185809852,18580985,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Fatigue,,2021,Q1,2,F,20200909.0,20201127.0,20201204,20210318,EXP,,SE-BAUSCH-BL-2020-035311,BAUSCH AND LOMB,,61.0,YR,,M,Y,101.0,KG,20210318.0,,MD,SE,SE,2021,Q1,Adult
185809852,18580985,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,2,F,20200909.0,20201127.0,20201204,20210318,EXP,,SE-BAUSCH-BL-2020-035311,BAUSCH AND LOMB,,61.0,YR,,M,Y,101.0,KG,20210318.0,,MD,SE,SE,2021,Q1,Adult
185858852,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2021,Q1,Blood glucose fluctuation,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2021,Q1,Dizziness,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2021,Q1,Malaise,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2021,Q1,Pancreatic disorder,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"8 INTERNATIONAL UNIT, EACH MORNING",,,Y,,,,20563.0,8.0,IU,,QD,2021,Q1,Postprandial hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2021,Q1,Blood glucose fluctuation,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2021,Q1,Dizziness,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2021,Q1,Malaise,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2021,Q1,Pancreatic disorder,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"2 INTERNATIONAL UNIT, EACH AFTERNOON",,,Y,,,,20563.0,2.0,IU,,,2021,Q1,Postprandial hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2021,Q1,Blood glucose fluctuation,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2021,Q1,Dizziness,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2021,Q1,Malaise,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2021,Q1,Pancreatic disorder,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, EACH EVENING",,,Y,,,,20563.0,4.0,IU,,QD,2021,Q1,Postprandial hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2021,Q1,Blood glucose fluctuation,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2021,Q1,Dizziness,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2021,Q1,Hyperglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2021,Q1,Malaise,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2021,Q1,Pancreatic disorder,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
185858852,18585885,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 INTERNATIONAL UNIT, UNKNOWN",,,Y,,,,20563.0,7.0,IU,,,2021,Q1,Postprandial hypoglycaemia,,2021,Q1,2,F,,20210311.0,20201207,20210323,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202011010713,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20210323.0,,CN,ES,ES,2021,Q1,Elderly
186017412,18601741,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,15 UNITS THREE TIMES A DAY BEFORE MEALS,,,U,,,,,,,,TID,2021,Q1,Acute kidney injury,,2021,Q1,2,F,,20210120.0,20201210,20210204,EXP,,US-TEVA-2020-US-1856289,TEVA,"MARINUCCI V, CHAHINE EB, BUSH LM. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J?PHARM?PRACT 2020?:NO PAGINATION.",18.0,YR,A,F,Y,80.0,KG,20210204.0,,PH,US,US,2021,Q1,Youth
186017412,18601741,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,15 UNITS THREE TIMES A DAY BEFORE MEALS,,,U,,,,,,,,TID,2021,Q1,Drug ineffective,,2021,Q1,2,F,,20210120.0,20201210,20210204,EXP,,US-TEVA-2020-US-1856289,TEVA,"MARINUCCI V, CHAHINE EB, BUSH LM. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J?PHARM?PRACT 2020?:NO PAGINATION.",18.0,YR,A,F,Y,80.0,KG,20210204.0,,PH,US,US,2021,Q1,Youth
186017412,18601741,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,15 UNITS THREE TIMES A DAY BEFORE MEALS,,,U,,,,,,,,TID,2021,Q1,Nausea,,2021,Q1,2,F,,20210120.0,20201210,20210204,EXP,,US-TEVA-2020-US-1856289,TEVA,"MARINUCCI V, CHAHINE EB, BUSH LM. INVASIVE FUNGAL RHINOSINUSITIS CAUSED BY CURVULARIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT. J?PHARM?PRACT 2020?:NO PAGINATION.",18.0,YR,A,F,Y,80.0,KG,20210204.0,,PH,US,US,2021,Q1,Youth
186639094,18663909,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Cytomegalovirus enteritis,,2021,Q1,4,F,20200504.0,20210222.0,20201225,20210305,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20210305.0,,MD,IT,IT,2021,Q1,Adult
186639094,18663909,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Parasitic gastroenteritis,,2021,Q1,4,F,20200504.0,20210222.0,20201225,20210305,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20210305.0,,MD,IT,IT,2021,Q1,Adult
186727852,18672785,7,C,INSULINE LISPRO 100E/ML INJVLST / HUMALOG INJVLST 100E/ML FLACON 10...,,2,Unknown,"INJECTIEVLOEISTOF, 100 EENHEDEN/ML (EENHEDEN PER MILLILITER) (VIA POMP ONG 40 IE PD)",,,U,,,,,,,,,2021,Q1,Cataract,,2021,Q1,2,F,20200530.0,20210112.0,20201229,20210127,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-273056,RANBAXY,,62.0,YR,,M,Y,80.0,KG,20210127.0,,HP,NL,NL,2021,Q1,Adult
186727852,18672785,7,C,INSULINE LISPRO 100E/ML INJVLST / HUMALOG INJVLST 100E/ML FLACON 10...,,2,Unknown,"INJECTIEVLOEISTOF, 100 EENHEDEN/ML (EENHEDEN PER MILLILITER) (VIA POMP ONG 40 IE PD)",,,U,,,,,,,,,2021,Q1,Retinal detachment,,2021,Q1,2,F,20200530.0,20210112.0,20201229,20210127,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-273056,RANBAXY,,62.0,YR,,M,Y,80.0,KG,20210127.0,,HP,NL,NL,2021,Q1,Adult
186727852,18672785,7,C,INSULINE LISPRO 100E/ML INJVLST / HUMALOG INJVLST 100E/ML FLACON 10...,,2,Unknown,"INJECTIEVLOEISTOF, 100 EENHEDEN/ML (EENHEDEN PER MILLILITER) (VIA POMP ONG 40 IE PD)",,,U,,,,,,,,,2021,Q1,Visual impairment,,2021,Q1,2,F,20200530.0,20210112.0,20201229,20210127,EXP,,NL-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-273056,RANBAXY,,62.0,YR,,M,Y,80.0,KG,20210127.0,,HP,NL,NL,2021,Q1,Adult
186730602,18673060,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,2,F,20201224.0,20210115.0,20201228,20210125,EXP,,US-EXELIXIS-XL18420036262,EXELIXIS,,79.0,YR,,M,Y,79.0,KG,20210125.0,,MD,US,US,2021,Q1,Elderly
186752412,18675241,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,2,F,20201224.0,20210125.0,20201229,20210127,EXP,,US-ROCHE-2741111,ROCHE,,79.0,YR,,M,Y,79.0,KG,20210127.0,,MD,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Abdominal pain upper,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Ascites,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Colitis,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Confusional state,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Diarrhoea,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Disorientation,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Eye discharge,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Hospitalisation,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Inability to afford medication,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Insurance issue,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Intentional product use issue,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Peripheral swelling,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Renal disorder,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Somnolence,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186755813,18675581,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,INJECTION,,2021,Q1,Therapy interrupted,,2021,Q1,3,F,2020.0,20210203.0,20201229,20210210,EXP,,US-BAUSCH-BL-2020-017267,BAUSCH AND LOMB,,70.0,YR,,F,Y,87.2,KG,20210210.0,,CN,US,US,2021,Q1,Elderly
186848802,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2021,Q1,Back pain,,2021,Q1,2,F,,20201222.0,20201230,20210116,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210116.0,,CN,US,US,2021,Q1,Adult
186848802,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2021,Q1,Blood pressure increased,,2021,Q1,2,F,,20201222.0,20201230,20210116,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210116.0,,CN,US,US,2021,Q1,Adult
186848802,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2021,Q1,Fluid retention,,2021,Q1,2,F,,20201222.0,20201230,20210116,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210116.0,,CN,US,US,2021,Q1,Adult
186848802,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2021,Q1,Maternal exposure during pregnancy,,2021,Q1,2,F,,20201222.0,20201230,20210116,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210116.0,,CN,US,US,2021,Q1,Adult
186848802,18684880,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID",,,,, D195320A,,,,,INJECTION,BID,2021,Q1,Seasonal allergy,,2021,Q1,2,F,,20201222.0,20201230,20210116,PER,,US-ELI_LILLY_AND_COMPANY-US202012014003,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210116.0,,CN,US,US,2021,Q1,Adult
186939191,18693919,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Chills,,2021,Q1,1,I,20201206.0,,20210102,20210102,DIR,,,FDA-CTU,,76.0,YR,,M,N,92.2,KG,20210102.0,N,PH,US,US,2021,Q1,Elderly
186939191,18693919,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Cough,,2021,Q1,1,I,20201206.0,,20210102,20210102,DIR,,,FDA-CTU,,76.0,YR,,M,N,92.2,KG,20210102.0,N,PH,US,US,2021,Q1,Elderly
186939191,18693919,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,20201206.0,,20210102,20210102,DIR,,,FDA-CTU,,76.0,YR,,M,N,92.2,KG,20210102.0,N,PH,US,US,2021,Q1,Elderly
186939191,18693919,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,20201206.0,,20210102,20210102,DIR,,,FDA-CTU,,76.0,YR,,M,N,92.2,KG,20210102.0,N,PH,US,US,2021,Q1,Elderly
186939191,18693919,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Sinus arrest,,2021,Q1,1,I,20201206.0,,20210102,20210102,DIR,,,FDA-CTU,,76.0,YR,,M,N,92.2,KG,20210102.0,N,PH,US,US,2021,Q1,Elderly
186939191,18693919,5,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,20201206.0,,20210102,20210102,DIR,,,FDA-CTU,,76.0,YR,,M,N,92.2,KG,20210102.0,N,PH,US,US,2021,Q1,Elderly
186955901,18695590,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Accidental exposure to product,,2021,Q1,1,I,20201231.0,20201231.0,20210104,20210104,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-113085,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20210104.0,,CN,US,US,2021,Q1,Elderly
186955901,18695590,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Device issue,,2021,Q1,1,I,20201231.0,20201231.0,20210104,20210104,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-113085,BRISTOL MYERS SQUIBB,,67.0,YR,,F,Y,,,20210104.0,,CN,US,US,2021,Q1,Elderly
186966731,18696673,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BEFORE MEALS,,,,,,,,5.0,IU,,TID,2021,Q1,Haemorrhagic transformation stroke,,2021,Q1,1,I,20200826.0,20200827.0,20210104,20210104,PER,,US-ROCHE-2668154,ROCHE,,97.0,YR,,M,Y,81.6,KG,20210104.0,,HP,US,US,2021,Q1,Elderly
186966731,18696673,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BEFORE MEALS,,,,,,,,5.0,IU,,TID,2021,Q1,Product complaint,,2021,Q1,1,I,20200826.0,20200827.0,20210104,20210104,PER,,US-ROCHE-2668154,ROCHE,,97.0,YR,,M,Y,81.6,KG,20210104.0,,HP,US,US,2021,Q1,Elderly
187002651,18700265,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Transaminases increased,,2021,Q1,1,I,20201206.0,,20210104,20210104,DIR,,,FDA-CTU,,53.0,YR,,M,N,102.4,KG,20210104.0,N,PH,US,US,2021,Q1,Adult
187030391,18703039,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D195320A,,,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,20160226.0,20160226.0,20210105,20210105,PER,,US-ELI_LILLY_AND_COMPANY-US201603000269,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20210105.0,,CN,US,US,2021,Q1,Adult
187030391,18703039,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D195320A,,,,,INJECTION,,2021,Q1,Scratch,,2021,Q1,1,I,20160226.0,20160226.0,20210105,20210105,PER,,US-ELI_LILLY_AND_COMPANY-US201603000269,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20210105.0,,CN,US,US,2021,Q1,Adult
187030391,18703039,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D195320A,,,,,INJECTION,,2021,Q1,Skin injury,,2021,Q1,1,I,20160226.0,20160226.0,20210105,20210105,PER,,US-ELI_LILLY_AND_COMPANY-US201603000269,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20210105.0,,CN,US,US,2021,Q1,Adult
187030391,18703039,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D195320A,,,,,INJECTION,,2021,Q1,Tremor,,2021,Q1,1,I,20160226.0,20160226.0,20210105,20210105,PER,,US-ELI_LILLY_AND_COMPANY-US201603000269,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20210105.0,,CN,US,US,2021,Q1,Adult
187040602,18704060,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Cerebrovascular accident,,2021,Q1,2,F,20201026.0,20210128.0,20210105,20210203,PER,,US-LUNDBECK-DKLU3023470,LUNDBECK,,72.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Elderly
187040602,18704060,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Fall,,2021,Q1,2,F,20201026.0,20210128.0,20210105,20210203,PER,,US-LUNDBECK-DKLU3023470,LUNDBECK,,72.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Elderly
187065441,18706544,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INSULIN LISPRO?LOW DOSE (INSULIN LISPRO)?0?6 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q1,Atrial flutter,,2021,Q1,1,I,20201215.0,20201228.0,20210106,20210106,EXP,,US-FRESENIUS KABI-FK202014093,FRESENIUS KABI,,53.0,YR,,M,Y,89.67,KG,20210106.0,,MD,US,US,2021,Q1,Adult
187065441,18706544,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,INSULIN LISPRO?LOW DOSE (INSULIN LISPRO)?0?6 UNITS,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q1,Pulmonary embolism,,2021,Q1,1,I,20201215.0,20201228.0,20210106,20210106,EXP,,US-FRESENIUS KABI-FK202014093,FRESENIUS KABI,,53.0,YR,,M,Y,89.67,KG,20210106.0,,MD,US,US,2021,Q1,Adult
187070222,18707022,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Asthenia,,2021,Q1,2,F,,20201230.0,20210106,20210113,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210113.0,,CN,CA,CA,2021,Q1,Adult
187070222,18707022,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose decreased,,2021,Q1,2,F,,20201230.0,20210106,20210113,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210113.0,,CN,CA,CA,2021,Q1,Adult
187070222,18707022,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, QD",,,U,,,,,40.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,2,F,,20201230.0,20210106,20210113,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20210113.0,,CN,CA,CA,2021,Q1,Adult
187073031,18707303,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U X 3 X 1 DAYS,,,,,,,,,,UNKNOWN,TID,2021,Q1,Encephalopathy,,2021,Q1,1,I,20200830.0,20201231.0,20210106,20210106,EXP,,US-CELGENEUS-USA-20201209414,CELGENE,,67.0,YR,,M,Y,110.0,KG,20210106.0,,MD,US,US,2021,Q1,Elderly
187084212,18708421,42,C,INSULIN LISPRO,INSULIN LISPRO,1,,2 U,,,,,,,,,,,QD,2021,Q1,Retroperitoneal haemorrhage,,2021,Q1,2,F,20201231.0,20210107.0,20210106,20210118,EXP,,US-ROCHE-2743190,ROCHE,,52.0,YR,,F,Y,110.4,KG,20210118.0,,MD,US,US,2021,Q1,Adult
187087291,18708729,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,INGESTION,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210106,20210106,EXP,,US-BAUSCH-BL-2020-039527,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",61.0,YR,,M,Y,,,20210106.0,,MD,US,US,2021,Q1,Adult
187087291,18708729,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210106,20210106,EXP,,US-BAUSCH-BL-2020-039527,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",61.0,YR,,M,Y,,,20210106.0,,MD,US,US,2021,Q1,Adult
187111451,18711145,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Interstitial lung disease,,2021,Q1,1,I,202004.0,20200820.0,20210107,20210107,EXP,,DE-ROCHE-2664249,ROCHE,,64.0,YR,,M,Y,,,20210107.0,,MD,DE,DE,2021,Q1,Adult
187134311,18713431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Dyspnoea exertional,,2021,Q1,1,I,20201226.0,20201229.0,20210107,20210107,EXP,,US-ELI_LILLY_AND_COMPANY-US202012014152,ELI LILLY AND CO,,67.0,YR,,M,Y,122.9,KG,20210107.0,,PH,US,US,2021,Q1,Elderly
187134311,18713431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Respiratory rate increased,,2021,Q1,1,I,20201226.0,20201229.0,20210107,20210107,EXP,,US-ELI_LILLY_AND_COMPANY-US202012014152,ELI LILLY AND CO,,67.0,YR,,M,Y,122.9,KG,20210107.0,,PH,US,US,2021,Q1,Elderly
187142513,18714251,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Completed suicide,,2021,Q1,3,F,,20210118.0,20210107,20210120,EXP,,US-SA-2021SA004620,SANOFI AVENTIS,"GUMMIN DD. , MOWRY JB., BEUHLER MC., SPYKER DA., BROOKS DE., DIBERT KW. ET AL. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY. 2020?58(12):1360?1541",61.0,YR,A,M,Y,,,20210120.0,,MD,US,US,2021,Q1,Adult
187142513,18714251,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,UNK,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Completed suicide,,2021,Q1,3,F,,20210118.0,20210107,20210120,EXP,,US-SA-2021SA004620,SANOFI AVENTIS,"GUMMIN DD. , MOWRY JB., BEUHLER MC., SPYKER DA., BROOKS DE., DIBERT KW. ET AL. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT.. CLINICAL TOXICOLOGY. 2020?58(12):1360?1541",61.0,YR,A,M,Y,,,20210120.0,,MD,US,US,2021,Q1,Adult
187155751,18715575,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Blood potassium abnormal,,2021,Q1,1,I,202012.0,20210104.0,20210108,20210108,PER,,US-ELI_LILLY_AND_COMPANY-US202101002192,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210108.0,,CN,US,US,2021,Q1,Adult
187155751,18715575,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Cardiac disorder,,2021,Q1,1,I,202012.0,20210104.0,20210108,20210108,PER,,US-ELI_LILLY_AND_COMPANY-US202101002192,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210108.0,,CN,US,US,2021,Q1,Adult
187155751,18715575,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Diarrhoea,,2021,Q1,1,I,202012.0,20210104.0,20210108,20210108,PER,,US-ELI_LILLY_AND_COMPANY-US202101002192,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210108.0,,CN,US,US,2021,Q1,Adult
187160162,18716016,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Extra dose administered,,2021,Q1,2,F,20201226.0,20201230.0,20210108,20210111,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000758,ELI LILLY AND CO,,62.0,YR,,M,Y,82.2,KG,20210111.0,,PH,US,US,2021,Q1,Adult
187168201,18716820,47,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2021,Q1,Burkholderia test positive,,2021,Q1,1,I,20201111.0,,20210107,20210107,DIR,,,FDA-CTU,,61.0,YR,,M,N,76.3,KG,20210106.0,N,PH,US,US,2021,Q1,Adult
187168201,18716820,47,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2021,Q1,Product contamination,,2021,Q1,1,I,20201111.0,,20210107,20210107,DIR,,,FDA-CTU,,61.0,YR,,M,N,76.3,KG,20210106.0,N,PH,US,US,2021,Q1,Adult
187168201,18716820,47,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2021,Q1,Recalled product administered,,2021,Q1,1,I,20201111.0,,20210107,20210107,DIR,,,FDA-CTU,,61.0,YR,,M,N,76.3,KG,20210106.0,N,PH,US,US,2021,Q1,Adult
187168201,18716820,47,C,INSULIN LISPRO (HUMALOG),,2,,,,,,,,,,,,,,2021,Q1,SARS-CoV-2 test positive,,2021,Q1,1,I,20201111.0,,20210107,20210107,DIR,,,FDA-CTU,,61.0,YR,,M,N,76.3,KG,20210106.0,N,PH,US,US,2021,Q1,Adult
187174311,18717431,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q1,Completed suicide,Completed suicide,2021,Q1,1,I,,20201225.0,20210108,20210108,EXP,,US-ALVOGEN-2021-ALVOGEN-115734,ALVOGEN,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, ET AL. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLIN TOXICOL (PHILA). 2020 DEC?58(12):1360?1541.",61.0,YR,,M,Y,,,20210108.0,,MD,US,US,2021,Q1,Adult
187177202,18717720,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20210105.0,20210107.0,20210108,20210113,PER,,US-SA-2021SA004265,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20210113.0,,CN,US,US,2021,Q1,Elderly
187177202,18717720,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Glycosylated haemoglobin abnormal,,2021,Q1,2,F,20210105.0,20210107.0,20210108,20210113,PER,,US-SA-2021SA004265,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20210113.0,,CN,US,US,2021,Q1,Elderly
187177202,18717720,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Off label use,,2021,Q1,2,F,20210105.0,20210107.0,20210108,20210113,PER,,US-SA-2021SA004265,SANOFI AVENTIS,,71.0,YR,E,M,Y,,,20210113.0,,CN,US,US,2021,Q1,Elderly
187177281,18717728,22,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Product contamination microbial,,2021,Q1,1,I,20201109.0,,20210107,20210107,DIR,,,FDA-CTU,,70.0,YR,,M,N,76.4,KG,20210106.0,N,PH,US,US,2021,Q1,Elderly
187177281,18717728,22,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Recalled product administered,,2021,Q1,1,I,20201109.0,,20210107,20210107,DIR,,,FDA-CTU,,70.0,YR,,M,N,76.4,KG,20210106.0,N,PH,US,US,2021,Q1,Elderly
187184492,18718449,45,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U X 3 X 1 DAYS,,,,,,,,,,UNKNOWN,TID,2021,Q1,Encephalopathy,,2021,Q1,2,F,20200924.0,20210208.0,20210108,20210212,EXP,,US-CELGENEUS-USA-20201209424,CELGENE,,67.0,YR,,M,Y,108.0,KG,20210212.0,,MD,US,US,2021,Q1,Elderly
187184492,18718449,46,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2?10 U X 3 X 1 DAYS,,,,,,,,,,UNKNOWN,TID,2021,Q1,Encephalopathy,,2021,Q1,2,F,20200924.0,20210208.0,20210108,20210212,EXP,,US-CELGENEUS-USA-20201209424,CELGENE,,67.0,YR,,M,Y,108.0,KG,20210212.0,,MD,US,US,2021,Q1,Elderly
187191511,18719151,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20201223.0,20201229.0,20210108,20210108,EXP,,US-ELI_LILLY_AND_COMPANY-US202012014077,ELI LILLY AND CO,,67.0,YR,,F,Y,86.7,KG,20210108.0,,PH,US,US,2021,Q1,Elderly
187191511,18719151,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Pulmonary congestion,,2021,Q1,1,I,20201223.0,20201229.0,20210108,20210108,EXP,,US-ELI_LILLY_AND_COMPANY-US202012014077,ELI LILLY AND CO,,67.0,YR,,F,Y,86.7,KG,20210108.0,,PH,US,US,2021,Q1,Elderly
187207452,18720745,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,2 U,,,,,,,,,,,,2021,Q1,Retroperitoneal haemorrhage,,2021,Q1,2,F,20201231.0,20210107.0,20210108,20210121,EXP,,US-GILEAD-2021-0512124,GILEAD,,52.0,YR,A,F,Y,110.4,KG,20210121.0,,MD,US,US,2021,Q1,Adult
187215661,18721566,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, UNKNOWN",,,,, D051995D,,,12.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210105.0,20210105.0,20210110,20210110,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210110.0,,CN,US,US,2021,Q1,Elderly
187215661,18721566,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, UNKNOWN",,,,, D051995D,,,12.0,IU,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,20210105.0,20210105.0,20210110,20210110,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210110.0,,CN,US,US,2021,Q1,Elderly
187230561,18723056,8,C,Insulin lispro sliding scale,,2,,,,,,,,,,,,,,2021,Q1,Dyskinesia,,2021,Q1,1,I,20210110.0,,20210110,20210110,DIR,,,FDA-CTU,,78.0,YR,,M,N,89.0,KG,20210110.0,N,PH,US,US,2021,Q1,Elderly
187230561,18723056,8,C,Insulin lispro sliding scale,,2,,,,,,,,,,,,,,2021,Q1,Muscle twitching,,2021,Q1,1,I,20210110.0,,20210110,20210110,DIR,,,FDA-CTU,,78.0,YR,,M,N,89.0,KG,20210110.0,N,PH,US,US,2021,Q1,Elderly
187237971,18723797,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",,,,, D049598F,,,10.0,IU,INJECTION,TID,2021,Q1,Visual impairment,,2021,Q1,1,I,202010.0,20201214.0,20210111,20210111,PER,,US-ELI_LILLY_AND_COMPANY-US202012007180,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210111.0,,CN,US,US,2021,Q1,Adult
187255302,18725530,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,2,F,2019.0,20210104.0,20210111,20210113,EXP,,US-APOTEX-2021AP000859,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187255302,18725530,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Respiratory (inhalation),UNK,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,2,F,2019.0,20210104.0,20210111,20210113,EXP,,US-APOTEX-2021AP000859,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187255302,18725530,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,UNK,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,2,F,2019.0,20210104.0,20210111,20210113,EXP,,US-APOTEX-2021AP000859,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187268721,18726872,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Muscle haemorrhage,,2021,Q1,1,I,20160607.0,20160621.0,20210111,20210111,EXP,,DE-TAKEDA-2016BLT004547,TAKEDA,,73.0,YR,,,Y,100.0,KG,20210111.0,,MD,DE,DE,2021,Q1,Elderly
187269291,18726929,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,INGESTION,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210111,20210111,EXP,,US-BAUSCH-BL-2020-039636,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",46.0,YR,,F,Y,,,20210111.0,,MD,US,US,2021,Q1,Adult
187269291,18726929,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Other,ASPIRATION (WITH INGESTION),,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210111,20210111,EXP,,US-BAUSCH-BL-2020-039636,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",46.0,YR,,F,Y,,,20210111.0,,MD,US,US,2021,Q1,Adult
187269291,18726929,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20201229.0,20210111,20210111,EXP,,US-BAUSCH-BL-2020-039636,BAUSCH AND LOMB,"GUMMIN D, MOWRY J, BEUHLER M, SPYKER D, BROOKS D, DIBERT K, RIVERS L, PHAM N, RYAN M. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020 DEC 11?58(12):1360?1541. DOI:10.1080/15563650.2020.1834219",46.0,YR,,F,Y,,,20210111.0,,MD,US,US,2021,Q1,Adult
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Asthenia,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Chest pain,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Chills,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Cough,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Decreased appetite,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Dysuria,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Palpitations,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Pyrexia,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187289541,18728954,8,C,Insulin (lispro and regular),,2,,,,,,,,,,,,,,2021,Q1,Respiratory failure,,2021,Q1,1,I,20210104.0,,20210111,20210111,DIR,,,FDA-CTU,,76.0,YR,,M,N,102.1,KG,20210111.0,Y,PH,US,US,2021,Q1,Elderly
187305961,18730596,9,C,Insulin (lispro),INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,20210108.0,,20210112,20210112,DIR,,,FDA-CTU,,69.0,YR,,F,N,58.5,KG,20210112.0,Y,PH,US,US,2021,Q1,Elderly
187305961,18730596,9,C,Insulin (lispro),INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Infection,,2021,Q1,1,I,20210108.0,,20210112,20210112,DIR,,,FDA-CTU,,69.0,YR,,F,N,58.5,KG,20210112.0,Y,PH,US,US,2021,Q1,Elderly
187305961,18730596,9,C,Insulin (lispro),INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pseudomonal bacteraemia,,2021,Q1,1,I,20210108.0,,20210112,20210112,DIR,,,FDA-CTU,,69.0,YR,,F,N,58.5,KG,20210112.0,Y,PH,US,US,2021,Q1,Elderly
187305961,18730596,9,C,Insulin (lispro),INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pseudomonas infection,,2021,Q1,1,I,20210108.0,,20210112,20210112,DIR,,,FDA-CTU,,69.0,YR,,F,N,58.5,KG,20210112.0,Y,PH,US,US,2021,Q1,Elderly
187308091,18730809,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5?10U, BEFORE EACH MEAL",,,,,,,20563.0,5.0,IU,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20180201.0,20201231.0,20210112,20210112,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000590,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210112.0,,CN,US,US,2021,Q1,Adult
187308091,18730809,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5?10U, BEFORE EACH MEAL",,,,,,,20563.0,5.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20180201.0,20201231.0,20210112,20210112,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000590,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210112.0,,CN,US,US,2021,Q1,Adult
187308091,18730809,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5?10U, BEFORE EACH MEAL",,,,,,,20563.0,5.0,IU,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,20180201.0,20201231.0,20210112,20210112,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000590,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210112.0,,CN,US,US,2021,Q1,Adult
187308091,18730809,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5?10U, BEFORE EACH MEAL",,,,,,,20563.0,5.0,IU,INJECTION,,2021,Q1,Ischaemic stroke,,2021,Q1,1,I,20180201.0,20201231.0,20210112,20210112,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000590,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210112.0,,CN,US,US,2021,Q1,Adult
187308091,18730809,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5?10U, BEFORE EACH MEAL",,,,, D243920A,,20563.0,5.0,IU,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20180201.0,20201231.0,20210112,20210112,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000590,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210112.0,,CN,US,US,2021,Q1,Adult
187308091,18730809,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5?10U, BEFORE EACH MEAL",,,,, D243920A,,20563.0,5.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20180201.0,20201231.0,20210112,20210112,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000590,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210112.0,,CN,US,US,2021,Q1,Adult
187308091,18730809,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5?10U, BEFORE EACH MEAL",,,,, D243920A,,20563.0,5.0,IU,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,20180201.0,20201231.0,20210112,20210112,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000590,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210112.0,,CN,US,US,2021,Q1,Adult
187308091,18730809,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"5?10U, BEFORE EACH MEAL",,,,, D243920A,,20563.0,5.0,IU,INJECTION,,2021,Q1,Ischaemic stroke,,2021,Q1,1,I,20180201.0,20201231.0,20210112,20210112,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000590,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210112.0,,CN,US,US,2021,Q1,Adult
187355151,18735515,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20201203.0,20210107.0,20210113,20210113,EXP,,SE-ASTRAZENECA-2021A002487,ASTRAZENECA,,31.0,YR,,F,Y,,,20210113.0,,MD,SE,SE,2021,Q1,Young Adult
187360551,18736055,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Atelectasis,,2021,Q1,1,I,20210110.0,,20210113,20210113,DIR,,,FDA-CTU,,60.0,YR,,F,N,58.95,KG,20210113.0,Y,CN,US,US,2021,Q1,Adult
187360551,18736055,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Chest discomfort,,2021,Q1,1,I,20210110.0,,20210113,20210113,DIR,,,FDA-CTU,,60.0,YR,,F,N,58.95,KG,20210113.0,Y,CN,US,US,2021,Q1,Adult
187360551,18736055,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Lung transplant,,2021,Q1,1,I,20210110.0,,20210113,20210113,DIR,,,FDA-CTU,,60.0,YR,,F,N,58.95,KG,20210113.0,Y,CN,US,US,2021,Q1,Adult
187360551,18736055,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Peripheral swelling,,2021,Q1,1,I,20210110.0,,20210113,20210113,DIR,,,FDA-CTU,,60.0,YR,,F,N,58.95,KG,20210113.0,Y,CN,US,US,2021,Q1,Adult
187360551,18736055,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pulmonary fibrosis,,2021,Q1,1,I,20210110.0,,20210113,20210113,DIR,,,FDA-CTU,,60.0,YR,,F,N,58.95,KG,20210113.0,Y,CN,US,US,2021,Q1,Adult
187360961,18736096,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210104.0,20210113,20210113,EXP,,US-APOTEX-2021AP000770,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",61.0,YR,,M,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187360961,18736096,17,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210104.0,20210113,20210113,EXP,,US-APOTEX-2021AP000770,APOTEX,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW, RIVERS LJ, PHAM NPT, RYAN ML. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",61.0,YR,,M,Y,,,20210113.0,,MD,US,US,2021,Q1,Adult
187394731,18739473,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,US-MYLANLABS-2021M1001540,MYLAN,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,,M,Y,,,20210114.0,,HP,US,US,2021,Q1,Elderly
187394731,18739473,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,US-MYLANLABS-2021M1001540,MYLAN,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,,M,Y,,,20210114.0,,HP,US,US,2021,Q1,Elderly
187394731,18739473,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,,20210104.0,20210114,20210114,EXP,,US-MYLANLABS-2021M1001540,MYLAN,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,,M,Y,,,20210114.0,,HP,US,US,2021,Q1,Elderly
187406471,18740647,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"UNK, INGESTION",,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210108.0,20210114,20210114,EXP,,US-PFIZER INC-2021016417,PFIZER,"GUMMIN, D.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210114.0,,MD,US,US,2021,Q1,Adult
187406471,18740647,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Respiratory (inhalation),"UNK, ASPIRATION",,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210108.0,20210114,20210114,EXP,,US-PFIZER INC-2021016417,PFIZER,"GUMMIN, D.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210114.0,,MD,US,US,2021,Q1,Adult
187406471,18740647,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,UNK,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210108.0,20210114,20210114,EXP,,US-PFIZER INC-2021016417,PFIZER,"GUMMIN, D.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",46.0,YR,,F,Y,,,20210114.0,,MD,US,US,2021,Q1,Adult
187408911,18740891,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,UNK (INGST),,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210108.0,20210114,20210114,EXP,,US-PFIZER INC-2021019776,PFIZER,"GUMMIN, D.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58 (12):1360?1541",61.0,YR,,M,Y,,,20210114.0,,MD,US,US,2021,Q1,Adult
187410631,18741063,17,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25?12?18/DAY, IU",,,,,,,,,,,,2021,Q1,Cardiac disorder,,2021,Q1,1,I,20140513.0,20140917.0,20210114,20210114,EXP,,DE-TAKEDA-2014BAX056499,TAKEDA,,71.0,YR,,,Y,100.0,KG,20210114.0,,MD,DE,DE,2021,Q1,Elderly
187410631,18741063,17,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25?12?18/DAY, IU",,,,,,,,,,,,2021,Q1,Embolic stroke,,2021,Q1,1,I,20140513.0,20140917.0,20210114,20210114,EXP,,DE-TAKEDA-2014BAX056499,TAKEDA,,71.0,YR,,,Y,100.0,KG,20210114.0,,MD,DE,DE,2021,Q1,Elderly
187512681,18751268,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Decreased appetite,,2021,Q1,1,I,,20210111.0,20210118,20210118,PER,,US-ELI_LILLY_AND_COMPANY-US202101007005,ELI LILLY AND CO,,74.0,YR,,F,Y,68.03,KG,20210118.0,,CN,US,US,2021,Q1,Elderly
187529161,18752916,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210105.0,20210118,20210118,EXP,,US-ENDO PHARMACEUTICALS INC-2021-000445,ENDO,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW., ET AL.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58(12):1360?1541",46.0,YR,,F,Y,,,20210118.0,,MD,US,US,2021,Q1,Adult
187555252,18755525,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 IU/ML AS DIRECTED WITH INSULIN PUMP,,,,,,,,,,,,2021,Q1,Drug hypersensitivity,,2021,Q1,2,F,20201219.0,20210202.0,20210119,20210205,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2020-12691,VIFOR,,29.0,YR,,F,Y,78.3,KG,20210205.0,,HP,US,US,2021,Q1,Young Adult
187555252,18755525,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 IU/ML AS DIRECTED WITH INSULIN PUMP,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,2,F,20201219.0,20210202.0,20210119,20210205,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2020-12691,VIFOR,,29.0,YR,,F,Y,78.3,KG,20210205.0,,HP,US,US,2021,Q1,Young Adult
187555252,18755525,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 IU/ML AS DIRECTED WITH INSULIN PUMP,,,,,,,,,,,,2021,Q1,Pruritus,,2021,Q1,2,F,20201219.0,20210202.0,20210119,20210205,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2020-12691,VIFOR,,29.0,YR,,F,Y,78.3,KG,20210205.0,,HP,US,US,2021,Q1,Young Adult
187555252,18755525,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 IU/ML AS DIRECTED WITH INSULIN PUMP,,,,,,,,,,,,2021,Q1,Urticaria,,2021,Q1,2,F,20201219.0,20210202.0,20210119,20210205,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2020-12691,VIFOR,,29.0,YR,,F,Y,78.3,KG,20210205.0,,HP,US,US,2021,Q1,Young Adult
187555252,18755525,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 IU/ML AS DIRECTED WITH INSULIN PUMP,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,2,F,20201219.0,20210202.0,20210119,20210205,PER,,US-VIFOR (INTERNATIONAL) INC.-VIT-2020-12691,VIFOR,,29.0,YR,,F,Y,78.3,KG,20210205.0,,HP,US,US,2021,Q1,Young Adult
187563341,18756334,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNKNOWN, UNKNOWN",,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,2019.0,20210105.0,20210119,20210119,EXP,,US-ENDO PHARMACEUTICALS INC-2021-000287,ENDO,"GUMMIN DD, MOWRY JB, BEUHLER MC, SPYKER DA, BROOKS DE, DIBERT KW., ET AL.. 2019 ANNUAL REPORT OF THE AMERICAN ASSOCIATION OF POISON CONTROL CENTERS^ NATIONAL POISON DATA SYSTEM (NPDS): 37TH ANNUAL REPORT. CLINICAL TOXICOLOGY. 2020?58(12):1360?1541",61.0,YR,,M,Y,,,20210119.0,,MD,US,US,2021,Q1,Adult
187587981,18758798,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, D185008D,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202011.0,20210107.0,20210119,20210119,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003692,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210119.0,,HP,US,US,2021,Q1,Adult
187587981,18758798,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, D185008D,,,,,INJECTION,,2021,Q1,Fall,,2021,Q1,1,I,202011.0,20210107.0,20210119,20210119,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003692,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210119.0,,HP,US,US,2021,Q1,Adult
187587981,18758798,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, D185008D,,,,,INJECTION,,2021,Q1,Fluid retention,,2021,Q1,1,I,202011.0,20210107.0,20210119,20210119,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003692,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210119.0,,HP,US,US,2021,Q1,Adult
187587981,18758798,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, D185008D,,,,,INJECTION,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,202011.0,20210107.0,20210119,20210119,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003692,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20210119.0,,HP,US,US,2021,Q1,Adult
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Drug intolerance,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Grip strength decreased,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Headache,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hepatic cirrhosis,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hepatotoxicity,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Movement disorder,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187611771,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Psoriatic arthropathy,,2021,Q1,1,I,,20210118.0,20210120,20210120,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210120.0,,CN,CA,CA,2021,Q1,Elderly
187615391,18761539,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202003.0,20210113.0,20210120,20210120,EXP,,IT-ASTELLAS-2021US002071,ASTELLAS,,73.0,YR,,M,Y,,,20210120.0,,CN,GB,IT,2021,Q1,Elderly
187634211,18763421,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,U,, D214632C,,20563.0,15.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,U,, D214632C,,20563.0,15.0,IU,INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,U,, D214632C,,20563.0,15.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,U,, D214632C,,20563.0,15.0,IU,INJECTION,QD,2021,Q1,Laryngeal cancer,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"15 U, EACH MORNING",,,U,, D214632C,,20563.0,15.0,IU,INJECTION,QD,2021,Q1,Radiation alopecia,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"13 U, DAILY, AFTERNOON",,,U,, D214632C,,20563.0,13.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"13 U, DAILY, AFTERNOON",,,U,, D214632C,,20563.0,13.0,IU,INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"13 U, DAILY, AFTERNOON",,,U,, D214632C,,20563.0,13.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"13 U, DAILY, AFTERNOON",,,U,, D214632C,,20563.0,13.0,IU,INJECTION,QD,2021,Q1,Laryngeal cancer,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"13 U, DAILY, AFTERNOON",,,U,, D214632C,,20563.0,13.0,IU,INJECTION,QD,2021,Q1,Radiation alopecia,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, EACH EVENING",,,U,, D214632C,,20563.0,25.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, EACH EVENING",,,U,, D214632C,,20563.0,25.0,IU,INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, EACH EVENING",,,U,, D214632C,,20563.0,25.0,IU,INJECTION,QD,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, EACH EVENING",,,U,, D214632C,,20563.0,25.0,IU,INJECTION,QD,2021,Q1,Laryngeal cancer,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187634211,18763421,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, EACH EVENING",,,U,, D214632C,,20563.0,25.0,IU,INJECTION,QD,2021,Q1,Radiation alopecia,,2021,Q1,1,I,20200108.0,20210108.0,20210120,20210120,EXP,,US-ELI_LILLY_AND_COMPANY-US202101003640,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210120.0,,CN,US,US,2021,Q1,Elderly
187653441,18765344,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNKNOWN, UNKNOWN",,,D,, UNKNOWN,,,,,,,2021,Q1,Exposure to toxic agent,,2021,Q1,1,I,,20210111.0,20210120,20210120,EXP,,US-PERRIGO-21US000481,PERRIGO,,61.0,YR,,M,Y,,,20210120.0,,PH,US,US,2021,Q1,Adult
187662271,18766227,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORM TOTAL,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Drug abuse,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,,IT-AUROBINDO-AUR-APL-2021-002302,AUROBINDO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187662271,18766227,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORM TOTAL,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,,IT-AUROBINDO-AUR-APL-2021-002302,AUROBINDO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187662271,18766227,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORM TOTAL,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Intentional self-injury,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,,IT-AUROBINDO-AUR-APL-2021-002302,AUROBINDO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187662271,18766227,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORM TOTAL,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,,IT-AUROBINDO-AUR-APL-2021-002302,AUROBINDO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187662271,18766227,2,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORM TOTAL,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Sopor,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,,IT-AUROBINDO-AUR-APL-2021-002302,AUROBINDO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187706131,18770613,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, ONCE/SINGLE (TOTAL)",1.0,DF,Y,, UNK,,,1.0,DF,,,2021,Q1,Drug abuse,,2021,Q1,1,I,20201201.0,20210118.0,20210121,20210121,EXP,IT-MINISAL02-653123,NVSC2021IT010023,NOVARTIS,,32.0,YR,,F,Y,,,20210121.0,,HP,IT,IT,2021,Q1,Young Adult
187706131,18770613,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, ONCE/SINGLE (TOTAL)",1.0,DF,Y,, UNK,,,1.0,DF,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20201201.0,20210118.0,20210121,20210121,EXP,IT-MINISAL02-653123,NVSC2021IT010023,NOVARTIS,,32.0,YR,,F,Y,,,20210121.0,,HP,IT,IT,2021,Q1,Young Adult
187706131,18770613,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, ONCE/SINGLE (TOTAL)",1.0,DF,Y,, UNK,,,1.0,DF,,,2021,Q1,Intentional self-injury,,2021,Q1,1,I,20201201.0,20210118.0,20210121,20210121,EXP,IT-MINISAL02-653123,NVSC2021IT010023,NOVARTIS,,32.0,YR,,F,Y,,,20210121.0,,HP,IT,IT,2021,Q1,Young Adult
187706131,18770613,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, ONCE/SINGLE (TOTAL)",1.0,DF,Y,, UNK,,,1.0,DF,,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20201201.0,20210118.0,20210121,20210121,EXP,IT-MINISAL02-653123,NVSC2021IT010023,NOVARTIS,,32.0,YR,,F,Y,,,20210121.0,,HP,IT,IT,2021,Q1,Young Adult
187706131,18770613,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DF, ONCE/SINGLE (TOTAL)",1.0,DF,Y,, UNK,,,1.0,DF,,,2021,Q1,Sopor,,2021,Q1,1,I,20201201.0,20210118.0,20210121,20210121,EXP,IT-MINISAL02-653123,NVSC2021IT010023,NOVARTIS,,32.0,YR,,F,Y,,,20210121.0,,HP,IT,IT,2021,Q1,Young Adult
187708981,18770898,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, OTHER (TOTAL)",1.0,DF,Y,,,,20563.0,1.0,DF,,,2021,Q1,Drug abuse,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,IT-MINISAL02-653123,IT-ELI_LILLY_AND_COMPANY-IT202101006403,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187708981,18770898,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, OTHER (TOTAL)",1.0,DF,Y,,,,20563.0,1.0,DF,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,IT-MINISAL02-653123,IT-ELI_LILLY_AND_COMPANY-IT202101006403,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187708981,18770898,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, OTHER (TOTAL)",1.0,DF,Y,,,,20563.0,1.0,DF,,,2021,Q1,Intentional self-injury,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,IT-MINISAL02-653123,IT-ELI_LILLY_AND_COMPANY-IT202101006403,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187708981,18770898,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, OTHER (TOTAL)",1.0,DF,Y,,,,20563.0,1.0,DF,,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,IT-MINISAL02-653123,IT-ELI_LILLY_AND_COMPANY-IT202101006403,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187708981,18770898,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, OTHER (TOTAL)",1.0,DF,Y,,,,20563.0,1.0,DF,,,2021,Q1,Sopor,,2021,Q1,1,I,20201201.0,20210115.0,20210121,20210121,EXP,IT-MINISAL02-653123,IT-ELI_LILLY_AND_COMPANY-IT202101006403,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210121.0,,MD,IT,IT,2021,Q1,Young Adult
187719741,18771974,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,COVID-19,,2021,Q1,1,I,20210104.0,20210111.0,20210121,20210121,EXP,,US-ELI_LILLY_AND_COMPANY-US202101004371,ELI LILLY AND CO,,76.0,YR,,M,Y,102.1,KG,20210121.0,,PH,US,US,2021,Q1,Elderly
187719741,18771974,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,1,I,20210104.0,20210111.0,20210121,20210121,EXP,,US-ELI_LILLY_AND_COMPANY-US202101004371,ELI LILLY AND CO,,76.0,YR,,M,Y,102.1,KG,20210121.0,,PH,US,US,2021,Q1,Elderly
187719741,18771974,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Respiratory failure,,2021,Q1,1,I,20210104.0,20210111.0,20210121,20210121,EXP,,US-ELI_LILLY_AND_COMPANY-US202101004371,ELI LILLY AND CO,,76.0,YR,,M,Y,102.1,KG,20210121.0,,PH,US,US,2021,Q1,Elderly
187759332,18775933,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,2,F,20210108.0,20210204.0,20210122,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005919,ELI LILLY AND CO,,69.0,YR,,F,Y,58.5,KG,20210216.0,,PH,US,US,2021,Q1,Elderly
187759332,18775933,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Hypernatraemia,,2021,Q1,2,F,20210108.0,20210204.0,20210122,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005919,ELI LILLY AND CO,,69.0,YR,,F,Y,58.5,KG,20210216.0,,PH,US,US,2021,Q1,Elderly
187759332,18775933,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,2,F,20210108.0,20210204.0,20210122,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005919,ELI LILLY AND CO,,69.0,YR,,F,Y,58.5,KG,20210216.0,,PH,US,US,2021,Q1,Elderly
187759332,18775933,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Pancreatitis acute,,2021,Q1,2,F,20210108.0,20210204.0,20210122,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005919,ELI LILLY AND CO,,69.0,YR,,F,Y,58.5,KG,20210216.0,,PH,US,US,2021,Q1,Elderly
187759332,18775933,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Toxic encephalopathy,,2021,Q1,2,F,20210108.0,20210204.0,20210122,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005919,ELI LILLY AND CO,,69.0,YR,,F,Y,58.5,KG,20210216.0,,PH,US,US,2021,Q1,Elderly
187784751,18778475,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210111.0,20210123,20210123,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210123.0,,HP,US,US,2021,Q1,Elderly
187784751,18778475,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,,20210111.0,20210123,20210123,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210123.0,,HP,US,US,2021,Q1,Elderly
187784751,18778475,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,,20210111.0,20210123,20210123,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210123.0,,HP,US,US,2021,Q1,Elderly
187792441,18779244,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, UNKNOWN",,,,, D185008D,,20563.0,6.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210108.0,20210111.0,20210125,20210125,PER,,US-ELI_LILLY_AND_COMPANY-US202101005296,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20210125.0,,CN,US,US,2021,Q1,Adult
187792441,18779244,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, UNKNOWN",,,,, D185008D,,20563.0,6.0,IU,INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,20210108.0,20210111.0,20210125,20210125,PER,,US-ELI_LILLY_AND_COMPANY-US202101005296,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20210125.0,,CN,US,US,2021,Q1,Adult
187792441,18779244,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, UNKNOWN",,,,, D185008D,,20563.0,6.0,IU,INJECTION,,2021,Q1,Myalgia,,2021,Q1,1,I,20210108.0,20210111.0,20210125,20210125,PER,,US-ELI_LILLY_AND_COMPANY-US202101005296,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20210125.0,,CN,US,US,2021,Q1,Adult
187792441,18779244,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, UNKNOWN",,,,, D185008D,,20563.0,6.0,IU,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,20210108.0,20210111.0,20210125,20210125,PER,,US-ELI_LILLY_AND_COMPANY-US202101005296,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20210125.0,,CN,US,US,2021,Q1,Adult
187822271,18782227,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION)",,,,,,,,,,,,2021,Q1,Cardiac failure,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,DE-MYLANLABS-2021M1003522,MYLAN,,67.0,YR,,M,Y,114.0,KG,20210125.0,,MD,DE,DE,2021,Q1,Elderly
187822271,18782227,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION)",,,,,,,,,,,,2021,Q1,Cough,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,DE-MYLANLABS-2021M1003522,MYLAN,,67.0,YR,,M,Y,114.0,KG,20210125.0,,MD,DE,DE,2021,Q1,Elderly
187822271,18782227,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION)",,,,,,,,,,,,2021,Q1,Dyspnoea exertional,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,DE-MYLANLABS-2021M1003522,MYLAN,,67.0,YR,,M,Y,114.0,KG,20210125.0,,MD,DE,DE,2021,Q1,Elderly
187822271,18782227,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (ACCORDING TO SCHEME, INJECTION/INFUSION SOLUTION)",,,,,,,,,,,,2021,Q1,Peripheral swelling,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,DE-MYLANLABS-2021M1003522,MYLAN,,67.0,YR,,M,Y,114.0,KG,20210125.0,,MD,DE,DE,2021,Q1,Elderly
187822341,18782234,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH BZ,,,,,,,,,,INJECTION,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,DE-MYLANLABS-2021M1003534,MYLAN,,59.0,YR,,M,Y,,,20210125.0,,MD,DE,DE,2021,Q1,Adult
187822341,18782234,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH BZ,,,,,,,,,,INJECTION,,2021,Q1,Dehydration,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,DE-MYLANLABS-2021M1003534,MYLAN,,59.0,YR,,M,Y,,,20210125.0,,MD,DE,DE,2021,Q1,Adult
187822341,18782234,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH BZ,,,,,,,,,,INJECTION,,2021,Q1,Hypotension,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,DE-MYLANLABS-2021M1003534,MYLAN,,59.0,YR,,M,Y,,,20210125.0,,MD,DE,DE,2021,Q1,Adult
187822341,18782234,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,NACH BZ,,,,,,,,,,INJECTION,,2021,Q1,Renal impairment,,2021,Q1,1,I,,20210118.0,20210125,20210125,EXP,,DE-MYLANLABS-2021M1003534,MYLAN,,59.0,YR,,M,Y,,,20210125.0,,MD,DE,DE,2021,Q1,Adult
187834292,18783429,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Anaphylactic shock,,2021,Q1,2,F,20201104.0,20210126.0,20210125,20210204,EXP,,DE-NOVOPROD-781171,NOVO NORDISK,,51.0,YR,,M,Y,108.2,KG,20210204.0,,MD,DE,DE,2021,Q1,Adult
187855332,18785533,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 IU, QD",,,,,,,209196.0,3.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Rash,,2021,Q1,2,F,20201221.0,20210315.0,20210125,20210319,EXP,FR-AFSSAPS-AM20201451,FR-SA-2021SA015271,SANOFI AVENTIS,,54.0,YR,A,M,Y,82.0,KG,20210319.0,,MD,FR,FR,2021,Q1,Adult
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Blood folate decreased,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Defaecation disorder,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Dementia,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Device delivery system issue,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Haemorrhoids,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Injection site pain,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Loss of consciousness,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Mental impairment,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Polyp,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Product use issue,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Vitamin B12 decreased,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859443,18785944,5,C,LISPRO,INSULIN LISPRO,1,Subcutaneous,THREE TIMES A DAY,,,,,,,,,,,,2021,Q1,Vitamin D decreased,,2021,Q1,3,F,20210112.0,20210223.0,20210125,20210303,EXP,,US-ASTRAZENECA-2021A007657,ASTRAZENECA,,27871.0,DY,,F,Y,73.5,KG,20210303.0,,CN,US,US,2021,Q1,Elderly
187859651,18785965,15,C,Insulin Lispro SQ w/meals + HS sliding scale,,2,,,,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,20210125.0,,20210125,20210125,DIR,,,FDA-CTU,,85.0,YR,,F,N,40.8,KG,20210125.0,Y,PH,US,US,2021,Q1,Elderly
187859651,18785965,15,C,Insulin Lispro SQ w/meals + HS sliding scale,,2,,,,,,,,,,,,,,2021,Q1,Cardiac arrest,,2021,Q1,1,I,20210125.0,,20210125,20210125,DIR,,,FDA-CTU,,85.0,YR,,F,N,40.8,KG,20210125.0,Y,PH,US,US,2021,Q1,Elderly
187859651,18785965,15,C,Insulin Lispro SQ w/meals + HS sliding scale,,2,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210125.0,,20210125,20210125,DIR,,,FDA-CTU,,85.0,YR,,F,N,40.8,KG,20210125.0,Y,PH,US,US,2021,Q1,Elderly
187859651,18785965,15,C,Insulin Lispro SQ w/meals + HS sliding scale,,2,,,,,,,,,,,,,,2021,Q1,Unresponsive to stimuli,,2021,Q1,1,I,20210125.0,,20210125,20210125,DIR,,,FDA-CTU,,85.0,YR,,F,N,40.8,KG,20210125.0,Y,PH,US,US,2021,Q1,Elderly
187895711,18789571,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN DOSE,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,20201224.0,20210119.0,20210126,20210126,EXP,,CN-EMD SERONO-9214203,EMD SERONO INC,,20.0,YR,A,F,Y,73.0,KG,20210126.0,,HP,CN,CN,2021,Q1,Youth
187895711,18789571,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN DOSE,,,,,,,,,,,,2021,Q1,Urine ketone body present,,2021,Q1,1,I,20201224.0,20210119.0,20210126,20210126,EXP,,CN-EMD SERONO-9214203,EMD SERONO INC,,20.0,YR,A,F,Y,73.0,KG,20210126.0,,HP,CN,CN,2021,Q1,Youth
187895711,18789571,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN DOSE,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,20201224.0,20210119.0,20210126,20210126,EXP,,CN-EMD SERONO-9214203,EMD SERONO INC,,20.0,YR,A,F,Y,73.0,KG,20210126.0,,HP,CN,CN,2021,Q1,Youth
187895711,18789571,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE INCREASED TO UNKNOWN DOSE,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,20201224.0,20210119.0,20210126,20210126,EXP,,CN-EMD SERONO-9214203,EMD SERONO INC,,20.0,YR,A,F,Y,73.0,KG,20210126.0,,HP,CN,CN,2021,Q1,Youth
187895711,18789571,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE INCREASED TO UNKNOWN DOSE,,,,,,,,,,,,2021,Q1,Urine ketone body present,,2021,Q1,1,I,20201224.0,20210119.0,20210126,20210126,EXP,,CN-EMD SERONO-9214203,EMD SERONO INC,,20.0,YR,A,F,Y,73.0,KG,20210126.0,,HP,CN,CN,2021,Q1,Youth
187895711,18789571,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE INCREASED TO UNKNOWN DOSE,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,20201224.0,20210119.0,20210126,20210126,EXP,,CN-EMD SERONO-9214203,EMD SERONO INC,,20.0,YR,A,F,Y,73.0,KG,20210126.0,,HP,CN,CN,2021,Q1,Youth
187908871,18790887,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"12 U, OTHER (WITH EACH MEAL)",,,U,, D214632C,,20563.0,12.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoacusis,,2021,Q1,1,I,2011.0,20210120.0,20210126,20210126,PER,,US-ELI_LILLY_AND_COMPANY-US202101009833,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20210126.0,,CN,US,US,2021,Q1,Elderly
187908871,18790887,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"12 U, OTHER (WITH EACH MEAL)",,,U,, D214632C,,20563.0,12.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Underdose,,2021,Q1,1,I,2011.0,20210120.0,20210126,20210126,PER,,US-ELI_LILLY_AND_COMPANY-US202101009833,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20210126.0,,CN,US,US,2021,Q1,Elderly
187908871,18790887,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D214632C,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Hypoacusis,,2021,Q1,1,I,2011.0,20210120.0,20210126,20210126,PER,,US-ELI_LILLY_AND_COMPANY-US202101009833,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20210126.0,,CN,US,US,2021,Q1,Elderly
187908871,18790887,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D214632C,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Underdose,,2021,Q1,1,I,2011.0,20210120.0,20210126,20210126,PER,,US-ELI_LILLY_AND_COMPANY-US202101009833,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20210126.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,Ankle fracture,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,COVID-19,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,Chronic obstructive pulmonary disease,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,Dementia,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,Depression,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,Oxygen saturation increased,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951011,18795101,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D243920A,,,,,INJECTION,,2021,Q1,Urinary tract infection,,2021,Q1,1,I,20210115.0,20210115.0,20210127,20210127,EXP,,US-ELI_LILLY_AND_COMPANY-US202101007582,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210127.0,,CN,US,US,2021,Q1,Elderly
187951731,18795173,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DF,1.0,DF,Y,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Drug abuse,,2021,Q1,1,I,20201201.0,20210120.0,20210127,20210127,EXP,IT-MINISAL02-653123,IT-SA-2021SA024765,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20210127.0,,MD,IT,IT,2021,Q1,Young Adult
187951731,18795173,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DF,1.0,DF,Y,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20201201.0,20210120.0,20210127,20210127,EXP,IT-MINISAL02-653123,IT-SA-2021SA024765,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20210127.0,,MD,IT,IT,2021,Q1,Young Adult
187951731,18795173,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DF,1.0,DF,Y,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Intentional self-injury,,2021,Q1,1,I,20201201.0,20210120.0,20210127,20210127,EXP,IT-MINISAL02-653123,IT-SA-2021SA024765,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20210127.0,,MD,IT,IT,2021,Q1,Young Adult
187951731,18795173,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DF,1.0,DF,Y,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20201201.0,20210120.0,20210127,20210127,EXP,IT-MINISAL02-653123,IT-SA-2021SA024765,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20210127.0,,MD,IT,IT,2021,Q1,Young Adult
187951731,18795173,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DF,1.0,DF,Y,,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,,2021,Q1,Sopor,,2021,Q1,1,I,20201201.0,20210120.0,20210127,20210127,EXP,IT-MINISAL02-653123,IT-SA-2021SA024765,SANOFI AVENTIS,,32.0,YR,A,F,Y,,,20210127.0,,MD,IT,IT,2021,Q1,Young Adult
187979381,18797938,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORMS,1.0,DF,Y,, UNKNOWN,,,1.0,DF,,,2021,Q1,Drug abuse,,2021,Q1,1,I,20201201.0,20210120.0,20210128,20210128,EXP,IT-MINISAL02-653123,IT-TEVA-2021-IT-1873145,TEVA,,32.0,YR,A,F,Y,,,20210128.0,,MD,IT,IT,2021,Q1,Young Adult
187979381,18797938,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORMS,1.0,DF,Y,, UNKNOWN,,,1.0,DF,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20201201.0,20210120.0,20210128,20210128,EXP,IT-MINISAL02-653123,IT-TEVA-2021-IT-1873145,TEVA,,32.0,YR,A,F,Y,,,20210128.0,,MD,IT,IT,2021,Q1,Young Adult
187979381,18797938,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORMS,1.0,DF,Y,, UNKNOWN,,,1.0,DF,,,2021,Q1,Intentional self-injury,,2021,Q1,1,I,20201201.0,20210120.0,20210128,20210128,EXP,IT-MINISAL02-653123,IT-TEVA-2021-IT-1873145,TEVA,,32.0,YR,A,F,Y,,,20210128.0,,MD,IT,IT,2021,Q1,Young Adult
187979381,18797938,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORMS,1.0,DF,Y,, UNKNOWN,,,1.0,DF,,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20201201.0,20210120.0,20210128,20210128,EXP,IT-MINISAL02-653123,IT-TEVA-2021-IT-1873145,TEVA,,32.0,YR,A,F,Y,,,20210128.0,,MD,IT,IT,2021,Q1,Young Adult
187979381,18797938,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORMS,1.0,DF,Y,, UNKNOWN,,,1.0,DF,,,2021,Q1,Sopor,,2021,Q1,1,I,20201201.0,20210120.0,20210128,20210128,EXP,IT-MINISAL02-653123,IT-TEVA-2021-IT-1873145,TEVA,,32.0,YR,A,F,Y,,,20210128.0,,MD,IT,IT,2021,Q1,Young Adult
187998511,18799851,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210121.0,20210128,20210128,PER,,US-SA-2021SA024348,SANOFI AVENTIS,,44.0,YR,A,F,Y,,,20210128.0,,CN,US,US,2021,Q1,Adult
188028011,18802801,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Intentional self-injury,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Lactic acidosis,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Pneumonia aspiration,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188028011,18802801,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,,20210126.0,20210129,20210129,EXP,,JP-009507513-2101JPN011960,MERCK,TANAKA H.. UTILITY OF METFORMIN AND ITS PROPER USE,48.0,YR,,M,Y,,,20210129.0,,MD,JP,JP,2021,Q1,Adult
188048731,18804873,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Gait disturbance,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Gait disturbance,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,,,,,35.0,IU,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Gait disturbance,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Gait disturbance,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"35 U, UNKNOWN",,,,, D195320A,,,35.0,IU,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Gait disturbance,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,7,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,7,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,7,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Gait disturbance,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,7,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188048731,18804873,7,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"50 U, UNKNOWN (AT NIGHT)",,,,, D195320A,,,50.0,IU,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,1,I,202012.0,20210115.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188075341,18807534,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Bradycardia,,2021,Q1,1,I,,,20210129,20210129,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,,N,MD,US,US,2021,Q1,Adult
188075341,18807534,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,,20210129,20210129,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,,N,MD,US,US,2021,Q1,Adult
188075341,18807534,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Respiratory alkalosis,,2021,Q1,1,I,,,20210129,20210129,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,,N,MD,US,US,2021,Q1,Adult
188075341,18807534,9,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Respiratory failure,,2021,Q1,1,I,,,20210129,20210129,DIR,,,FDA-CTU,,61.0,YR,,F,N,,,,N,MD,US,US,2021,Q1,Adult
188078041,18807804,10,C,correctional dose insulin lispro subQ,,2,,,,,,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210127.0,,20210129,20210129,DIR,,,FDA-CTU,,74.0,YR,,F,N,65.3,KG,20210129.0,N,PH,US,US,2021,Q1,Elderly
188078041,18807804,10,C,correctional dose insulin lispro subQ,,2,,,,,,,,,,,,,,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,20210127.0,,20210129,20210129,DIR,,,FDA-CTU,,74.0,YR,,F,N,65.3,KG,20210129.0,N,PH,US,US,2021,Q1,Elderly
188078041,18807804,10,C,correctional dose insulin lispro subQ,,2,,,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,20210127.0,,20210129,20210129,DIR,,,FDA-CTU,,74.0,YR,,F,N,65.3,KG,20210129.0,N,PH,US,US,2021,Q1,Elderly
188078041,18807804,10,C,correctional dose insulin lispro subQ,,2,,,,,,,,,,,,,,2021,Q1,Drug-induced liver injury,,2021,Q1,1,I,20210127.0,,20210129,20210129,DIR,,,FDA-CTU,,74.0,YR,,F,N,65.3,KG,20210129.0,N,PH,US,US,2021,Q1,Elderly
188078041,18807804,10,C,correctional dose insulin lispro subQ,,2,,,,,,,,,,,,,,2021,Q1,Intentional product use issue,,2021,Q1,1,I,20210127.0,,20210129,20210129,DIR,,,FDA-CTU,,74.0,YR,,F,N,65.3,KG,20210129.0,N,PH,US,US,2021,Q1,Elderly
188086431,18808643,3,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, TID",,,N,, D195320C,,,8.0,IU,INJECTION,TID,2021,Q1,Cataract,,2021,Q1,1,I,202003.0,20210120.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101009407,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188086431,18808643,3,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, TID",,,N,, D195320C,,,8.0,IU,INJECTION,TID,2021,Q1,Injection site haemorrhage,,2021,Q1,1,I,202003.0,20210120.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101009407,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188086431,18808643,3,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, TID",,,N,, D195320C,,,8.0,IU,INJECTION,TID,2021,Q1,Injection site rash,,2021,Q1,1,I,202003.0,20210120.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101009407,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188086431,18808643,3,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"8 U, TID",,,N,, D195320C,,,8.0,IU,INJECTION,TID,2021,Q1,Wrong technique in product usage process,,2021,Q1,1,I,202003.0,20210120.0,20210129,20210129,PER,,US-ELI_LILLY_AND_COMPANY-US202101009407,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20210129.0,,CN,US,US,2021,Q1,Elderly
188102381,18810238,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (20+25+20 U/DAY),,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,1,I,,20210118.0,20210129,20210129,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-00928,LUPIN,,73.0,YR,,M,Y,,,20210129.0,,HP,IT,IT,2021,Q1,Elderly
188119291,18811929,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Drug abuse,,2021,Q1,1,I,20201201.0,20210118.0,20210130,20210130,EXP,IT-MINISAL02-653123,IT-ACCORD-215764,ACCORD,,32.0,YR,,F,Y,,,20210130.0,,MD,IT,IT,2021,Q1,Young Adult
188119291,18811929,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20201201.0,20210118.0,20210130,20210130,EXP,IT-MINISAL02-653123,IT-ACCORD-215764,ACCORD,,32.0,YR,,F,Y,,,20210130.0,,MD,IT,IT,2021,Q1,Young Adult
188119291,18811929,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Intentional self-injury,,2021,Q1,1,I,20201201.0,20210118.0,20210130,20210130,EXP,IT-MINISAL02-653123,IT-ACCORD-215764,ACCORD,,32.0,YR,,F,Y,,,20210130.0,,MD,IT,IT,2021,Q1,Young Adult
188119291,18811929,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20201201.0,20210118.0,20210130,20210130,EXP,IT-MINISAL02-653123,IT-ACCORD-215764,ACCORD,,32.0,YR,,F,Y,,,20210130.0,,MD,IT,IT,2021,Q1,Young Adult
188119291,18811929,2,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,1.0,DF,D,,,,,1.0,DF,,,2021,Q1,Sopor,,2021,Q1,1,I,20201201.0,20210118.0,20210130,20210130,EXP,IT-MINISAL02-653123,IT-ACCORD-215764,ACCORD,,32.0,YR,,F,Y,,,20210130.0,,MD,IT,IT,2021,Q1,Young Adult
188143431,18814343,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, PRN (DEPENDS ON FOOD INTAKE)",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202001.0,20210126.0,20210201,20210201,PER,,US-ELI_LILLY_AND_COMPANY-US202101012407,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Elderly
188143431,18814343,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, PRN (DEPENDS ON FOOD INTAKE)",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202001.0,20210126.0,20210201,20210201,PER,,US-ELI_LILLY_AND_COMPANY-US202101012407,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Elderly
188143431,18814343,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, PRN (DEPENDS ON FOOD INTAKE)",,,U,, D235668A,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202001.0,20210126.0,20210201,20210201,PER,,US-ELI_LILLY_AND_COMPANY-US202101012407,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Elderly
188143431,18814343,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"12 U, PRN (DEPENDS ON FOOD INTAKE)",,,U,, D235668A,,,12.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,202001.0,20210126.0,20210201,20210201,PER,,US-ELI_LILLY_AND_COMPANY-US202101012407,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Elderly
188144551,18814455,15,C,insulin lispro,INSULIN LISPRO,1,Unknown,20+25+20 U/DAY,,,U,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210118.0,20210201,20210201,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-278420,RANBAXY,"ANTINORI S, RECH R, GALIMBERTI L, CASTELLI A, ANGELI E, FOSSALI T, ET AL. INVASIVE PULMONARY ASPERGILLOSIS COMPLICATING SARS?COV?2 PNEUMONIA: A DIAGNOSTIC CHALLENGE. TRAVEL MED INFECT DIS. 2020?38:101752",73.0,YR,,M,Y,,,20210201.0,,HP,IT,IT,2021,Q1,Elderly
188144551,18814455,15,C,insulin lispro,INSULIN LISPRO,1,Unknown,20+25+20 U/DAY,,,U,,,,,,,,,2021,Q1,Off label use,,2021,Q1,1,I,,20210118.0,20210201,20210201,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-278420,RANBAXY,"ANTINORI S, RECH R, GALIMBERTI L, CASTELLI A, ANGELI E, FOSSALI T, ET AL. INVASIVE PULMONARY ASPERGILLOSIS COMPLICATING SARS?COV?2 PNEUMONIA: A DIAGNOSTIC CHALLENGE. TRAVEL MED INFECT DIS. 2020?38:101752",73.0,YR,,M,Y,,,20210201.0,,HP,IT,IT,2021,Q1,Elderly
188182692,18818269,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,14 IU,,,U,,,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemic coma,,2021,Q1,2,F,20171026.0,20210127.0,20210201,20210203,EXP,IT-MINISAL02-448486,IT-SA-2021SA028378,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Elderly
188182692,18818269,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,14 IU,,,U,,,,,14.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Troponin I increased,,2021,Q1,2,F,20171026.0,20210127.0,20210201,20210203,EXP,IT-MINISAL02-448486,IT-SA-2021SA028378,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Elderly
188192751,18819275,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210107.0,20210202,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202101003760,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
188192751,18819275,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,,20210107.0,20210202,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202101003760,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
188192751,18819275,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Tremor,,2021,Q1,1,I,,20210107.0,20210202,20210202,PER,,US-ELI_LILLY_AND_COMPANY-US202101003760,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210202.0,,CN,US,US,2021,Q1,Elderly
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Burkholderia test positive,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Klebsiella test positive,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Mycobacterium test positive,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pneumonia staphylococcal,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pyelonephritis,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Renal failure,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Stag horn calculus,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Suspected transmission of an infectious agent via product,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203061,18820306,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Urosepsis,,2021,Q1,1,I,20201011.0,,20210201,20210201,DIR,,,FDA-CTU,,51.0,YR,,M,N,,,20210127.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Atrial fibrillation,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Atrioventricular block first degree,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Burkholderia test positive,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Delirium,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Mycobacterium test positive,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Recalled product,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Respiratory failure,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Suspected transmission of an infectious agent via product,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188203741,18820374,30,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Weaning failure,,2021,Q1,1,I,20200825.0,,20210201,20210201,DIR,,,FDA-CTU,,64.0,YR,,M,N,,,20210122.0,N,PH,US,US,2021,Q1,Adult
188205661,18820566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20180206.0,20210127.0,20210202,20210202,EXP,IT-MINISAL02-469920,IT-SA-2021SA029743,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20210202.0,,MD,IT,IT,2021,Q1,Elderly
188241911,18824191,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU,24.0,IU,Y,,,,209196.0,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Disorientation,,2021,Q1,1,I,20171121.0,20210127.0,20210202,20210202,EXP,IT-MINISAL02-450031,IT-SA-2021SA029749,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210202.0,,MD,IT,IT,2021,Q1,Elderly
188241911,18824191,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU,24.0,IU,Y,,,,209196.0,24.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20171121.0,20210127.0,20210202,20210202,EXP,IT-MINISAL02-450031,IT-SA-2021SA029749,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210202.0,,MD,IT,IT,2021,Q1,Elderly
188300441,18830044,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Decreased immune responsiveness,,2021,Q1,1,I,2020.0,20201027.0,20210201,20210201,PER,,US-ABBVIE-20K-163-3626526-00,ABBVIE,,50.0,YR,,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Adult
188300441,18830044,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hepatic cancer,,2021,Q1,1,I,2020.0,20201027.0,20210201,20210201,PER,,US-ABBVIE-20K-163-3626526-00,ABBVIE,,50.0,YR,,M,Y,,,20210201.0,,CN,US,US,2021,Q1,Adult
188335611,18833561,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 DF, QD",,,,,,,,3.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20190715.0,20190923.0,20210203,20210203,EXP,IT-MINISAL02-575175,IT-SA-2019SA264729,SANOFI AVENTIS,,56.0,YR,A,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Adult
188335611,18833561,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 DF, QD",,,,,,,,3.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Sopor,,2021,Q1,1,I,20190715.0,20190923.0,20210203,20210203,EXP,IT-MINISAL02-575175,IT-SA-2019SA264729,SANOFI AVENTIS,,56.0,YR,A,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Adult
188339031,18833903,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,20210203.0,,20210203,20210203,DIR,,,FDA-CTU,,58.0,YR,,F,N,92.1,KG,20210203.0,N,PH,US,US,2021,Q1,Adult
188341571,18834157,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 DF, QD",22482.0,DF,Y,,,,,18.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20170625.0,20210127.0,20210203,20210203,EXP,IT-MINISAL02-462291,IT-SA-2021SA031558,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Elderly
188341571,18834157,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 DF, QD",22482.0,DF,Y,,,,,18.0,DF,SOLUTION FOR INJECTION,QD,2021,Q1,Presyncope,,2021,Q1,1,I,20170625.0,20210127.0,20210203,20210203,EXP,IT-MINISAL02-462291,IT-SA-2021SA031558,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20210203.0,,MD,IT,IT,2021,Q1,Elderly
188357371,18835737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, AS NEEDED",,,,,,,,,,,,2021,Q1,Febrile neutropenia,,2021,Q1,1,I,,20210126.0,20210203,20210203,EXP,,US-PFIZER INC-2021078026,PFIZER,"FEIN LEVY, C.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER.. PEDIATRIC BLOOD AND CANCER. 2021?68 (2):1?5",24.0,YR,,F,Y,,,20210203.0,,HP,US,US,2021,Q1,Young Adult
188357371,18835737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, AS NEEDED",,,,,,,,,,,,2021,Q1,Hypertriglyceridaemia,,2021,Q1,1,I,,20210126.0,20210203,20210203,EXP,,US-PFIZER INC-2021078026,PFIZER,"FEIN LEVY, C.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER.. PEDIATRIC BLOOD AND CANCER. 2021?68 (2):1?5",24.0,YR,,F,Y,,,20210203.0,,HP,US,US,2021,Q1,Young Adult
188357371,18835737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, AS NEEDED",,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,,20210126.0,20210203,20210203,EXP,,US-PFIZER INC-2021078026,PFIZER,"FEIN LEVY, C.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER.. PEDIATRIC BLOOD AND CANCER. 2021?68 (2):1?5",24.0,YR,,F,Y,,,20210203.0,,HP,US,US,2021,Q1,Young Adult
188357371,18835737,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, AS NEEDED",,,,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210126.0,20210203,20210203,EXP,,US-PFIZER INC-2021078026,PFIZER,"FEIN LEVY, C.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER.. PEDIATRIC BLOOD AND CANCER. 2021?68 (2):1?5",24.0,YR,,F,Y,,,20210203.0,,HP,US,US,2021,Q1,Young Adult
188374791,18837479,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 IU,QD",756.0,IU,,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Kidney malformation,,2021,Q1,1,I,20171004.0,20210127.0,20210203,20210203,EXP,IT-MINISAL02-448625,IT-SA-2021SA031552,SANOFI AVENTIS,,31.0,YR,A,F,Y,74.0,KG,20210203.0,,HP,IT,IT,2021,Q1,Young Adult
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Drug intolerance,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Grip strength decreased,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Headache,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hepatic cirrhosis,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hepatotoxicity,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Movement disorder,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188378501,18837850,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Psoriatic arthropathy,,2021,Q1,1,I,,20210127.0,20210203,20210203,EXP,,CA-PFIZER INC-2021084361,PFIZER,,65.0,YR,,F,Y,,,20210203.0,,HP,CA,CA,2021,Q1,Elderly
188412811,18841281,7,C,INSULINA LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,20210104.0,20210129.0,20210203,20210203,EXP,IT-MINISAL02-658969,NVSC2021IT021846,NOVARTIS,,78.0,YR,,F,Y,,,20210203.0,,HP,IT,IT,2021,Q1,Elderly
188426501,18842650,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Abdominal discomfort,,2021,Q1,1,I,20210115.0,20210122.0,20210203,20210203,EXP,,US-ELI_LILLY_AND_COMPANY-US202101011634,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Adult
188426501,18842650,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Bladder disorder,,2021,Q1,1,I,20210115.0,20210122.0,20210203,20210203,EXP,,US-ELI_LILLY_AND_COMPANY-US202101011634,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Adult
188458901,18845890,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210102.0,20210125.0,20210203,20210203,PER,,US-ELI_LILLY_AND_COMPANY-US202101011548,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Elderly
188458901,18845890,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,20210102.0,20210125.0,20210203,20210203,PER,,US-ELI_LILLY_AND_COMPANY-US202101011548,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Elderly
188458901,18845890,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,1,I,20210102.0,20210125.0,20210203,20210203,PER,,US-ELI_LILLY_AND_COMPANY-US202101011548,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Elderly
188458901,18845890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D222829A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210102.0,20210125.0,20210203,20210203,PER,,US-ELI_LILLY_AND_COMPANY-US202101011548,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Elderly
188458901,18845890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D222829A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,20210102.0,20210125.0,20210203,20210203,PER,,US-ELI_LILLY_AND_COMPANY-US202101011548,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Elderly
188458901,18845890,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D222829A,,,,,SOLUTION FOR INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,1,I,20210102.0,20210125.0,20210203,20210203,PER,,US-ELI_LILLY_AND_COMPANY-US202101011548,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210203.0,,CN,US,US,2021,Q1,Elderly
188498712,18849871,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Rhabdomyolysis,,2021,Q1,2,F,20210116.0,20210202.0,20210204,20210210,EXP,,US-GILEAD-2021-0515836,GILEAD,,53.0,YR,A,F,Y,108.2,KG,20210210.0,,MD,US,US,2021,Q1,Adult
188507451,18850745,8,C,Insulina lispro Sanofi,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,20210104.0,20210127.0,20210205,20210205,EXP,,IT-AUROBINDO-AUR-APL-2021-004341,AUROBINDO,,78.0,YR,,F,Y,,,20210205.0,,MD,IT,IT,2021,Q1,Elderly
188517441,18851744,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210203.0,,20210205,20210205,DIR,,,FDA-CTU,,77.0,YR,,F,N,50.0,KG,20210205.0,N,PH,US,US,2021,Q1,Elderly
188517441,18851744,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Aspartate aminotransferase increased,,2021,Q1,1,I,20210203.0,,20210205,20210205,DIR,,,FDA-CTU,,77.0,YR,,F,N,50.0,KG,20210205.0,N,PH,US,US,2021,Q1,Elderly
188530691,18853069,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"52 IU, QD",13364.0,IU,,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20170915.0,20210127.0,20210205,20210205,EXP,IT-MINISAL02-449337,IT-SA-2021SA034882,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20210205.0,,MD,IT,IT,2021,Q1,Elderly
188530691,18853069,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"52 IU, QD",13364.0,IU,,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Psychomotor hyperactivity,,2021,Q1,1,I,20170915.0,20210127.0,20210205,20210205,EXP,IT-MINISAL02-449337,IT-SA-2021SA034882,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20210205.0,,MD,IT,IT,2021,Q1,Elderly
188532871,18853287,7,C,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,20210104.0,20210127.0,20210205,20210205,EXP,IT-MINISAL02-658969,IT-ELI_LILLY_AND_COMPANY-IT202101012633,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20210205.0,,MD,IT,IT,2021,Q1,Elderly
188541061,18854106,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU,QD",,,,,,,209196.0,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemic coma,,2021,Q1,1,I,20180206.0,20180222.0,20210205,20210205,EXP,IT-MINISAL02-458223,IT-SA-2018SA053498,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210205.0,,MD,IT,IT,2021,Q1,Elderly
188580931,18858093,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Angioedema,,2021,Q1,1,I,20210205.0,,20210205,20210205,DIR,,,FDA-CTU,,64.0,YR,,M,N,113.0,KG,20210205.0,N,PH,US,US,2021,Q1,Adult
188630231,18863023,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,19 UNITS ONCE DAILY,1634.0,IU,U,,,,209196.0,19.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemic coma,,2021,Q1,1,I,20170328.0,20210127.0,20210208,20210208,EXP,IT-MINISAL02-420048,IT-SA-2021SA036557,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
188630591,18863059,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2021,Q1,Encephalopathy,,2021,Q1,1,I,20180207.0,20210127.0,20210208,20210208,EXP,IT-MINISAL02-463787,IT-SA-2021SA034851,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
188630591,18863059,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20180207.0,20210127.0,20210208,20210208,EXP,IT-MINISAL02-463787,IT-SA-2021SA034851,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
188630591,18863059,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2021,Q1,Hypoxic-ischaemic encephalopathy,,2021,Q1,1,I,20180207.0,20210127.0,20210208,20210208,EXP,IT-MINISAL02-463787,IT-SA-2021SA034851,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
188630591,18863059,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,,,2021,Q1,Vascular encephalopathy,,2021,Q1,1,I,20180207.0,20210127.0,20210208,20210208,EXP,IT-MINISAL02-463787,IT-SA-2021SA034851,SANOFI AVENTIS,,86.0,YR,E,F,Y,,,20210208.0,,MD,IT,IT,2021,Q1,Elderly
188637742,18863774,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",20.0,IU,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,2,F,20180613.0,20210127.0,20210208,20210211,EXP,IT-MINISAL02-487762,IT-SA-2018SA195524,SANOFI AVENTIS,,85.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
188637742,18863774,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, QD",20.0,IU,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypotension,,2021,Q1,2,F,20180613.0,20210127.0,20210208,20210211,EXP,IT-MINISAL02-487762,IT-SA-2018SA195524,SANOFI AVENTIS,,85.0,YR,E,M,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
188645021,18864502,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,20201230.0,,20210208,20210208,DIR,,,FDA-CTU,,55.0,YR,,,N,99.0,KG,20210208.0,N,PH,US,US,2021,Q1,Adult
188645021,18864502,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Diverticular perforation,,2021,Q1,1,I,20201230.0,,20210208,20210208,DIR,,,FDA-CTU,,55.0,YR,,,N,99.0,KG,20210208.0,N,PH,US,US,2021,Q1,Adult
188645021,18864502,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20201230.0,,20210208,20210208,DIR,,,FDA-CTU,,55.0,YR,,,N,99.0,KG,20210208.0,N,PH,US,US,2021,Q1,Adult
188648971,18864897,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK,AS DIRECTED",,,,,,,,,,,,2021,Q1,Dyspnoea at rest,,2021,Q1,1,I,20210201.0,20210203.0,20210208,20210208,EXP,GB-MHRA-TPP32050866C6072074YC1612183206980,GB-MYLANLABS-2021M1007567,MYLAN,,62.0,YR,,F,Y,109.0,KG,20210208.0,,MD,GB,GB,2021,Q1,Adult
188648971,18864897,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK,AS DIRECTED",,,,,,,,,,,,2021,Q1,Swollen tongue,,2021,Q1,1,I,20210201.0,20210203.0,20210208,20210208,EXP,GB-MHRA-TPP32050866C6072074YC1612183206980,GB-MYLANLABS-2021M1007567,MYLAN,,62.0,YR,,F,Y,109.0,KG,20210208.0,,MD,GB,GB,2021,Q1,Adult
188651571,18865157,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Seizure,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Seizure,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Seizure,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Seizure,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Seizure,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088599D,,21017.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Seizure,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,7,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Accidental underdose,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,7,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,7,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,7,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Seizure,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188651571,18865157,7,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210127.0,20210127.0,20210208,20210208,PER,,US-ELI_LILLY_AND_COMPANY-US202101013252,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210208.0,,CN,US,US,2021,Q1,Adult
188663633,18866363,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,15.0,DF,INJECTION,,2021,Q1,Atrioventricular block complete,,2021,Q1,3,F,20200615.0,20210222.0,20210209,20210226,EXP,,US-ASTELLAS-2021US004462,ASTELLAS,,65.0,YR,,M,Y,,,20210226.0,,HP,US,US,2021,Q1,Elderly
188663633,18866363,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,15.0,DF,INJECTION,,2021,Q1,Nodal rhythm,,2021,Q1,3,F,20200615.0,20210222.0,20210209,20210226,EXP,,US-ASTELLAS-2021US004462,ASTELLAS,,65.0,YR,,M,Y,,,20210226.0,,HP,US,US,2021,Q1,Elderly
188689951,18868995,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 IU, QD",,,Y,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Epilepsy,,2021,Q1,1,I,20180921.0,20181101.0,20210209,20210209,EXP,IT-MINISAL02-507332,IT-SA-2018SA304050,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20210209.0,,MD,IT,IT,2021,Q1,Elderly
188689951,18868995,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 IU, QD",,,Y,,,,,28.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20180921.0,20181101.0,20210209,20210209,EXP,IT-MINISAL02-507332,IT-SA-2018SA304050,SANOFI AVENTIS,,88.0,YR,E,M,Y,,,20210209.0,,MD,IT,IT,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Agitation,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Confusional state,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Cough,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Fall,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Head injury,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Malaise,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Oedema,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Pain,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Somnolence,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Tachycardia,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188713061,18871306,19,C,Lispro SSI,,2,,,,,,,,,,,,,,2021,Q1,Tachypnoea,,2021,Q1,1,I,20201108.0,,20210209,20210209,DIR,,,FDA-CTU,,67.0,YR,,F,N,99.0,KG,20210209.0,N,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Aortic stenosis,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Blood pressure increased,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Cardiac perfusion defect,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Cough,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Dyspnoea exertional,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Ejection fraction decreased,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Electrocardiogram T wave inversion,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Left ventricular end-diastolic pressure increased,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Left ventricular hypertrophy,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Lung opacity,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Mitral valve incompetence,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Orthopnoea,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Pleural effusion,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188723051,18872305,4,C,insulin detemir and lispro,,2,,,,,,,,,,,,,,2021,Q1,Ventricular hypokinesia,,2021,Q1,1,I,20210119.0,,20210210,20210210,DIR,,,FDA-CTU,,74.0,YR,,F,N,59.1,KG,20210210.0,Y,PH,US,US,2021,Q1,Elderly
188755541,18875554,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,202008.0,20210127.0,20210211,20210211,PER,,US-ELI_LILLY_AND_COMPANY-US202102003185,ELI LILLY AND CO,,43.0,YR,,F,Y,,,20210211.0,,CN,US,US,2021,Q1,Adult
188773061,18877306,14,C,Lispro SSI TID and HS,,2,,,,,,,,,,,,,,2021,Q1,Blood creatinine increased,,2021,Q1,1,I,20201206.0,,20210210,20210210,DIR,,,FDA-CTU,,70.0,YR,,M,N,106.8,KG,20210210.0,N,PH,US,US,2021,Q1,Elderly
188773061,18877306,14,C,Lispro SSI TID and HS,,2,,,,,,,,,,,,,,2021,Q1,Blood pressure decreased,,2021,Q1,1,I,20201206.0,,20210210,20210210,DIR,,,FDA-CTU,,70.0,YR,,M,N,106.8,KG,20210210.0,N,PH,US,US,2021,Q1,Elderly
188773061,18877306,14,C,Lispro SSI TID and HS,,2,,,,,,,,,,,,,,2021,Q1,Cardiac arrest,,2021,Q1,1,I,20201206.0,,20210210,20210210,DIR,,,FDA-CTU,,70.0,YR,,M,N,106.8,KG,20210210.0,N,PH,US,US,2021,Q1,Elderly
188773061,18877306,14,C,Lispro SSI TID and HS,,2,,,,,,,,,,,,,,2021,Q1,Pyrexia,,2021,Q1,1,I,20201206.0,,20210210,20210210,DIR,,,FDA-CTU,,70.0,YR,,M,N,106.8,KG,20210210.0,N,PH,US,US,2021,Q1,Elderly
188773061,18877306,14,C,Lispro SSI TID and HS,,2,,,,,,,,,,,,,,2021,Q1,Urine output decreased,,2021,Q1,1,I,20201206.0,,20210210,20210210,DIR,,,FDA-CTU,,70.0,YR,,M,N,106.8,KG,20210210.0,N,PH,US,US,2021,Q1,Elderly
188774871,18877487,7,C,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,20210104.0,20210128.0,20210211,20210211,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-280478,RANBAXY,,78.0,YR,,F,Y,,,20210211.0,,HP,NL,IT,2021,Q1,Elderly
188784711,18878471,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,1,I,20210210.0,,20210211,20210211,DIR,,,FDA-CTU,,65.0,YR,,M,N,110.7,KG,20210211.0,Y,CN,US,US,2021,Q1,Elderly
188795361,18879536,6,C,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,20210104.0,20210203.0,20210211,20210211,EXP,IT-MINISAL02-658969,IT-TEVA-2021-IT-1878027,TEVA,,78.0,YR,E,F,Y,,,20210211.0,,MD,IT,IT,2021,Q1,Elderly
188862231,18886223,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"AS DIRECTED, SANOFI BRAND",,,,,,,,,,,,2021,Q1,Dyspnoea at rest,,2021,Q1,1,I,20210201.0,20210203.0,20210212,20210212,EXP,GB-MHRA-TPP32050866C6072074YC1612183206980,GB-PFIZER INC-2021111091,PFIZER,,62.0,YR,,F,Y,109.0,KG,20210212.0,,MD,GB,GB,2021,Q1,Adult
188862231,18886223,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"AS DIRECTED, SANOFI BRAND",,,,,,,,,,,,2021,Q1,Swollen tongue,,2021,Q1,1,I,20210201.0,20210203.0,20210212,20210212,EXP,GB-MHRA-TPP32050866C6072074YC1612183206980,GB-PFIZER INC-2021111091,PFIZER,,62.0,YR,,F,Y,109.0,KG,20210212.0,,MD,GB,GB,2021,Q1,Adult
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Angina unstable,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Arteriosclerosis,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Cardiac dysfunction,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Coronary artery disease,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Diabetic retinopathy,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Glaucoma,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Hypertension,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Left atrial enlargement,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Pneumonia,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Respiratory failure,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Sinus rhythm,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,8.0,IU,,TID,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Angina unstable,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Arteriosclerosis,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Cardiac dysfunction,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Coronary artery disease,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Diabetic retinopathy,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Glaucoma,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Hypertension,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Left atrial enlargement,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Pneumonia,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Respiratory failure,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Sinus rhythm,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188865601,18886560,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"6 INTERNATIONAL UNIT, TID",,,Y,, D229370C,,20563.0,6.0,IU,,TID,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,20210127.0,20210202.0,20210212,20210212,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202102002312,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210212.0,,HP,CN,CN,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Drug intolerance,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Grip strength decreased,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Headache,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hepatic cirrhosis,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hepatotoxicity,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Movement disorder,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Osteoarthritis,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188943953,18894395,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Psoriatic arthropathy,,2021,Q1,3,F,,20210217.0,20210215,20210223,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
188944231,18894423,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, OTHER",,,,,,,20563.0,14.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20201108.0,20210203.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003111,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Elderly
188944231,18894423,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, OTHER",,,,,,,20563.0,14.0,IU,INJECTION,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20201108.0,20210203.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003111,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Elderly
188944231,18894423,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, OTHER",,,,, D185008D,,20563.0,14.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20201108.0,20210203.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003111,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Elderly
188944231,18894423,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, OTHER",,,,, D185008D,,20563.0,14.0,IU,INJECTION,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,1,I,20201108.0,20210203.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003111,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Elderly
188957801,18895780,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Ankle fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Appendicitis,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Foot fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Lower limb fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Sepsis,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Stress,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Ankle fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Appendicitis,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Foot fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Lower limb fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Sepsis,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,INJECTION,,2021,Q1,Stress,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Ankle fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Appendicitis,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Foot fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Lower limb fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Sepsis,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Stress,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Ankle fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Appendicitis,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Foot fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Lower limb fracture,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Sepsis,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188957801,18895780,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D195320C,,,,,INJECTION,,2021,Q1,Stress,,2021,Q1,1,I,20200606.0,20191104.0,20210215,20210215,EXP,,US-ELI_LILLY_AND_COMPANY-US201911001248,ELI LILLY AND CO,,45.0,YR,,F,Y,,,20210215.0,,CN,US,US,2021,Q1,Adult
188989741,18898974,20,C,Insulin lispro SSI 4/xd,,2,,,,,,,,,,,,,,2021,Q1,Acidosis,,2021,Q1,1,I,20201223.0,,20210216,20210216,DIR,,,FDA-CTU,,59.0,YR,,M,N,106.0,KG,20210216.0,N,PH,US,US,2021,Q1,Adult
188989741,18898974,20,C,Insulin lispro SSI 4/xd,,2,,,,,,,,,,,,,,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20201223.0,,20210216,20210216,DIR,,,FDA-CTU,,59.0,YR,,M,N,106.0,KG,20210216.0,N,PH,US,US,2021,Q1,Adult
188989741,18898974,20,C,Insulin lispro SSI 4/xd,,2,,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,20201223.0,,20210216,20210216,DIR,,,FDA-CTU,,59.0,YR,,M,N,106.0,KG,20210216.0,N,PH,US,US,2021,Q1,Adult
188989741,18898974,20,C,Insulin lispro SSI 4/xd,,2,,,,,,,,,,,,,,2021,Q1,Procedural hypertension,,2021,Q1,1,I,20201223.0,,20210216,20210216,DIR,,,FDA-CTU,,59.0,YR,,M,N,106.0,KG,20210216.0,N,PH,US,US,2021,Q1,Adult
188994981,18899498,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,,,,20563.0,25.0,IU,INJECTION,,2021,Q1,Cellulitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,,,,20563.0,25.0,IU,INJECTION,,2021,Q1,Osteomyelitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,,,,20563.0,25.0,IU,INJECTION,,2021,Q1,Sepsis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,,,,20563.0,,,INJECTION,,2021,Q1,Cellulitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,,,,20563.0,,,INJECTION,,2021,Q1,Osteomyelitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,,,,20563.0,,,INJECTION,,2021,Q1,Sepsis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,,,,20563.0,4.0,IU,INJECTION,QD,2021,Q1,Cellulitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,,,,20563.0,4.0,IU,INJECTION,QD,2021,Q1,Osteomyelitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,,,,20563.0,4.0,IU,INJECTION,QD,2021,Q1,Sepsis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,, D195320A,,20563.0,25.0,IU,INJECTION,,2021,Q1,Cellulitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,, D195320A,,20563.0,25.0,IU,INJECTION,,2021,Q1,Osteomyelitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,, D195320A,,20563.0,25.0,IU,INJECTION,,2021,Q1,Sepsis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Cellulitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Osteomyelitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Sepsis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,, D195320A,,20563.0,4.0,IU,INJECTION,QD,2021,Q1,Cellulitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,, D195320A,,20563.0,4.0,IU,INJECTION,QD,2021,Q1,Osteomyelitis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188994981,18899498,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,, D195320A,,20563.0,4.0,IU,INJECTION,QD,2021,Q1,Sepsis,,2021,Q1,1,I,2020.0,20210205.0,20210216,20210216,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Adult
188998251,18899825,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,202012.0,20210203.0,20210216,20210216,PER,,US-SA-2021SA046284,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Elderly
188998251,18899825,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Back pain,,2021,Q1,1,I,202012.0,20210203.0,20210216,20210216,PER,,US-SA-2021SA046284,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Elderly
188998251,18899825,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210203.0,20210216,20210216,PER,,US-SA-2021SA046284,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Elderly
188998251,18899825,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,202012.0,20210203.0,20210216,20210216,PER,,US-SA-2021SA046284,SANOFI AVENTIS,,69.0,YR,E,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Elderly
188998951,18899895,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNK,,,,,INJECTION,,2021,Q1,Vasoplegia syndrome,,2021,Q1,1,I,,20210212.0,20210216,20210216,EXP,,CA-FRESENIUS KABI-FK202101448,FRESENIUS KABI,,83.0,YR,,M,Y,,,20210216.0,,PH,CA,CA,2021,Q1,Elderly
189004721,18900472,12,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2021,Q1,Hiccups,,2021,Q1,1,I,202101.0,20210201.0,20210216,20210216,PER,,US-CELGENEUS-USA-20210200635,CELGENE,,69.0,YR,,M,Y,,,20210216.0,,PH,US,US,2021,Q1,Elderly
189004721,18900472,12,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2021,Q1,Renal failure,,2021,Q1,1,I,202101.0,20210201.0,20210216,20210216,PER,,US-CELGENEUS-USA-20210200635,CELGENE,,69.0,YR,,M,Y,,,20210216.0,,PH,US,US,2021,Q1,Elderly
189004721,18900472,12,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,INJECTION,,2021,Q1,Spinal compression fracture,,2021,Q1,1,I,202101.0,20210201.0,20210216,20210216,PER,,US-CELGENEUS-USA-20210200635,CELGENE,,69.0,YR,,M,Y,,,20210216.0,,PH,US,US,2021,Q1,Elderly
189013471,18901347,2,C,Lispro protamine,,2,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Atrioventricular block complete,,2021,Q1,1,I,,20180403.0,20210217,20210217,EXP,,TR-ALKEM LABORATORIES LIMITED-GB-ALKEM-2018-02183,ALKEM,"DUFAYET D, MONNET F, LABORDE?CASTEROT H, CARE W, ET.AL. UNINTENTIONAL EXPOSURE TO PREGABALIN IN ?6?YEAR OLD CHILDREN: A NATIONWIDE FRENCH POISON CONTROL CENTER STUDY. CLINICAL TOXICOLOGY. 2020?UNK:UNK",65.0,YR,,F,Y,,,20210217.0,,HP,FR,TR,2021,Q1,Elderly
189013471,18901347,2,C,Lispro protamine,,2,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20180403.0,20210217,20210217,EXP,,TR-ALKEM LABORATORIES LIMITED-GB-ALKEM-2018-02183,ALKEM,"DUFAYET D, MONNET F, LABORDE?CASTEROT H, CARE W, ET.AL. UNINTENTIONAL EXPOSURE TO PREGABALIN IN ?6?YEAR OLD CHILDREN: A NATIONWIDE FRENCH POISON CONTROL CENTER STUDY. CLINICAL TOXICOLOGY. 2020?UNK:UNK",65.0,YR,,F,Y,,,20210217.0,,HP,FR,TR,2021,Q1,Elderly
189013471,18901347,3,C,Insulin lispro Humalog,,2,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Atrioventricular block complete,,2021,Q1,1,I,,20180403.0,20210217,20210217,EXP,,TR-ALKEM LABORATORIES LIMITED-GB-ALKEM-2018-02183,ALKEM,"DUFAYET D, MONNET F, LABORDE?CASTEROT H, CARE W, ET.AL. UNINTENTIONAL EXPOSURE TO PREGABALIN IN ?6?YEAR OLD CHILDREN: A NATIONWIDE FRENCH POISON CONTROL CENTER STUDY. CLINICAL TOXICOLOGY. 2020?UNK:UNK",65.0,YR,,F,Y,,,20210217.0,,HP,FR,TR,2021,Q1,Elderly
189013471,18901347,3,C,Insulin lispro Humalog,,2,Unknown,UNK,,,,, UNKNOWN,,,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20180403.0,20210217,20210217,EXP,,TR-ALKEM LABORATORIES LIMITED-GB-ALKEM-2018-02183,ALKEM,"DUFAYET D, MONNET F, LABORDE?CASTEROT H, CARE W, ET.AL. UNINTENTIONAL EXPOSURE TO PREGABALIN IN ?6?YEAR OLD CHILDREN: A NATIONWIDE FRENCH POISON CONTROL CENTER STUDY. CLINICAL TOXICOLOGY. 2020?UNK:UNK",65.0,YR,,F,Y,,,20210217.0,,HP,FR,TR,2021,Q1,Elderly
189027601,18902760,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,20201231.0,,20210216,20210216,DIR,,,FDA-CTU,,56.0,YR,,F,N,158.8,KG,20210216.0,N,PH,US,US,2021,Q1,Adult
189027601,18902760,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Therapy interrupted,,2021,Q1,1,I,20201231.0,,20210216,20210216,DIR,,,FDA-CTU,,56.0,YR,,F,N,158.8,KG,20210216.0,N,PH,US,US,2021,Q1,Adult
189035291,18903529,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D214632C,,20563.0,,,INJECTION,,2021,Q1,Blood insulin increased,,2021,Q1,1,I,202102.0,20210210.0,20210216,20210216,PER,,US-ELI_LILLY_AND_COMPANY-US202102005656,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20210216.0,,CN,US,US,2021,Q1,Elderly
189040501,18904050,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,AS DIRECTED,,,U,,,,,,,,,2021,Q1,Dyspnoea at rest,,2021,Q1,1,I,20210201.0,20210203.0,20210217,20210217,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-281573,RANBAXY,,62.0,YR,,F,Y,109.0,KG,20210217.0,,HP,GB,GB,2021,Q1,Adult
189040501,18904050,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,AS DIRECTED,,,U,,,,,,,,,2021,Q1,Swollen tongue,,2021,Q1,1,I,20210201.0,20210203.0,20210217,20210217,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-281573,RANBAXY,,62.0,YR,,F,Y,109.0,KG,20210217.0,,HP,GB,GB,2021,Q1,Adult
189041991,18904199,12,C,Lispro SSI TID + QHS,,2,,,,,,,,,,,,,,2021,Q1,Blood creatinine increased,,2021,Q1,1,I,20210108.0,,20210217,20210217,DIR,,,FDA-CTU,,54.0,YR,,M,N,64.4,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189041991,18904199,12,C,Lispro SSI TID + QHS,,2,,,,,,,,,,,,,,2021,Q1,Creatinine renal clearance decreased,,2021,Q1,1,I,20210108.0,,20210217,20210217,DIR,,,FDA-CTU,,54.0,YR,,M,N,64.4,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189041991,18904199,12,C,Lispro SSI TID + QHS,,2,,,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,1,I,20210108.0,,20210217,20210217,DIR,,,FDA-CTU,,54.0,YR,,M,N,64.4,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189041991,18904199,12,C,Lispro SSI TID + QHS,,2,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210108.0,,20210217,20210217,DIR,,,FDA-CTU,,54.0,YR,,M,N,64.4,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189041991,18904199,12,C,Lispro SSI TID + QHS,,2,,,,,,,,,,,,,,2021,Q1,Peripheral swelling,,2021,Q1,1,I,20210108.0,,20210217,20210217,DIR,,,FDA-CTU,,54.0,YR,,M,N,64.4,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189044511,18904451,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Agitation,,2021,Q1,1,I,20210123.0,,20210217,20210217,DIR,,,FDA-CTU,,46.0,YR,,M,N,45.6,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189044511,18904451,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Blood creatinine increased,,2021,Q1,1,I,20210123.0,,20210217,20210217,DIR,,,FDA-CTU,,46.0,YR,,M,N,45.6,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189044511,18904451,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Creatinine renal clearance decreased,,2021,Q1,1,I,20210123.0,,20210217,20210217,DIR,,,FDA-CTU,,46.0,YR,,M,N,45.6,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189044511,18904451,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Haemodialysis,,2021,Q1,1,I,20210123.0,,20210217,20210217,DIR,,,FDA-CTU,,46.0,YR,,M,N,45.6,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189044511,18904451,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Immunosuppressant drug level decreased,,2021,Q1,1,I,20210123.0,,20210217,20210217,DIR,,,FDA-CTU,,46.0,YR,,M,N,45.6,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189044511,18904451,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Proteinuria,,2021,Q1,1,I,20210123.0,,20210217,20210217,DIR,,,FDA-CTU,,46.0,YR,,M,N,45.6,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189044511,18904451,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,1,I,20210123.0,,20210217,20210217,DIR,,,FDA-CTU,,46.0,YR,,M,N,45.6,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189044511,18904451,15,C,insulin lispro SSI 4/xday,,2,,,,,,,,,,,,,,2021,Q1,Respiratory distress,,2021,Q1,1,I,20210123.0,,20210217,20210217,DIR,,,FDA-CTU,,46.0,YR,,M,N,45.6,KG,20210217.0,N,PH,US,US,2021,Q1,Adult
189045241,18904524,16,C,insulin lispro SSI 4/d,,2,,,,,,,,,,,,,,2021,Q1,Blood creatinine increased,,2021,Q1,1,I,20210209.0,,20210217,20210217,DIR,,,FDA-CTU,,71.0,YR,,M,N,75.8,KG,20210217.0,N,PH,US,US,2021,Q1,Elderly
189045241,18904524,16,C,insulin lispro SSI 4/d,,2,,,,,,,,,,,,,,2021,Q1,Creatinine renal clearance decreased,,2021,Q1,1,I,20210209.0,,20210217,20210217,DIR,,,FDA-CTU,,71.0,YR,,M,N,75.8,KG,20210217.0,N,PH,US,US,2021,Q1,Elderly
189047241,18904724,25,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210210.0,20210217,20210217,EXP,,CA-CELGENEUS-CAN-20210203210,CELGENE,,75.0,YR,,F,Y,,,20210217.0,,HP,CA,CA,2021,Q1,Elderly
189047241,18904724,25,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Dehydration,,2021,Q1,1,I,,20210210.0,20210217,20210217,EXP,,CA-CELGENEUS-CAN-20210203210,CELGENE,,75.0,YR,,F,Y,,,20210217.0,,HP,CA,CA,2021,Q1,Elderly
189047241,18904724,25,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Pyrexia,,2021,Q1,1,I,,20210210.0,20210217,20210217,EXP,,CA-CELGENEUS-CAN-20210203210,CELGENE,,75.0,YR,,F,Y,,,20210217.0,,HP,CA,CA,2021,Q1,Elderly
189047241,18904724,25,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Small intestinal obstruction,,2021,Q1,1,I,,20210210.0,20210217,20210217,EXP,,CA-CELGENEUS-CAN-20210203210,CELGENE,,75.0,YR,,F,Y,,,20210217.0,,HP,CA,CA,2021,Q1,Elderly
189047241,18904724,25,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Urinary tract obstruction,,2021,Q1,1,I,,20210210.0,20210217,20210217,EXP,,CA-CELGENEUS-CAN-20210203210,CELGENE,,75.0,YR,,F,Y,,,20210217.0,,HP,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Diabetes mellitus,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Drug ineffective,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Drug intolerance,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Grip strength decreased,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Headache,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hepatic cirrhosis,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hepatotoxicity,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Movement disorder,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Osteoarthritis,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189055063,18905506,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Psoriatic arthropathy,,2021,Q1,3,F,,20210217.0,20210217,20210223,EXP,,CA-JNJFOC-20210220513,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20210223.0,,CN,CA,CA,2021,Q1,Elderly
189085082,18908508,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 3 UNITS,,,,,,,,,,,,2021,Q1,Acidosis,,2021,Q1,2,F,20210211.0,20210225.0,20210218,20210302,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210225.0,,CN,US,US,2021,Q1,Adult
189085082,18908508,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 3 UNITS,,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,2,F,20210211.0,20210225.0,20210218,20210302,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210225.0,,CN,US,US,2021,Q1,Adult
189085082,18908508,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 3 UNITS,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,2,F,20210211.0,20210225.0,20210218,20210302,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210225.0,,CN,US,US,2021,Q1,Adult
189085082,18908508,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 7 UNITS,,,,,,,,,,,,2021,Q1,Acidosis,,2021,Q1,2,F,20210211.0,20210225.0,20210218,20210302,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210225.0,,CN,US,US,2021,Q1,Adult
189085082,18908508,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 7 UNITS,,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,2,F,20210211.0,20210225.0,20210218,20210302,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210225.0,,CN,US,US,2021,Q1,Adult
189085082,18908508,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 7 UNITS,,,,,,,,,,,,2021,Q1,Hypoxia,,2021,Q1,2,F,20210211.0,20210225.0,20210218,20210302,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210225.0,,CN,US,US,2021,Q1,Adult
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Asthma,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Blood count abnormal,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Chest discomfort,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Diaphragmatic disorder,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Discomfort,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Hypoxia,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Left ventricular hypertrophy,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Obstructive airways disorder,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Oropharyngeal pain,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Pyrexia,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189110101,18911010,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,2.0,,,QD,2021,Q1,Weight increased,,2021,Q1,1,I,,20210210.0,20210218,20210218,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-082728",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210218.0,,CN,CA,CA,2021,Q1,Elderly
189132211,18913221,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Blood uric acid decreased,,2021,Q1,1,I,,20210211.0,20210218,20210218,EXP,,CA-TAKEDA-2021TUS009357,TAKEDA,,61.0,YR,,M,Y,110.0,KG,20210218.0,,PH,CA,CA,2021,Q1,Adult
189132211,18913221,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Bradycardia,,2021,Q1,1,I,,20210211.0,20210218,20210218,EXP,,CA-TAKEDA-2021TUS009357,TAKEDA,,61.0,YR,,M,Y,110.0,KG,20210218.0,,PH,CA,CA,2021,Q1,Adult
189132211,18913221,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Cardiac arrest,,2021,Q1,1,I,,20210211.0,20210218,20210218,EXP,,CA-TAKEDA-2021TUS009357,TAKEDA,,61.0,YR,,M,Y,110.0,KG,20210218.0,,PH,CA,CA,2021,Q1,Adult
189132211,18913221,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Syncope,,2021,Q1,1,I,,20210211.0,20210218,20210218,EXP,,CA-TAKEDA-2021TUS009357,TAKEDA,,61.0,YR,,M,Y,110.0,KG,20210218.0,,PH,CA,CA,2021,Q1,Adult
189133041,18913304,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS DIRECTED,,,,,,,,,,,,2021,Q1,Dyspnoea at rest,,2021,Q1,1,I,20210201.0,20210203.0,20210218,20210218,EXP,GB-MHRA-TPP32050866C6072074YC1612183206980,GB-TEVA-2021-GB-1877969,TEVA,,62.0,YR,A,F,Y,109.0,KG,20210218.0,,MD,GB,GB,2021,Q1,Adult
189133041,18913304,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,AS DIRECTED,,,,,,,,,,,,2021,Q1,Swollen tongue,,2021,Q1,1,I,20210201.0,20210203.0,20210218,20210218,EXP,GB-MHRA-TPP32050866C6072074YC1612183206980,GB-TEVA-2021-GB-1877969,TEVA,,62.0,YR,A,F,Y,109.0,KG,20210218.0,,MD,GB,GB,2021,Q1,Adult
189133505,18913350,8,C,INSULIN LISPRO BS,,2,,"3 IU INTERNATIONAL UNIT(S, DAILY",,,,,,,,,,,,2021,Q1,Dry skin,,2021,Q1,5,F,20201124.0,20210316.0,20210218,20210323,EXP,,JP-ASTRAZENECA-2020SF61672,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20210323.0,,MD,JP,JP,2021,Q1,Elderly
189133505,18913350,8,C,INSULIN LISPRO BS,,2,,"3 IU INTERNATIONAL UNIT(S, DAILY",,,,,,,,,,,,2021,Q1,Lung disorder,,2021,Q1,5,F,20201124.0,20210316.0,20210218,20210323,EXP,,JP-ASTRAZENECA-2020SF61672,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20210323.0,,MD,JP,JP,2021,Q1,Elderly
189133505,18913350,8,C,INSULIN LISPRO BS,,2,,"3 IU INTERNATIONAL UNIT(S, DAILY",,,,,,,,,,,,2021,Q1,Off label use,,2021,Q1,5,F,20201124.0,20210316.0,20210218,20210323,EXP,,JP-ASTRAZENECA-2020SF61672,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20210323.0,,MD,JP,JP,2021,Q1,Elderly
189150041,18915004,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D214632C,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210204.0,20210209.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102005774,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20210219.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Arthralgia,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Depressed level of consciousness,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Fall,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Injury,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Localised infection,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Muscular weakness,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Arthralgia,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Depressed level of consciousness,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Fall,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Injury,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Localised infection,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Muscular weakness,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Arthralgia,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Depressed level of consciousness,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Fall,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Injury,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Localised infection,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Muscular weakness,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Arthralgia,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Depressed level of consciousness,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Diabetic ketoacidosis,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Fall,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Injury,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Localised infection,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Muscular weakness,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189150192,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q1,Pain in extremity,,2021,Q1,2,F,20151015.0,20210212.0,20210219,20210224,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210224.0,,CN,US,US,2021,Q1,Elderly
189156311,18915631,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,20563.0,,,INJECTION,,2021,Q1,Dementia,,2021,Q1,1,I,202008.0,20210216.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102008636,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Elderly
189156611,18915661,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,1,I,,20210210.0,20210219,20210219,PER,,US-SA-2021SA055581,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Elderly
189156611,18915661,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q1,Pruritus,,2021,Q1,1,I,,20210210.0,20210219,20210219,PER,,US-SA-2021SA055581,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Elderly
189165171,18916517,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189165171,18916517,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189165171,18916517,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Illness,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189165171,18916517,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D233321A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189165171,18916517,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D233321A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189165171,18916517,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D233321A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Illness,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189165171,18916517,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D204245A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189165171,18916517,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D204245A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189165171,18916517,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D204245A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q1,Illness,,2021,Q1,1,I,20210125.0,20210208.0,20210219,20210219,PER,,US-ELI_LILLY_AND_COMPANY-US202102007732,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210219.0,,CN,US,US,2021,Q1,Adult
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Aortic stenosis,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Blood pressure systolic decreased,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Cardiac perfusion defect,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Hypertension,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Hypokinesia,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Left ventricular end-diastolic pressure increased,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Lung opacity,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Mitral valve incompetence,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Pleural effusion,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189168581,18916858,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,Ventricular hypertrophy,,2021,Q1,1,I,202101.0,20210210.0,20210219,20210219,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006628,ELI LILLY AND CO,,74.0,YR,,F,Y,59.1,KG,20210219.0,,PH,US,US,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Asthma,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Blood count abnormal,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Chest discomfort,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Diaphragmatic disorder,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Discomfort,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Hypoxia,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Left ventricular hypertrophy,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Obstructive airways disorder,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Oropharyngeal pain,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Pyrexia,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189179061,18917906,18,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"2 DOSAGE FORM, ONCE A DAY",,,U,,,,,2.0,DF,,QD,2021,Q1,Weight increased,,2021,Q1,1,I,,20210210.0,20210220,20210220,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20210220.0,,HP,CA,CA,2021,Q1,Elderly
189199681,18919968,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D182600E,,20563.0,14.0,IU,INJECTION,QD,2021,Q1,Asthenia,,2021,Q1,1,I,202006.0,20210217.0,20210222,20210222,PER,,US-ELI_LILLY_AND_COMPANY-US202102008939,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189199681,18919968,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D182600E,,20563.0,14.0,IU,INJECTION,QD,2021,Q1,Fall,,2021,Q1,1,I,202006.0,20210217.0,20210222,20210222,PER,,US-ELI_LILLY_AND_COMPANY-US202102008939,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189199681,18919968,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, DAILY",,,U,, D182600E,,20563.0,14.0,IU,INJECTION,QD,2021,Q1,Pain,,2021,Q1,1,I,202006.0,20210217.0,20210222,20210222,PER,,US-ELI_LILLY_AND_COMPANY-US202102008939,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189212414,18921241,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q1,Fungal sepsis,,2021,Q1,4,F,20210216.0,20210302.0,20210222,20210308,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210308.0,,MD,US,US,2021,Q1,Elderly
189212414,18921241,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE U X 3 X 1 DAYS,,,,,,,,,,UNKNOWN,TID,2021,Q1,Fungal sepsis,,2021,Q1,4,F,20210216.0,20210302.0,20210222,20210308,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210308.0,,MD,US,US,2021,Q1,Elderly
189229261,18922926,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,1,I,20210210.0,20210211.0,20210222,20210222,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006653,ELI LILLY AND CO,,65.0,YR,,M,Y,111.57,KG,20210222.0,,CN,US,US,2021,Q1,Elderly
189236132,18923613,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"QD, SITE OF INJECTION: TUMMY",,,D,,,,209196.0,,,,QD,2021,Q1,Bladder disorder,,2021,Q1,2,F,,20210226.0,20210222,20210302,EXP,,GB-SA-2020SA361619,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20210302.0,,CN,GB,GB,2021,Q1,Elderly
189236132,18923613,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"QD, SITE OF INJECTION: TUMMY",,,D,,,,209196.0,,,,QD,2021,Q1,Hepatic failure,,2021,Q1,2,F,,20210226.0,20210222,20210302,EXP,,GB-SA-2020SA361619,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20210302.0,,CN,GB,GB,2021,Q1,Elderly
189236132,18923613,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"QD, SITE OF INJECTION: TUMMY",,,D,,,,209196.0,,,,QD,2021,Q1,Myocardial infarction,,2021,Q1,2,F,,20210226.0,20210222,20210302,EXP,,GB-SA-2020SA361619,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20210302.0,,CN,GB,GB,2021,Q1,Elderly
189243761,18924376,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, D243920A,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Back pain,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189243761,18924376,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, D243920A,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189243761,18924376,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, D243920A,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189243761,18924376,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, D243920A,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Back pain,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189243761,18924376,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, D243920A,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189243761,18924376,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, D243920A,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189243761,18924376,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, ASKU,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Back pain,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189243761,18924376,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, ASKU,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189243761,18924376,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, EACH EVENING",,,,, ASKU,,20563.0,7.0,IU,INJECTION,QD,2021,Q1,Visual impairment,,2021,Q1,1,I,202011.0,20210125.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202101011376,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210222.0,,CN,US,US,2021,Q1,Adult
189262651,18926265,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Confusional state,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Depression,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Confusional state,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Depression,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Confusional state,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Depression,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Confusional state,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Depression,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189262651,18926265,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Product storage error,,2021,Q1,1,I,202012.0,20210219.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010754,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189276941,18927694,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"14?18 U, PRN",,,U,U, C997208A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Rash,,2021,Q1,1,I,201912.0,20200106.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202001001666,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189276941,18927694,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"14?18 U, PRN",,,U,U, C997208A,,,18.0,IU,SOLUTION FOR INJECTION,,2021,Q1,Weight increased,,2021,Q1,1,I,201912.0,20200106.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202001001666,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189278551,18927855,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 U, PRN",,,U,,,,20563.0,4.0,IU,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210222.0,20210222.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010781,ELI LILLY AND CO,,84.0,YR,,F,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189278551,18927855,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 U, PRN",,,U,,,,20563.0,4.0,IU,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210222.0,20210222.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010781,ELI LILLY AND CO,,84.0,YR,,F,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189278551,18927855,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"4 U, PRN",,,U,,,,20563.0,4.0,IU,INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,20210222.0,20210222.0,20210223,20210223,PER,,US-ELI_LILLY_AND_COMPANY-US202102010781,ELI LILLY AND CO,,84.0,YR,,F,Y,,,20210223.0,,CN,US,US,2021,Q1,Elderly
189305473,18930547,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2021,Q1,Fungal sepsis,,2021,Q1,3,F,20210216.0,20210222.0,20210223,20210302,EXP,,US-ABBVIE-21P-163-3785222-00,ABBVIE,,68.0,YR,,F,Y,,,20210302.0,,MD,US,US,2021,Q1,Elderly
189305473,18930547,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,TID,2021,Q1,Fungal sepsis,,2021,Q1,3,F,20210216.0,20210222.0,20210223,20210302,EXP,,US-ABBVIE-21P-163-3785222-00,ABBVIE,,68.0,YR,,F,Y,,,20210302.0,,MD,US,US,2021,Q1,Elderly
189324061,18932406,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",60.0,IU,Y,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Acute kidney injury,,2021,Q1,1,I,20210106.0,20210218.0,20210224,20210224,EXP,FR-AFSSAPS-AM20210196,FR-SA-2021SA061669,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20210224.0,,PH,FR,FR,2021,Q1,Elderly
189324061,18932406,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",60.0,IU,Y,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Hypokalaemia,,2021,Q1,1,I,20210106.0,20210218.0,20210224,20210224,EXP,FR-AFSSAPS-AM20210196,FR-SA-2021SA061669,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20210224.0,,PH,FR,FR,2021,Q1,Elderly
189324061,18932406,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",60.0,IU,Y,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Product prescribing error,,2021,Q1,1,I,20210106.0,20210218.0,20210224,20210224,EXP,FR-AFSSAPS-AM20210196,FR-SA-2021SA061669,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20210224.0,,PH,FR,FR,2021,Q1,Elderly
189324061,18932406,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 IU, QD",60.0,IU,Y,,,,209196.0,30.0,IU,SOLUTION FOR INJECTION,QD,2021,Q1,Transcription medication error,,2021,Q1,1,I,20210106.0,20210218.0,20210224,20210224,EXP,FR-AFSSAPS-AM20210196,FR-SA-2021SA061669,SANOFI AVENTIS,,79.0,YR,E,F,Y,,,20210224.0,,PH,FR,FR,2021,Q1,Elderly
189350871,18935087,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, PREMEAL",,,,,,,,,,,,2021,Q1,Acute respiratory distress syndrome,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP002322,STRIDES,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER. 2021?68(2)",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189350871,18935087,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, PREMEAL",,,,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP002322,STRIDES,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER. 2021?68(2)",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189350871,18935087,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, PREMEAL",,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-STRIDES ARCOLAB LIMITED-2021SP002322,STRIDES,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER. 2021?68(2)",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189352871,18935287,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,PREMEAL INSULIN LISPRO,,,,,,,,,,UNKNOWN,,2021,Q1,Exfoliative rash,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101712,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189352871,18935287,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,PREMEAL INSULIN LISPRO,,,,,,,,,,UNKNOWN,,2021,Q1,Febrile neutropenia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101712,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189352871,18935287,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,PREMEAL INSULIN LISPRO,,,,,,,,,,UNKNOWN,,2021,Q1,Mucosal inflammation,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101712,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189352871,18935287,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,PREMEAL INSULIN LISPRO,,,,,,,,,,UNKNOWN,,2021,Q1,Pulmonary oedema,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101712,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",23.0,YR,,M,Y,,,20210224.0,,HP,US,US,2021,Q1,Youth
189359571,18935957,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE INSULIN LISPRO (AS NEEDED),,,,,,,,,,UNKNOWN,,2021,Q1,Febrile neutropenia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101725,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",13.0,YR,,F,Y,,,20210224.0,,HP,US,US,2021,Q1,Child
189359571,18935957,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE INSULIN LISPRO (AS NEEDED),,,,,,,,,,UNKNOWN,,2021,Q1,Hypertriglyceridaemia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101725,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",13.0,YR,,F,Y,,,20210224.0,,HP,US,US,2021,Q1,Child
189359571,18935957,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE INSULIN LISPRO (AS NEEDED),,,,,,,,,,UNKNOWN,,2021,Q1,Pancytopenia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101725,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",13.0,YR,,F,Y,,,20210224.0,,HP,US,US,2021,Q1,Child
189359571,18935957,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE INSULIN LISPRO (AS NEEDED),,,,,,,,,,UNKNOWN,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101725,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",13.0,YR,,F,Y,,,20210224.0,,HP,US,US,2021,Q1,Child
189359571,18935957,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Febrile neutropenia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101725,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",13.0,YR,,F,Y,,,20210224.0,,HP,US,US,2021,Q1,Child
189359571,18935957,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hypertriglyceridaemia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101725,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",13.0,YR,,F,Y,,,20210224.0,,HP,US,US,2021,Q1,Child
189359571,18935957,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101725,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",13.0,YR,,F,Y,,,20210224.0,,HP,US,US,2021,Q1,Child
189359571,18935957,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210215.0,20210224,20210224,EXP,,US-FRESENIUS KABI-FK202101725,FRESENIUS KABI,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES INPATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68 (2):.",13.0,YR,,F,Y,,,20210224.0,,HP,US,US,2021,Q1,Child
189419892,18941989,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,"6 UNIT, BID",,,U,,,,,6.0,DF,,BID,2021,Q1,Fatigue,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189419892,18941989,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,"6 UNIT, BID",,,U,,,,,6.0,DF,,BID,2021,Q1,Hypothyroidism,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189419892,18941989,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,"6 UNIT, BID",,,U,,,,,6.0,DF,,BID,2021,Q1,Hypovolaemic shock,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189419892,18941989,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,"6 UNIT, BID",,,U,,,,,6.0,DF,,BID,2021,Q1,Ketoacidosis,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189419892,18941989,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,"6 UNIT, BID",,,U,,,,,6.0,DF,,BID,2021,Q1,Multiple organ dysfunction syndrome,,2021,Q1,2,F,20201111.0,20210226.0,20210225,20210302,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-097416,BRISTOL MYERS SQUIBB,,68.0,YR,,M,Y,,,20210302.0,,HP,CN,CN,2021,Q1,Elderly
189425152,18942515,9,C,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q1,Renal impairment,,2021,Q1,2,F,20210201.0,20210301.0,20210225,20210303,EXP,PT-INFARMED-T202102-167,PT-GILEAD-2021-0518491,GILEAD,,55.0,YR,A,M,Y,107.0,KG,20210303.0,,PH,PT,PT,2021,Q1,Adult
189434681,18943468,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210223.0,20210224.0,20210226,20210226,PER,,US-ELI_LILLY_AND_COMPANY-US202102012860,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20210226.0,,CN,US,US,2021,Q1,Adult
189438301,18943830,6,SS,Lispro,INSULIN LISPRO,1,,UNK,,,D,, UNK,,,,,,,2021,Q1,Suspected suicide,,2021,Q1,1,I,,20210217.0,20210226,20210226,EXP,,US-NOVAST LABORATORIES LTD.-2021NOV000191,NOVAST,,61.0,YR,,M,Y,,,20210226.0,,MD,US,US,2021,Q1,Adult
189450821,18945082,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Adrenal insufficiency,,2021,Q1,1,I,,20210215.0,20210226,20210226,EXP,,US-MYLANLABS-2021M1011155,MYLAN,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,,F,Y,,,20210226.0,,HP,US,US,2021,Q1,Child
189450821,18945082,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210215.0,20210226,20210226,EXP,,US-MYLANLABS-2021M1011155,MYLAN,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,,F,Y,,,20210226.0,,HP,US,US,2021,Q1,Child
189450821,18945082,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Febrile neutropenia,,2021,Q1,1,I,,20210215.0,20210226,20210226,EXP,,US-MYLANLABS-2021M1011155,MYLAN,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,,F,Y,,,20210226.0,,HP,US,US,2021,Q1,Child
189450821,18945082,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210215.0,20210226,20210226,EXP,,US-MYLANLABS-2021M1011155,MYLAN,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,,F,Y,,,20210226.0,,HP,US,US,2021,Q1,Child
189450821,18945082,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,,20210215.0,20210226,20210226,EXP,,US-MYLANLABS-2021M1011155,MYLAN,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,,F,Y,,,20210226.0,,HP,US,US,2021,Q1,Child
189450821,18945082,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210215.0,20210226,20210226,EXP,,US-MYLANLABS-2021M1011155,MYLAN,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,,F,Y,,,20210226.0,,HP,US,US,2021,Q1,Child
189450821,18945082,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Steroid withdrawal syndrome,,2021,Q1,1,I,,20210215.0,20210226,20210226,EXP,,US-MYLANLABS-2021M1011155,MYLAN,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,,F,Y,,,20210226.0,,HP,US,US,2021,Q1,Child
189450821,18945082,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,,20210215.0,20210226,20210226,EXP,,US-MYLANLABS-2021M1011155,MYLAN,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,,F,Y,,,20210226.0,,HP,US,US,2021,Q1,Child
189515111,18951511,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Adrenal insufficiency,,2021,Q1,1,I,,20210215.0,20210301,20210301,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-02375,LUPIN,,24.0,YR,,F,Y,,,20210301.0,,HP,US,US,2021,Q1,Young Adult
189515111,18951511,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210215.0,20210301,20210301,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-02375,LUPIN,,24.0,YR,,F,Y,,,20210301.0,,HP,US,US,2021,Q1,Young Adult
189515111,18951511,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210215.0,20210301,20210301,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-02375,LUPIN,,24.0,YR,,F,Y,,,20210301.0,,HP,US,US,2021,Q1,Young Adult
189519132,18951913,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,2,F,,20210313.0,20210301,20210327,PER,,US-DRREDDYS-USA/USA/21/0132532,DR REDDYS,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68(2):1?5. DOI:10.1002/PBC.28815",13.0,YR,T,F,Y,,,20210327.0,,HP,US,US,2021,Q1,Child
189519132,18951913,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Febrile neutropenia,,2021,Q1,2,F,,20210313.0,20210301,20210327,PER,,US-DRREDDYS-USA/USA/21/0132532,DR REDDYS,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68(2):1?5. DOI:10.1002/PBC.28815",13.0,YR,T,F,Y,,,20210327.0,,HP,US,US,2021,Q1,Child
189519132,18951913,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Hypertriglyceridaemia,,2021,Q1,2,F,,20210313.0,20210301,20210327,PER,,US-DRREDDYS-USA/USA/21/0132532,DR REDDYS,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68(2):1?5. DOI:10.1002/PBC.28815",13.0,YR,T,F,Y,,,20210327.0,,HP,US,US,2021,Q1,Child
189519132,18951913,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,2,F,,20210313.0,20210301,20210327,PER,,US-DRREDDYS-USA/USA/21/0132532,DR REDDYS,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68(2):1?5. DOI:10.1002/PBC.28815",13.0,YR,T,F,Y,,,20210327.0,,HP,US,US,2021,Q1,Child
189519132,18951913,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Pneumonia,,2021,Q1,2,F,,20210313.0,20210301,20210327,PER,,US-DRREDDYS-USA/USA/21/0132532,DR REDDYS,"FEIN LEVY C, PRESSWALA L, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATRIC BLOOD AND CANCER. 2021 FEB?68(2):1?5. DOI:10.1002/PBC.28815",13.0,YR,T,F,Y,,,20210327.0,,HP,US,US,2021,Q1,Child
189525571,18952557,3,SS,Lispro,INSULIN LISPRO,1,,UNK,,,D,, UNK,,,,,,,2021,Q1,Suspected suicide,,2021,Q1,1,I,,20210217.0,20210301,20210301,EXP,,US-NOVAST LABORATORIES LTD.-2021NOV000136,NOVAST,,46.0,YR,,F,Y,,,20210301.0,,MD,US,US,2021,Q1,Adult
189537031,18953703,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, DAILY",,,D,,,,20563.0,,,,QD,2021,Q1,Myocardial infarction,,2021,Q1,1,I,,20210224.0,20210301,20210301,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202102012650,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20210301.0,,CN,GB,GB,2021,Q1,Elderly
189620801,18962080,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0?0?0?5, PEN)",,,U,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,DE-ADRED-04304-01,NVSC2021DE047347,NOVARTIS,,72.0,YR,,F,Y,,,20210303.0,,HP,DE,DE,2021,Q1,Elderly
189620801,18962080,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0?0?0?5, PEN)",,,U,,,,,,,,,2021,Q1,Fall,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,DE-ADRED-04304-01,NVSC2021DE047347,NOVARTIS,,72.0,YR,,F,Y,,,20210303.0,,HP,DE,DE,2021,Q1,Elderly
189620801,18962080,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0?0?0?5, PEN)",,,U,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,DE-ADRED-04304-01,NVSC2021DE047347,NOVARTIS,,72.0,YR,,F,Y,,,20210303.0,,HP,DE,DE,2021,Q1,Elderly
189620801,18962080,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0?0?0?5, PEN)",,,U,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,DE-ADRED-04304-01,NVSC2021DE047347,NOVARTIS,,72.0,YR,,F,Y,,,20210303.0,,HP,DE,DE,2021,Q1,Elderly
189636372,18963637,11,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,,,,,,,,SOLUTION,TID,2021,Q1,Rash,,2021,Q1,2,F,20210120.0,20210308.0,20210303,20210316,PER,,US-CELGENEUS-USA-20210300324,CELGENE,,81.0,YR,,F,Y,62.6,KG,20210316.0,,MD,US,US,2021,Q1,Elderly
189638331,18963833,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,DE-JNJFOC-20210300763,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,64.0,KG,20210303.0,,PH,DE,DE,2021,Q1,Elderly
189638331,18963833,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,DE-JNJFOC-20210300763,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,64.0,KG,20210303.0,,PH,DE,DE,2021,Q1,Elderly
189638331,18963833,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q1,Pain,,2021,Q1,1,I,,20210301.0,20210303,20210303,EXP,,DE-JNJFOC-20210300763,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,64.0,KG,20210303.0,,PH,DE,DE,2021,Q1,Elderly
189669724,18966972,16,C,Insulin lispro,INSULIN LISPRO,1,Unknown,100U/ML,,,,,,,,,,UNKNOWN,,2021,Q1,Bronchitis,,2021,Q1,4,F,202102.0,20210301.0,20210304,20210311,EXP,,US-CELGENEUS-USA-20210300282,CELGENE,,56.0,YR,,F,Y,95.34,KG,20210311.0,,PH,US,US,2021,Q1,Adult
189669724,18966972,16,C,Insulin lispro,INSULIN LISPRO,1,Unknown,100U/ML,,,,,,,,,,UNKNOWN,,2021,Q1,Haematochezia,,2021,Q1,4,F,202102.0,20210301.0,20210304,20210311,EXP,,US-CELGENEUS-USA-20210300282,CELGENE,,56.0,YR,,F,Y,95.34,KG,20210311.0,,PH,US,US,2021,Q1,Adult
189671491,18967149,4,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Angioedema,,2021,Q1,1,I,20210201.0,20210223.0,20210304,20210304,EXP,PT-INFARMED-R202102-1242,PT-TEVA-2021-PT-1885365,TEVA,,83.0,YR,E,F,Y,103.0,KG,20210304.0,,MD,PT,PT,2021,Q1,Elderly
189671491,18967149,4,C,INSULIN LISPRO PROTAMINE,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q1,Dysphonia,,2021,Q1,1,I,20210201.0,20210223.0,20210304,20210304,EXP,PT-INFARMED-R202102-1242,PT-TEVA-2021-PT-1885365,TEVA,,83.0,YR,E,F,Y,103.0,KG,20210304.0,,MD,PT,PT,2021,Q1,Elderly
189703281,18970328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 COFFEES, 4 LUNCHES AND DINNERS",,,,, UNKNOWN,,,,,,,2021,Q1,Hypoaesthesia,,2021,Q1,1,I,201906.0,20201022.0,20210304,20210304,EXP,,BR-NOVOPROD-790228,NOVO NORDISK,,43.0,YR,,M,Y,69.3,KG,20210304.0,,MD,BR,BR,2021,Q1,Adult
189703281,18970328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 COFFEES, 4 LUNCHES AND DINNERS",,,,, UNKNOWN,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,201906.0,20201022.0,20210304,20210304,EXP,,BR-NOVOPROD-790228,NOVO NORDISK,,43.0,YR,,M,Y,69.3,KG,20210304.0,,MD,BR,BR,2021,Q1,Adult
189703281,18970328,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 COFFEES, 4 LUNCHES AND DINNERS",,,,, UNKNOWN,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,201906.0,20201022.0,20210304,20210304,EXP,,BR-NOVOPROD-790228,NOVO NORDISK,,43.0,YR,,M,Y,69.3,KG,20210304.0,,MD,BR,BR,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Abscess,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Adrenal insufficiency,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Ascites,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Asthenia,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Blood alkaline phosphatase increased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Blood bilirubin increased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Blood potassium decreased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Blood pressure diastolic abnormal,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Blood pressure increased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Congestive hepatopathy,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Depression,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Diverticulitis,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Endometrial disorder,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Enterococcus test positive,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Fibrosis,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Gamma-glutamyltransferase increased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Gastrointestinal disorder,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Generalised oedema,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Heart rate increased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Herpes zoster,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hypersensitivity,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Increased appetite,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Influenza,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Infusion related reaction,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Injection site extravasation,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Intensive care unit acquired weakness,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Intervertebral disc protrusion,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Joint effusion,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Joint swelling,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Micturition disorder,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Myelopathy,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Myopathy,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Nasopharyngitis,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Nerve compression,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Neuropathy peripheral,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Peripheral sensorimotor neuropathy,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Peritonitis,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Pseudomonal bacteraemia,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Rheumatoid arthritis,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Therapeutic response decreased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189713561,18971356,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Weight increased,,2021,Q1,1,I,,20210226.0,20210304,20210304,EXP,,CA-ROCHE-2778675,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210305.0,,HP,CA,CA,2021,Q1,Adult
189714482,18971448,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,, UNK,,,,,,,2021,Q1,Cerebrovascular accident,,2021,Q1,2,F,20210209.0,20210315.0,20210305,20210324,EXP,,US-EXELIXIS-XL18421038013,EXELIXIS,,57.0,YR,,M,Y,130.0,KG,20210324.0,,MD,US,US,2021,Q1,Adult
189714482,18971448,6,C,Insulin lispro,INSULIN LISPRO,1,,,,,,, UNK,,,,,,,2021,Q1,Hypophysitis,,2021,Q1,2,F,20210209.0,20210315.0,20210305,20210324,EXP,,US-EXELIXIS-XL18421038013,EXELIXIS,,57.0,YR,,M,Y,130.0,KG,20210324.0,,MD,US,US,2021,Q1,Adult
189729581,18972958,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210225.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-008949,AUROBINDO,,74.0,YR,,M,Y,64.0,KG,20210305.0,,PH,DE,DE,2021,Q1,Elderly
189729581,18972958,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210225.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-008949,AUROBINDO,,74.0,YR,,M,Y,64.0,KG,20210305.0,,PH,DE,DE,2021,Q1,Elderly
189729581,18972958,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Pain,,2021,Q1,1,I,,20210225.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-008949,AUROBINDO,,74.0,YR,,M,Y,64.0,KG,20210305.0,,PH,DE,DE,2021,Q1,Elderly
189739311,18973931,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0?0?0?5, PEN)",,,U,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210301.0,20210305,20210305,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
189739311,18973931,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0?0?0?5, PEN)",,,U,,,,,,,,,2021,Q1,Fall,,2021,Q1,1,I,,20210301.0,20210305,20210305,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
189739311,18973931,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0?0?0?5, PEN)",,,U,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210305,20210305,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
189739311,18973931,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0?0?0?5, PEN)",,,U,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,,20210301.0,20210305,20210305,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,,,20210305.0,,HP,DE,DE,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Asthma,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Blood count abnormal,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Chest discomfort,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Cough,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Diaphragmatic disorder,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Discomfort,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Hypoxia,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Left ventricular hypertrophy,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Obstructive airways disorder,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Oedema peripheral,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Oropharyngeal pain,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Pyrexia,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Therapeutic product effect incomplete,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Weight increased,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189742071,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,BID,2021,Q1,Wheezing,,2021,Q1,1,I,,20210223.0,20210305,20210305,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20210305.0,,CN,CA,CA,2021,Q1,Elderly
189760171,18976017,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210226.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-009048,AUROBINDO,,82.0,YR,,F,Y,,,20210306.0,,PH,DE,DE,2021,Q1,Elderly
189760171,18976017,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,,,,,,,,,,2021,Q1,Apnoea,,2021,Q1,1,I,,20210226.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-009048,AUROBINDO,,82.0,YR,,F,Y,,,20210306.0,,PH,DE,DE,2021,Q1,Elderly
189760171,18976017,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,,,,,,,,,,2021,Q1,Aspiration,,2021,Q1,1,I,,20210226.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-009048,AUROBINDO,,82.0,YR,,F,Y,,,20210306.0,,PH,DE,DE,2021,Q1,Elderly
189760171,18976017,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210226.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-009048,AUROBINDO,,82.0,YR,,F,Y,,,20210306.0,,PH,DE,DE,2021,Q1,Elderly
189760171,18976017,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210226.0,20210305,20210305,EXP,,DE-AUROBINDO-AUR-APL-2021-009048,AUROBINDO,,82.0,YR,,F,Y,,,20210306.0,,PH,DE,DE,2021,Q1,Elderly
189774971,18977497,10,SS,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,D,,,,,,,,,2021,Q1,Completed suicide,,2021,Q1,1,I,,20210224.0,20210306,20210306,EXP,,US-TORRENT-00010910,TORRENT,,61.0,YR,A,M,Y,,,20210306.0,,MD,US,US,2021,Q1,Adult
189774971,18977497,10,SS,insulin lispro,INSULIN LISPRO,1,,UNKNOWN,,,D,,,,,,,,,2021,Q1,Toxicity to various agents,,2021,Q1,1,I,,20210224.0,20210306,20210306,EXP,,US-TORRENT-00010910,TORRENT,,61.0,YR,A,M,Y,,,20210306.0,,MD,US,US,2021,Q1,Adult
189776011,18977601,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,U,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210301.0,20210306,20210306,EXP,DE-ADRED-05954-01,NVSC2021DE047841,NOVARTIS,,82.0,YR,,F,Y,,,20210306.0,,HP,DE,DE,2021,Q1,Elderly
189776011,18977601,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,U,,,,,,,,,2021,Q1,Apnoea,,2021,Q1,1,I,,20210301.0,20210306,20210306,EXP,DE-ADRED-05954-01,NVSC2021DE047841,NOVARTIS,,82.0,YR,,F,Y,,,20210306.0,,HP,DE,DE,2021,Q1,Elderly
189776011,18977601,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,U,,,,,,,,,2021,Q1,Aspiration,,2021,Q1,1,I,,20210301.0,20210306,20210306,EXP,DE-ADRED-05954-01,NVSC2021DE047841,NOVARTIS,,82.0,YR,,F,Y,,,20210306.0,,HP,DE,DE,2021,Q1,Elderly
189776011,18977601,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,U,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210301.0,20210306,20210306,EXP,DE-ADRED-05954-01,NVSC2021DE047841,NOVARTIS,,82.0,YR,,F,Y,,,20210306.0,,HP,DE,DE,2021,Q1,Elderly
189776011,18977601,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (8?0?0?0),,,U,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210306,20210306,EXP,DE-ADRED-05954-01,NVSC2021DE047841,NOVARTIS,,82.0,YR,,F,Y,,,20210306.0,,HP,DE,DE,2021,Q1,Elderly
189792972,18979297,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK , DAILY",,,U,U,,,,,,,,2021,Q1,Myocardial infarction,,2021,Q1,2,F,,20210307.0,20210308,20210318,EXP,GB-MHRA-ADR 24817899,GB-NOVOPROD-791000,NOVO NORDISK,,72.0,YR,,F,Y,,,20210318.0,,CN,GB,GB,2021,Q1,Elderly
189797251,18979725,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Balance disorder,,2021,Q1,1,I,202010.0,20210226.0,20210308,20210308,EXP,,US-ELI_LILLY_AND_COMPANY-US202103000557,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20210308.0,,CN,US,US,2021,Q1,Adult
189797251,18979725,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202010.0,20210226.0,20210308,20210308,EXP,,US-ELI_LILLY_AND_COMPANY-US202103000557,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20210308.0,,CN,US,US,2021,Q1,Adult
189797251,18979725,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Fall,,2021,Q1,1,I,202010.0,20210226.0,20210308,20210308,EXP,,US-ELI_LILLY_AND_COMPANY-US202103000557,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20210308.0,,CN,US,US,2021,Q1,Adult
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Adrenal insufficiency,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Deafness,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Febrile neutropenia,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Hypoaesthesia,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Neuralgia,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Steroid withdrawal syndrome,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Tinnitus,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189819011,18981901,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q1,Type 2 diabetes mellitus,,2021,Q1,1,I,,20210222.0,20210308,20210308,EXP,,US-TEVA-2021-US-1885294,TEVA,"FEIN LEVY C, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR?BLOOD?CANCER 2021?68:NO. 2.",13.0,YR,T,F,Y,,,20210308.0,,HP,US,US,2021,Q1,Child
189820471,18982047,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010082,GLAXOSMITHKLINE,,74.0,YR,,M,Y,64.0,KG,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820471,18982047,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010082,GLAXOSMITHKLINE,,74.0,YR,,M,Y,64.0,KG,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189820471,18982047,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Pain,,2021,Q1,1,I,,20210301.0,20210308,20210308,EXP,,DE-GLAXOSMITHKLINE-DECH2021010082,GLAXOSMITHKLINE,,74.0,YR,,M,Y,64.0,KG,20210308.0,,PH,DE,DE,2021,Q1,Elderly
189837133,18983713,1,PS,Lispro,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q1,Blood glucose increased,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,1,PS,Lispro,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q1,Drug ineffective,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,1,PS,Lispro,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q1,Fear,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,1,PS,Lispro,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q1,Hyperglycaemia,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,1,PS,Lispro,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,1,PS,Lispro,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q1,Malaise,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189837133,18983713,1,PS,Lispro,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q1,Unhealthy diet,,2021,Q1,3,F,20210209.0,20210319.0,20210308,20210330,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20210330.0,,CN,ES,ES,2021,Q1,Adult
189917131,18991713,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"80 U, UNKNOWN",,,,,,,20563.0,80.0,IU,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210226.0,20210226.0,20210310,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202103003036,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Elderly
189917131,18991713,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"80 U, UNKNOWN",,,,,,,20563.0,80.0,IU,INJECTION,,2021,Q1,Hypopnoea,,2021,Q1,1,I,20210226.0,20210226.0,20210310,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202103003036,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Elderly
189917131,18991713,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"80 U, UNKNOWN",,,,,,,20563.0,80.0,IU,INJECTION,,2021,Q1,Injection site pain,,2021,Q1,1,I,20210226.0,20210226.0,20210310,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202103003036,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Elderly
189917131,18991713,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"80 U, UNKNOWN",,,,,,,20563.0,80.0,IU,INJECTION,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20210226.0,20210226.0,20210310,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202103003036,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Elderly
189917131,18991713,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"80 U, UNKNOWN",,,,, D261904A,,20563.0,80.0,IU,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,20210226.0,20210226.0,20210310,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202103003036,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Elderly
189917131,18991713,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"80 U, UNKNOWN",,,,, D261904A,,20563.0,80.0,IU,INJECTION,,2021,Q1,Hypopnoea,,2021,Q1,1,I,20210226.0,20210226.0,20210310,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202103003036,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Elderly
189917131,18991713,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"80 U, UNKNOWN",,,,, D261904A,,20563.0,80.0,IU,INJECTION,,2021,Q1,Injection site pain,,2021,Q1,1,I,20210226.0,20210226.0,20210310,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202103003036,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Elderly
189917131,18991713,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"80 U, UNKNOWN",,,,, D261904A,,20563.0,80.0,IU,INJECTION,,2021,Q1,Loss of consciousness,,2021,Q1,1,I,20210226.0,20210226.0,20210310,20210310,PER,,US-ELI_LILLY_AND_COMPANY-US202103003036,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20210310.0,,CN,US,US,2021,Q1,Elderly
189931381,18993138,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,DE-ADRED-04179-01,NVSC2021DE047148,NOVARTIS,,74.0,YR,,M,Y,64.0,KG,20210310.0,,HP,DE,DE,2021,Q1,Elderly
189931381,18993138,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,DE-ADRED-04179-01,NVSC2021DE047148,NOVARTIS,,74.0,YR,,M,Y,64.0,KG,20210310.0,,HP,DE,DE,2021,Q1,Elderly
189931381,18993138,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q1,Pain,,2021,Q1,1,I,,20210301.0,20210310,20210310,EXP,DE-ADRED-04179-01,NVSC2021DE047148,NOVARTIS,,74.0,YR,,M,Y,64.0,KG,20210310.0,,HP,DE,DE,2021,Q1,Elderly
189932191,18993219,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210127.0,20210224.0,20210310,20210310,EXP,GB-MHRA-EYC 00241587,GB-TEVA-2021-GB-1885966,TEVA,,63.0,YR,A,M,Y,65.0,KG,20210310.0,,HP,GB,GB,2021,Q1,Adult
189932191,18993219,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Cognitive disorder,,2021,Q1,1,I,20210127.0,20210224.0,20210310,20210310,EXP,GB-MHRA-EYC 00241587,GB-TEVA-2021-GB-1885966,TEVA,,63.0,YR,A,M,Y,65.0,KG,20210310.0,,HP,GB,GB,2021,Q1,Adult
189932191,18993219,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,20210127.0,20210224.0,20210310,20210310,EXP,GB-MHRA-EYC 00241587,GB-TEVA-2021-GB-1885966,TEVA,,63.0,YR,A,M,Y,65.0,KG,20210310.0,,HP,GB,GB,2021,Q1,Adult
189932191,18993219,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Oxygen saturation decreased,,2021,Q1,1,I,20210127.0,20210224.0,20210310,20210310,EXP,GB-MHRA-EYC 00241587,GB-TEVA-2021-GB-1885966,TEVA,,63.0,YR,A,M,Y,65.0,KG,20210310.0,,HP,GB,GB,2021,Q1,Adult
189938771,18993877,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,, UNK,,,,,,,2021,Q1,Death,,2021,Q1,1,I,20201214.0,20210302.0,20210310,20210310,EXP,,US-CHIESI-2021CHF00994,CHIESI,,70.0,YR,E,M,Y,103.0,KG,20210310.0,,HP,US,US,2021,Q1,Elderly
189951501,18995150,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 0?0?0?5, PEN",,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-MICRO LABS LIMITED-ML2021-00671,MICRO LABS,,72.0,YR,,F,Y,130.0,KG,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189951501,18995150,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 0?0?0?5, PEN",,,,,,,,,,,,2021,Q1,Fall,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-MICRO LABS LIMITED-ML2021-00671,MICRO LABS,,72.0,YR,,F,Y,130.0,KG,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189951501,18995150,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 0?0?0?5, PEN",,,,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-MICRO LABS LIMITED-ML2021-00671,MICRO LABS,,72.0,YR,,F,Y,130.0,KG,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189951501,18995150,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, 0?0?0?5, PEN",,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,,20210301.0,20210311,20210311,EXP,,DE-MICRO LABS LIMITED-ML2021-00671,MICRO LABS,,72.0,YR,,F,Y,130.0,KG,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189986781,18998678,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Arthralgia,,2021,Q1,1,I,,20210302.0,20210311,20210311,EXP,,DE-TEVA-2021-DE-1887347,TEVA,,74.0,YR,E,M,Y,64.0,KG,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189986781,18998678,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Contraindicated product administered,,2021,Q1,1,I,,20210302.0,20210311,20210311,EXP,,DE-TEVA-2021-DE-1887347,TEVA,,74.0,YR,E,M,Y,64.0,KG,20210311.0,,PH,DE,DE,2021,Q1,Elderly
189986781,18998678,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q1,Pain,,2021,Q1,1,I,,20210302.0,20210311,20210311,EXP,,DE-TEVA-2021-DE-1887347,TEVA,,74.0,YR,E,M,Y,64.0,KG,20210311.0,,PH,DE,DE,2021,Q1,Elderly
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Anxiety,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Blood glucose increased,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Depression,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Drug ineffective,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Intervertebral disc disorder,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Nerve compression,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Pain in extremity,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190018541,19001854,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"8?12 U, EACH EVENING (AT NIGHT TIME)",,,U,, D261904A,,20563.0,12.0,IU,INJECTION,QD,2021,Q1,Tremor,,2021,Q1,1,I,201703.0,20210302.0,20210312,20210312,EXP,,US-ELI_LILLY_AND_COMPANY-US202103002403,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210312.0,,CN,US,US,2021,Q1,Adult
190026681,19002668,9,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q1,Atrial fibrillation,,2021,Q1,1,I,20210201.0,20210305.0,20210312,20210312,PER,,US-CELGENEUS-USA-20210301969,CELGENE,,76.0,YR,,M,Y,101.8,KG,20210312.0,,MD,US,US,2021,Q1,Elderly
190034571,19003457,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05954-01,DE-TORRENT-00019800,TORRENT,,82.0,YR,E,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190034571,19003457,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,Apnoea,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05954-01,DE-TORRENT-00019800,TORRENT,,82.0,YR,E,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190034571,19003457,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,Aspiration,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05954-01,DE-TORRENT-00019800,TORRENT,,82.0,YR,E,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190034571,19003457,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05954-01,DE-TORRENT-00019800,TORRENT,,82.0,YR,E,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190034571,19003457,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210312,20210312,EXP,DE-ADRED-05954-01,DE-TORRENT-00019800,TORRENT,,82.0,YR,E,F,Y,,,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190036931,19003693,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"5 DOSAGE FORMS DAILY; 1 IU, 0?0?0?5",,,,,,,,5.0,DF,,QD,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210302.0,20210312,20210312,EXP,,DE-TEVA-2021-DE-1888015,TEVA,,72.0,YR,E,F,Y,130.0,KG,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190036931,19003693,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"5 DOSAGE FORMS DAILY; 1 IU, 0?0?0?5",,,,,,,,5.0,DF,,QD,2021,Q1,Fall,,2021,Q1,1,I,,20210302.0,20210312,20210312,EXP,,DE-TEVA-2021-DE-1888015,TEVA,,72.0,YR,E,F,Y,130.0,KG,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190036931,19003693,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"5 DOSAGE FORMS DAILY; 1 IU, 0?0?0?5",,,,,,,,5.0,DF,,QD,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210302.0,20210312,20210312,EXP,,DE-TEVA-2021-DE-1888015,TEVA,,72.0,YR,E,F,Y,130.0,KG,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190036931,19003693,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"5 DOSAGE FORMS DAILY; 1 IU, 0?0?0?5",,,,,,,,5.0,DF,,QD,2021,Q1,Nausea,,2021,Q1,1,I,,20210302.0,20210312,20210312,EXP,,DE-TEVA-2021-DE-1888015,TEVA,,72.0,YR,E,F,Y,130.0,KG,20210312.0,,PH,DE,DE,2021,Q1,Elderly
190042511,19004251,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210226.0,20210313,20210313,EXP,,DE-35507-2021-02828,LUPIN,,82.0,YR,,F,Y,,,20210313.0,,CN,NL,DE,2021,Q1,Elderly
190042511,19004251,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Apnoea,,2021,Q1,1,I,,20210226.0,20210313,20210313,EXP,,DE-35507-2021-02828,LUPIN,,82.0,YR,,F,Y,,,20210313.0,,CN,NL,DE,2021,Q1,Elderly
190042511,19004251,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Aspiration,,2021,Q1,1,I,,20210226.0,20210313,20210313,EXP,,DE-35507-2021-02828,LUPIN,,82.0,YR,,F,Y,,,20210313.0,,CN,NL,DE,2021,Q1,Elderly
190042511,19004251,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210226.0,20210313,20210313,EXP,,DE-35507-2021-02828,LUPIN,,82.0,YR,,F,Y,,,20210313.0,,CN,NL,DE,2021,Q1,Elderly
190042511,19004251,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210226.0,20210313,20210313,EXP,,DE-35507-2021-02828,LUPIN,,82.0,YR,,F,Y,,,20210313.0,,CN,NL,DE,2021,Q1,Elderly
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Abdominal distension,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Areflexia,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Cardiac arrest,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Cyanosis,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Eye movement disorder,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Head titubation,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Hypertension,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Hypokinesia,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Lung consolidation,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Overdose,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Pulse absent,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Pyrexia,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Seizure,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Unresponsive to stimuli,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190050981,19005098,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL OF 14.5 UNITS OF INSULIN VIA HIS PUMP,,,D,,,,209196.0,,,,,2021,Q1,Ventricular fibrillation,,2021,Q1,1,I,,20210308.0,20210312,20210312,EXP,,US-SA-2021SA081192,SANOFI AVENTIS,"SKOLNIK, A. EWALD, M.. CASE FILES OF THE HARVARD MEDICAL TOXICOLOGY FELLOWSHIP AT CHILDREN?S HOSPITAL BOSTON: AN INSULIN OVERDOSE. JOURNAL OF MEDICAL TOXICOLOGY. 2010?6:4:413?419",16.0,YR,T,M,Y,,,20210312.0,,HP,US,US,2021,Q1,Youth
190074671,19007467,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210122.0,,20210315,20210315,DIR,,,FDA-CTU,,80.0,YR,,F,N,49.3,KG,20210315.0,N,PH,US,US,2021,Q1,Elderly
190074671,19007467,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,COVID-19 pneumonia,,2021,Q1,1,I,20210122.0,,20210315,20210315,DIR,,,FDA-CTU,,80.0,YR,,F,N,49.3,KG,20210315.0,N,PH,US,US,2021,Q1,Elderly
190074671,19007467,5,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Intracranial mass,,2021,Q1,1,I,20210122.0,,20210315,20210315,DIR,,,FDA-CTU,,80.0,YR,,F,N,49.3,KG,20210315.0,N,PH,US,US,2021,Q1,Elderly
190087471,19008747,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0 (),,,U,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210301.0,20210316,20210316,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-285889,RANBAXY,,82.0,YR,,F,Y,,,20210316.0,,HP,NL,DE,2021,Q1,Elderly
190087471,19008747,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0 (),,,U,,,,,,,,,2021,Q1,Apnoea,,2021,Q1,1,I,,20210301.0,20210316,20210316,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-285889,RANBAXY,,82.0,YR,,F,Y,,,20210316.0,,HP,NL,DE,2021,Q1,Elderly
190087471,19008747,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0 (),,,U,,,,,,,,,2021,Q1,Aspiration,,2021,Q1,1,I,,20210301.0,20210316,20210316,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-285889,RANBAXY,,82.0,YR,,F,Y,,,20210316.0,,HP,NL,DE,2021,Q1,Elderly
190087471,19008747,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0 (),,,U,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210301.0,20210316,20210316,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-285889,RANBAXY,,82.0,YR,,F,Y,,,20210316.0,,HP,NL,DE,2021,Q1,Elderly
190087471,19008747,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0 (),,,U,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210301.0,20210316,20210316,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-285889,RANBAXY,,82.0,YR,,F,Y,,,20210316.0,,HP,NL,DE,2021,Q1,Elderly
190100781,19010078,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q1,Bradycardia,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190100781,19010078,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190100781,19010078,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190100781,19010078,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190100781,19010078,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210312.0,20210315,20210315,EXP,DE-ADRED-06274-01,NVSC2021DE058715,NOVARTIS,,71.0,YR,,F,Y,,,20210315.0,,HP,DE,DE,2021,Q1,Elderly
190109251,19010925,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Cerebral disorder,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Memory impairment,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Cerebral disorder,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Memory impairment,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Cerebral disorder,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Coma,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Memory impairment,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Product dose omission issue,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190109251,19010925,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,2017.0,20210304.0,20210316,20210316,EXP,,US-ELI_LILLY_AND_COMPANY-US202103003969,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210316.0,,CN,US,US,2021,Q1,Elderly
190112151,19011215,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-HETERO-HET2021DE00579,HETERO,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190112151,19011215,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,Apnoea,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-HETERO-HET2021DE00579,HETERO,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190112151,19011215,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,Aspiration,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-HETERO-HET2021DE00579,HETERO,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190112151,19011215,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-HETERO-HET2021DE00579,HETERO,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190112151,19011215,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,U,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-HETERO-HET2021DE00579,HETERO,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190129861,19012986,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q1,Hyperkalaemia,,2021,Q1,1,I,20210309.0,20210310.0,20210316,20210316,EXP,,US-GLAXOSMITHKLINE-US2021GSK060835,GLAXOSMITHKLINE,,70.0,YR,,M,Y,82.09,KG,20210316.0,,MD,US,US,2021,Q1,Elderly
190129861,19012986,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q1,Hyponatraemia,,2021,Q1,1,I,20210309.0,20210310.0,20210316,20210316,EXP,,US-GLAXOSMITHKLINE-US2021GSK060835,GLAXOSMITHKLINE,,70.0,YR,,M,Y,82.09,KG,20210316.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,Blood pressure increased,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,Dyspepsia,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,Extrasystoles,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,Fall,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,Hemiplegia,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,International normalised ratio decreased,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,Platelet count decreased,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190132091,19013209,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,"12 IU, TID",,,U,,,,,12.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,Q8H,2021,Q1,Unevaluable event,,2021,Q1,1,I,20210128.0,20210302.0,20210315,20210315,EXP,,US-SA-2021SA087342,SANOFI AVENTIS,,83.0,YR,E,F,Y,59.8,KG,20210315.0,,MD,US,US,2021,Q1,Elderly
190138351,19013835,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,DE-BFARM-21002014,DE-UCBSA-2021010784,UCB,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190138351,19013835,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Apnoea,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,DE-BFARM-21002014,DE-UCBSA-2021010784,UCB,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190138351,19013835,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Aspiration,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,DE-BFARM-21002014,DE-UCBSA-2021010784,UCB,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190138351,19013835,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,DE-BFARM-21002014,DE-UCBSA-2021010784,UCB,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190138351,19013835,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,DE-BFARM-21002014,DE-UCBSA-2021010784,UCB,,82.0,YR,,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190149511,19014951,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8 DOSAGE FORMS DAILY; 8?0?0?0,,,,,,,,8.0,DF,,QD,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,DE-TEVA-2021-DE-1890184,TEVA,,82.0,YR,E,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190149511,19014951,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8 DOSAGE FORMS DAILY; 8?0?0?0,,,,,,,,8.0,DF,,QD,2021,Q1,Apnoea,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,DE-TEVA-2021-DE-1890184,TEVA,,82.0,YR,E,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190149511,19014951,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8 DOSAGE FORMS DAILY; 8?0?0?0,,,,,,,,8.0,DF,,QD,2021,Q1,Aspiration,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,DE-TEVA-2021-DE-1890184,TEVA,,82.0,YR,E,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190149511,19014951,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8 DOSAGE FORMS DAILY; 8?0?0?0,,,,,,,,8.0,DF,,QD,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,DE-TEVA-2021-DE-1890184,TEVA,,82.0,YR,E,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190149511,19014951,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8 DOSAGE FORMS DAILY; 8?0?0?0,,,,,,,,8.0,DF,,QD,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210308.0,20210316,20210316,EXP,,DE-TEVA-2021-DE-1890184,TEVA,,82.0,YR,E,F,Y,,,20210316.0,,PH,DE,DE,2021,Q1,Elderly
190174971,19017497,3,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,20210211.0,,20210316,20210316,DIR,,,FDA-CTU,,66.0,YR,,M,N,88.0,KG,20210316.0,N,PH,US,US,2021,Q1,Elderly
190190831,19019083,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Bradycardia,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190190831,19019083,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190190831,19019083,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190190831,19019083,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190190831,19019083,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210310.0,20210316,20210316,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202103005528,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210316.0,,MD,DE,DE,2021,Q1,Elderly
190195831,19019583,8,C,INSULIN LISPRO/INSULIN LISPRO?ISOPHAN,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Acute respiratory failure,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-ASTRAZENECA-2021A103000,ASTRAZENECA,,82.0,YR,,F,Y,,,20210316.0,,,DE,DE,2021,Q1,Elderly
190195831,19019583,8,C,INSULIN LISPRO/INSULIN LISPRO?ISOPHAN,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Apnoea,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-ASTRAZENECA-2021A103000,ASTRAZENECA,,82.0,YR,,F,Y,,,20210316.0,,,DE,DE,2021,Q1,Elderly
190195831,19019583,8,C,INSULIN LISPRO/INSULIN LISPRO?ISOPHAN,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Aspiration,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-ASTRAZENECA-2021A103000,ASTRAZENECA,,82.0,YR,,F,Y,,,20210316.0,,,DE,DE,2021,Q1,Elderly
190195831,19019583,8,C,INSULIN LISPRO/INSULIN LISPRO?ISOPHAN,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,Condition aggravated,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-ASTRAZENECA-2021A103000,ASTRAZENECA,,82.0,YR,,F,Y,,,20210316.0,,,DE,DE,2021,Q1,Elderly
190195831,19019583,8,C,INSULIN LISPRO/INSULIN LISPRO?ISOPHAN,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210304.0,20210316,20210316,EXP,,DE-ASTRAZENECA-2021A103000,ASTRAZENECA,,82.0,YR,,F,Y,,,20210316.0,,,DE,DE,2021,Q1,Elderly
190225301,19022530,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210219.0,20210219.0,20210318,20210318,PER,,US-ELI_LILLY_AND_COMPANY-US202102011747,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210318.0,,CN,US,US,2021,Q1,Elderly
190225301,19022530,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,20210219.0,20210219.0,20210318,20210318,PER,,US-ELI_LILLY_AND_COMPANY-US202102011747,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210318.0,,CN,US,US,2021,Q1,Elderly
190225301,19022530,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210219.0,20210219.0,20210318,20210318,PER,,US-ELI_LILLY_AND_COMPANY-US202102011747,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210318.0,,CN,US,US,2021,Q1,Elderly
190225301,19022530,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,20210219.0,20210219.0,20210318,20210318,PER,,US-ELI_LILLY_AND_COMPANY-US202102011747,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210318.0,,CN,US,US,2021,Q1,Elderly
190234021,19023402,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137578A,,20563.0,,,INJECTION,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,202102.0,20210217.0,20210318,20210318,PER,,US-ELI_LILLY_AND_COMPANY-US202102010166,ELI LILLY AND CO,,12.0,YR,,F,Y,,,20210318.0,,CN,US,US,2021,Q1,Child
190249461,19024946,7,C,Insulin lispro SC 1 unit,,2,,,,,,,,,,,,,,2021,Q1,Agitation,,2021,Q1,1,I,20210311.0,,20210317,20210317,DIR,,,FDA-CTU,,73.0,YR,,M,N,110.7,KG,20210317.0,N,PH,US,US,2021,Q1,Elderly
190249461,19024946,7,C,Insulin lispro SC 1 unit,,2,,,,,,,,,,,,,,2021,Q1,Hypertension,,2021,Q1,1,I,20210311.0,,20210317,20210317,DIR,,,FDA-CTU,,73.0,YR,,M,N,110.7,KG,20210317.0,N,PH,US,US,2021,Q1,Elderly
190249461,19024946,7,C,Insulin lispro SC 1 unit,,2,,,,,,,,,,,,,,2021,Q1,Infusion related reaction,,2021,Q1,1,I,20210311.0,,20210317,20210317,DIR,,,FDA-CTU,,73.0,YR,,M,N,110.7,KG,20210317.0,N,PH,US,US,2021,Q1,Elderly
190249461,19024946,7,C,Insulin lispro SC 1 unit,,2,,,,,,,,,,,,,,2021,Q1,Stridor,,2021,Q1,1,I,20210311.0,,20210317,20210317,DIR,,,FDA-CTU,,73.0,YR,,M,N,110.7,KG,20210317.0,N,PH,US,US,2021,Q1,Elderly
190249461,19024946,7,C,Insulin lispro SC 1 unit,,2,,,,,,,,,,,,,,2021,Q1,Tachycardia,,2021,Q1,1,I,20210311.0,,20210317,20210317,DIR,,,FDA-CTU,,73.0,YR,,M,N,110.7,KG,20210317.0,N,PH,US,US,2021,Q1,Elderly
190249461,19024946,7,C,Insulin lispro SC 1 unit,,2,,,,,,,,,,,,,,2021,Q1,Tachypnoea,,2021,Q1,1,I,20210311.0,,20210317,20210317,DIR,,,FDA-CTU,,73.0,YR,,M,N,110.7,KG,20210317.0,N,PH,US,US,2021,Q1,Elderly
190249461,19024946,7,C,Insulin lispro SC 1 unit,,2,,,,,,,,,,,,,,2021,Q1,Wheezing,,2021,Q1,1,I,20210311.0,,20210317,20210317,DIR,,,FDA-CTU,,73.0,YR,,M,N,110.7,KG,20210317.0,N,PH,US,US,2021,Q1,Elderly
190253771,19025377,8,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,20210228.0,,20210318,20210318,DIR,,,FDA-CTU,,66.0,YR,,F,N,,,20210318.0,N,PH,US,US,2021,Q1,Elderly
190270431,19027043,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q1,Bradycardia,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190270431,19027043,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190270431,19027043,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190270431,19027043,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190270431,19027043,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210315.0,20210318,20210318,EXP,DE-BFARM-21002569,DE-SA-2021SA091608,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210318.0,,MD,DE,DE,2021,Q1,Elderly
190282221,19028222,15,C,Insulin Lispro Sanofi 100 E/ml SoloStar Fertigpen,,2,,USAGE: 3?3?3?2,,,,,,,,,,,,2021,Q1,Calculus bladder,,2021,Q1,1,I,2015.0,20210308.0,20210318,20210318,EXP,,DE-TEVA-2021-DE-1889845,TEVA,,72.0,YR,E,M,Y,,,20210318.0,,CN,DE,DE,2021,Q1,Elderly
190282221,19028222,15,C,Insulin Lispro Sanofi 100 E/ml SoloStar Fertigpen,,2,,USAGE: 3?3?3?2,,,,,,,,,,,,2021,Q1,Foot fracture,,2021,Q1,1,I,2015.0,20210308.0,20210318,20210318,EXP,,DE-TEVA-2021-DE-1889845,TEVA,,72.0,YR,E,M,Y,,,20210318.0,,CN,DE,DE,2021,Q1,Elderly
190282221,19028222,15,C,Insulin Lispro Sanofi 100 E/ml SoloStar Fertigpen,,2,,USAGE: 3?3?3?2,,,,,,,,,,,,2021,Q1,Haemorrhagic diathesis,,2021,Q1,1,I,2015.0,20210308.0,20210318,20210318,EXP,,DE-TEVA-2021-DE-1889845,TEVA,,72.0,YR,E,M,Y,,,20210318.0,,CN,DE,DE,2021,Q1,Elderly
190282221,19028222,15,C,Insulin Lispro Sanofi 100 E/ml SoloStar Fertigpen,,2,,USAGE: 3?3?3?2,,,,,,,,,,,,2021,Q1,Liver function test increased,,2021,Q1,1,I,2015.0,20210308.0,20210318,20210318,EXP,,DE-TEVA-2021-DE-1889845,TEVA,,72.0,YR,E,M,Y,,,20210318.0,,CN,DE,DE,2021,Q1,Elderly
190282221,19028222,15,C,Insulin Lispro Sanofi 100 E/ml SoloStar Fertigpen,,2,,USAGE: 3?3?3?2,,,,,,,,,,,,2021,Q1,Nephrolithiasis,,2021,Q1,1,I,2015.0,20210308.0,20210318,20210318,EXP,,DE-TEVA-2021-DE-1889845,TEVA,,72.0,YR,E,M,Y,,,20210318.0,,CN,DE,DE,2021,Q1,Elderly
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Agitation,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Depressed level of consciousness,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Depressed mood,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Diabetes mellitus inadequate control,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Diet noncompliance,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Memory impairment,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190292361,19029236,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q1,Thrombosis,,2021,Q1,1,I,,20210308.0,20210318,20210318,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202103004337,ELI LILLY AND CO,,55.0,YR,,M,Y,78.0,KG,20210318.0,,CN,ES,ES,2021,Q1,Adult
190326951,19032695,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,,,2021,Q1,Anaphylactic reaction,,2021,Q1,1,I,,20210308.0,20210319,20210319,EXP,,RO-SA-2021SA083163,SANOFI AVENTIS,CHICIUDEAN M.. ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009?64 (SUPPL 90):216,42.0,YR,A,F,Y,,,20210319.0,,HP,RO,RO,2021,Q1,Adult
190326951,19032695,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,,,2021,Q1,Blood immunoglobulin E increased,,2021,Q1,1,I,,20210308.0,20210319,20210319,EXP,,RO-SA-2021SA083163,SANOFI AVENTIS,CHICIUDEAN M.. ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009?64 (SUPPL 90):216,42.0,YR,A,F,Y,,,20210319.0,,HP,RO,RO,2021,Q1,Adult
190326951,19032695,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,,,2021,Q1,Drug ineffective,,2021,Q1,1,I,,20210308.0,20210319,20210319,EXP,,RO-SA-2021SA083163,SANOFI AVENTIS,CHICIUDEAN M.. ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009?64 (SUPPL 90):216,42.0,YR,A,F,Y,,,20210319.0,,HP,RO,RO,2021,Q1,Adult
190326951,19032695,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210308.0,20210319,20210319,EXP,,RO-SA-2021SA083163,SANOFI AVENTIS,CHICIUDEAN M.. ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009?64 (SUPPL 90):216,42.0,YR,A,F,Y,,,20210319.0,,HP,RO,RO,2021,Q1,Adult
190326951,19032695,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,,,2021,Q1,Injection site urticaria,,2021,Q1,1,I,,20210308.0,20210319,20210319,EXP,,RO-SA-2021SA083163,SANOFI AVENTIS,CHICIUDEAN M.. ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009?64 (SUPPL 90):216,42.0,YR,A,F,Y,,,20210319.0,,HP,RO,RO,2021,Q1,Adult
190326951,19032695,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,,,2021,Q1,Pruritus,,2021,Q1,1,I,,20210308.0,20210319,20210319,EXP,,RO-SA-2021SA083163,SANOFI AVENTIS,CHICIUDEAN M.. ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009?64 (SUPPL 90):216,42.0,YR,A,F,Y,,,20210319.0,,HP,RO,RO,2021,Q1,Adult
190326951,19032695,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,,,2021,Q1,Tongue oedema,,2021,Q1,1,I,,20210308.0,20210319,20210319,EXP,,RO-SA-2021SA083163,SANOFI AVENTIS,CHICIUDEAN M.. ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009?64 (SUPPL 90):216,42.0,YR,A,F,Y,,,20210319.0,,HP,RO,RO,2021,Q1,Adult
190326951,19032695,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,209196.0,,,,,2021,Q1,Urticaria,,2021,Q1,1,I,,20210308.0,20210319,20210319,EXP,,RO-SA-2021SA083163,SANOFI AVENTIS,CHICIUDEAN M.. ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN. ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2009?64 (SUPPL 90):216,42.0,YR,A,F,Y,,,20210319.0,,HP,RO,RO,2021,Q1,Adult
190342511,19034251,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,,,,INJECTION,,2021,Q1,Blood glucose decreased,,2021,Q1,1,I,202005.0,20210308.0,20210319,20210319,EXP,,US-ELI_LILLY_AND_COMPANY-US202103006153,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20210319.0,,CN,US,US,2021,Q1,Elderly
190342511,19034251,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,202005.0,20210308.0,20210319,20210319,EXP,,US-ELI_LILLY_AND_COMPANY-US202103006153,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20210319.0,,CN,US,US,2021,Q1,Elderly
190342511,19034251,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,,,,INJECTION,,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202005.0,20210308.0,20210319,20210319,EXP,,US-ELI_LILLY_AND_COMPANY-US202103006153,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20210319.0,,CN,US,US,2021,Q1,Elderly
190342511,19034251,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,202005.0,20210308.0,20210319,20210319,EXP,,US-ELI_LILLY_AND_COMPANY-US202103006153,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20210319.0,,CN,US,US,2021,Q1,Elderly
190342511,19034251,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,,,,INJECTION,,2021,Q1,Wrong technique in product usage process,,2021,Q1,1,I,202005.0,20210308.0,20210319,20210319,EXP,,US-ELI_LILLY_AND_COMPANY-US202103006153,ELI LILLY AND CO,,88.0,YR,,M,Y,,,20210319.0,,CN,US,US,2021,Q1,Elderly
190345491,19034549,4,C,RECOMBINANT HUMAN INSULIN LISPRO,,2,Subcutaneous,10 U,,,,, D248773A,,,,,INJECTION,,2021,Q1,Drug-induced liver injury,,2021,Q1,1,I,20210214.0,20210314.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A151167,ASTRAZENECA,,10967.0,DY,,M,Y,46.5,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190345491,19034549,4,C,RECOMBINANT HUMAN INSULIN LISPRO,,2,Subcutaneous,10 U,,,,, D248773A,,,,,INJECTION,,2021,Q1,Transaminases increased,,2021,Q1,1,I,20210214.0,20210314.0,20210319,20210319,EXP,,CN-ASTRAZENECA-2021A151167,ASTRAZENECA,,10967.0,DY,,M,Y,46.5,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190350701,19035070,2,SS,MIXED PROTAMINE ZINC RECOMBINANT HUMAN INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 UNITS, TWO TIMES A DAY",,,Y,," D180335C,D181403C",,,,,INJECTION,,2021,Q1,Hypoglycaemic coma,,2021,Q1,1,I,20210307.0,20210316.0,20210320,20210320,EXP,,CN-ASTRAZENECA-2021A164321,ASTRAZENECA,,26320.0,DY,,M,Y,48.5,KG,20210319.0,,HP,CN,CN,2021,Q1,Elderly
190359121,19035912,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D185008D,,,,,INJECTION,,2021,Q1,Intercepted product dispensing error,,2021,Q1,1,I,20201230.0,20210317.0,20210321,20210321,PER,,US-ELI_LILLY_AND_COMPANY-US202103008962,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210321.0,,CN,US,US,2021,Q1,Elderly
190369981,19036998,4,C,Insulin Lispro (1 Unit Dial),,2,,,,,,,,,,,,,,2021,Q1,Death,,2021,Q1,1,I,20210316.0,,20210322,20210322,DIR,,,FDA-CTU,,50.0,YR,,M,N,111.15,KG,20210322.0,N,,US,US,2021,Q1,Adult
190418263,19041826,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",300.0,IU,,, D248773A,,,10.0,IU,,TID,2021,Q1,Drug-induced liver injury,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",300.0,IU,,, D248773A,,,10.0,IU,,TID,2021,Q1,Transaminases increased,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",300.0,IU,,, D248773A,,,6.0,IU,,TID,2021,Q1,Drug-induced liver injury,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 U, TID",300.0,IU,,, D248773A,,,6.0,IU,,TID,2021,Q1,Transaminases increased,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",300.0,IU,,, D248773A,,,10.0,IU,,TID,2021,Q1,Drug-induced liver injury,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190418263,19041826,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, TID",300.0,IU,,, D248773A,,,10.0,IU,,TID,2021,Q1,Transaminases increased,,2021,Q1,3,F,20210214.0,20210325.0,20210322,20210325,EXP,,CN-BAYER-2021-104981,BAYER,,30.0,YR,A,M,Y,46.5,KG,20210325.0,,HP,CN,CN,2021,Q1,Young Adult
190440811,19044081,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2021,Q1,Abdominal abscess,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2021,Q1,Blood glucose abnormal,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2021,Q1,Abdominal abscess,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2021,Q1,Blood glucose abnormal,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D088600C,,,,,INJECTION,,2021,Q1,Abdominal abscess,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D088600C,,,,,INJECTION,,2021,Q1,Blood glucose abnormal,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D088600C,,,,,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D088600C,,,,,INJECTION,,2021,Q1,Abdominal abscess,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D088600C,,,,,INJECTION,,2021,Q1,Blood glucose abnormal,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190440811,19044081,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D088600C,,,,,INJECTION,,2021,Q1,Wrong product administered,,2021,Q1,1,I,202009.0,20210301.0,20210323,20210323,PER,,US-ELI_LILLY_AND_COMPANY-US202103001674,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Adult
190483661,19048366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Blood potassium increased,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Breast cancer,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,COVID-19,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebral disorder,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular arteriovenous malformation,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Fall,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Memory impairment,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Blood potassium increased,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Breast cancer,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,COVID-19,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebral disorder,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular arteriovenous malformation,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Fall,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Memory impairment,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Blood potassium increased,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Breast cancer,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,COVID-19,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebral disorder,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular arteriovenous malformation,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Fall,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Memory impairment,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Blood potassium increased,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Breast cancer,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,COVID-19,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebral disorder,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular arteriovenous malformation,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Fall,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,,,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Memory impairment,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Blood potassium increased,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Breast cancer,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,COVID-19,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebral disorder,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular arteriovenous malformation,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Fall,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Memory impairment,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Blood potassium increased,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Breast cancer,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,COVID-19,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebral disorder,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular arteriovenous malformation,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Fall,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Memory impairment,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Blood potassium increased,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Breast cancer,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,COVID-19,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebral disorder,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular arteriovenous malformation,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Fall,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Memory impairment,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,8,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Blood potassium increased,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,8,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Breast cancer,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,8,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,COVID-19,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,8,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebral disorder,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,8,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,8,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Cerebrovascular arteriovenous malformation,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,8,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Fall,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190483661,19048366,8,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"10 U, BID",,,,, D243920A,,20563.0,10.0,IU,INJECTION,BID,2021,Q1,Memory impairment,,2021,Q1,1,I,202008.0,20210311.0,20210323,20210323,EXP,,US-ELI_LILLY_AND_COMPANY-US202103008221,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20210323.0,,CN,US,US,2021,Q1,Elderly
190511641,19051164,3,C,MIXED PROTAMINE ZINC RECOMBINANT HUMAN INSULIN LISPRO,INSULIN LISPRO,1,Unknown,50R,,,,, UNKNOWN,,,,,,,2021,Q1,Ductal adenocarcinoma of pancreas,,2021,Q1,1,I,,20210312.0,20210324,20210324,EXP,,CN-NOVOPROD-795767,NOVO NORDISK,"SHENGJIE WU, JIABING WANG, LI JING AND LIPING CHEN. A DIABETIC PATIENT COMPLICATED WITH PANCREATIC CANCER AFTER USING LIRAGLUTIDE: A CASE REPORT. FRONTIERS IN ENDOCRINOLOGY. 2021?11",71.0,YR,,M,Y,,,20210324.0,,HP,CN,CN,2021,Q1,Elderly
190511641,19051164,3,C,MIXED PROTAMINE ZINC RECOMBINANT HUMAN INSULIN LISPRO,INSULIN LISPRO,1,Unknown,50R,,,,, UNKNOWN,,,,,,,2021,Q1,Metastases to lymph nodes,,2021,Q1,1,I,,20210312.0,20210324,20210324,EXP,,CN-NOVOPROD-795767,NOVO NORDISK,"SHENGJIE WU, JIABING WANG, LI JING AND LIPING CHEN. A DIABETIC PATIENT COMPLICATED WITH PANCREATIC CANCER AFTER USING LIRAGLUTIDE: A CASE REPORT. FRONTIERS IN ENDOCRINOLOGY. 2021?11",71.0,YR,,M,Y,,,20210324.0,,HP,CN,CN,2021,Q1,Elderly
190529551,19052955,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Fall,,2021,Q1,1,I,20210123.0,20210223.0,20210325,20210325,PER,,US-ELI_LILLY_AND_COMPANY-US202102011673,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210325.0,,CN,US,US,2021,Q1,Elderly
190529551,19052955,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q1,Upper limb fracture,,2021,Q1,1,I,20210123.0,20210223.0,20210325,20210325,PER,,US-ELI_LILLY_AND_COMPANY-US202102011673,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210325.0,,CN,US,US,2021,Q1,Elderly
190532501,19053250,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,DF,,QD,2021,Q1,Drug hypersensitivity,,2021,Q1,1,I,20210320.0,20210323.0,20210325,20210325,EXP,,US-ABBVIE-21K-163-3828110-00,ABBVIE,,69.0,YR,,M,Y,,,20210325.0,,HP,US,US,2021,Q1,Elderly
190571011,19057101,6,C,lispro insulin,INSULIN LISPRO,1,,,,,,N,,,,,,,,2021,Q1,Joint swelling,Joint swelling,2021,Q1,1,I,202002.0,20200330.0,20210324,20210324,PER,,US-HISAMITSU-2020-US-006706,HISAMITSU PHARM,,68.0,YR,,F,Y,59.42,KG,20210324.0,,CN,US,US,2021,Q1,Elderly
190571011,19057101,6,C,lispro insulin,INSULIN LISPRO,1,,,,,,N,,,,,,,,2021,Q1,Peripheral swelling,Peripheral swelling,2021,Q1,1,I,202002.0,20200330.0,20210324,20210324,PER,,US-HISAMITSU-2020-US-006706,HISAMITSU PHARM,,68.0,YR,,F,Y,59.42,KG,20210324.0,,CN,US,US,2021,Q1,Elderly
190574131,19057413,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS,,,,,,,,,,INJECTION,QID,2021,Q1,Cytokine release syndrome,,2021,Q1,1,I,20210314.0,20210315.0,20210324,20210324,EXP,,US-CELGENEUS-USA-20210304462,CELGENE,,78.0,YR,,F,Y,75.2,KG,20210324.0,,MD,US,US,2021,Q1,Elderly
190574131,19057413,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1?10 UNITS,,,,,,,,,,INJECTION,QID,2021,Q1,Immune effector cell-associated neurotoxicity syndrome,,2021,Q1,1,I,20210314.0,20210315.0,20210324,20210324,EXP,,US-CELGENEUS-USA-20210304462,CELGENE,,78.0,YR,,F,Y,75.2,KG,20210324.0,,MD,US,US,2021,Q1,Elderly
190579671,19057967,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Inappropriate antidiuretic hormone secretion,,2021,Q1,1,I,20201102.0,20201113.0,20210325,20210325,EXP,,JP-ORGANON-2011JPN010507,ORGANON,,71.0,YR,,M,Y,,,20210325.0,,PH,JP,JP,2021,Q1,Elderly
190580861,19058086,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Medication error,,2021,Q1,1,I,20200723.0,20200724.0,20210324,20210324,EXP,,PT-GILEAD-2020-0487041,GILEAD,,64.0,YR,,F,Y,85.0,KG,20210324.0,,PH,PT,PT,2021,Q1,Adult
190580861,19058086,10,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q1,Seroma,,2021,Q1,1,I,20200723.0,20200724.0,20210324,20210324,EXP,,PT-GILEAD-2020-0487041,GILEAD,,64.0,YR,,F,Y,85.0,KG,20210324.0,,PH,PT,PT,2021,Q1,Adult
190586581,19058658,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ. (WITH MEALS)",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Fatigue,,2021,Q1,1,I,20201211.0,20201221.0,20210325,20210325,PER,,US-ASTELLAS-2020US045358,ASTELLAS,,65.0,YR,,M,Y,,,20210325.0,,MD,US,US,2021,Q1,Elderly
190586581,19058658,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ. (WITH MEALS)",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Hyperglycaemia,,2021,Q1,1,I,20201211.0,20201221.0,20210325,20210325,PER,,US-ASTELLAS-2020US045358,ASTELLAS,,65.0,YR,,M,Y,,,20210325.0,,MD,US,US,2021,Q1,Elderly
190586581,19058658,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ. (WITH MEALS)",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q1,Rash,,2021,Q1,1,I,20201211.0,20201221.0,20210325,20210325,PER,,US-ASTELLAS-2020US045358,ASTELLAS,,65.0,YR,,M,Y,,,20210325.0,,MD,US,US,2021,Q1,Elderly
190647111,19064711,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Cerebrovascular accident,,2021,Q1,1,I,,20210315.0,20210326,20210326,EXP,,US-SA-2021SA090024,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20210326.0,,CN,US,US,2021,Q1,Adult
190663131,19066313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Eating disorder,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Feeling cold,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, ASKU,,20563.0,,,INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Blood glucose increased,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Drug ineffective,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Eating disorder,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Feeling cold,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Glycosylated haemoglobin increased,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663131,19066313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,,, D243920A,,20563.0,,,INJECTION,,2021,Q1,Inappropriate schedule of product administration,,2021,Q1,1,I,20210321.0,20210322.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103011562,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190663731,19066373,2,SS,Insulin lispro,INSULIN LISPRO,1,,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q1,Bradycardia,,2021,Q1,1,I,,20210315.0,20210328,20210328,EXP,,DE-TEVA-2021-DE-1892584,TEVA,,71.0,YR,E,F,Y,,,20210328.0,,MD,DE,DE,2021,Q1,Elderly
190663731,19066373,2,SS,Insulin lispro,INSULIN LISPRO,1,,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q1,Dizziness,,2021,Q1,1,I,,20210315.0,20210328,20210328,EXP,,DE-TEVA-2021-DE-1892584,TEVA,,71.0,YR,E,F,Y,,,20210328.0,,MD,DE,DE,2021,Q1,Elderly
190663731,19066373,2,SS,Insulin lispro,INSULIN LISPRO,1,,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q1,Dyspnoea,,2021,Q1,1,I,,20210315.0,20210328,20210328,EXP,,DE-TEVA-2021-DE-1892584,TEVA,,71.0,YR,E,F,Y,,,20210328.0,,MD,DE,DE,2021,Q1,Elderly
190663731,19066373,2,SS,Insulin lispro,INSULIN LISPRO,1,,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q1,General physical health deterioration,,2021,Q1,1,I,,20210315.0,20210328,20210328,EXP,,DE-TEVA-2021-DE-1892584,TEVA,,71.0,YR,E,F,Y,,,20210328.0,,MD,DE,DE,2021,Q1,Elderly
190663731,19066373,2,SS,Insulin lispro,INSULIN LISPRO,1,,ACCORDING TO PLAN,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210315.0,20210328,20210328,EXP,,DE-TEVA-2021-DE-1892584,TEVA,,71.0,YR,E,F,Y,,,20210328.0,,MD,DE,DE,2021,Q1,Elderly
190665891,19066589,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Malaise,,2021,Q1,1,I,20210323.0,20210323.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103013442,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190665891,19066589,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210323.0,20210323.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103013442,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190665891,19066589,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (18 TO 21 SLIDING SCALE)",,,U,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Malaise,,2021,Q1,1,I,20210323.0,20210323.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103013442,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190665891,19066589,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN (18 TO 21 SLIDING SCALE)",,,U,, D195320A,,20563.0,,,INJECTION,,2021,Q1,Visual impairment,,2021,Q1,1,I,20210323.0,20210323.0,20210328,20210328,PER,,US-ELI_LILLY_AND_COMPANY-US202103013442,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20210328.0,,CN,US,US,2021,Q1,Elderly
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Abdominal pain,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Abscess,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Adrenal insufficiency,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Alanine aminotransferase increased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Ascites,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Asthenia,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Blood alkaline phosphatase increased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Blood bilirubin increased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Blood potassium decreased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Blood pressure diastolic abnormal,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Blood pressure increased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Congestive hepatopathy,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Depression,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Diverticulitis,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Endometrial disorder,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Enterococcus test positive,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Fibrosis,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Gamma-glutamyltransferase increased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Gastrointestinal disorder,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Generalised oedema,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Heart rate increased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Herpes zoster,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hypersensitivity,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Hypotension,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Increased appetite,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Influenza,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Infusion related reaction,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Injection site extravasation,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Intensive care unit acquired weakness,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Intervertebral disc protrusion,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Joint effusion,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Joint swelling,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Micturition disorder,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Myelopathy,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Myopathy,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Nasopharyngitis,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Nausea,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Nerve compression,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Neuropathy peripheral,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Neutropenia,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Osteoarthritis,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Pancytopenia,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Peripheral sensorimotor neuropathy,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Peritonitis,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Pneumonia,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Pseudomonal bacteraemia,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Rheumatoid arthritis,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Septic shock,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Therapeutic response decreased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Vomiting,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Weight decreased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190702761,19070276,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q1,Weight increased,,2021,Q1,1,I,,20210319.0,20210329,20210329,EXP,,CA-TEVA-2021-CA-1894859,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210330.0,,HP,CA,CA,2021,Q1,Adult
190715201,19071520,10,C,Insulina lispro Sanofi,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Anaemia,,2021,Q1,1,I,20210104.0,20210320.0,20210330,20210330,EXP,,IT-AUROBINDO-AUR-APL-2021-012651,AUROBINDO,,74.0,YR,,F,Y,,,20210330.0,,MD,IT,IT,2021,Q1,Elderly
190715201,19071520,10,C,Insulina lispro Sanofi,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q1,Rectal haemorrhage,,2021,Q1,1,I,20210104.0,20210320.0,20210330,20210330,EXP,,IT-AUROBINDO-AUR-APL-2021-012651,AUROBINDO,,74.0,YR,,F,Y,,,20210330.0,,MD,IT,IT,2021,Q1,Elderly
190737441,19073744,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q1,Product storage error,,2021,Q1,1,I,,20210316.0,20210330,20210330,PER,,US-SA-2021SA093672,SANOFI AVENTIS,,51.0,YR,A,F,Y,,,20210330.0,,CN,US,US,2021,Q1,Adult
190784301,19078430,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,INJECTION,,2021,Q1,Death,,2021,Q1,1,I,20210317.0,20210319.0,20210331,20210331,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-028196,BRISTOL MYERS SQUIBB,,84.0,YR,,F,Y,70.0,KG,20210331.0,,CN,US,US,2021,Q1,Elderly
190784301,19078430,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,INJECTION,,2021,Q1,Prescribed underdose,,2021,Q1,1,I,20210317.0,20210319.0,20210331,20210331,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-028196,BRISTOL MYERS SQUIBB,,84.0,YR,,F,Y,70.0,KG,20210331.0,,CN,US,US,2021,Q1,Elderly
190786201,19078620,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D167335D,,20563.0,,,INJECTION,,2021,Q1,Blood glucose abnormal,,2021,Q1,1,I,,20210319.0,20210331,20210331,EXP,,IN-ELI_LILLY_AND_COMPANY-IN202103010549,ELI LILLY AND CO,,8.0,YR,,,Y,,,20210331.0,,MD,IN,IN,2021,Q1,Child
190786201,19078620,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D167335D,,20563.0,,,INJECTION,,2021,Q1,Incorrect dose administered,,2021,Q1,1,I,,20210319.0,20210331,20210331,EXP,,IN-ELI_LILLY_AND_COMPANY-IN202103010549,ELI LILLY AND CO,,8.0,YR,,,Y,,,20210331.0,,MD,IN,IN,2021,Q1,Child
190801391,19080139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2?7 UNITS, QD",,,U,,,,,,,,,2021,Q1,Diabetic foot,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2?7 UNITS, QD",,,U,,,,,,,,,2021,Q1,Diabetic nephropathy,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2?7 UNITS, QD",,,U,,,,,,,,,2021,Q1,Epilepsy,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2?7 UNITS, QD",,,U,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2?7 UNITS, QD",,,U,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 UNITS, UNK",,,U,,,,,,,,,2021,Q1,Diabetic foot,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 UNITS, UNK",,,U,,,,,,,,,2021,Q1,Diabetic nephropathy,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 UNITS, UNK",,,U,,,,,,,,,2021,Q1,Epilepsy,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 UNITS, UNK",,,U,,,,,,,,,2021,Q1,Hypoglycaemia,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
190801391,19080139,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 UNITS, UNK",,,U,,,,,,,,,2021,Q1,Pain in extremity,,2021,Q1,1,I,,20190102.0,20210331,20210331,EXP,,GR-VALIDUS PHARMACEUTICALS LLC-GR-2021VAL000696,VALIDUS,,53.0,YR,,F,Y,,,20210331.0,,CN,GR,GR,2021,Q1,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Arthralgia,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Hepatic enzyme increased,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Musculoskeletal stiffness,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Pain in extremity,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Pharyngitis,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Poor venous access,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Pruritus,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Swelling,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Therapeutic response decreased,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
131125432,13112543,16,C,INSULIN LISPRO PROTAMINE SUSPENSION,,2,,,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,2,F,,20210413.0,20170113,20210419,EXP,,CA-ROCHE-1878959,ROCHE,,62.0,YR,,M,Y,,,20210419.0,,HP,CA,CA,2021,Q2,Adult
136391787,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2021,Q2,Dyspnoea,,2021,Q2,7,F,20170410.0,20210407.0,20170609,20210408,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20210408.0,,MD,FR,FR,2021,Q2,Elderly
136391787,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2021,Q2,General physical health deterioration,,2021,Q2,7,F,20170410.0,20210407.0,20170609,20210408,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20210408.0,,MD,FR,FR,2021,Q2,Elderly
136391787,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2021,Q2,Lung adenocarcinoma,,2021,Q2,7,F,20170410.0,20210407.0,20170609,20210408,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20210408.0,,MD,FR,FR,2021,Q2,Elderly
136391787,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2021,Q2,Pleural effusion,,2021,Q2,7,F,20170410.0,20210407.0,20170609,20210408,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20210408.0,,MD,FR,FR,2021,Q2,Elderly
136391787,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2021,Q2,Respiratory disorder,,2021,Q2,7,F,20170410.0,20210407.0,20170609,20210408,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20210408.0,,MD,FR,FR,2021,Q2,Elderly
136391787,13639178,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1000 INTERNATIONAL UNIT,,,U,,,,,1000.0,IU,,,2021,Q2,Respiratory distress,,2021,Q2,7,F,20170410.0,20210407.0,20170609,20210408,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2017-048501,BRISTOL MYERS SQUIBB,,87.0,YR,,M,Y,,,20210408.0,,MD,FR,FR,2021,Q2,Elderly
143891962,14389196,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,U,,,,,,,,,2021,Q2,Alopecia,,2021,Q2,2,F,201411.0,20210518.0,20180115,20210527,PER,,US-SA-2017SA236016,SANOFI AVENTIS,,57.0,YR,A,F,Y,76.0,KG,20210527.0,,LW,US,US,2021,Q2,Adult
143891962,14389196,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,U,,,,,,,,,2021,Q2,Psychological trauma,,2021,Q2,2,F,201411.0,20210518.0,20180115,20210527,PER,,US-SA-2017SA236016,SANOFI AVENTIS,,57.0,YR,A,F,Y,76.0,KG,20210527.0,,LW,US,US,2021,Q2,Adult
144121142,14412114,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,INJECTION,,2021,Q2,Cataract,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,INJECTION,,2021,Q2,Cataract,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Cataract,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Cataract,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
144121142,14412114,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,2,F,201707.0,20210601.0,20180119,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US201801006217,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Arthralgia,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Cataract,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Clostridium difficile colitis,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Coxsackie viral infection,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Dry eye,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Dysgeusia,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Headache,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Hyperhidrosis,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Hypoacusis,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Hypogammaglobulinaemia,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Influenza like illness,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Myalgia,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Pollakiuria,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Product administration error,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Pyrexia,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Rash morbilliform,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Small fibre neuropathy,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Stevens-Johnson syndrome,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Urinary incontinence,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Vision blurred,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Vitamin D abnormal,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1456819610,14568196,5,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,D,, UNKNOWN,,,,,,,2021,Q2,Weight decreased,,2021,Q2,10,F,2017.0,20210521.0,20180223,20210604,EXP,,US-PERRIGO-18US001501,PERRIGO,,57.0,YR,,M,Y,77.55,KG,20210604.0,,MD,US,US,2021,Q2,Adult
1489664943,14896649,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2021,Q2,Foetal disorder,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2021,Q2,Low birth weight baby,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2021,Q2,Maternal exposure during pregnancy,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2021,Q2,Neutropenia neonatal,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, DAILY",,,D,,,,,21.0,UG/M**2,,,2021,Q2,Premature baby,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2021,Q2,Foetal disorder,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2021,Q2,Low birth weight baby,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2021,Q2,Maternal exposure during pregnancy,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2021,Q2,Neutropenia neonatal,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1489664943,14896649,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, DAILY",,,D,,,,,7.0,UG/M**2,,,2021,Q2,Premature baby,,2021,Q2,43,F,20170804.0,20210407.0,20180515,20210420,EXP,,FR-PFIZER INC-2018195935,PFIZER,,1.0,DY,,M,Y,1.89,KG,20210420.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,42,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,42,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,42,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,42,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,42,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,43,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, ONCE A DAY",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,43,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, ONCE A DAY",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,43,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, ONCE A DAY",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,43,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, ONCE A DAY",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1492875521,14928755,43,SS,Insulin lispro,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, ONCE A DAY",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,21,F,20170914.0,20210422.0,20180523,20210427,EXP,,FR-AUROBINDO-AUR-APL-2018-025734,AUROBINDO,,1.0,DY,,M,Y,1.89,KG,20210427.0,,HP,FR,FR,2021,Q2,Child
1506657618,15066576,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,7.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,21.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,21.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,21.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,21.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
1506657618,15066576,15,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,,,,N,,,,,21.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,18,F,2017.0,20210405.0,20180626,20210415,EXP,,FR-BAUSCH-BL-2018-017471,BAUSCH AND LOMB,,1.0,DY,,M,Y,1.89,KG,20210415.0,,CN,FR,FR,2021,Q2,Child
151853498,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Haematoma muscle,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Inhibiting antibodies,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Intestinal obstruction,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Therapy non-responder,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Underdose,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Haematoma muscle,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Inhibiting antibodies,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Intestinal obstruction,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Therapy non-responder,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
151853498,15185349,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Underdose,,2021,Q2,8,F,20180220.0,20210608.0,20180723,20210611,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210611.0,,MD,IT,IT,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Chronic kidney disease-mineral and bone disorder,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,End stage renal disease,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hyperkalaemia,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Nephrogenic anaemia,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Renal failure,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
152616443,15261644,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Renal tubular necrosis,,2021,Q2,3,F,20170614.0,20210607.0,20180809,20210615,EXP,,US-ASTRAZENECA-2018SE98064,ASTRAZENECA,,20410.0,DY,,M,Y,70.3,KG,20210615.0,,,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Acidosis,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Acute myocardial infarction,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Anaemia,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Aphasia,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Back pain,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Blood loss anaemia,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Clostridium difficile colitis,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Diarrhoea,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Gait disturbance,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Gastroenteritis,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Gastrointestinal haemorrhage,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Haematotoxicity,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Hyperkalaemia,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Influenza,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Internal haemorrhage,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Intervertebral disc disorder,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Lethargy,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Limb discomfort,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Metabolic acidosis,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Nervousness,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Pain in extremity,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Pulmonary oedema,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Renal failure,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Respiratory failure,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Sciatica,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Sepsis,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Septic shock,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Supraventricular tachycardia,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
155658256,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2X/DAY(AC (AFTER MEALS) AND HS (BEFORE MEALS)",,,,,,,,,,,BID,2021,Q2,Thrombocytopenia,,2021,Q2,6,F,2018.0,20210602.0,20181030,20210616,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20210616.0,,MD,US,US,2021,Q2,Elderly
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Abdominal pain,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Abscess,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Adrenal insufficiency,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Alanine aminotransferase increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Ascites,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Asthenia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Blood alkaline phosphatase increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Blood bilirubin increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Blood potassium decreased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Blood pressure increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Bone erosion,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Congestive hepatopathy,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Depression,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Diverticulitis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Endometrial disorder,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Enterococcus test positive,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Fibrosis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Gait disturbance,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Gastrointestinal disorder,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Generalised oedema,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Heart rate increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Herpes zoster,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Hypersensitivity,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Hypoglycaemia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Hypotension,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Increased appetite,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Influenza,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Infusion related reaction,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Injection site extravasation,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Intensive care unit acquired weakness,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Intervertebral disc protrusion,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Joint effusion,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Joint swelling,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Micturition disorder,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Myelopathy,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Myopathy,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Nasopharyngitis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Nausea,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Nerve compression,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Neuropathy peripheral,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Neutropenia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Osteoarthritis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Pain,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Pancytopenia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Peripheral sensorimotor neuropathy,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Peripheral swelling,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Peritonitis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Pneumonia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Pseudomonal bacteraemia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Rheumatoid arthritis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Septic shock,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Synovitis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Therapeutic response decreased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Tooth disorder,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Vomiting,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Weight decreased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, TID",,,,,,,,,,,TID,2021,Q2,Weight increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Abdominal pain,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Abscess,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Adrenal insufficiency,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Alanine aminotransferase increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Ascites,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Asthenia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Blood alkaline phosphatase increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Blood bilirubin increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Blood potassium decreased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Blood pressure increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Bone erosion,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Congestive hepatopathy,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Depression,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Diverticulitis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Endometrial disorder,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Enterococcus test positive,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Fibrosis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Gait disturbance,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Gastrointestinal disorder,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Generalised oedema,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Heart rate increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Herpes zoster,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Hypersensitivity,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Hypoglycaemia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Hypotension,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Increased appetite,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Influenza,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Infusion related reaction,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Injection site extravasation,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Intensive care unit acquired weakness,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Intervertebral disc protrusion,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Joint effusion,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Joint swelling,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Micturition disorder,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Myelopathy,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Myopathy,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Nasopharyngitis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Nausea,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Nerve compression,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Neuropathy peripheral,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Neutropenia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Osteoarthritis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Pain,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Pancytopenia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Peripheral sensorimotor neuropathy,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Peripheral swelling,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Peritonitis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Pneumonia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Pseudomonal bacteraemia,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Rheumatoid arthritis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Septic shock,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Synovitis,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Therapeutic response decreased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Tooth disorder,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Vomiting,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Weight decreased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1581940810,15819408,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 DOSAGE FORM, QD",,,,,,,,3.0,DF,,,2021,Q2,Weight increased,,2021,Q2,10,F,,20210604.0,20190114,20210618,EXP,,CA-APOTEX-2019AP005236,APOTEX,,62.0,YR,,F,Y,67.0,KG,20210618.0,,CN,CA,CA,2021,Q2,Adult
1586897513,15868975,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,21.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,21.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,21.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,21.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,21.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,7.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,7.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
1586897513,15868975,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 ?G/M2, 1D",4242.0,UG/M2,Y,,,,,7.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,13,F,20170914.0,20210407.0,20190125,20210506,EXP,,FR-GLAXOSMITHKLINE-FR2018GSK236959,GLAXOSMITHKLINE,,1.0,DY,,M,Y,1.89,KG,20210506.0,,CN,FR,FR,2021,Q2,Child
160715877,16071587,18,C,INSULIN LISPRO HUMAN,,2,,,,,,,,,,,,,,2021,Q2,Hepatic encephalopathy,Hepatic encephalopathy,2021,Q2,7,F,20181204.0,20210511.0,20190314,20210512,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-048932,EISAI,,68.0,YR,E,M,Y,124.6,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
160715877,16071587,18,C,INSULIN LISPRO HUMAN,,2,,,,,,,,,,,,,,2021,Q2,Pulmonary embolism,,2021,Q2,7,F,20181204.0,20210511.0,20190314,20210512,PER,,US-EISAI MEDICAL RESEARCH-EC-2018-048932,EISAI,,68.0,YR,E,M,Y,124.6,KG,20210512.0,,MD,US,US,2021,Q2,Elderly
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Blood creatinine increased,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Dehydration,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Gastroenteritis,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Gingivitis,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Haemorrhoids,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Kidney infection,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Product use in unapproved indication,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Renal impairment,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163305093,16330509,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 DF, BEFORE EACH MEAL",,,,,,,,5.0,DF,FORMULATION UNKNOWN,,2021,Q2,Swelling,,2021,Q2,3,F,20100122.0,20190612.0,20190520,20210419,EXP,,CO-ASTELLAS-2019US009553,ASTELLAS,,37.0,YR,,M,Y,62.0,KG,20210419.0,,CN,CO,CO,2021,Q2,Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Anhedonia,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Anxiety,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Bone density decreased,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Chronic kidney disease,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Economic problem,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Emotional distress,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,End stage renal disease,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Gait inability,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Nephropathy,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Renal failure,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Tooth loss,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
163384573,16338457,22,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Toothache,,2021,Q2,3,F,201011.0,20210616.0,20190521,20210624,EXP,,US-GILEAD-2019-0408526,GILEAD,,31.0,YR,A,M,Y,70.75,KG,20210623.0,,CN,US,US,2021,Q2,Young Adult
169388479,16938847,25,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Abscess,,2021,Q2,9,F,20190909.0,20210618.0,20191020,20210623,EXP,,PHHO2019US009197,NOVARTIS,,59.0,YR,,F,Y,65.9,KG,20210623.0,,HP,US,US,2021,Q2,Adult
169388479,16938847,26,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Abscess,,2021,Q2,9,F,20190909.0,20210618.0,20191020,20210623,EXP,,PHHO2019US009197,NOVARTIS,,59.0,YR,,F,Y,65.9,KG,20210623.0,,HP,US,US,2021,Q2,Adult
170007602,17000760,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Diabetes insipidus,,2021,Q2,2,F,,20210329.0,20191106,20210412,EXP,,US-PFIZER INC-2019469264,PFIZER,"HERITY, L.. DELAYED ONSET OF CENTRAL DIABETES INSIPIDUS WITH KETAMINE SEDATION: A REPORT OF 2 CASES. JOURNAL OF PHARMACY PRACTICE. 2021?34 (2):314?318",23.0,YR,,M,Y,86.2,KG,20210412.0,,PH,US,US,2021,Q2,Youth
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Abdominal pain,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Abscess,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Adrenal insufficiency,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Alanine aminotransferase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Ascites,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Asthenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Blood alkaline phosphatase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Blood bilirubin increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Blood potassium decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Blood pressure increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Bone erosion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Congestive hepatopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Depression,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Diverticulitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Endometrial disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Enterococcus test positive,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Fibrosis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Gait disturbance,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Gastrointestinal disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Generalised oedema,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Heart rate increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Herpes zoster,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Hypersensitivity,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Hypoglycaemia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Hypotension,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Increased appetite,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Influenza,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Infusion related reaction,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Injection site extravasation,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Intensive care unit acquired weakness,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Intervertebral disc protrusion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Joint effusion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Joint swelling,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Micturition disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Myelopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Myopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Nasopharyngitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Nausea,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Nerve compression,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Neuropathy peripheral,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Neutropenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Osteoarthritis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Pain,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Pancytopenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Peripheral sensorimotor neuropathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Peripheral swelling,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Peritonitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Pneumonia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Pseudomonal bacteraemia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Rheumatoid arthritis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Septic shock,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Synovitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Therapeutic response decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Tooth disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Vomiting,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Weight decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,55,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,TID,2021,Q2,Weight increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Abscess,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Adrenal insufficiency,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Alanine aminotransferase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Ascites,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood alkaline phosphatase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood bilirubin increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood potassium decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood pressure increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Bone erosion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Congestive hepatopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Depression,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Diverticulitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Endometrial disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Enterococcus test positive,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Fibrosis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Gait disturbance,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Gastrointestinal disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Generalised oedema,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Heart rate increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Herpes zoster,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Hypersensitivity,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Increased appetite,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Influenza,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Infusion related reaction,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Injection site extravasation,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Intensive care unit acquired weakness,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Intervertebral disc protrusion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Joint effusion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Joint swelling,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Micturition disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Myelopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Myopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Nasopharyngitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Nerve compression,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Neuropathy peripheral,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Neutropenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Osteoarthritis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Peripheral sensorimotor neuropathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Peritonitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Pseudomonal bacteraemia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Rheumatoid arthritis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Septic shock,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Synovitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Therapeutic response decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Tooth disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Abdominal pain,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Abscess,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Adrenal insufficiency,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Alanine aminotransferase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Ascites,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Asthenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Blood alkaline phosphatase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Blood bilirubin increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Blood potassium decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Blood pressure increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Bone erosion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Congestive hepatopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Depression,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Diverticulitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Endometrial disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Enterococcus test positive,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Fibrosis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Gait disturbance,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Gastrointestinal disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Generalised oedema,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Heart rate increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Herpes zoster,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Hypersensitivity,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Hypotension,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Increased appetite,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Influenza,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Infusion related reaction,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Injection site extravasation,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Intensive care unit acquired weakness,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Intervertebral disc protrusion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Joint effusion,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Joint swelling,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Micturition disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Myelopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Myopathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Nasopharyngitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Nausea,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Nerve compression,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Neuropathy peripheral,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Neutropenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Osteoarthritis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Pain,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Pancytopenia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Peripheral sensorimotor neuropathy,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Peripheral swelling,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Peritonitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Pneumonia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Pseudomonal bacteraemia,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Rheumatoid arthritis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Septic shock,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Synovitis,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Therapeutic response decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Tooth disorder,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Vomiting,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Weight decreased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
170382834,17038283,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 DOSAGE FORMS DAILY;,,,,,,,,3.0,DF,,QD,2021,Q2,Weight increased,,2021,Q2,4,F,,20210608.0,20191115,20210618,EXP,,CA-TEVA-2019-CA-1116759,TEVA,,62.0,YR,A,F,Y,67.0,KG,20210618.0,,HP,CA,CA,2021,Q2,Adult
174008458,17400845,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2021,Q2,Death,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2021,Q2,Dyspnoea,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2021,Q2,Ear haemorrhage,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2021,Q2,Enzyme level increased,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2021,Q2,Off label use,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174008458,17400845,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNIT/ML PEN WITH MEALS FOR 90 DAYS,,,,,,,,15.0,IU,,TID,2021,Q2,Product dispensing error,,2021,Q2,8,F,2020.0,20210329.0,20200211,20210402,EXP,,US-ABBVIE-20K-163-3269659-00,ABBVIE,,71.0,YR,,M,Y,118.04,KG,20210402.0,,HP,US,US,2021,Q2,Elderly
174251152,17425115,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,30 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,2,F,,20210513.0,20200217,20210516,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,"NAGASE T,IWAYA K, KOGURE K, ZAKO T, MISUMI Y, KIKUCHI M, ET AL. INSULIN?DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019?UNK:UNK",81.0,YR,E,M,Y,,,20210517.0,,HP,JP,JP,2021,Q2,Elderly
174251152,17425115,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,30 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Lipohypertrophy,,2021,Q2,2,F,,20210513.0,20200217,20210516,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,"NAGASE T,IWAYA K, KOGURE K, ZAKO T, MISUMI Y, KIKUCHI M, ET AL. INSULIN?DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019?UNK:UNK",81.0,YR,E,M,Y,,,20210517.0,,HP,JP,JP,2021,Q2,Elderly
174251152,17425115,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,30 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Secondary amyloidosis,,2021,Q2,2,F,,20210513.0,20200217,20210516,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,"NAGASE T,IWAYA K, KOGURE K, ZAKO T, MISUMI Y, KIKUCHI M, ET AL. INSULIN?DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019?UNK:UNK",81.0,YR,E,M,Y,,,20210517.0,,HP,JP,JP,2021,Q2,Elderly
174251152,17425115,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,2,F,,20210513.0,20200217,20210516,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,"NAGASE T,IWAYA K, KOGURE K, ZAKO T, MISUMI Y, KIKUCHI M, ET AL. INSULIN?DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019?UNK:UNK",81.0,YR,E,M,Y,,,20210517.0,,HP,JP,JP,2021,Q2,Elderly
174251152,17425115,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Lipohypertrophy,,2021,Q2,2,F,,20210513.0,20200217,20210516,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,"NAGASE T,IWAYA K, KOGURE K, ZAKO T, MISUMI Y, KIKUCHI M, ET AL. INSULIN?DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019?UNK:UNK",81.0,YR,E,M,Y,,,20210517.0,,HP,JP,JP,2021,Q2,Elderly
174251152,17425115,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 UNITS/DAY,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Secondary amyloidosis,,2021,Q2,2,F,,20210513.0,20200217,20210516,EXP,,JP-SA-2020SA035483,SANOFI AVENTIS,"NAGASE T,IWAYA K, KOGURE K, ZAKO T, MISUMI Y, KIKUCHI M, ET AL. INSULIN?DERIVED AMYLOIDOSIS WITHOUT A PALPABLE MASS AT THE INSULIN INJECTION SITE: A REPORT OF TWO CASES. JOURNAL OF DIABETES INVESTIGATION. 2019?UNK:UNK",81.0,YR,E,M,Y,,,20210517.0,,HP,JP,JP,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Gait disturbance,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,General physical health deterioration,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Hypoacusis,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Neuropathy peripheral,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Pollakiuria,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Vascular dementia,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
176941733,17694173,2,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Unknown,"15 U, PRN",,,U,,,,,15.0,IU,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,3,F,201908.0,20210514.0,20200422,20210526,EXP,,US-ELI_LILLY_AND_COMPANY-US202004005467,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210526.0,,CN,US,US,2021,Q2,Elderly
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Abscess,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Adrenal insufficiency,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Alanine aminotransferase increased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Ascites,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood alkaline phosphatase increased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood bilirubin increased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood potassium decreased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Blood pressure increased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Congestive hepatopathy,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Depression,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Diverticulitis,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Endometrial disorder,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Enterococcus test positive,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Fibrosis,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Gastrointestinal disorder,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Generalised oedema,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Heart rate increased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Herpes zoster,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Hypersensitivity,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Increased appetite,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Influenza,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Infusion related reaction,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Injection site extravasation,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Intensive care unit acquired weakness,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Intervertebral disc protrusion,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Joint effusion,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Joint swelling,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Micturition disorder,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Myelopathy,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Myopathy,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Nasopharyngitis,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Nerve compression,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Neuropathy peripheral,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Neutropenia,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Osteoarthritis,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Peripheral sensorimotor neuropathy,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Peritonitis,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Pseudomonal bacteraemia,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Rheumatoid arthritis,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Septic shock,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Therapeutic response decreased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177324133,17732413,41,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,3,F,,20210405.0,20200501,20210412,EXP,,CA-ROCHE-2587291,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210412.0,,HP,CA,CA,2021,Q2,Adult
177481762,17748176,3,SS,Lispro,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,UNKNOWN,,2021,Q2,Accidental overdose,,2021,Q2,2,F,20200427.0,20210326.0,20200506,20210405,EXP,,CA-BIOGEN-2020BI00869271,BIOGEN,,58.0,YR,,F,Y,,,20210404.0,,HP,CA,CA,2021,Q2,Adult
177481762,17748176,3,SS,Lispro,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,UNKNOWN,,2021,Q2,Hypoglycaemia,,2021,Q2,2,F,20200427.0,20210326.0,20200506,20210405,EXP,,CA-BIOGEN-2020BI00869271,BIOGEN,,58.0,YR,,F,Y,,,20210404.0,,HP,CA,CA,2021,Q2,Adult
178185393,17818539,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,3,F,20200519.0,20200605.0,20200522,20210428,EXP,,US-GILEAD-2020-0468282,GILEAD,,53.0,YR,A,M,Y,68.0,KG,20210428.0,,PH,US,US,2021,Q2,Adult
178185393,17818539,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Pulseless electrical activity,,2021,Q2,3,F,20200519.0,20200605.0,20200522,20210428,EXP,,US-GILEAD-2020-0468282,GILEAD,,53.0,YR,A,M,Y,68.0,KG,20210428.0,,PH,US,US,2021,Q2,Adult
178868342,17886834,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,2,F,20200531.0,20210526.0,20200611,20210526,EXP,,US-ROCHE-2615271,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210526.0,,HP,US,US,2021,Q2,Elderly
178955712,17895571,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Febrile neutropenia,,2021,Q2,2,F,20200528.0,20210526.0,20200615,20210531,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210531.0,,HP,US,US,2021,Q2,Elderly
178955712,17895571,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Neutrophil count decreased,,2021,Q2,2,F,20200528.0,20210526.0,20200615,20210531,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210531.0,,HP,US,US,2021,Q2,Elderly
178955712,17895571,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,2,F,20200528.0,20210526.0,20200615,20210531,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210531.0,,HP,US,US,2021,Q2,Elderly
178955712,17895571,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,White blood cell count decreased,,2021,Q2,2,F,20200528.0,20210526.0,20200615,20210531,EXP,,US-ROCHE-2617940,ROCHE,,71.0,YR,,F,Y,47.3,KG,20210531.0,,HP,US,US,2021,Q2,Elderly
179361869,17936186,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q2,Cardiac disorder,,2021,Q2,9,F,,20210617.0,20200624,20210625,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210625.0,,MD,US,US,2021,Q2,Adult
179361869,17936186,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q2,Colon cancer,,2021,Q2,9,F,,20210617.0,20200624,20210625,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210625.0,,MD,US,US,2021,Q2,Adult
179361869,17936186,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q2,Pulmonary oedema,,2021,Q2,9,F,,20210617.0,20200624,20210625,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210625.0,,MD,US,US,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Arrhythmia,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Aura,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Confusional state,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Disinhibition,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Disorientation,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Encephalitis,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Epilepsy,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Headache,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Intracranial pressure increased,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Meningoencephalitis herpetic,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Postictal state,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Syncope,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Therapeutic response unexpected,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Tonic clonic movements,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179401015,17940101,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 IU, QD",,,U,,,,,8.0,IU,,QD,2021,Q2,Ventricular extrasystoles,,2021,Q2,5,F,2020.0,20210528.0,20200625,20210603,EXP,,PT-SA-2020SA157721,SANOFI AVENTIS,,58.0,YR,A,M,Y,95.0,KG,20210603.0,,MD,PT,PT,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Encephalopathy,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Fournier's gangrene,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Muscular weakness,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Pain,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Sepsis,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Sinus tachycardia,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Tachypnoea,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179753296,17975329,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN LISPRO 100 UNITS/ML INJECTABLE SOLUTION STANDARD, SUBCUTANEOUS, ACHS",,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Urinary tract candidiasis,,2021,Q2,6,F,20180726.0,20210402.0,20200702,20210405,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-032801",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,122.5,KG,20210405.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,56,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,57,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,57,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,57,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,60,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,61,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,64,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Cholecystitis acute,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,64,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Peripheral ischaemia,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
179976469,17997646,64,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,9,F,20200603.0,20210514.0,20200708,20210519,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210519.0,,MD,US,US,2021,Q2,Adult
180352472,18035247,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, UNKNOWN",,,U,, D166927A,,20563.0,40.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202007.0,20210506.0,20200717,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202007006300,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
180352472,18035247,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, UNKNOWN",,,U,,,,20563.0,40.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202007.0,20210506.0,20200717,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202007006300,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
180352472,18035247,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, UNKNOWN",,,U,, D311791A,,20563.0,40.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,202007.0,20210506.0,20200717,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202007006300,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
180401535,18040153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,5,F,202007.0,20200820.0,20200717,20210511,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20210511.0,,PH,US,US,2021,Q2,Elderly
180401535,18040153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,5,F,202007.0,20200820.0,20200717,20210511,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20210511.0,,PH,US,US,2021,Q2,Elderly
180401535,18040153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,5,F,202007.0,20200820.0,20200717,20210511,EXP,,US-GILEAD-2020-0483271,GILEAD,,90.0,YR,E,M,Y,95.0,KG,20210511.0,,PH,US,US,2021,Q2,Elderly
180411835,18041183,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML INJECTABLE SOLUTION, 10 UNIT(S)=0.1ML, SUBCUTANEOUS , TIDML",,,,,,,,0.1,ML,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Acute kidney injury,,2021,Q2,5,F,20180513.0,20210402.0,20200719,20210410,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-035235",BOEHRINGER INGELHEIM,,46.0,YR,A,M,Y,122.6,KG,20210410.0,,MD,US,US,2021,Q2,Adult
180411835,18041183,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML INJECTABLE SOLUTION, 10 UNIT(S)=0.1ML, SUBCUTANEOUS , TIDML",,,,,,,,0.1,ML,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Fournier's gangrene,,2021,Q2,5,F,20180513.0,20210402.0,20200719,20210410,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-035235",BOEHRINGER INGELHEIM,,46.0,YR,A,M,Y,122.6,KG,20210410.0,,MD,US,US,2021,Q2,Adult
180411835,18041183,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNITS/ML INJECTABLE SOLUTION, 10 UNIT(S)=0.1ML, SUBCUTANEOUS , TIDML",,,,,,,,0.1,ML,SOLUTION FOR INJECTION/INFUSION,,2021,Q2,Sepsis,,2021,Q2,5,F,20180513.0,20210402.0,20200719,20210410,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2020-BI-035235",BOEHRINGER INGELHEIM,,46.0,YR,A,M,Y,122.6,KG,20210410.0,,MD,US,US,2021,Q2,Adult
181053372,18105337,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Coma scale abnormal,,2021,Q2,2,F,,20200728.0,20200803,20210628,EXP,,CA-TEVA-2020-CA-1808719,TEVA,,75.0,YR,E,M,Y,,,20210628.0,,CN,CA,CA,2021,Q2,Elderly
181053372,18105337,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,2,F,,20200728.0,20200803,20210628,EXP,,CA-TEVA-2020-CA-1808719,TEVA,,75.0,YR,E,M,Y,,,20210628.0,,CN,CA,CA,2021,Q2,Elderly
181053372,18105337,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Subdural haematoma,,2021,Q2,2,F,,20200728.0,20200803,20210628,EXP,,CA-TEVA-2020-CA-1808719,TEVA,,75.0,YR,E,M,Y,,,20210628.0,,CN,CA,CA,2021,Q2,Elderly
181053372,18105337,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Unresponsive to stimuli,,2021,Q2,2,F,,20200728.0,20200803,20210628,EXP,,CA-TEVA-2020-CA-1808719,TEVA,,75.0,YR,E,M,Y,,,20210628.0,,CN,CA,CA,2021,Q2,Elderly
181371672,18137167,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT (BY VALUE),,,,, UNKNOWN,,,,,,,2021,Q2,Cough,,2021,Q2,2,F,,20210515.0,20200812,20210527,PER,,DE-DRREDDYS-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20210527.0,,PH,DE,DE,2021,Q2,Elderly
181371672,18137167,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT (BY VALUE),,,,, UNKNOWN,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,2,F,,20210515.0,20200812,20210527,PER,,DE-DRREDDYS-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20210527.0,,PH,DE,DE,2021,Q2,Elderly
181371672,18137167,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT (BY VALUE),,,,, UNKNOWN,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,2,F,,20210515.0,20200812,20210527,PER,,DE-DRREDDYS-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20210527.0,,PH,DE,DE,2021,Q2,Elderly
181371672,18137167,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT (BY VALUE),,,,, UNKNOWN,,,,,,,2021,Q2,Weight increased,,2021,Q2,2,F,,20210515.0,20200812,20210527,PER,,DE-DRREDDYS-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20210527.0,,PH,DE,DE,2021,Q2,Elderly
181380613,18138061,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,3,F,,20210527.0,20200812,20210605,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20210605.0,,PH,DE,DE,2021,Q2,Elderly
181380613,18138061,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,U,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,3,F,,20210527.0,20200812,20210605,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20210605.0,,PH,DE,DE,2021,Q2,Elderly
181380613,18138061,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,U,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,3,F,,20210527.0,20200812,20210605,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20210605.0,,PH,DE,DE,2021,Q2,Elderly
181380613,18138061,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,3,F,,20210527.0,20200812,20210605,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20210605.0,,PH,DE,DE,2021,Q2,Elderly
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Catheter site infection,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Hypersensitivity,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Malaise,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Platelet count decreased,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Product dose omission issue,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Rash,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181417459,18141745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Red blood cell count decreased,,2021,Q2,9,F,20210310.0,20210622.0,20200812,20210628,EXP,,US-TAKEDA-2020TUS034132,TAKEDA,,28.0,YR,,F,Y,127.6,KG,20210628.0,,CN,US,US,2021,Q2,Young Adult
181561932,18156193,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (NACH WERT),,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,2,F,,20210517.0,20200817,20210524,EXP,DE-ADRED-05240-01,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20210524.0,,HP,DE,DE,2021,Q2,Elderly
181561932,18156193,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (NACH WERT),,,U,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,2,F,,20210517.0,20200817,20210524,EXP,DE-ADRED-05240-01,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20210524.0,,HP,DE,DE,2021,Q2,Elderly
181561932,18156193,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (NACH WERT),,,U,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,2,F,,20210517.0,20200817,20210524,EXP,DE-ADRED-05240-01,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20210524.0,,HP,DE,DE,2021,Q2,Elderly
181561932,18156193,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (NACH WERT),,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,2,F,,20210517.0,20200817,20210524,EXP,DE-ADRED-05240-01,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20210524.0,,HP,DE,DE,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Asthma,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Blood count abnormal,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Chest discomfort,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Diaphragmatic disorder,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Discomfort,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Dyspnoea,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Hypoxia,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Left ventricular hypertrophy,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Obstructive airways disorder,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Oedema peripheral,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Oropharyngeal pain,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Pyrexia,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q2,Weight increased,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Asthma,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Blood count abnormal,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Chest discomfort,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Diaphragmatic disorder,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Discomfort,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Dyspnoea,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Hypoxia,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Left ventricular hypertrophy,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Obstructive airways disorder,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Oedema peripheral,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Oropharyngeal pain,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Pyrexia,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181592403,18159240,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID (2 IN 1 D)",,,U,,,,,,,,Q12H,2021,Q2,Weight increased,,2021,Q2,3,F,,20210308.0,20200817,20210402,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210402.0,,HP,CA,CA,2021,Q2,Elderly
181807612,18180761,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,2,F,,20210517.0,20200821,20210525,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20210525.0,,PH,DE,DE,2021,Q2,Elderly
181807612,18180761,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,2,F,,20210517.0,20200821,20210525,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20210525.0,,PH,DE,DE,2021,Q2,Elderly
181807612,18180761,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,2,F,,20210517.0,20200821,20210525,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20210525.0,,PH,DE,DE,2021,Q2,Elderly
181807612,18180761,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,2,F,,20210517.0,20200821,20210525,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20210525.0,,PH,DE,DE,2021,Q2,Elderly
182004913,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,3,F,,20210531.0,20200826,20210603,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20210603.0,,PH,DE,DE,2021,Q2,Elderly
182004913,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,U,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,3,F,,20210531.0,20200826,20210603,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20210603.0,,PH,DE,DE,2021,Q2,Elderly
182004913,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,U,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,3,F,,20210531.0,20200826,20210603,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20210603.0,,PH,DE,DE,2021,Q2,Elderly
182004913,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,3,F,,20210531.0,20200826,20210603,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20210603.0,,PH,DE,DE,2021,Q2,Elderly
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Abdominal discomfort,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Abdominal distension,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Abdominal pain upper,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Anaemia,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Asthenia,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Cellulitis,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Constipation,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Decreased appetite,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Diarrhoea,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Dizziness,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Dyspnoea exertional,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Fatigue,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Gastric ulcer,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Haemorrhoids,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Headache,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Helicobacter infection,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Hepatomegaly,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Nausea,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Palpitations,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Portal hypertensive gastropathy,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Pyuria,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Transaminases increased,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Varices oesophageal,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182213045,18221304,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2?12 UNITS (1 UNIT/0.01ML), QID (WITH MEALS AND HS)",,,,,,,,,,INJECTION,QID,2021,Q2,Vomiting,,2021,Q2,5,F,2020.0,20210609.0,20200902,20210619,EXP,,US-UNITED THERAPEUTICS-UNT-2020-011302,UNITED THERAPEUTICS,,40.0,YR,,F,Y,79.2,KG,20210619.0,,CN,US,US,2021,Q2,Adult
182333473,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Atrial fibrillation,,2021,Q2,3,F,,20210412.0,20200904,20210421,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20210421.0,,PH,CA,CA,2021,Q2,Adult
182333473,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Dehydration,,2021,Q2,3,F,,20210412.0,20200904,20210421,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20210421.0,,PH,CA,CA,2021,Q2,Adult
182333473,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,3,F,,20210412.0,20200904,20210421,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20210421.0,,PH,CA,CA,2021,Q2,Adult
182333473,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Malaise,,2021,Q2,3,F,,20210412.0,20200904,20210421,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20210421.0,,PH,CA,CA,2021,Q2,Adult
182333473,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Product dose omission issue,,2021,Q2,3,F,,20210412.0,20200904,20210421,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20210421.0,,PH,CA,CA,2021,Q2,Adult
182333473,18233347,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,3,F,,20210412.0,20200904,20210421,EXP,,CA-TEVA-2020-CA-1822259,TEVA,,58.0,YR,A,M,Y,98.0,KG,20210421.0,,PH,CA,CA,2021,Q2,Adult
182473396,18247339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2021,Q2,Anaemia,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2021,Q2,Enteritis,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2021,Q2,Hospitalisation,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2021,Q2,Malaise,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2021,Q2,Nausea,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2021,Q2,Non-cardiac chest pain,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2021,Q2,Speech disorder,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, QID",,,,,,,,20.0,IU,,QID,2021,Q2,Vulvovaginal mycotic infection,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU INTERNATIONAL UNIT(S), PER HOUR CONTINOUS VIA PUMP",,,,,,,,0.9,IU,,,2021,Q2,Anaemia,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU INTERNATIONAL UNIT(S), PER HOUR CONTINOUS VIA PUMP",,,,,,,,0.9,IU,,,2021,Q2,Enteritis,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU INTERNATIONAL UNIT(S), PER HOUR CONTINOUS VIA PUMP",,,,,,,,0.9,IU,,,2021,Q2,Hospitalisation,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU INTERNATIONAL UNIT(S), PER HOUR CONTINOUS VIA PUMP",,,,,,,,0.9,IU,,,2021,Q2,Malaise,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU INTERNATIONAL UNIT(S), PER HOUR CONTINOUS VIA PUMP",,,,,,,,0.9,IU,,,2021,Q2,Nausea,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU INTERNATIONAL UNIT(S), PER HOUR CONTINOUS VIA PUMP",,,,,,,,0.9,IU,,,2021,Q2,Non-cardiac chest pain,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU INTERNATIONAL UNIT(S), PER HOUR CONTINOUS VIA PUMP",,,,,,,,0.9,IU,,,2021,Q2,Speech disorder,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182473396,18247339,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU INTERNATIONAL UNIT(S), PER HOUR CONTINOUS VIA PUMP",,,,,,,,0.9,IU,,,2021,Q2,Vulvovaginal mycotic infection,,2021,Q2,6,F,20200831.0,20210506.0,20200909,20210512,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR004958,AEGERION,,38.0,YR,,F,Y,,,20210512.0,,HP,US,US,2021,Q2,Adult
182585336,18258533,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,U,, ASKED BUT UNKNOWN,,,,,,,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,6,F,20200809.0,20210423.0,20200911,20210507,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-260814,RANBAXY,,74.0,YR,,M,Y,,,20210507.0,,HP,NL,FR,2021,Q2,Elderly
182846332,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,2,F,,20210407.0,20200918,20210416,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20210415.0,,HP,CA,CA,2021,Q2,Elderly
182846332,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Dehydration,,2021,Q2,2,F,,20210407.0,20200918,20210416,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20210415.0,,HP,CA,CA,2021,Q2,Elderly
182846332,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,2,F,,20210407.0,20200918,20210416,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20210415.0,,HP,CA,CA,2021,Q2,Elderly
182846332,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Small intestinal obstruction,,2021,Q2,2,F,,20210407.0,20200918,20210416,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20210415.0,,HP,CA,CA,2021,Q2,Elderly
182846332,18284633,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q2,Urinary tract obstruction,,2021,Q2,2,F,,20210407.0,20200918,20210416,EXP,,CA-ASTRAZENECA-2020SF16518,ASTRAZENECA,,72.0,YR,,F,Y,,,20210415.0,,HP,CA,CA,2021,Q2,Elderly
182859905,18285990,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO,",,,U,, ASKU,,,1.0,IU,,,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,5,F,20200809.0,20210425.0,20200919,20210505,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-TEVA-2020-FR-1828416,TEVA,,74.0,YR,E,M,Y,,,20210505.0,,MD,FR,FR,2021,Q2,Elderly
183243814,18324381,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,4,F,20200820.0,20210518.0,20200929,20210521,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20210521.0,,HP,US,US,2021,Q2,Adult
183243814,18324381,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,4,F,20200820.0,20210518.0,20200929,20210521,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20210521.0,,HP,US,US,2021,Q2,Adult
183243814,18324381,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,4,F,20200820.0,20210518.0,20200929,20210521,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20210521.0,,HP,US,US,2021,Q2,Adult
183243814,18324381,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,4,F,20200820.0,20210518.0,20200929,20210521,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20210521.0,,HP,US,US,2021,Q2,Adult
183243814,18324381,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,4,F,20200820.0,20210518.0,20200929,20210521,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20210521.0,,HP,US,US,2021,Q2,Adult
183243814,18324381,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,4,F,20200820.0,20210518.0,20200929,20210521,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20210521.0,,HP,US,US,2021,Q2,Adult
183243814,18324381,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,4,F,20200820.0,20210518.0,20200929,20210521,EXP,,NVSC2020US232957,NOVARTIS,,61.0,YR,,M,Y,82.0,KG,20210521.0,,HP,US,US,2021,Q2,Adult
183247173,18324717,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,, UNK,,,1.0,IU,UNKNOWN,,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,3,F,20200809.0,20210607.0,20200929,20210614,EXP,,FR-FRESENIUS KABI-FK202008998,FRESENIUS KABI,,75.0,YR,,M,Y,,,20210614.0,,HP,NL,FR,2021,Q2,Elderly
1837317711,18373177,34,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 ? 12 UNITS, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Acute kidney injury,,2021,Q2,11,F,20200928.0,20210617.0,20201012,20210618,EXP,,US-ASTELLAS-2020US034378,ASTELLAS,,73.0,YR,,M,Y,,,20210618.0,,MD,US,US,2021,Q2,Elderly
1837317711,18373177,34,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 ? 12 UNITS, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Septic shock,,2021,Q2,11,F,20200928.0,20210617.0,20201012,20210618,EXP,,US-ASTELLAS-2020US034378,ASTELLAS,,73.0,YR,,M,Y,,,20210618.0,,MD,US,US,2021,Q2,Elderly
1837317711,18373177,34,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 ? 12 UNITS, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Stevens-Johnson syndrome,,2021,Q2,11,F,20200928.0,20210617.0,20201012,20210618,EXP,,US-ASTELLAS-2020US034378,ASTELLAS,,73.0,YR,,M,Y,,,20210618.0,,MD,US,US,2021,Q2,Elderly
183958303,18395830,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,3,F,20201012.0,20201106.0,20201018,20210429,EXP,,US-GILEAD-2020-0499349,GILEAD,,85.0,YR,E,F,Y,52.02,KG,20210429.0,,PH,US,US,2021,Q2,Elderly
184453883,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2021,Q2,Bone cancer,,2021,Q2,3,F,202009.0,20210520.0,20201030,20210527,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210527.0,,CN,US,US,2021,Q2,Elderly
184453883,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2021,Q2,Dementia,,2021,Q2,3,F,202009.0,20210520.0,20201030,20210527,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210527.0,,CN,US,US,2021,Q2,Elderly
184453883,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,3,F,202009.0,20210520.0,20201030,20210527,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210527.0,,CN,US,US,2021,Q2,Elderly
184453883,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2021,Q2,Incorrect dose administered,,2021,Q2,3,F,202009.0,20210520.0,20201030,20210527,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210527.0,,CN,US,US,2021,Q2,Elderly
184453883,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2021,Q2,Memory impairment,,2021,Q2,3,F,202009.0,20210520.0,20201030,20210527,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210527.0,,CN,US,US,2021,Q2,Elderly
184453883,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2021,Q2,Recurrent cancer,,2021,Q2,3,F,202009.0,20210520.0,20201030,20210527,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210527.0,,CN,US,US,2021,Q2,Elderly
184453883,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2021,Q2,Vision blurred,,2021,Q2,3,F,202009.0,20210520.0,20201030,20210527,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210527.0,,CN,US,US,2021,Q2,Elderly
184453883,18445388,5,SS,Insulin Lispro Lilly (MirioPen) (KwikPen),INSULIN LISPRO,1,Subcutaneous,"4 U, OTHER AT EACH MEAL",,,,, D195320A,,,4.0,IU,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,3,F,202009.0,20210520.0,20201030,20210527,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210527.0,,CN,US,US,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Asthma,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Blood count abnormal,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Chest discomfort,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Cough,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Diaphragmatic disorder,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Discomfort,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Dyspnoea,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Hypoxia,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Left ventricular hypertrophy,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Obstructive airways disorder,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Oedema peripheral,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Oropharyngeal pain,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Pyrexia,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Weight increased,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q2,Wheezing,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Asthma,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Blood count abnormal,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Chest discomfort,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Cough,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Diaphragmatic disorder,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Discomfort,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Dyspnoea,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Hypoxia,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Left ventricular hypertrophy,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Obstructive airways disorder,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Oedema peripheral,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Oropharyngeal pain,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Pyrexia,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Weight increased,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184534196,18453419,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q2,Wheezing,,2021,Q2,6,F,,20210519.0,20201102,20210531,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210531.0,,HP,CA,CA,2021,Q2,Elderly
184611323,18461132,3,C,INSULIN LISPRO/ISOPHANE INSULIN,,2,,12UI,,,,,,,,12.0,IU,,,2021,Q2,Colitis microscopic,,2021,Q2,3,F,,20210531.0,20201104,20210614,EXP,PT-EMA-DD-20201027-GONUGUNTLA_N1-112356,PT-ACCORD-207297,ACCORD,,69.0,YR,E,M,Y,,,20210614.0,,HP,PT,PT,2021,Q2,Elderly
184636182,18463618,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Product storage error,,2021,Q2,2,F,20190430.0,20210407.0,20201104,20210419,EXP,,US-NOVOPROD-764149,NOVO NORDISK,,63.0,YR,,M,Y,,,20210419.0,,CN,US,US,2021,Q2,Adult
184636182,18463618,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Spinal operation,,2021,Q2,2,F,20190430.0,20210407.0,20201104,20210419,EXP,,US-NOVOPROD-764149,NOVO NORDISK,,63.0,YR,,M,Y,,,20210419.0,,CN,US,US,2021,Q2,Adult
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Abdominal distension,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Arthralgia,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,C-reactive protein increased,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Joint swelling,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Muscle spasms,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Myositis,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pain,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pain in extremity,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184696624,18469662,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Urinary tract infection,,2021,Q2,4,F,20200805.0,20210519.0,20201105,20210527,EXP,,NVSC2020CA221004,NOVARTIS,,65.0,YR,,F,Y,,,20210527.0,,CN,COUNTRY NOT SPECIFIED,CA,2021,Q2,Elderly
184744322,18474432,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20140311.0,20210614.0,20201106,20210622,EXP,,US-ASTRAZENECA-2020SF43876,ASTRAZENECA,,20744.0,DY,,F,Y,85.3,KG,20210622.0,,,US,US,2021,Q2,Elderly
184744322,18474432,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Gastric cancer stage IV,,2021,Q2,2,F,20140311.0,20210614.0,20201106,20210622,EXP,,US-ASTRAZENECA-2020SF43876,ASTRAZENECA,,20744.0,DY,,F,Y,85.3,KG,20210622.0,,,US,US,2021,Q2,Elderly
184744322,18474432,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Rebound acid hypersecretion,,2021,Q2,2,F,20140311.0,20210614.0,20201106,20210622,EXP,,US-ASTRAZENECA-2020SF43876,ASTRAZENECA,,20744.0,DY,,F,Y,85.3,KG,20210622.0,,,US,US,2021,Q2,Elderly
184744322,18474432,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Renal failure,,2021,Q2,2,F,20140311.0,20210614.0,20201106,20210622,EXP,,US-ASTRAZENECA-2020SF43876,ASTRAZENECA,,20744.0,DY,,F,Y,85.3,KG,20210622.0,,,US,US,2021,Q2,Elderly
184821755,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q2,Arthralgia,,2021,Q2,5,F,20201019.0,20210601.0,20201110,20210605,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20210604.0,,MD,JP,JP,2021,Q2,Adult
184821755,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q2,Cataract,,2021,Q2,5,F,20201019.0,20210601.0,20201110,20210605,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20210604.0,,MD,JP,JP,2021,Q2,Adult
184821755,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q2,Eczema asteatotic,,2021,Q2,5,F,20201019.0,20210601.0,20201110,20210605,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20210604.0,,MD,JP,JP,2021,Q2,Adult
184821755,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q2,Rash pruritic,,2021,Q2,5,F,20201019.0,20210601.0,20201110,20210605,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20210604.0,,MD,JP,JP,2021,Q2,Adult
186225887,18622588,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,7,F,20201210.0,20210602.0,20201216,20210603,EXP,,NVSC2020US330022,NOVARTIS,,68.0,YR,,M,Y,87.1,KG,20210603.0,,HP,US,US,2021,Q2,Elderly
186225887,18622588,35,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,7,F,20201210.0,20210602.0,20201216,20210603,EXP,,NVSC2020US330022,NOVARTIS,,68.0,YR,,M,Y,87.1,KG,20210603.0,,HP,US,US,2021,Q2,Elderly
186595772,18659577,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,300.0,IU,,,2021,Q2,Abdominal pain upper,,2021,Q2,2,F,20201209.0,20210519.0,20201224,20210529,EXP,,DE-JNJFOC-20201232483,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,82.0,KG,20210528.0,,MD,DE,DE,2021,Q2,Child
186595772,18659577,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,300.0,IU,,,2021,Q2,Chills,,2021,Q2,2,F,20201209.0,20210519.0,20201224,20210529,EXP,,DE-JNJFOC-20201232483,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,82.0,KG,20210528.0,,MD,DE,DE,2021,Q2,Child
186595772,18659577,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,300.0,IU,,,2021,Q2,Ecthyma,,2021,Q2,2,F,20201209.0,20210519.0,20201224,20210529,EXP,,DE-JNJFOC-20201232483,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,82.0,KG,20210528.0,,MD,DE,DE,2021,Q2,Child
186595772,18659577,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,300.0,IU,,,2021,Q2,Necrosis,,2021,Q2,2,F,20201209.0,20210519.0,20201224,20210529,EXP,,DE-JNJFOC-20201232483,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,82.0,KG,20210528.0,,MD,DE,DE,2021,Q2,Child
186877202,18687720,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q2,Abdominal pain upper,,2021,Q2,2,F,20201209.0,20210603.0,20201231,20210614,EXP,,NVSC2020DE344121,NOVARTIS,,8.0,DEC,,F,Y,82.0,KG,20210614.0,,HP,DE,DE,2021,Q2,Child
186877202,18687720,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q2,Chills,,2021,Q2,2,F,20201209.0,20210603.0,20201231,20210614,EXP,,NVSC2020DE344121,NOVARTIS,,8.0,DEC,,F,Y,82.0,KG,20210614.0,,HP,DE,DE,2021,Q2,Child
186877202,18687720,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q2,Ecthyma,,2021,Q2,2,F,20201209.0,20210603.0,20201231,20210614,EXP,,NVSC2020DE344121,NOVARTIS,,8.0,DEC,,F,Y,82.0,KG,20210614.0,,HP,DE,DE,2021,Q2,Child
186877202,18687720,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q2,Necrosis,,2021,Q2,2,F,20201209.0,20210603.0,20201231,20210614,EXP,,NVSC2020DE344121,NOVARTIS,,8.0,DEC,,F,Y,82.0,KG,20210614.0,,HP,DE,DE,2021,Q2,Child
1869104717,18691047,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,End stage renal disease,,2021,Q2,17,F,20201202.0,20210611.0,20210101,20210614,EXP,,NVSC2020US325160,NOVARTIS,,73.0,YR,,F,Y,88.8,KG,20210614.0,,HP,US,US,2021,Q2,Elderly
187160163,18716016,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Extra dose administered,,2021,Q2,3,F,20201226.0,20210423.0,20210108,20210428,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000758,ELI LILLY AND CO,,62.0,YR,,M,Y,82.2,KG,20210428.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Flank pain,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Pyuria,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187325532,18732553,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2021,Q2,Unresponsive to stimuli,,2021,Q2,2,F,20201224.0,20210329.0,20210112,20210401,EXP,,US-ELI_LILLY_AND_COMPANY-US202101000649,ELI LILLY AND CO,,58.0,YR,,F,Y,104.3,KG,20210401.0,,PH,US,US,2021,Q2,Adult
187410632,18741063,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25?12?18/DAY, IU",,,,,,,,,,,,2021,Q2,Embolic stroke,,2021,Q2,2,F,20140513.0,20210608.0,20210114,20210617,EXP,,DE-TAKEDA-2014BAX056499,TAKEDA,,73.0,YR,,,Y,100.0,KG,20210617.0,,MD,DE,DE,2021,Q2,Elderly
187410632,18741063,20,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25?12?18/DAY, IU",,,,,,,,,,,,2021,Q2,Muscle haemorrhage,,2021,Q2,2,F,20140513.0,20210608.0,20210114,20210617,EXP,,DE-TAKEDA-2014BAX056499,TAKEDA,,73.0,YR,,,Y,100.0,KG,20210617.0,,MD,DE,DE,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Diabetes mellitus,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Drug intolerance,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Grip strength decreased,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Headache,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hepatic cirrhosis,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hepatotoxicity,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Movement disorder,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Osteoarthritis,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pain in extremity,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187611773,18761177,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Psoriatic arthropathy,,2021,Q2,3,F,,20210614.0,20210120,20210616,EXP,,CA-ABBVIE-21K-028-3736809-00,ABBVIE,,65.0,YR,,F,Y,,,20210616.0,,CN,CA,CA,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Acute respiratory failure,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Amnestic disorder,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Cough,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Cystitis,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Deep vein thrombosis,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Head injury,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Hyperhidrosis,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Pulmonary embolism,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
187850703,18785070,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, OTHER",,,,,,,,,,,,2021,Q2,Syncope,,2021,Q2,3,F,202101.0,20210525.0,20210125,20210603,EXP,,US-ELI_LILLY_AND_COMPANY-US202101005867,ELI LILLY AND CO,,79.0,YR,,M,Y,100.0,KG,20210603.0,,PH,US,US,2021,Q2,Elderly
188727933,18872793,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Bacteraemia,,2021,Q2,3,F,20210119.0,20210329.0,20210210,20210408,EXP,,US-FRESENIUS KABI-FK202101282,FRESENIUS KABI,,54.0,YR,,M,Y,84.17,KG,20210408.0,,MD,US,US,2021,Q2,Adult
188727933,18872793,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Infection,,2021,Q2,3,F,20210119.0,20210329.0,20210210,20210408,EXP,,US-FRESENIUS KABI-FK202101282,FRESENIUS KABI,,54.0,YR,,M,Y,84.17,KG,20210408.0,,MD,US,US,2021,Q2,Adult
188727933,18872793,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0?6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q2,Mucosal infection,,2021,Q2,3,F,20210119.0,20210329.0,20210210,20210408,EXP,,US-FRESENIUS KABI-FK202101282,FRESENIUS KABI,,54.0,YR,,M,Y,84.17,KG,20210408.0,,MD,US,US,2021,Q2,Adult
189085085,18908508,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 3 UNITS,,,,,,,,,,,,2021,Q2,Acidosis,Acidosis,2021,Q2,5,F,20210211.0,20210510.0,20210218,20210519,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210514.0,,CN,US,US,2021,Q2,Adult
189085085,18908508,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 3 UNITS,,,,,,,,,,,,2021,Q2,COVID-19 pneumonia,,2021,Q2,5,F,20210211.0,20210510.0,20210218,20210519,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210514.0,,CN,US,US,2021,Q2,Adult
189085085,18908508,14,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 3 UNITS,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,5,F,20210211.0,20210510.0,20210218,20210519,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210514.0,,CN,US,US,2021,Q2,Adult
189085085,18908508,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 7 UNITS,,,,,,,,,,,,2021,Q2,Acidosis,Acidosis,2021,Q2,5,F,20210211.0,20210510.0,20210218,20210519,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210514.0,,CN,US,US,2021,Q2,Adult
189085085,18908508,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 7 UNITS,,,,,,,,,,,,2021,Q2,COVID-19 pneumonia,,2021,Q2,5,F,20210211.0,20210510.0,20210218,20210519,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210514.0,,CN,US,US,2021,Q2,Adult
189085085,18908508,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,1 TO 7 UNITS,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,5,F,20210211.0,20210510.0,20210218,20210519,EXP,,"US-SECURA BIO, INC.-2021US001258",SECURA BIO,,48.0,YR,,M,Y,100.5,KG,20210514.0,,CN,US,US,2021,Q2,Adult
189132212,18913221,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Blood uric acid decreased,,2021,Q2,2,F,20200501.0,20210608.0,20210218,20210610,EXP,,CA-TAKEDA-2021TUS009357,TAKEDA,,61.0,YR,,M,Y,110.0,KG,20210610.0,,PH,CA,CA,2021,Q2,Adult
189132212,18913221,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,2,F,20200501.0,20210608.0,20210218,20210610,EXP,,CA-TAKEDA-2021TUS009357,TAKEDA,,61.0,YR,,M,Y,110.0,KG,20210610.0,,PH,CA,CA,2021,Q2,Adult
189132212,18913221,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,2,F,20200501.0,20210608.0,20210218,20210610,EXP,,CA-TAKEDA-2021TUS009357,TAKEDA,,61.0,YR,,M,Y,110.0,KG,20210610.0,,PH,CA,CA,2021,Q2,Adult
189132212,18913221,12,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Syncope,,2021,Q2,2,F,20200501.0,20210608.0,20210218,20210610,EXP,,CA-TAKEDA-2021TUS009357,TAKEDA,,61.0,YR,,M,Y,110.0,KG,20210610.0,,PH,CA,CA,2021,Q2,Adult
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Depressed level of consciousness,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Injury,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Localised infection,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Muscular weakness,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Pain in extremity,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Depressed level of consciousness,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Injury,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Localised infection,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Muscular weakness,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Pain in extremity,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Depressed level of consciousness,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Injury,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Localised infection,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Muscular weakness,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Pain in extremity,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Depressed level of consciousness,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Injury,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Localised infection,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Muscular weakness,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189150193,18915019,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Pain in extremity,,2021,Q2,3,F,20151015.0,20210412.0,20210219,20210422,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210422.0,,CN,US,US,2021,Q2,Elderly
189170632,18917063,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,,,2021,Q2,Blindness,,2021,Q2,2,F,20210120.0,20210406.0,20210219,20210419,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102004691,ELI LILLY AND CO,,66.0,YR,,M,Y,93.0,KG,20210419.0,,CN,ES,ES,2021,Q2,Elderly
189170632,18917063,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,,,2021,Q2,Blister,,2021,Q2,2,F,20210120.0,20210406.0,20210219,20210419,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102004691,ELI LILLY AND CO,,66.0,YR,,M,Y,93.0,KG,20210419.0,,CN,ES,ES,2021,Q2,Elderly
189170632,18917063,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,,,2021,Q2,Extra dose administered,,2021,Q2,2,F,20210120.0,20210406.0,20210219,20210419,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102004691,ELI LILLY AND CO,,66.0,YR,,M,Y,93.0,KG,20210419.0,,CN,ES,ES,2021,Q2,Elderly
189170632,18917063,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,,,2021,Q2,Feeling hot,,2021,Q2,2,F,20210120.0,20210406.0,20210219,20210419,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102004691,ELI LILLY AND CO,,66.0,YR,,M,Y,93.0,KG,20210419.0,,CN,ES,ES,2021,Q2,Elderly
189170632,18917063,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,20210120.0,20210406.0,20210219,20210419,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102004691,ELI LILLY AND CO,,66.0,YR,,M,Y,93.0,KG,20210419.0,,CN,ES,ES,2021,Q2,Elderly
189170632,18917063,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,,,2021,Q2,Limb injury,,2021,Q2,2,F,20210120.0,20210406.0,20210219,20210419,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102004691,ELI LILLY AND CO,,66.0,YR,,M,Y,93.0,KG,20210419.0,,CN,ES,ES,2021,Q2,Elderly
189170632,18917063,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,,,2021,Q2,Ocular hyperaemia,,2021,Q2,2,F,20210120.0,20210406.0,20210219,20210419,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102004691,ELI LILLY AND CO,,66.0,YR,,M,Y,93.0,KG,20210419.0,,CN,ES,ES,2021,Q2,Elderly
189170632,18917063,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,,,2021,Q2,Peripheral swelling,,2021,Q2,2,F,20210120.0,20210406.0,20210219,20210419,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102004691,ELI LILLY AND CO,,66.0,YR,,M,Y,93.0,KG,20210419.0,,CN,ES,ES,2021,Q2,Elderly
189182927,18918292,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Abscess,,2021,Q2,7,F,20210216.0,20210503.0,20210219,20210505,EXP,,US-GILEAD-2021-0518037,GILEAD,,72.0,YR,E,M,Y,121.09,KG,20210505.0,,HP,US,US,2021,Q2,Elderly
189212418,18921241,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Fungal sepsis,,2021,Q2,8,F,20210216.0,20210608.0,20210222,20210611,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210611.0,,MD,US,US,2021,Q2,Elderly
189212418,18921241,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE U X 3 X 1 DAYS,,,,,,,,,,UNKNOWN,TID,2021,Q2,Fungal sepsis,,2021,Q2,8,F,20210216.0,20210608.0,20210222,20210611,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210611.0,,MD,US,US,2021,Q2,Elderly
189305476,18930547,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,QD,2021,Q2,Fungal sepsis,,2021,Q2,6,F,20210216.0,20210608.0,20210223,20210615,EXP,,US-ABBVIE-21P-163-3785222-00,ABBVIE,,68.0,YR,,F,Y,46.0,KG,20210615.0,,MD,US,US,2021,Q2,Elderly
189305476,18930547,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,TID,2021,Q2,Fungal sepsis,,2021,Q2,6,F,20210216.0,20210608.0,20210223,20210615,EXP,,US-ABBVIE-21P-163-3785222-00,ABBVIE,,68.0,YR,,F,Y,46.0,KG,20210615.0,,MD,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Exostosis,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Fracture,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Humerus fracture,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Osteonecrosis,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Rotator cuff syndrome,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Scar,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189316893,18931689,18,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Tendon rupture,,2021,Q2,3,F,20200513.0,20210415.0,20210224,20210419,EXP,,US-ABBVIE-21K-163-3785258-00,ABBVIE,,67.0,YR,,F,Y,90.8,KG,20210419.0,,CN,US,US,2021,Q2,Elderly
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Abdominal pain,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Abscess,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Adrenal insufficiency,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Alanine aminotransferase increased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Ascites,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Asthenia,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Blood alkaline phosphatase increased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Blood bilirubin increased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Blood potassium decreased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Blood pressure increased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Bone erosion,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Congestive hepatopathy,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Depression,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Diverticulitis,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Endometrial disorder,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Enterococcus test positive,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Fibrosis,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Gait disturbance,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Gastrointestinal disorder,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Generalised oedema,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Heart rate increased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Herpes zoster,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Hypersensitivity,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Hypoglycaemia,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Hypotension,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Increased appetite,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Influenza,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Infusion related reaction,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Injection site extravasation,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Intensive care unit acquired weakness,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Intervertebral disc protrusion,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Joint effusion,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Joint swelling,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Micturition disorder,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Myelopathy,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Myopathy,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Nasopharyngitis,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Nausea,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Nerve compression,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Neuropathy peripheral,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Neutropenia,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Osteoarthritis,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Pain,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Pancytopenia,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Peripheral sensorimotor neuropathy,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Peripheral swelling,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Peritonitis,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Pneumonia,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Pseudomonal bacteraemia,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Rheumatoid arthritis,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Septic shock,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Synovitis,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Therapeutic response decreased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Tooth disorder,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Vomiting,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Weight decreased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
189813992,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 DOSAGE FORMS,,,,,,,,,,,QD,2021,Q2,Weight increased,,2021,Q2,2,F,,20210228.0,20210308,20210401,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20210401.0,,CN,CA,CA,2021,Q2,Adult
190026682,19002668,9,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Atrial fibrillation,,2021,Q2,2,F,20210122.0,20210430.0,20210312,20210510,PER,,US-CELGENEUS-USA-20210301969,CELGENE,,76.0,YR,,M,Y,101.8,KG,20210510.0,,MD,US,US,2021,Q2,Elderly
190088063,19008806,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"THREE TIMES DAILY BEFORE MEALS, PRE?FILLED PEN",,,U,,,,,,,INJECTION,,2021,Q2,Blood pressure increased,,2021,Q2,3,F,20210226.0,20210331.0,20210315,20210416,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-021275,BRISTOL MYERS SQUIBB,,83.0,YR,,F,Y,59.87,KG,20210416.0,,CN,US,US,2021,Q2,Elderly
190088063,19008806,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"THREE TIMES DAILY BEFORE MEALS, PRE?FILLED PEN",,,U,,,,,,,INJECTION,,2021,Q2,Extrasystoles,,2021,Q2,3,F,20210226.0,20210331.0,20210315,20210416,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-021275,BRISTOL MYERS SQUIBB,,83.0,YR,,F,Y,59.87,KG,20210416.0,,CN,US,US,2021,Q2,Elderly
190088063,19008806,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"THREE TIMES DAILY BEFORE MEALS, PRE?FILLED PEN",,,U,,,,,,,INJECTION,,2021,Q2,Heart rate irregular,,2021,Q2,3,F,20210226.0,20210331.0,20210315,20210416,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-021275,BRISTOL MYERS SQUIBB,,83.0,YR,,F,Y,59.87,KG,20210416.0,,CN,US,US,2021,Q2,Elderly
190088063,19008806,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"THREE TIMES DAILY BEFORE MEALS, PRE?FILLED PEN",,,U,,,,,,,INJECTION,,2021,Q2,Platelet count decreased,,2021,Q2,3,F,20210226.0,20210331.0,20210315,20210416,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-021275,BRISTOL MYERS SQUIBB,,83.0,YR,,F,Y,59.87,KG,20210416.0,,CN,US,US,2021,Q2,Elderly
190088063,19008806,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"THREE TIMES DAILY BEFORE MEALS, PRE?FILLED PEN",,,U,,,,,,,INJECTION,,2021,Q2,Prescribed overdose,,2021,Q2,3,F,20210226.0,20210331.0,20210315,20210416,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-021275,BRISTOL MYERS SQUIBB,,83.0,YR,,F,Y,59.87,KG,20210416.0,,CN,US,US,2021,Q2,Elderly
190113684,19011368,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 U,,,,,,,,,,,TID,2021,Q2,Cytokine release syndrome,,2021,Q2,4,F,20201212.0,20210514.0,20210316,20210520,EXP,,US-ROCHE-2734786,ROCHE,,72.0,YR,,M,Y,82.5,KG,20210520.0,,MD,US,US,2021,Q2,Elderly
190129864,19012986,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Hyperkalaemia,,2021,Q2,4,F,20210309.0,20210528.0,20210316,20210531,EXP,,US-GLAXOSMITHKLINE-US2021GSK060835,GLAXOSMITHKLINE,,70.0,YR,,M,Y,81.63,KG,20210531.0,,MD,US,US,2021,Q2,Elderly
190129864,19012986,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,4,F,20210309.0,20210528.0,20210316,20210531,EXP,,US-GLAXOSMITHKLINE-US2021GSK060835,GLAXOSMITHKLINE,,70.0,YR,,M,Y,81.63,KG,20210531.0,,MD,US,US,2021,Q2,Elderly
190325292,19032529,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,TID,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,TID,2021,Q2,Bradycardia,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,TID,2021,Q2,Cardiac failure,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,TID,2021,Q2,Fall,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,TID,2021,Q2,Haemoglobin decreased,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190325292,19032529,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,3.0,ML,INJECTION,TID,2021,Q2,Iron deficiency anaemia,,2021,Q2,2,F,20210204.0,20210430.0,20210319,20210512,EXP,,US-JNJFOC-20210219816,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,93.52,KG,20210512.0,,CN,US,US,2021,Q2,Elderly
190509724,19050972,9,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,COVID-19,,2021,Q2,4,F,20201021.0,20210401.0,20210323,20210409,EXP,,US-CELGENEUS-USA-20210304870,CELGENE,,66.0,YR,,M,Y,98.0,KG,20210409.0,,MD,US,US,2021,Q2,Elderly
190509724,19050972,9,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Erythema,,2021,Q2,4,F,20201021.0,20210401.0,20210323,20210409,EXP,,US-CELGENEUS-USA-20210304870,CELGENE,,66.0,YR,,M,Y,98.0,KG,20210409.0,,MD,US,US,2021,Q2,Elderly
190509724,19050972,9,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Flushing,,2021,Q2,4,F,20201021.0,20210401.0,20210323,20210409,EXP,,US-CELGENEUS-USA-20210304870,CELGENE,,66.0,YR,,M,Y,98.0,KG,20210409.0,,MD,US,US,2021,Q2,Elderly
190509724,19050972,9,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Memory impairment,,2021,Q2,4,F,20201021.0,20210401.0,20210323,20210409,EXP,,US-CELGENEUS-USA-20210304870,CELGENE,,66.0,YR,,M,Y,98.0,KG,20210409.0,,MD,US,US,2021,Q2,Elderly
190509724,19050972,9,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Plasma cell myeloma,,2021,Q2,4,F,20201021.0,20210401.0,20210323,20210409,EXP,,US-CELGENEUS-USA-20210304870,CELGENE,,66.0,YR,,M,Y,98.0,KG,20210409.0,,MD,US,US,2021,Q2,Elderly
190509724,19050972,9,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Speech disorder,,2021,Q2,4,F,20201021.0,20210401.0,20210323,20210409,EXP,,US-CELGENEUS-USA-20210304870,CELGENE,,66.0,YR,,M,Y,98.0,KG,20210409.0,,MD,US,US,2021,Q2,Elderly
190586582,19058658,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ. (WITH MEALS)",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Fatigue,,2021,Q2,2,F,20201211.0,20210319.0,20210325,20210625,PER,,US-ASTELLAS-2020US045358,ASTELLAS,,65.0,YR,,M,Y,,,20210625.0,,MD,US,US,2021,Q2,Elderly
190586582,19058658,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ. (WITH MEALS)",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,20201211.0,20210319.0,20210325,20210625,PER,,US-ASTELLAS-2020US045358,ASTELLAS,,65.0,YR,,M,Y,,,20210625.0,,MD,US,US,2021,Q2,Elderly
190586582,19058658,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ. (WITH MEALS)",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Rash,,2021,Q2,2,F,20201211.0,20210319.0,20210325,20210625,PER,,US-ASTELLAS-2020US045358,ASTELLAS,,65.0,YR,,M,Y,,,20210625.0,,MD,US,US,2021,Q2,Elderly
190613762,19061376,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,2,F,2017.0,20210322.0,20210326,20210406,PER,,US-AMGEN-USASP2021045078,AMGEN,,62.0,YR,A,F,Y,,,20210406.0,,HP,US,US,2021,Q2,Adult
190613762,19061376,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Drug hypersensitivity,,2021,Q2,2,F,2017.0,20210322.0,20210326,20210406,PER,,US-AMGEN-USASP2021045078,AMGEN,,62.0,YR,A,F,Y,,,20210406.0,,HP,US,US,2021,Q2,Adult
190613762,19061376,11,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Memory impairment,,2021,Q2,2,F,2017.0,20210322.0,20210326,20210406,PER,,US-AMGEN-USASP2021045078,AMGEN,,62.0,YR,A,F,Y,,,20210406.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Encephalopathy,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Haemolytic anaemia,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Hepatitis,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Hypernatraemia,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Myositis,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Rhabdomyolysis,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Septic shock,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?3 UNITS,NIGHTLY",,,U,,,,,,,,,2021,Q2,Thrombocytopenia,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Acute myocardial infarction,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Encephalopathy,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Haemolytic anaemia,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Hepatitis,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Hypernatraemia,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Myositis,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Rhabdomyolysis,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Septic shock,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190723095,19072309,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1?5 UNITS,THRICE DAILY WITH MEALS",,,U,,,,,,,,,2021,Q2,Thrombocytopenia,,2021,Q2,5,F,20210322.0,20210624.0,20210330,20210630,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-029673,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,83.9,KG,20210630.0,,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Acidosis,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Agitation,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Atelectasis,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Colitis ischaemic,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Cytomegalovirus viraemia,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Dehydration,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Gastrointestinal haemorrhage,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Haematemesis,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Pneumatosis,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Shock haemorrhagic,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Splenic infarction,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Thrombocytopenia,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190830921,19083092,9,C,insulin lispro 1?21 Units Q6H,,2,,,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210118.0,,20210401,20210401,DIR,,,FDA-CTU,,62.0,YR,,M,N,100.0,KG,20210401.0,Y,HP,US,US,2021,Q2,Adult
190831261,19083126,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,20563.0,,,,,2021,Q2,Anaphylactic reaction,,2021,Q2,1,I,,20210322.0,20210401,20210401,EXP,,RO-ELI_LILLY_AND_COMPANY-RO202103011381,ELI LILLY AND CO,M CHICIUDEAN.ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN.ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2009?64 (SUPPL 90):216.DOI:10.1111/J.1398?9995.2009.02076.X,42.0,YR,,F,Y,,,20210401.0,,HP,RO,RO,2021,Q2,Adult
190831261,19083126,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,20563.0,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210322.0,20210401,20210401,EXP,,RO-ELI_LILLY_AND_COMPANY-RO202103011381,ELI LILLY AND CO,M CHICIUDEAN.ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN.ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2009?64 (SUPPL 90):216.DOI:10.1111/J.1398?9995.2009.02076.X,42.0,YR,,F,Y,,,20210401.0,,HP,RO,RO,2021,Q2,Adult
190831261,19083126,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,Y,,,,20563.0,,,,,2021,Q2,Rhinitis allergic,,2021,Q2,1,I,,20210322.0,20210401,20210401,EXP,,RO-ELI_LILLY_AND_COMPANY-RO202103011381,ELI LILLY AND CO,M CHICIUDEAN.ANAPHYLAXIS DUE TO A HUMAN RECOMBINANT INSULIN.ALLERGY: EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2009?64 (SUPPL 90):216.DOI:10.1111/J.1398?9995.2009.02076.X,42.0,YR,,F,Y,,,20210401.0,,HP,RO,RO,2021,Q2,Adult
190834882,19083488,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Pulmonary embolism,,2021,Q2,2,F,20190901.0,20210521.0,20210401,20210526,PER,,US-PFIZER INC-2021350717,PFIZER,,84.0,YR,,,Y,,,20210526.0,,LW,US,US,2021,Q2,Elderly
190840282,19084028,18,C,LISPRO,INSULIN LISPRO,1,,100 PEN BEFORE MEALS SLIDING SCALE,,,,, UNKNOWN,,,,,,,2021,Q2,Chills,,2021,Q2,2,F,202101.0,20210602.0,20210401,20210608,EXP,,US-ABBVIE-21K-163-3835967-00,ABBVIE,,64.0,YR,,M,Y,83.99,KG,20210608.0,,CN,US,US,2021,Q2,Adult
190840282,19084028,18,C,LISPRO,INSULIN LISPRO,1,,100 PEN BEFORE MEALS SLIDING SCALE,,,,, UNKNOWN,,,,,,,2021,Q2,Clostridium difficile infection,,2021,Q2,2,F,202101.0,20210602.0,20210401,20210608,EXP,,US-ABBVIE-21K-163-3835967-00,ABBVIE,,64.0,YR,,M,Y,83.99,KG,20210608.0,,CN,US,US,2021,Q2,Adult
190840282,19084028,18,C,LISPRO,INSULIN LISPRO,1,,100 PEN BEFORE MEALS SLIDING SCALE,,,,, UNKNOWN,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,2,F,202101.0,20210602.0,20210401,20210608,EXP,,US-ABBVIE-21K-163-3835967-00,ABBVIE,,64.0,YR,,M,Y,83.99,KG,20210608.0,,CN,US,US,2021,Q2,Adult
190840282,19084028,18,C,LISPRO,INSULIN LISPRO,1,,100 PEN BEFORE MEALS SLIDING SCALE,,,,, UNKNOWN,,,,,,,2021,Q2,Fatigue,,2021,Q2,2,F,202101.0,20210602.0,20210401,20210608,EXP,,US-ABBVIE-21K-163-3835967-00,ABBVIE,,64.0,YR,,M,Y,83.99,KG,20210608.0,,CN,US,US,2021,Q2,Adult
190840282,19084028,18,C,LISPRO,INSULIN LISPRO,1,,100 PEN BEFORE MEALS SLIDING SCALE,,,,, UNKNOWN,,,,,,,2021,Q2,Immunodeficiency,,2021,Q2,2,F,202101.0,20210602.0,20210401,20210608,EXP,,US-ABBVIE-21K-163-3835967-00,ABBVIE,,64.0,YR,,M,Y,83.99,KG,20210608.0,,CN,US,US,2021,Q2,Adult
190840282,19084028,18,C,LISPRO,INSULIN LISPRO,1,,100 PEN BEFORE MEALS SLIDING SCALE,,,,, UNKNOWN,,,,,,,2021,Q2,Klebsiella infection,,2021,Q2,2,F,202101.0,20210602.0,20210401,20210608,EXP,,US-ABBVIE-21K-163-3835967-00,ABBVIE,,64.0,YR,,M,Y,83.99,KG,20210608.0,,CN,US,US,2021,Q2,Adult
190840282,19084028,18,C,LISPRO,INSULIN LISPRO,1,,100 PEN BEFORE MEALS SLIDING SCALE,,,,, UNKNOWN,,,,,,,2021,Q2,Nephrolithiasis,,2021,Q2,2,F,202101.0,20210602.0,20210401,20210608,EXP,,US-ABBVIE-21K-163-3835967-00,ABBVIE,,64.0,YR,,M,Y,83.99,KG,20210608.0,,CN,US,US,2021,Q2,Adult
190840282,19084028,18,C,LISPRO,INSULIN LISPRO,1,,100 PEN BEFORE MEALS SLIDING SCALE,,,,, UNKNOWN,,,,,,,2021,Q2,Renal disorder,,2021,Q2,2,F,202101.0,20210602.0,20210401,20210608,EXP,,US-ABBVIE-21K-163-3835967-00,ABBVIE,,64.0,YR,,M,Y,83.99,KG,20210608.0,,CN,US,US,2021,Q2,Adult
190874552,19087455,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,60.0,ML,,QD,2021,Q2,Acute kidney injury,,2021,Q2,2,F,20210212.0,20210420.0,20210402,20210426,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-086461",BOEHRINGER INGELHEIM,,74.0,YR,E,F,Y,89.0,KG,20210426.0,,MD,US,US,2021,Q2,Elderly
190874552,19087455,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,60.0,ML,,QD,2021,Q2,Colitis ischaemic,,2021,Q2,2,F,20210212.0,20210420.0,20210402,20210426,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-086461",BOEHRINGER INGELHEIM,,74.0,YR,E,F,Y,89.0,KG,20210426.0,,MD,US,US,2021,Q2,Elderly
190874552,19087455,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,60.0,ML,,QD,2021,Q2,Renal impairment,,2021,Q2,2,F,20210212.0,20210420.0,20210402,20210426,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-086461",BOEHRINGER INGELHEIM,,74.0,YR,E,F,Y,89.0,KG,20210426.0,,MD,US,US,2021,Q2,Elderly
190879601,19087960,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,AT MEALS,,,U,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210322.0,20210322.0,20210402,20210402,PER,,US-SA-2021SA099950,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20210402.0,,CN,US,US,2021,Q2,Elderly
190879601,19087960,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,AT MEALS,,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,1,I,20210322.0,20210322.0,20210402,20210402,PER,,US-SA-2021SA099950,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20210402.0,,CN,US,US,2021,Q2,Elderly
190879601,19087960,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,AT MEALS,,,U,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,20210322.0,20210322.0,20210402,20210402,PER,,US-SA-2021SA099950,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20210402.0,,CN,US,US,2021,Q2,Elderly
190879601,19087960,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,AT MEALS,,,U,,,,,,,,,2021,Q2,Hospitalisation,,2021,Q2,1,I,20210322.0,20210322.0,20210402,20210402,PER,,US-SA-2021SA099950,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20210402.0,,CN,US,US,2021,Q2,Elderly
190879601,19087960,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,AT MEALS,,,U,,,,,,,,,2021,Q2,Intentional product misuse,,2021,Q2,1,I,20210322.0,20210322.0,20210402,20210402,PER,,US-SA-2021SA099950,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20210402.0,,CN,US,US,2021,Q2,Elderly
190885591,19088559,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20180927.0,20181018.0,20210402,20210402,EXP,IT-MINISAL02-502630,IT-VALIDUS PHARMACEUTICALS LLC-IT-2021VAL000532,VALIDUS,,82.0,YR,,F,Y,,,20210402.0,,PH,IT,IT,2021,Q2,Elderly
190885591,19088559,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20180927.0,20181018.0,20210402,20210402,EXP,IT-MINISAL02-502630,IT-VALIDUS PHARMACEUTICALS LLC-IT-2021VAL000532,VALIDUS,,82.0,YR,,F,Y,,,20210402.0,,PH,IT,IT,2021,Q2,Elderly
190885591,19088559,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Overdose,,2021,Q2,1,I,20180927.0,20181018.0,20210402,20210402,EXP,IT-MINISAL02-502630,IT-VALIDUS PHARMACEUTICALS LLC-IT-2021VAL000532,VALIDUS,,82.0,YR,,F,Y,,,20210402.0,,PH,IT,IT,2021,Q2,Elderly
190887631,19088763,11,C,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Anaemia,,2021,Q2,1,I,20210104.0,20210325.0,20210403,20210403,EXP,IT-MINISAL02-701972,IT-TEVA-2021-IT-1896548,TEVA,,74.0,YR,E,F,Y,,,20210403.0,,MD,IT,IT,2021,Q2,Elderly
190887631,19088763,11,C,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Rectal haemorrhage,,2021,Q2,1,I,20210104.0,20210325.0,20210403,20210403,EXP,IT-MINISAL02-701972,IT-TEVA-2021-IT-1896548,TEVA,,74.0,YR,E,F,Y,,,20210403.0,,MD,IT,IT,2021,Q2,Elderly
190899761,19089976,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, ASKU,,,16.0,IU,INJECTION,TID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190899761,19089976,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, ASKU,,,16.0,IU,INJECTION,TID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190899761,19089976,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, ASKU,,,16.0,IU,INJECTION,TID,2021,Q2,Visual impairment,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190899761,19089976,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, D243920A,,,16.0,IU,INJECTION,TID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190899761,19089976,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, D243920A,,,16.0,IU,INJECTION,TID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190899761,19089976,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, D243920A,,,16.0,IU,INJECTION,TID,2021,Q2,Visual impairment,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190899761,19089976,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, D243920A,,,16.0,IU,INJECTION,TID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190899761,19089976,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, D243920A,,,16.0,IU,INJECTION,TID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190899761,19089976,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"16 U, TID",,,,, D243920A,,,16.0,IU,INJECTION,TID,2021,Q2,Visual impairment,,2021,Q2,1,I,,20210322.0,20210404,20210404,PER,,US-ELI_LILLY_AND_COMPANY-US202103011319,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210404.0,,CN,US,US,2021,Q2,Elderly
190919041,19091904,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hepatic enzyme increased,,2021,Q2,1,I,20210402.0,,20210402,20210402,DIR,,,FDA-CTU,,77.0,YR,,M,N,99.7,KG,20210402.0,N,PH,US,US,2021,Q2,Elderly
190924911,19092491,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Arthralgia,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,DE-BFARM-21001932,DE-ACCORD-221973,ACCORD,,74.0,YR,E,M,Y,64.0,KG,20210405.0,,PH,DE,DE,2021,Q2,Elderly
190924911,19092491,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Contraindicated product administered,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,DE-BFARM-21001932,DE-ACCORD-221973,ACCORD,,74.0,YR,E,M,Y,64.0,KG,20210405.0,,PH,DE,DE,2021,Q2,Elderly
190924911,19092491,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Medication error,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,DE-BFARM-21001932,DE-ACCORD-221973,ACCORD,,74.0,YR,E,M,Y,64.0,KG,20210405.0,,PH,DE,DE,2021,Q2,Elderly
190924911,19092491,3,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,DE-BFARM-21001932,DE-ACCORD-221973,ACCORD,,74.0,YR,E,M,Y,64.0,KG,20210405.0,,PH,DE,DE,2021,Q2,Elderly
190927911,19092791,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,,US-SA-2021SA101432,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210405.0,,CN,US,US,2021,Q2,Elderly
190927911,19092791,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,,US-SA-2021SA101432,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210405.0,,CN,US,US,2021,Q2,Elderly
190927911,19092791,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Head discomfort,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,,US-SA-2021SA101432,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210405.0,,CN,US,US,2021,Q2,Elderly
190927911,19092791,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Lid sulcus deepened,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,,US-SA-2021SA101432,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210405.0,,CN,US,US,2021,Q2,Elderly
190927911,19092791,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Loss of consciousness,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,,US-SA-2021SA101432,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210405.0,,CN,US,US,2021,Q2,Elderly
190927911,19092791,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210323.0,20210405,20210405,EXP,,US-SA-2021SA101432,SANOFI AVENTIS,,73.0,YR,E,F,Y,,,20210405.0,,CN,US,US,2021,Q2,Elderly
190940282,19094028,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, DAILY",,,,,,,20563.0,40.0,IU,INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210324.0,20210427.0,20210405,20210509,PER,,US-ELI_LILLY_AND_COMPANY-US202104001280,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210509.0,,CN,US,US,2021,Q2,Adult
190940282,19094028,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, DAILY",,,,,,,20563.0,40.0,IU,INJECTION,QD,2021,Q2,Depressed mood,,2021,Q2,2,F,20210324.0,20210427.0,20210405,20210509,PER,,US-ELI_LILLY_AND_COMPANY-US202104001280,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210509.0,,CN,US,US,2021,Q2,Adult
190940282,19094028,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, DAILY",,,,,,,20563.0,40.0,IU,INJECTION,QD,2021,Q2,Mood altered,,2021,Q2,2,F,20210324.0,20210427.0,20210405,20210509,PER,,US-ELI_LILLY_AND_COMPANY-US202104001280,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210509.0,,CN,US,US,2021,Q2,Adult
190940282,19094028,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, DAILY",,,,, D305094A,,20563.0,40.0,IU,INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210324.0,20210427.0,20210405,20210509,PER,,US-ELI_LILLY_AND_COMPANY-US202104001280,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210509.0,,CN,US,US,2021,Q2,Adult
190940282,19094028,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, DAILY",,,,, D305094A,,20563.0,40.0,IU,INJECTION,QD,2021,Q2,Depressed mood,,2021,Q2,2,F,20210324.0,20210427.0,20210405,20210509,PER,,US-ELI_LILLY_AND_COMPANY-US202104001280,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210509.0,,CN,US,US,2021,Q2,Adult
190940282,19094028,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"40 U, DAILY",,,,, D305094A,,20563.0,40.0,IU,INJECTION,QD,2021,Q2,Mood altered,,2021,Q2,2,F,20210324.0,20210427.0,20210405,20210509,PER,,US-ELI_LILLY_AND_COMPANY-US202104001280,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210509.0,,CN,US,US,2021,Q2,Adult
190940951,19094095,7,C,"Insulin Lispro, human",,2,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,20.0,IU,INJECTION,BID,2021,Q2,Basal cell carcinoma,,2021,Q2,1,I,20210325.0,20210329.0,20210405,20210405,EXP,,US-CELGENEUS-USA-20210307983,CELGENE,,71.0,YR,,M,Y,87.17,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190940951,19094095,7,C,"Insulin Lispro, human",,2,Subcutaneous,40 IU (INTERNATIONAL UNIT),,,,,,,,20.0,IU,INJECTION,BID,2021,Q2,Squamous cell carcinoma,,2021,Q2,1,I,20210325.0,20210329.0,20210405,20210405,EXP,,US-CELGENEUS-USA-20210307983,CELGENE,,71.0,YR,,M,Y,87.17,KG,20210405.0,,MD,US,US,2021,Q2,Elderly
190949001,19094900,5,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,100.0,IU,UNKNOWN,,2021,Q2,Neutropenia,,2021,Q2,1,I,20210225.0,20210330.0,20210405,20210405,PER,,US-CELGENEUS-USA-20210308469,CELGENE,,71.0,YR,,F,Y,68.7,KG,20210405.0,,PH,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Dyskinesia,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Expired product administered,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Incorrect dose administered,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Injection site reaction,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Limb discomfort,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Loss of consciousness,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Memory impairment,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Seizure,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Dyskinesia,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Expired product administered,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Incorrect dose administered,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Injection site reaction,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Limb discomfort,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Loss of consciousness,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Memory impairment,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190978241,19097824,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D137578A,,,,,INJECTION,,2021,Q2,Seizure,,2021,Q2,1,I,202012.0,20210324.0,20210406,20210406,EXP,,US-ELI_LILLY_AND_COMPANY-US202104001317,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210406.0,,CN,US,US,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Asthma,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Blood count abnormal,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Chest discomfort,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Cough,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Diaphragmatic disorder,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Discomfort,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Dyspnoea,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Hypoxia,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Left ventricular hypertrophy,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Obstructive airways disorder,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Oedema peripheral,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Oropharyngeal pain,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Pyrexia,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Weight increased,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q2,Wheezing,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Asthma,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Blood count abnormal,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Chest discomfort,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Cough,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Diaphragmatic disorder,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Discomfort,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Dyspnoea,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Hypoxia,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Left ventricular hypertrophy,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Obstructive airways disorder,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Oedema peripheral,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Oropharyngeal pain,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Pyrexia,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Therapeutic product effect incomplete,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Weight increased,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190983782,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q2,Wheezing,,2021,Q2,2,F,,20210601.0,20210406,20210609,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210610.0,,HP,CA,CA,2021,Q2,Elderly
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Abscess,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Adrenal insufficiency,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Alanine aminotransferase increased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Ascites,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood alkaline phosphatase increased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood bilirubin increased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood potassium increased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure diastolic abnormal,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure increased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Congestive hepatopathy,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Depression,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Diverticulitis,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Endometrial disorder,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Enterococcus test positive,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Fibrosis,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gamma-glutamyltransferase increased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gastrointestinal disorder,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Heart rate increased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Herpes zoster,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hypersensitivity,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Increased appetite,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Influenza,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Infusion related reaction,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Injection site extravasation,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Intensive care unit acquired weakness,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Intervertebral disc protrusion,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Joint effusion,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Joint swelling,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Micturition disorder,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Myelopathy,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Myopathy,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Nasopharyngitis,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Nerve compression,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Neuropathy peripheral,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Neutropenia,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Osteoarthritis,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peripheral sensorimotor neuropathy,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peritonitis,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Pseudomonal bacteraemia,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Rheumatoid arthritis,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Septic shock,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Therapeutic response decreased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
190986661,19098666,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210329.0,20210406,20210406,EXP,,NVSC2021CA075423,NOVARTIS,,62.0,YR,,F,Y,67.0,KG,20210406.0,,HP,CA,CA,2021,Q2,Adult
191007891,19100789,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, TID",,,,,,,20563.0,20.0,IU,INJECTION,TID,2021,Q2,Accidental underdose,,2021,Q2,1,I,202103.0,20210331.0,20210407,20210407,PER,,US-ELI_LILLY_AND_COMPANY-US202104001913,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210407.0,,CN,US,US,2021,Q2,Adult
191019201,19101920,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2021,Q2,Arthralgia,,2021,Q2,1,I,,20210324.0,20210407,20210407,EXP,,DE-DRREDDYS-GER/GER/21/0133630,DR REDDYS,,74.0,YR,E,M,Y,64.0,KG,20210407.0,,PH,DE,DE,2021,Q2,Elderly
191019201,19101920,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2021,Q2,Contraindicated product administered,,2021,Q2,1,I,,20210324.0,20210407,20210407,EXP,,DE-DRREDDYS-GER/GER/21/0133630,DR REDDYS,,74.0,YR,E,M,Y,64.0,KG,20210407.0,,PH,DE,DE,2021,Q2,Elderly
191019201,19101920,4,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,, UNKNOWN,,,,,,,2021,Q2,Pain,,2021,Q2,1,I,,20210324.0,20210407,20210407,EXP,,DE-DRREDDYS-GER/GER/21/0133630,DR REDDYS,,74.0,YR,E,M,Y,64.0,KG,20210407.0,,PH,DE,DE,2021,Q2,Elderly
191027181,19102718,8,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210403.0,,20210407,20210407,DIR,,,FDA-CTU,,55.0,YR,,M,N,135.45,KG,20210407.0,N,PH,US,US,2021,Q2,Adult
191027181,19102718,8,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Rhabdomyolysis,,2021,Q2,1,I,20210403.0,,20210407,20210407,DIR,,,FDA-CTU,,55.0,YR,,M,N,135.45,KG,20210407.0,N,PH,US,US,2021,Q2,Adult
191027181,19102718,8,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Transaminases increased,,2021,Q2,1,I,20210403.0,,20210407,20210407,DIR,,,FDA-CTU,,55.0,YR,,M,N,135.45,KG,20210407.0,N,PH,US,US,2021,Q2,Adult
191125384,19112538,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?2 U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q2,Sepsis,,2021,Q2,4,F,20210403.0,20210430.0,20210408,20210506,EXP,,US-CELGENEUS-USA-20210401065,CELGENE,,80.0,YR,,F,Y,66.0,KG,20210506.0,,MD,US,US,2021,Q2,Elderly
191142481,19114248,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, SLIDING SCALE",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, SLIDING SCALE",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Cardio-respiratory arrest,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, SLIDING SCALE",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, SLIDING SCALE",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Product dispensing error,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, SLIDING SCALE",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, SLIDING SCALE",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Cardio-respiratory arrest,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, SLIDING SCALE",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, SLIDING SCALE",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Product dispensing error,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,3,SS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, SLIDING SCALE",,,Y,, D195320C,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,3,SS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, SLIDING SCALE",,,Y,, D195320C,,20563.0,,,INJECTION,,2021,Q2,Cardio-respiratory arrest,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,3,SS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, SLIDING SCALE",,,Y,, D195320C,,20563.0,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,3,SS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, SLIDING SCALE",,,Y,, D195320C,,20563.0,,,INJECTION,,2021,Q2,Product dispensing error,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, SLIDING SCALE",,,Y,, D195320C,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, SLIDING SCALE",,,Y,, D195320C,,20563.0,,,INJECTION,,2021,Q2,Cardio-respiratory arrest,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, SLIDING SCALE",,,Y,, D195320C,,20563.0,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191142481,19114248,4,SS,Insulin Lispro,INSULIN LISPRO,1,,"UNK, SLIDING SCALE",,,Y,, D195320C,,20563.0,,,INJECTION,,2021,Q2,Product dispensing error,,2021,Q2,1,I,202103.0,20210405.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003481,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191160321,19116032,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(25/75: + 20U 20U / D) , QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Chest pain,,2021,Q2,1,I,,20190702.0,20210409,20210409,EXP,PT-EMA-DD-20181204-KUMARVN_P-105153,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000461,VALIDUS,,54.0,YR,,F,Y,,,20210409.0,,HP,PT,PT,2021,Q2,Adult
191160321,19116032,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(25/75: + 20U 20U / D) , QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Headache,,2021,Q2,1,I,,20190702.0,20210409,20210409,EXP,PT-EMA-DD-20181204-KUMARVN_P-105153,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000461,VALIDUS,,54.0,YR,,F,Y,,,20210409.0,,HP,PT,PT,2021,Q2,Adult
191160321,19116032,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(25/75: + 20U 20U / D) , QD",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Ischaemic stroke,,2021,Q2,1,I,,20190702.0,20210409,20210409,EXP,PT-EMA-DD-20181204-KUMARVN_P-105153,PT-VALIDUS PHARMACEUTICALS LLC-PT-2021VAL000461,VALIDUS,,54.0,YR,,F,Y,,,20210409.0,,HP,PT,PT,2021,Q2,Adult
191162971,19116297,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"50 IU, QD",,,,,,,,50.0,IU,,,2021,Q2,Immune thrombocytopenia,,2021,Q2,1,I,20181022.0,20190117.0,20210409,20210409,EXP,,FR-VALIDUS PHARMACEUTICALS LLC-FR-2021VAL000484,VALIDUS,,70.0,YR,,F,Y,91.0,KG,20210409.0,,MD,FR,FR,2021,Q2,Elderly
191163551,19116355,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20190710.0,20210409,20210409,EXP,DE-ADRED-02762-02,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL001071,VALIDUS,,78.0,YR,,F,Y,,,20210409.0,,PH,DE,DE,2021,Q2,Elderly
191163551,19116355,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Anuria,,2021,Q2,1,I,,20190710.0,20210409,20210409,EXP,DE-ADRED-02762-02,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL001071,VALIDUS,,78.0,YR,,F,Y,,,20210409.0,,PH,DE,DE,2021,Q2,Elderly
191163551,19116355,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Overdose,,2021,Q2,1,I,,20190710.0,20210409,20210409,EXP,DE-ADRED-02762-02,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL001071,VALIDUS,,78.0,YR,,F,Y,,,20210409.0,,PH,DE,DE,2021,Q2,Elderly
191163551,19116355,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q2,Therapeutic drug monitoring analysis not performed,,2021,Q2,1,I,,20190710.0,20210409,20210409,EXP,DE-ADRED-02762-02,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL001071,VALIDUS,,78.0,YR,,F,Y,,,20210409.0,,PH,DE,DE,2021,Q2,Elderly
191172531,19117253,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Cough,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Macular degeneration,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Skin laceration,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Sneezing,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Cough,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Macular degeneration,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Skin laceration,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Sneezing,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D34173C,,20563.0,,,INJECTION,,2021,Q2,Cough,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D34173C,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D34173C,,20563.0,,,INJECTION,,2021,Q2,Macular degeneration,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D34173C,,20563.0,,,INJECTION,,2021,Q2,Skin laceration,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172531,19117253,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D34173C,,20563.0,,,INJECTION,,2021,Q2,Sneezing,,2021,Q2,1,I,2010.0,20210331.0,20210409,20210409,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003375,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210409.0,,CN,US,US,2021,Q2,Elderly
191172881,19117288,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"45 IU, QD",,,,, UNKNOWN,,,45.0,IU,,QD,2021,Q2,Acute myocardial infarction,,2021,Q2,1,I,,20200914.0,20210409,20210409,EXP,,BR-NOVOPROD-801712,NOVO NORDISK,,59.0,YR,,M,Y,,,20210409.0,,MD,BR,BR,2021,Q2,Adult
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blister,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Conjunctivitis,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Lip erosion,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Mouth ulceration,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Nikolsky's sign,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Ocular hyperaemia,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Oral disorder,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Pruritus,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Purpura,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Skin reaction,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Stevens-Johnson syndrome,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191184941,19118494,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,DOSE AS USED: 24?24?26 IU,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Swollen tongue,,2021,Q2,1,I,20041104.0,20180906.0,20210409,20210409,EXP,,DE-VALIDUS PHARMACEUTICALS LLC-DE-2021VAL000206,VALIDUS,,71.0,YR,,F,Y,,,20210409.0,,HP,DE,DE,2021,Q2,Elderly
191185571,19118557,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2,",,,D,,,,,,,,,2021,Q2,Foetal disorder,,2021,Q2,1,I,,20190213.0,20210409,20210409,EXP,FR-AFSSAPS-PC20180352,FR-VALIDUS PHARMACEUTICALS LLC-FR-2021VAL000334,VALIDUS,,1.0,DY,,M,Y,1.89,KG,20210409.0,,PH,FR,FR,2021,Q2,Child
191185571,19118557,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2,",,,D,,,,,,,,,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,1,I,,20190213.0,20210409,20210409,EXP,FR-AFSSAPS-PC20180352,FR-VALIDUS PHARMACEUTICALS LLC-FR-2021VAL000334,VALIDUS,,1.0,DY,,M,Y,1.89,KG,20210409.0,,PH,FR,FR,2021,Q2,Child
191185571,19118557,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2,",,,D,,,,,,,,,2021,Q2,Low birth weight baby,,2021,Q2,1,I,,20190213.0,20210409,20210409,EXP,FR-AFSSAPS-PC20180352,FR-VALIDUS PHARMACEUTICALS LLC-FR-2021VAL000334,VALIDUS,,1.0,DY,,M,Y,1.89,KG,20210409.0,,PH,FR,FR,2021,Q2,Child
191185571,19118557,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2,",,,D,,,,,,,,,2021,Q2,Neutropenia neonatal,,2021,Q2,1,I,,20190213.0,20210409,20210409,EXP,FR-AFSSAPS-PC20180352,FR-VALIDUS PHARMACEUTICALS LLC-FR-2021VAL000334,VALIDUS,,1.0,DY,,M,Y,1.89,KG,20210409.0,,PH,FR,FR,2021,Q2,Child
191185571,19118557,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2,",,,D,,,,,,,,,2021,Q2,Premature baby,,2021,Q2,1,I,,20190213.0,20210409,20210409,EXP,FR-AFSSAPS-PC20180352,FR-VALIDUS PHARMACEUTICALS LLC-FR-2021VAL000334,VALIDUS,,1.0,DY,,M,Y,1.89,KG,20210409.0,,PH,FR,FR,2021,Q2,Child
191186296,19118629,66,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Circulatory collapse,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,66,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Graft versus host disease,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,66,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,66,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,66,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Circulatory collapse,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Graft versus host disease,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Circulatory collapse,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Graft versus host disease,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,69,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Circulatory collapse,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,69,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Graft versus host disease,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,69,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Multiple organ dysfunction syndrome,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,69,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pancytopenia,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191186296,19118629,69,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q2,Pyrexia,,2021,Q2,6,F,20210313.0,20210609.0,20210410,20210611,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20210611.0,,HP,US,US,2021,Q2,Elderly
191196641,19119664,10,C,insulin lispro,INSULIN LISPRO,1,Unknown,65 IU (INTERNATIONAL UNIT),,,,,,,,65.0,IU,UNKNOWN,QD,2021,Q2,Plasma cell myeloma,,2021,Q2,1,I,20210303.0,20210401.0,20210412,20210412,PER,,US-CELGENEUS-USA-20210400509,CELGENE,,49.0,YR,,M,Y,136.0,KG,20210412.0,,MD,US,US,2021,Q2,Adult
191248431,19124843,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,1,I,,20210324.0,20210413,20210413,PER,,US-ELI_LILLY_AND_COMPANY-US202104000469,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210413.0,,CN,US,US,2021,Q2,Elderly
191249221,19124922,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH PLAN, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,1,I,,20210401.0,20210412,20210412,EXP,DE-ADRED-06333-01,NVSC2021DE076298,NOVARTIS,,73.0,YR,,M,Y,,,20210412.0,,HP,DE,DE,2021,Q2,Elderly
191249221,19124922,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH PLAN, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q2,Haematochezia,,2021,Q2,1,I,,20210401.0,20210412,20210412,EXP,DE-ADRED-06333-01,NVSC2021DE076298,NOVARTIS,,73.0,YR,,M,Y,,,20210412.0,,HP,DE,DE,2021,Q2,Elderly
191270151,19127015,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,,20210407.0,20210412,20210412,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-034211,BRISTOL MYERS SQUIBB,,69.0,YR,,F,Y,60.32,KG,20210412.0,,CN,US,US,2021,Q2,Elderly
191270151,19127015,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210407.0,20210412,20210412,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-034211,BRISTOL MYERS SQUIBB,,69.0,YR,,F,Y,60.32,KG,20210412.0,,CN,US,US,2021,Q2,Elderly
191302111,19130211,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202101.0,20210330.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202104000934,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191302111,19130211,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Memory impairment,,2021,Q2,1,I,202101.0,20210330.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202104000934,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,,,,20563.0,45.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,,,,20563.0,45.0,IU,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,,,,20563.0,45.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,,,,20563.0,45.0,IU,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,,,,20563.0,45.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,,,,20563.0,45.0,IU,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,, D185008D,,20563.0,45.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,, D185008D,,20563.0,45.0,IU,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,, D185008D,,20563.0,45.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,, D185008D,,20563.0,45.0,IU,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,, D261904A,,20563.0,45.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,, D261904A,,20563.0,45.0,IU,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,, D261904A,,20563.0,45.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191305631,19130563,7,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"45 U, UNKNOWN",,,U,, D261904A,,20563.0,45.0,IU,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202103.0,20210315.0,20210414,20210414,PER,,US-ELI_LILLY_AND_COMPANY-US202103008219,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Elderly
191341061,19134106,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Death,,2021,Q2,1,I,20210209.0,20210406.0,20210414,20210414,EXP,,US-ACORDA-ACO_168542_2021,ACORDA,,63.0,YR,,M,Y,,,20210414.0,,CN,US,US,2021,Q2,Adult
191341481,19134148,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,,, UNKNOWN,,,8.0,DF,,QD,2021,Q2,Acute respiratory failure,,2021,Q2,1,I,,20210401.0,20210414,20210414,PER,,DE-DRREDDYS-GER/GER/21/0133856,DR REDDYS,,82.0,YR,E,F,Y,,,20210414.0,,PH,DE,DE,2021,Q2,Elderly
191341481,19134148,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,,, UNKNOWN,,,8.0,DF,,QD,2021,Q2,Apnoea,,2021,Q2,1,I,,20210401.0,20210414,20210414,PER,,DE-DRREDDYS-GER/GER/21/0133856,DR REDDYS,,82.0,YR,E,F,Y,,,20210414.0,,PH,DE,DE,2021,Q2,Elderly
191341481,19134148,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,,, UNKNOWN,,,8.0,DF,,QD,2021,Q2,Aspiration,,2021,Q2,1,I,,20210401.0,20210414,20210414,PER,,DE-DRREDDYS-GER/GER/21/0133856,DR REDDYS,,82.0,YR,E,F,Y,,,20210414.0,,PH,DE,DE,2021,Q2,Elderly
191341481,19134148,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,,, UNKNOWN,,,8.0,DF,,QD,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210401.0,20210414,20210414,PER,,DE-DRREDDYS-GER/GER/21/0133856,DR REDDYS,,82.0,YR,E,F,Y,,,20210414.0,,PH,DE,DE,2021,Q2,Elderly
191341481,19134148,8,C,insulin lispro/Insulin lispro?Isophan,,2,Subcutaneous,8?0?0?0,,,,, UNKNOWN,,,8.0,DF,,QD,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210401.0,20210414,20210414,PER,,DE-DRREDDYS-GER/GER/21/0133856,DR REDDYS,,82.0,YR,E,F,Y,,,20210414.0,,PH,DE,DE,2021,Q2,Elderly
191382841,19138284,2,SS,Insulin lispro,INSULIN LISPRO,1,,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,U, UNKNOWN,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,,20210401.0,20210415,20210415,PER,,DE-DRREDDYS-GER/GER/21/0133916,DR REDDYS,,71.0,YR,E,F,Y,,,20210415.0,,MD,DE,DE,2021,Q2,Elderly
191382841,19138284,2,SS,Insulin lispro,INSULIN LISPRO,1,,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,U, UNKNOWN,,,,,,,2021,Q2,Dizziness,,2021,Q2,1,I,,20210401.0,20210415,20210415,PER,,DE-DRREDDYS-GER/GER/21/0133916,DR REDDYS,,71.0,YR,E,F,Y,,,20210415.0,,MD,DE,DE,2021,Q2,Elderly
191382841,19138284,2,SS,Insulin lispro,INSULIN LISPRO,1,,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,U, UNKNOWN,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,1,I,,20210401.0,20210415,20210415,PER,,DE-DRREDDYS-GER/GER/21/0133916,DR REDDYS,,71.0,YR,E,F,Y,,,20210415.0,,MD,DE,DE,2021,Q2,Elderly
191382841,19138284,2,SS,Insulin lispro,INSULIN LISPRO,1,,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,U, UNKNOWN,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210401.0,20210415,20210415,PER,,DE-DRREDDYS-GER/GER/21/0133916,DR REDDYS,,71.0,YR,E,F,Y,,,20210415.0,,MD,DE,DE,2021,Q2,Elderly
191382841,19138284,2,SS,Insulin lispro,INSULIN LISPRO,1,,"NACH PLAN, INJEKTIONS?/INFUSIONSL?SUNG",,,U,U, UNKNOWN,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210401.0,20210415,20210415,PER,,DE-DRREDDYS-GER/GER/21/0133916,DR REDDYS,,71.0,YR,E,F,Y,,,20210415.0,,MD,DE,DE,2021,Q2,Elderly
191402061,19140206,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Death,,2021,Q2,1,I,20210112.0,,20210415,20210415,DIR,,,FDA-CTU,,81.0,YR,,M,N,87.75,KG,20210415.0,Y,CN,US,US,2021,Q2,Elderly
191450151,19145015,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450151,19145015,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Visual impairment,,2021,Q2,1,I,202010.0,20210406.0,20210416,20210416,EXP,,US-ELI_LILLY_AND_COMPANY-US202104003103,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20210416.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Hypoaesthesia,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Nerve injury,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Hypoaesthesia,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Nerve injury,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Hypoaesthesia,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Nerve injury,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Hypoaesthesia,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Nerve injury,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Hypoaesthesia,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,20563.0,,,INJECTION,,2021,Q2,Nerve injury,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Hypoaesthesia,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191450342,19145034,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Nerve injury,,2021,Q2,2,F,202010.0,20210412.0,20210416,20210423,EXP,,US-ELI_LILLY_AND_COMPANY-US202104005852,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20210423.0,,CN,US,US,2021,Q2,Adult
191463561,19146356,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,U,,,,20563.0,10.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20200415.0,20210415.0,20210416,20210416,PER,,US-ELI_LILLY_AND_COMPANY-US202104007294,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20210416.0,,CN,US,US,2021,Q2,Elderly
191481181,19148118,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,16.0,IU,INJECTION,,2021,Q2,Cold sweat,,2021,Q2,1,I,20200906.0,20210412.0,20210416,20210416,EXP,IT-MINISAL02-712516,IT-ELI_LILLY_AND_COMPANY-IT202104005486,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20210416.0,,MD,IT,IT,2021,Q2,Adult
191481181,19148118,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,16.0,IU,INJECTION,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20200906.0,20210412.0,20210416,20210416,EXP,IT-MINISAL02-712516,IT-ELI_LILLY_AND_COMPANY-IT202104005486,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20210416.0,,MD,IT,IT,2021,Q2,Adult
191481181,19148118,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"16 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,16.0,IU,INJECTION,,2021,Q2,Loss of consciousness,,2021,Q2,1,I,20200906.0,20210412.0,20210416,20210416,EXP,IT-MINISAL02-712516,IT-ELI_LILLY_AND_COMPANY-IT202104005486,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20210416.0,,MD,IT,IT,2021,Q2,Adult
191521391,19152139,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Visual impairment,,2021,Q2,1,I,,20210405.0,20210419,20210419,PER,,US-SA-2021SA114616,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20210419.0,,CN,US,US,2021,Q2,Elderly
191531831,19153183,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D337388E,,20563.0,,,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210320.0,20210407.0,20210419,20210419,EXP,,US-ELI_LILLY_AND_COMPANY-US202104004289,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210419.0,,CN,US,US,2021,Q2,Elderly
191531831,19153183,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D337388E,,20563.0,,,INJECTION,,2021,Q2,Loss of consciousness,,2021,Q2,1,I,20210320.0,20210407.0,20210419,20210419,EXP,,US-ELI_LILLY_AND_COMPANY-US202104004289,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210419.0,,CN,US,US,2021,Q2,Elderly
191531831,19153183,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D337388E,,20563.0,,,INJECTION,,2021,Q2,Vomiting,,2021,Q2,1,I,20210320.0,20210407.0,20210419,20210419,EXP,,US-ELI_LILLY_AND_COMPANY-US202104004289,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210419.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Abdominal pain,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Confusional state,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Depression,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Drug hypersensitivity,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Drug ineffective,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Dyspnoea,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Fatigue,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Hypersomnia,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Illness,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Lethargy,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Mood altered,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Myalgia,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Pain,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Pain in extremity,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Peripheral swelling,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Pollakiuria,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Product storage error,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"30 U, BID",,,Y,,,,,30.0,IU,INJECTION,BID,2021,Q2,Urinary incontinence,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Abdominal pain,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Confusional state,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Depression,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Drug hypersensitivity,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Drug ineffective,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Dyspnoea,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Fatigue,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Hypersomnia,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Illness,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Lethargy,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Mood altered,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Myalgia,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Pain,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Pain in extremity,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Peripheral swelling,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Pollakiuria,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Product storage error,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191557455,19155745,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"28 U, BID (20?28 UNITS)",,,Y,,,,,28.0,IU,INJECTION,BID,2021,Q2,Urinary incontinence,,2021,Q2,5,F,20200831.0,20210527.0,20210419,20210611,PER,,US-ELI_LILLY_AND_COMPANY-US202104008231,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210611.0,,CN,US,US,2021,Q2,Elderly
191592252,19159225,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Maternal exposure during pregnancy,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 UG/M2, QD",21.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,33,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Foetal disorder,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,33,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Foetal exposure during pregnancy,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,33,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Low birth weight baby,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,33,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Maternal exposure during pregnancy,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,33,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Neutropenia neonatal,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191592252,19159225,33,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 UG/M2, QD",21.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q2,Premature baby,,2021,Q2,2,F,20170804.0,20210426.0,20210420,20210507,EXP,,FR-PERRIGO-18FR019715,PERRIGO,,1.0,DY,,M,Y,1.89,KG,20210507.0,,HP,FR,FR,2021,Q2,Child
191610993,19161099,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2021,Q2,Lacunar infarction,,2021,Q2,3,F,20201018.0,20210528.0,20210421,20210607,PER,,JP-AMGEN-JPNSP2020208222,AMGEN,,80.0,YR,E,F,Y,,,20210607.0,,PH,JP,JP,2021,Q2,Elderly
191610993,19161099,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,INJECTION,,2021,Q2,Ventricular tachycardia,,2021,Q2,3,F,20201018.0,20210528.0,20210421,20210607,PER,,JP-AMGEN-JPNSP2020208222,AMGEN,,80.0,YR,E,F,Y,,,20210607.0,,PH,JP,JP,2021,Q2,Elderly
191653641,19165364,2,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,1,I,201910.0,20210409.0,20210421,20210421,PER,,US-SA-2021SA121700,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210421.0,,CN,US,US,2021,Q2,Elderly
191653641,19165364,2,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,1,I,201910.0,20210409.0,20210421,20210421,PER,,US-SA-2021SA121700,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210421.0,,CN,US,US,2021,Q2,Elderly
191653641,19165364,2,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Lung disorder,,2021,Q2,1,I,201910.0,20210409.0,20210421,20210421,PER,,US-SA-2021SA121700,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210421.0,,CN,US,US,2021,Q2,Elderly
191653641,19165364,2,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Visual impairment,,2021,Q2,1,I,201910.0,20210409.0,20210421,20210421,PER,,US-SA-2021SA121700,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210421.0,,CN,US,US,2021,Q2,Elderly
191706582,19170658,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,STANDARD (MEDIUM) DOSE INSULIN CORRECTION?AC HS SUBQ,,,,,,,,,,,,2021,Q2,Erythema,,2021,Q2,2,F,20190114.0,20210510.0,20210422,20210517,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-097348",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210517.0,,MD,US,US,2021,Q2,Adult
191706582,19170658,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,STANDARD (MEDIUM) DOSE INSULIN CORRECTION?AC HS SUBQ,,,,,,,,,,,,2021,Q2,Fournier's gangrene,,2021,Q2,2,F,20190114.0,20210510.0,20210422,20210517,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-097348",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210517.0,,MD,US,US,2021,Q2,Adult
191706582,19170658,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,STANDARD (MEDIUM) DOSE INSULIN CORRECTION?AC HS SUBQ,,,,,,,,,,,,2021,Q2,Oedema,,2021,Q2,2,F,20190114.0,20210510.0,20210422,20210517,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-097348",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210517.0,,MD,US,US,2021,Q2,Adult
191706582,19170658,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,STANDARD (MEDIUM) DOSE INSULIN CORRECTION?AC HS SUBQ,,,,,,,,,,,,2021,Q2,Sepsis,,2021,Q2,2,F,20190114.0,20210510.0,20210422,20210517,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-097348",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210517.0,,MD,US,US,2021,Q2,Adult
191706582,19170658,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,STANDARD (MEDIUM) DOSE INSULIN CORRECTION?AC HS SUBQ,,,,,,,,,,,,2021,Q2,Septic shock,,2021,Q2,2,F,20190114.0,20210510.0,20210422,20210517,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-097348",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210517.0,,MD,US,US,2021,Q2,Adult
191747732,19174773,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH BZ INSULIN GLARGIN 30 IE ABENDS (AS REPORTED),,,,,,,,,,,,2021,Q2,Cutaneous vasculitis,,2021,Q2,2,F,20200701.0,20210510.0,20210423,20210518,EXP,,DE-EMD SERONO-9233033,EMD SERONO INC,"ROLFES L, PFEUFFER S, PAWLITZKI M, RUCK T, WIENDL H, HACKERT J, KLEINSCHNITZ C, PUL R, SONDERMANN W, KORSEN M, MEUTH S. SKIN REACTIONS IN PATIENTS WITH MULTIPLE SCLEROSIS RECEIVING CLADRIBINE TREATMENT. NEUROLOGY(R) NEUROIMMUNOLOGY AND NEUROINFLAMMATION. 2021?8(3):. DOI:10.1212/NXI.0000000000000990",46.0,YR,A,F,Y,,,20210518.0,,MD,DE,DE,2021,Q2,Adult
191747732,19174773,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,NACH BZ INSULIN GLARGIN 30 IE ABENDS (AS REPORTED),,,,,,,,,,,,2021,Q2,Lymphopenia,,2021,Q2,2,F,20200701.0,20210510.0,20210423,20210518,EXP,,DE-EMD SERONO-9233033,EMD SERONO INC,"ROLFES L, PFEUFFER S, PAWLITZKI M, RUCK T, WIENDL H, HACKERT J, KLEINSCHNITZ C, PUL R, SONDERMANN W, KORSEN M, MEUTH S. SKIN REACTIONS IN PATIENTS WITH MULTIPLE SCLEROSIS RECEIVING CLADRIBINE TREATMENT. NEUROLOGY(R) NEUROIMMUNOLOGY AND NEUROINFLAMMATION. 2021?8(3):. DOI:10.1212/NXI.0000000000000990",46.0,YR,A,F,Y,,,20210518.0,,MD,DE,DE,2021,Q2,Adult
191817453,19181745,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, TID",,,,,,,,8.0,IU,,TID,2021,Q2,Anaemia,,2021,Q2,3,F,,20210510.0,20210426,20210519,EXP,,PL-NOVOPROD-804724,NOVO NORDISK,,32.0,YR,,F,Y,95.0,KG,20210519.0,,MD,PL,PL,2021,Q2,Young Adult
191817453,19181745,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, TID",,,,,,,,8.0,IU,,TID,2021,Q2,Maternal exposure during pregnancy,,2021,Q2,3,F,,20210510.0,20210426,20210519,EXP,,PL-NOVOPROD-804724,NOVO NORDISK,,32.0,YR,,F,Y,95.0,KG,20210519.0,,MD,PL,PL,2021,Q2,Young Adult
191817453,19181745,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, TID",,,,,,,,8.0,IU,,TID,2021,Q2,Pre-eclampsia,,2021,Q2,3,F,,20210510.0,20210426,20210519,EXP,,PL-NOVOPROD-804724,NOVO NORDISK,,32.0,YR,,F,Y,95.0,KG,20210519.0,,MD,PL,PL,2021,Q2,Young Adult
191817453,19181745,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, TID",,,,,,,,8.0,IU,,TID,2021,Q2,Premature delivery,,2021,Q2,3,F,,20210510.0,20210426,20210519,EXP,,PL-NOVOPROD-804724,NOVO NORDISK,,32.0,YR,,F,Y,95.0,KG,20210519.0,,MD,PL,PL,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood bicarbonate decreased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood creatinine increased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood urea decreased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Cardiac failure,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Cardiomyopathy,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Gait inability,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Guillain-Barre syndrome,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hyponatraemia,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Muscular weakness,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Myocarditis,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pulmonary oedema,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191849881,19184988,2,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Syringomyelia,,2021,Q2,1,I,20210404.0,,20210426,20210426,DIR,,,FDA-CTU,,31.0,YR,,M,N,,,20210426.0,N,,US,US,2021,Q2,Young Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Circumcision,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Coordination abnormal,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Depression,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Device dislocation,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Device leakage,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Dizziness,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Dyskinesia,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Dysstasia,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hyperphagia,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Urinary incontinence,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Urinary retention,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191861455,19186145,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,5,F,2020.0,20210607.0,20210427,20210609,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20210609.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,,,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,,,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,,,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Diabetic retinopathy,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,,,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Malaise,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,,,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Somnolence,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D305094A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D305094A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D305094A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Diabetic retinopathy,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D305094A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Malaise,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D305094A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Somnolence,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D311791A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D311791A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D311791A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Diabetic retinopathy,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D311791A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Malaise,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191910522,19191052,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"100 U, DAILY",,,,, D311791A,,20563.0,100.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Somnolence,,2021,Q2,2,F,20210417.0,20210422.0,20210428,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104010746,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Adult
191921272,19192127,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,12 IU,,,,,,,,12.0,IU,,,2021,Q2,Diarrhoea,,2021,Q2,2,F,20210403.0,20210526.0,20210428,20210602,EXP,,AE-KARYOPHARM-2021KPT000561,KARYOPHARM THERAPEUTICS,,73.0,YR,,F,Y,124.0,KG,20210602.0,,MD,AE,AE,2021,Q2,Elderly
191921272,19192127,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,12 IU,,,,,,,,12.0,IU,,,2021,Q2,Urinary tract infection,,2021,Q2,2,F,20210403.0,20210526.0,20210428,20210602,EXP,,AE-KARYOPHARM-2021KPT000561,KARYOPHARM THERAPEUTICS,,73.0,YR,,F,Y,124.0,KG,20210602.0,,MD,AE,AE,2021,Q2,Elderly
191927531,19192753,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,, ASKU,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210419.0,20210420.0,20210428,20210428,PER,,US-ELI_LILLY_AND_COMPANY-US202104010139,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210428.0,,CN,US,US,2021,Q2,Elderly
191927531,19192753,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,, D337388E,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210419.0,20210420.0,20210428,20210428,PER,,US-ELI_LILLY_AND_COMPANY-US202104010139,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210428.0,,CN,US,US,2021,Q2,Elderly
191927531,19192753,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK, PRN",,,,, D337388E,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210419.0,20210420.0,20210428,20210428,PER,,US-ELI_LILLY_AND_COMPANY-US202104010139,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210428.0,,CN,US,US,2021,Q2,Elderly
191978311,19197831,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q2,Systemic candida,,2021,Q2,1,I,,20210427.0,20210430,20210430,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-100238",BOEHRINGER INGELHEIM,,82.0,YR,E,M,Y,64.0,KG,20210430.0,,PH,CA,CA,2021,Q2,Elderly
191978311,19197831,13,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q2,Urinary tract candidiasis,,2021,Q2,1,I,,20210427.0,20210430,20210430,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-100238",BOEHRINGER INGELHEIM,,82.0,YR,E,M,Y,64.0,KG,20210430.0,,PH,CA,CA,2021,Q2,Elderly
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Abdominal discomfort,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Chromophobe renal cell carcinoma,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Flatulence,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Kidney fibrosis,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Neovascularisation,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Nephrectomy,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Oedema,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Pelvi-ureteric obstruction,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Product dose omission issue,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Renal haemorrhage,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Tenderness,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Thrombocytopenia,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Ureteric injury,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Ureteric obstruction,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192019013,19201901,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Varicose vein,,2021,Q2,3,F,20210420.0,20210517.0,20210430,20210526,EXP,,US-INTERCEPT-PM2021001351,INTERCEPT PHARMACEUTICALS,,54.0,YR,,F,Y,70.0,KG,20210526.0,,HP,US,US,2021,Q2,Adult
192035711,19203571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, UNKNOWN,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210422.0,20210422.0,20210503,20210503,PER,,US-ELI_LILLY_AND_COMPANY-US202104013942,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192035711,19203571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, UNKNOWN,,20563.0,,,INJECTION,,2021,Q2,Feeling abnormal,,2021,Q2,1,I,20210422.0,20210422.0,20210503,20210503,PER,,US-ELI_LILLY_AND_COMPANY-US202104013942,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192035711,19203571,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, UNKNOWN,,20563.0,,,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,20210422.0,20210422.0,20210503,20210503,PER,,US-ELI_LILLY_AND_COMPANY-US202104013942,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192037553,19203755,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Brain stem syndrome,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Erysipelas,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Seizure,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D026668,,,,,,,2021,Q2,Brain stem syndrome,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D026668,,,,,,,2021,Q2,Erysipelas,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D026668,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D026668,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192037553,19203755,3,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D026668,,,,,,,2021,Q2,Seizure,,2021,Q2,3,F,20200731.0,20210604.0,20210430,20210610,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202104011239,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20210610.0,,CN,DE,DE,2021,Q2,Elderly
192063141,19206314,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210412.0,20210420.0,20210503,20210503,EXP,GB-MHRA-ADR 25147789,GB-ACCORD-223604,ACCORD,,75.0,YR,,M,Y,81.64,KG,20210503.0,,CN,GB,GB,2021,Q2,Elderly
192063141,19206314,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,20210412.0,20210420.0,20210503,20210503,EXP,GB-MHRA-ADR 25147789,GB-ACCORD-223604,ACCORD,,75.0,YR,,M,Y,81.64,KG,20210503.0,,CN,GB,GB,2021,Q2,Elderly
192066681,19206668,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT/ML,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,COVID-19,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Hypertension,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Tachycardia,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192066681,19206668,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Tremor,,2021,Q2,1,I,20200426.0,20200428.0,20210430,20210430,EXP,,US-GILEAD-2020-0463184,GILEAD,,64.0,YR,,M,Y,94.8,KG,20210430.0,,HP,US,US,2021,Q2,Adult
192093351,19209335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,20563.0,,,INJECTION,,2021,Q2,Cerebrovascular accident,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,20563.0,,,INJECTION,,2021,Q2,Dysarthria,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,20563.0,,,INJECTION,,2021,Q2,Organ failure,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,20563.0,,,INJECTION,,2021,Q2,Seizure,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,20563.0,,,INJECTION,,2021,Q2,Vision blurred,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, D341138C,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Cerebrovascular accident,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Dysarthria,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Fall,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Organ failure,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Seizure,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192093351,19209335,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Vision blurred,,2021,Q2,1,I,20201205.0,20210426.0,20210503,20210503,EXP,,US-ELI_LILLY_AND_COMPANY-US202104012872,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210503.0,,CN,US,US,2021,Q2,Adult
192094771,19209477,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 UNITS,,,,,,,,,,,TID,2021,Q2,Blood creatinine increased,,2021,Q2,1,I,,20200302.0,20210503,20210503,EXP,,US-ROCHE-2562362,ROCHE,"HANNA R, ABDELNOUR L, HASNAIN H, SELAMET U AND KURTZ I. INTRAVITREAL BEVACIZUMAB?INDUCED EXACERBATION OF PROTEINURIA IN DIABETIC NEPHROPATHY, AND AMELIORATION BY SWITCHING TO RANIBIZUMAB. SAGE OPEN MEDICAL CASE REPORTS 2020 FEB 16?8:1?5.",37.0,YR,,F,Y,,,20210504.0,,HP,US,US,2021,Q2,Adult
192094771,19209477,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 UNITS,,,,,,,,,,,TID,2021,Q2,Blood pressure increased,,2021,Q2,1,I,,20200302.0,20210503,20210503,EXP,,US-ROCHE-2562362,ROCHE,"HANNA R, ABDELNOUR L, HASNAIN H, SELAMET U AND KURTZ I. INTRAVITREAL BEVACIZUMAB?INDUCED EXACERBATION OF PROTEINURIA IN DIABETIC NEPHROPATHY, AND AMELIORATION BY SWITCHING TO RANIBIZUMAB. SAGE OPEN MEDICAL CASE REPORTS 2020 FEB 16?8:1?5.",37.0,YR,,F,Y,,,20210504.0,,HP,US,US,2021,Q2,Adult
192094771,19209477,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18 UNITS,,,,,,,,,,,TID,2021,Q2,Proteinuria,,2021,Q2,1,I,,20200302.0,20210503,20210503,EXP,,US-ROCHE-2562362,ROCHE,"HANNA R, ABDELNOUR L, HASNAIN H, SELAMET U AND KURTZ I. INTRAVITREAL BEVACIZUMAB?INDUCED EXACERBATION OF PROTEINURIA IN DIABETIC NEPHROPATHY, AND AMELIORATION BY SWITCHING TO RANIBIZUMAB. SAGE OPEN MEDICAL CASE REPORTS 2020 FEB 16?8:1?5.",37.0,YR,,F,Y,,,20210504.0,,HP,US,US,2021,Q2,Adult
192111881,19211188,8,C,insulin lispro?isophane,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q2,Acute respiratory failure,,2021,Q2,1,I,,20210421.0,20210501,20210501,EXP,DE-BFARM-21002014,DE-ACCORD-223980,ACCORD,,82.0,YR,E,F,Y,,,20210501.0,,PH,DE,DE,2021,Q2,Elderly
192111881,19211188,8,C,insulin lispro?isophane,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q2,Apnoea,,2021,Q2,1,I,,20210421.0,20210501,20210501,EXP,DE-BFARM-21002014,DE-ACCORD-223980,ACCORD,,82.0,YR,E,F,Y,,,20210501.0,,PH,DE,DE,2021,Q2,Elderly
192111881,19211188,8,C,insulin lispro?isophane,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q2,Aspiration,,2021,Q2,1,I,,20210421.0,20210501,20210501,EXP,DE-BFARM-21002014,DE-ACCORD-223980,ACCORD,,82.0,YR,E,F,Y,,,20210501.0,,PH,DE,DE,2021,Q2,Elderly
192111881,19211188,8,C,insulin lispro?isophane,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q2,Condition aggravated,,2021,Q2,1,I,,20210421.0,20210501,20210501,EXP,DE-BFARM-21002014,DE-ACCORD-223980,ACCORD,,82.0,YR,E,F,Y,,,20210501.0,,PH,DE,DE,2021,Q2,Elderly
192111881,19211188,8,C,insulin lispro?isophane,,2,Subcutaneous,8?0?0?0,,,,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210421.0,20210501,20210501,EXP,DE-BFARM-21002014,DE-ACCORD-223980,ACCORD,,82.0,YR,E,F,Y,,,20210501.0,,PH,DE,DE,2021,Q2,Elderly
192113791,19211379,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,20563.0,,,INJECTION,BID,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210422.0,20210423.0,20210501,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104012722,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Elderly
192113791,19211379,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,20563.0,,,INJECTION,BID,2021,Q2,Injection site pain,,2021,Q2,1,I,20210422.0,20210423.0,20210501,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104012722,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Elderly
192113791,19211379,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,, D261904A,,20563.0,,,INJECTION,BID,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210422.0,20210423.0,20210501,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104012722,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Elderly
192113791,19211379,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,, D261904A,,20563.0,,,INJECTION,BID,2021,Q2,Injection site pain,,2021,Q2,1,I,20210422.0,20210423.0,20210501,20210501,PER,,US-ELI_LILLY_AND_COMPANY-US202104012722,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210501.0,,CN,US,US,2021,Q2,Elderly
192117501,19211750,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, PRN (BEFORE MEALS)",,,,, D261904A,,20563.0,10.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210422.0,20210423.0,20210504,20210504,PER,,US-ELI_LILLY_AND_COMPANY-US202104012607,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
192117501,19211750,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, PRN (BEFORE MEALS)",,,,, D261904A,,20563.0,10.0,IU,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,20210422.0,20210423.0,20210504,20210504,PER,,US-ELI_LILLY_AND_COMPANY-US202104012607,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
192117501,19211750,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, PRN (BEFORE MEALS)",,,,, D261904A,,20563.0,10.0,IU,INJECTION,,2021,Q2,Insomnia,,2021,Q2,1,I,20210422.0,20210423.0,20210504,20210504,PER,,US-ELI_LILLY_AND_COMPANY-US202104012607,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
192117501,19211750,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, OTHER (5 TIMES)",,,,, D261904A,,20563.0,10.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210422.0,20210423.0,20210504,20210504,PER,,US-ELI_LILLY_AND_COMPANY-US202104012607,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
192117501,19211750,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, OTHER (5 TIMES)",,,,, D261904A,,20563.0,10.0,IU,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,20210422.0,20210423.0,20210504,20210504,PER,,US-ELI_LILLY_AND_COMPANY-US202104012607,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
192117501,19211750,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, OTHER (5 TIMES)",,,,, D261904A,,20563.0,10.0,IU,INJECTION,,2021,Q2,Insomnia,,2021,Q2,1,I,20210422.0,20210423.0,20210504,20210504,PER,,US-ELI_LILLY_AND_COMPANY-US202104012607,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20210504.0,,CN,US,US,2021,Q2,Elderly
192174231,19217423,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U,,,,,,,,,,INJECTION,QD,2021,Q2,Arthralgia,,2021,Q2,1,I,20210226.0,20210302.0,20210505,20210505,PER,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-01058,HIKMA,,65.0,YR,,F,Y,,,20210505.0,,CN,US,US,2021,Q2,Elderly
192174231,19217423,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U,,,,,,,,,,INJECTION,QD,2021,Q2,Gait inability,,2021,Q2,1,I,20210226.0,20210302.0,20210505,20210505,PER,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-01058,HIKMA,,65.0,YR,,F,Y,,,20210505.0,,CN,US,US,2021,Q2,Elderly
192177991,19217799,34,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,U,, ASKED BUT UNKNOWN,,,1.0,IU,UNKNOWN,,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,1,I,20200809.0,20210426.0,20210505,20210505,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-FRESENIUS KABI-FK202104345,FRESENIUS KABI,,74.0,YR,,M,Y,,,20210505.0,,HP,NL,FR,2021,Q2,Elderly
192177991,19217799,49,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,, UNKNOWN,,,1.0,IU,UNKNOWN,,2021,Q2,Toxic epidermal necrolysis,,2021,Q2,1,I,20200809.0,20210426.0,20210505,20210505,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-FRESENIUS KABI-FK202104345,FRESENIUS KABI,,74.0,YR,,M,Y,,,20210505.0,,HP,NL,FR,2021,Q2,Elderly
192182601,19218260,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210426.0,20210426.0,20210502,20210502,PER,,US-ELI_LILLY_AND_COMPANY-US202104012947,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210502.0,,CN,US,US,2021,Q2,Elderly
192182601,19218260,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210426.0,20210426.0,20210502,20210502,PER,,US-ELI_LILLY_AND_COMPANY-US202104012947,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210502.0,,CN,US,US,2021,Q2,Elderly
192182601,19218260,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,20210426.0,20210426.0,20210502,20210502,PER,,US-ELI_LILLY_AND_COMPANY-US202104012947,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210502.0,,CN,US,US,2021,Q2,Elderly
192182601,19218260,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,,,,INJECTION,,2021,Q2,Product storage error,,2021,Q2,1,I,20210426.0,20210426.0,20210502,20210502,PER,,US-ELI_LILLY_AND_COMPANY-US202104012947,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20210502.0,,CN,US,US,2021,Q2,Elderly
192212921,19221292,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,COVID-19,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Sinusitis,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q2,COVID-19,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192212921,19221292,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Sinusitis,,2021,Q2,1,I,202012.0,20210407.0,20210505,20210505,PER,,US-ELI_LILLY_AND_COMPANY-US202104004891,ELI LILLY AND CO,,19.0,YR,,M,Y,,,20210505.0,,CN,US,US,2021,Q2,Youth
192217462,19221746,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,, D137578A,,20563.0,10.0,IU,INJECTION,QD,2021,Q2,Blood glucose abnormal,,2021,Q2,2,F,202104.0,20210525.0,20210505,20210530,PER,,US-ELI_LILLY_AND_COMPANY-US202104011407,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20210530.0,,CN,US,US,2021,Q2,Elderly
192217462,19221746,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,, D137578A,,20563.0,10.0,IU,INJECTION,QD,2021,Q2,Blood glucose fluctuation,,2021,Q2,2,F,202104.0,20210525.0,20210505,20210530,PER,,US-ELI_LILLY_AND_COMPANY-US202104011407,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20210530.0,,CN,US,US,2021,Q2,Elderly
192217462,19221746,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"10 U, DAILY",,,U,, D137578A,,20563.0,10.0,IU,INJECTION,QD,2021,Q2,Incorrect dose administered,,2021,Q2,2,F,202104.0,20210525.0,20210505,20210530,PER,,US-ELI_LILLY_AND_COMPANY-US202104011407,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20210530.0,,CN,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood culture positive,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Cryptococcosis,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hypotension,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hypothermia,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Lethargy,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192225431,19222543,12,C,Insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Urine output decreased,,2021,Q2,1,I,20210428.0,,20210506,20210506,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.1,KG,20210506.0,N,PH,US,US,2021,Q2,Elderly
192252602,19225260,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, OTHER (ACCORDING TO PRE?PRANDIAL BLOOD GLUCOSE)",,,U,,,,20563.0,4.0,IU,,,2021,Q2,Asthenia,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, OTHER (ACCORDING TO PRE?PRANDIAL BLOOD GLUCOSE)",,,U,,,,20563.0,4.0,IU,,,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, OTHER (ACCORDING TO PRE?PRANDIAL BLOOD GLUCOSE)",,,U,,,,20563.0,4.0,IU,,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, OTHER (ACCORDING TO PRE?PRANDIAL BLOOD GLUCOSE)",,,U,,,,20563.0,4.0,IU,,,2021,Q2,Cardiac valve disease,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, OTHER (ACCORDING TO PRE?PRANDIAL BLOOD GLUCOSE)",,,U,,,,20563.0,4.0,IU,,,2021,Q2,Choking,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, OTHER (ACCORDING TO PRE?PRANDIAL BLOOD GLUCOSE)",,,U,,,,20563.0,4.0,IU,,,2021,Q2,Hypoglycaemia,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, OTHER (ACCORDING TO PRE?PRANDIAL BLOOD GLUCOSE)",,,U,,,,20563.0,4.0,IU,,,2021,Q2,Poor quality sleep,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192252602,19225260,1,PS,Lispro,INSULIN LISPRO,1,Subcutaneous,"4 INTERNATIONAL UNIT, OTHER (ACCORDING TO PRE?PRANDIAL BLOOD GLUCOSE)",,,U,,,,20563.0,4.0,IU,,,2021,Q2,Weight decreased,,2021,Q2,2,F,20210330.0,20210614.0,20210505,20210628,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202104012469,ELI LILLY AND CO,,89.0,YR,,M,Y,70.0,KG,20210628.0,,CN,ES,ES,2021,Q2,Elderly
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Asthmatic crisis,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Choking sensation,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Illness,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Inflammation,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Movement disorder,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Oral mucosal eruption,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Product dose omission issue,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Product use issue,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pruritus,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Rash,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Rash macular,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192279033,19227903,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Urticaria,,2021,Q2,3,F,20201010.0,20210616.0,20210506,20210628,EXP,,CO-ROCHE-1744075,ROCHE,,45.0,YR,,F,Y,62.0,KG,20210628.0,,CN,CO,CO,2021,Q2,Adult
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Abnormal dreams,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Aggression,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Aspiration,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Bedridden,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Brain death,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,"Hallucination, visual",,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hypopnoea,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Myocardial infarction,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Sleep talking,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192306461,19230646,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Somnolence,,2021,Q2,1,I,20210323.0,,20210506,20210506,DIR,,,FDA-CTU,,81.0,YR,,M,N,,,20210506.0,N,CN,US,US,2021,Q2,Elderly
192341181,19234118,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"50 U, EACH MORNING",,,,, D166927A,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Intercepted product selection error,,2021,Q2,1,I,20210505.0,20210505.0,20210508,20210508,PER,,US-ELI_LILLY_AND_COMPANY-US202105002861,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210508.0,,CN,US,US,2021,Q2,Elderly
192341181,19234118,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"50 U, EACH EVENING",,,,, D166927A,,,50.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Intercepted product selection error,,2021,Q2,1,I,20210505.0,20210505.0,20210508,20210508,PER,,US-ELI_LILLY_AND_COMPANY-US202105002861,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210508.0,,CN,US,US,2021,Q2,Elderly
192341181,19234118,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY AT NIGHT",,,,, D166927A,,,25.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Intercepted product selection error,,2021,Q2,1,I,20210505.0,20210505.0,20210508,20210508,PER,,US-ELI_LILLY_AND_COMPANY-US202105002861,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210508.0,,CN,US,US,2021,Q2,Elderly
192353891,19235389,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Brain injury,,2021,Q2,1,I,20210423.0,20210503.0,20210510,20210510,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-043638,BRISTOL MYERS SQUIBB,,94.0,YR,,F,Y,,,20210510.0,,CN,US,US,2021,Q2,Elderly
192360591,19236059,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2021,Q2,Acute coronary syndrome,,2021,Q2,1,I,2020.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809629,NOVO NORDISK,,62.0,YR,,F,Y,83.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192360591,19236059,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2021,Q2,COVID-19,,2021,Q2,1,I,2020.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809629,NOVO NORDISK,,62.0,YR,,F,Y,83.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192360591,19236059,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2021,Q2,Decreased appetite,,2021,Q2,1,I,2020.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809629,NOVO NORDISK,,62.0,YR,,F,Y,83.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192360591,19236059,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2021,Q2,Nausea,,2021,Q2,1,I,2020.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809629,NOVO NORDISK,,62.0,YR,,F,Y,83.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192360591,19236059,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2021,Q2,Pleurisy,,2021,Q2,1,I,2020.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809629,NOVO NORDISK,,62.0,YR,,F,Y,83.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192360591,19236059,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"8 IU, QD",,,,, UNKNOWN,,,8.0,IU,,QD,2021,Q2,Vomiting,,2021,Q2,1,I,2020.0,20210429.0,20210510,20210510,EXP,,BR-NOVOPROD-809629,NOVO NORDISK,,62.0,YR,,F,Y,83.0,KG,20210510.0,,MD,BR,BR,2021,Q2,Adult
192401342,19240134,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 UNITS, SUBCUTANEOUS QHS",,,,,,,,,,SOLUTION,QD,2021,Q2,Fall,,2021,Q2,2,F,20210501.0,20210610.0,20210510,20210617,EXP,,US-JNJFOC-20210505725,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,124.4,KG,20210617.0,,HP,US,US,2021,Q2,Elderly
192401342,19240134,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 UNITS, SUBCUTANEOUS QHS",,,,,,,,,,SOLUTION,QD,2021,Q2,Rib fracture,,2021,Q2,2,F,20210501.0,20210610.0,20210510,20210617,EXP,,US-JNJFOC-20210505725,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,124.4,KG,20210617.0,,HP,US,US,2021,Q2,Elderly
192500431,19250043,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,U,,,,20563.0,24.0,IU,,QD,2021,Q2,Dysphagia,,2021,Q2,1,I,20210408.0,20210430.0,20210512,20210512,EXP,IT-MINISAL02-721991,IT-ELI_LILLY_AND_COMPANY-IT202105000561,ELI LILLY AND CO,,84.0,YR,,M,Y,86.0,KG,20210512.0,,CN,IT,IT,2021,Q2,Elderly
192500431,19250043,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,U,,,,20563.0,24.0,IU,,QD,2021,Q2,Haemorrhagic stroke,,2021,Q2,1,I,20210408.0,20210430.0,20210512,20210512,EXP,IT-MINISAL02-721991,IT-ELI_LILLY_AND_COMPANY-IT202105000561,ELI LILLY AND CO,,84.0,YR,,M,Y,86.0,KG,20210512.0,,CN,IT,IT,2021,Q2,Elderly
192500431,19250043,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,U,,,,20563.0,24.0,IU,,QD,2021,Q2,Paresis,,2021,Q2,1,I,20210408.0,20210430.0,20210512,20210512,EXP,IT-MINISAL02-721991,IT-ELI_LILLY_AND_COMPANY-IT202105000561,ELI LILLY AND CO,,84.0,YR,,M,Y,86.0,KG,20210512.0,,CN,IT,IT,2021,Q2,Elderly
192500431,19250043,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, DAILY",,,U,,,,20563.0,24.0,IU,,QD,2021,Q2,Speech disorder,,2021,Q2,1,I,20210408.0,20210430.0,20210512,20210512,EXP,IT-MINISAL02-721991,IT-ELI_LILLY_AND_COMPANY-IT202105000561,ELI LILLY AND CO,,84.0,YR,,M,Y,86.0,KG,20210512.0,,CN,IT,IT,2021,Q2,Elderly
192588321,19258832,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, TID",,,,,,,,,,,TID,2021,Q2,Adrenocortical insufficiency acute,,2021,Q2,1,I,20151129.0,20210510.0,20210514,20210514,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105005094,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210514.0,,MD,DE,DE,2021,Q2,Adult
192593851,19259385,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 IU, 3 IU AND 5 IU (BREAKFAST, LUNCH, DINNER)",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210430.0,20210514,20210514,PER,,US-SA-2021SA149311,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20210514.0,,HP,US,US,2021,Q2,Elderly
192593851,19259385,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 IU, 3 IU AND 5 IU (BREAKFAST, LUNCH, DINNER)",,,,,,,,,,SOLUTION FOR INJECTION,Q8H,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210430.0,20210514,20210514,PER,,US-SA-2021SA149311,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20210514.0,,HP,US,US,2021,Q2,Elderly
192593851,19259385,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210430.0,20210514,20210514,PER,,US-SA-2021SA149311,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20210514.0,,HP,US,US,2021,Q2,Elderly
192593851,19259385,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Weight decreased,,2021,Q2,1,I,,20210430.0,20210514,20210514,PER,,US-SA-2021SA149311,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20210514.0,,HP,US,US,2021,Q2,Elderly
192599202,19259920,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Atrial fibrillation,,2021,Q2,2,F,20201207.0,20210512.0,20210514,20210518,EXP,,US-PFIZER INC-2021531600,PFIZER,,87.0,YR,,M,Y,60.2,KG,20210518.0,,MD,US,US,2021,Q2,Elderly
192599202,19259920,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,2,F,20201207.0,20210512.0,20210514,20210518,EXP,,US-PFIZER INC-2021531600,PFIZER,,87.0,YR,,M,Y,60.2,KG,20210518.0,,MD,US,US,2021,Q2,Elderly
192599202,19259920,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Cardio-respiratory arrest,,2021,Q2,2,F,20201207.0,20210512.0,20210514,20210518,EXP,,US-PFIZER INC-2021531600,PFIZER,,87.0,YR,,M,Y,60.2,KG,20210518.0,,MD,US,US,2021,Q2,Elderly
192599202,19259920,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Cerebrovascular accident,,2021,Q2,2,F,20201207.0,20210512.0,20210514,20210518,EXP,,US-PFIZER INC-2021531600,PFIZER,,87.0,YR,,M,Y,60.2,KG,20210518.0,,MD,US,US,2021,Q2,Elderly
192599202,19259920,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Electrocardiogram QT prolonged,,2021,Q2,2,F,20201207.0,20210512.0,20210514,20210518,EXP,,US-PFIZER INC-2021531600,PFIZER,,87.0,YR,,M,Y,60.2,KG,20210518.0,,MD,US,US,2021,Q2,Elderly
192599202,19259920,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Respiratory arrest,,2021,Q2,2,F,20201207.0,20210512.0,20210514,20210518,EXP,,US-PFIZER INC-2021531600,PFIZER,,87.0,YR,,M,Y,60.2,KG,20210518.0,,MD,US,US,2021,Q2,Elderly
192623111,19262311,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Product use in unapproved indication,,2021,Q2,1,I,,20210506.0,20210516,20210516,EXP,,US-DRREDDYS-USA/USA/21/0135516,DR REDDYS,"LEWIS P, THARP J. BREAKTHROUGH VENOUS THROMBOEMBOLIC EVENTS IN FIVE PATIENTS WITH COVID?19 ON DIRECT ORAL ANTICOAGULANTS. J CLIN PHARM THER. 2021?46(2):519?23. DOI:10.1111/JCPT.13311",76.0,YR,E,M,Y,,,20210517.0,,HP,US,US,2021,Q2,Elderly
192656952,19265695,7,C,Insulin lispro,INSULIN LISPRO,1,Intramuscular,,,,,,,,,,,INJECTION,,2021,Q2,Acute respiratory failure,,2021,Q2,2,F,20210412.0,20210520.0,20210517,20210525,EXP,,US-CELGENEUS-USA-20210402786,CELGENE,,57.0,YR,,M,Y,106.0,KG,20210525.0,,MD,US,US,2021,Q2,Adult
192656952,19265695,7,C,Insulin lispro,INSULIN LISPRO,1,Intramuscular,,,,,,,,,,,INJECTION,,2021,Q2,Septic shock,,2021,Q2,2,F,20210412.0,20210520.0,20210517,20210525,EXP,,US-CELGENEUS-USA-20210402786,CELGENE,,57.0,YR,,M,Y,106.0,KG,20210525.0,,MD,US,US,2021,Q2,Adult
192657711,19265771,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU,,,U,,,,209196.0,24.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Dysphagia,,2021,Q2,1,I,20210408.0,20210505.0,20210517,20210517,EXP,IT-MINISAL02-721991,IT-SA-2021SA152535,SANOFI AVENTIS,,84.0,YR,E,M,Y,86.0,KG,20210517.0,,CN,IT,IT,2021,Q2,Elderly
192657711,19265771,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU,,,U,,,,209196.0,24.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Haemorrhagic stroke,,2021,Q2,1,I,20210408.0,20210505.0,20210517,20210517,EXP,IT-MINISAL02-721991,IT-SA-2021SA152535,SANOFI AVENTIS,,84.0,YR,E,M,Y,86.0,KG,20210517.0,,CN,IT,IT,2021,Q2,Elderly
192657711,19265771,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU,,,U,,,,209196.0,24.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Paresis,,2021,Q2,1,I,20210408.0,20210505.0,20210517,20210517,EXP,IT-MINISAL02-721991,IT-SA-2021SA152535,SANOFI AVENTIS,,84.0,YR,E,M,Y,86.0,KG,20210517.0,,CN,IT,IT,2021,Q2,Elderly
192657711,19265771,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 IU,,,U,,,,209196.0,24.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Speech disorder,,2021,Q2,1,I,20210408.0,20210505.0,20210517,20210517,EXP,IT-MINISAL02-721991,IT-SA-2021SA152535,SANOFI AVENTIS,,84.0,YR,E,M,Y,86.0,KG,20210517.0,,CN,IT,IT,2021,Q2,Elderly
192671381,19267138,11,C,Insul lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,,20210506.0,20210518,20210518,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-07218,LUPIN,,76.0,YR,,M,Y,,,20210518.0,,HP,US,US,2021,Q2,Elderly
192692451,19269245,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Administration site extravasation,,2021,Q2,1,I,20210426.0,20210426.0,20210517,20210517,PER,,US-GILEAD-2021-0527011,GILEAD,,81.0,YR,E,M,Y,82.1,KG,20210517.0,,PH,US,US,2021,Q2,Elderly
192692451,19269245,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Infusion site swelling,,2021,Q2,1,I,20210426.0,20210426.0,20210517,20210517,PER,,US-GILEAD-2021-0527011,GILEAD,,81.0,YR,E,M,Y,82.1,KG,20210517.0,,PH,US,US,2021,Q2,Elderly
192717941,19271794,1,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"20 U, PRN",,,,,,,,20.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202105.0,20210517.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007282,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192717941,19271794,1,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"20 U, PRN",,,,,,,,20.0,IU,INJECTION,,2021,Q2,Therapeutic response delayed,,2021,Q2,1,I,202105.0,20210517.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007282,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192717941,19271794,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"20 U, PRN",,,,, D305094A,,,20.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202105.0,20210517.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007282,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192717941,19271794,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"20 U, PRN",,,,, D305094A,,,20.0,IU,INJECTION,,2021,Q2,Therapeutic response delayed,,2021,Q2,1,I,202105.0,20210517.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007282,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192728361,19272836,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,1,I,20210417.0,20210514.0,20210518,20210518,EXP,,US-GILEAD-2021-0530870,GILEAD,,73.0,YR,E,M,Y,78.2,KG,20210518.0,,HP,US,US,2021,Q2,Elderly
192728361,19272836,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,20210417.0,20210514.0,20210518,20210518,EXP,,US-GILEAD-2021-0530870,GILEAD,,73.0,YR,E,M,Y,78.2,KG,20210518.0,,HP,US,US,2021,Q2,Elderly
192734321,19273432,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,,,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,,,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,,,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,,,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,,,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,,,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,,,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,, D355431A,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,, D355431A,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,, D355431A,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,, D355431A,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,, D355431A,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"13 U, BID (BREAKFAST AND AT LUNCH)",,,,, D355431A,,20563.0,13.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,7,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,, D355431A,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,7,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,, D355431A,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,7,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,, D355431A,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,8,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,, D355431A,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,8,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,, D355431A,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192734321,19273432,8,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"18 U, EACH EVENING",,,,, D355431A,,20563.0,18.0,IU,INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210512.0,20210514.0,20210519,20210519,PER,,US-ELI_LILLY_AND_COMPANY-US202105007995,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210519.0,,CN,US,US,2021,Q2,Adult
192772202,19277220,2,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,2,F,2021.0,20210615.0,20210520,20210617,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-104614",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Elderly
192772202,19277220,2,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Dyspnoea,,2021,Q2,2,F,2021.0,20210615.0,20210520,20210617,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-104614",BOEHRINGER INGELHEIM,,81.0,YR,E,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Elderly
192778391,19277839,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Asthma,,2021,Q2,1,I,,20210507.0,20210520,20210520,EXP,,US-SA-2021SA157755,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20210520.0,,CN,US,US,2021,Q2,Adult
192778391,19277839,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,,20210507.0,20210520,20210520,EXP,,US-SA-2021SA157755,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20210520.0,,CN,US,US,2021,Q2,Adult
192778391,19277839,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Product use issue,,2021,Q2,1,I,,20210507.0,20210520,20210520,EXP,,US-SA-2021SA157755,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20210520.0,,CN,US,US,2021,Q2,Adult
192799281,19279928,2,C,HUMAN INSULIN LISPRO,,2,Unknown,,,,,,,,,,,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,,20210511.0,20210520,20210520,EXP,,CN-ASTRAZENECA-2021A427451,ASTRAZENECA,,55.0,YR,,M,Y,,,20210520.0,,MD,CN,CN,2021,Q2,Adult
192814891,19281489,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK(CCHO 1: 15 COFFEE AND 1:20, TABLE: 250?330)",,,,, UNKNOWN,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202008.0,20210511.0,20210521,20210521,EXP,,BR-NOVOPROD-813369,NOVO NORDISK,,5.0,YR,,,Y,25.7,KG,20210521.0,,MD,BR,BR,2021,Q2,Child
192814891,19281489,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK(CCHO 1: 15 COFFEE AND 1:20, TABLE: 250?330)",,,,, UNKNOWN,,,,,,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,202008.0,20210511.0,20210521,20210521,EXP,,BR-NOVOPROD-813369,NOVO NORDISK,,5.0,YR,,,Y,25.7,KG,20210521.0,,MD,BR,BR,2021,Q2,Child
192814891,19281489,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,"UNK(CCHO 1: 15 COFFEE AND 1:20, TABLE: 250?330)",,,,, UNKNOWN,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,202008.0,20210511.0,20210521,20210521,EXP,,BR-NOVOPROD-813369,NOVO NORDISK,,5.0,YR,,,Y,25.7,KG,20210521.0,,MD,BR,BR,2021,Q2,Child
192816641,19281664,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,,"UNK, UNKNOWN",,,U,, D051995D,,20563.0,,,INJECTION,,2021,Q2,Injury associated with device,,2021,Q2,1,I,20210503.0,20210503.0,20210521,20210521,PER,,US-ELI_LILLY_AND_COMPANY-US202105001444,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210521.0,,CN,US,US,2021,Q2,Elderly
192820841,19282084,19,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q2,Mental disorder,,2021,Q2,1,I,202104.0,20210514.0,20210520,20210520,EXP,,US-GILEAD-2021-0530959,GILEAD,,24.0,YR,A,F,Y,,,20210520.0,,CN,US,US,2021,Q2,Young Adult
192822552,19282255,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PER SLIDING SCALE,,,,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PER SLIDING SCALE,,,,,,,,,,,,2021,Q2,Cardiac failure congestive,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PER SLIDING SCALE,,,,,,,,,,,,2021,Q2,Device related sepsis,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PER SLIDING SCALE,,,,,,,,,,,,2021,Q2,Infusion site phlebitis,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192822552,19282255,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PER SLIDING SCALE,,,,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,2,F,20201103.0,20210608.0,20210521,20210615,EXP,,US-JNJFOC-20201110900,JOHNSON AND JOHNSON,,71.0,YR,E,F,Y,61.29,KG,20210616.0,,HP,US,US,2021,Q2,Elderly
192839431,19283943,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Myalgia,,2021,Q2,1,I,20210429.0,,20210520,20210520,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20210520.0,Y,PH,US,US,2021,Q2,Elderly
192839431,19283943,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pain in extremity,,2021,Q2,1,I,20210429.0,,20210520,20210520,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20210520.0,Y,PH,US,US,2021,Q2,Elderly
192839431,19283943,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Radicular pain,,2021,Q2,1,I,20210429.0,,20210520,20210520,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20210520.0,Y,PH,US,US,2021,Q2,Elderly
192839431,19283943,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Tenderness,,2021,Q2,1,I,20210429.0,,20210520,20210520,DIR,,,FDA-CTU,,75.0,YR,,M,N,,,20210520.0,Y,PH,US,US,2021,Q2,Elderly
192850501,19285050,10,C,LISPRO SANOFI,,2,,,,,,,,,,,,,,2021,Q2,Anaemia,,2021,Q2,1,I,20210104.0,20210507.0,20210521,20210521,EXP,IT-MINISAL02-701972,IT-ACCORD-225538,ACCORD,,74.0,YR,,F,Y,,,20210521.0,,MD,IT,IT,2021,Q2,Elderly
192850501,19285050,10,C,LISPRO SANOFI,,2,,,,,,,,,,,,,,2021,Q2,Rectal haemorrhage,,2021,Q2,1,I,20210104.0,20210507.0,20210521,20210521,EXP,IT-MINISAL02-701972,IT-ACCORD-225538,ACCORD,,74.0,YR,,F,Y,,,20210521.0,,MD,IT,IT,2021,Q2,Elderly
192910451,19291045,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D153476H,,20563.0,,,INJECTION,,2021,Q2,Abdominal pain upper,,2021,Q2,1,I,20210518.0,20210518.0,20210523,20210523,PER,,US-ELI_LILLY_AND_COMPANY-US202105008515,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210523.0,,CN,US,US,2021,Q2,Elderly
192910451,19291045,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Abdominal pain upper,,2021,Q2,1,I,20210518.0,20210518.0,20210523,20210523,PER,,US-ELI_LILLY_AND_COMPANY-US202105008515,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210523.0,,CN,US,US,2021,Q2,Elderly
192913271,19291327,12,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Asthenia,,2021,Q2,1,I,20210428.0,20210512.0,20210523,20210523,PER,,US-CELGENEUS-USA-20210503238,CELGENE,,66.0,YR,,F,Y,72.0,KG,20210523.0,,HP,US,US,2021,Q2,Elderly
192913271,19291327,12,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q2,Diarrhoea,,2021,Q2,1,I,20210428.0,20210512.0,20210523,20210523,PER,,US-CELGENEUS-USA-20210503238,CELGENE,,66.0,YR,,F,Y,72.0,KG,20210523.0,,HP,US,US,2021,Q2,Elderly
192947481,19294748,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q2,Arthralgia,,2021,Q2,1,I,202104.0,20210521.0,20210524,20210524,PER,,US-ELI_LILLY_AND_COMPANY-US202105010456,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210524.0,,CN,US,US,2021,Q2,Adult
192947481,19294748,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q2,Back pain,,2021,Q2,1,I,202104.0,20210521.0,20210524,20210524,PER,,US-ELI_LILLY_AND_COMPANY-US202105010456,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210524.0,,CN,US,US,2021,Q2,Adult
192947481,19294748,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q2,Hypokinesia,,2021,Q2,1,I,202104.0,20210521.0,20210524,20210524,PER,,US-ELI_LILLY_AND_COMPANY-US202105010456,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210524.0,,CN,US,US,2021,Q2,Adult
192947481,19294748,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q2,"Sleep disorder due to general medical condition, insomnia type",,2021,Q2,1,I,202104.0,20210521.0,20210524,20210524,PER,,US-ELI_LILLY_AND_COMPANY-US202105010456,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210524.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Accidental underdose,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Astigmatism,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Glaucoma,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Accidental underdose,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Astigmatism,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Glaucoma,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Accidental underdose,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Astigmatism,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Glaucoma,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Accidental underdose,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Astigmatism,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
192983131,19298313,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q2,Glaucoma,,2021,Q2,1,I,202009.0,20210513.0,20210525,20210525,PER,,US-ELI_LILLY_AND_COMPANY-US202105009918,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20210525.0,,CN,US,US,2021,Q2,Adult
193008001,19300800,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 3X/DAY:TID",,,,,,,,,,,Q8H,2021,Q2,Adrenocortical insufficiency acute,,2021,Q2,1,I,20151129.0,20210512.0,20210524,20210524,EXP,,DE-BAUSCH-BL-2021-017378,BAUSCH AND LOMB,,64.0,YR,,F,Y,,,20210524.0,,MD,DE,DE,2021,Q2,Adult
193008691,19300869,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,,,2021,Q2,Pulmonary haemorrhage,,2021,Q2,1,I,20210310.0,20210312.0,20210524,20210524,EXP,,US-ABBVIE-21P-163-3816074-00,ABBVIE,,35.0,YR,,M,Y,78.0,KG,20210524.0,,MD,US,US,2021,Q2,Adult
193033233,19303323,10,C,Insulin Lispro BS,,2,Subcutaneous,,,,,,,,,,,UNKNOWN,,2021,Q2,Interstitial lung disease,,2021,Q2,3,F,20201216.0,20210525.0,20210525,20210602,EXP,,JP-CELGENEUS-JPN-20210505440,CELGENE,,80.0,YR,,F,Y,,,20210602.0,,PH,JP,JP,2021,Q2,Elderly
193077942,19307794,55,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peritonitis bacterial,,2021,Q2,2,F,20210520.0,20210602.0,20210526,20210604,EXP,,NVSC2021US115927,NOVARTIS,,58.0,YR,,M,Y,72.6,KG,20210604.0,,HP,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood albumin decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood calcium decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood chloride increased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood magnesium decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood pH increased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood potassium decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Blood urea increased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Haematocrit decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Haemoglobin decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,PCO2 decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,PO2 increased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Platelet count decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193197011,19319701,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Red blood cell count decreased,,2021,Q2,1,I,,,20210527,20210527,DIR,,,FDA-CTU,,52.0,YR,,F,N,,,,N,MD,US,US,2021,Q2,Adult
193208901,19320890,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"12 U, DAILY",,,U,, D185008D,,20563.0,12.0,IU,INJECTION,QD,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210428.0,20210428.0,20210528,20210528,PER,,US-ELI_LILLY_AND_COMPANY-US202105000798,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Elderly
193209221,19320922,8,C,Insulin Lispro 100 unit/mL injection 0?5 units,,2,,,,,,,,,,,,,,2021,Q2,Haematuria,,2021,Q2,1,I,20210527.0,,20210528,20210528,DIR,,,FDA-CTU,,85.0,YR,,M,N,69.7,KG,20210528.0,N,PH,US,US,2021,Q2,Elderly
193221282,19322128,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D235668A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,2,F,20210518.0,20210524.0,20210528,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US202105010266,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
193221282,19322128,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D235668A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210518.0,20210524.0,20210528,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US202105010266,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
193221282,19322128,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D235668A,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,2,F,20210518.0,20210524.0,20210528,20210603,PER,,US-ELI_LILLY_AND_COMPANY-US202105010266,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20210603.0,,CN,US,US,2021,Q2,Elderly
193233502,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q2,Cough,,2021,Q2,2,F,,20210529.0,20210528,20210610,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20210610.0,,PH,DE,DE,2021,Q2,Elderly
193233502,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,2,F,,20210529.0,20210528,20210610,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20210610.0,,PH,DE,DE,2021,Q2,Elderly
193233502,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,2,F,,20210529.0,20210528,20210610,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20210610.0,,PH,DE,DE,2021,Q2,Elderly
193233502,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,2,F,,20210529.0,20210528,20210610,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20210610.0,,PH,DE,DE,2021,Q2,Elderly
193236081,19323608,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, UNKNOWN",,,U,, D355431A,,20563.0,10.0,IU,INJECTION,,2021,Q2,Injury associated with device,,2021,Q2,1,I,20210525.0,20210525.0,20210528,20210528,PER,,US-ELI_LILLY_AND_COMPANY-US202105011969,ELI LILLY AND CO,,81.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Elderly
193254081,19325408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 IU,,,U,, SAKNAS,,209196.0,6.0,IU,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210420.0,20210517.0,20210528,20210528,EXP,,SE-SA-2021SA169021,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210528.0,,MD,SE,SE,2021,Q2,Adult
193254081,19325408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 IU,,,U,, SAKNAS,,209196.0,6.0,IU,,,2021,Q2,Intentional overdose,,2021,Q2,1,I,20210420.0,20210517.0,20210528,20210528,EXP,,SE-SA-2021SA169021,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210528.0,,MD,SE,SE,2021,Q2,Adult
193254081,19325408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 IU,,,U,, SAKNAS,,209196.0,6.0,IU,,,2021,Q2,Intentional self-injury,,2021,Q2,1,I,20210420.0,20210517.0,20210528,20210528,EXP,,SE-SA-2021SA169021,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210528.0,,MD,SE,SE,2021,Q2,Adult
193254081,19325408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 IU,,,U,, SAKNAS,,209196.0,6.0,IU,,,2021,Q2,Loss of consciousness,,2021,Q2,1,I,20210420.0,20210517.0,20210528,20210528,EXP,,SE-SA-2021SA169021,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210528.0,,MD,SE,SE,2021,Q2,Adult
193254081,19325408,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 IU,,,U,, SAKNAS,,209196.0,6.0,IU,,,2021,Q2,Poisoning,,2021,Q2,1,I,20210420.0,20210517.0,20210528,20210528,EXP,,SE-SA-2021SA169021,SANOFI AVENTIS,,53.0,YR,A,F,Y,,,20210528.0,,MD,SE,SE,2021,Q2,Adult
193277202,19327720,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,ONGOING,,,,," UNKNOWN,UNKNOWN",,,,,INJECTION,,2021,Q2,Acute respiratory failure,,2021,Q2,2,F,20210412.0,20210527.0,20210528,20210603,EXP,,US-FRESENIUS KABI-FK202105256,FRESENIUS KABI,,57.0,YR,,M,Y,106.0,KG,20210603.0,,MD,US,US,2021,Q2,Adult
193277202,19327720,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,ONGOING,,,,," UNKNOWN,UNKNOWN",,,,,INJECTION,,2021,Q2,Septic shock,,2021,Q2,2,F,20210412.0,20210527.0,20210528,20210603,EXP,,US-FRESENIUS KABI-FK202105256,FRESENIUS KABI,,57.0,YR,,M,Y,106.0,KG,20210603.0,,MD,US,US,2021,Q2,Adult
193283811,19328381,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, QID (8 UNITES BEFORE MEALS AND SLIDING SCALE 4 X DAILY)",,,D,,,,,8.0,IU,INJECTION,QID,2021,Q2,Blood glucose abnormal,,2021,Q2,1,I,202012.0,20210518.0,20210528,20210528,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010287,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Adult
193283811,19328381,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, QID (8 UNITES BEFORE MEALS AND SLIDING SCALE 4 X DAILY)",,,D,,,,,8.0,IU,INJECTION,QID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202012.0,20210518.0,20210528,20210528,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010287,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Adult
193283811,19328381,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, QID (8 UNITES BEFORE MEALS AND SLIDING SCALE 4 X DAILY)",,,D,,,,,8.0,IU,INJECTION,QID,2021,Q2,Cerebrovascular accident,,2021,Q2,1,I,202012.0,20210518.0,20210528,20210528,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010287,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Adult
193283811,19328381,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, QID (8 UNITES BEFORE MEALS AND SLIDING SCALE 4 X DAILY)",,,D,,,,,8.0,IU,INJECTION,QID,2021,Q2,Diabetic foot,,2021,Q2,1,I,202012.0,20210518.0,20210528,20210528,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010287,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Adult
193283811,19328381,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, QID (8 UNITES BEFORE MEALS AND SLIDING SCALE 4 X DAILY)",,,D,,,,,8.0,IU,INJECTION,QID,2021,Q2,Diabetic foot infection,,2021,Q2,1,I,202012.0,20210518.0,20210528,20210528,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010287,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Adult
193283811,19328381,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, QID (8 UNITES BEFORE MEALS AND SLIDING SCALE 4 X DAILY)",,,D,,,,,8.0,IU,INJECTION,QID,2021,Q2,Splinter,,2021,Q2,1,I,202012.0,20210518.0,20210528,20210528,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010287,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Adult
193283811,19328381,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, QID (8 UNITES BEFORE MEALS AND SLIDING SCALE 4 X DAILY)",,,D,,,,,8.0,IU,INJECTION,QID,2021,Q2,Visual impairment,,2021,Q2,1,I,202012.0,20210518.0,20210528,20210528,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010287,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210528.0,,CN,US,US,2021,Q2,Adult
193284191,19328419,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, BID, (MORNING, NIGHT)",,,,,,,,12.0,IU,,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105007926,ELI LILLY AND CO,,73.0,YR,,F,Y,62.0,KG,20210528.0,,CN,CN,CN,2021,Q2,Elderly
193284191,19328419,2,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"12 U, BID, (MORNING, NIGHT)",,,,,,,,12.0,IU,,BID,2021,Q2,Cerebral infarction,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105007926,ELI LILLY AND CO,,73.0,YR,,F,Y,62.0,KG,20210528.0,,CN,CN,CN,2021,Q2,Elderly
193284191,19328419,3,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, DAILY(4 OR 6 UNITS AT NOON )",,,,,,,,6.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105007926,ELI LILLY AND CO,,73.0,YR,,F,Y,62.0,KG,20210528.0,,CN,CN,CN,2021,Q2,Elderly
193284191,19328419,3,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, DAILY(4 OR 6 UNITS AT NOON )",,,,,,,,6.0,IU,,QD,2021,Q2,Cerebral infarction,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105007926,ELI LILLY AND CO,,73.0,YR,,F,Y,62.0,KG,20210528.0,,CN,CN,CN,2021,Q2,Elderly
193284191,19328419,4,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH EVENING",,,,,,,,14.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105007926,ELI LILLY AND CO,,73.0,YR,,F,Y,62.0,KG,20210528.0,,CN,CN,CN,2021,Q2,Elderly
193284191,19328419,4,SS,Lispro,INSULIN LISPRO,1,Subcutaneous,"14 U, EACH EVENING",,,,,,,,14.0,IU,,QD,2021,Q2,Cerebral infarction,,2021,Q2,1,I,,20210517.0,20210528,20210528,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202105007926,ELI LILLY AND CO,,73.0,YR,,F,Y,62.0,KG,20210528.0,,CN,CN,CN,2021,Q2,Elderly
193291381,19329138,7,C,PRANDIAL INSULIN LISPRO,,2,,,,,,,,,,,,,,2021,Q2,Insulin autoimmune syndrome,,2021,Q2,1,I,,20210523.0,20210528,20210528,EXP,,US-ASTRAZENECA-2021A472939,ASTRAZENECA,,63.0,YR,,M,Y,,,20210528.0,,MD,US,US,2021,Q2,Adult
193291381,19329138,7,C,PRANDIAL INSULIN LISPRO,,2,,,,,,,,,,,,,,2021,Q2,Type 1 diabetes mellitus,,2021,Q2,1,I,,20210523.0,20210528,20210528,EXP,,US-ASTRAZENECA-2021A472939,ASTRAZENECA,,63.0,YR,,M,Y,,,20210528.0,,MD,US,US,2021,Q2,Adult
193502911,19350291,11,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Needle issue,,2021,Q2,1,I,20210523.0,20210524.0,20210531,20210531,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-050823,BRISTOL MYERS SQUIBB,,77.0,YR,,F,Y,66.21,KG,20210531.0,,CN,US,US,2021,Q2,Elderly
193515462,19351546,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210527.0,20210528.0,20210531,20210608,PER,,US-ELI_LILLY_AND_COMPANY-US202105013729,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210608.0,,CN,US,US,2021,Q2,Adult
193515462,19351546,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,2,F,20210527.0,20210528.0,20210531,20210608,PER,,US-ELI_LILLY_AND_COMPANY-US202105013729,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210608.0,,CN,US,US,2021,Q2,Adult
193515462,19351546,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,,,,20563.0,,,INJECTION,,2021,Q2,Wrong technique in product usage process,,2021,Q2,2,F,20210527.0,20210528.0,20210531,20210608,PER,,US-ELI_LILLY_AND_COMPANY-US202105013729,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210608.0,,CN,US,US,2021,Q2,Adult
193515462,19351546,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,, D235668A,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,2,F,20210527.0,20210528.0,20210531,20210608,PER,,US-ELI_LILLY_AND_COMPANY-US202105013729,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210608.0,,CN,US,US,2021,Q2,Adult
193515462,19351546,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,, D235668A,,20563.0,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,2,F,20210527.0,20210528.0,20210531,20210608,PER,,US-ELI_LILLY_AND_COMPANY-US202105013729,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210608.0,,CN,US,US,2021,Q2,Adult
193515462,19351546,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,Y,, D235668A,,20563.0,,,INJECTION,,2021,Q2,Wrong technique in product usage process,,2021,Q2,2,F,20210527.0,20210528.0,20210531,20210608,PER,,US-ELI_LILLY_AND_COMPANY-US202105013729,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20210608.0,,CN,US,US,2021,Q2,Adult
193520591,19352059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2021,Q2,Product dispensing error,,2021,Q2,1,I,,20210524.0,20210601,20210601,PER,,US-SA-2021SA176529,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Adult
193520591,19352059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2021,Q2,Product storage error,,2021,Q2,1,I,,20210524.0,20210601,20210601,PER,,US-SA-2021SA176529,SANOFI AVENTIS,,44.0,YR,A,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Adult
193575871,19357587,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,,,,,8.0,IU,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,,,,,8.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,,,,,8.0,IU,INJECTION,,2021,Q2,Incorrect product administration duration,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,,,,,8.0,IU,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,,,,,8.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,,,,,8.0,IU,INJECTION,,2021,Q2,Incorrect product administration duration,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,7,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,, D355431A,,,8.0,IU,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,7,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,, D355431A,,,8.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,7,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,, D355431A,,,8.0,IU,INJECTION,,2021,Q2,Incorrect product administration duration,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,8,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,, D355431A,,,8.0,IU,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,8,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,, D355431A,,,8.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193575871,19357587,8,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"8 U, PRN (4?8)",,,U,, D355431A,,,8.0,IU,INJECTION,,2021,Q2,Incorrect product administration duration,,2021,Q2,1,I,20210401.0,20210528.0,20210601,20210601,PER,,US-ELI_LILLY_AND_COMPANY-US202105013903,ELI LILLY AND CO,,23.0,YR,,M,Y,,,20210601.0,,CN,US,US,2021,Q2,Youth
193579501,19357950,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0?12 UNITS,,,U,U,,,,,,,,2021,Q2,Abdominal pain,,2021,Q2,1,I,20210513.0,20210527.0,20210602,20210602,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052021,BRISTOL MYERS SQUIBB,,47.0,YR,,M,Y,93.1,KG,20210602.0,,HP,US,US,2021,Q2,Adult
193579501,19357950,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,0?12 UNITS,,,U,U,,,,,,,,2021,Q2,Metabolic acidosis,,2021,Q2,1,I,20210513.0,20210527.0,20210602,20210602,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-052021,BRISTOL MYERS SQUIBB,,47.0,YR,,M,Y,93.1,KG,20210602.0,,HP,US,US,2021,Q2,Adult
193582131,19358213,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4?8 UNITS WITH EACH MEAL,STRENGTH REPORTED AS U?100",,,,,,,,,,,,2021,Q2,Contraindicated product administered,,2021,Q2,1,I,,20210513.0,20210602,20210602,PER,,US-009507513-2105USA004232,MERCK,"KUHADIYA ND, ISRAA M. EFFECTS OF CONCOMITANT COMBINATION OF SGLT?2 INHIBITOR AND GLP?1 RECEPTOR AGONIST ON RENAL OUTCOMES IN T2D WITH EGFR BELOW 30 AND MACROALBUMINURIA: A CASE SERIES. CLINICAL CASE REPORTS. 2021?9(9):2310?6",62.0,YR,,M,Y,87.1,KG,20210602.0,,HP,US,US,2021,Q2,Adult
193585181,19358518,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Ankle fracture,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Cataract,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Loss of consciousness,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Mobility decreased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Pain in extremity,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Product storage error,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Ankle fracture,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Cataract,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Loss of consciousness,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Mobility decreased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Pain in extremity,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,,,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Product storage error,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Ankle fracture,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Cataract,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Loss of consciousness,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Mobility decreased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Pain in extremity,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Product storage error,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Ankle fracture,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Cataract,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Loss of consciousness,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Mobility decreased,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Pain in extremity,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193585181,19358518,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, BID",,,Y,, D088600C,,21017.0,15.0,IU,INJECTION,BID,2021,Q2,Product storage error,,2021,Q2,1,I,202004.0,20210520.0,20210602,20210602,EXP,,US-ELI_LILLY_AND_COMPANY-US202105010873,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20210602.0,,CN,US,US,2021,Q2,Adult
193613521,19361352,2,SS,INSULIN LISPRO BS Injection Solostar HU [Sanofi],INSULIN LISPRO,1,Subcutaneous,300 UNITS,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Altered state of consciousness,,2021,Q2,1,I,,20210531.0,20210603,20210603,EXP,,JP-SA-2021SA180717,SANOFI AVENTIS,"TOKUMARU M, IWAZAKI A, WATAHIKI M, HAYASHI C, KASHIWABARA Y, SASAKI S. II?81?6: A CASE OF LACTIC ACIDOSIS DUE TO OVERDOSE OF METFORMIN AND INSULIN IN A SUICIDE ATTEMPT. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2021?64:UNK",28.0,YR,A,F,Y,,,20210603.0,,MD,JP,JP,2021,Q2,Young Adult
193613521,19361352,2,SS,INSULIN LISPRO BS Injection Solostar HU [Sanofi],INSULIN LISPRO,1,Subcutaneous,300 UNITS,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Intentional overdose,,2021,Q2,1,I,,20210531.0,20210603,20210603,EXP,,JP-SA-2021SA180717,SANOFI AVENTIS,"TOKUMARU M, IWAZAKI A, WATAHIKI M, HAYASHI C, KASHIWABARA Y, SASAKI S. II?81?6: A CASE OF LACTIC ACIDOSIS DUE TO OVERDOSE OF METFORMIN AND INSULIN IN A SUICIDE ATTEMPT. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2021?64:UNK",28.0,YR,A,F,Y,,,20210603.0,,MD,JP,JP,2021,Q2,Young Adult
193613521,19361352,2,SS,INSULIN LISPRO BS Injection Solostar HU [Sanofi],INSULIN LISPRO,1,Subcutaneous,300 UNITS,,,D,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Lactic acidosis,,2021,Q2,1,I,,20210531.0,20210603,20210603,EXP,,JP-SA-2021SA180717,SANOFI AVENTIS,"TOKUMARU M, IWAZAKI A, WATAHIKI M, HAYASHI C, KASHIWABARA Y, SASAKI S. II?81?6: A CASE OF LACTIC ACIDOSIS DUE TO OVERDOSE OF METFORMIN AND INSULIN IN A SUICIDE ATTEMPT. JOURNAL OF THE JAPAN DIABETES SOCIETY. 2021?64:UNK",28.0,YR,A,F,Y,,,20210603.0,,MD,JP,JP,2021,Q2,Young Adult
193624981,19362498,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, QD (LUNCH)",,,,,,,,4.0,IU,,QD,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, QD (LUNCH)",,,,,,,,4.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, QD (LUNCH)",,,,,,,,4.0,IU,,QD,2021,Q2,Limb injury,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, QD (LUNCH)",,,,,,,,4.0,IU,,QD,2021,Q2,Malignant melanoma,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 IU, QD (LUNCH)",,,,,,,,4.0,IU,,QD,2021,Q2,Wound infection,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, QD (02UI COFFEE, 04UI LUNCH, 02UI DINNER)",,,,,,,,8.0,IU,,QD,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, QD (02UI COFFEE, 04UI LUNCH, 02UI DINNER)",,,,,,,,8.0,IU,,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, QD (02UI COFFEE, 04UI LUNCH, 02UI DINNER)",,,,,,,,8.0,IU,,QD,2021,Q2,Limb injury,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, QD (02UI COFFEE, 04UI LUNCH, 02UI DINNER)",,,,,,,,8.0,IU,,QD,2021,Q2,Malignant melanoma,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193624981,19362498,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, QD (02UI COFFEE, 04UI LUNCH, 02UI DINNER)",,,,,,,,8.0,IU,,QD,2021,Q2,Wound infection,,2021,Q2,1,I,,20210521.0,20210602,20210602,EXP,,BR-NOVOPROD-816270,NOVO NORDISK,,63.0,YR,,F,Y,127.2,KG,20210602.0,,MD,BR,BR,2021,Q2,Adult
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blindness transient,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Facial discomfort,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Hyperhidrosis,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Incorrect dose administered,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Injection site induration,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Product administered at inappropriate site,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Seizure,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Shock hypoglycaemic,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Unresponsive to stimuli,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Vomiting,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Blindness transient,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Facial discomfort,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Hyperhidrosis,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Incorrect dose administered,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Injection site induration,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Product administered at inappropriate site,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Seizure,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Shock hypoglycaemic,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Unresponsive to stimuli,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU,,,D,,,,,20.0,IU,SOLUTION FOR INJECTION,,2021,Q2,Vomiting,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blindness transient,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Blood glucose increased,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Facial discomfort,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Hyperhidrosis,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Incorrect dose administered,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Injection site induration,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Product administered at inappropriate site,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Seizure,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Shock hypoglycaemic,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Unresponsive to stimuli,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193626941,19362694,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,D,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q2,Vomiting,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-SA-2021SA173759,SANOFI AVENTIS,,75.0,YR,E,M,Y,,,20210602.0,,CN,US,US,2021,Q2,Elderly
193642081,19364208,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 UNITS,,,U,U,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-MYLANLABS-2021M1031503,MYLAN,"ZHANG F, KARAM JG. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM?J?CASE?REP 2021?NULL:NULL.",70.0,YR,,F,Y,,,20210602.0,,HP,US,US,2021,Q2,Elderly
193642081,19364208,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INCREASED TO 15 UNITS WITH AN ADDITIONAL..,,,U,U,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-MYLANLABS-2021M1031503,MYLAN,"ZHANG F, KARAM JG. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM?J?CASE?REP 2021?NULL:NULL.",70.0,YR,,F,Y,,,20210602.0,,HP,US,US,2021,Q2,Elderly
193642081,19364208,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"BASED ON THE CGM REPORTS, A HIGHER INSULIN REGIMEN WAS PRESCRIBED ON HER CHEMOTHERAP..",,,U,U,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210524.0,20210602,20210602,EXP,,US-MYLANLABS-2021M1031503,MYLAN,"ZHANG F, KARAM JG. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM?J?CASE?REP 2021?NULL:NULL.",70.0,YR,,F,Y,,,20210602.0,,HP,US,US,2021,Q2,Elderly
193646141,19364614,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,,20210525.0,20210603,20210603,EXP,,US-JNJFOC-20210552052,JOHNSON AND JOHNSON,"SCHNEIDER R, LIZER M. APPARENT SEIZURE AND ATRIAL FIBRILLATION ASSOCIATED WITH PALIPERIDONE. AM J HEALTH SYST PHARM. 2008 NOV 15?65 (22):2122?2125.",46.0,YR,A,M,Y,,,20210603.0,,HP,US,US,2021,Q2,Adult
193646141,19364614,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Seizure,,2021,Q2,1,I,,20210525.0,20210603,20210603,EXP,,US-JNJFOC-20210552052,JOHNSON AND JOHNSON,"SCHNEIDER R, LIZER M. APPARENT SEIZURE AND ATRIAL FIBRILLATION ASSOCIATED WITH PALIPERIDONE. AM J HEALTH SYST PHARM. 2008 NOV 15?65 (22):2122?2125.",46.0,YR,A,M,Y,,,20210603.0,,HP,US,US,2021,Q2,Adult
193711601,19371160,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202011.0,20210507.0,20210604,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202105004192,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
193711601,19371160,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,1,I,202011.0,20210507.0,20210604,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202105004192,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
193711601,19371160,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202011.0,20210507.0,20210604,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202105004192,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
193711601,19371160,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,1,I,202011.0,20210507.0,20210604,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202105004192,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
193711601,19371160,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202011.0,20210507.0,20210604,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202105004192,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
193711601,19371160,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,1,I,202011.0,20210507.0,20210604,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202105004192,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
193711601,19371160,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202011.0,20210507.0,20210604,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202105004192,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
193711601,19371160,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q2,COVID-19,,2021,Q2,1,I,202011.0,20210507.0,20210604,20210604,PER,,US-ELI_LILLY_AND_COMPANY-US202105004192,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210604.0,,CN,US,US,2021,Q2,Elderly
193759461,19375946,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT?BY VALUE,,,U,, UNKNOWN,,,,,,,2021,Q2,Cough,,2021,Q2,1,I,,20210527.0,20210605,20210605,PER,DE-EMA-DD-20210526-BISHT_P-105858,DE-DRREDDYS-GER/GER/21/0136118,DR REDDYS,,83.0,YR,E,M,Y,,,20210605.0,,PH,DE,DE,2021,Q2,Elderly
193759461,19375946,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT?BY VALUE,,,U,, UNKNOWN,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210527.0,20210605,20210605,PER,DE-EMA-DD-20210526-BISHT_P-105858,DE-DRREDDYS-GER/GER/21/0136118,DR REDDYS,,83.0,YR,E,M,Y,,,20210605.0,,PH,DE,DE,2021,Q2,Elderly
193759461,19375946,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT?BY VALUE,,,U,, UNKNOWN,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,1,I,,20210527.0,20210605,20210605,PER,DE-EMA-DD-20210526-BISHT_P-105858,DE-DRREDDYS-GER/GER/21/0136118,DR REDDYS,,83.0,YR,E,M,Y,,,20210605.0,,PH,DE,DE,2021,Q2,Elderly
193759461,19375946,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT?BY VALUE,,,U,, UNKNOWN,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210527.0,20210605,20210605,PER,DE-EMA-DD-20210526-BISHT_P-105858,DE-DRREDDYS-GER/GER/21/0136118,DR REDDYS,,83.0,YR,E,M,Y,,,20210605.0,,PH,DE,DE,2021,Q2,Elderly
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Feeling abnormal,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Flushing,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Oxygen consumption increased,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Respiratory distress,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Restlessness,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Rhonchi,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Urticaria,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193760361,19376036,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q2,Vomiting,,2021,Q2,1,I,20210519.0,20210521.0,20210604,20210604,PER,,US-IGSA-BIG0014669,GRIFOLS,,7.0,YR,,F,Y,26.0,KG,20210604.0,,MD,US,US,2021,Q2,Child
193771912,19377191,2,SS,Insulina lispro Sanofi,INSULIN LISPRO,1,Unknown,"UNK, MAX 250 CRTS",,,U,U,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,2,F,20210401.0,20210601.0,20210605,20210613,EXP,,IT-AUROBINDO-AUR-APL-2021-022966,AUROBINDO,,68.0,YR,,F,Y,,,20210614.0,,MD,IT,IT,2021,Q2,Elderly
193771912,19377191,2,SS,Insulina lispro Sanofi,INSULIN LISPRO,1,Unknown,"UNK, MAX 250 CRTS",,,U,U,,,,,,,,2021,Q2,Syncope,,2021,Q2,2,F,20210401.0,20210601.0,20210605,20210613,EXP,,IT-AUROBINDO-AUR-APL-2021-022966,AUROBINDO,,68.0,YR,,F,Y,,,20210614.0,,MD,IT,IT,2021,Q2,Elderly
193801311,19380131,7,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,60 INTERNATIONAL UNIT,,,U,U,,,,60.0,IU,,,2021,Q2,Serotonin syndrome,,2021,Q2,1,I,,20101030.0,20210607,20210607,EXP,,US-AUROBINDO-AUR-APL-2019-100698,AUROBINDO,,46.0,YR,,F,Y,,,20210607.0,,MD,US,US,2021,Q2,Adult
193812021,19381202,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210401.0,20210531.0,20210607,20210607,EXP,IT-MINISAL02-733597,NVSC2021IT123197,NOVARTIS,,68.0,YR,,F,Y,,,20210607.0,,HP,IT,IT,2021,Q2,Elderly
193812021,19381202,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Syncope,,2021,Q2,1,I,20210401.0,20210531.0,20210607,20210607,EXP,IT-MINISAL02-733597,NVSC2021IT123197,NOVARTIS,,68.0,YR,,F,Y,,,20210607.0,,HP,IT,IT,2021,Q2,Elderly
193824451,19382445,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (NACH WERT),,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-EMA-DD-20210526-BISHT_P-105858,NVSC2021DE123610,NOVARTIS,,83.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193824451,19382445,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (NACH WERT),,,U,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-EMA-DD-20210526-BISHT_P-105858,NVSC2021DE123610,NOVARTIS,,83.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193824451,19382445,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (NACH WERT),,,U,,,,,,,,,2021,Q2,Oedema peripheral,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-EMA-DD-20210526-BISHT_P-105858,NVSC2021DE123610,NOVARTIS,,83.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193824451,19382445,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (NACH WERT),,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210531.0,20210607,20210607,EXP,DE-EMA-DD-20210526-BISHT_P-105858,NVSC2021DE123610,NOVARTIS,,83.0,YR,,M,Y,,,20210607.0,,HP,DE,DE,2021,Q2,Elderly
193891331,19389133,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,0?12UNITS,,,U,,,,,,,,,2021,Q2,Atrial fibrillation,,2021,Q2,1,I,20210422.0,20210427.0,20210608,20210608,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-041116,BRISTOL MYERS SQUIBB,,46.0,YR,,M,Y,111.5,KG,20210608.0,,HP,US,US,2021,Q2,Adult
193891331,19389133,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,0?12UNITS,,,U,,,,,,,,,2021,Q2,Clostridium difficile colitis,,2021,Q2,1,I,20210422.0,20210427.0,20210608,20210608,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-041116,BRISTOL MYERS SQUIBB,,46.0,YR,,M,Y,111.5,KG,20210608.0,,HP,US,US,2021,Q2,Adult
193891331,19389133,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,0?12UNITS,,,U,,,,,,,,,2021,Q2,Pulmonary oedema,,2021,Q2,1,I,20210422.0,20210427.0,20210608,20210608,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-041116,BRISTOL MYERS SQUIBB,,46.0,YR,,M,Y,111.5,KG,20210608.0,,HP,US,US,2021,Q2,Adult
193925121,19392512,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"10?10?12?0, FERTIGSPRITZEN (HUMALOG 100 EINHEITEN/ML INJ.LSG.IN PATRONE 3ML)",,,U,,,,20563.0,,,,,2021,Q2,Pain in extremity,,2021,Q2,1,I,20200914.0,20210527.0,20210608,20210608,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105013040,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210608.0,,PH,DE,DE,2021,Q2,Elderly
193925121,19392512,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"10?10?12?0, FERTIGSPRITZEN (HUMALOG 100 EINHEITEN/ML INJ.LSG.IN PATRONE 3ML)",,,U,,,,20563.0,,,,,2021,Q2,Peripheral swelling,,2021,Q2,1,I,20200914.0,20210527.0,20210608,20210608,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105013040,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210608.0,,PH,DE,DE,2021,Q2,Elderly
193925121,19392512,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Subcutaneous,"10?10?12?0, FERTIGSPRITZEN (HUMALOG 100 EINHEITEN/ML INJ.LSG.IN PATRONE 3ML)",,,U,,,,20563.0,,,,,2021,Q2,Product prescribing error,,2021,Q2,1,I,20200914.0,20210527.0,20210608,20210608,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202105013040,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210608.0,,PH,DE,DE,2021,Q2,Elderly
193956151,19395615,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q2,Bronchopulmonary aspergillosis,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q2,Encephalopathy,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q2,Klebsiella infection,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q2,Pulmonary mucormycosis,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q2,Respiratory failure,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SLIDING SCALE,,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q2,Staphylococcal infection,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Bronchopulmonary aspergillosis,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Encephalopathy,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Klebsiella infection,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Pneumonia,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Pulmonary mucormycosis,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193956151,19395615,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,, UNKNOWN,,,,,,,2021,Q2,Staphylococcal infection,,2021,Q2,1,I,,20210603.0,20210609,20210609,EXP,,US-FRESENIUS KABI-FK202105811,FRESENIUS KABI,"JOHNSON A, GHAZARIAN Z, CENDROWSKI K, PERSICHINO J. PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS IN A PATIENT WITH COVID?19. MEDICAL MYCOLOGY CASE REPORTS. 2021 JUN?32:64?67.",79.0,YR,,M,Y,,,20210609.0,,HP,US,US,2021,Q2,Elderly
193969321,19396932,2,SS,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210401.0,20210529.0,20210609,20210609,EXP,IT-MINISAL02-733597,IT-BAUSCH-BL-2021-019410,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20210609.0,,MD,IT,IT,2021,Q2,Elderly
193969321,19396932,2,SS,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q2,Syncope,,2021,Q2,1,I,20210401.0,20210529.0,20210609,20210609,EXP,IT-MINISAL02-733597,IT-BAUSCH-BL-2021-019410,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20210609.0,,MD,IT,IT,2021,Q2,Elderly
193969861,19396986,3,SS,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210401.0,20210528.0,20210610,20210610,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-300128,RANBAXY,,68.0,YR,,F,Y,,,20210610.0,,HP,NL,IT,2021,Q2,Elderly
193969861,19396986,3,SS,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Syncope,,2021,Q2,1,I,20210401.0,20210528.0,20210610,20210610,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-300128,RANBAXY,,68.0,YR,,F,Y,,,20210610.0,,HP,NL,IT,2021,Q2,Elderly
193987372,19398737,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,5 INTERNATIONAL UNIT,,,U,,,,,5.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,,20210618.0,20210610,20210625,EXP,,US-AUROBINDO-AUR-APL-2021-023799,AUROBINDO,,70.0,YR,,F,Y,,,20210625.0,,HP,US,US,2021,Q2,Elderly
193987372,19398737,7,C,Insulin lispro,INSULIN LISPRO,1,Unknown,15 INTERNATIONAL UNIT,,,U,,,,,15.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,,20210618.0,20210610,20210625,EXP,,US-AUROBINDO-AUR-APL-2021-023799,AUROBINDO,,70.0,YR,,F,Y,,,20210625.0,,HP,US,US,2021,Q2,Elderly
193987372,19398737,8,C,Insulin lispro,INSULIN LISPRO,1,Unknown,17 INTERNATIONAL UNIT (15 UNITS WITH AN ADDITIONAL 2 UNITS),,,U,,,,,17.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,,20210618.0,20210610,20210625,EXP,,US-AUROBINDO-AUR-APL-2021-023799,AUROBINDO,,70.0,YR,,F,Y,,,20210625.0,,HP,US,US,2021,Q2,Elderly
193987372,19398737,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,3 INTERNATIONAL UNIT,,,U,,,,,3.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,,20210618.0,20210610,20210625,EXP,,US-AUROBINDO-AUR-APL-2021-023799,AUROBINDO,,70.0,YR,,F,Y,,,20210625.0,,HP,US,US,2021,Q2,Elderly
193987372,19398737,10,C,Insulin lispro,INSULIN LISPRO,1,Unknown,2 INTERNATIONAL UNIT (INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE),,,U,,,,,2.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,2,F,,20210618.0,20210610,20210625,EXP,,US-AUROBINDO-AUR-APL-2021-023799,AUROBINDO,,70.0,YR,,F,Y,,,20210625.0,,HP,US,US,2021,Q2,Elderly
194017562,19401756,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Death,,2021,Q2,2,F,20210413.0,20210625.0,20210610,20210629,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-036830,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20210629.0,,CN,IT,IT,2021,Q2,Adult
194017562,19401756,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Flank pain,,2021,Q2,2,F,20210413.0,20210625.0,20210610,20210629,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-036830,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20210629.0,,CN,IT,IT,2021,Q2,Adult
194017562,19401756,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Gastrointestinal hypomotility,,2021,Q2,2,F,20210413.0,20210625.0,20210610,20210629,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-036830,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20210629.0,,CN,IT,IT,2021,Q2,Adult
194017562,19401756,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Intentional product use issue,,2021,Q2,2,F,20210413.0,20210625.0,20210610,20210629,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-036830,BRISTOL MYERS SQUIBB,,64.0,YR,,M,Y,,,20210629.0,,CN,IT,IT,2021,Q2,Adult
194049261,19404926,2,SS,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210401.0,20210601.0,20210611,20210611,EXP,IT-MINISAL02-733597,IT-TEVA-2021-IT-1920320,TEVA,,68.0,YR,E,F,Y,,,20210611.0,,MD,IT,IT,2021,Q2,Elderly
194049261,19404926,2,SS,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,Unknown,,,,U,, UNKNOWN,,,,,,,2021,Q2,Syncope,,2021,Q2,1,I,20210401.0,20210601.0,20210611,20210611,EXP,IT-MINISAL02-733597,IT-TEVA-2021-IT-1920320,TEVA,,68.0,YR,E,F,Y,,,20210611.0,,MD,IT,IT,2021,Q2,Elderly
194083791,19408379,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Cough,,2021,Q2,1,I,,20210603.0,20210612,20210612,PER,,US-SA-2021SA187632,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210612.0,,CN,US,US,2021,Q2,Elderly
194083791,19408379,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Glossitis,,2021,Q2,1,I,,20210603.0,20210612,20210612,PER,,US-SA-2021SA187632,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210612.0,,CN,US,US,2021,Q2,Elderly
194083791,19408379,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,,20210603.0,20210612,20210612,PER,,US-SA-2021SA187632,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210612.0,,CN,US,US,2021,Q2,Elderly
194083791,19408379,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Peripheral swelling,,2021,Q2,1,I,,20210603.0,20210612,20210612,PER,,US-SA-2021SA187632,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210612.0,,CN,US,US,2021,Q2,Elderly
194083791,19408379,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Swollen tongue,,2021,Q2,1,I,,20210603.0,20210612,20210612,PER,,US-SA-2021SA187632,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210612.0,,CN,US,US,2021,Q2,Elderly
194083791,19408379,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Tongue discolouration,,2021,Q2,1,I,,20210603.0,20210612,20210612,PER,,US-SA-2021SA187632,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210612.0,,CN,US,US,2021,Q2,Elderly
194083791,19408379,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,,20210603.0,20210612,20210612,PER,,US-SA-2021SA187632,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20210612.0,,CN,US,US,2021,Q2,Elderly
194097721,19409772,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10?10?12?0, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2021,Q2,Pain in extremity,,2021,Q2,1,I,20200914.0,20210601.0,20210614,20210614,EXP,,DE-SA-2021SA184794,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20210614.0,,PH,DE,DE,2021,Q2,Elderly
194097721,19409772,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10?10?12?0, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2021,Q2,Peripheral swelling,,2021,Q2,1,I,20200914.0,20210601.0,20210614,20210614,EXP,,DE-SA-2021SA184794,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20210614.0,,PH,DE,DE,2021,Q2,Elderly
194097721,19409772,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10?10?12?0, TID",,,U,,,,,,,SOLUTION FOR INJECTION,Q8H,2021,Q2,Product prescribing error,,2021,Q2,1,I,20200914.0,20210601.0,20210614,20210614,EXP,,DE-SA-2021SA184794,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20210614.0,,PH,DE,DE,2021,Q2,Elderly
194099091,19409909,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20210401.0,20210601.0,20210614,20210614,EXP,IT-MINISAL02-733597,IT-SA-2021SA185982,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210614.0,,MD,IT,IT,2021,Q2,Elderly
194099091,19409909,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,,,,,,,SOLUTION FOR INJECTION,,2021,Q2,Syncope,,2021,Q2,1,I,20210401.0,20210601.0,20210614,20210614,EXP,IT-MINISAL02-733597,IT-SA-2021SA185982,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20210614.0,,MD,IT,IT,2021,Q2,Elderly
194113411,19411341,8,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,20210614.0,,20210614,20210614,DIR,,,FDA-CTU,,77.0,YR,,M,N,85.5,KG,20210614.0,N,CN,US,US,2021,Q2,Elderly
194128161,19412816,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Aspergillus infection,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Bronchopulmonary aspergillosis,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Encephalopathy,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Mucormycosis,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Pulmonary mucormycosis,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194128161,19412816,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q2,Respiratory failure,,2021,Q2,1,I,,20210603.0,20210614,20210614,EXP,,US-MYLANLABS-2021M1033984,MYLAN,,79.0,YR,,M,Y,,,20210614.0,,HP,US,US,2021,Q2,Elderly
194133331,19413333,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210604.0,20210608.0,20210615,20210615,PER,,US-ELI_LILLY_AND_COMPANY-US202106005361,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194133331,19413333,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,21017.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210604.0,20210608.0,20210615,20210615,PER,,US-ELI_LILLY_AND_COMPANY-US202106005361,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194133331,19413333,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210604.0,20210608.0,20210615,20210615,PER,,US-ELI_LILLY_AND_COMPANY-US202106005361,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194133331,19413333,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D088600C,,21017.0,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210604.0,20210608.0,20210615,20210615,PER,,US-ELI_LILLY_AND_COMPANY-US202106005361,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Cataract,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Feeling abnormal,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Glycosylated haemoglobin increased,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Illness,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Malaise,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Somnolence,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Thinking abnormal,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Vision blurred,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160481,19416048,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D332676A,,,,,SOLUTION FOR INJECTION,,2021,Q2,Wrong product administered,,2021,Q2,1,I,201712.0,20210602.0,20210614,20210614,EXP,,US-ELI_LILLY_AND_COMPANY-US202106001195,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194160752,19416075,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"3 U, TID",,,,,,,20563.0,3.0,IU,INJECTION,TID,2021,Q2,Cerebrovascular accident,,2021,Q2,2,F,202011.0,20210610.0,20210614,20210615,EXP,,US-ELI_LILLY_AND_COMPANY-US202106003512,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210615.0,,CN,US,US,2021,Q2,Elderly
194160752,19416075,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"3 U, TID",,,,,,,20563.0,3.0,IU,INJECTION,TID,2021,Q2,Haematochezia,,2021,Q2,2,F,202011.0,20210610.0,20210614,20210615,EXP,,US-ELI_LILLY_AND_COMPANY-US202106003512,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210615.0,,CN,US,US,2021,Q2,Elderly
194160752,19416075,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"3 U, TID",,,,, D337388E,,20563.0,3.0,IU,INJECTION,TID,2021,Q2,Cerebrovascular accident,,2021,Q2,2,F,202011.0,20210610.0,20210614,20210615,EXP,,US-ELI_LILLY_AND_COMPANY-US202106003512,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210615.0,,CN,US,US,2021,Q2,Elderly
194160752,19416075,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"3 U, TID",,,,, D337388E,,20563.0,3.0,IU,INJECTION,TID,2021,Q2,Haematochezia,,2021,Q2,2,F,202011.0,20210610.0,20210614,20210615,EXP,,US-ELI_LILLY_AND_COMPANY-US202106003512,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210615.0,,CN,US,US,2021,Q2,Elderly
194163031,19416303,3,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210605.0,20210608.0,20210614,20210614,PER,,US-SA-2021SA194308,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210614.0,,CN,US,US,2021,Q2,Adult
194175171,19417517,5,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Incontinence,,2021,Q2,1,I,20210520.0,,20210615,20210615,DIR,,,FDA-CTU,,59.0,YR,,F,N,90.0,KG,20210615.0,N,CN,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Bronchopulmonary aspergillosis,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Clostridium difficile colitis,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Mental status changes,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Neutropenia,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Pneumonia acinetobacter,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Pneumonia escherichia,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Pneumonia klebsiella,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Sepsis,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194178821,19417882,6,C,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2021,Q2,Toxicity to various agents,,2021,Q2,1,I,202105.0,20210609.0,20210615,20210615,EXP,,US-ASTELLAS-2021US021572,ASTELLAS,,57.0,YR,,F,Y,,,20210615.0,,MD,US,US,2021,Q2,Adult
194233081,19423308,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q2,Off label use,,2021,Q2,1,I,,20210603.0,20210616,20210616,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-09529,LUPIN,,79.0,YR,,M,Y,,,20210616.0,,HP,US,US,2021,Q2,Elderly
194233912,19423391,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Death,,2021,Q2,2,F,202105.0,20210615.0,20210616,20210621,EXP,,US-ELI_LILLY_AND_COMPANY-US202106006744,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210621.0,,CN,US,US,2021,Q2,Young Adult
194233912,19423391,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Incorrect dose administered,,2021,Q2,2,F,202105.0,20210615.0,20210616,20210621,EXP,,US-ELI_LILLY_AND_COMPANY-US202106006744,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210621.0,,CN,US,US,2021,Q2,Young Adult
194233912,19423391,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Death,,2021,Q2,2,F,202105.0,20210615.0,20210616,20210621,EXP,,US-ELI_LILLY_AND_COMPANY-US202106006744,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210621.0,,CN,US,US,2021,Q2,Young Adult
194233912,19423391,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q2,Incorrect dose administered,,2021,Q2,2,F,202105.0,20210615.0,20210616,20210621,EXP,,US-ELI_LILLY_AND_COMPANY-US202106006744,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210621.0,,CN,US,US,2021,Q2,Young Adult
194302531,19430253,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood glucose abnormal,,2021,Q2,1,I,,20210608.0,20210617,20210617,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Elderly
194302531,19430253,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Dementia,,2021,Q2,1,I,,20210608.0,20210617,20210617,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Elderly
194302531,19430253,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Injection site pain,,2021,Q2,1,I,,20210608.0,20210617,20210617,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Elderly
194302531,19430253,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Mobility decreased,,2021,Q2,1,I,,20210608.0,20210617,20210617,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Elderly
194302531,19430253,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Wrong technique in product usage process,,2021,Q2,1,I,,20210608.0,20210617,20210617,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20210617.0,,CN,US,US,2021,Q2,Elderly
194307841,19430784,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8+8+8 IU,,,U,U,,,,,,,,2021,Q2,Coronary artery disease,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8+8+8 IU,,,U,U,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8+8+8 IU,,,U,U,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8+8+8 IU,,,U,U,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8+8+8 IU,,,U,U,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10+10+0 CORRECTION 1UI: 30MG/DL + CHO COUNTING ORIENTATION,,,U,U,,,,,,,,2021,Q2,Coronary artery disease,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10+10+0 CORRECTION 1UI: 30MG/DL + CHO COUNTING ORIENTATION,,,U,U,,,,,,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10+10+0 CORRECTION 1UI: 30MG/DL + CHO COUNTING ORIENTATION,,,U,U,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10+10+0 CORRECTION 1UI: 30MG/DL + CHO COUNTING ORIENTATION,,,U,U,,,,,,,,2021,Q2,Inappropriate schedule of product administration,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194307841,19430784,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10+10+0 CORRECTION 1UI: 30MG/DL + CHO COUNTING ORIENTATION,,,U,U,,,,,,,,2021,Q2,Weight increased,,2021,Q2,1,I,202005.0,20201009.0,20210617,20210617,EXP,,BR-NOVOPROD-819005,NOVO NORDISK,,40.0,YR,,M,Y,85.0,KG,20210617.0,,MD,BR,BR,2021,Q2,Adult
194308201,19430820,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Femur fracture,,2021,Q2,1,I,,20210611.0,20210617,20210617,EXP,,"US-JACOBUS PHARMACEUTICAL COMPANY, INC.-2112837",JACOBUS PHARM,,78.0,YR,,M,Y,,,20210617.0,,,US,US,2021,Q2,Elderly
194308201,19430820,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Fracture treatment,,2021,Q2,1,I,,20210611.0,20210617,20210617,EXP,,"US-JACOBUS PHARMACEUTICAL COMPANY, INC.-2112837",JACOBUS PHARM,,78.0,YR,,M,Y,,,20210617.0,,,US,US,2021,Q2,Elderly
194308201,19430820,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,1,I,,20210611.0,20210617,20210617,EXP,,"US-JACOBUS PHARMACEUTICAL COMPANY, INC.-2112837",JACOBUS PHARM,,78.0,YR,,M,Y,,,20210617.0,,,US,US,2021,Q2,Elderly
194334061,19433406,8,C,Lispro Insulin,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Acute kidney injury,,2021,Q2,1,I,,20210608.0,20210618,20210618,EXP,,CA-AUROBINDO-AUR-APL-2021-024891,AUROBINDO,,73.0,YR,,M,Y,86.0,KG,20210618.0,,PH,CA,CA,2021,Q2,Elderly
194355581,19435558,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D355431A,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210519.0,20210519.0,20210618,20210618,PER,,US-ELI_LILLY_AND_COMPANY-US202105010155,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210618.0,,CN,US,US,2021,Q2,Elderly
194399121,19439912,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137576E,,20563.0,,,INJECTION,,2021,Q2,Blood glucose decreased,,2021,Q2,1,I,20201221.0,20210617.0,20210620,20210620,PER,,US-ELI_LILLY_AND_COMPANY-US202106009182,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210620.0,,CN,US,US,2021,Q2,Elderly
194399121,19439912,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D137576E,,20563.0,,,INJECTION,,2021,Q2,Product prescribing error,,2021,Q2,1,I,20201221.0,20210617.0,20210620,20210620,PER,,US-ELI_LILLY_AND_COMPANY-US202106009182,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210620.0,,CN,US,US,2021,Q2,Elderly
194436321,19443632,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Atrial flutter,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Bradycardia,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Bundle branch block left,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Bundle branch block right,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Cardiac arrest,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Hypoxia,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436321,19443632,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pulseless electrical activity,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,53.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Adult
194436391,19443639,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Atrioventricular block second degree,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Elderly
194436391,19443639,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Electrocardiogram QRS complex prolonged,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Elderly
194436391,19443639,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Heart rate irregular,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Elderly
194436391,19443639,9,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Sinus bradycardia,,2021,Q2,1,I,,,20210621,20210621,DIR,,,FDA-CTU,,67.0,YR,,M,N,,,,N,MD,US,US,2021,Q2,Elderly
194445671,19444567,18,C,LISPRO,INSULIN LISPRO,1,Unknown,100 PEN BEFORE MEALS SLIDING SCALE (1 IN 3 D),,,,,,,,,,,,2021,Q2,Chills,,2021,Q2,1,I,202101.0,20210610.0,20210621,20210621,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301356,RANBAXY,,64.0,YR,A,M,Y,83.9,KG,20210622.0,,MD,US,US,2021,Q2,Adult
194445671,19444567,18,C,LISPRO,INSULIN LISPRO,1,Unknown,100 PEN BEFORE MEALS SLIDING SCALE (1 IN 3 D),,,,,,,,,,,,2021,Q2,Clostridium difficile infection,,2021,Q2,1,I,202101.0,20210610.0,20210621,20210621,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301356,RANBAXY,,64.0,YR,A,M,Y,83.9,KG,20210622.0,,MD,US,US,2021,Q2,Adult
194445671,19444567,18,C,LISPRO,INSULIN LISPRO,1,Unknown,100 PEN BEFORE MEALS SLIDING SCALE (1 IN 3 D),,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,202101.0,20210610.0,20210621,20210621,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301356,RANBAXY,,64.0,YR,A,M,Y,83.9,KG,20210622.0,,MD,US,US,2021,Q2,Adult
194445671,19444567,18,C,LISPRO,INSULIN LISPRO,1,Unknown,100 PEN BEFORE MEALS SLIDING SCALE (1 IN 3 D),,,,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,202101.0,20210610.0,20210621,20210621,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301356,RANBAXY,,64.0,YR,A,M,Y,83.9,KG,20210622.0,,MD,US,US,2021,Q2,Adult
194445671,19444567,18,C,LISPRO,INSULIN LISPRO,1,Unknown,100 PEN BEFORE MEALS SLIDING SCALE (1 IN 3 D),,,,,,,,,,,,2021,Q2,Immunodeficiency,,2021,Q2,1,I,202101.0,20210610.0,20210621,20210621,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301356,RANBAXY,,64.0,YR,A,M,Y,83.9,KG,20210622.0,,MD,US,US,2021,Q2,Adult
194445671,19444567,18,C,LISPRO,INSULIN LISPRO,1,Unknown,100 PEN BEFORE MEALS SLIDING SCALE (1 IN 3 D),,,,,,,,,,,,2021,Q2,Klebsiella infection,,2021,Q2,1,I,202101.0,20210610.0,20210621,20210621,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301356,RANBAXY,,64.0,YR,A,M,Y,83.9,KG,20210622.0,,MD,US,US,2021,Q2,Adult
194445671,19444567,18,C,LISPRO,INSULIN LISPRO,1,Unknown,100 PEN BEFORE MEALS SLIDING SCALE (1 IN 3 D),,,,,,,,,,,,2021,Q2,Nephrolithiasis,,2021,Q2,1,I,202101.0,20210610.0,20210621,20210621,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301356,RANBAXY,,64.0,YR,A,M,Y,83.9,KG,20210622.0,,MD,US,US,2021,Q2,Adult
194445671,19444567,18,C,LISPRO,INSULIN LISPRO,1,Unknown,100 PEN BEFORE MEALS SLIDING SCALE (1 IN 3 D),,,,,,,,,,,,2021,Q2,Renal disorder,,2021,Q2,1,I,202101.0,20210610.0,20210621,20210621,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-301356,RANBAXY,,64.0,YR,A,M,Y,83.9,KG,20210622.0,,MD,US,US,2021,Q2,Adult
194502951,19450295,13,C,LYUMJEV [INSULIN LISPRO],,2,Unknown,UNK,,,,,,,,,,,,2021,Q2,Drug ineffective,,2021,Q2,1,I,,20191224.0,20210622,20210622,PER,,US-AMGEN-USA-20191209414,AMGEN,,62.0,YR,A,M,Y,,,20210622.0,,CN,US,US,2021,Q2,Adult
194502951,19450295,13,C,LYUMJEV [INSULIN LISPRO],,2,Unknown,UNK,,,,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20191224.0,20210622,20210622,PER,,US-AMGEN-USA-20191209414,AMGEN,,62.0,YR,A,M,Y,,,20210622.0,,CN,US,US,2021,Q2,Adult
194502951,19450295,13,C,LYUMJEV [INSULIN LISPRO],,2,Unknown,UNK,,,,,,,,,,,,2021,Q2,Pain,,2021,Q2,1,I,,20191224.0,20210622,20210622,PER,,US-AMGEN-USA-20191209414,AMGEN,,62.0,YR,A,M,Y,,,20210622.0,,CN,US,US,2021,Q2,Adult
194577991,19457799,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,100/ML,,,,,,,,,,UNKNOWN,,2021,Q2,Platelet count decreased,,2021,Q2,1,I,202106.0,20210617.0,20210624,20210624,PER,,US-CELGENEUS-USA-20210605438,CELGENE,,73.0,YR,,M,Y,68.87,KG,20210624.0,,PH,US,US,2021,Q2,Elderly
194579941,19457994,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 INTERNATIONAL UNIT, QD (90 IU,QD)",,,,,,,,90.0,IU,INJECTION,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 INTERNATIONAL UNIT, QD (90 IU,QD)",,,,,,,,90.0,IU,INJECTION,QD,2021,Q2,Exposure during pregnancy,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 INTERNATIONAL UNIT, QD (90 IU,QD)",,,,,,,,90.0,IU,INJECTION,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 INTERNATIONAL UNIT, QD (90 IU,QD)",,,,,,,,90.0,IU,INJECTION,QD,2021,Q2,Infection,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 INTERNATIONAL UNIT, QD (90 IU,QD)",,,,,,,,90.0,IU,INJECTION,QD,2021,Q2,Intentional product misuse,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 INTERNATIONAL UNIT, QD (90 IU,QD)",,,,,,,,90.0,IU,INJECTION,QD,2021,Q2,Medication error,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 INTERNATIONAL UNIT, QD (90 IU,QD)",,,,,,,,90.0,IU,INJECTION,QD,2021,Q2,Postpartum haemorrhage,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 INTERNATIONAL UNIT, QD (90 IU,QD)",,,,,,,,90.0,IU,INJECTION,QD,2021,Q2,Product use issue,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 INTERNATIONAL UNIT, QD (86 IU,QD)",,,,,,,,86.0,IU,INJECTION,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 INTERNATIONAL UNIT, QD (86 IU,QD)",,,,,,,,86.0,IU,INJECTION,QD,2021,Q2,Exposure during pregnancy,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 INTERNATIONAL UNIT, QD (86 IU,QD)",,,,,,,,86.0,IU,INJECTION,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 INTERNATIONAL UNIT, QD (86 IU,QD)",,,,,,,,86.0,IU,INJECTION,QD,2021,Q2,Infection,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 INTERNATIONAL UNIT, QD (86 IU,QD)",,,,,,,,86.0,IU,INJECTION,QD,2021,Q2,Intentional product misuse,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 INTERNATIONAL UNIT, QD (86 IU,QD)",,,,,,,,86.0,IU,INJECTION,QD,2021,Q2,Medication error,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 INTERNATIONAL UNIT, QD (86 IU,QD)",,,,,,,,86.0,IU,INJECTION,QD,2021,Q2,Postpartum haemorrhage,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"86 INTERNATIONAL UNIT, QD (86 IU,QD)",,,,,,,,86.0,IU,INJECTION,QD,2021,Q2,Product use issue,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 INTERNATIONAL UNIT, QD (72 IU,QD)",,,,,,,,72.0,IU,INJECTION,QD,2021,Q2,Diabetes mellitus inadequate control,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 INTERNATIONAL UNIT, QD (72 IU,QD)",,,,,,,,72.0,IU,INJECTION,QD,2021,Q2,Exposure during pregnancy,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 INTERNATIONAL UNIT, QD (72 IU,QD)",,,,,,,,72.0,IU,INJECTION,QD,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 INTERNATIONAL UNIT, QD (72 IU,QD)",,,,,,,,72.0,IU,INJECTION,QD,2021,Q2,Infection,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 INTERNATIONAL UNIT, QD (72 IU,QD)",,,,,,,,72.0,IU,INJECTION,QD,2021,Q2,Intentional product misuse,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 INTERNATIONAL UNIT, QD (72 IU,QD)",,,,,,,,72.0,IU,INJECTION,QD,2021,Q2,Medication error,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 INTERNATIONAL UNIT, QD (72 IU,QD)",,,,,,,,72.0,IU,INJECTION,QD,2021,Q2,Postpartum haemorrhage,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194579941,19457994,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"72 INTERNATIONAL UNIT, QD (72 IU,QD)",,,,,,,,72.0,IU,INJECTION,QD,2021,Q2,Product use issue,,2021,Q2,1,I,20170420.0,20210621.0,20210624,20210624,EXP,,IE-MYLANLABS-2021M1037067,MYLAN,,35.0,YR,,F,Y,91.0,KG,20210624.0,,CN,DK,IE,2021,Q2,Adult
194601751,19460175,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 UNITS FOR EVERY 50 MG/DL GLUCOSE ABOVE 200 MG/DL ON THE FIRST AND SECOND DAY FOLLOWING CHEMOTHERAP,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,3.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210618.0,20210625,20210625,EXP,,US-DRREDDYS-SPO/USA/21/0136728,DR REDDYS,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM J CASE REP. 2021?22(1):UNKNOWN?UNKNOWN. DOI:10.12659/AJCR.930733",70.0,YR,E,F,Y,,,20210625.0,,MD,US,US,2021,Q2,Elderly
194601751,19460175,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,5.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210618.0,20210625,20210625,EXP,,US-DRREDDYS-SPO/USA/21/0136728,DR REDDYS,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM J CASE REP. 2021?22(1):UNKNOWN?UNKNOWN. DOI:10.12659/AJCR.930733",70.0,YR,E,F,Y,,,20210625.0,,MD,US,US,2021,Q2,Elderly
194601751,19460175,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,15.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210618.0,20210625,20210625,EXP,,US-DRREDDYS-SPO/USA/21/0136728,DR REDDYS,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM J CASE REP. 2021?22(1):UNKNOWN?UNKNOWN. DOI:10.12659/AJCR.930733",70.0,YR,E,F,Y,,,20210625.0,,MD,US,US,2021,Q2,Elderly
194601751,19460175,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,IU,,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210618.0,20210625,20210625,EXP,,US-DRREDDYS-SPO/USA/21/0136728,DR REDDYS,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM J CASE REP. 2021?22(1):UNKNOWN?UNKNOWN. DOI:10.12659/AJCR.930733",70.0,YR,E,F,Y,,,20210625.0,,MD,US,US,2021,Q2,Elderly
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Extradural haematoma,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Fall,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Lower limb fracture,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Pneumothorax,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Rib fracture,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Skull fracture,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Spinal fracture,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Subarachnoid haematoma,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194603031,19460303,7,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q2,Weight decreased,,2021,Q2,1,I,20210411.0,20210520.0,20210625,20210625,EXP,,SE-NOVOPROD-816577,NOVO NORDISK,,59.0,YR,,M,Y,,,20210625.0,,MD,SE,SE,2021,Q2,Adult
194618591,19461859,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"3 U, PRN",,,,, D214632C,,20563.0,3.0,IU,INJECTION,,2021,Q2,Accidental underdose,,2021,Q2,1,I,20210526.0,20210527.0,20210625,20210625,PER,,US-ELI_LILLY_AND_COMPANY-US202105013315,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210623.0,,CN,US,US,2021,Q2,Elderly
194618591,19461859,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"3 U, PRN",,,,, D214632C,,20563.0,3.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210526.0,20210527.0,20210625,20210625,PER,,US-ELI_LILLY_AND_COMPANY-US202105013315,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210623.0,,CN,US,US,2021,Q2,Elderly
194618591,19461859,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"3 U, PRN",,,,, D214632C,,20563.0,3.0,IU,INJECTION,,2021,Q2,Product dose omission issue,,2021,Q2,1,I,20210526.0,20210527.0,20210625,20210625,PER,,US-ELI_LILLY_AND_COMPANY-US202105013315,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210623.0,,CN,US,US,2021,Q2,Elderly
194660791,19466079,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,20563.0,9.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210620.0,20210622.0,20210627,20210627,PER,,US-ELI_LILLY_AND_COMPANY-US202106012990,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20210627.0,,CN,US,US,2021,Q2,Adult
194660791,19466079,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,20563.0,9.0,IU,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,20210620.0,20210622.0,20210627,20210627,PER,,US-ELI_LILLY_AND_COMPANY-US202106012990,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20210627.0,,CN,US,US,2021,Q2,Adult
194660791,19466079,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,20563.0,9.0,IU,INJECTION,,2021,Q2,Renal disorder,,2021,Q2,1,I,20210620.0,20210622.0,20210627,20210627,PER,,US-ELI_LILLY_AND_COMPANY-US202106012990,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20210627.0,,CN,US,US,2021,Q2,Adult
194671431,19467143,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"25 U, UNKNOWN(20?25 UNITS)",,,U,,,,20563.0,25.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202106.0,20210625.0,20210628,20210628,PER,,US-ELI_LILLY_AND_COMPANY-US202106013281,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Elderly
194671431,19467143,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"25 U, UNKNOWN(20?25 UNITS)",,,U,,,,20563.0,25.0,IU,INJECTION,,2021,Q2,Injury associated with device,,2021,Q2,1,I,202106.0,20210625.0,20210628,20210628,PER,,US-ELI_LILLY_AND_COMPANY-US202106013281,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Elderly
194671431,19467143,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"25 U, UNKNOWN(20?25 UNITS)",,,U,,,,20563.0,25.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202106.0,20210625.0,20210628,20210628,PER,,US-ELI_LILLY_AND_COMPANY-US202106013281,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Elderly
194671431,19467143,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"25 U, UNKNOWN(20?25 UNITS)",,,U,,,,20563.0,25.0,IU,INJECTION,,2021,Q2,Injury associated with device,,2021,Q2,1,I,202106.0,20210625.0,20210628,20210628,PER,,US-ELI_LILLY_AND_COMPANY-US202106013281,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Elderly
194671431,19467143,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"25 U, UNKNOWN(20?25 UNITS)",,,U,, D261904A,,20563.0,25.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202106.0,20210625.0,20210628,20210628,PER,,US-ELI_LILLY_AND_COMPANY-US202106013281,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Elderly
194671431,19467143,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"25 U, UNKNOWN(20?25 UNITS)",,,U,, D261904A,,20563.0,25.0,IU,INJECTION,,2021,Q2,Injury associated with device,,2021,Q2,1,I,202106.0,20210625.0,20210628,20210628,PER,,US-ELI_LILLY_AND_COMPANY-US202106013281,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Elderly
194671431,19467143,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"25 U, UNKNOWN(20?25 UNITS)",,,U,, D261904A,,20563.0,25.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,202106.0,20210625.0,20210628,20210628,PER,,US-ELI_LILLY_AND_COMPANY-US202106013281,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Elderly
194671431,19467143,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"25 U, UNKNOWN(20?25 UNITS)",,,U,, D261904A,,20563.0,25.0,IU,INJECTION,,2021,Q2,Injury associated with device,,2021,Q2,1,I,202106.0,20210625.0,20210628,20210628,PER,,US-ELI_LILLY_AND_COMPANY-US202106013281,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Elderly
194682401,19468240,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 UNITS FOR EVERY 50 MG/DL GLUCOSE ABOVE 200 MG/DL ON THE FIRST AND SECOND DAY FOLLOWING CHEMOTHERAP,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,3.0,IU,UNKNOWN,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210618.0,20210628,20210628,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-54720,HIKMA,"ZHANG F, KARAM JG. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AMERICAN JOURNAL OF CASE REPORTS. 2021?22(1):ARTICLE NUMBER E930733. DOI: 10.12659/AJCR.930733.",70.0,YR,,F,Y,,,20210628.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
194682401,19468240,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,5.0,IU,UNKNOWN,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210618.0,20210628,20210628,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-54720,HIKMA,"ZHANG F, KARAM JG. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AMERICAN JOURNAL OF CASE REPORTS. 2021?22(1):ARTICLE NUMBER E930733. DOI: 10.12659/AJCR.930733.",70.0,YR,,F,Y,,,20210628.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
194682401,19468240,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,15.0,IU,UNKNOWN,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210618.0,20210628,20210628,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-54720,HIKMA,"ZHANG F, KARAM JG. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AMERICAN JOURNAL OF CASE REPORTS. 2021?22(1):ARTICLE NUMBER E930733. DOI: 10.12659/AJCR.930733.",70.0,YR,,F,Y,,,20210628.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
194682401,19468240,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,IU,UNKNOWN,,2021,Q2,Hyperglycaemia,,2021,Q2,1,I,,20210618.0,20210628,20210628,EXP,,US-HIKMA PHARMACEUTICALS USA INC.-US-H14001-21-54720,HIKMA,"ZHANG F, KARAM JG. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AMERICAN JOURNAL OF CASE REPORTS. 2021?22(1):ARTICLE NUMBER E930733. DOI: 10.12659/AJCR.930733.",70.0,YR,,F,Y,,,20210628.0,,,COUNTRY NOT SPECIFIED,US,2021,Q2,Elderly
194693441,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194693441,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194693441,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194693441,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2021,Q2,Medication error,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194693441,19469344,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,,,,,,,,2021,Q2,Night sweats,,2021,Q2,1,I,,20210622.0,20210629,20210629,PER,DE-ADRED-06496-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00833,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20210629.0,,MD,DE,DE,2021,Q2,Elderly
194710271,19471027,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210608.0,20210614.0,20210628,20210628,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Young Adult
194710271,19471027,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q2,Diabetic ketoacidosis,,2021,Q2,1,I,20210608.0,20210614.0,20210628,20210628,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Young Adult
194710271,19471027,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q2,Wrong technique in product usage process,,2021,Q2,1,I,20210608.0,20210614.0,20210628,20210628,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210628.0,,CN,US,US,2021,Q2,Young Adult
194726991,19472699,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Asthenia,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194726991,19472699,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Confusional state,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194726991,19472699,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Decreased appetite,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194726991,19472699,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194726991,19472699,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q2,Nausea,,2021,Q2,1,I,202106.0,20210609.0,20210629,20210629,EXP,,US-EISAI MEDICAL RESEARCH-EC-2021-094247,EISAI,,77.0,YR,E,M,Y,86.0,KG,20210629.0,,CN,US,US,2021,Q2,Elderly
194733711,19473371,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Blood pressure decreased,,2021,Q2,1,I,202102.0,20210621.0,20210629,20210629,EXP,,CN-SA-2021SA208585,SANOFI AVENTIS,,54.0,YR,A,M,Y,47.0,KG,20210629.0,,CN,CN,CN,2021,Q2,Adult
194733711,19473371,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Diabetic ulcer,,2021,Q2,1,I,202102.0,20210621.0,20210629,20210629,EXP,,CN-SA-2021SA208585,SANOFI AVENTIS,,54.0,YR,A,M,Y,47.0,KG,20210629.0,,CN,CN,CN,2021,Q2,Adult
194733711,19473371,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Essential hypertension,,2021,Q2,1,I,202102.0,20210621.0,20210629,20210629,EXP,,CN-SA-2021SA208585,SANOFI AVENTIS,,54.0,YR,A,M,Y,47.0,KG,20210629.0,,CN,CN,CN,2021,Q2,Adult
194735601,19473560,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Altered state of consciousness,,2021,Q2,1,I,,20210624.0,20210629,20210629,EXP,,JP-009507513-2106JPN002242J,MERCK,,72.0,YR,,M,Y,,,20210629.0,,MD,JP,JP,2021,Q2,Elderly
194735601,19473560,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Oedema,,2021,Q2,1,I,,20210624.0,20210629,20210629,EXP,,JP-009507513-2106JPN002242J,MERCK,,72.0,YR,,M,Y,,,20210629.0,,MD,JP,JP,2021,Q2,Elderly
194735601,19473560,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q2,Oliguria,,2021,Q2,1,I,,20210624.0,20210629,20210629,EXP,,JP-009507513-2106JPN002242J,MERCK,,72.0,YR,,M,Y,,,20210629.0,,MD,JP,JP,2021,Q2,Elderly
194738801,19473880,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D142268A,,,,,INJECTION,,2021,Q2,Blood glucose increased,,2021,Q2,1,I,20210626.0,20210628.0,20210629,20210629,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210629.0,,HP,US,US,2021,Q2,Elderly
194738801,19473880,1,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D142268A,,,,,INJECTION,,2021,Q2,Drug ineffective,,2021,Q2,1,I,20210626.0,20210628.0,20210629,20210629,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20210629.0,,HP,US,US,2021,Q2,Elderly
194746321,19474632,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NEED, SOLUTION FOR INJECTION / INFUSION)",,,U,U,,,,,,,,2021,Q2,Depressed level of consciousness,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-AUROBINDO-AUR-APL-2021-027227,AUROBINDO,,82.0,YR,,F,Y,89.0,KG,20210630.0,,PH,DE,DE,2021,Q2,Elderly
194746321,19474632,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NEED, SOLUTION FOR INJECTION / INFUSION)",,,U,U,,,,,,,,2021,Q2,Hypoglycaemia,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-AUROBINDO-AUR-APL-2021-027227,AUROBINDO,,82.0,YR,,F,Y,89.0,KG,20210630.0,,PH,DE,DE,2021,Q2,Elderly
194746321,19474632,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NEED, SOLUTION FOR INJECTION / INFUSION)",,,U,U,,,,,,,,2021,Q2,Medication error,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-AUROBINDO-AUR-APL-2021-027227,AUROBINDO,,82.0,YR,,F,Y,89.0,KG,20210630.0,,PH,DE,DE,2021,Q2,Elderly
194746321,19474632,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NEED, SOLUTION FOR INJECTION / INFUSION)",,,U,U,,,,,,,,2021,Q2,Product administration error,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-AUROBINDO-AUR-APL-2021-027227,AUROBINDO,,82.0,YR,,F,Y,89.0,KG,20210630.0,,PH,DE,DE,2021,Q2,Elderly
194746321,19474632,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK (NEED, SOLUTION FOR INJECTION / INFUSION)",,,U,U,,,,,,,,2021,Q2,Product prescribing error,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-AUROBINDO-AUR-APL-2021-027227,AUROBINDO,,82.0,YR,,F,Y,89.0,KG,20210630.0,,PH,DE,DE,2021,Q2,Elderly
194793451,19479345,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Diarrhoea,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194793451,19479345,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Fatigue,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194793451,19479345,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,General physical health deterioration,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194793451,19479345,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Medication error,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
194793451,19479345,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,,,,,,,,,2021,Q2,Night sweats,,2021,Q2,1,I,,20210622.0,20210630,20210630,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011375,ELI LILLY AND CO,,78.0,YR,,M,Y,88.4,KG,20210630.0,,MD,DE,DE,2021,Q2,Elderly
102624243,10262424,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"2 AMPULE, SINGLE",,,D,U,,,,2.0,DF,,,2021,Q3,Completed suicide,,2021,Q3,3,F,,20210908.0,20140626,20210915,EXP,,DE-NAPPMUNDI-GBR-2014-0018915,PURDUE,"DOI:10.1002/DTA.1500 HESS C, MADEA B, DALDRUP T, MUSSHOFF F. DETERMINATION OF HYPOGLYCAEMIA INDUCED BY INSULIN OR ITS SYNTHETIC ANALOGUES POST MORTEM. DRUG TESTING AND ANALYSIS. 2013?V5:P802?7",62.0,YR,,F,Y,,,20210915.0,,,COUNTRY NOT SPECIFIED,DE,2021,Q3,Adult
102624243,10262424,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"2 AMPULE, SINGLE",,,D,U,,,,2.0,DF,,,2021,Q3,Toxicity to various agents,,2021,Q3,3,F,,20210908.0,20140626,20210915,EXP,,DE-NAPPMUNDI-GBR-2014-0018915,PURDUE,"DOI:10.1002/DTA.1500 HESS C, MADEA B, DALDRUP T, MUSSHOFF F. DETERMINATION OF HYPOGLYCAEMIA INDUCED BY INSULIN OR ITS SYNTHETIC ANALOGUES POST MORTEM. DRUG TESTING AND ANALYSIS. 2013?V5:P802?7",62.0,YR,,F,Y,,,20210915.0,,,COUNTRY NOT SPECIFIED,DE,2021,Q3,Adult
143291752,14329175,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Chest pain,,2021,Q3,2,F,20140308.0,20210920.0,20171227,20210922,EXP,IT-MINISAL02-444262,IT-SA-2017SA263130,SANOFI AVENTIS,,22.0,YR,A,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Youth
143291752,14329175,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Vomiting,,2021,Q3,2,F,20140308.0,20210920.0,20171227,20210922,EXP,IT-MINISAL02-444262,IT-SA-2017SA263130,SANOFI AVENTIS,,22.0,YR,A,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Youth
143293202,14329320,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"26 IU,QD",,,U,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20171107.0,20210914.0,20171227,20210922,EXP,IT-MINISAL02-442669,IT-SA-2017SA258455,SANOFI AVENTIS,,26.0,YR,A,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Young Adult
143293202,14329320,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"26 IU,QD",,,U,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Disease risk factor,,2021,Q3,2,F,20171107.0,20210914.0,20171227,20210922,EXP,IT-MINISAL02-442669,IT-SA-2017SA258455,SANOFI AVENTIS,,26.0,YR,A,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Young Adult
143293202,14329320,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"26 IU,QD",,,U,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypertension,,2021,Q3,2,F,20171107.0,20210914.0,20171227,20210922,EXP,IT-MINISAL02-442669,IT-SA-2017SA258455,SANOFI AVENTIS,,26.0,YR,A,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Young Adult
143293202,14329320,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"26 IU,QD",,,U,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20171107.0,20210914.0,20171227,20210922,EXP,IT-MINISAL02-442669,IT-SA-2017SA258455,SANOFI AVENTIS,,26.0,YR,A,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Young Adult
143293202,14329320,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"26 IU,QD",,,U,,,,,26.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Type 1 diabetes mellitus,,2021,Q3,2,F,20171107.0,20210914.0,20171227,20210922,EXP,IT-MINISAL02-442669,IT-SA-2017SA258455,SANOFI AVENTIS,,26.0,YR,A,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Young Adult
143772502,14377250,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"52 IU,QD",13416.0,IU,U,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20170915.0,20210914.0,20180111,20210921,EXP,IT-SA-2018SA006717,IT-SA-2018SA006717,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
143772502,14377250,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"52 IU,QD",13416.0,IU,U,,,,,52.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Psychomotor hyperactivity,,2021,Q3,2,F,20170915.0,20210914.0,20180111,20210921,EXP,IT-SA-2018SA006717,IT-SA-2018SA006717,SANOFI AVENTIS,,80.0,YR,E,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
147941172,14794117,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU,UNK",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Confusional state,,2021,Q3,2,F,20180307.0,20210914.0,20180423,20210920,EXP,IT-MINISAL02-469162,IT-SA-2018SA113411,SANOFI AVENTIS,,53.0,YR,A,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Adult
147941172,14794117,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU,UNK",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperhidrosis,,2021,Q3,2,F,20180307.0,20210914.0,20180423,20210920,EXP,IT-MINISAL02-469162,IT-SA-2018SA113411,SANOFI AVENTIS,,53.0,YR,A,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Adult
147941172,14794117,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU,UNK",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20180307.0,20210914.0,20180423,20210920,EXP,IT-MINISAL02-469162,IT-SA-2018SA113411,SANOFI AVENTIS,,53.0,YR,A,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Adult
147941172,14794117,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU,UNK",,,Y,,,,,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Tremor,,2021,Q3,2,F,20180307.0,20210914.0,20180423,20210920,EXP,IT-MINISAL02-469162,IT-SA-2018SA113411,SANOFI AVENTIS,,53.0,YR,A,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Adult
1518534910,15185349,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,,,,,,24.0,IU,,QD,2021,Q3,Haematoma,,2021,Q3,10,F,20180220.0,20210901.0,20180723,20210910,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210910.0,,MD,IT,IT,2021,Q3,Elderly
1518534910,15185349,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,,,,,,24.0,IU,,QD,2021,Q3,Inhibiting antibodies,,2021,Q3,10,F,20180220.0,20210901.0,20180723,20210910,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210910.0,,MD,IT,IT,2021,Q3,Elderly
1518534910,15185349,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,,,,,,24.0,IU,,QD,2021,Q3,Intestinal obstruction,,2021,Q3,10,F,20180220.0,20210901.0,20180723,20210910,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210910.0,,MD,IT,IT,2021,Q3,Elderly
1518534910,15185349,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,,,,,,24.0,IU,,QD,2021,Q3,Therapy non-responder,,2021,Q3,10,F,20180220.0,20210901.0,20180723,20210910,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210910.0,,MD,IT,IT,2021,Q3,Elderly
1518534910,15185349,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 INTERNATIONAL UNIT, QD",,,,,,,,24.0,IU,,QD,2021,Q3,Underdose,,2021,Q3,10,F,20180220.0,20210901.0,20180723,20210910,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,54.0,KG,20210910.0,,MD,IT,IT,2021,Q3,Elderly
152861303,15286130,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",3240.0,IU,U,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Confusional state,,2021,Q3,3,F,20180611.0,20210909.0,20180816,20210922,EXP,IT-MINISAL02-492970,IT-ELI_LILLY_AND_COMPANY-IT201808003200,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
152861303,15286130,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"20 INTERNATIONAL UNIT, DAILY",3240.0,IU,U,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,20180611.0,20210909.0,20180816,20210922,EXP,IT-MINISAL02-492970,IT-ELI_LILLY_AND_COMPANY-IT201808003200,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
154194644,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depressed level of consciousness,,2021,Q3,4,F,20180203.0,20210914.0,20180924,20210922,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
154194644,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Dizziness,,2021,Q3,4,F,20180203.0,20210914.0,20180924,20210922,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
154194644,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,4,F,20180203.0,20210914.0,20180924,20210922,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
154194644,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Malaise,,2021,Q3,4,F,20180203.0,20210914.0,20180924,20210922,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
154194644,15419464,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 IU, QD",,,,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Neurological symptom,,2021,Q3,4,F,20180203.0,20210914.0,20180924,20210922,EXP,IT-MINISAL02-497583,IT-SA-2018SA257799,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
1543145622,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q3,Foetal disorder,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q3,Foetal exposure during pregnancy,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q3,Low birth weight baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q3,Neutropenia neonatal,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,57,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"7 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,7.0,UG/M**2,,QD,2021,Q3,Premature baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Foetal disorder,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Foetal exposure during pregnancy,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Low birth weight baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Neutropenia neonatal,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Premature baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,59,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Foetal disorder,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,59,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Foetal exposure during pregnancy,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,59,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Low birth weight baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,59,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Neutropenia neonatal,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
1543145622,15431456,59,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 MICROGRAM/SQ. METER, QD",4263.0,UG/M2,D,,,,,21.0,UG/M**2,,QD,2021,Q3,Premature baby,,2021,Q3,22,F,20170914.0,20210807.0,20180926,20210812,EXP,FR-AFSSAPS-PC20180352,FR-MYLANLABS-2018M1070214,MYLAN,,1.0,DY,,M,Y,1.89,KG,20210812.0,,CN,FR,FR,2021,Q3,Child
156578454,15657845,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 IU, QD",5406.0,IU,Y,,,,,17.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Fall,,2021,Q3,4,F,20171114.0,20210914.0,20181126,20210920,EXP,IT-MINISAL02-477128,IT-SAKK-2018SA169229AA,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
156578454,15657845,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 IU, QD",5406.0,IU,Y,,,,,17.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,4,F,20171114.0,20210914.0,20181126,20210920,EXP,IT-MINISAL02-477128,IT-SAKK-2018SA169229AA,SANOFI AVENTIS,,87.0,YR,E,F,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Acute kidney injury,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Addison's disease,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Adrenal insufficiency,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Adrenomegaly,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Blood pressure increased,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Chest pain,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Colitis,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Device related infection,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Dyspnoea,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Heparin-induced thrombocytopenia,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Hypertensive crisis,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Klebsiella infection,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Malignant neoplasm progression,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Meningitis,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Metastases to meninges,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Pulmonary oedema,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Retinal detachment,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Retinopathy,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Tachycardia,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
156620018,15662001,24,C,INSULINE LISPRO,,2,Subcutaneous,300 DF,,,D,,,,,300.0,DF,INJECTION,,2021,Q3,Urosepsis,,2021,Q3,8,F,20180419.0,20210705.0,20181127,20210707,EXP,,PHHY2018DE166582,NOVARTIS,,71.0,YR,,M,Y,,,20210707.0,,PH,DE,DE,2021,Q3,Elderly
159407515,15940751,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,End stage renal disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Nephrogenic anaemia,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Nephropathy,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Renal failure,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159407515,15940751,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Renal injury,,2021,Q3,5,F,2012.0,20210714.0,20190208,20210726,EXP,,US-ASTRAZENECA-2018SF34722,ASTRAZENECA,,51.0,YR,,M,Y,71.2,KG,20210726.0,,,US,US,2021,Q3,Adult
159484252,15948425,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, QD",360.0,IU,Y,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Depressed level of consciousness,,2021,Q3,2,F,20180115.0,20210914.0,20190212,20210920,EXP,IT-MINISAL02-526902,IT-SA-2019SA034960,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
159484252,15948425,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, QD",360.0,IU,Y,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperhidrosis,,2021,Q3,2,F,20180115.0,20210914.0,20190212,20210920,EXP,IT-MINISAL02-526902,IT-SA-2019SA034960,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
159484252,15948425,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, QD",360.0,IU,Y,,,,,24.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20180115.0,20210914.0,20190212,20210920,EXP,IT-MINISAL02-526902,IT-SA-2019SA034960,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
160212692,16021269,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q3,Injury associated with device,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q3,Visual impairment,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q3,Injury associated with device,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q3,Visual impairment,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,,,,INJECTION,,2021,Q3,Injury associated with device,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,,,,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,,,,INJECTION,,2021,Q3,Visual impairment,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,,,,INJECTION,,2021,Q3,Injury associated with device,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,,,,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160212692,16021269,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D261904A,,,,,INJECTION,,2021,Q3,Visual impairment,,2021,Q3,2,F,20190215.0,20210813.0,20190301,20210818,PER,,US-ELI_LILLY_AND_COMPANY-US201902007422,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210818.0,,CN,US,US,2021,Q3,Elderly
160564474,16056447,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q3,Pyrexia,,2021,Q3,4,F,20190301.0,20210716.0,20190311,20210721,EXP,,US-ROCHE-2276777,ROCHE,,80.0,YR,,F,Y,56.2,KG,20210721.0,,MD,US,US,2021,Q3,Elderly
165699152,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Chest pain,,2021,Q3,2,F,20180616.0,20210914.0,20190715,20210920,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
165699152,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Cold sweat,,2021,Q3,2,F,20180616.0,20210914.0,20190715,20210920,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
165699152,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20180616.0,20210914.0,20190715,20210920,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
165699152,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Malaise,,2021,Q3,2,F,20180616.0,20210914.0,20190715,20210920,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
165699152,16569915,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, QD",,,Y,,,,,16.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Product administration error,,2021,Q3,2,F,20180616.0,20210914.0,20190715,20210920,EXP,IT-MINISAL02-560546,IT-SA-2019SA183789,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
168225665,16822566,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (100 UNIT/ML; DIRECTED PER SLIDING SCALE, 4?0?10)",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Depression,,2021,Q3,5,F,,20210829.0,20190918,20210902,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20210902.0,,HP,US,US,2021,Q3,Adult
168225665,16822566,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK (100 UNIT/ML; DIRECTED PER SLIDING SCALE, 4?0?10)",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Off label use,,2021,Q3,5,F,,20210829.0,20190918,20210902,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20210902.0,,HP,US,US,2021,Q3,Adult
168225665,16822566,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, DAILY, (USE CARB RATIO 1:10 BREAKFAST 1:7 LUNCH AND DINNER PLUS SLIDING SCALE OF 1:50}150)",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Depression,,2021,Q3,5,F,,20210829.0,20190918,20210902,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20210902.0,,HP,US,US,2021,Q3,Adult
168225665,16822566,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, DAILY, (USE CARB RATIO 1:10 BREAKFAST 1:7 LUNCH AND DINNER PLUS SLIDING SCALE OF 1:50}150)",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Off label use,,2021,Q3,5,F,,20210829.0,20190918,20210902,PER,,US-PFIZER INC-2015330930,PFIZER,,45.0,YR,,F,Y,61.22,KG,20210902.0,,HP,US,US,2021,Q3,Adult
168744013,16874401,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 DOSAGE FORM, UNKNOWN",,,,,,,20563.0,3.0,DF,,,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,20190715.0,20210909.0,20191001,20210923,EXP,IT-MINISAL02-575175,IT-ELI_LILLY_AND_COMPANY-IT201909009354,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20210923.0,,MD,IT,IT,2021,Q3,Adult
168744013,16874401,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"3 DOSAGE FORM, UNKNOWN",,,,,,,20563.0,3.0,DF,,,2021,Q3,Sopor,,2021,Q3,3,F,20190715.0,20210909.0,20191001,20210923,EXP,IT-MINISAL02-575175,IT-ELI_LILLY_AND_COMPANY-IT201909009354,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20210923.0,,MD,IT,IT,2021,Q3,Adult
168994442,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,,,,20563.0,30.0,IU,,QD,2021,Q3,Bradycardia,,2021,Q3,2,F,20190806.0,20210909.0,20191009,20210922,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
168994442,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,,,,20563.0,30.0,IU,,QD,2021,Q3,Chest pain,,2021,Q3,2,F,20190806.0,20210909.0,20191009,20210922,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
168994442,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,,,,20563.0,30.0,IU,,QD,2021,Q3,Drug interaction,,2021,Q3,2,F,20190806.0,20210909.0,20191009,20210922,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
168994442,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,,,,20563.0,30.0,IU,,QD,2021,Q3,Hyperhidrosis,,2021,Q3,2,F,20190806.0,20210909.0,20191009,20210922,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
168994442,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,,,,20563.0,30.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20190806.0,20210909.0,20191009,20210922,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
168994442,16899444,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Subcutaneous,"30 INTERNATIONAL UNIT, DAILY",,,Y,,,,20563.0,30.0,IU,,QD,2021,Q3,Hypotension,,2021,Q3,2,F,20190806.0,20210909.0,20191009,20210922,EXP,IT-MINISAL02-576602,IT-ELI_LILLY_AND_COMPANY-IT201909014080,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Adult
169324976,16932497,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Leukopenia,,2021,Q3,6,F,20190723.0,20210701.0,20191017,20210706,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20210706.0,,MD,PL,PL,2021,Q3,Adult
169324976,16932497,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Neutropenia,,2021,Q3,6,F,20190723.0,20210701.0,20191017,20210706,EXP,,PHHO2019PL007720,NOVARTIS,,63.0,YR,,M,Y,104.0,KG,20210706.0,,MD,PL,PL,2021,Q3,Adult
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Abdominal pain upper,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Blood urine present,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Chronic kidney disease,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Confusional state,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Feeling abnormal,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Hepatic enzyme decreased,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Nephropathy,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Pancreatitis acute,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Weight decreased,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
170611653,17061165,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Q8H",,,U,,,,,,,,Q8H,2021,Q3,Wrong technique in product usage process,,2021,Q3,3,F,20210410.0,20210917.0,20191121,20210924,PER,,US-SA-2019SA323063,SANOFI AVENTIS,,66.0,YR,E,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
171829483,17182948,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50?60 U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Vitamin B1 decreased,,2021,Q3,3,F,20191016.0,20200114.0,20191220,20210714,EXP,,US-CELGENEUS-USA-20191205924,CELGENE,,78.0,YR,,M,Y,90.0,KG,20210714.0,,MD,US,US,2021,Q3,Elderly
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cholelithiasis,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Food intolerance,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Malaise,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Photophobia,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pituitary enlargement,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Vision blurred,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
172933826,17293382,14,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,6,F,,20210730.0,20200121,20210805,EXP,,CO-EMD SERONO-9140479,EMD SERONO INC,,49.0,YR,A,M,Y,104.0,KG,20210805.0,,CN,CO,CO,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Aphonia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Blood glucose increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Dizziness,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Drug ineffective,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Frequent bowel movements,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Insomnia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"12 IU?14 IU, BID",,,,,,,20563.0,,,,BID,2021,Q3,Insulin resistance,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Aphonia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Blood glucose decreased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Dizziness,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Drug ineffective,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Frequent bowel movements,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Insomnia,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
177002133,17700213,2,SS,Insulin Lispro,INSULIN LISPRO,1,,DOSE INCREASED,,,,,,,20563.0,,,,,2021,Q3,Insulin resistance,,2021,Q3,3,F,201905.0,20210723.0,20200423,20210805,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202004005297,ELI LILLY AND CO,,39.0,YR,,F,Y,70.0,KG,20210805.0,,CN,ES,ES,2021,Q3,Adult
1793618610,17936186,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q3,Cardiac disorder,,2021,Q3,10,F,,20210819.0,20200624,20210826,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210826.0,,MD,US,US,2021,Q3,Adult
1793618610,17936186,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q3,Colon cancer,,2021,Q3,10,F,,20210819.0,20200624,20210826,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210826.0,,MD,US,US,2021,Q3,Adult
1793618610,17936186,28,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,10?20 UNITS 3X DAILY,,,,,,,,,,,,2021,Q3,Pulmonary oedema,,2021,Q3,10,F,,20210819.0,20200624,20210826,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20210826.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,67,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,8.0,IU,UNKNOWN,,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,69,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,69,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,69,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,70,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,70,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,70,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,71,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,71,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,71,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,72,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,72,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,72,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,73,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,73,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,73,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Cholecystitis acute,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Peripheral ischaemia,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
1799764612,17997646,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 UNITS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,12,F,20200603.0,20210827.0,20200708,20210831,EXP,,US-CELGENEUS-USA-20200700184,CELGENE,,62.0,YR,,M,Y,,,20210831.0,,MD,US,US,2021,Q3,Adult
180401413,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Dialysis,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Disturbance in attention,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Inability to afford medication,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Liver dialysis,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
180401413,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Therapy interrupted,,2021,Q3,3,F,20210813.0,20210817.0,20200717,20210823,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,89.6,KG,20210823.0,,CN,US,US,2021,Q3,Elderly
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Abdominal pain,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Abscess,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Adrenal insufficiency,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Ascites,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Asthenia,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Blood alkaline phosphatase increased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Blood bilirubin increased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Blood potassium decreased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Blood pressure diastolic abnormal,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Blood pressure increased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Bone erosion,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Congestive hepatopathy,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Depression,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Diverticulitis,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Endometrial disorder,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Enterococcus test positive,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Fibrosis,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Gait disturbance,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Gamma-glutamyltransferase increased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Generalised oedema,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Heart rate increased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Herpes zoster,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Hypersensitivity,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Hypotension,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Increased appetite,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Influenza,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Infusion related reaction,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Injection site extravasation,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Intensive care unit acquired weakness,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Intervertebral disc protrusion,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Joint effusion,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Joint swelling,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Micturition disorder,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Myelopathy,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Myopathy,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Nasopharyngitis,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Nausea,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Nerve compression,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Neuropathy peripheral,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Neutropenia,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Osteoarthritis,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Pain,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Pancytopenia,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Peripheral sensorimotor neuropathy,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Peripheral swelling,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Peritonitis,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Pneumonia,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Pseudomonal bacteraemia,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Rheumatoid arthritis,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Septic shock,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Synovitis,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Therapeutic response decreased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Tooth disorder,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Weight decreased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181129192,18112919,31,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,1 EVERY 1 DAYS,,,U,,,,,3.0,DF,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210914.0,20200805,20210925,EXP,CA-MHPD-E2B_03083944,CA-ACCORD-193944,ACCORD,,62.0,YR,,F,Y,67.0,KG,20210925.0,,HP,CA,CA,2021,Q3,Adult
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Asthma,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Blood count abnormal,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Chest discomfort,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Cough,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Diaphragmatic disorder,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Discomfort,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Dyspnoea,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Hypoxia,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Left ventricular hypertrophy,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Obstructive airways disorder,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Oedema peripheral,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Oropharyngeal pain,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Pyrexia,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Weight increased,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Wheezing,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Asthma,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Blood count abnormal,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Chest discomfort,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Diaphragmatic disorder,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Discomfort,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Hypoxia,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Left ventricular hypertrophy,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Obstructive airways disorder,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Oropharyngeal pain,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181369894,18136989,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Wheezing,,2021,Q3,4,F,,20210705.0,20200811,20210713,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,CN,CA,CA,2021,Q3,Elderly
181380614,18138061,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,U,,,,,,,,,2021,Q3,Cough,,2021,Q3,4,F,,20210909.0,20200812,20210918,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20210918.0,,PH,DE,DE,2021,Q3,Elderly
181380614,18138061,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,4,F,,20210909.0,20200812,20210918,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20210918.0,,PH,DE,DE,2021,Q3,Elderly
181380614,18138061,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,4,F,,20210909.0,20200812,20210918,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20210918.0,,PH,DE,DE,2021,Q3,Elderly
181380614,18138061,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, (BY VALUE)",,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,4,F,,20210909.0,20200812,20210918,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20210918.0,,PH,DE,DE,2021,Q3,Elderly
181509642,18150964,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,2,F,,20210617.0,20200814,20210701,EXP,DE-BFARM-20008561,DE-ACCORD-195398,ACCORD,,83.0,YR,E,M,Y,,,20210701.0,,PH,DE,DE,2021,Q3,Elderly
181509642,18150964,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210617.0,20200814,20210701,EXP,DE-BFARM-20008561,DE-ACCORD-195398,ACCORD,,83.0,YR,E,M,Y,,,20210701.0,,PH,DE,DE,2021,Q3,Elderly
181509642,18150964,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210617.0,20200814,20210701,EXP,DE-BFARM-20008561,DE-ACCORD-195398,ACCORD,,83.0,YR,E,M,Y,,,20210701.0,,PH,DE,DE,2021,Q3,Elderly
181509642,18150964,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210617.0,20200814,20210701,EXP,DE-BFARM-20008561,DE-ACCORD-195398,ACCORD,,83.0,YR,E,M,Y,,,20210701.0,,PH,DE,DE,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Asthma,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Blood count abnormal,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Cough,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Diaphragmatic disorder,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Discomfort,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Dyspnoea,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoxia,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Left ventricular hypertrophy,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Obstructive airways disorder,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Oedema peripheral,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Pyrexia,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Weight increased,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, QD",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Wheezing,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Asthma,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Blood count abnormal,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Chest discomfort,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Cough,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Diaphragmatic disorder,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Discomfort,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Dyspnoea,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Hypoxia,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Left ventricular hypertrophy,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Obstructive airways disorder,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Oedema peripheral,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Oropharyngeal pain,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Pyrexia,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Weight increased,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Wheezing,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Asthma,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Blood count abnormal,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Chest discomfort,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Cough,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Diaphragmatic disorder,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Discomfort,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Dyspnoea,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Hypoxia,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Left ventricular hypertrophy,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Obstructive airways disorder,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Oedema peripheral,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Oropharyngeal pain,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Pyrexia,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Weight increased,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181592404,18159240,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,1 DF (1IN 5D),,,U,,,,,1.0,DF,,,2021,Q3,Wheezing,,2021,Q3,4,F,,20210705.0,20200817,20210720,EXP,,CA-SA-2020SA210054,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210720.0,,HP,CA,CA,2021,Q3,Elderly
181794212,18179421,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,2,F,,20210915.0,20200821,20210924,EXP,,DE-TEVA-2020-DE-1816027,TEVA,,83.0,YR,E,M,Y,,,20210924.0,,PH,DE,DE,2021,Q3,Elderly
181794212,18179421,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210915.0,20200821,20210924,EXP,,DE-TEVA-2020-DE-1816027,TEVA,,83.0,YR,E,M,Y,,,20210924.0,,PH,DE,DE,2021,Q3,Elderly
181794212,18179421,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210915.0,20200821,20210924,EXP,,DE-TEVA-2020-DE-1816027,TEVA,,83.0,YR,E,M,Y,,,20210924.0,,PH,DE,DE,2021,Q3,Elderly
181794212,18179421,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210915.0,20200821,20210924,EXP,,DE-TEVA-2020-DE-1816027,TEVA,,83.0,YR,E,M,Y,,,20210924.0,,PH,DE,DE,2021,Q3,Elderly
182004914,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,U,,,,,,,,,2021,Q3,Cough,,2021,Q3,4,F,,20210916.0,20200826,20210921,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20210921.0,,PH,DE,DE,2021,Q3,Elderly
182004914,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,4,F,,20210916.0,20200826,20210921,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20210921.0,,PH,DE,DE,2021,Q3,Elderly
182004914,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,4,F,,20210916.0,20200826,20210921,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20210921.0,,PH,DE,DE,2021,Q3,Elderly
182004914,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,BY VALUE,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,4,F,,20210916.0,20200826,20210921,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20210921.0,,PH,DE,DE,2021,Q3,Elderly
1820848926,18208489,91,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),CO,,,U,,,,,1.0,IU,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,26,F,20200809.0,20210920.0,20200828,20210924,EXP,,FR-BAUSCH-BL-2020-024487,BAUSCH AND LOMB,,75.0,YR,,M,Y,,,20210924.0,,MD,FR,FR,2021,Q3,Elderly
182201712,18220171,13,I,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, BEFORE FOOD",,,U,U,,,,,,,,2021,Q3,Drug interaction,,2021,Q3,2,F,,20210805.0,20200902,20210816,EXP,,DE-AUROBINDO-AUR-APL-2020-045481,AUROBINDO,,87.0,YR,,F,Y,60.0,KG,20210816.0,,MD,DE,DE,2021,Q3,Elderly
182201712,18220171,13,I,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK, BEFORE FOOD",,,U,U,,,,,,,,2021,Q3,Gastrointestinal haemorrhage,,2021,Q3,2,F,,20210805.0,20200902,20210816,EXP,,DE-AUROBINDO-AUR-APL-2020-045481,AUROBINDO,,87.0,YR,,F,Y,60.0,KG,20210816.0,,MD,DE,DE,2021,Q3,Elderly
1822823729,18228237,94,SS,INSULIN LISPRO DCI,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 IU,,,D,,,,,1.0,IU,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,29,F,20200809.0,20210810.0,20200903,20210819,EXP,,FR-PFIZER INC-2020340763,PFIZER,,74.0,YR,,M,Y,,,20210819.0,,CN,FR,FR,2021,Q3,Elderly
1823583915,18235839,59,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 IU,,,U,,,,,1.0,IU,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,15,F,20200809.0,20210726.0,20200905,20210806,EXP,,FR-SA-2020SA239827,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20210806.0,,MD,FR,FR,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Asthma,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Blood count abnormal,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Chest discomfort,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Cough,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Diaphragmatic disorder,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Discomfort,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Dyspnoea,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Hypoxia,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Left ventricular hypertrophy,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Obstructive airways disorder,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Oedema peripheral,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Oropharyngeal pain,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Pyrexia,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Weight increased,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182376114,18237611,17,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Unknown,2 EVERY 1 DAYS,,,,,,,,2.0,DF,,BID,2021,Q3,Wheezing,,2021,Q3,4,F,,20210816.0,20200907,20210831,EXP,CA-MHPD-E2B_03156762,CA-ACCORD-198951,ACCORD,,83.0,YR,,M,Y,100.0,KG,20210831.0,,CN,CA,CA,2021,Q3,Elderly
182451699,18245169,21,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,, ASKED BUT UNKNOWN,,,1.0,IU,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,9,F,20200809.0,20210729.0,20200908,20210804,EXP,,FR-ROCHE-2670079,ROCHE,,75.0,YR,,M,Y,,,20210804.0,,MD,FR,FR,2021,Q3,Elderly
184017806,18401780,154,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0?6 UNITS SLIDING SCALE, 3X DAILY MEALS",,,U,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,6,F,20201014.0,20210626.0,20201019,20210701,EXP,,NVSC2020US277751,NOVARTIS,,63.0,YR,,F,Y,76.3,KG,20210701.0,,HP,US,US,2021,Q3,Adult
184017806,18401780,155,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0?6 UNITS SLIDING SCALE, 3X DAILY MEALS",,,U,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,6,F,20201014.0,20210626.0,20201019,20210701,EXP,,NVSC2020US277751,NOVARTIS,,63.0,YR,,F,Y,76.3,KG,20210701.0,,HP,US,US,2021,Q3,Adult
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Asthma,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Blood count abnormal,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Chest discomfort,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Cough,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Diaphragmatic disorder,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Discomfort,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Dyspnoea,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Hypoxia,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Left ventricular hypertrophy,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Obstructive airways disorder,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Oedema peripheral,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Oropharyngeal pain,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Pyrexia,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Weight increased,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID, 2 EVERY 1 DAYS",,,D,,,,,2.0,DF,,,2021,Q3,Wheezing,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Asthma,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Blood count abnormal,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Chest discomfort,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Cough,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Diaphragmatic disorder,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Discomfort,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Dyspnoea,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Hypoxia,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Left ventricular hypertrophy,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Obstructive airways disorder,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Oedema peripheral,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Oropharyngeal pain,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Pyrexia,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Weight increased,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184534197,18453419,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,D,,,,,,,,BID,2021,Q3,Wheezing,,2021,Q3,7,F,,20210805.0,20201102,20210816,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20210816.0,,CN,CA,CA,2021,Q3,Elderly
184627782,18462778,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"16 INTERNATIONAL UNIT, DAILY",3696.0,IU,U,,,,20563.0,16.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,20200919.0,20210909.0,20201104,20210922,EXP,IT-MINISAL02-640998,IT-ELI_LILLY_AND_COMPANY-IT202010013450,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
184627782,18462778,1,PS,"INSULIN, LISPRO",INSULIN LISPRO,1,Unknown,"16 INTERNATIONAL UNIT, DAILY",3696.0,IU,U,,,,20563.0,16.0,IU,,QD,2021,Q3,Sopor,,2021,Q3,2,F,20200919.0,20210909.0,20201104,20210922,EXP,IT-MINISAL02-640998,IT-ELI_LILLY_AND_COMPANY-IT202010013450,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20210922.0,,MD,IT,IT,2021,Q3,Elderly
186639095,18663909,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cytomegalovirus enteritis,,2021,Q3,5,F,20200504.0,20210630.0,20201225,20210707,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20210707.0,,MD,IT,IT,2021,Q3,Adult
186639095,18663909,8,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Parasitic gastroenteritis,,2021,Q3,5,F,20200504.0,20210630.0,20201225,20210707,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20210707.0,,MD,IT,IT,2021,Q3,Adult
186644202,18664420,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,2015.0,20210826.0,20201225,20210903,EXP,,US-ASTRAZENECA-2020SF69786,ASTRAZENECA,,60.0,YR,,F,Y,,,20210903.0,,,US,US,2021,Q3,Adult
186644202,18664420,32,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Chronic kidney disease,,2021,Q3,2,F,2015.0,20210826.0,20201225,20210903,EXP,,US-ASTRAZENECA-2020SF69786,ASTRAZENECA,,60.0,YR,,F,Y,,,20210903.0,,,US,US,2021,Q3,Adult
186653489,18665348,68,SS,Insulin Lispro Dci,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,,,,,,,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,9,F,20200809.0,20210726.0,20201225,20210802,EXP,,FR-TAKEDA-2020TEU008275,TAKEDA,,74.0,YR,,M,Y,,,20210802.0,,MD,FR,FR,2021,Q3,Elderly
187463693,18746369,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,,,2021,Q3,Anxiety,,2021,Q3,3,F,2000.0,20210805.0,20210115,20210809,EXP,,US-JNJFOC-20210120224,JOHNSON AND JOHNSON,,4.0,DEC,A,F,Y,,,20210809.0,,CN,US,US,2021,Q3,Child
187463693,18746369,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,,,2021,Q3,Cataract,,2021,Q3,3,F,2000.0,20210805.0,20210115,20210809,EXP,,US-JNJFOC-20210120224,JOHNSON AND JOHNSON,,4.0,DEC,A,F,Y,,,20210809.0,,CN,US,US,2021,Q3,Child
187463693,18746369,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,,,2021,Q3,Depression,,2021,Q3,3,F,2000.0,20210805.0,20210115,20210809,EXP,,US-JNJFOC-20210120224,JOHNSON AND JOHNSON,,4.0,DEC,A,F,Y,,,20210809.0,,CN,US,US,2021,Q3,Child
187463693,18746369,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,,,2021,Q3,Macular degeneration,,2021,Q3,3,F,2000.0,20210805.0,20210115,20210809,EXP,,US-JNJFOC-20210120224,JOHNSON AND JOHNSON,,4.0,DEC,A,F,Y,,,20210809.0,,CN,US,US,2021,Q3,Child
187463693,18746369,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,,,2021,Q3,Off label use,,2021,Q3,3,F,2000.0,20210805.0,20210115,20210809,EXP,,US-JNJFOC-20210120224,JOHNSON AND JOHNSON,,4.0,DEC,A,F,Y,,,20210809.0,,CN,US,US,2021,Q3,Child
187463693,18746369,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,,,2021,Q3,Product use issue,,2021,Q3,3,F,2000.0,20210805.0,20210115,20210809,EXP,,US-JNJFOC-20210120224,JOHNSON AND JOHNSON,,4.0,DEC,A,F,Y,,,20210809.0,,CN,US,US,2021,Q3,Child
187463693,18746369,11,C,LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,,,2021,Q3,Retinopathy,,2021,Q3,3,F,2000.0,20210805.0,20210115,20210809,EXP,,US-JNJFOC-20210120224,JOHNSON AND JOHNSON,,4.0,DEC,A,F,Y,,,20210809.0,,CN,US,US,2021,Q3,Child
187784752,18778475,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,2,F,,20210703.0,20210123,20210713,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210713.0,,HP,US,US,2021,Q3,Elderly
187784752,18778475,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,2,F,,20210703.0,20210123,20210713,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210713.0,,HP,US,US,2021,Q3,Elderly
187784752,18778475,5,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q3,Neutropenia,,2021,Q3,2,F,,20210703.0,20210123,20210713,EXP,,US-TEVA-2021-US-1869964,TEVA,"TORRICO T, KIAI N, MEZA C, SALAM MT, ABDIJADID S. SUSPECTED ARIPIPRAZOLE?INDUCED NEUTROPENIA IN A GERIATRIC PATIENT: A CASE REPORT. BMC?GERIATR 2020?20:NO. 1.",68.0,YR,E,M,Y,,,20210713.0,,HP,US,US,2021,Q3,Elderly
187849454,18784945,7,C,Lispro Insulin,INSULIN LISPRO,1,,4 INTERNATIONAL UNIT,,,,,,,,4.0,IU,,,2021,Q3,Abdominal pain,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,7,C,Lispro Insulin,INSULIN LISPRO,1,,4 INTERNATIONAL UNIT,,,,,,,,4.0,IU,,,2021,Q3,Colitis ulcerative,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,7,C,Lispro Insulin,INSULIN LISPRO,1,,4 INTERNATIONAL UNIT,,,,,,,,4.0,IU,,,2021,Q3,Haematochezia,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,7,C,Lispro Insulin,INSULIN LISPRO,1,,4 INTERNATIONAL UNIT,,,,,,,,4.0,IU,,,2021,Q3,Latent tuberculosis,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,7,C,Lispro Insulin,INSULIN LISPRO,1,,4 INTERNATIONAL UNIT,,,,,,,,4.0,IU,,,2021,Q3,Type 2 diabetes mellitus,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
187849454,18784945,7,C,Lispro Insulin,INSULIN LISPRO,1,,4 INTERNATIONAL UNIT,,,,,,,,4.0,IU,,,2021,Q3,Weight increased,,2021,Q3,4,F,20210112.0,20210813.0,20210125,20210819,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20210819.0,,CN,CO,CO,2021,Q3,Adult
188399123,18839912,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D357990A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20201023.0,20210827.0,20210203,20210906,PER,,US-ELI_LILLY_AND_COMPANY-US202001006970,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20210906.0,,CN,US,US,2021,Q3,Adult
188399123,18839912,9,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D357990A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,3,F,20201023.0,20210827.0,20210203,20210906,PER,,US-ELI_LILLY_AND_COMPANY-US202001006970,ELI LILLY AND CO,,39.0,YR,,M,Y,,,20210906.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,,,,20563.0,25.0,IU,INJECTION,,2021,Q3,Cellulitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,,,,20563.0,25.0,IU,INJECTION,,2021,Q3,Osteomyelitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,,,,20563.0,25.0,IU,INJECTION,,2021,Q3,Sepsis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,,,,20563.0,,,INJECTION,,2021,Q3,Cellulitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,,,,20563.0,,,INJECTION,,2021,Q3,Osteomyelitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,,,,20563.0,,,INJECTION,,2021,Q3,Sepsis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,,,,20563.0,4.0,IU,INJECTION,QD,2021,Q3,Cellulitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,,,,20563.0,4.0,IU,INJECTION,QD,2021,Q3,Osteomyelitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,3,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,,,,20563.0,4.0,IU,INJECTION,QD,2021,Q3,Sepsis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,, D195320A,,20563.0,25.0,IU,INJECTION,,2021,Q3,Cellulitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,, D195320A,,20563.0,25.0,IU,INJECTION,,2021,Q3,Osteomyelitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,4,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"25 U, UNKNOWN",,,,, D195320A,,20563.0,25.0,IU,INJECTION,,2021,Q3,Sepsis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q3,Cellulitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q3,Osteomyelitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,5,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN (SLIDING SCALE)",,,,, D195320A,,20563.0,,,INJECTION,,2021,Q3,Sepsis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,, D195320A,,20563.0,4.0,IU,INJECTION,QD,2021,Q3,Cellulitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,, D195320A,,20563.0,4.0,IU,INJECTION,QD,2021,Q3,Osteomyelitis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
188994982,18899498,6,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"4 U, DAILY",,,,, D195320A,,20563.0,4.0,IU,INJECTION,QD,2021,Q3,Sepsis,,2021,Q3,2,F,2020.0,20210804.0,20210216,20210816,EXP,,US-ELI_LILLY_AND_COMPANY-US202102003794,ELI LILLY AND CO,,42.0,YR,,F,Y,,,20210816.0,,CN,US,US,2021,Q3,Adult
189212419,18921241,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Fungal sepsis,,2021,Q3,9,F,20210216.0,20210721.0,20210222,20210727,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210727.0,,MD,US,US,2021,Q3,Elderly
189212419,18921241,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE U X 3 X 1 DAYS,,,,,,,,,,UNKNOWN,TID,2021,Q3,Fungal sepsis,,2021,Q3,9,F,20210216.0,20210721.0,20210222,20210727,EXP,,US-CELGENEUS-USA-20210204648,CELGENE,,68.0,YR,,F,Y,46.0,KG,20210727.0,,MD,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Anxiety,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Beta haemolytic streptococcal infection,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Cellulitis,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Cellulitis orbital,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Crying,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Drug hypersensitivity,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Empty sella syndrome,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Erythema,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Hemianopia,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Hypokalaemia,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Insomnia,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Nervousness,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Neuropathy peripheral,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Osteoarthritis,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Pollakiuria,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Presyncope,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Rhinorrhoea,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Throat tightness,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Tooth disorder,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Tremor,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Vision blurred,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190516232,19051623,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,1?5 UNITS,,,,,,,,,,,,2021,Q3,White blood cell count increased,,2021,Q3,2,F,2021.0,20210804.0,20210324,20210813,EXP,,US-NOVOPROD-795692,NOVO NORDISK,,69.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Elderly
190834883,19083488,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Pulmonary embolism,,2021,Q3,3,F,20190901.0,20210723.0,20210401,20210803,PER,,US-PFIZER INC-2021350717,PFIZER,,84.0,YR,,M,Y,,,20210803.0,,LW,US,US,2021,Q3,Elderly
190840032,19084003,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, OTHER (BEFORE EVERY MEAL)",,,U,,,,21017.0,20.0,IU,INJECTION,,2021,Q3,Coma,,2021,Q3,2,F,202008.0,20210827.0,20210401,20210908,EXP,,US-ELI_LILLY_AND_COMPANY-US202103011845,ELI LILLY AND CO,,58.0,YR,,M,Y,138.0,KG,20210908.0,,CN,US,US,2021,Q3,Adult
190840032,19084003,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, OTHER (BEFORE EVERY MEAL)",,,U,,,,21017.0,20.0,IU,INJECTION,,2021,Q3,Delusion,,2021,Q3,2,F,202008.0,20210827.0,20210401,20210908,EXP,,US-ELI_LILLY_AND_COMPANY-US202103011845,ELI LILLY AND CO,,58.0,YR,,M,Y,138.0,KG,20210908.0,,CN,US,US,2021,Q3,Adult
190840032,19084003,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, OTHER (BEFORE EVERY MEAL)",,,U,,,,21017.0,20.0,IU,INJECTION,,2021,Q3,Feeling abnormal,,2021,Q3,2,F,202008.0,20210827.0,20210401,20210908,EXP,,US-ELI_LILLY_AND_COMPANY-US202103011845,ELI LILLY AND CO,,58.0,YR,,M,Y,138.0,KG,20210908.0,,CN,US,US,2021,Q3,Adult
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Asthma,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Blood count abnormal,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Chest discomfort,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Cough,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Diaphragmatic disorder,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Discomfort,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Dyspnoea,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Hypoxia,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Left ventricular hypertrophy,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Obstructive airways disorder,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Oedema peripheral,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Oropharyngeal pain,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Pyrexia,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Weight increased,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Wheezing,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Asthma,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Blood count abnormal,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Chest discomfort,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Cough,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Diaphragmatic disorder,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Discomfort,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Dyspnoea,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Hypoxia,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Left ventricular hypertrophy,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Obstructive airways disorder,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Oedema peripheral,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Pyrexia,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Weight increased,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
190983783,19098378,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 DOSAGE FORMS DAILY;,,,,,,,,2.0,DF,,QD,2021,Q3,Wheezing,,2021,Q3,3,F,,20210909.0,20210406,20210920,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
191125386,19112538,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1?2 U X 1 X 1 DAYS,,,,,,,,,,UNKNOWN,QD,2021,Q3,Sepsis,,2021,Q3,6,F,20210403.0,20210830.0,20210408,20210902,EXP,,US-CELGENEUS-USA-20210401065,CELGENE,,80.0,YR,,F,Y,66.0,KG,20210902.0,,MD,US,US,2021,Q3,Elderly
191429532,19142953,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Diabetes insipidus,,2021,Q3,2,F,,20210705.0,20210416,20210714,EXP,,US-AUROBINDO-AUR-APL-2021-015088,AUROBINDO,,23.0,YR,,M,Y,86.2,KG,20210714.0,,PH,US,US,2021,Q3,Youth
191429532,19142953,21,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Product use in unapproved indication,,2021,Q3,2,F,,20210705.0,20210416,20210714,EXP,,US-AUROBINDO-AUR-APL-2021-015088,AUROBINDO,,23.0,YR,,M,Y,86.2,KG,20210714.0,,PH,US,US,2021,Q3,Youth
192177992,19217799,34,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,U,, ASKED BUT UNKNOWN,,,1.0,IU,UNKNOWN,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,2,F,20200809.0,20210812.0,20210505,20210818,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-FRESENIUS KABI-FK202104345,FRESENIUS KABI,,74.0,YR,,M,Y,,,20210818.0,,HP,NL,FR,2021,Q3,Elderly
192177992,19217799,49,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,, UNKNOWN,,,1.0,IU,UNKNOWN,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,2,F,20200809.0,20210812.0,20210505,20210818,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-FRESENIUS KABI-FK202104345,FRESENIUS KABI,,74.0,YR,,M,Y,,,20210818.0,,HP,NL,FR,2021,Q3,Elderly
193759462,19375946,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT?BY VALUE,,,U,, UNKNOWN,,,,,,,2021,Q3,Cough,,2021,Q3,2,F,,20210917.0,20210605,20210923,PER,DE-EMA-DD-20210526-BISHT_P-105858,DE-DRREDDYS-GER/GER/21/0136118,DR REDDYS,,83.0,YR,E,M,Y,,,20210923.0,,PH,DE,DE,2021,Q3,Elderly
193759462,19375946,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT?BY VALUE,,,U,, UNKNOWN,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210917.0,20210605,20210923,PER,DE-EMA-DD-20210526-BISHT_P-105858,DE-DRREDDYS-GER/GER/21/0136118,DR REDDYS,,83.0,YR,E,M,Y,,,20210923.0,,PH,DE,DE,2021,Q3,Elderly
193759462,19375946,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT?BY VALUE,,,U,, UNKNOWN,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210917.0,20210605,20210923,PER,DE-EMA-DD-20210526-BISHT_P-105858,DE-DRREDDYS-GER/GER/21/0136118,DR REDDYS,,83.0,YR,E,M,Y,,,20210923.0,,PH,DE,DE,2021,Q3,Elderly
193759462,19375946,12,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NACH WERT?BY VALUE,,,U,, UNKNOWN,,,,,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210917.0,20210605,20210923,PER,DE-EMA-DD-20210526-BISHT_P-105858,DE-DRREDDYS-GER/GER/21/0136118,DR REDDYS,,83.0,YR,E,M,Y,,,20210923.0,,PH,DE,DE,2021,Q3,Elderly
193825752,19382575,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Atypical pneumonia,,2021,Q3,2,F,2019.0,20210820.0,20210607,20210901,EXP,,US-ELI_LILLY_AND_COMPANY-US202105012879,ELI LILLY AND CO,,46.0,YR,,F,Y,53.0,KG,20210901.0,,CN,US,US,2021,Q3,Adult
193825752,19382575,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,2,F,2019.0,20210820.0,20210607,20210901,EXP,,US-ELI_LILLY_AND_COMPANY-US202105012879,ELI LILLY AND CO,,46.0,YR,,F,Y,53.0,KG,20210901.0,,CN,US,US,2021,Q3,Adult
193825752,19382575,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Illness,,2021,Q3,2,F,2019.0,20210820.0,20210607,20210901,EXP,,US-ELI_LILLY_AND_COMPANY-US202105012879,ELI LILLY AND CO,,46.0,YR,,F,Y,53.0,KG,20210901.0,,CN,US,US,2021,Q3,Adult
193825752,19382575,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Mental impairment,,2021,Q3,2,F,2019.0,20210820.0,20210607,20210901,EXP,,US-ELI_LILLY_AND_COMPANY-US202105012879,ELI LILLY AND CO,,46.0,YR,,F,Y,53.0,KG,20210901.0,,CN,US,US,2021,Q3,Adult
193851042,19385104,7,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 6U AT 7.00 A.M",,,D,, UNKNOWN,,,,,,,2021,Q3,Hypertensive crisis,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,7,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 6U AT 7.00 A.M",,,D,, UNKNOWN,,,,,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,7,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 6U AT 7.00 A.M",,,D,, UNKNOWN,,,,,,,2021,Q3,Off label use,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,7,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 6U AT 7.00 A.M",,,D,, UNKNOWN,,,,,,,2021,Q3,Phaeochromocytoma,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,7,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 6U AT 7.00 A.M",,,D,, UNKNOWN,,,,,,,2021,Q3,Premature delivery,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,8,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 10U AT 12.00 A.M AND 10U AT 06.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Hypertensive crisis,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,8,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 10U AT 12.00 A.M AND 10U AT 06.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,8,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 10U AT 12.00 A.M AND 10U AT 06.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Off label use,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,8,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 10U AT 12.00 A.M AND 10U AT 06.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Phaeochromocytoma,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193851042,19385104,8,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, INSULIN LISPRO 10U AT 12.00 A.M AND 10U AT 06.00 P.M.",,,D,, UNKNOWN,,,,,,,2021,Q3,Premature delivery,,2021,Q3,2,F,,20210721.0,20210608,20210803,EXP,,IT-LUPIN PHARMACEUTICALS INC.-2021-08770,LUPIN,,33.0,YR,,F,Y,,,20210803.0,,HP,IT,IT,2021,Q3,Young Adult
193908983,19390898,5,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,8.0,IU,,,2021,Q3,Amniotic cavity infection,,2021,Q3,3,F,20210324.0,20210820.0,20210609,20210924,PER,,US-COVIS PHARMA GMBH-2021COV01358,COVIS PHARMA,,40.0,YR,A,F,Y,,,20210924.0,,MD,US,US,2021,Q3,Adult
193908983,19390898,5,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,8.0,IU,,,2021,Q3,Premature delivery,,2021,Q3,3,F,20210324.0,20210820.0,20210609,20210924,PER,,US-COVIS PHARMA GMBH-2021COV01358,COVIS PHARMA,,40.0,YR,A,F,Y,,,20210924.0,,MD,US,US,2021,Q3,Adult
193908983,19390898,5,C,Lispro,INSULIN LISPRO,1,,,,,,,,,,8.0,IU,,,2021,Q3,Retroplacental haematoma,,2021,Q3,3,F,20210324.0,20210820.0,20210609,20210924,PER,,US-COVIS PHARMA GMBH-2021COV01358,COVIS PHARMA,,40.0,YR,A,F,Y,,,20210924.0,,MD,US,US,2021,Q3,Adult
193918992,19391899,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,COVID-19,,2021,Q3,2,F,20210607.0,20210607.0,20210609,20210707,PER,,US-ELI_LILLY_AND_COMPANY-US202106003869,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20210707.0,,CN,US,US,2021,Q3,Adult
193918992,19391899,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Irritability,,2021,Q3,2,F,20210607.0,20210607.0,20210609,20210707,PER,,US-ELI_LILLY_AND_COMPANY-US202106003869,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20210707.0,,CN,US,US,2021,Q3,Adult
193918992,19391899,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Malaise,,2021,Q3,2,F,20210607.0,20210607.0,20210609,20210707,PER,,US-ELI_LILLY_AND_COMPANY-US202106003869,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20210707.0,,CN,US,US,2021,Q3,Adult
193918992,19391899,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Pain,,2021,Q3,2,F,20210607.0,20210607.0,20210609,20210707,PER,,US-ELI_LILLY_AND_COMPANY-US202106003869,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20210707.0,,CN,US,US,2021,Q3,Adult
194123394,19412339,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML, BID",,,,,,,,,,,,2021,Q3,Influenza like illness,,2021,Q3,4,F,20210606.0,20210721.0,20210614,20210728,EXP,,NVSC2021US131276,NOVARTIS,,49.0,YR,,M,Y,69.0,KG,20210728.0,,MD,US,US,2021,Q3,Adult
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Alcohol abuse,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Allergy to animal,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Anxiety,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Asthma,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Back pain,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Depression,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Drug hypersensitivity,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Generalised tonic-clonic seizure,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Heart rate increased,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Limb injury,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Memory impairment,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Mobility decreased,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Product dose omission issue,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Seasonal allergy,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Sleep apnoea syndrome,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Sleep disorder,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Staphylococcal bacteraemia,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Staphylococcal sepsis,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Toxic encephalopathy,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194141293,19414129,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 UNK, UNKNOWN (HUMALOG U?100)",,,U,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,3,F,2018.0,20210714.0,20210614,20210728,EXP,,NVSC2021US124162,NOVARTIS,,65.0,YR,,M,Y,121.0,KG,20210728.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q3,Elderly
194163032,19416303,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210605.0,20210907.0,20210614,20210908,PER,,US-SA-2021SA194308,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210908.0,,CN,US,US,2021,Q3,Adult
194163032,19416303,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210605.0,20210907.0,20210614,20210908,PER,,US-SA-2021SA194308,SANOFI AVENTIS,,56.0,YR,A,F,Y,,,20210908.0,,CN,US,US,2021,Q3,Adult
194173552,19417355,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,50 ML,,,U,,,,,50.0,ML,INJECTION,,2021,Q3,Decreased activity,,2021,Q3,2,F,,20210630.0,20210614,20210712,EXP,,NVSJ2021JP008821,NOVARTIS,,86.0,YR,,F,Y,,,20210712.0,,PH,JP,JP,2021,Q3,Elderly
194173552,19417355,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,50 ML,,,U,,,,,50.0,ML,INJECTION,,2021,Q3,Gastrointestinal haemorrhage,,2021,Q3,2,F,,20210630.0,20210614,20210712,EXP,,NVSJ2021JP008821,NOVARTIS,,86.0,YR,,F,Y,,,20210712.0,,PH,JP,JP,2021,Q3,Elderly
194173552,19417355,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,50 ML,,,U,,,,,50.0,ML,INJECTION,,2021,Q3,Glomerular filtration rate decreased,,2021,Q3,2,F,,20210630.0,20210614,20210712,EXP,,NVSJ2021JP008821,NOVARTIS,,86.0,YR,,F,Y,,,20210712.0,,PH,JP,JP,2021,Q3,Elderly
194173552,19417355,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,50 ML,,,U,,,,,50.0,ML,INJECTION,,2021,Q3,Hypotension,,2021,Q3,2,F,,20210630.0,20210614,20210712,EXP,,NVSJ2021JP008821,NOVARTIS,,86.0,YR,,F,Y,,,20210712.0,,PH,JP,JP,2021,Q3,Elderly
194233082,19423308,9,C,Insulin lispro,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,2,F,,20210820.0,20210616,20210902,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-09529,LUPIN,,79.0,YR,,M,Y,,,20210902.0,,HP,US,US,2021,Q3,Elderly
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,13,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,14,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,15,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,,,,,16.0,IU,INJECTION,QOD,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,16,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,17,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,18,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"16?18 U, QOD",,,U,, D341139A,,,16.0,IU,INJECTION,QOD,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,19,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,20,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Dizziness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Incorrect dose administered,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Influenza like illness,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Nasopharyngitis,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Vertigo,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194399073,19439907,21,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"25 U, QID",,,U,,,,,25.0,IU,INJECTION,QID,2021,Q3,Vomiting,,2021,Q3,3,F,20210808.0,20210811.0,20210620,20210909,PER,,US-ELI_LILLY_AND_COMPANY-US202106009177,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20210909.0,,CN,US,US,2021,Q3,Adult
194468912,19446891,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"100 U, OTHER, MAXIMUM DAILY DOSE",,,U,, D341138C,,20563.0,100.0,IU,INJECTION,,2021,Q3,Accidental underdose,,2021,Q3,2,F,20210621.0,20210621.0,20210622,20210701,PER,,US-ELI_LILLY_AND_COMPANY-US202106010309,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210701.0,,CN,US,US,2021,Q3,Elderly
194577995,19457799,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,100/ML,,,,,,,,,,UNKNOWN,,2021,Q3,Insomnia,,2021,Q3,5,F,202106.0,20210831.0,20210624,20210908,EXP,,US-CELGENEUS-USA-20210605438,CELGENE,,73.0,YR,,M,Y,68.87,KG,20210908.0,,PH,US,US,2021,Q3,Elderly
194577995,19457799,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,100/ML,,,,,,,,,,UNKNOWN,,2021,Q3,Lower limb fracture,,2021,Q3,5,F,202106.0,20210831.0,20210624,20210908,EXP,,US-CELGENEUS-USA-20210605438,CELGENE,,73.0,YR,,M,Y,68.87,KG,20210908.0,,PH,US,US,2021,Q3,Elderly
194577995,19457799,15,C,Insulin lispro,INSULIN LISPRO,1,Unknown,100/ML,,,,,,,,,,UNKNOWN,,2021,Q3,Platelet count decreased,,2021,Q3,5,F,202106.0,20210831.0,20210624,20210908,EXP,,US-CELGENEUS-USA-20210605438,CELGENE,,73.0,YR,,M,Y,68.87,KG,20210908.0,,PH,US,US,2021,Q3,Elderly
194601752,19460175,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,3 UNITS FOR EVERY 50 MG/DL GLUCOSE ABOVE 200 MG/DL ON THE FIRST AND SECOND DAY FOLLOWING CHEMOTHERAP,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,3.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,,20210917.0,20210625,20210923,EXP,,US-DRREDDYS-SPO/USA/21/0136728,DR REDDYS,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM J CASE REP. 2021?22(1):E930733?1?7. DOI:10.12659/AJCR.930733",70.0,YR,E,F,Y,,,20210923.0,,MD,US,US,2021,Q3,Elderly
194601752,19460175,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,5.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,,20210917.0,20210625,20210923,EXP,,US-DRREDDYS-SPO/USA/21/0136728,DR REDDYS,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM J CASE REP. 2021?22(1):E930733?1?7. DOI:10.12659/AJCR.930733",70.0,YR,E,F,Y,,,20210923.0,,MD,US,US,2021,Q3,Elderly
194601752,19460175,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,15.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,,20210917.0,20210625,20210923,EXP,,US-DRREDDYS-SPO/USA/21/0136728,DR REDDYS,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM J CASE REP. 2021?22(1):E930733?1?7. DOI:10.12659/AJCR.930733",70.0,YR,E,F,Y,,,20210923.0,,MD,US,US,2021,Q3,Elderly
194601752,19460175,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE,,,U,," UNKNOWN,UNKNOWN,UNKNOWN,UNKNOWN",,,2.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,,20210917.0,20210625,20210923,EXP,,US-DRREDDYS-SPO/USA/21/0136728,DR REDDYS,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AM J CASE REP. 2021?22(1):E930733?1?7. DOI:10.12659/AJCR.930733",70.0,YR,E,F,Y,,,20210923.0,,MD,US,US,2021,Q3,Elderly
194701792,19470179,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT PER MILLILTER,,,,,,,,,,INJECTION,,2021,Q3,Spinal cord compression,,2021,Q3,2,F,20210618.0,20210629.0,20210628,20210705,PER,,US-AMGEN-USACT2021096089,AMGEN,,64.0,YR,A,M,Y,121.2,KG,20210705.0,,CN,US,US,2021,Q3,Adult
194710272,19471027,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Wrong technique in product usage process,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Wrong technique in product usage process,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Wrong technique in product usage process,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Wrong technique in product usage process,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194710272,19471027,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20?30 U, DAILY PRN",,,U,, D214632C,,20563.0,30.0,IU,INJECTION,,2021,Q3,Wrong technique in product usage process,,2021,Q3,2,F,20210608.0,20210823.0,20210628,20210827,EXP,,US-ELI_LILLY_AND_COMPANY-US202106008397,ELI LILLY AND CO,,32.0,YR,,F,Y,,,20210827.0,,CN,US,US,2021,Q3,Young Adult
194791803,19479180,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,,,,20563.0,2.0,IU,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D337388E,,20563.0,2.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D337388E,,20563.0,2.0,IU,INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D337388E,,20563.0,2.0,IU,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D337388E,,20563.0,2.0,IU,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D261904A,,20563.0,2.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D261904A,,20563.0,2.0,IU,INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D261904A,,20563.0,2.0,IU,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D261904A,,20563.0,2.0,IU,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D261904A,,20563.0,2.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D261904A,,20563.0,2.0,IU,INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D261904A,,20563.0,2.0,IU,INJECTION,,2021,Q3,Memory impairment,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194791803,19479180,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"2 U, OTHER (EACH MEAL)",,,,, D261904A,,20563.0,2.0,IU,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,3,F,20210531.0,20210730.0,20210701,20210804,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210804.0,,CN,US,US,2021,Q3,Elderly
194799942,19479994,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, D270624A/FF5Z38B,,20563.0,,,,,2021,Q3,Gait disturbance,,2021,Q3,2,F,,20210618.0,20210630,20210721,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106009069,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210721.0,,CN,DE,DE,2021,Q3,Adult
194799942,19479994,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK, UNKNOWN",,,U,, D270624A/FF5Z38B,,20563.0,,,,,2021,Q3,Limb discomfort,,2021,Q3,2,F,,20210618.0,20210630,20210721,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106009069,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20210721.0,,CN,DE,DE,2021,Q3,Adult
194799981,19479998,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK (45?30?35?0),,,,,,,,,,INJECTION FOR INFUSION,,2021,Q3,Fall,,2021,Q3,1,I,,20210622.0,20210701,20210701,EXP,,DE-AUROBINDO-AUR-APL-2021-027220,AUROBINDO,,82.0,YR,,F,Y,,,20210701.0,,PH,DE,DE,2021,Q3,Elderly
194799981,19479998,10,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,UNK (45?30?35?0),,,,,,,,,,INJECTION FOR INFUSION,,2021,Q3,Pain,,2021,Q3,1,I,,20210622.0,20210701,20210701,EXP,,DE-AUROBINDO-AUR-APL-2021-027220,AUROBINDO,,82.0,YR,,F,Y,,,20210701.0,,PH,DE,DE,2021,Q3,Elderly
194822811,19482281,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cardiac failure,,2021,Q3,1,I,202106.0,20210621.0,20210701,20210701,EXP,,JP-EMD SERONO-9247189,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Elderly
194822811,19482281,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,202106.0,20210621.0,20210701,20210701,EXP,,JP-EMD SERONO-9247189,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Elderly
194822811,19482281,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hepatic function abnormal,,2021,Q3,1,I,202106.0,20210621.0,20210701,20210701,EXP,,JP-EMD SERONO-9247189,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Elderly
194822811,19482281,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,202106.0,20210621.0,20210701,20210701,EXP,,JP-EMD SERONO-9247189,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Elderly
194822811,19482281,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Rhabdomyolysis,,2021,Q3,1,I,202106.0,20210621.0,20210701,20210701,EXP,,JP-EMD SERONO-9247189,EMD SERONO INC,,78.0,YR,E,M,Y,,,20210701.0,,MD,JP,JP,2021,Q3,Elderly
194828381,19482838,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Product storage error,,2021,Q3,1,I,,20210624.0,20210701,20210701,PER,,US-SA-2021SA212050,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20210701.0,,CN,US,US,2021,Q3,Adult
194828381,19482838,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Visual impairment,,2021,Q3,1,I,,20210624.0,20210701,20210701,PER,,US-SA-2021SA212050,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20210701.0,,CN,US,US,2021,Q3,Adult
194840544,19484054,81,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,U,,,,,1.0,IU,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,4,F,20200809.0,20210809.0,20210701,20210812,EXP,,NVSC2021FR146473,NOVARTIS,,74.0,YR,,M,Y,,,20210812.0,,HP,FR,FR,2021,Q3,Elderly
194842301,19484230,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-06411-02,DE-DSJP-DSE-2021-119629,DAIICHI,,84.0,YR,,M,Y,,,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194842301,19484230,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Haematochezia,,2021,Q3,1,I,,20210625.0,20210701,20210701,EXP,DE-ADRED-06411-02,DE-DSJP-DSE-2021-119629,DAIICHI,,84.0,YR,,M,Y,,,20210701.0,,MD,DE,DE,2021,Q3,Elderly
194846976,19484697,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1IU, CO",,,U,, ASKED BUT UNKNOWN,,,1.0,IU,UNKNOWN,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,6,F,20200809.0,20210916.0,20210702,20210922,EXP,,FR-ROCHE-2860051,ROCHE,,74.0,YR,,M,Y,,,20210922.0,,MD,FR,FR,2021,Q3,Elderly
194868331,19486833,27,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,1,I,20210503.0,20210604.0,20210702,20210702,EXP,,US-PFIZER INC-2021666333,PFIZER,,64.0,YR,,M,Y,,,20210702.0,,HP,US,US,2021,Q3,Adult
194868331,19486833,27,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Pharyngeal swelling,,2021,Q3,1,I,20210503.0,20210604.0,20210702,20210702,EXP,,US-PFIZER INC-2021666333,PFIZER,,64.0,YR,,M,Y,,,20210702.0,,HP,US,US,2021,Q3,Adult
194868331,19486833,27,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Rash,,2021,Q3,1,I,20210503.0,20210604.0,20210702,20210702,EXP,,US-PFIZER INC-2021666333,PFIZER,,64.0,YR,,M,Y,,,20210702.0,,HP,US,US,2021,Q3,Adult
194868331,19486833,27,C,LISPRO INSULIN,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,20210503.0,20210604.0,20210702,20210702,EXP,,US-PFIZER INC-2021666333,PFIZER,,64.0,YR,,M,Y,,,20210702.0,,HP,US,US,2021,Q3,Adult
194872961,19487296,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE UNSPECIFIED,,,,,,,,,,INJECTION,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE UNSPECIFIED,,,,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,DOSE UNSPECIFIED,,,,,,,,,,INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Weight increased,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,INJECTION,QD,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194872961,19487296,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,15.0,IU,INJECTION,QD,2021,Q3,Weight increased,,2021,Q3,1,I,201605.0,20210622.0,20210702,20210702,EXP,,SK-EMD SERONO-9247559,EMD SERONO INC,UNKNOWN. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61.,53.0,YR,A,M,Y,,,20210702.0,,MD,SK,SK,2021,Q3,Adult
194880686,19488068,4,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Acute kidney injury,,2021,Q3,6,F,20210626.0,20210907.0,20210702,20210908,EXP,,US-CELGENEUS-USA-20210700150,CELGENE,,69.0,YR,,M,Y,,,20210908.0,,HP,US,US,2021,Q3,Elderly
194880686,19488068,4,C,Insulin lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Pneumonia fungal,,2021,Q3,6,F,20210626.0,20210907.0,20210702,20210908,EXP,,US-CELGENEUS-USA-20210700150,CELGENE,,69.0,YR,,M,Y,,,20210908.0,,HP,US,US,2021,Q3,Elderly
194881301,19488130,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1000 UNITS PER ML INJECTION, 10 UNITS",,,,,,,,10.0,IU,INJECTION,BID,2021,Q3,Decreased activity,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1000 UNITS PER ML INJECTION, 10 UNITS",,,,,,,,10.0,IU,INJECTION,BID,2021,Q3,Disturbance in attention,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1000 UNITS PER ML INJECTION, 10 UNITS",,,,,,,,10.0,IU,INJECTION,BID,2021,Q3,Dizziness,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1000 UNITS PER ML INJECTION, 10 UNITS",,,,,,,,10.0,IU,INJECTION,BID,2021,Q3,Lethargy,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1000 UNITS PER ML INJECTION, 10 UNITS",,,,,,,,10.0,IU,INJECTION,BID,2021,Q3,Malaise,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1000 UNITS PER ML INJECTION, 10 UNITS",,,,,,,,10.0,IU,INJECTION,BID,2021,Q3,Nausea,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1000 UNITS PER ML INJECTION, 10 UNITS",,,,,,,,10.0,IU,INJECTION,BID,2021,Q3,Oral administration complication,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194881301,19488130,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1000 UNITS PER ML INJECTION, 10 UNITS",,,,,,,,10.0,IU,INJECTION,BID,2021,Q3,Product adhesion issue,,2021,Q3,1,I,20210222.0,20210224.0,20210702,20210702,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0086,BIODELIVERY SCIENCES INTERNATIONAL,,42.0,YR,A,F,Y,118.04,KG,20210702.0,,CN,US,US,2021,Q3,Adult
194888241,19488824,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,FOR EVERY 50 MG/DL GLUCOSE ABOVE 200 MG/DL ON THE FIRST AND SECOND DAY FOLLOWING CHEMOTHERAPY,,,U,,,,,3.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210618.0,20210702,20210702,EXP,,US-BAUSCH-BL-2021-021917,BAUSCH AND LOMB,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AMERICAN JOURNAL OF CASE REPORTS. 2021 APR 28?22(1):E930733?1?E930733?7. DOI:10.12659/AJCR.930733",70.0,YR,,F,Y,,,20210702.0,,MD,US,US,2021,Q3,Elderly
194888241,19488824,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,5.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210618.0,20210702,20210702,EXP,,US-BAUSCH-BL-2021-021917,BAUSCH AND LOMB,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AMERICAN JOURNAL OF CASE REPORTS. 2021 APR 28?22(1):E930733?1?E930733?7. DOI:10.12659/AJCR.930733",70.0,YR,,F,Y,,,20210702.0,,MD,US,US,2021,Q3,Elderly
194888241,19488824,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE,,,U,,,,,15.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210618.0,20210702,20210702,EXP,,US-BAUSCH-BL-2021-021917,BAUSCH AND LOMB,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AMERICAN JOURNAL OF CASE REPORTS. 2021 APR 28?22(1):E930733?1?E930733?7. DOI:10.12659/AJCR.930733",70.0,YR,,F,Y,,,20210702.0,,MD,US,US,2021,Q3,Elderly
194888241,19488824,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,INCREASED TO 15 UNITS WITH AN ADDITIONAL 2 UNITS FOR EVERY 50 MG/DL GLUCOSE,,,U,,,,,2.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210618.0,20210702,20210702,EXP,,US-BAUSCH-BL-2021-021917,BAUSCH AND LOMB,"ZHANG F, KARAM J. GLYCEMIC PROFILE OF INTRAVENOUS DEXAMETHASONE?INDUCED HYPERGLYCEMIA USING CONTINUOUS GLUCOSE MONITORING. AMERICAN JOURNAL OF CASE REPORTS. 2021 APR 28?22(1):E930733?1?E930733?7. DOI:10.12659/AJCR.930733",70.0,YR,,F,Y,,,20210702.0,,MD,US,US,2021,Q3,Elderly
194893391,19489339,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PLAN,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928412,TEVA,,74.0,YR,E,M,Y,,,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194893391,19489339,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PLAN,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Dehydration,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928412,TEVA,,74.0,YR,E,M,Y,,,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194893391,19489339,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PLAN,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928412,TEVA,,74.0,YR,E,M,Y,,,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194893391,19489339,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PLAN,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928412,TEVA,,74.0,YR,E,M,Y,,,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194893391,19489339,8,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,ACCORDING TO PLAN,,,,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Haematochezia,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928412,TEVA,,74.0,YR,E,M,Y,,,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194894141,19489414,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NEED,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Depressed level of consciousness,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928368,TEVA,,82.0,YR,E,F,Y,89.0,KG,20210703.0,,PH,DE,DE,2021,Q3,Elderly
194894141,19489414,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NEED,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928368,TEVA,,82.0,YR,E,F,Y,89.0,KG,20210703.0,,PH,DE,DE,2021,Q3,Elderly
194894141,19489414,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NEED,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Medication error,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928368,TEVA,,82.0,YR,E,F,Y,89.0,KG,20210703.0,,PH,DE,DE,2021,Q3,Elderly
194894141,19489414,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NEED,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928368,TEVA,,82.0,YR,E,F,Y,89.0,KG,20210703.0,,PH,DE,DE,2021,Q3,Elderly
194894141,19489414,4,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,NEED,,,U,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Product prescribing error,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928368,TEVA,,82.0,YR,E,F,Y,89.0,KG,20210703.0,,PH,DE,DE,2021,Q3,Elderly
194894481,19489448,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,, UNKNOWN,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928344,TEVA,,78.0,YR,E,M,Y,88.4,KG,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194894481,19489448,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,, UNKNOWN,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928344,TEVA,,78.0,YR,E,M,Y,88.4,KG,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194894481,19489448,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,, UNKNOWN,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928344,TEVA,,78.0,YR,E,M,Y,88.4,KG,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194894481,19489448,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,, UNKNOWN,,,,,,,2021,Q3,Medication error,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928344,TEVA,,78.0,YR,E,M,Y,88.4,KG,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194894481,19489448,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,U,, UNKNOWN,,,,,,,2021,Q3,Night sweats,,2021,Q3,1,I,,20210628.0,20210703,20210703,EXP,,DE-TEVA-2021-DE-1928344,TEVA,,78.0,YR,E,M,Y,88.4,KG,20210703.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q3,Medication error,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194908981,19490898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,,,2021,Q3,Night sweats,,2021,Q3,1,I,,20210625.0,20210705,20210705,EXP,,DE-SA-2021SA213229,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20210705.0,,MD,DE,DE,2021,Q3,Elderly
194913521,19491352,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CYLINDRICAL AMPOULES",,,U,,,,,,,,TID,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210630.0,20210705,20210705,EXP,,DE-009507513-2107DEU000011,MERCK,,70.0,YR,,M,Y,89.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Elderly
194913521,19491352,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CYLINDRICAL AMPOULES",,,U,,,,,,,,TID,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210630.0,20210705,20210705,EXP,,DE-009507513-2107DEU000011,MERCK,,70.0,YR,,M,Y,89.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Elderly
194934691,19493469,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q3,Asthma,,2021,Q3,1,I,,20210608.0,20210705,20210705,PER,,US-PFIZER INC-2021678275,PFIZER,,62.0,YR,,F,Y,,,20210705.0,,CN,US,US,2021,Q3,Adult
194934691,19493469,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,1,I,,20210608.0,20210705,20210705,PER,,US-PFIZER INC-2021678275,PFIZER,,62.0,YR,,F,Y,,,20210705.0,,CN,US,US,2021,Q3,Adult
194934691,19493469,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q3,Product use issue,,2021,Q3,1,I,,20210608.0,20210705,20210705,PER,,US-PFIZER INC-2021678275,PFIZER,,62.0,YR,,F,Y,,,20210705.0,,CN,US,US,2021,Q3,Adult
194942661,19494266,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 15?6?6?0, FERTIGSPRITZEN",,,,,,,,27.0,IU,,QD,2021,Q3,Cough,,2021,Q3,1,I,,20210630.0,20210705,20210705,EXP,,DE-ROCHE-2860921,ROCHE,,50.0,YR,,F,Y,74.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Adult
194942661,19494266,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 15?6?6?0, FERTIGSPRITZEN",,,,,,,,27.0,IU,,QD,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210630.0,20210705,20210705,EXP,,DE-ROCHE-2860921,ROCHE,,50.0,YR,,F,Y,74.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Adult
194942661,19494266,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 15?6?6?0, FERTIGSPRITZEN",,,,,,,,27.0,IU,,QD,2021,Q3,Infection,,2021,Q3,1,I,,20210630.0,20210705,20210705,EXP,,DE-ROCHE-2860921,ROCHE,,50.0,YR,,F,Y,74.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Adult
194942661,19494266,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 15?6?6?0, FERTIGSPRITZEN",,,,,,,,27.0,IU,,QD,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210630.0,20210705,20210705,EXP,,DE-ROCHE-2860921,ROCHE,,50.0,YR,,F,Y,74.0,KG,20210705.0,,PH,DE,DE,2021,Q3,Adult
194945521,19494552,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (BEDARF, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Depressed level of consciousness,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06520-01,NVSC2021DE142824,NOVARTIS,,82.0,YR,,F,Y,89.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194945521,19494552,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (BEDARF, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06520-01,NVSC2021DE142824,NOVARTIS,,82.0,YR,,F,Y,89.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194945521,19494552,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (BEDARF, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Medication error,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06520-01,NVSC2021DE142824,NOVARTIS,,82.0,YR,,F,Y,89.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194945521,19494552,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (BEDARF, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06520-01,NVSC2021DE142824,NOVARTIS,,82.0,YR,,F,Y,89.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194945521,19494552,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (BEDARF, INJEKTIONS?/INFUSIONSLOSUNG)",,,U,,,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Product prescribing error,,2021,Q3,1,I,,20210624.0,20210705,20210705,EXP,DE-ADRED-06520-01,NVSC2021DE142824,NOVARTIS,,82.0,YR,,F,Y,89.0,KG,20210705.0,,HP,DE,DE,2021,Q3,Elderly
194951681,19495168,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210628.0,20210706,20210706,EXP,,DE-TEVA-2021-DE-1928318,TEVA,,82.0,YR,E,F,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194951681,19495168,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210628.0,20210706,20210706,EXP,,DE-TEVA-2021-DE-1928318,TEVA,,82.0,YR,E,F,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194964111,19496411,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0,",,,U,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,DE-ADRED-06007-02,DE-TORRENT-00020596,TORRENT,,82.0,YR,E,F,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194964111,19496411,8,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0,",,,U,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,DE-ADRED-06007-02,DE-TORRENT-00020596,TORRENT,,82.0,YR,E,F,Y,,,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194974261,19497426,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, AS NEEDED",,,D,,,,,,,,,2021,Q3,Foot amputation,,2021,Q3,1,I,20200922.0,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA212380,SANOFI AVENTIS,,71.0,YR,E,M,Y,93.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194974261,19497426,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, AS NEEDED",,,D,,,,,,,,,2021,Q3,Wound dehiscence,,2021,Q3,1,I,20200922.0,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA212380,SANOFI AVENTIS,,71.0,YR,E,M,Y,93.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194974971,19497497,6,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CYLINDRICAL AMPOULES",,,U,, UNKNOWN,,,,,,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210630.0,20210706,20210706,EXP,,DE-TEVA-2021-DE-1929533,TEVA,,70.0,YR,E,M,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194974971,19497497,6,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CYLINDRICAL AMPOULES",,,U,, UNKNOWN,,,,,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210630.0,20210706,20210706,EXP,,DE-TEVA-2021-DE-1929533,TEVA,,70.0,YR,E,M,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194983391,19498339,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,U,,,,209196.0,1.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210630.0,20210706,20210706,EXP,,DE-SA-2021SA218615,SANOFI AVENTIS,,70.0,YR,E,M,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194983391,19498339,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,U,,,,209196.0,1.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210630.0,20210706,20210706,EXP,,DE-SA-2021SA218615,SANOFI AVENTIS,,70.0,YR,E,M,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194986983,19498698,16,C,Insulin Lispro,INSULIN LISPRO,1,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Febrile neutropenia,,2021,Q3,3,F,20210618.0,20210730.0,20210706,20210804,PER,,US-CELGENEUS-USA-20210607882,CELGENE,,69.0,YR,,M,Y,,,20210804.0,,MD,US,US,2021,Q3,Elderly
194989381,19498938,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NEED, SOLUTION FOR INJECTION/INFUSION",,,D,,,,,,,,,2021,Q3,Depressed level of consciousness,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA213279,SANOFI AVENTIS,,82.0,YR,E,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194989381,19498938,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NEED, SOLUTION FOR INJECTION/INFUSION",,,D,,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA213279,SANOFI AVENTIS,,82.0,YR,E,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194989381,19498938,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NEED, SOLUTION FOR INJECTION/INFUSION",,,D,,,,,,,,,2021,Q3,Medication error,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA213279,SANOFI AVENTIS,,82.0,YR,E,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194989381,19498938,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NEED, SOLUTION FOR INJECTION/INFUSION",,,D,,,,,,,,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA213279,SANOFI AVENTIS,,82.0,YR,E,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194989381,19498938,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NEED, SOLUTION FOR INJECTION/INFUSION",,,D,,,,,,,,,2021,Q3,Product prescribing error,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,DE-SA-2021SA213279,SANOFI AVENTIS,,82.0,YR,E,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Arthritis,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cardiac failure congestive,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Chest pain,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Eye haemorrhage,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Malnutrition,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Multi-organ disorder,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Myalgia,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Neuropathy peripheral,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Pericardial effusion,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Pulmonary oedema,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Thyroid disorder,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Arthritis,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Cardiac failure congestive,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Chest pain,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Eye haemorrhage,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Malnutrition,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Multi-organ disorder,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Myalgia,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Neuropathy peripheral,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Pericardial effusion,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Pulmonary oedema,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Thyroid disorder,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194989971,19498997,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20210706.0,,CN,CA,CA,2021,Q3,Adult
194992971,19499297,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, PRN",,,U,,,,20563.0,300.0,IU,INJECTION,,2021,Q3,Foot amputation,,2021,Q3,1,I,20200922.0,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011393,ELI LILLY AND CO,,71.0,YR,,M,Y,93.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194992971,19499297,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"300 INTERNATIONAL UNIT, PRN",,,U,,,,20563.0,300.0,IU,INJECTION,,2021,Q3,Wound dehiscence,,2021,Q3,1,I,20200922.0,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011393,ELI LILLY AND CO,,71.0,YR,,M,Y,93.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194993031,19499303,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2021,Q3,Depressed level of consciousness,,2021,Q3,1,I,,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011387,ELI LILLY AND CO,,82.0,YR,,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194993031,19499303,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011387,ELI LILLY AND CO,,82.0,YR,,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194993031,19499303,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2021,Q3,Medication error,,2021,Q3,1,I,,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011387,ELI LILLY AND CO,,82.0,YR,,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194993031,19499303,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011387,ELI LILLY AND CO,,82.0,YR,,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194993031,19499303,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,,,2021,Q3,Product prescribing error,,2021,Q3,1,I,,20210622.0,20210706,20210706,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011387,ELI LILLY AND CO,,82.0,YR,,F,Y,89.0,KG,20210706.0,,PH,DE,DE,2021,Q3,Elderly
194999951,19499995,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CARTRIDGES",,,U,U,,,,,,,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210625.0,20210707,20210707,EXP,DE-ADRED-06617-01,DE-NOVOPROD-824135,NOVO NORDISK,,70.0,YR,,M,Y,89.0,KG,20210707.0,,PH,DE,DE,2021,Q3,Elderly
194999951,19499995,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CARTRIDGES",,,U,U,,,,,,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210625.0,20210707,20210707,EXP,DE-ADRED-06617-01,DE-NOVOPROD-824135,NOVO NORDISK,,70.0,YR,,M,Y,89.0,KG,20210707.0,,PH,DE,DE,2021,Q3,Elderly
195000551,19500055,10,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210622.0,20210707,20210707,EXP,DE-ADRED-06007-02,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-04132,ALKEM,,82.0,YR,,F,Y,,,20210707.0,,HP,DE,DE,2021,Q3,Elderly
195000551,19500055,10,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210622.0,20210707,20210707,EXP,DE-ADRED-06007-02,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2021-04132,ALKEM,,82.0,YR,,F,Y,,,20210707.0,,HP,DE,DE,2021,Q3,Elderly
195001441,19500144,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-54794,HIKMA,,78.0,YR,,M,Y,88.4,KG,20210707.0,,MD,DE,DE,2021,Q3,Elderly
195001441,19500144,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-54794,HIKMA,,78.0,YR,,M,Y,88.4,KG,20210707.0,,MD,DE,DE,2021,Q3,Elderly
195001441,19500144,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-54794,HIKMA,,78.0,YR,,M,Y,88.4,KG,20210707.0,,MD,DE,DE,2021,Q3,Elderly
195001441,19500144,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q3,Medication error,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-54794,HIKMA,,78.0,YR,,M,Y,88.4,KG,20210707.0,,MD,DE,DE,2021,Q3,Elderly
195001441,19500144,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNKNOWN,,,,,,,,,,UNKNOWN,,2021,Q3,Night sweats,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-HIKMA PHARMACEUTICALS USA INC.-DE-H14001-21-54794,HIKMA,,78.0,YR,,M,Y,88.4,KG,20210707.0,,MD,DE,DE,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Asthma,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Discomfort,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,10,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 DF, (1 EVERY 1 DAY)",,,D,,,,209196.0,2.0,DF,SOLUTION FOR INJECTION,QD,2021,Q3,Weight increased,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Asthma,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Discomfort,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195001981,19500198,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"2 DF, (1 EVERY 1 DAY)",,,U,,,,,2.0,DF,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210625.0,20210706,20210706,EXP,,CA-SA-2021SA212867,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210707.0,,HP,CA,CA,2021,Q3,Elderly
195009654,19500965,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,U,,,,,,,,,2021,Q3,Encephalopathy,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,U,,,,,,,,,2021,Q3,Multiple organ dysfunction syndrome,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,U,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,U,,,,,,,,,2021,Q3,Pneumonitis,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,U,,,,,,,,,2021,Q3,Respiratory failure,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195009654,19500965,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,4,F,20210620.0,20210721.0,20210707,20210727,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-061237,BRISTOL MYERS SQUIBB,,65.0,YR,,F,Y,52.5,KG,20210727.0,,HP,US,US,2021,Q3,Elderly
195017151,19501715,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cytokine release syndrome,,2021,Q3,1,I,20210523.0,,20210707,20210707,DIR,,,FDA-CTU,,77.0,YR,,M,N,54.9,KG,20210707.0,N,HP,US,US,2021,Q3,Elderly
195017151,19501715,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Neurotoxicity,,2021,Q3,1,I,20210523.0,,20210707,20210707,DIR,,,FDA-CTU,,77.0,YR,,M,N,54.9,KG,20210707.0,N,HP,US,US,2021,Q3,Elderly
195025341,19502534,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Arthralgia,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-FRESENIUS KABI-FK202106796,FRESENIUS KABI,,77.0,YR,,F,Y,50.0,KG,20210707.0,,HP,NL,DE,2021,Q3,Elderly
195025341,19502534,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Joint swelling,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-FRESENIUS KABI-FK202106796,FRESENIUS KABI,,77.0,YR,,F,Y,50.0,KG,20210707.0,,HP,NL,DE,2021,Q3,Elderly
195025341,19502534,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-FRESENIUS KABI-FK202106796,FRESENIUS KABI,,77.0,YR,,F,Y,50.0,KG,20210707.0,,HP,NL,DE,2021,Q3,Elderly
195025341,19502534,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Peripheral swelling,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-FRESENIUS KABI-FK202106796,FRESENIUS KABI,,77.0,YR,,F,Y,50.0,KG,20210707.0,,HP,NL,DE,2021,Q3,Elderly
195025341,19502534,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, INJECTION / INFUSION SOLUTION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Thrombosis,,2021,Q3,1,I,,20210628.0,20210707,20210707,EXP,,DE-FRESENIUS KABI-FK202106796,FRESENIUS KABI,,77.0,YR,,F,Y,50.0,KG,20210707.0,,HP,NL,DE,2021,Q3,Elderly
195035431,19503543,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0, INJEKTIONS?/INFUSIONSLOSUNG ()",,,U,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210623.0,20210708,20210708,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303245,RANBAXY,,82.0,YR,,F,Y,,,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195035431,19503543,10,C,insulin lispro,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0, INJEKTIONS?/INFUSIONSLOSUNG ()",,,U,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210623.0,20210708,20210708,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303245,RANBAXY,,82.0,YR,,F,Y,,,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195036191,19503619,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210624.0,20210707,20210707,EXP,,US-MYLANLABS-2021M1039341,MYLAN,,23.0,YR,,M,Y,,,20210707.0,,HP,US,US,2021,Q3,Youth
195037021,19503702,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Candida infection,,2021,Q3,1,I,,20210702.0,20210707,20210707,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-113308",BOEHRINGER INGELHEIM,"WOLOSHUK A, LEE M, ASSMUS M, AGARWAL D, KRAMBECK A, LARGE T. ET AL. A CASE OF URETHRAL FUNGAL MASS REMOVAL IN A PATIENT TAKING EMPAGLIFLOZIN. CEN CASE REPORTS. 2021?",67.0,YR,E,F,Y,,,20210707.0,,HP,US,US,2021,Q3,Elderly
195037021,19503702,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pyelitis,,2021,Q3,1,I,,20210702.0,20210707,20210707,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-113308",BOEHRINGER INGELHEIM,"WOLOSHUK A, LEE M, ASSMUS M, AGARWAL D, KRAMBECK A, LARGE T. ET AL. A CASE OF URETHRAL FUNGAL MASS REMOVAL IN A PATIENT TAKING EMPAGLIFLOZIN. CEN CASE REPORTS. 2021?",67.0,YR,E,F,Y,,,20210707.0,,HP,US,US,2021,Q3,Elderly
195039141,19503914,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CYLINDRICAL AMPOULES",,,U,,,,20563.0,,,,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210625.0,20210707,20210707,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106013456,ELI LILLY AND CO,,70.0,YR,,M,Y,89.0,KG,20210707.0,,PH,DE,DE,2021,Q3,Elderly
195039141,19503914,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CYLINDRICAL AMPOULES",,,U,,,,20563.0,,,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210625.0,20210707,20210707,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106013456,ELI LILLY AND CO,,70.0,YR,,M,Y,89.0,KG,20210707.0,,PH,DE,DE,2021,Q3,Elderly
195049201,19504920,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, INJECTION / INFUSION SOLUTION ()",,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210623.0,20210708,20210708,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195049201,19504920,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, INJECTION / INFUSION SOLUTION ()",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210623.0,20210708,20210708,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195049201,19504920,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, INJECTION / INFUSION SOLUTION ()",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210623.0,20210708,20210708,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195049201,19504920,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, INJECTION / INFUSION SOLUTION ()",,,U,,,,,,,,,2021,Q3,Medication error,,2021,Q3,1,I,,20210623.0,20210708,20210708,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195049201,19504920,3,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO SCHEME, INJECTION / INFUSION SOLUTION ()",,,U,,,,,,,,,2021,Q3,Night sweats,,2021,Q3,1,I,,20210623.0,20210708,20210708,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195050113,19505011,13,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Cough,,2021,Q3,3,F,20210601.0,20210824.0,20210707,20210830,PER,,US-SA-2021SA221705,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
195050113,19505011,13,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Impaired work ability,,2021,Q3,3,F,20210601.0,20210824.0,20210707,20210830,PER,,US-SA-2021SA221705,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
195050113,19505011,13,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Product use issue,,2021,Q3,3,F,20210601.0,20210824.0,20210707,20210830,PER,,US-SA-2021SA221705,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
195050113,19505011,13,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Therapeutic response shortened,,2021,Q3,3,F,20210601.0,20210824.0,20210707,20210830,PER,,US-SA-2021SA221705,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
195050113,19505011,13,C,INSULINA LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q3,Therapeutic response unexpected,,2021,Q3,3,F,20210601.0,20210824.0,20210707,20210830,PER,,US-SA-2021SA221705,SANOFI AVENTIS,,72.0,YR,E,F,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
195050911,19505091,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cytokine release syndrome,,2021,Q3,1,I,20210527.0,,20210707,20210707,DIR,,,FDA-CTU,,83.0,YR,,M,N,83.3,KG,20210707.0,N,HP,US,US,2021,Q3,Elderly
195050911,19505091,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Neurotoxicity,,2021,Q3,1,I,20210527.0,,20210707,20210707,DIR,,,FDA-CTU,,83.0,YR,,M,N,83.3,KG,20210707.0,N,HP,US,US,2021,Q3,Elderly
195072321,19507232,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072321,19507232,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072321,19507232,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072321,19507232,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Medication error,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195072321,19507232,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Night sweats,,2021,Q3,1,I,,20210628.0,20210708,20210708,EXP,,DE-FRESENIUS KABI-FK202106883,FRESENIUS KABI,,78.0,YR,,M,Y,88.4,KG,20210708.0,,HP,NL,DE,2021,Q3,Elderly
195086741,19508674,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195086741,19508674,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195086741,19508674,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195086741,19508674,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195086741,19508674,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,Haematochezia,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06282-01,DE-PFIZER INC-2021770582,PFIZER,,74.0,YR,,M,Y,,,20210708.0,,MD,DE,DE,2021,Q3,Elderly
195087211,19508721,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0, INJECTION?/INFUSION SOLUTION",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06007-02,DE-PFIZER INC-2021770596,PFIZER,,82.0,YR,,F,Y,,,20210708.0,,PH,DE,DE,2021,Q3,Elderly
195087211,19508721,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0, INJECTION?/INFUSION SOLUTION",,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210624.0,20210708,20210708,EXP,DE-ADRED-06007-02,DE-PFIZER INC-2021770596,PFIZER,,82.0,YR,,F,Y,,,20210708.0,,PH,DE,DE,2021,Q3,Elderly
195093931,19509393,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20200605.0,20200605.0,20210708,20210708,PER,,US-ELI_LILLY_AND_COMPANY-US202006003940,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20210708.0,,CN,US,US,2021,Q3,Adult
195093931,19509393,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,20200605.0,20200605.0,20210708,20210708,PER,,US-ELI_LILLY_AND_COMPANY-US202006003940,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20210708.0,,CN,US,US,2021,Q3,Adult
195093931,19509393,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,,,,INJECTION,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,20200605.0,20200605.0,20210708,20210708,PER,,US-ELI_LILLY_AND_COMPANY-US202006003940,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20210708.0,,CN,US,US,2021,Q3,Adult
195093931,19509393,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D051995D,,,,,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,1,I,20200605.0,20200605.0,20210708,20210708,PER,,US-ELI_LILLY_AND_COMPANY-US202006003940,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20210708.0,,CN,US,US,2021,Q3,Adult
195105332,19510533,34,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,0?12 UNITS,,,,,,,,,,UNKNOWN,Q3H,2021,Q3,Acute respiratory distress syndrome,,2021,Q3,2,F,20210611.0,20210714.0,20210708,20210723,EXP,,US-CELGENEUS-USA-20210604663,CELGENE,,75.0,YR,,M,Y,67.6,KG,20210723.0,,HP,US,US,2021,Q3,Elderly
195105332,19510533,34,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,0?12 UNITS,,,,,,,,,,UNKNOWN,Q3H,2021,Q3,Pneumonia,,2021,Q3,2,F,20210611.0,20210714.0,20210708,20210723,EXP,,US-CELGENEUS-USA-20210604663,CELGENE,,75.0,YR,,M,Y,67.6,KG,20210723.0,,HP,US,US,2021,Q3,Elderly
195105332,19510533,34,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,0?12 UNITS,,,,,,,,,,UNKNOWN,Q3H,2021,Q3,Respiratory failure,,2021,Q3,2,F,20210611.0,20210714.0,20210708,20210723,EXP,,US-CELGENEUS-USA-20210604663,CELGENE,,75.0,YR,,M,Y,67.6,KG,20210723.0,,HP,US,US,2021,Q3,Elderly
195105332,19510533,34,C,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,0?12 UNITS,,,,,,,,,,UNKNOWN,Q3H,2021,Q3,Sepsis,,2021,Q3,2,F,20210611.0,20210714.0,20210708,20210723,EXP,,US-CELGENEUS-USA-20210604663,CELGENE,,75.0,YR,,M,Y,67.6,KG,20210723.0,,HP,US,US,2021,Q3,Elderly
195111671,19511167,6,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT (3?3?2?0, CYLINDRICAL AMPOULES)",,,U,U,,,,1.0,IU,,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210628.0,20210709,20210709,EXP,,DE-AUROBINDO-AUR-APL-2021-028067,AUROBINDO,,70.0,YR,,M,Y,89.0,KG,20210709.0,,PH,DE,DE,2021,Q3,Elderly
195111671,19511167,6,SS,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT (3?3?2?0, CYLINDRICAL AMPOULES)",,,U,U,,,,1.0,IU,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210628.0,20210709,20210709,EXP,,DE-AUROBINDO-AUR-APL-2021-028067,AUROBINDO,,70.0,YR,,M,Y,89.0,KG,20210709.0,,PH,DE,DE,2021,Q3,Elderly
195134351,19513435,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",1.0,DF,Y,U,,,,1.0,DF,INJECTION,,2021,Q3,Drug abuse,,2021,Q3,1,I,20201201.0,20210630.0,20210709,20210709,EXP,IT-MINISAL02-653123,IT-MYLANLABS-2021M1039298,MYLAN,,32.0,YR,,F,Y,,,20210709.0,,MD,IT,IT,2021,Q3,Young Adult
195134351,19513435,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",1.0,DF,Y,U,,,,1.0,DF,INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20201201.0,20210630.0,20210709,20210709,EXP,IT-MINISAL02-653123,IT-MYLANLABS-2021M1039298,MYLAN,,32.0,YR,,F,Y,,,20210709.0,,MD,IT,IT,2021,Q3,Young Adult
195134351,19513435,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",1.0,DF,Y,U,,,,1.0,DF,INJECTION,,2021,Q3,Intentional self-injury,,2021,Q3,1,I,20201201.0,20210630.0,20210709,20210709,EXP,IT-MINISAL02-653123,IT-MYLANLABS-2021M1039298,MYLAN,,32.0,YR,,F,Y,,,20210709.0,,MD,IT,IT,2021,Q3,Young Adult
195134351,19513435,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",1.0,DF,Y,U,,,,1.0,DF,INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20201201.0,20210630.0,20210709,20210709,EXP,IT-MINISAL02-653123,IT-MYLANLABS-2021M1039298,MYLAN,,32.0,YR,,F,Y,,,20210709.0,,MD,IT,IT,2021,Q3,Young Adult
195134351,19513435,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 DOSAGE FORM, TOTAL",1.0,DF,Y,U,,,,1.0,DF,INJECTION,,2021,Q3,Sopor,,2021,Q3,1,I,20201201.0,20210630.0,20210709,20210709,EXP,IT-MINISAL02-653123,IT-MYLANLABS-2021M1039298,MYLAN,,32.0,YR,,F,Y,,,20210709.0,,MD,IT,IT,2021,Q3,Young Adult
195140671,19514067,45,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,U,, UNK,,,1.0,IU,UNKNOWN,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,1,I,20200809.0,20210629.0,20210709,20210709,EXP,,FR-FRESENIUS KABI-FK202106759,FRESENIUS KABI,,74.0,YR,,M,Y,,,20210709.0,,HP,NL,FR,2021,Q3,Elderly
195140671,19514067,60,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,U,, UNK,,,1.0,IU,UNKNOWN,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,1,I,20200809.0,20210629.0,20210709,20210709,EXP,,FR-FRESENIUS KABI-FK202106759,FRESENIUS KABI,,74.0,YR,,M,Y,,,20210709.0,,HP,NL,FR,2021,Q3,Elderly
195153041,19515304,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,20.0,IU,UNKNOWN,TID,2021,Q3,Arthralgia,,2021,Q3,1,I,20210625.0,20210706.0,20210709,20210709,EXP,,US-FRESENIUS KABI-FK202106988,FRESENIUS KABI,,80.0,YR,,M,Y,97.5,KG,20210709.0,,CN,US,US,2021,Q3,Elderly
195153041,19515304,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,20.0,IU,UNKNOWN,TID,2021,Q3,Contraindicated product administered,,2021,Q3,1,I,20210625.0,20210706.0,20210709,20210709,EXP,,US-FRESENIUS KABI-FK202106988,FRESENIUS KABI,,80.0,YR,,M,Y,97.5,KG,20210709.0,,CN,US,US,2021,Q3,Elderly
195153631,19515363,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 3?3?2?0, ZYLINDERAMPULLEN)",,,U,, UNK,,,,,,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210628.0,20210710,20210710,EXP,,NVSC2021DE145323,NOVARTIS,,70.0,YR,,M,Y,89.0,KG,20210710.0,,HP,DE,DE,2021,Q3,Elderly
195153631,19515363,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 3?3?2?0, ZYLINDERAMPULLEN)",,,U,, UNK,,,,,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210628.0,20210710,20210710,EXP,,NVSC2021DE145323,NOVARTIS,,70.0,YR,,M,Y,89.0,KG,20210710.0,,HP,DE,DE,2021,Q3,Elderly
195198431,19519843,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Confusional state,,2021,Q3,1,I,,20210629.0,20210712,20210712,EXP,,"DE-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00813",COLLEGIUM PHARMACEUTICAL,,86.0,YR,,F,Y,64.0,KG,20210712.0,,CN,DE,DE,2021,Q3,Elderly
195198431,19519843,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210629.0,20210712,20210712,EXP,,"DE-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00813",COLLEGIUM PHARMACEUTICAL,,86.0,YR,,F,Y,64.0,KG,20210712.0,,CN,DE,DE,2021,Q3,Elderly
195198431,19519843,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210629.0,20210712,20210712,EXP,,"DE-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00813",COLLEGIUM PHARMACEUTICAL,,86.0,YR,,F,Y,64.0,KG,20210712.0,,CN,DE,DE,2021,Q3,Elderly
195198431,19519843,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210629.0,20210712,20210712,EXP,,"DE-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00813",COLLEGIUM PHARMACEUTICAL,,86.0,YR,,F,Y,64.0,KG,20210712.0,,CN,DE,DE,2021,Q3,Elderly
195198431,19519843,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Malaise,,2021,Q3,1,I,,20210629.0,20210712,20210712,EXP,,"DE-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00813",COLLEGIUM PHARMACEUTICAL,,86.0,YR,,F,Y,64.0,KG,20210712.0,,CN,DE,DE,2021,Q3,Elderly
195198431,19519843,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Musculoskeletal pain,,2021,Q3,1,I,,20210629.0,20210712,20210712,EXP,,"DE-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00813",COLLEGIUM PHARMACEUTICAL,,86.0,YR,,F,Y,64.0,KG,20210712.0,,CN,DE,DE,2021,Q3,Elderly
195198431,19519843,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pruritus,,2021,Q3,1,I,,20210629.0,20210712,20210712,EXP,,"DE-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00813",COLLEGIUM PHARMACEUTICAL,,86.0,YR,,F,Y,64.0,KG,20210712.0,,CN,DE,DE,2021,Q3,Elderly
195198431,19519843,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Rash,,2021,Q3,1,I,,20210629.0,20210712,20210712,EXP,,"DE-COLLEGIUM PHARMACEUTICAL, INC.-2021CGM00813",COLLEGIUM PHARMACEUTICAL,,86.0,YR,,F,Y,64.0,KG,20210712.0,,CN,DE,DE,2021,Q3,Elderly
195207361,19520736,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,NVSC2021DE148852,NOVARTIS,,79.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Elderly
195207361,19520736,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,NVSC2021DE148852,NOVARTIS,,79.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Elderly
195207361,19520736,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NACH SCHEMA, INJEKTIONS?/INFUSIONSL?SUNG",,,U,,,,,,,,,2021,Q3,Pallor,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,NVSC2021DE148852,NOVARTIS,,79.0,YR,,F,Y,,,20210712.0,,HP,DE,DE,2021,Q3,Elderly
195217131,19521713,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 3?3?2?0, CYLINDER AMPOULES",,,U,, UNKNOWN,,,,,,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,DE-PFIZER INC-2021795618,PFIZER,,70.0,YR,,M,Y,89.0,KG,20210712.0,,PH,DE,DE,2021,Q3,Elderly
195217131,19521713,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 3?3?2?0, CYLINDER AMPOULES",,,U,, UNKNOWN,,,,,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210628.0,20210712,20210712,EXP,,DE-PFIZER INC-2021795618,PFIZER,,70.0,YR,,M,Y,89.0,KG,20210712.0,,PH,DE,DE,2021,Q3,Elderly
195220841,19522084,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210627.0,20210630.0,20210712,20210712,PER,,US-ELI_LILLY_AND_COMPANY-US202107001897,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195220841,19522084,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Wrong technique in product usage process,,2021,Q3,1,I,20210627.0,20210630.0,20210712,20210712,PER,,US-ELI_LILLY_AND_COMPANY-US202107001897,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195220841,19522084,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210627.0,20210630.0,20210712,20210712,PER,,US-ELI_LILLY_AND_COMPANY-US202107001897,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195220841,19522084,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,,,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Wrong technique in product usage process,,2021,Q3,1,I,20210627.0,20210630.0,20210712,20210712,PER,,US-ELI_LILLY_AND_COMPANY-US202107001897,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195220841,19522084,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,, D134925H,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210627.0,20210630.0,20210712,20210712,PER,,US-ELI_LILLY_AND_COMPANY-US202107001897,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195220841,19522084,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,, D134925H,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Wrong technique in product usage process,,2021,Q3,1,I,20210627.0,20210630.0,20210712,20210712,PER,,US-ELI_LILLY_AND_COMPANY-US202107001897,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195220841,19522084,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,, D134925H,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210627.0,20210630.0,20210712,20210712,PER,,US-ELI_LILLY_AND_COMPANY-US202107001897,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195220841,19522084,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, EACH MORNING",,,,, D134925H,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Wrong technique in product usage process,,2021,Q3,1,I,20210627.0,20210630.0,20210712,20210712,PER,,US-ELI_LILLY_AND_COMPANY-US202107001897,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195236281,19523628,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN (3?4 TIMES PER DAY)",,,,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Blindness,,2021,Q3,1,I,202106.0,20210630.0,20210712,20210712,EXP,,US-ELI_LILLY_AND_COMPANY-US202107001205,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195236281,19523628,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN (3?4 TIMES PER DAY)",,,,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,202106.0,20210630.0,20210712,20210712,EXP,,US-ELI_LILLY_AND_COMPANY-US202107001205,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195236281,19523628,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN (3?4 TIMES PER DAY)",,,,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202106.0,20210630.0,20210712,20210712,EXP,,US-ELI_LILLY_AND_COMPANY-US202107001205,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195236281,19523628,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN (3?4 TIMES PER DAY)",,,,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Cataract,,2021,Q3,1,I,202106.0,20210630.0,20210712,20210712,EXP,,US-ELI_LILLY_AND_COMPANY-US202107001205,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195236281,19523628,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN (3?4 TIMES PER DAY)",,,,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Feeding disorder,,2021,Q3,1,I,202106.0,20210630.0,20210712,20210712,EXP,,US-ELI_LILLY_AND_COMPANY-US202107001205,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195236281,19523628,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN (3?4 TIMES PER DAY)",,,,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Food allergy,,2021,Q3,1,I,202106.0,20210630.0,20210712,20210712,EXP,,US-ELI_LILLY_AND_COMPANY-US202107001205,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195236281,19523628,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN (3?4 TIMES PER DAY)",,,,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Stress,,2021,Q3,1,I,202106.0,20210630.0,20210712,20210712,EXP,,US-ELI_LILLY_AND_COMPANY-US202107001205,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195236281,19523628,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN (3?4 TIMES PER DAY)",,,,,,,20563.0,20.0,IU,INJECTION,QD,2021,Q3,Visual impairment,,2021,Q3,1,I,202106.0,20210630.0,20210712,20210712,EXP,,US-ELI_LILLY_AND_COMPANY-US202107001205,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20210712.0,,CN,US,US,2021,Q3,Elderly
195260601,19526060,19,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2021,Q3,Diabetes insipidus,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,US-TEVA-2021-US-1931390,TEVA,"HERITY LB, BAKER C, KIM C, LOWE DK, CAHOON WD JR. DELAYED ONSET OF CENTRAL DIABETES INSIPIDUS WITH KETAMINE SEDATION: A REPORT OF 2 CASES. J?PHARM?PRACT 2021?34(2):314?318.",23.0,YR,A,M,Y,,,20210713.0,,HP,US,US,2021,Q3,Youth
195260601,19526060,19,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2021,Q3,Therapy non-responder,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,US-TEVA-2021-US-1931390,TEVA,"HERITY LB, BAKER C, KIM C, LOWE DK, CAHOON WD JR. DELAYED ONSET OF CENTRAL DIABETES INSIPIDUS WITH KETAMINE SEDATION: A REPORT OF 2 CASES. J?PHARM?PRACT 2021?34(2):314?318.",23.0,YR,A,M,Y,,,20210713.0,,HP,US,US,2021,Q3,Youth
195266211,19526621,2,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Appendicitis,,2021,Q3,1,I,20200218.0,20210702.0,20210713,20210713,EXP,,BR-NOVOPROD-828189,NOVO NORDISK,,33.0,YR,,F,Y,62.0,KG,20210713.0,,MD,BR,BR,2021,Q3,Young Adult
195266211,19526621,2,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,COVID-19,,2021,Q3,1,I,20200218.0,20210702.0,20210713,20210713,EXP,,BR-NOVOPROD-828189,NOVO NORDISK,,33.0,YR,,F,Y,62.0,KG,20210713.0,,MD,BR,BR,2021,Q3,Young Adult
195313971,19531397,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY (20?25UNIT BEFORE BREAKFAST)",,,U,, D134925H,,21017.0,25.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,1,PS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY (20?25UNIT BEFORE BREAKFAST)",,,U,, D134925H,,21017.0,25.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY (20?25UNIT BEFORE BREAKFAST)",,,U,, D134925H,,21017.0,25.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,2,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY (20?25UNIT BEFORE BREAKFAST)",,,U,, D134925H,,21017.0,25.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY (40?45UNIT BEFORE DINNER)",,,U,, D134925H,,21017.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,3,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY (40?45UNIT BEFORE DINNER)",,,U,, D134925H,,21017.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY (40?45UNIT BEFORE DINNER)",,,U,, D134925H,,21017.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,4,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY (40?45UNIT BEFORE DINNER)",,,U,, D134925H,,21017.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY (20?25UNIT BEFORE BREAKFAST)",,,U,,,,21017.0,25.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,5,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY (20?25UNIT BEFORE BREAKFAST)",,,U,,,,21017.0,25.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY (20?25UNIT BEFORE BREAKFAST)",,,U,,,,21017.0,25.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,6,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"25 U, DAILY (20?25UNIT BEFORE BREAKFAST)",,,U,,,,21017.0,25.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,7,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY (40?45UNIT BEFORE DINNER)",,,U,,,,21017.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,7,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY (40?45UNIT BEFORE DINNER)",,,U,,,,21017.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,8,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY (40?45UNIT BEFORE DINNER)",,,U,,,,21017.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,8,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY (40?45UNIT BEFORE DINNER)",,,U,,,,21017.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,9,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, PRN",,,U,,,,21017.0,15.0,IU,INJECTION,,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,9,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, PRN",,,U,,,,21017.0,15.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,10,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, PRN",,,U,,,,21017.0,15.0,IU,INJECTION,,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,10,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"15 U, PRN",,,U,,,,21017.0,15.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,11,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, DAILY (BEFORE DINNER)",,,U,,,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,11,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, DAILY (BEFORE DINNER)",,,U,,,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,12,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, DAILY (BEFORE DINNER)",,,U,,,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195313971,19531397,12,SS,Insulin Lispro Lilly 25LIS75NPL KwikPen/MirioPen,INSULIN LISPRO,1,Subcutaneous,"20 U, DAILY (BEFORE DINNER)",,,U,,,,21017.0,20.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210706.0,20210707.0,20210713,20210713,PER,,US-ELI_LILLY_AND_COMPANY-US202107004219,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210713.0,,CN,US,US,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Abscess,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Adrenal insufficiency,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Ascites,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Asthenia,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Blood alkaline phosphatase increased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Blood bilirubin increased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Blood potassium decreased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Blood pressure diastolic abnormal,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Blood pressure increased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Congestive hepatopathy,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Depression,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Diverticulitis,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Endometrial disorder,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Enterococcus test positive,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Fibrosis,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Gamma-glutamyltransferase increased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Gastrointestinal disorder,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Generalised oedema,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Heart rate increased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Herpes zoster,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hypersensitivity,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Increased appetite,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Influenza,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Infusion related reaction,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Injection site extravasation,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Intensive care unit acquired weakness,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Intervertebral disc protrusion,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Joint effusion,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Joint swelling,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Micturition disorder,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Myelopathy,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Myopathy,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Nasopharyngitis,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Nerve compression,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Neuropathy peripheral,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Neutropenia,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Osteoarthritis,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pancytopenia,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Peripheral sensorimotor neuropathy,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Peritonitis,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pseudomonal bacteraemia,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Rheumatoid arthritis,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Septic shock,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Therapeutic response decreased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Weight decreased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195342062,19534206,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210723.0,20210713,20210803,EXP,,CA-VALIDUS PHARMACEUTICALS LLC-VDP-2021-000085,VALIDUS,,62.0,YR,,F,Y,67.0,KG,20210803.0,,CN,US,CA,2021,Q3,Adult
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Asthma,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Cough,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Discomfort,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Weight increased,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195412601,19541260,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Wheezing,,2021,Q3,1,I,,20210705.0,20210713,20210713,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20210713.0,,HP,CA,CA,2021,Q3,Elderly
195439931,19543993,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210708.0,20210709.0,20210714,20210714,PER,,US-ELI_LILLY_AND_COMPANY-US202107005580,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Adult
195439931,19543993,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,20210708.0,20210709.0,20210714,20210714,PER,,US-ELI_LILLY_AND_COMPANY-US202107005580,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Adult
195439931,19543993,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Injection site pain,,2021,Q3,1,I,20210708.0,20210709.0,20210714,20210714,PER,,US-ELI_LILLY_AND_COMPANY-US202107005580,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Adult
195439931,19543993,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Product storage error,,2021,Q3,1,I,20210708.0,20210709.0,20210714,20210714,PER,,US-ELI_LILLY_AND_COMPANY-US202107005580,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Adult
195439931,19543993,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D185008D,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210708.0,20210709.0,20210714,20210714,PER,,US-ELI_LILLY_AND_COMPANY-US202107005580,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Adult
195439931,19543993,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D185008D,,20563.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,20210708.0,20210709.0,20210714,20210714,PER,,US-ELI_LILLY_AND_COMPANY-US202107005580,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Adult
195439931,19543993,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D185008D,,20563.0,,,INJECTION,,2021,Q3,Injection site pain,,2021,Q3,1,I,20210708.0,20210709.0,20210714,20210714,PER,,US-ELI_LILLY_AND_COMPANY-US202107005580,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Adult
195439931,19543993,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D185008D,,20563.0,,,INJECTION,,2021,Q3,Product storage error,,2021,Q3,1,I,20210708.0,20210709.0,20210714,20210714,PER,,US-ELI_LILLY_AND_COMPANY-US202107005580,ELI LILLY AND CO,,42.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Adult
195456124,19545612,25,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE,,,,,,,,,,UNKNOWN,TID,2021,Q3,Hypotension,,2021,Q3,4,F,20210628.0,20210810.0,20210714,20210816,PER,,US-CELGENEUS-USA-20210702095,CELGENE,,78.0,YR,,F,Y,70.3,KG,20210816.0,,HP,US,US,2021,Q3,Elderly
195568401,19556840,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,SUBCUTANEOUS INJECTION,,2021,Q3,Diabetes insipidus,,2021,Q3,1,I,,20210706.0,20210715,20210715,EXP,,US-ENDO PHARMACEUTICALS INC-2021-010219,ENDO,"HERITY LB, BAKER C, KIM C, LOWE DK, CAHOON WD JR.. DELAYED ONSET OF CENTRAL DIABETES INSIPIDUS WITH KETAMINE SEDATION: A REPORT OF 2 CASES. JOURNAL OF PHARMACY PRACTICE. 2021?34(2):314?318",23.0,YR,,M,Y,86.2,KG,20210715.0,,PH,US,US,2021,Q3,Youth
195568861,19556886,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN",,,,,,,20563.0,20.0,IU,INJECTION,,2021,Q3,Accidental underdose,,2021,Q3,1,I,20210613.0,20210616.0,20210716,20210716,PER,,US-ELI_LILLY_AND_COMPANY-US202106008963,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210716.0,,CN,US,US,2021,Q3,Elderly
195568861,19556886,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"20 U, UNKNOWN",,,,, D261904A,,20563.0,20.0,IU,INJECTION,,2021,Q3,Accidental underdose,,2021,Q3,1,I,20210613.0,20210616.0,20210716,20210716,PER,,US-ELI_LILLY_AND_COMPANY-US202106008963,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20210716.0,,CN,US,US,2021,Q3,Elderly
195680861,19568086,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210301.0,20210324.0,20210714,20210714,PER,,US-NOVOPROD-799074,NOVO NORDISK,,77.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Elderly
195680861,19568086,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,20210301.0,20210324.0,20210714,20210714,PER,,US-NOVOPROD-799074,NOVO NORDISK,,77.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Elderly
195680861,19568086,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Dysphagia,,2021,Q3,1,I,20210301.0,20210324.0,20210714,20210714,PER,,US-NOVOPROD-799074,NOVO NORDISK,,77.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Elderly
195680861,19568086,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,20210301.0,20210324.0,20210714,20210714,PER,,US-NOVOPROD-799074,NOVO NORDISK,,77.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Elderly
195680861,19568086,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210301.0,20210324.0,20210714,20210714,PER,,US-NOVOPROD-799074,NOVO NORDISK,,77.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Elderly
195680861,19568086,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,20210301.0,20210324.0,20210714,20210714,PER,,US-NOVOPROD-799074,NOVO NORDISK,,77.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Elderly
195680861,19568086,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,, UNKNOWN,,,,,,,2021,Q3,Pharyngeal swelling,,2021,Q3,1,I,20210301.0,20210324.0,20210714,20210714,PER,,US-NOVOPROD-799074,NOVO NORDISK,,77.0,YR,,M,Y,,,20210714.0,,CN,US,US,2021,Q3,Elderly
195699932,19569993,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE UNSPECIFIED,,,,,,,,,,INJECTION,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE UNSPECIFIED,,,,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE UNSPECIFIED,,,,,,,,,,INJECTION,,2021,Q3,Injection site nodule,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,,,,,,,,INJECTION,,2021,Q3,Injection site nodule,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,15.0,IU,INJECTION,QD,2021,Q3,Diabetic metabolic decompensation,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,15.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195699932,19569993,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,15.0,IU,INJECTION,QD,2021,Q3,Injection site nodule,,2021,Q3,2,F,201605.0,20210713.0,20210715,20210721,EXP,,SK-ASTRAZENECA-2021A601970,ASTRAZENECA,,53.0,YR,,M,Y,,,20210721.0,,HP,SK,SK,2021,Q3,Adult
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Asthma,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Cough,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Discomfort,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Weight increased,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,8,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, BID",,,D,U,,,209196.0,1.0,DF,SOLUTION FOR INJECTION,Q12H,2021,Q3,Wheezing,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Asthma,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Cough,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Discomfort,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Weight increased,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195703451,19570345,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 DF, Q12H",,,U,,,,,1.0,DF,,Q12H,2021,Q3,Wheezing,,2021,Q3,1,I,,20210705.0,20210716,20210716,EXP,,CA-SA-2021SA233256,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210716.0,,HP,CA,CA,2021,Q3,Elderly
195726741,19572674,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,2004.0,20210706.0,20210716,20210716,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002741,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210716.0,,CN,US,US,2021,Q3,Adult
195726741,19572674,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Cardiac disorder,,2021,Q3,1,I,2004.0,20210706.0,20210716,20210716,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002741,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210716.0,,CN,US,US,2021,Q3,Adult
195726741,19572674,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,2004.0,20210706.0,20210716,20210716,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002741,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210716.0,,CN,US,US,2021,Q3,Adult
195726741,19572674,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Myocardial infarction,,2021,Q3,1,I,2004.0,20210706.0,20210716,20210716,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002741,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210716.0,,CN,US,US,2021,Q3,Adult
195726741,19572674,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D305094A,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,2004.0,20210706.0,20210716,20210716,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002741,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210716.0,,CN,US,US,2021,Q3,Adult
195726741,19572674,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D305094A,,20563.0,,,INJECTION,,2021,Q3,Cardiac disorder,,2021,Q3,1,I,2004.0,20210706.0,20210716,20210716,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002741,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210716.0,,CN,US,US,2021,Q3,Adult
195726741,19572674,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D305094A,,20563.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,2004.0,20210706.0,20210716,20210716,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002741,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210716.0,,CN,US,US,2021,Q3,Adult
195726741,19572674,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D305094A,,20563.0,,,INJECTION,,2021,Q3,Myocardial infarction,,2021,Q3,1,I,2004.0,20210706.0,20210716,20210716,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002741,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210716.0,,CN,US,US,2021,Q3,Adult
195739461,19573946,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,20563.0,,,INJECTION,,2021,Q3,Psoriasis,,2021,Q3,1,I,,20210713.0,20210718,20210718,PER,,US-ELI_LILLY_AND_COMPANY-US202107007407,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20210718.0,,CN,US,US,2021,Q3,Elderly
195750921,19575092,10,C,Lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,20210713.0,,20210716,20210716,DIR,,,FDA-CTU,,60.0,YR,,F,N,85.4,KG,20210716.0,N,PH,US,US,2021,Q3,Adult
195750921,19575092,10,C,Lispro insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,20210713.0,,20210716,20210716,DIR,,,FDA-CTU,,60.0,YR,,F,N,85.4,KG,20210716.0,N,PH,US,US,2021,Q3,Adult
195753181,19575318,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,,,,,15.0,IU,,,2021,Q3,Vision blurred,,2021,Q3,1,I,202011.0,20210714.0,20210719,20210719,PER,,US-ELI_LILLY_AND_COMPANY-US202107006418,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195753181,19575318,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U, UNKNOWN",,,,, D371847A,,,15.0,IU,,,2021,Q3,Vision blurred,,2021,Q3,1,I,202011.0,20210714.0,20210719,20210719,PER,,US-ELI_LILLY_AND_COMPANY-US202107006418,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195769041,19576904,13,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,20210702.0,,20210705,20210705,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.8,KG,20210705.0,N,PH,US,US,2021,Q3,Elderly
195769041,19576904,13,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Therapy cessation,,2021,Q3,1,I,20210702.0,,20210705,20210705,DIR,,,FDA-CTU,,75.0,YR,,M,N,91.8,KG,20210705.0,N,PH,US,US,2021,Q3,Elderly
195781981,19578198,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,6U AT 7 AM; 10 U AT 12 AM AND 6  PM AT SUBCUTANEOUS,,,U,,,,,6.0,IU,,,2021,Q3,Exposure during pregnancy,Exposure during pregnancy,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,IT-INVATECH-000118,INVATECH PHARMA SOLUTIONS,,33.0,YR,A,F,Y,,,20210714.0,,HP,IT,IT,2021,Q3,Young Adult
195781981,19578198,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,6U AT 7 AM; 10 U AT 12 AM AND 6  PM AT SUBCUTANEOUS,,,U,,,,,6.0,IU,,,2021,Q3,Hypertension,Hypertension,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,IT-INVATECH-000118,INVATECH PHARMA SOLUTIONS,,33.0,YR,A,F,Y,,,20210714.0,,HP,IT,IT,2021,Q3,Young Adult
195781981,19578198,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,6U AT 7 AM; 10 U AT 12 AM AND 6  PM AT SUBCUTANEOUS,,,U,,,,,6.0,IU,,,2021,Q3,Phaeochromocytoma,Phaeochromocytoma,2021,Q3,1,I,,20210706.0,20210719,20210719,EXP,,IT-INVATECH-000118,INVATECH PHARMA SOLUTIONS,,33.0,YR,A,F,Y,,,20210714.0,,HP,IT,IT,2021,Q3,Young Adult
195793991,19579399,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20201215.0,20201218.0,20210719,20210719,PER,,US-NOVOPROD-776992,NOVO NORDISK,,75.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195793991,19579399,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20201215.0,20201218.0,20210719,20210719,PER,,US-NOVOPROD-776992,NOVO NORDISK,,75.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195793991,19579399,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,20201215.0,20201218.0,20210719,20210719,PER,,US-NOVOPROD-776992,NOVO NORDISK,,75.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195793991,19579399,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Eructation,,2021,Q3,1,I,20201215.0,20201218.0,20210719,20210719,PER,,US-NOVOPROD-776992,NOVO NORDISK,,75.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195793991,19579399,3,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Extra dose administered,,2021,Q3,1,I,20201215.0,20201218.0,20210719,20210719,PER,,US-NOVOPROD-776992,NOVO NORDISK,,75.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195798351,19579835,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 IU MORNING; 50 IU EVENING; 25 IU AT BEDTIME,,,,, UNKNOWN,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,20201207.0,20210118.0,20210719,20210719,PER,,US-NOVOPROD-782099,NOVO NORDISK,,84.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195798351,19579835,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 IU MORNING; 50 IU EVENING; 25 IU AT BEDTIME,,,,, UNKNOWN,,,,,,,2021,Q3,Gastrointestinal motility disorder,,2021,Q3,1,I,20201207.0,20210118.0,20210719,20210719,PER,,US-NOVOPROD-782099,NOVO NORDISK,,84.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195798351,19579835,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 IU MORNING; 50 IU EVENING; 25 IU AT BEDTIME,,,,, UNKNOWN,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,20201207.0,20210118.0,20210719,20210719,PER,,US-NOVOPROD-782099,NOVO NORDISK,,84.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195798351,19579835,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 IU MORNING; 50 IU EVENING; 25 IU AT BEDTIME,,,,, UNKNOWN,,,,,,,2021,Q3,Rectal tenesmus,,2021,Q3,1,I,20201207.0,20210118.0,20210719,20210719,PER,,US-NOVOPROD-782099,NOVO NORDISK,,84.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195798351,19579835,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 IU MORNING; 50 IU EVENING; 25 IU AT BEDTIME,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,20201207.0,20210118.0,20210719,20210719,PER,,US-NOVOPROD-782099,NOVO NORDISK,,84.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195798351,19579835,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 IU MORNING; 50 IU EVENING; 25 IU AT BEDTIME,,,,,,,,,,,,2021,Q3,Gastrointestinal motility disorder,,2021,Q3,1,I,20201207.0,20210118.0,20210719,20210719,PER,,US-NOVOPROD-782099,NOVO NORDISK,,84.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195798351,19579835,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 IU MORNING; 50 IU EVENING; 25 IU AT BEDTIME,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,20201207.0,20210118.0,20210719,20210719,PER,,US-NOVOPROD-782099,NOVO NORDISK,,84.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195798351,19579835,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,50 IU MORNING; 50 IU EVENING; 25 IU AT BEDTIME,,,,,,,,,,,,2021,Q3,Rectal tenesmus,,2021,Q3,1,I,20201207.0,20210118.0,20210719,20210719,PER,,US-NOVOPROD-782099,NOVO NORDISK,,84.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195805151,19580515,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,,, D207627A,,20563.0,,,INJECTION,,2021,Q3,Arthritis,,2021,Q3,1,I,20210706.0,20210706.0,20210719,20210719,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002730,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195805151,19580515,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,,, D207627A,,20563.0,,,INJECTION,,2021,Q3,Chronic obstructive pulmonary disease,,2021,Q3,1,I,20210706.0,20210706.0,20210719,20210719,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002730,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195805151,19580515,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, PRN",,,,, D207627A,,20563.0,,,INJECTION,,2021,Q3,Dysphonia,,2021,Q3,1,I,20210706.0,20210706.0,20210719,20210719,EXP,,US-ELI_LILLY_AND_COMPANY-US202107002730,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210719.0,,CN,US,US,2021,Q3,Elderly
195810882,19581088,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,,,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,,,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,,,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,,,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,,,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,,,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,,,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,,,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341138C,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,5,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341138C,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341138C,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,6,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341138C,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,7,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341138C,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,7,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341138C,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,8,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341139A,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,8,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341139A,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,9,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341139A,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195810882,19581088,9,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"45 U, DAILY",,,,, D341139A,,20563.0,45.0,IU,INJECTION,QD,2021,Q3,Drug ineffective,,2021,Q3,2,F,20210714.0,20210728.0,20210720,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202107007274,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210802.0,,HP,US,US,2021,Q3,Elderly
195815641,19581564,4,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Rash,,2021,Q3,1,I,20210714.0,,20210720,20210720,DIR,,,FDA-CTU,,51.0,YR,,F,N,86.1,KG,20210720.0,N,PH,US,US,2021,Q3,Adult
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Asthma,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Blood count abnormal,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Chest discomfort,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Cough,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Diaphragmatic disorder,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Discomfort,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Hypoxia,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Left ventricular hypertrophy,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Obstructive airways disorder,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Pyrexia,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Weight increased,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195840272,19584027,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2021,Q3,Wheezing,,2021,Q3,2,F,,20210903.0,20210720,20210903,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20210903.0,,CN,CA,CA,2021,Q3,Elderly
195842311,19584231,7,C,INSULINA LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,20210104.0,20210715.0,20210720,20210720,EXP,IT-MINISAL02-658969,IT-MYLANLABS-2021M1043336,MYLAN,,78.0,YR,,F,Y,,,20210720.0,,MD,IT,IT,2021,Q3,Elderly
195844471,19584447,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,,20210708.0,20210720,20210720,EXP,,"US-JACOBUS PHARMACEUTICAL COMPANY, INC.-2114038",JACOBUS PHARM,,78.0,YR,,M,Y,,,20210720.0,,,US,US,2021,Q3,Elderly
195844881,19584488,2,SS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,INJECTION,,2021,Q3,Vision blurred,,2021,Q3,1,I,20210715.0,20210715.0,20210720,20210720,PER,,US-ELI_LILLY_AND_COMPANY-US202107007785,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20210720.0,,CN,US,US,2021,Q3,Elderly
195848272,19584827,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,DOSE UNSPECIFIED,,,D,,,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,201605.0,20210910.0,20210720,20210923,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"MARTINKA E, KOLLAROVA D, URBANOVA M. SKUSENOSTI Z PRAXE POTVRDZUJU VYSLEDKY STUDII RCT A RWE S EMPAGLIFLOZINOM: KAZUISTIKY. FORUM DIABETOLOGICUM. 2021?10(1):53?61.",53.0,YR,,M,Y,,,20210923.0,,MD,SK,SK,2021,Q3,Adult
195848272,19584827,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,TOTAL DAILY INSULIN DOSE WAS 80 UNITS/DAY (INSULIN LISPRO PLUS GLARGINE),,,D,,,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,201605.0,20210910.0,20210720,20210923,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"MARTINKA E, KOLLAROVA D, URBANOVA M. SKUSENOSTI Z PRAXE POTVRDZUJU VYSLEDKY STUDII RCT A RWE S EMPAGLIFLOZINOM: KAZUISTIKY. FORUM DIABETOLOGICUM. 2021?10(1):53?61.",53.0,YR,,M,Y,,,20210923.0,,MD,SK,SK,2021,Q3,Adult
195848272,19584827,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,15 UNITS PER DAY,,,D,,,,,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,201605.0,20210910.0,20210720,20210923,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"MARTINKA E, KOLLAROVA D, URBANOVA M. SKUSENOSTI Z PRAXE POTVRDZUJU VYSLEDKY STUDII RCT A RWE S EMPAGLIFLOZINOM: KAZUISTIKY. FORUM DIABETOLOGICUM. 2021?10(1):53?61.",53.0,YR,,M,Y,,,20210923.0,,MD,SK,SK,2021,Q3,Adult
195851692,19585169,23,C,LISPRO?INSULIN,INSULIN LISPRO,1,Subcutaneous,"50 UNITS, QD",,,,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,2,F,20210520.0,20210921.0,20210720,20210929,EXP,,US-GLAXOSMITHKLINE-US2021GSK111808,GLAXOSMITHKLINE,,74.0,YR,,M,Y,,,20210929.0,,MD,US,US,2021,Q3,Elderly
195873351,19587335,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CYLINDER AMPOULES",,,U,, UNKNOWN,,,,,,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210720.0,20210721,20210721,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116210",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,89.0,KG,20210721.0,,PH,DE,DE,2021,Q3,Elderly
195873351,19587335,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 3?3?2?0, CYLINDER AMPOULES",,,U,, UNKNOWN,,,,,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210720.0,20210721,20210721,EXP,,"DE-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-116210",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,89.0,KG,20210721.0,,PH,DE,DE,2021,Q3,Elderly
195875142,19587514,12,C,INSULINE LISPRO,,2,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,20210524.0,20210719.0,20210721,20210729,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20210729.0,,HP,FR,FR,2021,Q3,Adult
195875142,19587514,12,C,INSULINE LISPRO,,2,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q3,Bronchopulmonary aspergillosis,,2021,Q3,2,F,20210524.0,20210719.0,20210721,20210729,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20210729.0,,HP,FR,FR,2021,Q3,Adult
195875142,19587514,12,C,INSULINE LISPRO,,2,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q3,Cholestasis,,2021,Q3,2,F,20210524.0,20210719.0,20210721,20210729,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20210729.0,,HP,FR,FR,2021,Q3,Adult
195875142,19587514,12,C,INSULINE LISPRO,,2,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q3,Diabetes insipidus,,2021,Q3,2,F,20210524.0,20210719.0,20210721,20210729,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20210729.0,,HP,FR,FR,2021,Q3,Adult
195875142,19587514,12,C,INSULINE LISPRO,,2,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q3,Systemic candida,,2021,Q3,2,F,20210524.0,20210719.0,20210721,20210729,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20210729.0,,HP,FR,FR,2021,Q3,Adult
195879511,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195879511,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195879511,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195879511,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,Medication error,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195879511,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"ACCORDING TO THE SCHEME, SOLUTION FOR INJECTION/INFUSION",,,U,,,,,,,,,2021,Q3,Night sweats,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005977,DE-ACCORD-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20210721.0,,MD,DE,DE,2021,Q3,Elderly
195883921,19588392,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005983,DE-ACCORD-232213,ACCORD,,82.0,YR,E,F,Y,,,20210721.0,,PH,DE,DE,2021,Q3,Elderly
195883921,19588392,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"45?30?35?0, SOLUTION FOR INJECTION / INFUSION",,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210709.0,20210721,20210721,EXP,DE-BFARM-21005983,DE-ACCORD-232213,ACCORD,,82.0,YR,E,F,Y,,,20210721.0,,PH,DE,DE,2021,Q3,Elderly
195896831,19589683,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,2019.0,20210713.0,20210721,20210721,EXP,,US-AMERICAN REGENT INC-2021001892,AMERICAN REGENT,,61.0,YR,,M,Y,,,20210721.0,,PH,US,US,2021,Q3,Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Exposure during pregnancy,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypertensive crisis,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypokalaemia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Irritability,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Proteinuria,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 12.00 A.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Tachycardia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Exposure during pregnancy,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypertensive crisis,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypokalaemia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Irritability,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Proteinuria,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU AT 7.00 A.M,,,D,,,,209196.0,6.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Tachycardia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Anxiety,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Asthenia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Exposure during pregnancy,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Headache,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypertensive crisis,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypokalaemia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Irritability,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Proteinuria,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195909902,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU AT 06.00 P.M,,,D,,,,209196.0,10.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Tachycardia,,2021,Q3,2,F,,20210715.0,20210721,20210726,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL.. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE.. J HYPERTENS.. 2021?39 SUPPL 1:E342",33.0,YR,A,F,Y,,,20210726.0,,MD,IT,IT,2021,Q3,Young Adult
195912971,19591297,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN (VIA SLIDING SCALE)",,,U,, D195320A,,20563.0,,,INJECTION,,2021,Q3,Accidental underdose,,2021,Q3,1,I,20210707.0,20210709.0,20210721,20210721,EXP,,US-ELI_LILLY_AND_COMPANY-US202107004852,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210721.0,,CN,US,US,2021,Q3,Elderly
195912971,19591297,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN (VIA SLIDING SCALE)",,,U,, D195320A,,20563.0,,,INJECTION,,2021,Q3,Asthenia,,2021,Q3,1,I,20210707.0,20210709.0,20210721,20210721,EXP,,US-ELI_LILLY_AND_COMPANY-US202107004852,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210721.0,,CN,US,US,2021,Q3,Elderly
195912971,19591297,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN (VIA SLIDING SCALE)",,,U,, D195320A,,20563.0,,,INJECTION,,2021,Q3,Blood glucose fluctuation,,2021,Q3,1,I,20210707.0,20210709.0,20210721,20210721,EXP,,US-ELI_LILLY_AND_COMPANY-US202107004852,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210721.0,,CN,US,US,2021,Q3,Elderly
195912971,19591297,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN (VIA SLIDING SCALE)",,,U,, D195320A,,20563.0,,,INJECTION,,2021,Q3,Gastrointestinal disorder,,2021,Q3,1,I,20210707.0,20210709.0,20210721,20210721,EXP,,US-ELI_LILLY_AND_COMPANY-US202107004852,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210721.0,,CN,US,US,2021,Q3,Elderly
195912971,19591297,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN (VIA SLIDING SCALE)",,,U,, D195320A,,20563.0,,,INJECTION,,2021,Q3,Nausea,,2021,Q3,1,I,20210707.0,20210709.0,20210721,20210721,EXP,,US-ELI_LILLY_AND_COMPANY-US202107004852,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20210721.0,,CN,US,US,2021,Q3,Elderly
195997141,19599714,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pancreatitis,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Treatment noncompliance,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
195997141,19599714,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20201225.0,,20210723,20210723,DIR,,,FDA-CTU,,54.0,YR,,M,N,127.7,KG,20210723.0,N,PH,US,US,2021,Q3,Adult
196008271,19600827,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blindness unilateral,,2021,Q3,1,I,202006.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107006258,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196008271,19600827,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202006.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107006258,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196008271,19600827,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,,,,SOLUTION FOR INJECTION,,2021,Q3,COVID-19,,2021,Q3,1,I,202006.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107006258,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196008271,19600827,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, ASKU,,,,,SOLUTION FOR INJECTION,,2021,Q3,Insulin resistance,,2021,Q3,1,I,202006.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107006258,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196015671,19601567,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"20 U, BID",,,,, D261904A,,20563.0,20.0,IU,INJECTION,BID,2021,Q3,Blindness,,2021,Q3,1,I,202101.0,20210713.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005752,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196015671,19601567,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"20 U, BID",,,,, D261904A,,20563.0,20.0,IU,INJECTION,BID,2021,Q3,Eye haemorrhage,,2021,Q3,1,I,202101.0,20210713.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005752,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196015671,19601567,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, PRN",,,,, D261904A,,20563.0,10.0,IU,INJECTION,,2021,Q3,Blindness,,2021,Q3,1,I,202101.0,20210713.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005752,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196015671,19601567,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"10 U, PRN",,,,, D261904A,,20563.0,10.0,IU,INJECTION,,2021,Q3,Eye haemorrhage,,2021,Q3,1,I,202101.0,20210713.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005752,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196018221,19601822,5,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1 IE, 3?3?2?0, CYLINDRICAL AMPOULES",,,U,,,,,,,,,2021,Q3,Cellulitis,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,DE-BFARM-21006294,DE-ACCORD-232689,ACCORD,,70.0,YR,E,M,Y,89.0,KG,20210723.0,,PH,DE,DE,2021,Q3,Elderly
196018221,19601822,5,SS,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1 IE, 3?3?2?0, CYLINDRICAL AMPOULES",,,U,,,,,,,,,2021,Q3,Skin ulcer,,2021,Q3,1,I,,20210713.0,20210723,20210723,EXP,DE-BFARM-21006294,DE-ACCORD-232689,ACCORD,,70.0,YR,E,M,Y,89.0,KG,20210723.0,,PH,DE,DE,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Diabetes mellitus,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Drug intolerance,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Grip strength decreased,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hepatic cirrhosis,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hepatotoxicity,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Movement disorder,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Osteoarthritis,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196018281,19601828,10,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Psoriatic arthropathy,,2021,Q3,1,I,,20210712.0,20210723,20210723,EXP,CA-MHPD-E2B-03367549,CA-ACCORD-232704,ACCORD,,65.0,YR,,F,Y,,,20210723.0,,HP,CA,CA,2021,Q3,Elderly
196042634,19604263,100,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 INTERNATIONAL UNIT, CO",,,,, UNKNOWN,,,1.0,IU,,,2021,Q3,Achromobacter infection,,2021,Q3,4,F,20200809.0,20210810.0,20210723,20210819,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-MALLINCKRODT-T202101014,MALLINCKRODT,,74.0,YR,,M,Y,,,20210819.0,,CN,US,FR,2021,Q3,Elderly
196042634,19604263,100,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 INTERNATIONAL UNIT, CO",,,,, UNKNOWN,,,1.0,IU,,,2021,Q3,Pneumonia bacterial,,2021,Q3,4,F,20200809.0,20210810.0,20210723,20210819,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-MALLINCKRODT-T202101014,MALLINCKRODT,,74.0,YR,,M,Y,,,20210819.0,,CN,US,FR,2021,Q3,Elderly
196042634,19604263,100,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 INTERNATIONAL UNIT, CO",,,,, UNKNOWN,,,1.0,IU,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,4,F,20200809.0,20210810.0,20210723,20210819,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-MALLINCKRODT-T202101014,MALLINCKRODT,,74.0,YR,,M,Y,,,20210819.0,,CN,US,FR,2021,Q3,Elderly
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Anal cancer,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose abnormal,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Colon cancer,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Gait disturbance,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Glycosylated haemoglobin decreased,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Hypersensitivity,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Injection site bruising,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Pain of skin,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Plasma cell myeloma,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Skin disorder,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Skin exfoliation,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196058411,19605841,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Skin haemorrhage,,2021,Q3,1,I,2017.0,20210712.0,20210723,20210723,EXP,,US-ELI_LILLY_AND_COMPANY-US202107005893,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20210723.0,,CN,US,US,2021,Q3,Adult
196060041,19606004,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,15 UNITS,,,Y,,,,209196.0,,,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,1,I,,20210714.0,20210723,20210723,EXP,,SK-SA-2021SA233415,SANOFI AVENTIS,"MARTINKA E, KOLLAROVA D, URBANOVA M.. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61",53.0,YR,A,M,Y,,,20210724.0,,HP,SK,SK,2021,Q3,Adult
196060041,19606004,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,15 UNITS,,,Y,,,,209196.0,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210714.0,20210723,20210723,EXP,,SK-SA-2021SA233415,SANOFI AVENTIS,"MARTINKA E, KOLLAROVA D, URBANOVA M.. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61",53.0,YR,A,M,Y,,,20210724.0,,HP,SK,SK,2021,Q3,Adult
196060041,19606004,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,15 UNITS,,,Y,,,,209196.0,,,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210714.0,20210723,20210723,EXP,,SK-SA-2021SA233415,SANOFI AVENTIS,"MARTINKA E, KOLLAROVA D, URBANOVA M.. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61",53.0,YR,A,M,Y,,,20210724.0,,HP,SK,SK,2021,Q3,Adult
196060041,19606004,4,PS,INSULIN LISPRO,INSULIN LISPRO,1,,15 UNITS,,,Y,,,,209196.0,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210714.0,20210723,20210723,EXP,,SK-SA-2021SA233415,SANOFI AVENTIS,"MARTINKA E, KOLLAROVA D, URBANOVA M.. PRACTICAL EXPERIENCE CONFIRMS THE RESULTS OF THE RCT AND RWE STUDIES WITH EMPAGLIFLOSIN: CASE REPORTS. FORUM DIABETOLOGICUM. 2021?10(1):53?61",53.0,YR,A,M,Y,,,20210724.0,,HP,SK,SK,2021,Q3,Adult
196071811,19607181,19,SS,Insulin lispro,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031103,AUROBINDO,,61.0,YR,,M,Y,,,20210726.0,,HP,US,US,2021,Q3,Adult
196071811,19607181,20,SS,Insulin lispro,INSULIN LISPRO,1,Parenteral,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031103,AUROBINDO,,61.0,YR,,M,Y,,,20210726.0,,HP,US,US,2021,Q3,Adult
196078591,19607859,10,SS,Insulin lispro,INSULIN LISPRO,1,Oral,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031206,AUROBINDO,,46.0,YR,,F,Y,,,20210726.0,,MD,US,US,2021,Q3,Adult
196078591,19607859,11,SS,Insulin lispro,INSULIN LISPRO,1,Respiratory (inhalation),UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031206,AUROBINDO,,46.0,YR,,F,Y,,,20210726.0,,MD,US,US,2021,Q3,Adult
196078591,19607859,12,SS,Insulin lispro,INSULIN LISPRO,1,Parenteral,UNK,,,D,,,,,,,,,2021,Q3,Completed suicide,,2021,Q3,1,I,,20210712.0,20210726,20210726,EXP,,US-AUROBINDO-AUR-APL-2021-031206,AUROBINDO,,46.0,YR,,F,Y,,,20210726.0,,MD,US,US,2021,Q3,Adult
196093272,19609327,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Gastrointestinal haemorrhage,,2021,Q3,2,F,20210714.0,20210723.0,20210726,20210729,EXP,,DE-BAYER-2021-176752,BAYER,,68.0,YR,E,M,Y,66.0,KG,20210729.0,,MD,DE,DE,2021,Q3,Elderly
196093821,19609382,1,PS,INSULIN LISPRO INJECTION U?100.,INSULIN LISPRO,1,Intramuscular,?          QUANTITY:65 INJECTION(S);?,,,,, 178725134251,20231030.0,,1.0,DF,SUSPENSION FOR INJECTION,PRN,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,20210726.0,,20210726,20210726,DIR,,,FDA-CTU,,29.0,YR,,M,N,74.25,KG,20210726.0,N,CN,US,US,2021,Q3,Young Adult
196093821,19609382,1,PS,INSULIN LISPRO INJECTION U?100.,INSULIN LISPRO,1,Intramuscular,?          QUANTITY:65 INJECTION(S);?,,,,, 178725134251,20231030.0,,1.0,DF,SUSPENSION FOR INJECTION,PRN,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210726.0,,20210726,20210726,DIR,,,FDA-CTU,,29.0,YR,,M,N,74.25,KG,20210726.0,N,CN,US,US,2021,Q3,Young Adult
196093821,19609382,1,PS,INSULIN LISPRO INJECTION U?100.,INSULIN LISPRO,1,Intramuscular,?          QUANTITY:65 INJECTION(S);?,,,,, 178725134251,20231030.0,,1.0,DF,SUSPENSION FOR INJECTION,PRN,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210726.0,,20210726,20210726,DIR,,,FDA-CTU,,29.0,YR,,M,N,74.25,KG,20210726.0,N,CN,US,US,2021,Q3,Young Adult
196093821,19609382,1,PS,INSULIN LISPRO INJECTION U?100.,INSULIN LISPRO,1,Intramuscular,?          QUANTITY:65 INJECTION(S);?,,,,, 178725134251,20231030.0,,1.0,DF,SUSPENSION FOR INJECTION,PRN,2021,Q3,Product substitution issue,,2021,Q3,1,I,20210726.0,,20210726,20210726,DIR,,,FDA-CTU,,29.0,YR,,M,N,74.25,KG,20210726.0,N,CN,US,US,2021,Q3,Young Adult
196128781,19612878,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"10U AT 12.00 A.M, 6U AT 7.00 A.M, 10U AT 06.00 P.M",,,U,,,,,10.0,IU,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196128781,19612878,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"10U AT 12.00 A.M, 6U AT 7.00 A.M, 10U AT 06.00 P.M",,,U,,,,,10.0,IU,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196128781,19612878,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"10U AT 12.00 A.M, 6U AT 7.00 A.M, 10U AT 06.00 P.M",,,U,,,,,10.0,IU,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196128781,19612878,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"10U AT 12.00 A.M, 6U AT 7.00 A.M, 10U AT 06.00 P.M",,,U,,,,,10.0,IU,,,2021,Q3,Phaeochromocytoma,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196128781,19612878,5,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"10U AT 12.00 A.M, 6U AT 7.00 A.M, 10U AT 06.00 P.M",,,U,,,,,10.0,IU,,,2021,Q3,Unmasking of previously unidentified disease,,2021,Q3,1,I,,20210601.0,20210727,20210727,EXP,,IT-ACCORD-227448,ACCORD,"NEGRO A, SANTI R, VERZICCO I, GIUNTA A, TEDESCHI S, GRAIANI G, ET AL. A RARE CASE OF PHEOCROMOCYTOMA IN PREGNANCY EXACERBATED BY METOCLOPRAMIDE. JOURNAL OF HYPERTENSION. 2021?39(1):E342.",33.0,YR,,F,Y,,,20210727.0,,MD,IT,IT,2021,Q3,Young Adult
196177692,19617769,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7.00 A.M.,,,D,,,,,6.0,IU,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210712.0,20210727,20210825,EXP,,IT-BAUSCH-BL-2021-025030,BAUSCH AND LOMB,"NEGRO A, VERZICCO I, TEDESCHI S, SANTI R, PALLADINI B, CALVI A, GIUNTA A, CUNZI D, COGHI P, VOLPI R, CABASSI A. UNRECOGNISED PHEOCHROMOCYTOMA IN PREGNANCY DISCOVERED THROUGH METOCLOPRAMIDE?TRIGGERED HYPERTENSIVE EMERGENCY. BLOOD PRESSURE. 2021?1?5. DOI:10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20210825.0,,HP,IT,IT,2021,Q3,Young Adult
196177692,19617769,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7.00 A.M.,,,D,,,,,6.0,IU,,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,2,F,,20210712.0,20210727,20210825,EXP,,IT-BAUSCH-BL-2021-025030,BAUSCH AND LOMB,"NEGRO A, VERZICCO I, TEDESCHI S, SANTI R, PALLADINI B, CALVI A, GIUNTA A, CUNZI D, COGHI P, VOLPI R, CABASSI A. UNRECOGNISED PHEOCHROMOCYTOMA IN PREGNANCY DISCOVERED THROUGH METOCLOPRAMIDE?TRIGGERED HYPERTENSIVE EMERGENCY. BLOOD PRESSURE. 2021?1?5. DOI:10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20210825.0,,HP,IT,IT,2021,Q3,Young Adult
196177692,19617769,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12.00 A.M.,,,D,,,,,10.0,IU,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210712.0,20210727,20210825,EXP,,IT-BAUSCH-BL-2021-025030,BAUSCH AND LOMB,"NEGRO A, VERZICCO I, TEDESCHI S, SANTI R, PALLADINI B, CALVI A, GIUNTA A, CUNZI D, COGHI P, VOLPI R, CABASSI A. UNRECOGNISED PHEOCHROMOCYTOMA IN PREGNANCY DISCOVERED THROUGH METOCLOPRAMIDE?TRIGGERED HYPERTENSIVE EMERGENCY. BLOOD PRESSURE. 2021?1?5. DOI:10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20210825.0,,HP,IT,IT,2021,Q3,Young Adult
196177692,19617769,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12.00 A.M.,,,D,,,,,10.0,IU,,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,2,F,,20210712.0,20210727,20210825,EXP,,IT-BAUSCH-BL-2021-025030,BAUSCH AND LOMB,"NEGRO A, VERZICCO I, TEDESCHI S, SANTI R, PALLADINI B, CALVI A, GIUNTA A, CUNZI D, COGHI P, VOLPI R, CABASSI A. UNRECOGNISED PHEOCHROMOCYTOMA IN PREGNANCY DISCOVERED THROUGH METOCLOPRAMIDE?TRIGGERED HYPERTENSIVE EMERGENCY. BLOOD PRESSURE. 2021?1?5. DOI:10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20210825.0,,HP,IT,IT,2021,Q3,Young Adult
196177692,19617769,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6:00 P.M.,,,D,,,,,10.0,IU,,,2021,Q3,Maternal exposure during pregnancy,,2021,Q3,2,F,,20210712.0,20210727,20210825,EXP,,IT-BAUSCH-BL-2021-025030,BAUSCH AND LOMB,"NEGRO A, VERZICCO I, TEDESCHI S, SANTI R, PALLADINI B, CALVI A, GIUNTA A, CUNZI D, COGHI P, VOLPI R, CABASSI A. UNRECOGNISED PHEOCHROMOCYTOMA IN PREGNANCY DISCOVERED THROUGH METOCLOPRAMIDE?TRIGGERED HYPERTENSIVE EMERGENCY. BLOOD PRESSURE. 2021?1?5. DOI:10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20210825.0,,HP,IT,IT,2021,Q3,Young Adult
196177692,19617769,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6:00 P.M.,,,D,,,,,10.0,IU,,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,2,F,,20210712.0,20210727,20210825,EXP,,IT-BAUSCH-BL-2021-025030,BAUSCH AND LOMB,"NEGRO A, VERZICCO I, TEDESCHI S, SANTI R, PALLADINI B, CALVI A, GIUNTA A, CUNZI D, COGHI P, VOLPI R, CABASSI A. UNRECOGNISED PHEOCHROMOCYTOMA IN PREGNANCY DISCOVERED THROUGH METOCLOPRAMIDE?TRIGGERED HYPERTENSIVE EMERGENCY. BLOOD PRESSURE. 2021?1?5. DOI:10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20210825.0,,HP,IT,IT,2021,Q3,Young Adult
196217061,19621706,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,4 IU,,,D,,,,,4.0,IU,,,2021,Q3,Jaundice,,2021,Q3,1,I,20210308.0,20210318.0,20210728,20210728,EXP,,NVSC2021IT065833,NOVARTIS,,79.0,YR,,F,Y,,,20210728.0,,HP,IT,IT,2021,Q3,Elderly
196384482,19638448,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Acute respiratory failure,,2021,Q3,2,F,20210319.0,20210921.0,20210729,20210927,EXP,,US-GILEAD-2021-0526296,GILEAD,,49.0,YR,A,F,Y,,,20210927.0,,MD,US,US,2021,Q3,Adult
196384482,19638448,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pulmonary embolism,,2021,Q3,2,F,20210319.0,20210921.0,20210729,20210927,EXP,,US-GILEAD-2021-0526296,GILEAD,,49.0,YR,A,F,Y,,,20210927.0,,MD,US,US,2021,Q3,Adult
196387081,19638708,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118221",BOEHRINGER INGELHEIM,,53.0,YR,A,F,Y,,,20210729.0,,MD,CA,CA,2021,Q3,Adult
196387081,19638708,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118221",BOEHRINGER INGELHEIM,,53.0,YR,A,F,Y,,,20210729.0,,MD,CA,CA,2021,Q3,Adult
196387081,19638708,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Leukocytosis,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118221",BOEHRINGER INGELHEIM,,53.0,YR,A,F,Y,,,20210729.0,,MD,CA,CA,2021,Q3,Adult
196387081,19638708,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118221",BOEHRINGER INGELHEIM,,53.0,YR,A,F,Y,,,20210729.0,,MD,CA,CA,2021,Q3,Adult
196387081,19638708,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pancreatitis,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118221",BOEHRINGER INGELHEIM,,53.0,YR,A,F,Y,,,20210729.0,,MD,CA,CA,2021,Q3,Adult
196387081,19638708,6,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210728.0,20210729,20210729,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-118221",BOEHRINGER INGELHEIM,,53.0,YR,A,F,Y,,,20210729.0,,MD,CA,CA,2021,Q3,Adult
196393303,19639330,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"20 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,20.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,202104.0,20210812.0,20210729,20210813,EXP,,US-ELI_LILLY_AND_COMPANY-US202107009372,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Adult
196393303,19639330,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"20 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,20.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,202104.0,20210812.0,20210729,20210813,EXP,,US-ELI_LILLY_AND_COMPANY-US202107009372,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Adult
196393303,19639330,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"20 INTERNATIONAL UNIT, UNKNOWN",,,U,, D341139A,,20563.0,20.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,202104.0,20210812.0,20210729,20210813,EXP,,US-ELI_LILLY_AND_COMPANY-US202107009372,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Adult
196393303,19639330,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"20 INTERNATIONAL UNIT, UNKNOWN",,,U,, D341139A,,20563.0,20.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,3,F,202104.0,20210812.0,20210729,20210813,EXP,,US-ELI_LILLY_AND_COMPANY-US202107009372,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20210813.0,,CN,US,US,2021,Q3,Adult
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Asthma,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Blood count abnormal,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Chest discomfort,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Diaphragmatic disorder,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Discomfort,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hypoxia,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Left ventricular hypertrophy,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Obstructive airways disorder,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196452162,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Wheezing,,2021,Q3,2,F,,20210903.0,20210802,20210917,EXP,,CA-COVIS PHARMA GMBH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210917.0,,CN,CA,CA,2021,Q3,Elderly
196456121,19645612,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Bradyphrenia,,2021,Q3,1,I,20210515.0,20210721.0,20210802,20210802,EXP,IT-MINISAL02-759178,IT-NOVOPROD-831603,NOVO NORDISK,,72.0,YR,,M,Y,,,20210802.0,,MD,IT,IT,2021,Q3,Elderly
196456121,19645612,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210515.0,20210721.0,20210802,20210802,EXP,IT-MINISAL02-759178,IT-NOVOPROD-831603,NOVO NORDISK,,72.0,YR,,M,Y,,,20210802.0,,MD,IT,IT,2021,Q3,Elderly
196456121,19645612,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Hypokinesia,,2021,Q3,1,I,20210515.0,20210721.0,20210802,20210802,EXP,IT-MINISAL02-759178,IT-NOVOPROD-831603,NOVO NORDISK,,72.0,YR,,M,Y,,,20210802.0,,MD,IT,IT,2021,Q3,Elderly
196456121,19645612,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q3,Medication error,,2021,Q3,1,I,20210515.0,20210721.0,20210802,20210802,EXP,IT-MINISAL02-759178,IT-NOVOPROD-831603,NOVO NORDISK,,72.0,YR,,M,Y,,,20210802.0,,MD,IT,IT,2021,Q3,Elderly
196473583,19647358,16,C,INSULINE LISPRO,,2,Subcutaneous,"50 DF, QD",,,,,,,,50.0,DF,,QD,2021,Q3,Pneumonia,,2021,Q3,3,F,20210721.0,20210921.0,20210802,20210928,EXP,,US-GLAXOSMITHKLINE-US2021GSK159888,GLAXOSMITHKLINE,,75.0,YR,,M,Y,,,20210928.0,,MD,US,US,2021,Q3,Elderly
196473583,19647358,16,C,INSULINE LISPRO,,2,Subcutaneous,"50 DF, QD",,,,,,,,50.0,DF,,QD,2021,Q3,Pulmonary oedema,,2021,Q3,3,F,20210721.0,20210921.0,20210802,20210928,EXP,,US-GLAXOSMITHKLINE-US2021GSK159888,GLAXOSMITHKLINE,,75.0,YR,,M,Y,,,20210928.0,,MD,US,US,2021,Q3,Elderly
196477041,19647704,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, UNKNOWN",,,,, D355431A,,,7.0,IU,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210730.0,20210730.0,20210802,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202108000155,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210802.0,,CN,US,US,2021,Q3,Elderly
196477041,19647704,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"7 U, UNKNOWN",,,,, D355431A,,,7.0,IU,INJECTION,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,20210730.0,20210730.0,20210802,20210802,PER,,US-ELI_LILLY_AND_COMPANY-US202108000155,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210802.0,,CN,US,US,2021,Q3,Elderly
196513891,19651389,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,RECEIVED BASAL BOLUS INSULIN REGIMEN ACCORDING TO PREPRANDIAL BLOOD GLUCOSE,,,U,U,,,,,,INJECTION,,2021,Q3,Diabetic neuropathy,,2021,Q3,1,I,,20210726.0,20210803,20210803,EXP,,PT-MYLANLABS-2021M1047946,MYLAN,"FERREIRA M, CAMOES G, GOMES JFF, FERREIRA DM. TREATMENT?INDUCED DIABETES NEUROPATHY: REMINDER OF AN IMPORTANT CLINICAL LESSON. BMJ?CASE?REP 2021?14(5):1?3.",32.0,YR,,M,Y,72.0,KG,20210803.0,,MD,PT,PT,2021,Q3,Young Adult
196513891,19651389,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,RECEIVED BASAL BOLUS INSULIN REGIMEN ACCORDING TO PREPRANDIAL BLOOD GLUCOSE,,,U,U,,,,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210726.0,20210803,20210803,EXP,,PT-MYLANLABS-2021M1047946,MYLAN,"FERREIRA M, CAMOES G, GOMES JFF, FERREIRA DM. TREATMENT?INDUCED DIABETES NEUROPATHY: REMINDER OF AN IMPORTANT CLINICAL LESSON. BMJ?CASE?REP 2021?14(5):1?3.",32.0,YR,,M,Y,72.0,KG,20210803.0,,MD,PT,PT,2021,Q3,Young Adult
196513891,19651389,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,RECEIVED BASAL BOLUS INSULIN REGIMEN ACCORDING TO PREPRANDIAL BLOOD GLUCOSE,,,U,U,,,,,,INJECTION,,2021,Q3,Intentional product misuse,,2021,Q3,1,I,,20210726.0,20210803,20210803,EXP,,PT-MYLANLABS-2021M1047946,MYLAN,"FERREIRA M, CAMOES G, GOMES JFF, FERREIRA DM. TREATMENT?INDUCED DIABETES NEUROPATHY: REMINDER OF AN IMPORTANT CLINICAL LESSON. BMJ?CASE?REP 2021?14(5):1?3.",32.0,YR,,M,Y,72.0,KG,20210803.0,,MD,PT,PT,2021,Q3,Young Adult
196537302,19653730,63,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 INTERNATIONAL UNIT,,,U,,,,,1.0,IU,,,2021,Q3,Toxic epidermal necrolysis,,2021,Q3,2,F,20200809.0,20210726.0,20210804,20210810,EXP,,FR-VALIDUS PHARMACEUTICALS LLC-FR-VDP-2021-000013,VALIDUS,,74.0,YR,,M,Y,,,20210810.0,,CN,FR,FR,2021,Q3,Elderly
196543701,19654370,9,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,8UI COFFEE AND DINNER,,,,, UNKNOWN,,,,,,,2021,Q3,Amaurosis,,2021,Q3,1,I,,20210726.0,20210804,20210804,EXP,,BR-NOVOPROD-833828,NOVO NORDISK,,81.0,YR,,M,Y,85.0,KG,20210804.0,,MD,BR,BR,2021,Q3,Elderly
196581081,19658108,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210706.0,20210728.0,20210804,20210804,EXP,IT-MINISAL02-762477,IT-ELI_LILLY_AND_COMPANY-IT202107012108,ELI LILLY AND CO,,18.0,YR,,M,Y,,,20210804.0,,PH,IT,IT,2021,Q3,Youth
196581081,19658108,1,PS,Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q3,Weight decreased,,2021,Q3,1,I,20210706.0,20210728.0,20210804,20210804,EXP,IT-MINISAL02-762477,IT-ELI_LILLY_AND_COMPANY-IT202107012108,ELI LILLY AND CO,,18.0,YR,,M,Y,,,20210804.0,,PH,IT,IT,2021,Q3,Youth
196610731,19661073,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PREMEAL INSULIN LISPRO,,,U,,,,,,,,,2021,Q3,Drug eruption,,2021,Q3,1,I,,20210729.0,20210805,20210805,EXP,,US-SA-2021SA253128,SANOFI AVENTIS,"FEIN LC, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR BLOOD CANCER.. 2021?68(2):1?5",23.0,YR,A,M,Y,,,20210805.0,,HP,US,US,2021,Q3,Youth
196610731,19661073,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PREMEAL INSULIN LISPRO,,,U,,,,,,,,,2021,Q3,Pancytopenia,,2021,Q3,1,I,,20210729.0,20210805,20210805,EXP,,US-SA-2021SA253128,SANOFI AVENTIS,"FEIN LC, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR BLOOD CANCER.. 2021?68(2):1?5",23.0,YR,A,M,Y,,,20210805.0,,HP,US,US,2021,Q3,Youth
196610731,19661073,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PREMEAL INSULIN LISPRO,,,U,,,,,,,,,2021,Q3,Pulmonary oedema,,2021,Q3,1,I,,20210729.0,20210805,20210805,EXP,,US-SA-2021SA253128,SANOFI AVENTIS,"FEIN LC, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR BLOOD CANCER.. 2021?68(2):1?5",23.0,YR,A,M,Y,,,20210805.0,,HP,US,US,2021,Q3,Youth
196610731,19661073,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,PREMEAL INSULIN LISPRO,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210729.0,20210805,20210805,EXP,,US-SA-2021SA253128,SANOFI AVENTIS,"FEIN LC, PRESSWALA LS, SLOMOVIC A, STIEFEL J, SCHULMAN?ROSENBAUM R.. MULTIDISCIPLINARY MANAGEMENT OF ENDOCRINOPATHIES AND TREATMENT?RELATED TOXICITIES IN PATIENTS WITH BLOOM SYNDROME AND CANCER. PEDIATR BLOOD CANCER.. 2021?68(2):1?5",23.0,YR,A,M,Y,,,20210805.0,,HP,US,US,2021,Q3,Youth
196630631,19663063,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML DAILY; 4 UNITS AT BREAKFAST, 4 UNITS AT LUNCH AND 3 UNITS AT NIGHT TAKING A TOTAL OF ABOUT",,,U,, D154228A,,,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML DAILY; 4 UNITS AT BREAKFAST, 4 UNITS AT LUNCH AND 3 UNITS AT NIGHT TAKING A TOTAL OF ABOUT",,,U,, D154228A,,,,,INJECTION,,2021,Q3,Disturbance in attention,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML DAILY; 4 UNITS AT BREAKFAST, 4 UNITS AT LUNCH AND 3 UNITS AT NIGHT TAKING A TOTAL OF ABOUT",,,U,, D154228A,,,,,INJECTION,,2021,Q3,Expired product administered,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML DAILY; 4 UNITS AT BREAKFAST, 4 UNITS AT LUNCH AND 3 UNITS AT NIGHT TAKING A TOTAL OF ABOUT",,,U,, D154228A,,,,,INJECTION,,2021,Q3,Fungal infection,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML DAILY; 4 UNITS AT BREAKFAST, 4 UNITS AT LUNCH AND 3 UNITS AT NIGHT TAKING A TOTAL OF ABOUT",,,U,, D154228A,,,,,INJECTION,,2021,Q3,Glycosuria,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ML DAILY; 4 UNITS AT BREAKFAST, 4 UNITS AT LUNCH AND 3 UNITS AT NIGHT TAKING A TOTAL OF ABOUT",,,U,, D154228A,,,,,INJECTION,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,, UNKNOWN,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,, UNKNOWN,,,,,,,2021,Q3,Disturbance in attention,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,, UNKNOWN,,,,,,,2021,Q3,Expired product administered,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,, UNKNOWN,,,,,,,2021,Q3,Fungal infection,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,, UNKNOWN,,,,,,,2021,Q3,Glycosuria,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196630631,19663063,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,, UNKNOWN,,,,,,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,,20201030.0,20210805,20210805,PER,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-119780",BOEHRINGER INGELHEIM,,66.0,YR,E,M,Y,,,20210805.0,,CN,US,US,2021,Q3,Elderly
196643401,19664340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,1.0,IU,,,2021,Q3,Acute respiratory failure,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,1.0,IU,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,1.0,IU,,,2021,Q3,Cough,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,1.0,IU,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,1.0,IU,,,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196643401,19664340,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"1 INTERNATIONAL UNIT, UNKNOWN",,,U,,,,20563.0,1.0,IU,,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210730.0,20210805,20210805,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202107013221,ELI LILLY AND CO,,56.0,YR,,F,Y,105.0,KG,20210805.0,,PH,DE,DE,2021,Q3,Adult
196657721,19665772,6,C,Lispro kwik pen,,2,Unknown,,,,,,,,,,,UNKNOWN,,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,20210712.0,20210727.0,20210806,20210806,PER,,US-CELGENEUS-USA-20210706978,CELGENE,,76.0,YR,,M,Y,,,20210806.0,,HP,US,US,2021,Q3,Elderly
196666251,19666625,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,?          OTHER STRENGTH:100 UNITS/ML;?,,,,,,,,,,,,2021,Q3,Intercepted product prescribing error,,2021,Q3,1,I,,,20210806,20210806,DIR,,,FDA-CTU,,86.0,YR,,,N,,,20200915.0,N,PH,US,US,2021,Q3,Elderly
196666251,19666625,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,?          OTHER STRENGTH:100 UNITS/ML;?,,,,,,,,,,,,2021,Q3,Product prescribing error,,2021,Q3,1,I,,,20210806,20210806,DIR,,,FDA-CTU,,86.0,YR,,,N,,,20200915.0,N,PH,US,US,2021,Q3,Elderly
196692491,19669249,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2021,Q3,Acute respiratory failure,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2021,Q3,Cough,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196692491,19669249,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU,,,D,,,,,1.0,IU,,,2021,Q3,Product administration error,,2021,Q3,1,I,,20210804.0,20210806,20210806,EXP,,DE-SA-2021SA260866,SANOFI AVENTIS,,56.0,YR,A,F,Y,105.0,KG,20210806.0,,PH,DE,DE,2021,Q3,Adult
196749321,19674932,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cognitive disorder,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cytokine release syndrome,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Cytomegalovirus viraemia,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Dementia,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Immune effector cell-associated neurotoxicity syndrome,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196749321,19674932,10,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Urinary tract infection,,2021,Q3,1,I,20210528.0,,20210809,20210809,DIR,,,FDA-CTU,,66.0,YR,,M,N,107.0,KG,20210809.0,N,HP,US,US,2021,Q3,Elderly
196752461,19675246,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ML, 4?2?3?0, INJEKTIONS?/INFUSIONSLOSUNG",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Chills,,2021,Q3,1,I,20200716.0,20210731.0,20210809,20210809,PER,DE-ADRED-05843-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00965,SHILPA MEDICARE,,72.0,YR,E,F,Y,,,20210809.0,,PH,DE,DE,2021,Q3,Elderly
196752461,19675246,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ML, 4?2?3?0, INJEKTIONS?/INFUSIONSLOSUNG",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,20200716.0,20210731.0,20210809,20210809,PER,DE-ADRED-05843-01,DE-SHILPA MEDICARE LIMITED-SML-DE-2021-00965,SHILPA MEDICARE,,72.0,YR,E,F,Y,,,20210809.0,,PH,DE,DE,2021,Q3,Elderly
196754751,19675475,13,C,Lispro Insulin,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Appendicitis perforated,,2021,Q3,1,I,20210429.0,20210802.0,20210809,20210809,EXP,,US-EXELIXIS-XL18421042981,EXELIXIS,,58.0,YR,,M,Y,112.0,KG,20210809.0,,MD,US,US,2021,Q3,Adult
196757881,19675788,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D185008D,,20563.0,,,INJECTION,,2021,Q3,Upper limb fracture,,2021,Q3,1,I,20210618.0,20210803.0,20210809,20210809,PER,,US-ELI_LILLY_AND_COMPANY-US202108003178,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210808.0,,CN,US,US,2021,Q3,Elderly
196784701,19678470,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,,,2021,Q3,Epistaxis,,2021,Q3,1,I,20190901.0,20190916.0,20210809,20210809,EXP,,"US-SHIONOGI, INC-2019001014",SHIONOGI,,25.0,YR,,F,Y,35.0,KG,20210809.0,,MD,US,US,2021,Q3,Young Adult
196784701,19678470,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,,,2021,Q3,Hypoaesthesia,,2021,Q3,1,I,20190901.0,20190916.0,20210809,20210809,EXP,,"US-SHIONOGI, INC-2019001014",SHIONOGI,,25.0,YR,,F,Y,35.0,KG,20210809.0,,MD,US,US,2021,Q3,Young Adult
196784701,19678470,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,, UNKNOWN,,,,,,,2021,Q3,Paraesthesia,,2021,Q3,1,I,20190901.0,20190916.0,20210809,20210809,EXP,,"US-SHIONOGI, INC-2019001014",SHIONOGI,,25.0,YR,,F,Y,35.0,KG,20210809.0,,MD,US,US,2021,Q3,Young Adult
196827622,19682762,29,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,2?12 UNITS,,,,,,,,,,UNKNOWN,,2021,Q3,Lung infiltration,,2021,Q3,2,F,20210729.0,20210810.0,20210810,20210812,EXP,,US-CELGENEUS-USA-20210800965,CELGENE,,85.0,YR,,F,Y,55.84,KG,20210812.0,,MD,US,US,2021,Q3,Elderly
196835231,19683523,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10?15?18 IU TID,,,U,,,,209196.0,,,,Q8H,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210706.0,20210802.0,20210811,20210811,EXP,IT-MINISAL02-762477,IT-SA-2021SA256152,SANOFI AVENTIS,,18.0,YR,A,M,Y,,,20210811.0,,PH,IT,IT,2021,Q3,Youth
196835231,19683523,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10?15?18 IU TID,,,U,,,,209196.0,,,,Q8H,2021,Q3,Weight decreased,,2021,Q3,1,I,20210706.0,20210802.0,20210811,20210811,EXP,IT-MINISAL02-762477,IT-SA-2021SA256152,SANOFI AVENTIS,,18.0,YR,A,M,Y,,,20210811.0,,PH,IT,IT,2021,Q3,Youth
196852646,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 UNITS, OD",,,,,,,,,,,QD,2021,Q3,Aortic valve incompetence,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 UNITS, OD",,,,,,,,,,,QD,2021,Q3,Endocarditis,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 UNITS, OD",,,,,,,,,,,QD,2021,Q3,Endotracheal intubation,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 UNITS, OD",,,,,,,,,,,QD,2021,Q3,Hospitalisation,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 UNITS, OD",,,,,,,,,,,QD,2021,Q3,Palpitations,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 UNITS, OD",,,,,,,,,,,QD,2021,Q3,Portal hypertension,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 UNITS, QD",,,,,,,,,,,QD,2021,Q3,Aortic valve incompetence,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 UNITS, QD",,,,,,,,,,,QD,2021,Q3,Endocarditis,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 UNITS, QD",,,,,,,,,,,QD,2021,Q3,Endotracheal intubation,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 UNITS, QD",,,,,,,,,,,QD,2021,Q3,Hospitalisation,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 UNITS, QD",,,,,,,,,,,QD,2021,Q3,Palpitations,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196852646,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 UNITS, QD",,,,,,,,,,,QD,2021,Q3,Portal hypertension,,2021,Q3,6,F,20201117.0,20210921.0,20210811,20210930,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20210930.0,,HP,US,US,2021,Q3,Adult
196883431,19688343,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D355431A,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210805.0,20210809.0,20210812,20210812,PER,,US-ELI_LILLY_AND_COMPANY-US202108005156,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210812.0,,CN,US,US,2021,Q3,Elderly
196901451,19690145,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"HUMALOG 100 E/ML, SOLUTION FOR INJECTION ?100 IE/ML, 4?2?3?0, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,Chills,,2021,Q3,1,I,20200716.0,20210802.0,20210812,20210812,EXP,,DE-FRESENIUS KABI-FK202108273,FRESENIUS KABI,,72.0,YR,,F,Y,,,20210812.0,,HP,NL,DE,2021,Q3,Elderly
196901451,19690145,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"HUMALOG 100 E/ML, SOLUTION FOR INJECTION ?100 IE/ML, 4?2?3?0, SOLUTION FOR INJECTION/INFUSION",,,,, UNKNOWN,,,,,UNKNOWN,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,20200716.0,20210802.0,20210812,20210812,EXP,,DE-FRESENIUS KABI-FK202108273,FRESENIUS KABI,,72.0,YR,,F,Y,,,20210812.0,,HP,NL,DE,2021,Q3,Elderly
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Acute respiratory failure,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Culture urine positive,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Encephalopathy,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Enterococcal infection,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Haemodialysis,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Haemodynamic instability,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Oliguria,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Pericardial effusion,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Respiratory failure,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Septic shock,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Thrombocytopenia,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196907531,19690753,18,C,insulin lispro 1?21 Units SQ,,2,,,,,,,,,,,,,,2021,Q3,Transfusion,,2021,Q3,1,I,20210806.0,,20210812,20210812,DIR,,,FDA-CTU,,52.0,YR,,F,N,63.3,KG,20210812.0,Y,HP,US,US,2021,Q3,Adult
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Cough,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196952501,19695250,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40?0?25?0),,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210806.0,20210813,20210813,EXP,DE-ADRED-07014-01,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210813.0,,HP,DE,DE,2021,Q3,Elderly
196970651,19697065,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT,,,,,,,,,,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,20161101.0,20171107.0,20210813,20210813,EXP,,IL-ASTRAZENECA-2017SF13991,ASTRAZENECA,,51.0,YR,,M,Y,63.0,KG,20210813.0,,MD,IL,IL,2021,Q3,Adult
196970651,19697065,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,1,I,20161101.0,20171107.0,20210813,20210813,EXP,,IL-ASTRAZENECA-2017SF13991,ASTRAZENECA,,51.0,YR,,M,Y,63.0,KG,20210813.0,,MD,IL,IL,2021,Q3,Adult
196970651,19697065,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNIT,,,,,,,,,,,,2021,Q3,Product use in unapproved indication,,2021,Q3,1,I,20161101.0,20171107.0,20210813,20210813,EXP,,IL-ASTRAZENECA-2017SF13991,ASTRAZENECA,,51.0,YR,,M,Y,63.0,KG,20210813.0,,MD,IL,IL,2021,Q3,Adult
196982801,19698280,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,COVID-19,,2021,Q3,1,I,,20210802.0,20210813,20210813,EXP,,US-ELI_LILLY_AND_COMPANY-US202108000741,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210813.0,,HP,US,US,2021,Q3,Elderly
196983521,19698352,23,C,INSULIN LISPRO (HUMALOG KWIKPEN INSULIN),,2,,,,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,20210807.0,,20210813,20210813,DIR,,,FDA-CTU,,62.0,YR,,M,N,124.0,KG,20210813.0,Y,CN,US,US,2021,Q3,Adult
196983521,19698352,23,C,INSULIN LISPRO (HUMALOG KWIKPEN INSULIN),,2,,,,,,,,,,,,,,2021,Q3,Adverse drug reaction,,2021,Q3,1,I,20210807.0,,20210813,20210813,DIR,,,FDA-CTU,,62.0,YR,,M,N,124.0,KG,20210813.0,Y,CN,US,US,2021,Q3,Adult
197017156,19701715,7,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,6,F,20210305.0,20210913.0,20210813,20210916,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-023178,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,96.0,KG,20210916.0,,HP,BR,BR,2021,Q3,Elderly
197023351,19702335,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,, UNK,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,20210109.0,20210809.0,20210814,20210814,EXP,IT-MINISAL02-766973,NVSC2021IT180180,NOVARTIS,,82.0,YR,,M,Y,,,20210815.0,,HP,IT,IT,2021,Q3,Elderly
197023351,19702335,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,, UNK,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,20210109.0,20210809.0,20210814,20210814,EXP,IT-MINISAL02-766973,NVSC2021IT180180,NOVARTIS,,82.0,YR,,M,Y,,,20210815.0,,HP,IT,IT,2021,Q3,Elderly
197023351,19702335,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,, UNK,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,20210109.0,20210809.0,20210814,20210814,EXP,IT-MINISAL02-766973,NVSC2021IT180180,NOVARTIS,,82.0,YR,,M,Y,,,20210815.0,,HP,IT,IT,2021,Q3,Elderly
197045071,19704507,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 0?0?0?5, PEN",,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210811.0,20210816,20210816,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197045071,19704507,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 0?0?0?5, PEN",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210811.0,20210816,20210816,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197045071,19704507,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 0?0?0?5, PEN",,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210811.0,20210816,20210816,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197045071,19704507,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 0?0?0?5, PEN",,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210811.0,20210816,20210816,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20210816.0,,PH,DE,DE,2021,Q3,Elderly
197075091,19707509,19,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Anxiety,,2021,Q3,1,I,202104.0,20210514.0,20210817,20210817,PER,,US-VERTEX PHARMACEUTICALS-2021-007862,VERTEX,,24.0,YR,,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Young Adult
197075091,19707509,19,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Depression,,2021,Q3,1,I,202104.0,20210514.0,20210817,20210817,PER,,US-VERTEX PHARMACEUTICALS-2021-007862,VERTEX,,24.0,YR,,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Young Adult
197075091,19707509,19,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Mental disorder,,2021,Q3,1,I,202104.0,20210514.0,20210817,20210817,PER,,US-VERTEX PHARMACEUTICALS-2021-007862,VERTEX,,24.0,YR,,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Young Adult
197075091,19707509,19,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Stress,,2021,Q3,1,I,202104.0,20210514.0,20210817,20210817,PER,,US-VERTEX PHARMACEUTICALS-2021-007862,VERTEX,,24.0,YR,,F,Y,,,20210817.0,,HP,US,US,2021,Q3,Young Adult
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Acute painful neuropathy of rapid glycaemic control,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Autonomic nervous system imbalance,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Diabetic retinopathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Dizziness,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Impaired gastric emptying,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Microalbuminuria,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Nausea,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Orthostatic hypotension,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Pain,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Peripheral sensory neuropathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (BEFORE BREAKFAST, LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q8H,2021,Q3,Vomiting,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Acute painful neuropathy of rapid glycaemic control,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Autonomic nervous system imbalance,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Diabetic retinopathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Dizziness,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Impaired gastric emptying,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Microalbuminuria,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Nausea,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Orthostatic hypotension,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Pain,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Peripheral sensory neuropathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (BEFORE BREAKFAST)",,,Y,,,,209196.0,,,,QD,2021,Q3,Vomiting,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Acute painful neuropathy of rapid glycaemic control,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Autonomic nervous system imbalance,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Diabetic retinopathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Dizziness,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Impaired gastric emptying,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Microalbuminuria,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Nausea,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Orthostatic hypotension,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Pain,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Peripheral sensory neuropathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (BEFORE LUNCH AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Vomiting,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Acute painful neuropathy of rapid glycaemic control,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Autonomic nervous system imbalance,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Diabetic retinopathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Dizziness,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Impaired gastric emptying,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Microalbuminuria,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Nausea,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Orthostatic hypotension,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Pain,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Peripheral sensory neuropathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (BEFORE BREAKFAST AND DINNER)",,,Y,,,,209196.0,,,,Q12H,2021,Q3,Vomiting,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Acute painful neuropathy of rapid glycaemic control,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Autonomic nervous system imbalance,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Diabetic retinopathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Dizziness,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Impaired gastric emptying,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Microalbuminuria,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Nausea,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Orthostatic hypotension,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Pain,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Pain in extremity,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Peripheral sensory neuropathy,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197099131,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (BEFORE LUNCHTIME)",,,Y,,,,209196.0,,,,QD,2021,Q3,Vomiting,,2021,Q3,1,I,,20210805.0,20210816,20210816,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,DUBOIS M.S.? MCDONALD E.G.. TREATMENT?INDUCED NEUROPATHY OF DIABETES RELATED TO ABRUPT GLYCEMIC CONTROL. CANADIAN MEDICAL ASSOCIATION JOURNAL. 2021?193(28):E1085?E1088,20.0,YR,A,F,Y,47.8,KG,20210816.0,,MD,CA,CA,2021,Q3,Youth
197100252,19710025,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,20210225.0,20210921.0,20210816,20210924,EXP,,US-GILEAD-2021-0520462,GILEAD,,69.0,YR,E,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
197100252,19710025,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Respiratory failure,,2021,Q3,2,F,20210225.0,20210921.0,20210816,20210924,EXP,,US-GILEAD-2021-0520462,GILEAD,,69.0,YR,E,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
197100252,19710025,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Staphylococcal sepsis,,2021,Q3,2,F,20210225.0,20210921.0,20210816,20210924,EXP,,US-GILEAD-2021-0520462,GILEAD,,69.0,YR,E,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
197128763,19712876,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Balance disorder,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Therapeutic product effect delayed,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Balance disorder,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Therapeutic product effect delayed,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Balance disorder,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Therapeutic product effect delayed,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Balance disorder,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Therapeutic product effect delayed,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Balance disorder,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,5,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D243920A,,20563.0,,,INJECTION,,2021,Q3,Therapeutic product effect delayed,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341139A,,20563.0,,,INJECTION,,2021,Q3,Balance disorder,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341139A,,20563.0,,,INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,6,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341139A,,20563.0,,,INJECTION,,2021,Q3,Therapeutic product effect delayed,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,7,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341139A,,20563.0,,,INJECTION,,2021,Q3,Balance disorder,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,7,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341139A,,20563.0,,,INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197128763,19712876,7,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D341139A,,20563.0,,,INJECTION,,2021,Q3,Therapeutic product effect delayed,,2021,Q3,3,F,202108.0,20210824.0,20210817,20210903,PER,,US-ELI_LILLY_AND_COMPANY-US202108006685,ELI LILLY AND CO,,86.0,YR,,M,Y,,,20210903.0,,CN,US,US,2021,Q3,Elderly
197134822,19713482,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,N,, D341138C,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210812.0,20210826.0,20210818,20210924,PER,,US-ELI_LILLY_AND_COMPANY-US202108006888,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20210924.0,,CN,US,US,2021,Q3,Elderly
197134822,19713482,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,N,, D341138C,,20563.0,,,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,2,F,20210812.0,20210826.0,20210818,20210924,PER,,US-ELI_LILLY_AND_COMPANY-US202108006888,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20210924.0,,CN,US,US,2021,Q3,Elderly
197134822,19713482,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,N,, D371847A,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,20210812.0,20210826.0,20210818,20210924,PER,,US-ELI_LILLY_AND_COMPANY-US202108006888,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20210924.0,,CN,US,US,2021,Q3,Elderly
197134822,19713482,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,N,, D371847A,,20563.0,,,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,2,F,20210812.0,20210826.0,20210818,20210924,PER,,US-ELI_LILLY_AND_COMPANY-US202108006888,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20210924.0,,CN,US,US,2021,Q3,Elderly
197163051,19716305,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Arthralgia,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051742,MYLAN,,74.0,YR,,M,Y,64.0,KG,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163051,19716305,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Contraindicated product administered,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051742,MYLAN,,74.0,YR,,M,Y,64.0,KG,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197163051,19716305,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,,20210811.0,20210818,20210818,EXP,,DE-MYLANLABS-2021M1051742,MYLAN,,74.0,YR,,M,Y,64.0,KG,20210818.0,,PH,DE,DE,2021,Q3,Elderly
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Anxiety,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Asthenia,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Blood catecholamines abnormal,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Exposure during pregnancy,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Hypokalaemia,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Illness,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Irritability,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Live birth,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Myalgia,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Palpitations,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Phaeochromocytoma,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Phaeochromocytoma crisis,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Premature labour,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Product selection error,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Proteinuria,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Renal disorder,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Skin striae,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197186811,19718681,6,SS,Insulin lispro,INSULIN LISPRO,1,Unknown,"UNK(6U S.C. AT 7.00 AM, 10U S.C. AT 12.00 AM, 10U S.C. AT 06.00 PM)",,,U,U,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210804.0,20210818,20210818,EXP,,IT-AUROBINDO-AUR-APL-2021-034480,AUROBINDO,,33.0,YR,,F,Y,,,20210818.0,,HP,IT,IT,2021,Q3,Young Adult
197191092,19719109,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,INJECTION,,2021,Q3,Acute respiratory failure,,2021,Q3,2,F,,20210812.0,20210819,20210823,EXP,,DE-MYLANLABS-2021M1052098,MYLAN,,82.0,YR,,F,Y,,,20210823.0,,PH,DE,DE,2021,Q3,Elderly
197191092,19719109,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,INJECTION,,2021,Q3,Apnoea,,2021,Q3,2,F,,20210812.0,20210819,20210823,EXP,,DE-MYLANLABS-2021M1052098,MYLAN,,82.0,YR,,F,Y,,,20210823.0,,PH,DE,DE,2021,Q3,Elderly
197191092,19719109,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,INJECTION,,2021,Q3,Aspiration,,2021,Q3,2,F,,20210812.0,20210819,20210823,EXP,,DE-MYLANLABS-2021M1052098,MYLAN,,82.0,YR,,F,Y,,,20210823.0,,PH,DE,DE,2021,Q3,Elderly
197191092,19719109,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,INJECTION,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210812.0,20210819,20210823,EXP,,DE-MYLANLABS-2021M1052098,MYLAN,,82.0,YR,,F,Y,,,20210823.0,,PH,DE,DE,2021,Q3,Elderly
197191092,19719109,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8?0?0?0,,,,,,,,,,INJECTION,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210812.0,20210819,20210823,EXP,,DE-MYLANLABS-2021M1052098,MYLAN,,82.0,YR,,F,Y,,,20210823.0,,PH,DE,DE,2021,Q3,Elderly
197201162,19720116,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 IU, UNK",,,Y,,,,,10.0,IU,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,2,F,,20210809.0,20210818,20210818,PER,,US-SA-2021SA269591,SANOFI AVENTIS,,25.0,YR,A,F,Y,,,20210818.0,,HP,US,US,2021,Q3,Young Adult
197201162,19720116,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 IU, UNK",,,Y,,,,,10.0,IU,,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,2,F,,20210809.0,20210818,20210818,PER,,US-SA-2021SA269591,SANOFI AVENTIS,,25.0,YR,A,F,Y,,,20210818.0,,HP,US,US,2021,Q3,Young Adult
197201162,19720116,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 IU, UNK",,,Y,,,,,10.0,IU,,,2021,Q3,Retinopathy,,2021,Q3,2,F,,20210809.0,20210818,20210818,PER,,US-SA-2021SA269591,SANOFI AVENTIS,,25.0,YR,A,F,Y,,,20210818.0,,HP,US,US,2021,Q3,Young Adult
197262451,19726245,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,28 IU,,,Y,,,,,28.0,IU,,,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,202107.0,20210811.0,20210819,20210819,EXP,LU-ALMPS-202102904,LU-SA-2021SA267281,SANOFI AVENTIS,,48.0,YR,A,F,Y,95.0,KG,20210819.0,,MD,LU,LU,2021,Q3,Adult
197262451,19726245,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,28 IU,,,Y,,,,,28.0,IU,,,2021,Q3,Euglycaemic diabetic ketoacidosis,,2021,Q3,1,I,202107.0,20210811.0,20210819,20210819,EXP,LU-ALMPS-202102904,LU-SA-2021SA267281,SANOFI AVENTIS,,48.0,YR,A,F,Y,95.0,KG,20210819.0,,MD,LU,LU,2021,Q3,Adult
197262451,19726245,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,28 IU,,,Y,,,,,28.0,IU,,,2021,Q3,Vomiting,,2021,Q3,1,I,202107.0,20210811.0,20210819,20210819,EXP,LU-ALMPS-202102904,LU-SA-2021SA267281,SANOFI AVENTIS,,48.0,YR,A,F,Y,95.0,KG,20210819.0,,MD,LU,LU,2021,Q3,Adult
197265811,19726581,16,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,100.0,ML,UNKNOWN,,2021,Q3,Platelet count decreased,,2021,Q3,1,I,20210716.0,20210810.0,20210819,20210819,PER,,US-CELGENEUS-USA-20210803103,CELGENE,,68.0,YR,,M,Y,89.44,KG,20210819.0,,PH,US,US,2021,Q3,Elderly
197265811,19726581,16,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,100.0,ML,UNKNOWN,,2021,Q3,Red blood cell count decreased,,2021,Q3,1,I,20210716.0,20210810.0,20210819,20210819,PER,,US-CELGENEUS-USA-20210803103,CELGENE,,68.0,YR,,M,Y,89.44,KG,20210819.0,,PH,US,US,2021,Q3,Elderly
197278081,19727808,7,C,insulin glargine/insulin lispro,,2,,,,,,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,20210816.0,,20210820,20210820,DIR,,,FDA-CTU,,68.0,YR,,M,N,100.0,KG,20210820.0,N,PH,US,US,2021,Q3,Elderly
197278081,19727808,7,C,insulin glargine/insulin lispro,,2,,,,,,,,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,20210816.0,,20210820,20210820,DIR,,,FDA-CTU,,68.0,YR,,M,N,100.0,KG,20210820.0,N,PH,US,US,2021,Q3,Elderly
197278081,19727808,7,C,insulin glargine/insulin lispro,,2,,,,,,,,,,,,,,2021,Q3,Rhythm idioventricular,,2021,Q3,1,I,20210816.0,,20210820,20210820,DIR,,,FDA-CTU,,68.0,YR,,M,N,100.0,KG,20210820.0,N,PH,US,US,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Cough,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197278301,19727830,6,C,insulin lispro/Insulin lispro?Isophan,,2,,40?0?25?0,,,,, UNKNOWN,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210810.0,20210820,20210820,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210820.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Constipation,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Cough,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Dysuria,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Flank pain,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Localised infection,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Pyrexia,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Renal impairment,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Renal pain,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 ? 0 ?  25 ? 0,,,,, UNKNOWN,,,,,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Abdominal pain,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Atrial fibrillation,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Constipation,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Cough,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Dysuria,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Flank pain,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Localised infection,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Pyrexia,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Renal impairment,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Renal pain,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Tachypnoea,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197289072,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 ? 0 ? 36 ? 0",,,,,,,,50.0,IU,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210909.0,20210820,20210917,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,95.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
197318852,19731885,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 DOSAGE FORM=100 UNIT NOS,,,U,,,,,1.0,DF,,,2021,Q3,Chest pain,,2021,Q3,2,F,20210811.0,20210823.0,20210820,20210831,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-081497,BRISTOL MYERS SQUIBB,,50.0,YR,,M,Y,61.0,KG,20210831.0,,HP,US,US,2021,Q3,Adult
197326571,19732657,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (100 MICROGRAM PER ML KWIKPEN 3ML),,,,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,20210729.0,20210817.0,20210823,20210823,PER,,US-AMGEN-USASP2021127315,AMGEN,,79.0,YR,E,F,Y,,,20210822.0,,PH,US,US,2021,Q3,Elderly
197350201,19735020,2,SS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2021,Q3,Acute myocardial infarction,,2021,Q3,1,I,,20210811.0,20210823,20210823,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108005914,ELI LILLY AND CO,"MINEOKA Y,ET AL..A CASE OF TYPE 2 DIABETES MICHIOCARDIAL INFARCTION DURING PERIOPERATIVE GLYCEMIC CONTROL.MUNICIPAL OTSU MUNICIPAL HOSPITAL MAGAZINE 2021?21:31?34.",75.0,YR,,M,Y,61.0,KG,20210823.0,,MD,JP,JP,2021,Q3,Elderly
197376102,19737610,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Cardiac failure congestive,,2021,Q3,2,F,20210619.0,20210826.0,20210824,20210827,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20210827.0,,HP,US,US,2021,Q3,Adult
197376102,19737610,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,2,F,20210619.0,20210826.0,20210824,20210827,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20210827.0,,HP,US,US,2021,Q3,Adult
197398071,19739807,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210816.0,20210824,20210824,EXP,,CA-BAYER-2021-194575,BAYER,,73.0,YR,E,F,Y,,,20210824.0,,HP,CA,CA,2021,Q3,Elderly
197398071,19739807,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Clostridium test positive,,2021,Q3,1,I,,20210816.0,20210824,20210824,EXP,,CA-BAYER-2021-194575,BAYER,,73.0,YR,E,F,Y,,,20210824.0,,HP,CA,CA,2021,Q3,Elderly
197398071,19739807,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,,20210816.0,20210824,20210824,EXP,,CA-BAYER-2021-194575,BAYER,,73.0,YR,E,F,Y,,,20210824.0,,HP,CA,CA,2021,Q3,Elderly
197398071,19739807,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Feeling abnormal,,2021,Q3,1,I,,20210816.0,20210824,20210824,EXP,,CA-BAYER-2021-194575,BAYER,,73.0,YR,E,F,Y,,,20210824.0,,HP,CA,CA,2021,Q3,Elderly
197398071,19739807,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210816.0,20210824,20210824,EXP,,CA-BAYER-2021-194575,BAYER,,73.0,YR,E,F,Y,,,20210824.0,,HP,CA,CA,2021,Q3,Elderly
197398071,19739807,12,C,LISPRO INSULIN,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210816.0,20210824,20210824,EXP,,CA-BAYER-2021-194575,BAYER,,73.0,YR,E,F,Y,,,20210824.0,,HP,CA,CA,2021,Q3,Elderly
197398601,19739860,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"18 U, DAILY (NIGHT)",,,U,,,,,18.0,IU,,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,,20210812.0,20210823,20210823,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202108006036,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210823.0,,CN,PL,PL,2021,Q3,Elderly
197398601,19739860,2,SS,Liprolog Lispro,INSULIN LISPRO,1,Unknown,"18 U, DAILY (NIGHT)",,,U,,,,,18.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210812.0,20210823,20210823,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202108006036,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210823.0,,CN,PL,PL,2021,Q3,Elderly
197403321,19740332,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,202102.0,20210811.0,20210824,20210824,EXP,,US-ELI_LILLY_AND_COMPANY-US202108006403,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210824.0,,CN,US,US,2021,Q3,Adult
197403321,19740332,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Fall,,2021,Q3,1,I,202102.0,20210811.0,20210824,20210824,EXP,,US-ELI_LILLY_AND_COMPANY-US202108006403,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210824.0,,CN,US,US,2021,Q3,Adult
197403321,19740332,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Glycosylated haemoglobin increased,,2021,Q3,1,I,202102.0,20210811.0,20210824,20210824,EXP,,US-ELI_LILLY_AND_COMPANY-US202108006403,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210824.0,,CN,US,US,2021,Q3,Adult
197403321,19740332,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Mobility decreased,,2021,Q3,1,I,202102.0,20210811.0,20210824,20210824,EXP,,US-ELI_LILLY_AND_COMPANY-US202108006403,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210824.0,,CN,US,US,2021,Q3,Adult
197403321,19740332,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Skin laceration,,2021,Q3,1,I,202102.0,20210811.0,20210824,20210824,EXP,,US-ELI_LILLY_AND_COMPANY-US202108006403,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210824.0,,CN,US,US,2021,Q3,Adult
197403321,19740332,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,, D233321A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Wrist fracture,,2021,Q3,1,I,202102.0,20210811.0,20210824,20210824,EXP,,US-ELI_LILLY_AND_COMPANY-US202108006403,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20210824.0,,CN,US,US,2021,Q3,Adult
197442521,19744252,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197442521,19744252,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,,,,,2021,Q3,Dizziness,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197442521,19744252,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197442521,19744252,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197442521,19744252,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"ACCORDING TO PLAN, SOLUTION FOR INJECTION / INFUSION",,,U,U,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,,20210817.0,20210825,20210825,EXP,,DE-MYLANLABS-2021M1053684,MYLAN,,71.0,YR,,F,Y,,,20210825.0,,MD,DE,DE,2021,Q3,Elderly
197444331,19744433,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Arthralgia,,2021,Q3,1,I,,20210614.0,20210825,20210825,PER,,US-PFIZER INC-2021713377,PFIZER,,57.0,YR,,F,Y,,,20210825.0,,CN,US,US,2021,Q3,Adult
197444331,19744433,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210614.0,20210825,20210825,PER,,US-PFIZER INC-2021713377,PFIZER,,57.0,YR,,F,Y,,,20210825.0,,CN,US,US,2021,Q3,Adult
197446901,19744690,2,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2021,Q3,Ascites,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,AT-MYLANLABS-2021M1053132,MYLAN,NEPHROTIC SYNDROM AT DIABETES MELLITUS IT IS NOT ALWAYS DIABETIC NEPHROPATHY,51.0,YR,,M,Y,,,20210825.0,,MD,AT,AT,2021,Q3,Adult
197446901,19744690,2,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2021,Q3,Blood cholesterol increased,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,AT-MYLANLABS-2021M1053132,MYLAN,NEPHROTIC SYNDROM AT DIABETES MELLITUS IT IS NOT ALWAYS DIABETIC NEPHROPATHY,51.0,YR,,M,Y,,,20210825.0,,MD,AT,AT,2021,Q3,Adult
197446901,19744690,2,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2021,Q3,Fluid overload,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,AT-MYLANLABS-2021M1053132,MYLAN,NEPHROTIC SYNDROM AT DIABETES MELLITUS IT IS NOT ALWAYS DIABETIC NEPHROPATHY,51.0,YR,,M,Y,,,20210825.0,,MD,AT,AT,2021,Q3,Adult
197446901,19744690,2,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2021,Q3,Haematuria,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,AT-MYLANLABS-2021M1053132,MYLAN,NEPHROTIC SYNDROM AT DIABETES MELLITUS IT IS NOT ALWAYS DIABETIC NEPHROPATHY,51.0,YR,,M,Y,,,20210825.0,,MD,AT,AT,2021,Q3,Adult
197446901,19744690,2,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2021,Q3,Kidney enlargement,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,AT-MYLANLABS-2021M1053132,MYLAN,NEPHROTIC SYNDROM AT DIABETES MELLITUS IT IS NOT ALWAYS DIABETIC NEPHROPATHY,51.0,YR,,M,Y,,,20210825.0,,MD,AT,AT,2021,Q3,Adult
197446901,19744690,2,C,INSULINE LISPRO,,2,,UNK,,,,,,,,,,,,2021,Q3,Proteinuria,,2021,Q3,1,I,,20210816.0,20210825,20210825,EXP,,AT-MYLANLABS-2021M1053132,MYLAN,NEPHROTIC SYNDROM AT DIABETES MELLITUS IT IS NOT ALWAYS DIABETIC NEPHROPATHY,51.0,YR,,M,Y,,,20210825.0,,MD,AT,AT,2021,Q3,Adult
197471162,19747116,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D245042F,,20563.0,,,INJECTION,,2021,Q3,Balance disorder,,2021,Q3,2,F,,20210913.0,20210825,20210927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108007373,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210927.0,,PH,DE,DE,2021,Q3,Elderly
197471162,19747116,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D245042F,,20563.0,,,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,2,F,,20210913.0,20210825,20210927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108007373,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210927.0,,PH,DE,DE,2021,Q3,Elderly
197471162,19747116,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D245042F,,20563.0,,,INJECTION,,2021,Q3,Syncope,,2021,Q3,2,F,,20210913.0,20210825,20210927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202108007373,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210927.0,,PH,DE,DE,2021,Q3,Elderly
197491081,19749108,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Peripheral artery thrombosis,,2021,Q3,1,I,20210824.0,,20210825,20210825,DIR,,,FDA-CTU,,73.0,YR,,M,N,86.5,KG,20210825.0,N,PH,US,US,2021,Q3,Elderly
197491081,19749108,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Thrombosis,,2021,Q3,1,I,20210824.0,,20210825,20210825,DIR,,,FDA-CTU,,73.0,YR,,M,N,86.5,KG,20210825.0,N,PH,US,US,2021,Q3,Elderly
197495171,19749517,12,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,20210715.0,,20210824,20210824,DIR,,,FDA-CTU,,74.0,YR,,F,N,,,20210824.0,Y,PH,US,US,2021,Q3,Elderly
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Abdominal discomfort,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Abdominal distension,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Accidental underdose,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Blood glucose decreased,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Cataract,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Diabetic neuropathy,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Ear congestion,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Ear injury,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Hypersensitivity,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Insulin resistance,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Malaise,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Memory impairment,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Rhinorrhoea,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,"Sleep disorder due to general medical condition, insomnia type",,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Tinnitus,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197518561,19751856,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNKNOWN,,,U,, UNKNOWN,,,,,,,2021,Q3,Vision blurred,,2021,Q3,1,I,2014.0,20210818.0,20210826,20210826,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-123675",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,,,20210826.0,,CN,US,US,2021,Q3,Adult
197526791,19752679,1,PS,INSULIN LISPRO BS Injection Solostar HU [Sanofi],INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210823.0,20210827,20210827,EXP,,JP-SAKK-2021SA278878AA,SANOFI AVENTIS,"YOSHIMURA Y, NAKAMURA S, KAWANO S, OKAMURA K, SHIMOKAMA T, TORISU T.. A CASE OF DRUG?INDUCED ENTEROCOLITIS ASSOCIATED WITH EOSINOPHILIC INFILTRATION POSSIBLY CAUSED BY INSULIN PREPARATIONS. THE 117TH REGULAR MEETING OF THE JAPANESE SOCIETY OF GASTROENTEROLOGY, THE 111TH. UNK?UNK:148",16.0,YR,T,F,Y,,,20210827.0,,MD,JP,JP,2021,Q3,Youth
197526791,19752679,1,PS,INSULIN LISPRO BS Injection Solostar HU [Sanofi],INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q3,Enterocolitis,,2021,Q3,1,I,,20210823.0,20210827,20210827,EXP,,JP-SAKK-2021SA278878AA,SANOFI AVENTIS,"YOSHIMURA Y, NAKAMURA S, KAWANO S, OKAMURA K, SHIMOKAMA T, TORISU T.. A CASE OF DRUG?INDUCED ENTEROCOLITIS ASSOCIATED WITH EOSINOPHILIC INFILTRATION POSSIBLY CAUSED BY INSULIN PREPARATIONS. THE 117TH REGULAR MEETING OF THE JAPANESE SOCIETY OF GASTROENTEROLOGY, THE 111TH. UNK?UNK:148",16.0,YR,T,F,Y,,,20210827.0,,MD,JP,JP,2021,Q3,Youth
197526791,19752679,1,PS,INSULIN LISPRO BS Injection Solostar HU [Sanofi],INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q3,Gastrooesophageal reflux disease,,2021,Q3,1,I,,20210823.0,20210827,20210827,EXP,,JP-SAKK-2021SA278878AA,SANOFI AVENTIS,"YOSHIMURA Y, NAKAMURA S, KAWANO S, OKAMURA K, SHIMOKAMA T, TORISU T.. A CASE OF DRUG?INDUCED ENTEROCOLITIS ASSOCIATED WITH EOSINOPHILIC INFILTRATION POSSIBLY CAUSED BY INSULIN PREPARATIONS. THE 117TH REGULAR MEETING OF THE JAPANESE SOCIETY OF GASTROENTEROLOGY, THE 111TH. UNK?UNK:148",16.0,YR,T,F,Y,,,20210827.0,,MD,JP,JP,2021,Q3,Youth
197526791,19752679,1,PS,INSULIN LISPRO BS Injection Solostar HU [Sanofi],INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q3,Weight decreased,,2021,Q3,1,I,,20210823.0,20210827,20210827,EXP,,JP-SAKK-2021SA278878AA,SANOFI AVENTIS,"YOSHIMURA Y, NAKAMURA S, KAWANO S, OKAMURA K, SHIMOKAMA T, TORISU T.. A CASE OF DRUG?INDUCED ENTEROCOLITIS ASSOCIATED WITH EOSINOPHILIC INFILTRATION POSSIBLY CAUSED BY INSULIN PREPARATIONS. THE 117TH REGULAR MEETING OF THE JAPANESE SOCIETY OF GASTROENTEROLOGY, THE 111TH. UNK?UNK:148",16.0,YR,T,F,Y,,,20210827.0,,MD,JP,JP,2021,Q3,Youth
197549902,19754990,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,202108.0,20210818.0,20210827,20210830,PER,,US-ELI_LILLY_AND_COMPANY-US202108008645,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
197549902,19754990,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Counterfeit product administered,,2021,Q3,2,F,202108.0,20210818.0,20210827,20210830,PER,,US-ELI_LILLY_AND_COMPANY-US202108008645,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
197549902,19754990,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,U,, D341139A,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,2,F,202108.0,20210818.0,20210827,20210830,PER,,US-ELI_LILLY_AND_COMPANY-US202108008645,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
197549902,19754990,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK, PRN",,,U,, D341139A,,20563.0,,,INJECTION,,2021,Q3,Counterfeit product administered,,2021,Q3,2,F,202108.0,20210818.0,20210827,20210830,PER,,US-ELI_LILLY_AND_COMPANY-US202108008645,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
197605951,19760595,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,7 IU,,,U,,,,,7.0,IU,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210817.0,20210825.0,20210830,20210830,PER,,US-SA-2021SA284047,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
197605951,19760595,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Unknown,7 IU,,,U,,,,,7.0,IU,,,2021,Q3,Product storage error,,2021,Q3,1,I,20210817.0,20210825.0,20210830,20210830,PER,,US-SA-2021SA284047,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20210830.0,,CN,US,US,2021,Q3,Elderly
197643541,19764354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210817.0,20210825.0,20210831,20210831,PER,,US-ELI_LILLY_AND_COMPANY-US202108011176,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210831.0,,CN,US,US,2021,Q3,Elderly
197643541,19764354,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D341138C,,20563.0,,,INJECTION,,2021,Q3,Product storage error,,2021,Q3,1,I,20210817.0,20210825.0,20210831,20210831,PER,,US-ELI_LILLY_AND_COMPANY-US202108011176,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20210831.0,,CN,US,US,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Asthma,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Discomfort,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Hypoxia,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197651531,19765153,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 UNITS, TWO TIMES A DAY",,,,,,,,,,,,2021,Q3,Wheezing,,2021,Q3,1,I,,20200327.0,20210831,20210831,EXP,,CA-COVIS PHARMA GMBH-2021COV21919,COVIS PHARMA,,83.0,YR,E,M,Y,,,20210831.0,,CN,CA,CA,2021,Q3,Elderly
197657513,19765751,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"42.0,U,THRICE DAILY",,,,,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,3,F,20210805.0,20210908.0,20210831,20210920,EXP,,JP-NOVOPROD-841098,NOVO NORDISK,,66.0,YR,,M,Y,80.0,KG,20210921.0,,MD,JP,JP,2021,Q3,Elderly
197666541,19766654,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Hepatic failure,,2021,Q3,1,I,20210825.0,,20210830,20210830,DIR,,,FDA-CTU,,58.0,YR,,M,N,101.0,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197666541,19766654,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pulmonary embolism,,2021,Q3,1,I,20210825.0,,20210830,20210830,DIR,,,FDA-CTU,,58.0,YR,,M,N,101.0,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197666541,19766654,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pulseless electrical activity,,2021,Q3,1,I,20210825.0,,20210830,20210830,DIR,,,FDA-CTU,,58.0,YR,,M,N,101.0,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197666541,19766654,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Renal failure,,2021,Q3,1,I,20210825.0,,20210830,20210830,DIR,,,FDA-CTU,,58.0,YR,,M,N,101.0,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197666541,19766654,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Respiratory failure,,2021,Q3,1,I,20210825.0,,20210830,20210830,DIR,,,FDA-CTU,,58.0,YR,,M,N,101.0,KG,20210830.0,N,PH,US,US,2021,Q3,Adult
197674551,19767455,11,C,INSULINA LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,20210104.0,20210824.0,20210830,20210830,EXP,IT-MINISAL02-701972,IT-MYLANLABS-2021M1055870,MYLAN,,74.0,YR,,F,Y,,,20210830.0,,MD,IT,IT,2021,Q3,Elderly
197674551,19767455,11,C,INSULINA LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Rectal haemorrhage,,2021,Q3,1,I,20210104.0,20210824.0,20210830,20210830,EXP,IT-MINISAL02-701972,IT-MYLANLABS-2021M1055870,MYLAN,,74.0,YR,,F,Y,,,20210830.0,,MD,IT,IT,2021,Q3,Elderly
197714951,19771495,7,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,20210830.0,,20210901,20210901,DIR,,,FDA-CTU,,44.0,YR,,M,N,152.3,KG,20210901.0,N,PH,US,US,2021,Q3,Adult
197714951,19771495,7,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Pulmonary embolism,,2021,Q3,1,I,20210830.0,,20210901,20210901,DIR,,,FDA-CTU,,44.0,YR,,M,N,152.3,KG,20210901.0,N,PH,US,US,2021,Q3,Adult
197719631,19771963,7,C,INSULIN LISPRO SANOFI 100 UNITS/ML,,2,Intravenous (not otherwise specified),4?6 E IF NEEDED,,,,, UNKNOWN,,,,,SOLUTION FOR INJECTION/INFUSION,,2021,Q3,Status epilepticus,,2021,Q3,1,I,20210810.0,20210830.0,20210901,20210901,EXP,SE-MPA-2021-075240,"SE-SHIONOGI, INC-2021000372",SHIONOGI,,75.0,YR,,M,Y,,,20210901.0,,MD,SE,SE,2021,Q3,Elderly
197741832,19774183,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Aphasia,,2021,Q3,2,F,202105.0,20210908.0,20210901,20210920,EXP,,US-ELI_LILLY_AND_COMPANY-US202108012205,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20210920.0,,CN,US,US,2021,Q3,Adult
197741832,19774183,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Cerebrovascular accident,,2021,Q3,2,F,202105.0,20210908.0,20210901,20210920,EXP,,US-ELI_LILLY_AND_COMPANY-US202108012205,ELI LILLY AND CO,,48.0,YR,,M,Y,,,20210920.0,,CN,US,US,2021,Q3,Adult
197744421,19774442,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D058036A,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202108.0,20210817.0,20210901,20210901,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20210901.0,,CN,US,US,2021,Q3,Elderly
197767281,19776728,3,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Abdominal distension,,2021,Q3,1,I,20210727.0,20210803.0,20210902,20210902,PER,,US-ELI_LILLY_AND_COMPANY-US202108002565,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20210902.0,,CN,US,US,2021,Q3,Elderly
197767281,19776728,3,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,20210727.0,20210803.0,20210902,20210902,PER,,US-ELI_LILLY_AND_COMPANY-US202108002565,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20210902.0,,CN,US,US,2021,Q3,Elderly
197767281,19776728,3,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Muscle spasms,,2021,Q3,1,I,20210727.0,20210803.0,20210902,20210902,PER,,US-ELI_LILLY_AND_COMPANY-US202108002565,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20210902.0,,CN,US,US,2021,Q3,Elderly
197767281,19776728,3,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210727.0,20210803.0,20210902,20210902,PER,,US-ELI_LILLY_AND_COMPANY-US202108002565,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20210902.0,,CN,US,US,2021,Q3,Elderly
197767281,19776728,3,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Off label use,,2021,Q3,1,I,20210727.0,20210803.0,20210902,20210902,PER,,US-ELI_LILLY_AND_COMPANY-US202108002565,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20210902.0,,CN,US,US,2021,Q3,Elderly
197767281,19776728,3,C,LYUMJEV [INSULIN LISPRO],,2,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20210727.0,20210803.0,20210902,20210902,PER,,US-ELI_LILLY_AND_COMPANY-US202108002565,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20210902.0,,CN,US,US,2021,Q3,Elderly
197841641,19784164,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,1,I,20210830.0,,20210903,20210903,DIR,,,FDA-CTU,,41.0,YR,,M,N,79.65,KG,20210903.0,N,PH,US,US,2021,Q3,Adult
197841641,19784164,4,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Therapy cessation,,2021,Q3,1,I,20210830.0,,20210903,20210903,DIR,,,FDA-CTU,,41.0,YR,,M,N,79.65,KG,20210903.0,N,PH,US,US,2021,Q3,Adult
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Constipation,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Cough,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Dysuria,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Flank pain,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Localised infection,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Renal pain,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197857412,19785741,6,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,,40?0?25?0,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,2,F,,20210908.0,20210903,20210920,EXP,DE-BFARM-21007554,DE-ACCORD-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20210920.0,,PH,DE,DE,2021,Q3,Elderly
197903441,19790344,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,7 UNITS THREE TIMES DAILY WITH MEALS,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,US-ROCHE-2904271,ROCHE,"CLONTZ R, DANG D, HIEGER M AND BECKER B. ATEZOLIZUMAB?INDUCED AUTOIMMUNE DIABETES IN A PATIENT WITH METASTATIC BREAST CANCER: A CASE REPORT. CLINICAL PRACTICE AND CASES IN EMERGENCY MEDICINE 2021 MAY?5 (2):190?3.",74.0,YR,,F,Y,,,20210906.0,,MD,US,US,2021,Q3,Elderly
197903441,19790344,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,7 UNITS THREE TIMES DAILY WITH MEALS,,,,,,,,,,,,2021,Q3,Neuropathy peripheral,,2021,Q3,1,I,,20210830.0,20210906,20210906,EXP,,US-ROCHE-2904271,ROCHE,"CLONTZ R, DANG D, HIEGER M AND BECKER B. ATEZOLIZUMAB?INDUCED AUTOIMMUNE DIABETES IN A PATIENT WITH METASTATIC BREAST CANCER: A CASE REPORT. CLINICAL PRACTICE AND CASES IN EMERGENCY MEDICINE 2021 MAY?5 (2):190?3.",74.0,YR,,F,Y,,,20210906.0,,MD,US,US,2021,Q3,Elderly
197904912,19790491,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Blood glucose abnormal,,2021,Q3,2,F,,20210909.0,20210906,20210910,PER,,US-SA-2021SA290257,SANOFI AVENTIS,,7.0,YR,C,F,Y,,,20210910.0,,CN,US,US,2021,Q3,Child
197904912,19790491,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Device issue,,2021,Q3,2,F,,20210909.0,20210906,20210910,PER,,US-SA-2021SA290257,SANOFI AVENTIS,,7.0,YR,C,F,Y,,,20210910.0,,CN,US,US,2021,Q3,Child
197904912,19790491,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2021,Q3,Intentional product use issue,,2021,Q3,2,F,,20210909.0,20210906,20210910,PER,,US-SA-2021SA290257,SANOFI AVENTIS,,7.0,YR,C,F,Y,,,20210910.0,,CN,US,US,2021,Q3,Child
197906291,19790629,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 INTERNATIONAL UNIT,,,,,,,209196.0,300.0,IU,,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 INTERNATIONAL UNIT,,,,,,,209196.0,300.0,IU,,,2021,Q3,Lactic acidosis,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 INTERNATIONAL UNIT,,,,,,,209196.0,300.0,IU,,,2021,Q3,Suicide attempt,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 INTERNATIONAL UNIT, DAILY",,,,,,,209196.0,16.0,IU,,QD,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 INTERNATIONAL UNIT, DAILY",,,,,,,209196.0,16.0,IU,,QD,2021,Q3,Lactic acidosis,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197906291,19790629,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 INTERNATIONAL UNIT, DAILY",,,,,,,209196.0,16.0,IU,,QD,2021,Q3,Suicide attempt,,2021,Q3,1,I,,20210901.0,20210906,20210906,EXP,,JP-SA-2021SA292383,SANOFI AVENTIS,TOKUMARU M.. A CASE OF LACTIC ACIDOSIS IN OVERDOSE OF METFORMIN AND INSULIN FOR SUICIDE ATTEMPT. DIABETES. 2021?64(S):UNK,28.0,YR,A,F,Y,,,20210906.0,,MD,JP,JP,2021,Q3,Young Adult
197938932,19793893,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 UNIT/ML, 3 ML",,,,,,,,1.0,IU,,Q8H,2021,Q3,Acute kidney injury,,2021,Q3,2,F,20210811.0,20210921.0,20210907,20210927,EXP,,ES-EMD SERONO-9262879,EMD SERONO INC,,87.0,YR,E,M,Y,72.0,KG,20210927.0,,HP,ES,ES,2021,Q3,Elderly
197942253,19794225,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 IU, UNK",,,U,,,,,15.0,IU,,,2021,Q3,Device delivery system issue,,2021,Q3,3,F,,20210921.0,20210907,20210929,EXP,,US-SA-2021SA293481,SANOFI AVENTIS,,74.0,YR,E,F,Y,103.0,KG,20210929.0,,CN,US,US,2021,Q3,Elderly
197942253,19794225,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 IU, UNK",,,U,,,,,15.0,IU,,,2021,Q3,Diabetes mellitus inadequate control,,2021,Q3,3,F,,20210921.0,20210907,20210929,EXP,,US-SA-2021SA293481,SANOFI AVENTIS,,74.0,YR,E,F,Y,103.0,KG,20210929.0,,CN,US,US,2021,Q3,Elderly
197942253,19794225,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 IU, UNK",,,U,,,,,15.0,IU,,,2021,Q3,Incorrect dose administered by device,,2021,Q3,3,F,,20210921.0,20210907,20210929,EXP,,US-SA-2021SA293481,SANOFI AVENTIS,,74.0,YR,E,F,Y,103.0,KG,20210929.0,,CN,US,US,2021,Q3,Elderly
197942253,19794225,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 IU, UNK",,,U,,,,,15.0,IU,,,2021,Q3,Pancreatic failure,,2021,Q3,3,F,,20210921.0,20210907,20210929,EXP,,US-SA-2021SA293481,SANOFI AVENTIS,,74.0,YR,E,F,Y,103.0,KG,20210929.0,,CN,US,US,2021,Q3,Elderly
197984182,19798418,2,C,LYUMJEV [INSULIN LISPRO],,2,Subcutaneous,"7 IU IN THE MORNING, 8 IU IN THE AFTERNOON, 4 IU IN THE EVENING",,,,,,,,19.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,QD,2021,Q3,Adenocarcinoma pancreas,,2021,Q3,2,F,20210725.0,20210910.0,20210906,20210921,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108011688,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210921.0,,MD,JP,JP,2021,Q3,Elderly
197984182,19798418,2,C,LYUMJEV [INSULIN LISPRO],,2,Subcutaneous,"7 IU IN THE MORNING, 8 IU IN THE AFTERNOON, 4 IU IN THE EVENING",,,,,,,,19.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,QD,2021,Q3,Jaundice cholestatic,,2021,Q3,2,F,20210725.0,20210910.0,20210906,20210921,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108011688,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210921.0,,MD,JP,JP,2021,Q3,Elderly
197984182,19798418,2,C,LYUMJEV [INSULIN LISPRO],,2,Subcutaneous,"7 IU IN THE MORNING, 8 IU IN THE AFTERNOON, 4 IU IN THE EVENING",,,,,,,,19.0,IU,SOLUTION FOR INJECTION IN PRE-FILLED PEN,QD,2021,Q3,Off label use,,2021,Q3,2,F,20210725.0,20210910.0,20210906,20210921,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202108011688,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20210921.0,,MD,JP,JP,2021,Q3,Elderly
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Adrenomegaly,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Anaemia,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Asthenia,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Chronic gastritis,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Duodenitis,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Gastric ulcer,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Gastritis,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Gastritis erosive,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Hypermagnesaemia,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Hypertriglyceridaemia,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Hypoproteinaemia,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Lacunar infarction,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Nephrolithiasis,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198008861,19800886,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 IU, Q12H",944.0,IU,U,,,,209196.0,16.0,IU,,Q12H,2021,Q3,Sinusitis,,2021,Q3,1,I,20210424.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA292501,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Anaemia,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Chronic gastritis,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Duodenitis,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Gastric ulcer,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Hypermagnesaemia,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Hypertension,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Hypertriglyceridaemia,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Hypoproteinaemia,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Lacunar infarction,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Nephrolithiasis,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Renal disorder,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Sinusitis,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198009181,19800918,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 IU, Q12H",,,U,,,,209196.0,8.0,IU,,Q12H,2021,Q3,Stomatitis,,2021,Q3,1,I,2021.0,20210831.0,20210908,20210908,EXP,,CN-SA-2021SA291247,SANOFI AVENTIS,,58.0,YR,A,F,Y,51.0,KG,20210908.0,,HP,CN,CN,2021,Q3,Adult
198011122,19801112,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Feeling abnormal,,2021,Q3,2,F,202106.0,20210830.0,20210907,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202108011803,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20210909.0,,HP,US,US,2021,Q3,Young Adult
198011122,19801112,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Pain,,2021,Q3,2,F,202106.0,20210830.0,20210907,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202108011803,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20210909.0,,HP,US,US,2021,Q3,Young Adult
198011122,19801112,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Superior mesenteric artery syndrome,,2021,Q3,2,F,202106.0,20210830.0,20210907,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202108011803,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20210909.0,,HP,US,US,2021,Q3,Young Adult
198012291,19801229,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q3,Diarrhoea,,2021,Q3,1,I,20210620.0,20210903.0,20210908,20210908,EXP,,DE-SA-2021SA294075,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20210908.0,,MD,DE,DE,2021,Q3,Elderly
198012501,19801250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,SLIDING SCALE 0?8 UNITS WITH MEALS,,,D,,,,,,,,,2021,Q3,Pneumonia,,2021,Q3,1,I,20210723.0,20210903.0,20210907,20210907,EXP,,NVSC2021US202125,NOVARTIS,,40.0,YR,,M,Y,90.4,KG,20210907.0,,MD,US,US,2021,Q3,Adult
198030281,19803028,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Mobility decreased,,2021,Q3,1,I,202108.0,20210903.0,20210908,20210908,PER,,US-ELI_LILLY_AND_COMPANY-US202109002681,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210908.0,,CN,US,US,2021,Q3,Elderly
198030281,19803028,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Mobility decreased,,2021,Q3,1,I,202108.0,20210903.0,20210908,20210908,PER,,US-ELI_LILLY_AND_COMPANY-US202109002681,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210908.0,,CN,US,US,2021,Q3,Elderly
198030281,19803028,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,, D355431A,,20563.0,,,INJECTION,,2021,Q3,Mobility decreased,,2021,Q3,1,I,202108.0,20210903.0,20210908,20210908,PER,,US-ELI_LILLY_AND_COMPANY-US202109002681,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210908.0,,CN,US,US,2021,Q3,Elderly
198030281,19803028,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, PRN",,,U,, D355431A,,20563.0,,,INJECTION,,2021,Q3,Mobility decreased,,2021,Q3,1,I,202108.0,20210903.0,20210908,20210908,PER,,US-ELI_LILLY_AND_COMPANY-US202109002681,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20210908.0,,CN,US,US,2021,Q3,Elderly
198074133,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML INJECTION 1?2 UNITS NIGHTLY,,,U,,,,,,,,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML INJECTION 1?2 UNITS NIGHTLY,,,U,,,,,,,,,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML INJECTION 1?2 UNITS NIGHTLY,,,U,,,,,,,,,2021,Q3,Eyelid ptosis,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML INJECTION 1?2 UNITS NIGHTLY,,,U,,,,,,,,,2021,Q3,Immune-mediated myositis,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML INJECTION 1?2 UNITS NIGHTLY,,,U,,,,,,,,,2021,Q3,Myasthenia gravis,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 UNIT/ML INJECTION 1?2 UNITS NIGHTLY,,,U,,,,,,,,,2021,Q3,Troponin I increased,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNIT/ML INJECTION 1?3 UNITS, 3 TIMES DAILY",,,U,,,,,,,,,2021,Q3,Alanine aminotransferase increased,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNIT/ML INJECTION 1?3 UNITS, 3 TIMES DAILY",,,U,,,,,,,,,2021,Q3,Aspartate aminotransferase increased,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNIT/ML INJECTION 1?3 UNITS, 3 TIMES DAILY",,,U,,,,,,,,,2021,Q3,Eyelid ptosis,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNIT/ML INJECTION 1?3 UNITS, 3 TIMES DAILY",,,U,,,,,,,,,2021,Q3,Immune-mediated myositis,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNIT/ML INJECTION 1?3 UNITS, 3 TIMES DAILY",,,U,,,,,,,,,2021,Q3,Myasthenia gravis,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198074133,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UNIT/ML INJECTION 1?3 UNITS, 3 TIMES DAILY",,,U,,,,,,,,,2021,Q3,Troponin I increased,,2021,Q3,3,F,20210830.0,20210917.0,20210908,20210924,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20210924.0,,HP,US,US,2021,Q3,Elderly
198089401,19808940,7,C,insulin (regular ??} glargine and lispro),,2,,,,,,,,,,,,,,2021,Q3,Deep vein thrombosis,,2021,Q3,1,I,20210905.0,,20210909,20210909,DIR,,,FDA-CTU,,32.0,YR,,M,N,161.2,KG,20210909.0,N,PH,US,US,2021,Q3,Young Adult
198089401,19808940,7,C,insulin (regular ??} glargine and lispro),,2,,,,,,,,,,,,,,2021,Q3,Hypoxia,,2021,Q3,1,I,20210905.0,,20210909,20210909,DIR,,,FDA-CTU,,32.0,YR,,M,N,161.2,KG,20210909.0,N,PH,US,US,2021,Q3,Young Adult
198089401,19808940,7,C,insulin (regular ??} glargine and lispro),,2,,,,,,,,,,,,,,2021,Q3,Pulmonary embolism,,2021,Q3,1,I,20210905.0,,20210909,20210909,DIR,,,FDA-CTU,,32.0,YR,,M,N,161.2,KG,20210909.0,N,PH,US,US,2021,Q3,Young Adult
198089401,19808940,7,C,insulin (regular ??} glargine and lispro),,2,,,,,,,,,,,,,,2021,Q3,Supraventricular tachycardia,,2021,Q3,1,I,20210905.0,,20210909,20210909,DIR,,,FDA-CTU,,32.0,YR,,M,N,161.2,KG,20210909.0,N,PH,US,US,2021,Q3,Young Adult
198093441,19809344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198093441,19809344,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210903.0,20210909,20210909,EXP,DE-ADRED-07171-01,NVSC2021DE200937,NOVARTIS,,55.0,YR,,F,Y,62.0,KG,20210909.0,,HP,DE,DE,2021,Q3,Adult
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Chills,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198098201,19809820,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210909,20210909,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20210909.0,,PH,DE,DE,2021,Q3,Elderly
198155381,19815538,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Fall,,2021,Q3,1,I,20210830.0,20210831.0,20210909,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202109000089,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210909.0,,CN,US,US,2021,Q3,Elderly
198155381,19815538,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Limb injury,,2021,Q3,1,I,20210830.0,20210831.0,20210909,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202109000089,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210909.0,,CN,US,US,2021,Q3,Elderly
198155381,19815538,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN(RE?STARTED)",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Fall,,2021,Q3,1,I,20210830.0,20210831.0,20210909,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202109000089,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210909.0,,CN,US,US,2021,Q3,Elderly
198155381,19815538,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN(RE?STARTED)",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Limb injury,,2021,Q3,1,I,20210830.0,20210831.0,20210909,20210909,EXP,,US-ELI_LILLY_AND_COMPANY-US202109000089,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20210909.0,,CN,US,US,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Disorientation,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198172711,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210910,20210910,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20210910.0,,PH,DE,DE,2021,Q3,Elderly
198180891,19818089,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,MEDICATION DOSE 20 U (UNIT),,,,,,,,,,INJECTION,,2021,Q3,Bartholin's abscess,,2021,Q3,1,I,20210811.0,20210903.0,20210911,20210911,EXP,,RU-ROCHE-2905644,ROCHE,,37.0,YR,,F,Y,84.0,KG,20210911.0,,MD,RU,RU,2021,Q3,Adult
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184651,19818465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,,NVSC2021DE202703,NOVARTIS,,69.0,YR,,F,Y,93.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Disorientation,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198184671,19818467,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210911,20210911,EXP,DE-ADRED-07164-01,NVSC2021DE200928,NOVARTIS,,75.0,YR,,M,Y,90.0,KG,20210911.0,,HP,DE,DE,2021,Q3,Elderly
198188791,19818879,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198188791,19818879,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IE, BEDARF, FERTIGSPRITZEN",,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210901.0,20210912,20210912,EXP,,DE-AUROBINDO-AUR-APL-2021-038201,AUROBINDO,,55.0,YR,,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Musculoskeletal pain,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198192521,19819252,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEMA,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,20210119.0,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021137133,AMGEN,,70.0,YR,E,F,Y,,,20210912.0,,PH,DE,DE,2021,Q3,Elderly
198200451,19820045,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q3,Death,,2021,Q3,1,I,20210828.0,20210907.0,20210913,20210913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-091307,BRISTOL MYERS SQUIBB,,79.0,YR,,M,Y,,,20210913.0,,HP,US,US,2021,Q3,Elderly
198201631,19820163,15,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,2,,100 INTERNATIONAL UNIT,,,,,,,,100.0,IU,,,2021,Q3,Death,,2021,Q3,1,I,20210814.0,20210908.0,20210913,20210913,PER,,US-AMGEN-USASP2021140290,AMGEN,,68.0,YR,E,F,Y,,,20210913.0,,MD,US,US,2021,Q3,Elderly
198201691,19820169,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 UNITS BEFORE MEALS,,,U,,,,,,,,,2021,Q3,Myocardial infarction,,2021,Q3,1,I,20210823.0,20210907.0,20210913,20210913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-090270,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,82.99,KG,20210913.0,,CN,US,US,2021,Q3,Adult
198201691,19820169,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 UNITS BEFORE MEALS,,,U,,,,,,,,,2021,Q3,Pain,,2021,Q3,1,I,20210823.0,20210907.0,20210913,20210913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-090270,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,82.99,KG,20210913.0,,CN,US,US,2021,Q3,Adult
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Abdominal distension,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Hypotension,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198203551,19820355,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210913,20210913,PER,,DE-AMGEN-DEUSP2021138408,AMGEN,,69.0,YR,E,F,Y,93.0,KG,20210913.0,,HP,DE,DE,2021,Q3,Elderly
198212261,19821226,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198212261,19821226,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, BEDARF, FERTIGSPRITZEN)",,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210903.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-GLAXOSMITHKLINE-DECH2021061542,GLAXOSMITHKLINE,,55.0,YR,,F,Y,,,20210913.0,,HP,DE,DE,2021,Q3,Adult
198216371,19821637,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"10 U, DAILY(1?10 UNITS)",,,U,,,,20563.0,10.0,IU,INJECTION,QD,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210827.0,20210901.0,20210913,20210913,EXP,,US-ELI_LILLY_AND_COMPANY-US202109000890,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20210913.0,,CN,US,US,2021,Q3,Adult
198216371,19821637,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"20 U, TID",,,U,, D571847A,,20563.0,20.0,IU,INJECTION,TID,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210827.0,20210901.0,20210913,20210913,EXP,,US-ELI_LILLY_AND_COMPANY-US202109000890,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20210913.0,,CN,US,US,2021,Q3,Adult
198218591,19821859,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IE,,,U,,,,,1.0,IU,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210902.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-TORRENT-00021122,TORRENT,,55.0,YR,A,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198218591,19821859,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IE,,,U,,,,,1.0,IU,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210902.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-TORRENT-00021122,TORRENT,,55.0,YR,A,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198218591,19821859,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IE,,,U,,,,,1.0,IU,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210902.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-TORRENT-00021122,TORRENT,,55.0,YR,A,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198218591,19821859,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IE,,,U,,,,,1.0,IU,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210902.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-TORRENT-00021122,TORRENT,,55.0,YR,A,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198218591,19821859,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IE,,,U,,,,,1.0,IU,,,2021,Q3,Headache,,2021,Q3,1,I,,20210902.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-TORRENT-00021122,TORRENT,,55.0,YR,A,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198218591,19821859,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IE,,,U,,,,,1.0,IU,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210902.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-TORRENT-00021122,TORRENT,,55.0,YR,A,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198218591,19821859,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,1 IE,,,U,,,,,1.0,IU,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210902.0,20210913,20210913,EXP,DE-ADRED-07171-01,DE-TORRENT-00021122,TORRENT,,55.0,YR,A,F,Y,62.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Adult
198242351,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19?17?25?0",,,U,,,,209196.0,,,,Q8H,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198242351,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19?17?25?0",,,U,,,,209196.0,,,,Q8H,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198242351,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19?17?25?0",,,U,,,,209196.0,,,,Q8H,2021,Q3,Fatigue,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198242351,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19?17?25?0",,,U,,,,209196.0,,,,Q8H,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198242351,19824235,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 19?17?25?0",,,U,,,,209196.0,,,,Q8H,2021,Q3,Lack of application site rotation,,2021,Q3,1,I,20210111.0,20210907.0,20210913,20210913,EXP,,DE-SA-2021SA297063,SANOFI AVENTIS,,73.0,YR,E,M,Y,74.0,KG,20210913.0,,PH,DE,DE,2021,Q3,Elderly
198244731,19824473,2,C,LISPRO INSULIN,INSULIN LISPRO,1,Subcutaneous,8U,,,,,,,,,,,,2021,Q3,Diabetic ketoacidosis,,2021,Q3,1,I,,20210831.0,20210913,20210913,EXP,,CN-ASTRAZENECA-2021A711188,ASTRAZENECA,,43.0,YR,,M,Y,,,20210913.0,,HP,CN,CN,2021,Q3,Adult
198264311,19826431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-MICRO LABS LIMITED-ML2021-02239,MICRO LABS,,55.0,YR,,F,Y,62.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Adult
198264311,19826431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-MICRO LABS LIMITED-ML2021-02239,MICRO LABS,,55.0,YR,,F,Y,62.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Adult
198264311,19826431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-MICRO LABS LIMITED-ML2021-02239,MICRO LABS,,55.0,YR,,F,Y,62.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Adult
198264311,19826431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-MICRO LABS LIMITED-ML2021-02239,MICRO LABS,,55.0,YR,,F,Y,62.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Adult
198264311,19826431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-MICRO LABS LIMITED-ML2021-02239,MICRO LABS,,55.0,YR,,F,Y,62.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Adult
198264311,19826431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-MICRO LABS LIMITED-ML2021-02239,MICRO LABS,,55.0,YR,,F,Y,62.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Adult
198264311,19826431,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210906.0,20210914,20210914,EXP,,DE-MICRO LABS LIMITED-ML2021-02239,MICRO LABS,,55.0,YR,,F,Y,62.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Adult
198267771,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,2021.0,20210902.0,20210914,20210914,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20210914.0,,HP,US,US,2021,Q3,Adult
198267771,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,2021.0,20210902.0,20210914,20210914,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20210914.0,,HP,US,US,2021,Q3,Adult
198267771,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Diabetes mellitus,,2021,Q3,1,I,2021.0,20210902.0,20210914,20210914,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20210914.0,,HP,US,US,2021,Q3,Adult
198267771,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Endoscopy,,2021,Q3,1,I,2021.0,20210902.0,20210914,20210914,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20210914.0,,HP,US,US,2021,Q3,Adult
198267771,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,2021.0,20210902.0,20210914,20210914,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20210914.0,,HP,US,US,2021,Q3,Adult
198267771,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,2021.0,20210902.0,20210914,20210914,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20210914.0,,HP,US,US,2021,Q3,Adult
198269481,19826948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,, UNK,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,20210118.0,20210903.0,20210914,20210914,EXP,,NVSC2021DE200957,NOVARTIS,,79.0,YR,,M,Y,75.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269481,19826948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,, UNK,,,,,,,2021,Q3,Angina pectoris,,2021,Q3,1,I,20210118.0,20210903.0,20210914,20210914,EXP,,NVSC2021DE200957,NOVARTIS,,79.0,YR,,M,Y,75.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269481,19826948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,, UNK,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,20210118.0,20210903.0,20210914,20210914,EXP,,NVSC2021DE200957,NOVARTIS,,79.0,YR,,M,Y,75.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269481,19826948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,, UNK,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,20210118.0,20210903.0,20210914,20210914,EXP,,NVSC2021DE200957,NOVARTIS,,79.0,YR,,M,Y,75.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269481,19826948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,, UNK,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,20210118.0,20210903.0,20210914,20210914,EXP,,NVSC2021DE200957,NOVARTIS,,79.0,YR,,M,Y,75.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269481,19826948,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (SCHEMA),,,U,, UNK,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,20210118.0,20210903.0,20210914,20210914,EXP,,NVSC2021DE200957,NOVARTIS,,79.0,YR,,M,Y,75.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Chills,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198269521,19826952,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE201784,NOVARTIS,,69.0,YR,,F,Y,91.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198271071,19827107,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D337388E,,,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210902.0,20210909.0,20210914,20210914,PER,,US-ELI_LILLY_AND_COMPANY-US202109005094,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210914.0,,CN,US,US,2021,Q3,Elderly
198271071,19827107,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D337388E,,,,,INJECTION,,2021,Q3,Product dose omission issue,,2021,Q3,1,I,20210902.0,20210909.0,20210914,20210914,PER,,US-ELI_LILLY_AND_COMPANY-US202109005094,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20210914.0,,CN,US,US,2021,Q3,Elderly
198275951,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, BID (50 IE, 56?0?36?0)",,,U,,,,,50.0,IU,,BID,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210909.0,20210914,20210914,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198275951,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, BID (50 IE, 56?0?36?0)",,,U,,,,,50.0,IU,,BID,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210909.0,20210914,20210914,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198275951,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, BID (50 IE, 56?0?36?0)",,,U,,,,,50.0,IU,,BID,2021,Q3,Flank pain,,2021,Q3,1,I,,20210909.0,20210914,20210914,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198275951,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, BID (50 IE, 56?0?36?0)",,,U,,,,,50.0,IU,,BID,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210909.0,20210914,20210914,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198275951,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, BID (50 IE, 56?0?36?0)",,,U,,,,,50.0,IU,,BID,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210909.0,20210914,20210914,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198275951,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, BID (50 IE, 56?0?36?0)",,,U,,,,,50.0,IU,,BID,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210909.0,20210914,20210914,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198275951,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, BID (50 IE, 56?0?36?0)",,,U,,,,,50.0,IU,,BID,2021,Q3,Renal pain,,2021,Q3,1,I,,20210909.0,20210914,20210914,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Musculoskeletal pain,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198276411,19827641,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,SCHEMA,,,U,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210914,20210914,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20210914.0,,HP,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Chills,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198295941,19829594,14,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210907.0,20210914,20210914,EXP,,DE-TEVA-2021-DE-1951958,TEVA,,69.0,YR,E,F,Y,91.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19?17?25?0, FERTIGSPRITZEN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Abdominal pain upper,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19?17?25?0, FERTIGSPRITZEN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19?17?25?0, FERTIGSPRITZEN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Fatigue,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19?17?25?0, FERTIGSPRITZEN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198326171,19832617,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"300 IE, 19?17?25?0, FERTIGSPRITZEN",,,U,,,,20563.0,,,SOLUTION FOR INJECTION,,2021,Q3,Lack of application site rotation,,2021,Q3,1,I,20210111.0,20210902.0,20210914,20210914,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202109001407,ELI LILLY AND CO,,73.0,YR,,M,Y,74.0,KG,20210914.0,,PH,DE,DE,2021,Q3,Elderly
198370751,19837075,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Ascites,,2021,Q3,1,I,,20210831.0,20210915,20210915,EXP,,AT-ALVOGEN-2021-ALVOGEN-117476,ALVOGEN,,51.0,YR,,M,Y,,,20210915.0,,MD,AT,AT,2021,Q3,Adult
198370751,19837075,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Blood cholesterol increased,,2021,Q3,1,I,,20210831.0,20210915,20210915,EXP,,AT-ALVOGEN-2021-ALVOGEN-117476,ALVOGEN,,51.0,YR,,M,Y,,,20210915.0,,MD,AT,AT,2021,Q3,Adult
198370751,19837075,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Fluid overload,,2021,Q3,1,I,,20210831.0,20210915,20210915,EXP,,AT-ALVOGEN-2021-ALVOGEN-117476,ALVOGEN,,51.0,YR,,M,Y,,,20210915.0,,MD,AT,AT,2021,Q3,Adult
198370751,19837075,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Haematuria,,2021,Q3,1,I,,20210831.0,20210915,20210915,EXP,,AT-ALVOGEN-2021-ALVOGEN-117476,ALVOGEN,,51.0,YR,,M,Y,,,20210915.0,,MD,AT,AT,2021,Q3,Adult
198370751,19837075,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Kidney enlargement,,2021,Q3,1,I,,20210831.0,20210915,20210915,EXP,,AT-ALVOGEN-2021-ALVOGEN-117476,ALVOGEN,,51.0,YR,,M,Y,,,20210915.0,,MD,AT,AT,2021,Q3,Adult
198370751,19837075,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Proteinuria,,2021,Q3,1,I,,20210831.0,20210915,20210915,EXP,,AT-ALVOGEN-2021-ALVOGEN-117476,ALVOGEN,,51.0,YR,,M,Y,,,20210915.0,,MD,AT,AT,2021,Q3,Adult
198394161,19839416,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210909.0,20210916,20210916,EXP,DE-ADRED-07014-03,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210916.0,,HP,DE,DE,2021,Q3,Elderly
198394161,19839416,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Flank pain,,2021,Q3,1,I,,20210909.0,20210916,20210916,EXP,DE-ADRED-07014-03,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210916.0,,HP,DE,DE,2021,Q3,Elderly
198394161,19839416,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210909.0,20210916,20210916,EXP,DE-ADRED-07014-03,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210916.0,,HP,DE,DE,2021,Q3,Elderly
198394161,19839416,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210909.0,20210916,20210916,EXP,DE-ADRED-07014-03,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210916.0,,HP,DE,DE,2021,Q3,Elderly
198394161,19839416,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210909.0,20210916,20210916,EXP,DE-ADRED-07014-03,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20210916.0,,HP,DE,DE,2021,Q3,Elderly
198410951,19841095,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 IU, QD",3976.0,IU,Y,,,,209196.0,14.0,IU,,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20171012.0,20210914.0,20210915,20210915,EXP,IT-MINISAL02-450882,IT-SA-2021SA303682,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Adult
198410951,19841095,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 IU, QD",3976.0,IU,Y,,,,209196.0,14.0,IU,,QD,2021,Q3,Hypokalaemia,,2021,Q3,1,I,20171012.0,20210914.0,20210915,20210915,EXP,IT-MINISAL02-450882,IT-SA-2021SA303682,SANOFI AVENTIS,,57.0,YR,A,F,Y,,,20210915.0,,MD,IT,IT,2021,Q3,Adult
198420921,19842092,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,U,, D371847A,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210914.0,20210914.0,20210915,20210915,PER,,US-ELI_LILLY_AND_COMPANY-US202109005907,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20210915.0,,CN,US,US,2021,Q3,Elderly
198448221,19844822,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q3,Type I hypersensitivity,,2021,Q3,1,I,,20210817.0,20210916,20210916,EXP,,RO-ASTRAZENECA-2021A685925,ASTRAZENECA,,49.0,YR,,F,Y,,,20210916.0,,HP,RO,RO,2021,Q3,Adult
198466211,19846621,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,1.0,IU,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1951964,TEVA,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466211,19846621,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,1.0,IU,,,2021,Q3,Dehydration,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1951964,TEVA,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466211,19846621,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,1.0,IU,,,2021,Q3,Fall,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1951964,TEVA,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466211,19846621,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,1.0,IU,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1951964,TEVA,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466211,19846621,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,1.0,IU,,,2021,Q3,Insomnia,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1951964,TEVA,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466211,19846621,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,1.0,IU,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1951964,TEVA,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1 IE, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1 IE, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,,,,,2021,Q3,Dehydration,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1 IE, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,,,,,2021,Q3,Fall,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1 IE, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1 IE, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,,,,,2021,Q3,Insomnia,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198466931,19846693,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPE,INSULIN LISPRO,1,Subcutaneous,"1 IE, 24?24?32?0, CYLINDRICAL AMPOULES",,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210906.0,20210917,20210917,EXP,DE-BFARM-21008457,DE-ACCORD-238783,ACCORD,,77.0,YR,E,F,Y,79.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198470591,19847059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, UNK",,,U,,,,,15.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Clonic convulsion,,2021,Q3,1,I,20170527.0,20210914.0,20210917,20210917,EXP,IT-MINISAL02-414982,IT-SA-2021SA306020,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20210917.0,,MD,IT,IT,2021,Q3,Youth
198470591,19847059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, UNK",,,U,,,,,15.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20170527.0,20210914.0,20210917,20210917,EXP,IT-MINISAL02-414982,IT-SA-2021SA306020,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20210917.0,,MD,IT,IT,2021,Q3,Youth
198470591,19847059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, UNK",,,U,,,,,15.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20170527.0,20210914.0,20210917,20210917,EXP,IT-MINISAL02-414982,IT-SA-2021SA306020,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20210917.0,,MD,IT,IT,2021,Q3,Youth
198470591,19847059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 IU, UNK",,,U,,,,,15.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Trismus,,2021,Q3,1,I,20170527.0,20210914.0,20210917,20210917,EXP,IT-MINISAL02-414982,IT-SA-2021SA306020,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20210917.0,,MD,IT,IT,2021,Q3,Youth
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Disorientation,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Hypertension,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198473821,19847382,13,C,Insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952458,TEVA,,75.0,YR,E,M,Y,90.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198474121,19847412,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,1.0,IU,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952453,TEVA,,55.0,YR,A,F,Y,62.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Adult
198474121,19847412,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,1.0,IU,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952453,TEVA,,55.0,YR,A,F,Y,62.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Adult
198474121,19847412,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,1.0,IU,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952453,TEVA,,55.0,YR,A,F,Y,62.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Adult
198474121,19847412,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,1.0,IU,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952453,TEVA,,55.0,YR,A,F,Y,62.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Adult
198474121,19847412,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,1.0,IU,,,2021,Q3,Headache,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952453,TEVA,,55.0,YR,A,F,Y,62.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Adult
198474121,19847412,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,1.0,IU,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952453,TEVA,,55.0,YR,A,F,Y,62.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Adult
198474121,19847412,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,1.0,IU,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952453,TEVA,,55.0,YR,A,F,Y,62.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Adult
198474301,19847430,11,C,insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,20210118.0,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952326,TEVA,,79.0,YR,E,M,Y,75.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198474301,19847430,11,C,insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Angina pectoris,,2021,Q3,1,I,20210118.0,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952326,TEVA,,79.0,YR,E,M,Y,75.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198474301,19847430,11,C,insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Bradycardia,,2021,Q3,1,I,20210118.0,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952326,TEVA,,79.0,YR,E,M,Y,75.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198474301,19847430,11,C,insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,20210118.0,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952326,TEVA,,79.0,YR,E,M,Y,75.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198474301,19847430,11,C,insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,20210118.0,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952326,TEVA,,79.0,YR,E,M,Y,75.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198474301,19847430,11,C,insulin lispro,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,20210118.0,20210907.0,20210917,20210917,EXP,,DE-TEVA-2021-DE-1952326,TEVA,,79.0,YR,E,M,Y,75.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Anaemia,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Chills,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Sepsis,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Systemic infection,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Tachycardia,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198496321,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,SCHEME,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210903.0,20210917,20210917,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20210917.0,,PH,DE,DE,2021,Q3,Elderly
198546911,19854691,7,C,insulin lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Electrocardiogram QT prolonged,,2021,Q3,1,I,20210918.0,,20210919,20210919,DIR,,,FDA-CTU,,79.0,YR,,F,N,61.5,KG,20210919.0,N,PH,US,US,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Asthma,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Cough,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Discomfort,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Weight increased,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198557111,19855711,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2021,Q3,Wheezing,,2021,Q3,1,I,,20210909.0,20210920,20210920,EXP,,CA-TEVA-2021-CA-1954199,TEVA,,83.0,YR,E,M,Y,100.0,KG,20210919.0,,HP,CA,CA,2021,Q3,Elderly
198560101,19856010,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,34 IU,,,U,,,,,34.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20170521.0,20210914.0,20210920,20210920,EXP,IT-MINISAL02-414908,IT-SA-2021SA305961,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Young Adult
198560101,19856010,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,34 IU,,,U,,,,,34.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Vomiting,,2021,Q3,1,I,20170521.0,20210914.0,20210920,20210920,EXP,IT-MINISAL02-414908,IT-SA-2021SA305961,SANOFI AVENTIS,,25.0,YR,A,M,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Young Adult
198560271,19856027,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),10 DOSAGE FORM (10 UNITS),,,U,U,,,,10.0,DF,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210913.0,20210920,20210920,EXP,,US-MYLANLABS-2021M1063836,MYLAN,,85.0,YR,,F,Y,,,20210920.0,,PH,US,US,2021,Q3,Elderly
198563981,19856398,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 IU,,,U,,,,,8.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Confusional state,,2021,Q3,1,I,20170202.0,20210914.0,20210920,20210920,EXP,IT-MINISAL02-432132,IT-SA-2021SA306037,SANOFI AVENTIS,,93.0,YR,E,F,Y,,,20210920.0,,PH,IT,IT,2021,Q3,Elderly
198563981,19856398,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 IU,,,U,,,,,8.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,20170202.0,20210914.0,20210920,20210920,EXP,IT-MINISAL02-432132,IT-SA-2021SA306037,SANOFI AVENTIS,,93.0,YR,E,F,Y,,,20210920.0,,PH,IT,IT,2021,Q3,Elderly
198563981,19856398,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 IU,,,U,,,,,8.0,IU,SOLUTION FOR INJECTION,,2021,Q3,Malaise,,2021,Q3,1,I,20170202.0,20210914.0,20210920,20210920,EXP,IT-MINISAL02-432132,IT-SA-2021SA306037,SANOFI AVENTIS,,93.0,YR,E,F,Y,,,20210920.0,,PH,IT,IT,2021,Q3,Elderly
198568871,19856887,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20170714.0,20210914.0,20210920,20210920,EXP,IT-MINISAL02-462726,IT-SA-2021SA306198,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
198568871,19856887,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,209196.0,,,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemic coma,,2021,Q3,1,I,20170714.0,20210914.0,20210920,20210920,EXP,IT-MINISAL02-462726,IT-SA-2021SA306198,SANOFI AVENTIS,,91.0,YR,E,F,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
198593571,19859357,2,C,Insulin lispro injection,,2,,,,,,,,,,,,,,2021,Q3,Hospitalisation,,2021,Q3,1,I,20210904.0,,20210920,20210920,DIR,,,FDA-CTU,,54.0,YR,,M,N,35.8,KG,20210920.0,Y,HP,US,US,2021,Q3,Adult
198595041,19859504,16,C,Insulin Lispro,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,20210917.0,,20210920,20210920,DIR,,,FDA-CTU,,43.0,YR,,F,N,128.4,KG,20210920.0,N,PH,US,US,2021,Q3,Adult
198608571,19860857,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 DF (4 UNITS CLOSE TO BREAKFAST, 6 UNITS FOR LUNCH, 6 UNITS FOR DINNER)",,,U,,,,,16.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20171226.0,20180207.0,20210920,20210920,EXP,IT-SA-2018SA036414,IT-SA-2018SA036414,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
198608571,19860857,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 DF (4 UNITS CLOSE TO BREAKFAST, 6 UNITS FOR LUNCH, 6 UNITS FOR DINNER)",,,U,,,,,16.0,DF,SOLUTION FOR INJECTION,,2021,Q3,Loss of consciousness,,2021,Q3,1,I,20171226.0,20180207.0,20210920,20210920,EXP,IT-SA-2018SA036414,IT-SA-2018SA036414,SANOFI AVENTIS,,78.0,YR,E,F,Y,,,20210920.0,,MD,IT,IT,2021,Q3,Elderly
198635981,19863598,7,C,INSULIN LISPRO 100 U/ml,,2,Subcutaneous,ONCE AFTER MEALS AND AT BEDTIME,,,U,, UNKNOWN,,,,,,,2021,Q3,Myopathy,,2021,Q3,1,I,,20210915.0,20210922,20210922,EXP,,US-DRREDDYS-SPO/USA/21/0140225,DR REDDYS,"VALCHEV P, PARAMANATHAN P, ABBAS M, ITUA P, TARAVATI P. A CASE OF STATIN?INDUCED MYOPATHY. CONSULTANT. 2021?61(5):E3?5. DOI:10.25270/CON.2020.06.00022",79.0,YR,E,M,Y,,,20210922.0,,HP,US,US,2021,Q3,Elderly
198645851,19864585,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,,20210907.0,20210922,20210922,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-311907,RANBAXY,,55.0,YR,,F,Y,62.0,KG,20210922.0,,HP,NL,DE,2021,Q3,Adult
198645851,19864585,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,1,I,,20210907.0,20210922,20210922,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-311907,RANBAXY,,55.0,YR,,F,Y,62.0,KG,20210922.0,,HP,NL,DE,2021,Q3,Adult
198645851,19864585,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,1,I,,20210907.0,20210922,20210922,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-311907,RANBAXY,,55.0,YR,,F,Y,62.0,KG,20210922.0,,HP,NL,DE,2021,Q3,Adult
198645851,19864585,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210907.0,20210922,20210922,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-311907,RANBAXY,,55.0,YR,,F,Y,62.0,KG,20210922.0,,HP,NL,DE,2021,Q3,Adult
198645851,19864585,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Headache,,2021,Q3,1,I,,20210907.0,20210922,20210922,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-311907,RANBAXY,,55.0,YR,,F,Y,62.0,KG,20210922.0,,HP,NL,DE,2021,Q3,Adult
198645851,19864585,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,1,I,,20210907.0,20210922,20210922,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-311907,RANBAXY,,55.0,YR,,F,Y,62.0,KG,20210922.0,,HP,NL,DE,2021,Q3,Adult
198645851,19864585,11,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,,20210907.0,20210922,20210922,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-311907,RANBAXY,,55.0,YR,,F,Y,62.0,KG,20210922.0,,HP,NL,DE,2021,Q3,Adult
198648601,19864860,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q3,Expired product administered,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,2,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,,,,20563.0,,,INJECTION,,2021,Q3,Expired product administered,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D306029AC,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D306029AC,,20563.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,3,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D306029AC,,20563.0,,,INJECTION,,2021,Q3,Expired product administered,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D306029AC,,20563.0,,,INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D306029AC,,20563.0,,,INJECTION,,2021,Q3,Drug ineffective,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648601,19864860,4,SS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK, UNKNOWN",,,,, D306029AC,,20563.0,,,INJECTION,,2021,Q3,Expired product administered,,2021,Q3,1,I,202107.0,20210908.0,20210921,20210921,EXP,,US-ELI_LILLY_AND_COMPANY-US202109003625,ELI LILLY AND CO,,6.0,YR,,F,Y,,,20210921.0,,CN,US,US,2021,Q3,Child
198648811,19864881,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU, QD",,,U,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hyperhidrosis,,2021,Q3,1,I,20170214.0,20210914.0,20210921,20210921,EXP,IT-MINISAL02-404194,IT-SA-2021SA305925,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20210921.0,,MD,IT,IT,2021,Q3,Elderly
198648811,19864881,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU, QD",,,U,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20170214.0,20210914.0,20210921,20210921,EXP,IT-MINISAL02-404194,IT-SA-2021SA305925,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20210921.0,,MD,IT,IT,2021,Q3,Elderly
198648811,19864881,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 IU, QD",,,U,,,,,18.0,IU,SOLUTION FOR INJECTION,QD,2021,Q3,Sopor,,2021,Q3,1,I,20170214.0,20210914.0,20210921,20210921,EXP,IT-MINISAL02-404194,IT-SA-2021SA305925,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20210921.0,,MD,IT,IT,2021,Q3,Elderly
198676311,19867631,1,PS,Insulin  Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,,,2021,Q3,Hyperinsulinaemic hypoglycaemia,,2021,Q3,1,I,20210822.0,20210909.0,20210921,20210921,EXP,IT-MINISAL02-781451,IT-ELI_LILLY_AND_COMPANY-IT202109004748,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20210921.0,,PH,IT,IT,2021,Q3,Elderly
198684491,19868449,12,C,insulin lispro /Insulin lispro?Isophan,,2,,"50 IU, 56?0?36?0",,,,,,,,50.0,IU,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210921.0,,PH,DE,DE,2021,Q3,Elderly
198684491,19868449,12,C,insulin lispro /Insulin lispro?Isophan,,2,,"50 IU, 56?0?36?0",,,,,,,,50.0,IU,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210921.0,,PH,DE,DE,2021,Q3,Elderly
198684491,19868449,12,C,insulin lispro /Insulin lispro?Isophan,,2,,"50 IU, 56?0?36?0",,,,,,,,50.0,IU,,,2021,Q3,Flank pain,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210921.0,,PH,DE,DE,2021,Q3,Elderly
198684491,19868449,12,C,insulin lispro /Insulin lispro?Isophan,,2,,"50 IU, 56?0?36?0",,,,,,,,50.0,IU,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210921.0,,PH,DE,DE,2021,Q3,Elderly
198684491,19868449,12,C,insulin lispro /Insulin lispro?Isophan,,2,,"50 IU, 56?0?36?0",,,,,,,,50.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210921.0,,PH,DE,DE,2021,Q3,Elderly
198684491,19868449,12,C,insulin lispro /Insulin lispro?Isophan,,2,,"50 IU, 56?0?36?0",,,,,,,,50.0,IU,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210921.0,,PH,DE,DE,2021,Q3,Elderly
198684491,19868449,12,C,insulin lispro /Insulin lispro?Isophan,,2,,"50 IU, 56?0?36?0",,,,,,,,50.0,IU,,,2021,Q3,Renal pain,,2021,Q3,1,I,,20210914.0,20210921,20210921,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210921.0,,PH,DE,DE,2021,Q3,Elderly
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Abdominal discomfort,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Abdominal pain,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Blood glucose decreased,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Blood glucose increased,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Constipation,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Flatulence,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Muscle strain,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Osteoarthritis,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Product dose omission issue,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198700832,19870083,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"30 U, TID",,,,,,,,30.0,IU,INJECTION,TID,2021,Q3,Rheumatoid arthritis,,2021,Q3,2,F,202101.0,20210916.0,20210922,20210927,EXP,,US-ELI_LILLY_AND_COMPANY-US202109007254,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198727171,19872717,4,C,insulin lispro,INSULIN LISPRO,1,,"50 IE, 56?0?36?0",,,,, UNKNOWN,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955916,TEVA,,73.0,YR,E,F,Y,100.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727171,19872717,4,C,insulin lispro,INSULIN LISPRO,1,,"50 IE, 56?0?36?0",,,,, UNKNOWN,,,,,,,2021,Q3,Flank pain,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955916,TEVA,,73.0,YR,E,F,Y,100.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727171,19872717,4,C,insulin lispro,INSULIN LISPRO,1,,"50 IE, 56?0?36?0",,,,, UNKNOWN,,,,,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955916,TEVA,,73.0,YR,E,F,Y,100.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727171,19872717,4,C,insulin lispro,INSULIN LISPRO,1,,"50 IE, 56?0?36?0",,,,, UNKNOWN,,,,,,,2021,Q3,Localised infection,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955916,TEVA,,73.0,YR,E,F,Y,100.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727171,19872717,4,C,insulin lispro,INSULIN LISPRO,1,,"50 IE, 56?0?36?0",,,,, UNKNOWN,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955916,TEVA,,73.0,YR,E,F,Y,100.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727171,19872717,4,C,insulin lispro,INSULIN LISPRO,1,,"50 IE, 56?0?36?0",,,,, UNKNOWN,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955916,TEVA,,73.0,YR,E,F,Y,100.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727171,19872717,4,C,insulin lispro,INSULIN LISPRO,1,,"50 IE, 56?0?36?0",,,,, UNKNOWN,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955916,TEVA,,73.0,YR,E,F,Y,100.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727531,19872753,2,C,Insulin lispro/Insulin lispro?Isophan,,2,,"50 IE, 56?0?36?0",,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727531,19872753,2,C,Insulin lispro/Insulin lispro?Isophan,,2,,"50 IE, 56?0?36?0",,,,,,,,,,,,2021,Q3,Flank pain,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727531,19872753,2,C,Insulin lispro/Insulin lispro?Isophan,,2,,"50 IE, 56?0?36?0",,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727531,19872753,2,C,Insulin lispro/Insulin lispro?Isophan,,2,,"50 IE, 56?0?36?0",,,,,,,,,,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727531,19872753,2,C,Insulin lispro/Insulin lispro?Isophan,,2,,"50 IE, 56?0?36?0",,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210914.0,20210922,20210922,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20210922.0,,PH,DE,DE,2021,Q3,Elderly
198727671,19872767,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210909.0,20210922,20210922,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20210922.0,,HP,DE,DE,2021,Q3,Elderly
198727671,19872767,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Flank pain,,2021,Q3,1,I,,20210909.0,20210922,20210922,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20210922.0,,HP,DE,DE,2021,Q3,Elderly
198727671,19872767,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Hyperglycaemia,,2021,Q3,1,I,,20210909.0,20210922,20210922,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20210922.0,,HP,DE,DE,2021,Q3,Elderly
198727671,19872767,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Localised infection,,2021,Q3,1,I,,20210909.0,20210922,20210922,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20210922.0,,HP,DE,DE,2021,Q3,Elderly
198727671,19872767,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Renal impairment,,2021,Q3,1,I,,20210909.0,20210922,20210922,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20210922.0,,HP,DE,DE,2021,Q3,Elderly
198727671,19872767,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210909.0,20210922,20210922,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20210922.0,,HP,DE,DE,2021,Q3,Elderly
198727671,19872767,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56?0?36?0",,,U,,,,,50.0,IU,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210909.0,20210922,20210922,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20210922.0,,HP,DE,DE,2021,Q3,Elderly
198735032,19873503,1,PS,Liprolog Lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,U,, D245042,,20563.0,,,INJECTION,,2021,Q3,Syncope,,2021,Q3,2,F,,20210913.0,20210923,20210927,EXP,DE-AMK-252560,DE-ELI_LILLY_AND_COMPANY-DE202109005116,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198737451,19873745,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Dementia,,2021,Q3,1,I,202103.0,20210913.0,20210922,20210922,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210922.0,,CN,US,US,2021,Q3,Elderly
198737451,19873745,1,PS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,202103.0,20210913.0,20210922,20210922,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210922.0,,CN,US,US,2021,Q3,Elderly
198737451,19873745,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Dementia,,2021,Q3,1,I,202103.0,20210913.0,20210922,20210922,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210922.0,,CN,US,US,2021,Q3,Elderly
198737451,19873745,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,,,,20563.0,,,INJECTION,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,202103.0,20210913.0,20210922,20210922,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210922.0,,CN,US,US,2021,Q3,Elderly
198737451,19873745,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D355431A,,20563.0,,,INJECTION,,2021,Q3,Dementia,,2021,Q3,1,I,202103.0,20210913.0,20210922,20210922,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210922.0,,CN,US,US,2021,Q3,Elderly
198737451,19873745,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D355431A,,20563.0,,,INJECTION,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,202103.0,20210913.0,20210922,20210922,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210922.0,,CN,US,US,2021,Q3,Elderly
198737451,19873745,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D355431A,,20563.0,,,INJECTION,,2021,Q3,Dementia,,2021,Q3,1,I,202103.0,20210913.0,20210922,20210922,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210922.0,,CN,US,US,2021,Q3,Elderly
198737451,19873745,4,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D355431A,,20563.0,,,INJECTION,,2021,Q3,Incorrect dose administered,,2021,Q3,1,I,202103.0,20210913.0,20210922,20210922,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20210922.0,,CN,US,US,2021,Q3,Elderly
198770232,19877023,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,2,F,,20210924.0,20210924,20210926,EXP,DE-ADRED-07171-01,DE-DEXPHARM-20211553,DEXCEL,,55.0,YR,A,F,Y,62.0,KG,20210926.0,,HP,DE,DE,2021,Q3,Adult
198770232,19877023,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Decreased appetite,,2021,Q3,2,F,,20210924.0,20210924,20210926,EXP,DE-ADRED-07171-01,DE-DEXPHARM-20211553,DEXCEL,,55.0,YR,A,F,Y,62.0,KG,20210926.0,,HP,DE,DE,2021,Q3,Adult
198770232,19877023,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Fatigue,,2021,Q3,2,F,,20210924.0,20210924,20210926,EXP,DE-ADRED-07171-01,DE-DEXPHARM-20211553,DEXCEL,,55.0,YR,A,F,Y,62.0,KG,20210926.0,,HP,DE,DE,2021,Q3,Adult
198770232,19877023,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,2,F,,20210924.0,20210924,20210926,EXP,DE-ADRED-07171-01,DE-DEXPHARM-20211553,DEXCEL,,55.0,YR,A,F,Y,62.0,KG,20210926.0,,HP,DE,DE,2021,Q3,Adult
198770232,19877023,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Headache,,2021,Q3,2,F,,20210924.0,20210924,20210926,EXP,DE-ADRED-07171-01,DE-DEXPHARM-20211553,DEXCEL,,55.0,YR,A,F,Y,62.0,KG,20210926.0,,HP,DE,DE,2021,Q3,Adult
198770232,19877023,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Jaundice,,2021,Q3,2,F,,20210924.0,20210924,20210926,EXP,DE-ADRED-07171-01,DE-DEXPHARM-20211553,DEXCEL,,55.0,YR,A,F,Y,62.0,KG,20210926.0,,HP,DE,DE,2021,Q3,Adult
198770232,19877023,2,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"1 IU, AS NEEDED, PRE?FILLED SYRINGES",,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,2,F,,20210924.0,20210924,20210926,EXP,DE-ADRED-07171-01,DE-DEXPHARM-20211553,DEXCEL,,55.0,YR,A,F,Y,62.0,KG,20210926.0,,HP,DE,DE,2021,Q3,Adult
198783181,19878318,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Foot amputation,,2021,Q3,1,I,20200922.0,20210916.0,20210924,20210924,EXP,,DE-009507513-2109DEU004147,MERCK,,71.0,YR,,M,Y,93.0,KG,20210924.0,,PH,DE,DE,2021,Q3,Elderly
198783181,19878318,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, REQUIREMENT, PRE?FILLED SYRINGES",,,U,,,,,,,,,2021,Q3,Wound dehiscence,,2021,Q3,1,I,20200922.0,20210916.0,20210924,20210924,EXP,,DE-009507513-2109DEU004147,MERCK,,71.0,YR,,M,Y,93.0,KG,20210924.0,,PH,DE,DE,2021,Q3,Elderly
198805301,19880530,5,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"10 INTERNATIONAL UNIT, TID",,,,,,,,10.0,IU,,TID,2021,Q3,Febrile neutropenia,,2021,Q3,1,I,20210904.0,20210915.0,20210924,20210924,EXP,,US-TAKEDA-2021TUS057379,TAKEDA,,67.0,YR,,M,Y,97.6,KG,20210924.0,,MD,US,US,2021,Q3,Elderly
198814141,19881414,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Malaise,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Middle ear disorder,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Underdose,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D222829A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D222829A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Dizziness,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D222829A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Malaise,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D222829A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Middle ear disorder,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198814141,19881414,3,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,, D222829A,,,,,SOLUTION FOR INJECTION,,2021,Q3,Underdose,,2021,Q3,1,I,20210923.0,20210923.0,20210925,20210925,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20210925.0,,CN,US,US,2021,Q3,Elderly
198830311,19883031,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210919.0,20210923.0,20210926,20210926,PER,,US-ELI_LILLY_AND_COMPANY-US202109010068,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20210926.0,,CN,US,US,2021,Q3,Adult
198830311,19883031,2,SS,Insulin Lispro Lilly,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, UNKNOWN",,,,,,,,,,SOLUTION FOR INJECTION,,2021,Q3,Therapeutic product effect delayed,,2021,Q3,1,I,20210919.0,20210923.0,20210926,20210926,PER,,US-ELI_LILLY_AND_COMPANY-US202109010068,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20210926.0,,CN,US,US,2021,Q3,Adult
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Acute kidney injury,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Anion gap increased,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Blood potassium decreased,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Blood pressure systolic increased,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Blood sodium decreased,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Diarrhoea,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Dysphagia,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Fibrin D dimer increased,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Haemoglobin decreased,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Hydronephrosis,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Hypophagia,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Leukocytosis,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Nausea,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198838761,19883876,15,C,Insulin lispro SQ,,2,,,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,20210914.0,,20210925,20210925,DIR,,,FDA-CTU,,74.0,YR,,F,N,74.8,KG,20210925.0,Y,HP,US,US,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Abdominal pain,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Atrial fibrillation,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Constipation,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Cough,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Dysuria,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Electrocardiogram abnormal,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,General physical health deterioration,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Tachypnoea,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Vomiting,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198839811,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Weight increased,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20210927.0,,PH,DE,DE,2021,Q3,Elderly
198855511,19885551,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN PEN PER SLIDING SCALE DAILY, AS NEEDED",,,,,,,,,,,,2021,Q3,Abdominal pain,Abdominal pain,2021,Q3,1,I,20200807.0,20200811.0,20210927,20210927,PER,,"US-MELINTA THERAPEUTICS, LLC-US-MLNT-20-00289",MELINTA THERAPEUTICS,,59.0,YR,,M,Y,113.85,KG,20210927.0,,HP,US,US,2021,Q3,Adult
198855511,19885551,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN PEN PER SLIDING SCALE DAILY, AS NEEDED",,,,,,,,,,,,2021,Q3,Back pain,Back pain,2021,Q3,1,I,20200807.0,20200811.0,20210927,20210927,PER,,"US-MELINTA THERAPEUTICS, LLC-US-MLNT-20-00289",MELINTA THERAPEUTICS,,59.0,YR,,M,Y,113.85,KG,20210927.0,,HP,US,US,2021,Q3,Adult
198855511,19885551,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN PEN PER SLIDING SCALE DAILY, AS NEEDED",,,,,,,,,,,,2021,Q3,Muscle spasms,Muscle spasms,2021,Q3,1,I,20200807.0,20200811.0,20210927,20210927,PER,,"US-MELINTA THERAPEUTICS, LLC-US-MLNT-20-00289",MELINTA THERAPEUTICS,,59.0,YR,,M,Y,113.85,KG,20210927.0,,HP,US,US,2021,Q3,Adult
198855511,19885551,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"INSULIN PEN PER SLIDING SCALE DAILY, AS NEEDED",,,,,,,,,,,,2021,Q3,Pain in extremity,Pain in extremity,2021,Q3,1,I,20200807.0,20200811.0,20210927,20210927,PER,,"US-MELINTA THERAPEUTICS, LLC-US-MLNT-20-00289",MELINTA THERAPEUTICS,,59.0,YR,,M,Y,113.85,KG,20210927.0,,HP,US,US,2021,Q3,Adult
198856171,19885617,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3.0U QD,,,U,, D276024C,,,,,INJECTION,,2021,Q3,Hypoglycaemic coma,,2021,Q3,1,I,20210915.0,20210919.0,20210927,20210927,EXP,,CN-ASTRAZENECA-2021A739349,ASTRAZENECA,,63.0,YR,,M,Y,50.0,KG,20210927.0,,HP,CN,CN,2021,Q3,Adult
198856171,19885617,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3.0U QD,,,U,, D276024C,,,,,INJECTION,,2021,Q3,Hypoglycaemic coma,,2021,Q3,1,I,20210915.0,20210919.0,20210927,20210927,EXP,,CN-ASTRAZENECA-2021A739349,ASTRAZENECA,,63.0,YR,,M,Y,50.0,KG,20210927.0,,HP,CN,CN,2021,Q3,Adult
198856171,19885617,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2.0U QD,,,U,, D276024C,,,,,INJECTION,,2021,Q3,Hypoglycaemic coma,,2021,Q3,1,I,20210915.0,20210919.0,20210927,20210927,EXP,,CN-ASTRAZENECA-2021A739349,ASTRAZENECA,,63.0,YR,,M,Y,50.0,KG,20210927.0,,HP,CN,CN,2021,Q3,Adult
198856961,19885696,2,SS,Insulin lispro,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK 10 UNITS,,,D,, UNKNOWN,,,,,,,2021,Q3,Condition aggravated,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-18143,LUPIN,,85.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
198856961,19885696,2,SS,Insulin lispro,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK 10 UNITS,,,D,, UNKNOWN,,,,,,,2021,Q3,Drug ineffective,,2021,Q3,1,I,,20210913.0,20210927,20210927,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-18143,LUPIN,,85.0,YR,,F,Y,,,20210927.0,,HP,US,US,2021,Q3,Elderly
198866151,19886615,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,,,,,,,,INJECTION,,2021,Q3,Inappropriate schedule of product administration,,2021,Q3,1,I,20210904.0,20210920.0,20210928,20210928,PER,,US-ELI_LILLY_AND_COMPANY-US202109008186,ELI LILLY AND CO,,54.0,YR,,M,Y,35.8,KG,20210928.0,,HP,US,US,2021,Q3,Adult
198876301,19887630,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D371847A,,20563.0,,,INJECTION,,2021,Q3,Injury associated with device,,2021,Q3,1,I,20210924.0,20210924.0,20210927,20210927,PER,,US-ELI_LILLY_AND_COMPANY-US202109010530,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198876301,19887630,1,PS,Insulin Lispro,INSULIN LISPRO,1,Unknown,"UNK UNK, UNKNOWN",,,U,, D371847A,,20563.0,,,INJECTION,,2021,Q3,Product storage error,,2021,Q3,1,I,20210924.0,20210924.0,20210927,20210927,PER,,US-ELI_LILLY_AND_COMPANY-US202109010530,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20210927.0,,CN,US,US,2021,Q3,Adult
198902891,19890289,7,C,Insulin lispro,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, BID (100 U/ML ONCE AFTER MEALS AND AT BEDTIME)",,,,,,,,,,,BID,2021,Q3,Myopathy,,2021,Q3,1,I,,20210915.0,20210928,20210928,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-18089,LUPIN,,79.0,YR,,M,Y,,,20210928.0,,CN,NL,US,2021,Q3,Elderly
198906701,19890670,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID (THREE TIMES A DAY)",342.0,IU,Y,, D229370A,,20563.0,6.0,IU,SOLUTION FOR INJECTION,TID,2021,Q3,Blood glucose increased,,2021,Q3,1,I,20210831.0,20210915.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109005970,ELI LILLY AND CO,,63.0,YR,,M,Y,50.0,KG,20210927.0,,HP,CN,CN,2021,Q3,Adult
198906701,19890670,1,PS,Insulin Lispro,INSULIN LISPRO,1,Subcutaneous,"6 U, TID (THREE TIMES A DAY)",342.0,IU,Y,, D229370A,,20563.0,6.0,IU,SOLUTION FOR INJECTION,TID,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210831.0,20210915.0,20210927,20210927,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109005970,ELI LILLY AND CO,,63.0,YR,,M,Y,50.0,KG,20210927.0,,HP,CN,CN,2021,Q3,Adult
198928321,19892832,2,SS,INSULINA LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,,,2021,Q3,Hypoglycaemia,,2021,Q3,1,I,20210401.0,20210924.0,20210928,20210928,EXP,IT-MINISAL02-733597,IT-MYLANLABS-2021M1066280,MYLAN,,68.0,YR,,F,Y,,,20210928.0,,MD,IT,IT,2021,Q3,Elderly
198928321,19892832,2,SS,INSULINA LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,,,2021,Q3,Syncope,,2021,Q3,1,I,20210401.0,20210924.0,20210928,20210928,EXP,IT-MINISAL02-733597,IT-MYLANLABS-2021M1066280,MYLAN,,68.0,YR,,F,Y,,,20210928.0,,MD,IT,IT,2021,Q3,Elderly
198939781,19893978,9,C,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Normocytic anaemia,,2021,Q3,1,I,20210101.0,20210922.0,20210928,20210928,EXP,IT-MINISAL02-787345,IT-DSJP-DSE-2021-131111,DAIICHI,,85.0,YR,,F,Y,,,20210928.0,,MD,IT,IT,2021,Q3,Elderly
198939781,19893978,9,C,INSULINA LISPRO SANOFI,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q3,Product use in unapproved indication,,2021,Q3,1,I,20210101.0,20210922.0,20210928,20210928,EXP,IT-MINISAL02-787345,IT-DSJP-DSE-2021-131111,DAIICHI,,85.0,YR,,F,Y,,,20210928.0,,MD,IT,IT,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Asthma,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Cough,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Discomfort,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Weight increased,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,SOLUTION FOR INJECTION,Q12H,2021,Q3,Wheezing,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Asthma,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Blood count abnormal,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Chest discomfort,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Cough,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Diaphragmatic disorder,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Discomfort,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Dyspnoea,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Hypoxia,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Left ventricular hypertrophy,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Obstructive airways disorder,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Oedema peripheral,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Oropharyngeal pain,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Pyrexia,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Therapeutic product effect incomplete,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Weight increased,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
198977741,19897774,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2021,Q3,Wheezing,,2021,Q3,1,I,,20210923.0,20210930,20210930,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20210930.0,,HP,CA,CA,2021,Q3,Elderly
104868163,10486816,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,TID",,,U,,,,,,,Injection,Q8H,2021,Q4,Febrile neutropenia,,2021,Q4,3,F,20140905.0,20211018.0,20141001,20211124,EXP,,US-SA-2014SA133718,SANOFI AVENTIS,,63.0,YR,A,F,Y,76.0,KG,20211124.0,,HP,US,US,2021,Q4,Adult
104868163,10486816,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,TID",,,U,,,,,,,Injection,Q8H,2021,Q4,Mitral valve disease,,2021,Q4,3,F,20140905.0,20211018.0,20141001,20211124,EXP,,US-SA-2014SA133718,SANOFI AVENTIS,,63.0,YR,A,F,Y,76.0,KG,20211124.0,,HP,US,US,2021,Q4,Adult
104868163,10486816,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK,TID",,,U,,,,,,,Injection,Q8H,2021,Q4,Gastric haemorrhage,,2021,Q4,3,F,20140905.0,20211018.0,20141001,20211124,EXP,,US-SA-2014SA133718,SANOFI AVENTIS,,63.0,YR,A,F,Y,76.0,KG,20211124.0,,HP,US,US,2021,Q4,Adult
109982199,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 Unit per 12 grams as directed),,,,,,,,,,,,2021,Q4,Blindness,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 Unit per 12 grams as directed),,,,,,,,,,,,2021,Q4,Diabetic coma,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 Unit per 12 grams as directed),,,,,,,,,,,,2021,Q4,Myocardial infarction,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 Unit per 12 grams as directed),,,,,,,,,,,,2021,Q4,Steroid diabetes,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 Unit per 12 grams as directed),,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
109982199,10998219,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (1 Unit per 12 grams as directed),,,,,,,,,,,,2021,Q4,Product dispensing error,,2021,Q4,9,F,20050414.0,20210930.0,20150408,20211008,EXP,,US-PFIZER INC-2015119344,PFIZER,,44.0,YR,,M,Y,75.0,KG,20211008.0,,CN,US,US,2021,Q4,Adult
132596438,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2021,Q4,Blindness,,2021,Q4,8,F,20161201.0,20211004.0,20170222,20211013,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20211013.0,,CN,US,US,2021,Q4,Elderly
132596438,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,8,F,20161201.0,20211004.0,20170222,20211013,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20211013.0,,CN,US,US,2021,Q4,Elderly
138415294,13841529,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Alopecia,,2021,Q4,4,F,20150501.0,20211015.0,20170807,20211018,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20211018.0,,LW,US,US,2021,Q4,Adult
138415294,13841529,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Madarosis,,2021,Q4,4,F,20150501.0,20211015.0,20170807,20211018,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20211018.0,,LW,US,US,2021,Q4,Adult
138415294,13841529,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Hair disorder,,2021,Q4,4,F,20150501.0,20211015.0,20170807,20211018,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20211018.0,,LW,US,US,2021,Q4,Adult
138415294,13841529,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Hair colour changes,,2021,Q4,4,F,20150501.0,20211015.0,20170807,20211018,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20211018.0,,LW,US,US,2021,Q4,Adult
138415294,13841529,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Hair texture abnormal,,2021,Q4,4,F,20150501.0,20211015.0,20170807,20211018,PER,,US-PFIZER INC-2017241719,PFIZER,,50.0,YR,,F,Y,118.0,KG,20211018.0,,LW,US,US,2021,Q4,Adult
148300327,14830032,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75-25),,,,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,7,F,19920101.0,20211115.0,20180430,20211116,EXP,,US-PFIZER INC-2018177451,PFIZER,,55.0,YR,,F,Y,,,20211116.0,,LW,US,US,2021,Q4,Adult
148300327,14830032,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75-25),,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,7,F,19920101.0,20211115.0,20180430,20211116,EXP,,US-PFIZER INC-2018177451,PFIZER,,55.0,YR,,F,Y,,,20211116.0,,LW,US,US,2021,Q4,Adult
148300327,14830032,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75-25),,,,,,,,,,,,2021,Q4,Renal failure,,2021,Q4,7,F,19920101.0,20211115.0,20180430,20211116,EXP,,US-PFIZER INC-2018177451,PFIZER,,55.0,YR,,F,Y,,,20211116.0,,LW,US,US,2021,Q4,Adult
148300327,14830032,46,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75-25),,,,,,,,,,,,2021,Q4,Gastrooesophageal reflux disease,,2021,Q4,7,F,19920101.0,20211115.0,20180430,20211116,EXP,,US-PFIZER INC-2018177451,PFIZER,,55.0,YR,,F,Y,,,20211116.0,,LW,US,US,2021,Q4,Adult
151583332,15158333,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,,,,,,,,Formulation unknown,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,,,,,,,,Formulation unknown,,2021,Q4,Increased insulin requirement,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,,,,,,,,Formulation unknown,,2021,Q4,Nephrotic syndrome,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,,,,,,,,Formulation unknown,,2021,Q4,Renal failure,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,,,,,,,,Formulation unknown,,2021,Q4,Liver transplant rejection,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,,,,,,,,Formulation unknown,,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,,,,,,,,Formulation unknown,,2021,Q4,Weight increased,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,,,,,,,,Formulation unknown,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,,,,,,,,Formulation unknown,,2021,Q4,Increased insulin requirement,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,,,,,,,,Formulation unknown,,2021,Q4,Nephrotic syndrome,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,,,,,,,,Formulation unknown,,2021,Q4,Renal failure,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,,,,,,,,Formulation unknown,,2021,Q4,Liver transplant rejection,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,,,,,,,,Formulation unknown,,2021,Q4,Toxicity to various agents,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
151583332,15158333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,,,,,,,,Formulation unknown,,2021,Q4,Weight increased,,2021,Q4,2,F,20180401.0,20211214.0,20180718,20211217,EXP,,CZ-ASTELLAS-2018US031794,ASTELLAS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. Kazuistiky v diabetologii. 2018;2:32-4,61.0,YR,,F,Y,,,20211217.0,,HP,CZ,CZ,2021,Q4,Adult
1518534912,15185349,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 international unit, qd",,,,,,,,24.0,IU,,QD,2021,Q4,Underdose,,2021,Q4,12,F,20180220.0,20211118.0,20180723,20211119,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,53.968,KG,20211119.0,,MD,IT,IT,2021,Q4,Elderly
1518534912,15185349,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 international unit, qd",,,,,,,,24.0,IU,,QD,2021,Q4,Intestinal obstruction,,2021,Q4,12,F,20180220.0,20211118.0,20180723,20211119,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,53.968,KG,20211119.0,,MD,IT,IT,2021,Q4,Elderly
1518534912,15185349,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 international unit, qd",,,,,,,,24.0,IU,,QD,2021,Q4,Inhibiting antibodies,,2021,Q4,12,F,20180220.0,20211118.0,20180723,20211119,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,53.968,KG,20211119.0,,MD,IT,IT,2021,Q4,Elderly
1518534912,15185349,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 international unit, qd",,,,,,,,24.0,IU,,QD,2021,Q4,Therapy non-responder,,2021,Q4,12,F,20180220.0,20211118.0,20180723,20211119,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,53.968,KG,20211119.0,,MD,IT,IT,2021,Q4,Elderly
1518534912,15185349,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 international unit, qd",,,,,,,,24.0,IU,,QD,2021,Q4,Haematoma,,2021,Q4,12,F,20180220.0,20211118.0,20180723,20211119,EXP,,IT-SHIRE-IT201815770,TAKEDA,,69.0,YR,,M,Y,53.968,KG,20211119.0,,MD,IT,IT,2021,Q4,Elderly
153613933,15361393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2021,Q4,Increased insulin requirement,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2021,Q4,Proteinuria,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2021,Q4,Renal failure,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2021,Q4,Liver transplant rejection,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2021,Q4,Nephrotic syndrome,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2021,Q4,Increased insulin requirement,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2021,Q4,Proteinuria,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2021,Q4,Renal failure,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2021,Q4,Liver transplant rejection,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
153613933,15361393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2021,Q4,Nephrotic syndrome,,2021,Q4,3,F,20130101.0,20211220.0,20180907,20211223,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20211223.0,,HP,CZ,CZ,2021,Q4,Adult
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Dyspnoea,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Adrenal insufficiency,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Klebsiella infection,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Addison's disease,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Adrenomegaly,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Retinal detachment,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Device related infection,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Colitis,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Meningitis,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Heparin-induced thrombocytopenia,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Urosepsis,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Acute kidney injury,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Malignant neoplasm progression,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Metastases to meninges,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Hypertensive crisis,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Pulmonary oedema,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Tachycardia,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Blood pressure increased,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Chest pain,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
1549343224,15493432,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 unit, UNK",,,U,,,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,24,F,20180419.0,20210926.0,20181012,20211005,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-093229,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20211005.0,,CN,DE,DE,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Diarrhoea,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Respiratory failure,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Nervousness,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Lethargy,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Septic shock,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Gastrointestinal haemorrhage,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Thrombocytopenia,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Metabolic acidosis,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Surgery,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Clostridium difficile colitis,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Sciatica,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Internal haemorrhage,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Pain in extremity,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Haematotoxicity,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Influenza,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Limb discomfort,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Renal failure,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Hyperkalaemia,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Gastroenteritis,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Blood loss anaemia,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Gait disturbance,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Acute myocardial infarction,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Anaemia,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Acidosis,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Sepsis,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Aphasia,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Pulmonary oedema,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Intervertebral disc disorder,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Back pain,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
155658257,15565825,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 2x/day(AC (After meals) and HS (before meals)",,,,,,,,,,,BID,2021,Q4,Supraventricular tachycardia,,2021,Q4,7,F,20180101.0,20211220.0,20181030,20211230,EXP,,US-PFIZER INC-2017123658,PFIZER,,65.0,YR,,F,Y,48.0,KG,20211230.0,,CN,US,US,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pulmonary congestion,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Skin disorder,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Presyncope,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Renal disorder,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Heart rate irregular,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Mucosal dryness,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Hypovolaemia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Syncope,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Haematocrit increased,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Haemoglobin increased,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Left atrial dilatation,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Pulmonary congestion,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Skin disorder,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Presyncope,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Drug interaction,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Renal disorder,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Heart rate irregular,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Mucosal dryness,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Hypovolaemia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Syncope,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Haematocrit increased,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Haemoglobin increased,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Left atrial dilatation,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
161236889,16123688,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,9,F,20180101.0,20211112.0,20190327,20211117,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20211117.0,,HP,PT,PT,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Serum sickness,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Pyelonephritis,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Underdose,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Hypervolaemia,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Acidosis,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Blood creatine increased,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Hypertension,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Hypomagnesaemia,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Hyperkalaemia,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Haematuria,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Overdose,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Cardiac disorder,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Carotid artery stenosis,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Nausea,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
165219739,16521973,37,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,Y,U,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,9,F,20181122.0,20211025.0,20190702,20211101,EXP,,FR-MYLANLABS-2019M1061210,MYLAN,,69.0,YR,,F,Y,83.3,KG,20211101.0,,MD,FR,FR,2021,Q4,Elderly
1696951025,16969510,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Myocardial injury,,2021,Q4,25,F,20191021.0,20211030.0,20191029,20211105,EXP,,CN-Eisai Medical Research-EC-2019-064326,EISAI,,62.0,YR,A,M,Y,69.0,KG,20211105.0,,MD,CN,,2021,Q4,Adult
172869022,17286902,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12IU at breakfast, 12IU at dinner, 12IU at lunch",,,,,,,,36.0,IU,Solution for injection,QD,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,,20211101.0,20200120,20211109,EXP,ES-AEMPS-585631,ES-SA-2020SA010568,SANOFI AVENTIS,,57.0,YR,A,M,Y,60.5,KG,20211109.0,,PH,ES,ES,2021,Q4,Adult
172869022,17286902,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12IU at breakfast, 12IU at dinner, 12IU at lunch",,,,,,,,36.0,IU,Solution for injection,QD,2021,Q4,Nausea,,2021,Q4,2,F,,20211101.0,20200120,20211109,EXP,ES-AEMPS-585631,ES-SA-2020SA010568,SANOFI AVENTIS,,57.0,YR,A,M,Y,60.5,KG,20211109.0,,PH,ES,ES,2021,Q4,Adult
1793618612,17936186,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 u/ml, 10-20 units 3X daily with meals",,,,,,,,,,,,2021,Q4,Cardiac disorder,,2021,Q4,12,F,,20211130.0,20200624,20211209,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20211209.0,,LW,US,US,2021,Q4,Adult
1793618612,17936186,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 u/ml, 10-20 units 3X daily with meals",,,,,,,,,,,,2021,Q4,Colon cancer,,2021,Q4,12,F,,20211130.0,20200624,20211209,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20211209.0,,LW,US,US,2021,Q4,Adult
1793618612,17936186,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 u/ml, 10-20 units 3X daily with meals",,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,12,F,,20211130.0,20200624,20211209,EXP,,US-TEVA-2020-US-1792706,TEVA,,56.0,YR,A,M,Y,,,20211209.0,,LW,US,US,2021,Q4,Adult
181658322,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert,,,U,U,,,,,,,,2021,Q4,Cough,,2021,Q4,2,F,,20211113.0,20200818,20211119,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20211119.0,,PH,DE,DE,2021,Q4,Elderly
181658322,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert,,,U,U,,,,,,,,2021,Q4,Weight increased,,2021,Q4,2,F,,20211113.0,20200818,20211119,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20211119.0,,PH,DE,DE,2021,Q4,Elderly
181658322,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert,,,U,U,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211113.0,20200818,20211119,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20211119.0,,PH,DE,DE,2021,Q4,Elderly
181658322,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert,,,U,U,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,2,F,,20211113.0,20200818,20211119,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20211119.0,,PH,DE,DE,2021,Q4,Elderly
1822823730,18228237,94,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iU, CO",,,U,,,,,1.0,IU,,,2021,Q4,Toxic epidermal necrolysis,,2021,Q4,30,F,20200809.0,20211013.0,20200903,20211020,EXP,,FR-PFIZER INC-2020340763,PFIZER,,74.0,YR,,M,Y,,,20211020.0,,MD,FR,FR,2021,Q4,Elderly
1823583916,18235839,58,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 iU,,,U,,,,,1.0,IU,,,2021,Q4,Toxic epidermal necrolysis,,2021,Q4,16,F,20200809.0,20211013.0,20200905,20211020,EXP,,FR-SA-2020SA239827,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20211020.0,,HP,FR,FR,2021,Q4,Elderly
184453884,18445388,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Recurrent cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Bone cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Visual impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Vision blurred,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Dementia,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Recurrent cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Bone cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Visual impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Vision blurred,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, other at each meal",,,,,D195320A,,,4.0,IU,Injection,,2021,Q4,Dementia,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Recurrent cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Bone cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Vision blurred,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Dementia,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Recurrent cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Bone cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Vision blurred,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Dementia,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,,,,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,,,,Injection,,2021,Q4,Recurrent cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,,,,Injection,,2021,Q4,Bone cancer,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,,,,Injection,,2021,Q4,Vision blurred,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184453884,18445388,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,,,,Injection,,2021,Q4,Dementia,,2021,Q4,4,F,20200901.0,20211220.0,20201030,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202010009237,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Elderly
184821756,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q4,Arthralgia,,2021,Q4,6,F,20201019.0,20211015.0,20201110,20211020,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20211020.0,,MD,COUNTRY NOT SPECIFIED,JP,2021,Q4,Adult
184821756,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q4,Eczema asteatotic,,2021,Q4,6,F,20201019.0,20211015.0,20201110,20211020,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20211020.0,,MD,COUNTRY NOT SPECIFIED,JP,2021,Q4,Adult
184821756,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q4,Rash pruritic,,2021,Q4,6,F,20201019.0,20211015.0,20201110,20211020,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20211020.0,,MD,COUNTRY NOT SPECIFIED,JP,2021,Q4,Adult
184821756,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2021,Q4,Cataract,,2021,Q4,6,F,20201019.0,20211015.0,20201110,20211020,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20211020.0,,MD,COUNTRY NOT SPECIFIED,JP,2021,Q4,Adult
185380444,18538044,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,4,F,20191008.0,20211216.0,20201123,20211221,EXP,,US-GILEAD-2019-0432608,GILEAD,,81.0,YR,E,M,Y,94.0,KG,20211221.0,,MD,US,US,2021,Q4,Elderly
185380444,18538044,39,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Toxic encephalopathy,,2021,Q4,4,F,20191008.0,20211216.0,20201123,20211221,EXP,,US-GILEAD-2019-0432608,GILEAD,,81.0,YR,E,M,Y,94.0,KG,20211221.0,,MD,US,US,2021,Q4,Elderly
185953593,18595359,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Hyperhidrosis,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Confusional state,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Aggression,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Agitation,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Communication disorder,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Mental disorder,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
185953593,18595359,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Disorientation,,2021,Q4,3,F,,20211029.0,20201209,20211103,EXP,,GR-ELI_LILLY_AND_COMPANY-GR202011013750,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20211103.0,,CN,GR,GR,2021,Q4,Elderly
1866534810,18665348,71,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iU, CO",,,U,U,,,,,,,,2021,Q4,Toxic epidermal necrolysis,,2021,Q4,10,F,20200809.0,20211013.0,20201225,20211015,EXP,,FR-TAKEDA-2020TEU008275,TAKEDA,,74.0,YR,,M,Y,,,20211015.0,,HP,FR,FR,2021,Q4,Elderly
187070223,18707022,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, QD(24 to 40 u daily)",,,,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,3,F,20200323.0,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Adult
187070223,18707022,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, QD(24 to 40 u daily)",,,,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20200323.0,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Adult
187070223,18707022,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, QD(24 to 40 u daily)",,,,,,,,40.0,IU,Solution for injection,QD,2021,Q4,Asthenia,,2021,Q4,3,F,20200323.0,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376667,SANOFI AVENTIS,,57.0,YR,A,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Adult
187078932,18707893,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, QD",,,Y,U,,,,4.0,IU,Solution for injection,QD,2021,Q4,Loss of consciousness,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, QD",,,Y,U,,,,4.0,IU,Solution for injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, QD",,,Y,U,,,,4.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, QD",,,Y,U,,,,4.0,IU,Solution for injection,QD,2021,Q4,Chronic kidney disease,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, QD",,,Y,U,,,,4.0,IU,Solution for injection,QD,2021,Q4,Cardiac failure congestive,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, QD",,,Y,U,,,,4.0,IU,Solution for injection,QD,2021,Q4,Plasma cell myeloma,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, QD",,,Y,U,,,,4.0,IU,Solution for injection,QD,2021,Q4,Oral disorder,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, QD",,,Y,U,,,,4.0,IU,Solution for injection,QD,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,U,,,,,,Solution for injection,,2021,Q4,Loss of consciousness,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,U,,,,,,Solution for injection,,2021,Q4,Blood glucose decreased,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,U,,,,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,U,,,,,,Solution for injection,,2021,Q4,Chronic kidney disease,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,U,,,,,,Solution for injection,,2021,Q4,Cardiac failure congestive,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,U,,,,,,Solution for injection,,2021,Q4,Plasma cell myeloma,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,U,,,,,,Solution for injection,,2021,Q4,Oral disorder,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
187078932,18707893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,U,,,,,,Solution for injection,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,2,F,,20211102.0,20210106,20211109,EXP,,CA-SA-2020SA376658,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20211109.0,,CN,CA,CA,2021,Q4,Elderly
189739312,18973931,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0-0-0-5, Pen)",,,U,,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,,20211019.0,20210305,20211021,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,130.0,KG,20211021.0,,PH,DE,DE,2021,Q4,Elderly
189739312,18973931,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0-0-0-5, Pen)",,,U,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211019.0,20210305,20211021,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,130.0,KG,20211021.0,,PH,DE,DE,2021,Q4,Elderly
189739312,18973931,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0-0-0-5, Pen)",,,U,,,,,,,,,2021,Q4,Fall,,2021,Q4,2,F,,20211019.0,20210305,20211021,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,130.0,KG,20211021.0,,PH,DE,DE,2021,Q4,Elderly
189739312,18973931,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0-0-0-5, Pen)",,,U,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211019.0,20210305,20211021,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,130.0,KG,20211021.0,,PH,DE,DE,2021,Q4,Elderly
189739312,18973931,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 24-0-14-0, Pen)",,,U,,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,,20211019.0,20210305,20211021,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,130.0,KG,20211021.0,,PH,DE,DE,2021,Q4,Elderly
189739312,18973931,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 24-0-14-0, Pen)",,,U,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211019.0,20210305,20211021,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,130.0,KG,20211021.0,,PH,DE,DE,2021,Q4,Elderly
189739312,18973931,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 24-0-14-0, Pen)",,,U,,,,,,,,,2021,Q4,Fall,,2021,Q4,2,F,,20211019.0,20210305,20211021,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,130.0,KG,20211021.0,,PH,DE,DE,2021,Q4,Elderly
189739312,18973931,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 24-0-14-0, Pen)",,,U,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211019.0,20210305,20211021,EXP,DE-ADRED-04304-01,DE-GLAXOSMITHKLINE-DECH2021011068,GLAXOSMITHKLINE,,72.0,YR,,F,Y,130.0,KG,20211021.0,,PH,DE,DE,2021,Q4,Elderly
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Drug ineffective,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Malaise,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Fear,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Malaise,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Unhealthy diet,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
189837134,18983713,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,20563.0,,,,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210209.0,20211022.0,20210308,20211104,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202102013185,ELI LILLY AND CO,,49.0,YR,,F,Y,,,20211104.0,,CN,US,ES,2021,Q4,Adult
190213692,19021369,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Appendix cancer metastatic,,2021,Q4,2,F,20150112.0,20211013.0,20210317,20211026,EXP,,US-MYLANLABS-2021M1016158,MYLAN,,58.0,YR,,M,Y,,,20211026.0,,LW,US,US,2021,Q4,Adult
190213692,19021369,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Gastric cancer,,2021,Q4,2,F,20150112.0,20211013.0,20210317,20211026,EXP,,US-MYLANLABS-2021M1016158,MYLAN,,58.0,YR,,M,Y,,,20211026.0,,LW,US,US,2021,Q4,Adult
190213692,19021369,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Colon cancer stage IV,,2021,Q4,2,F,20150112.0,20211013.0,20210317,20211026,EXP,,US-MYLANLABS-2021M1016158,MYLAN,,58.0,YR,,M,Y,,,20211026.0,,LW,US,US,2021,Q4,Adult
190213692,19021369,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Gallbladder cancer,,2021,Q4,2,F,20150112.0,20211013.0,20210317,20211026,EXP,,US-MYLANLABS-2021M1016158,MYLAN,,58.0,YR,,M,Y,,,20211026.0,,LW,US,US,2021,Q4,Adult
190213692,19021369,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Colorectal cancer,,2021,Q4,2,F,20150112.0,20211013.0,20210317,20211026,EXP,,US-MYLANLABS-2021M1016158,MYLAN,,58.0,YR,,M,Y,,,20211026.0,,LW,US,US,2021,Q4,Adult
191186298,19118629,80,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Circulatory collapse,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,80,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,80,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Graft versus host disease,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,80,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,80,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pancytopenia,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Circulatory collapse,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Graft versus host disease,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pancytopenia,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Circulatory collapse,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Graft versus host disease,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,82,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pancytopenia,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Circulatory collapse,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Graft versus host disease,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191186298,19118629,83,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pancytopenia,,2021,Q4,8,F,20210313.0,20211104.0,20210410,20211108,EXP,,NVSC2021US063910,NOVARTIS,,68.0,YR,,F,Y,67.7,KG,20211108.0,,MD,US,US,2021,Q4,Elderly
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Circumcision,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Hyperphagia,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Dysstasia,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Coordination abnormal,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Urinary retention,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Fall,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Urinary incontinence,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Depression,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Dyskinesia,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Device leakage,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
191861456,19186145,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Device dislocation,,2021,Q4,6,F,20200101.0,20210929.0,20210427,20211005,EXP,,US-ABBVIE-21K-163-3872037-00,ABBVIE,,59.0,YR,,M,Y,83.99,KG,20211005.0,,CN,COUNTRY NOT SPECIFIED,US,2021,Q4,Adult
192334502,19233450,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Gastrooesophageal reflux disease,,2021,Q4,2,F,20180101.0,20211115.0,20210507,20211123,EXP,,US-AstraZeneca-2021A390984,ASTRAZENECA,,43.0,YR,,M,Y,113.4,KG,20211123.0,,LW,US,,2021,Q4,Adult
192334502,19233450,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20180101.0,20211115.0,20210507,20211123,EXP,,US-AstraZeneca-2021A390984,ASTRAZENECA,,43.0,YR,,M,Y,113.4,KG,20211123.0,,LW,US,,2021,Q4,Adult
192334502,19233450,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,End stage renal disease,,2021,Q4,2,F,20180101.0,20211115.0,20210507,20211123,EXP,,US-AstraZeneca-2021A390984,ASTRAZENECA,,43.0,YR,,M,Y,113.4,KG,20211123.0,,LW,US,,2021,Q4,Adult
192334502,19233450,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Renal failure,,2021,Q4,2,F,20180101.0,20211115.0,20210507,20211123,EXP,,US-AstraZeneca-2021A390984,ASTRAZENECA,,43.0,YR,,M,Y,113.4,KG,20211123.0,,LW,US,,2021,Q4,Adult
192334502,19233450,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,2,F,20180101.0,20211115.0,20210507,20211123,EXP,,US-AstraZeneca-2021A390984,ASTRAZENECA,,43.0,YR,,M,Y,113.4,KG,20211123.0,,LW,US,,2021,Q4,Adult
194302533,19430253,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Device issue,,2021,Q4,3,F,20210928.0,20211004.0,20210617,20211011,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
194302533,19430253,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20210928.0,20211004.0,20210617,20211011,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
194302533,19430253,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Wrong technique in product usage process,,2021,Q4,3,F,20210928.0,20211004.0,20210617,20211011,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
194302533,19430253,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Injection site pain,,2021,Q4,3,F,20210928.0,20211004.0,20210617,20211011,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
194302533,19430253,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood glucose abnormal,,2021,Q4,3,F,20210928.0,20211004.0,20210617,20211011,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
194302533,19430253,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Dementia,,2021,Q4,3,F,20210928.0,20211004.0,20210617,20211011,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
194302533,19430253,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Mobility decreased,,2021,Q4,3,F,20210928.0,20211004.0,20210617,20211011,EXP,,US-SA-2021SA192666,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Confusional state,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Confusional state,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Confusional state,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,,,20563.0,2.0,IU,Injection,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D337388E,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D337388E,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D337388E,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D337388E,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D337388E,,20563.0,2.0,IU,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D337388E,,20563.0,2.0,IU,Injection,,2021,Q4,Confusional state,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D337388E,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D337388E,,20563.0,2.0,IU,Injection,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Confusional state,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Memory impairment,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Confusional state,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194791804,19479180,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"2 u, other (each meal)",,,,,D261904A,,20563.0,2.0,IU,Injection,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,4,F,20210531.0,20211015.0,20210701,20211020,PER,,US-ELI_LILLY_AND_COMPANY-US202106000807,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20211020.0,,CN,US,US,2021,Q4,Elderly
194846977,19484697,35,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,U,,ASKED BUT UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Toxic epidermal necrolysis,,2021,Q4,7,F,20200809.0,20211013.0,20210702,20211019,EXP,,FR-ROCHE-2860051,ROCHE,,74.0,YR,,M,Y,,,20211019.0,,MD,FR,FR,2021,Q4,Elderly
1948806812,19488068,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Pneumonia fungal,,2021,Q4,12,F,20210626.0,20211207.0,20210702,20211209,EXP,,US-CELGENEUS-USA-20210700150,CELGENE,,69.0,YR,,M,Y,,,20211209.0,,HP,US,US,2021,Q4,Elderly
1948806812,19488068,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Acute kidney injury,,2021,Q4,12,F,20210626.0,20211207.0,20210702,20211209,EXP,,US-CELGENEUS-USA-20210700150,CELGENE,,69.0,YR,,M,Y,,,20211209.0,,HP,US,US,2021,Q4,Elderly
195212322,19521232,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, tid, Before each meal",,,,,,,,6.0,IU,,Q8H,2021,Q4,Renal impairment,,2021,Q4,2,F,,20210928.0,20210712,20211011,EXP,,JP-DSJP-DSJ-2021-120956AA,DAIICHI,"Yagi I, Fujinaga H, Iima T, Fujisawa K, Kawata A, Okada A, et al.. A Case of Diuretic Resistant Ischemic Heart Failure With 2 Type Diabetes Which Empagliflozin Was Effective. Heart. 2021;53(6):583-590",8.0,DEC,,M,Y,64.0,KG,20211011.0,,MD,JP,JP,2021,Q4,Child
195212322,19521232,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, tid, Before each meal",,,,,,,,6.0,IU,,Q8H,2021,Q4,Pneumonia,,2021,Q4,2,F,,20210928.0,20210712,20211011,EXP,,JP-DSJP-DSJ-2021-120956AA,DAIICHI,"Yagi I, Fujinaga H, Iima T, Fujisawa K, Kawata A, Okada A, et al.. A Case of Diuretic Resistant Ischemic Heart Failure With 2 Type Diabetes Which Empagliflozin Was Effective. Heart. 2021;53(6):583-590",8.0,DEC,,M,Y,64.0,KG,20211011.0,,MD,JP,JP,2021,Q4,Child
195212322,19521232,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 IU, tid, Before each meal",,,,,,,,6.0,IU,,Q8H,2021,Q4,Cardiac failure acute,,2021,Q4,2,F,,20210928.0,20210712,20211011,EXP,,JP-DSJP-DSJ-2021-120956AA,DAIICHI,"Yagi I, Fujinaga H, Iima T, Fujisawa K, Kawata A, Okada A, et al.. A Case of Diuretic Resistant Ischemic Heart Failure With 2 Type Diabetes Which Empagliflozin Was Effective. Heart. 2021;53(6):583-590",8.0,DEC,,M,Y,64.0,KG,20211011.0,,MD,JP,JP,2021,Q4,Child
195848273,19584827,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,dose unspecified,,,D,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,3,F,20160501.0,20210910.0,20210720,20211015,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"Martinka E, Kollarova D, Urbanova M. Skusenosti z praxe potvrdzuju vysledky studii RCT a RWE s empagliflozinom: kazuistiky. Forum Diabetologicum. 2021;10(1):53-61.",53.0,YR,,M,Y,,,20211015.0,,MD,SK,SK,2021,Q4,Adult
195848273,19584827,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,D,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,3,F,20160501.0,20210910.0,20210720,20211015,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"Martinka E, Kollarova D, Urbanova M. Skusenosti z praxe potvrdzuju vysledky studii RCT a RWE s empagliflozinom: kazuistiky. Forum Diabetologicum. 2021;10(1):53-61.",53.0,YR,,M,Y,,,20211015.0,,MD,SK,SK,2021,Q4,Adult
195848273,19584827,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,15 units per day,,,D,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,3,F,20160501.0,20210910.0,20210720,20211015,EXP,,SK-BAUSCH-BL-2021-023831,BAUSCH AND LOMB,"Martinka E, Kollarova D, Urbanova M. Skusenosti z praxe potvrdzuju vysledky studii RCT a RWE s empagliflozinom: kazuistiky. Forum Diabetologicum. 2021;10(1):53-61.",53.0,YR,,M,Y,,,20211015.0,,MD,SK,SK,2021,Q4,Adult
195875144,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q4,Stomatitis,,2021,Q4,4,F,20210509.0,20211119.0,20210721,20211124,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20211124.0,,MD,FR,FR,2021,Q4,Adult
195875144,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q4,Bronchopulmonary aspergillosis,,2021,Q4,4,F,20210509.0,20211119.0,20210721,20211124,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20211124.0,,MD,FR,FR,2021,Q4,Adult
195875144,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q4,Cholestasis,,2021,Q4,4,F,20210509.0,20211119.0,20210721,20211124,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20211124.0,,MD,FR,FR,2021,Q4,Adult
195875144,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q4,Diabetes insipidus,,2021,Q4,4,F,20210509.0,20211119.0,20210721,20211124,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20211124.0,,MD,FR,FR,2021,Q4,Adult
195875144,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q4,Acute kidney injury,,2021,Q4,4,F,20210509.0,20211119.0,20210721,20211124,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20211124.0,,MD,FR,FR,2021,Q4,Adult
195875144,19587514,12,C,INSULINE LISPRO,,1,Subcutaneous,100 IU,,,U,,,,,100.0,IU,,,2021,Q4,Systemic candida,,2021,Q4,4,F,20210509.0,20211119.0,20210721,20211124,EXP,,NVSC2021FR162731,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20211124.0,,MD,FR,FR,2021,Q4,Adult
1964310812,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,D,,,,,,,,BID,2021,Q4,Pancreatic carcinoma,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,D,,,,,,,,BID,2021,Q4,Liver abscess,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,D,,,,,,,,BID,2021,Q4,Malignant neoplasm progression,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 U/ml, BID",,,D,,,,,,,,BID,2021,Q4,Enterocolitis,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Pancreatic carcinoma,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Liver abscess,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
1964310812,19643108,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Enterocolitis,,2021,Q4,12,F,20210713.0,20211022.0,20210730,20211029,EXP,,NVSC2021US163698,NOVARTIS,,49.0,YR,,M,Y,64.0,KG,20211029.0,,MD,US,US,2021,Q4,Adult
196543702,19654370,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8UI coffee and dinner,,,,,Unknown,,,,,,,2021,Q4,Amaurosis,,2021,Q4,2,F,,20211110.0,20210804,20211119,EXP,,BR-NOVOPROD-833828,NOVO NORDISK,,81.0,YR,,M,Y,85.0,KG,20211119.0,,MD,BR,BR,2021,Q4,Elderly
196583442,19658344,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,20201030.0,20210920.0,20210804,20211001,EXP,,US-ELI_LILLY_AND_COMPANY-US202107011185,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211001.0,,CN,US,US,2021,Q4,Elderly
196583442,19658344,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20201030.0,20210920.0,20210804,20211001,EXP,,US-ELI_LILLY_AND_COMPANY-US202107011185,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211001.0,,CN,US,US,2021,Q4,Elderly
196583442,19658344,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Injury,,2021,Q4,2,F,20201030.0,20210920.0,20210804,20211001,EXP,,US-ELI_LILLY_AND_COMPANY-US202107011185,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211001.0,,CN,US,US,2021,Q4,Elderly
196583442,19658344,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,,,,Injection,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,2,F,20201030.0,20210920.0,20210804,20211001,EXP,,US-ELI_LILLY_AND_COMPANY-US202107011185,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211001.0,,CN,US,US,2021,Q4,Elderly
196583442,19658344,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20201030.0,20210920.0,20210804,20211001,EXP,,US-ELI_LILLY_AND_COMPANY-US202107011185,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211001.0,,CN,US,US,2021,Q4,Elderly
196583442,19658344,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,,,,Injection,,2021,Q4,Injury,,2021,Q4,2,F,20201030.0,20210920.0,20210804,20211001,EXP,,US-ELI_LILLY_AND_COMPANY-US202107011185,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211001.0,,CN,US,US,2021,Q4,Elderly
196827623,19682762,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-12 units,,,,,,,,,,Unknown,,2021,Q4,Lung infiltration,,2021,Q4,3,F,20210706.0,20211015.0,20210810,20211020,EXP,,US-CELGENEUS-USA-20210800965,CELGENE,,85.0,YR,,F,Y,55.84,KG,20211020.0,,MD,US,US,2021,Q4,Elderly
196827623,19682762,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2-12 units,,,,,,,,,,Unknown,,2021,Q4,Asthenia,,2021,Q4,3,F,20210706.0,20211015.0,20210810,20211020,EXP,,US-CELGENEUS-USA-20210800965,CELGENE,,85.0,YR,,F,Y,55.84,KG,20211020.0,,MD,US,US,2021,Q4,Elderly
197018889,19701888,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,9,F,20210809.0,20211025.0,20210813,20211028,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-079796,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,96.0,KG,20211028.0,,HP,BR,BR,2021,Q4,Elderly
197045072,19704507,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 24-0-14-0, Pen)",,,,,,,,,,,,2021,Q4,Fall,,2021,Q4,2,F,,20211126.0,20210816,20211201,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20211201.0,,PH,DE,DE,2021,Q4,Elderly
197045072,19704507,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 24-0-14-0, Pen)",,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211126.0,20210816,20211201,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20211201.0,,PH,DE,DE,2021,Q4,Elderly
197045072,19704507,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 24-0-14-0, Pen)",,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,,20211126.0,20210816,20211201,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20211201.0,,PH,DE,DE,2021,Q4,Elderly
197045072,19704507,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 24-0-14-0, Pen)",,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211126.0,20210816,20211201,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20211201.0,,PH,DE,DE,2021,Q4,Elderly
197045072,19704507,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0-0-0-5, Pen)",,,U,U,,,,,,,,2021,Q4,Fall,,2021,Q4,2,F,,20211126.0,20210816,20211201,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20211201.0,,PH,DE,DE,2021,Q4,Elderly
197045072,19704507,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0-0-0-5, Pen)",,,U,U,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211126.0,20210816,20211201,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20211201.0,,PH,DE,DE,2021,Q4,Elderly
197045072,19704507,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0-0-0-5, Pen)",,,U,U,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,,20211126.0,20210816,20211201,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20211201.0,,PH,DE,DE,2021,Q4,Elderly
197045072,19704507,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, 0-0-0-5, Pen)",,,U,U,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211126.0,20210816,20211201,EXP,DE-ADRED-04304-01,DE-MYLANLABS-2021M1051698,MYLAN,,72.0,YR,,F,Y,130.0,KG,20211201.0,,PH,DE,DE,2021,Q4,Elderly
197100253,19710025,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,3,F,20210225.0,20211018.0,20210816,20211025,EXP,,US-GILEAD-2021-0520462,GILEAD,,70.0,YR,E,M,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
197100253,19710025,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Respiratory failure,,2021,Q4,3,F,20210225.0,20211018.0,20210816,20211025,EXP,,US-GILEAD-2021-0520462,GILEAD,,70.0,YR,E,M,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
197100253,19710025,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Staphylococcal sepsis,,2021,Q4,3,F,20210225.0,20211018.0,20210816,20211025,EXP,,US-GILEAD-2021-0520462,GILEAD,,70.0,YR,E,M,Y,,,20211025.0,,HP,US,US,2021,Q4,Elderly
197176505,19717650,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Toxic encephalopathy,,2021,Q4,5,F,20210611.0,20210929.0,20210818,20211008,EXP,,US-ROCHE-2888743,ROCHE,,66.0,YR,,F,Y,,,20211008.0,,MD,US,US,2021,Q4,Elderly
197176505,19717650,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Encephalopathy,,2021,Q4,5,F,20210611.0,20210929.0,20210818,20211008,EXP,,US-ROCHE-2888743,ROCHE,,66.0,YR,,F,Y,,,20211008.0,,MD,US,US,2021,Q4,Elderly
197317232,19731723,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Q12H(10-40 units),,,D,,,,,,,Solution for injection,Q12H,2021,Q4,Cardiac arrest,,2021,Q4,2,F,20210720.0,20211001.0,20210820,20211007,EXP,,US-SA-2021SA243192,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20211007.0,,HP,US,US,2021,Q4,Adult
197376104,19737610,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cardiac failure congestive,,2021,Q4,4,F,20210619.0,20211014.0,20210824,20211018,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20211018.0,,MD,US,US,2021,Q4,Adult
197376104,19737610,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Cardiac failure congestive,,2021,Q4,4,F,20210619.0,20211014.0,20210824,20211018,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20211018.0,,MD,US,US,2021,Q4,Adult
197376104,19737610,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,4,F,20210619.0,20211014.0,20210824,20211018,EXP,,NVSC2021US141256,NOVARTIS,,41.0,YR,,F,Y,92.6,KG,20211018.0,,MD,US,US,2021,Q4,Adult
197703934,19770393,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, each morning (during breakfast)",,,U,,D341138C,,20563.0,8.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,U,,D341138C,,20563.0,5.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197703934,19770393,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (supper)",,,U,,D341138C,,20563.0,10.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,4,F,20170101.0,20210930.0,20210831,20211007,EXP,,US-ELI_LILLY_AND_COMPANY-US202108009100,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20211007.0,,CN,US,US,2021,Q4,Elderly
197740752,19774075,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2021,Q4,Injection site mass,,2021,Q4,2,F,20210301.0,20210930.0,20210901,20211008,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20211008.0,,MD,US,US,2021,Q4,Adult
197740752,19774075,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,2,F,20210301.0,20210930.0,20210901,20211008,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20211008.0,,MD,US,US,2021,Q4,Adult
197740752,19774075,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2021,Q4,Disease progression,,2021,Q4,2,F,20210301.0,20210930.0,20210901,20211008,EXP,,"US-IPSEN BIOPHARMACEUTICALS, INC.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20211008.0,,MD,US,US,2021,Q4,Adult
197885063,19788506,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"300 U, 1X",,,D,,,,209196.0,,,,1X,2021,Q4,Cardio-respiratory arrest,,2021,Q4,3,F,,20211116.0,20210903,20211116,EXP,,JP-SA-2021SA292048,SANOFI AVENTIS,Tokimaru.. A case developed lactic acidosis following overdose of metformin and insulin in a suicide attempt. a presentation at YIA. Young investigator award.. unk;unknown:61-65,28.0,YR,A,F,Y,,,20211116.0,,HP,JP,JP,2021,Q4,Young Adult
197885063,19788506,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"300 U, 1X",,,D,,,,209196.0,,,,1X,2021,Q4,Intentional overdose,,2021,Q4,3,F,,20211116.0,20210903,20211116,EXP,,JP-SA-2021SA292048,SANOFI AVENTIS,Tokimaru.. A case developed lactic acidosis following overdose of metformin and insulin in a suicide attempt. a presentation at YIA. Young investigator award.. unk;unknown:61-65,28.0,YR,A,F,Y,,,20211116.0,,HP,JP,JP,2021,Q4,Young Adult
197885063,19788506,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"300 U, 1X",,,D,,,,209196.0,,,,1X,2021,Q4,Lactic acidosis,,2021,Q4,3,F,,20211116.0,20210903,20211116,EXP,,JP-SA-2021SA292048,SANOFI AVENTIS,Tokimaru.. A case developed lactic acidosis following overdose of metformin and insulin in a suicide attempt. a presentation at YIA. Young investigator award.. unk;unknown:61-65,28.0,YR,A,F,Y,,,20211116.0,,HP,JP,JP,2021,Q4,Young Adult
197885063,19788506,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"300 U, 1X",,,D,,,,209196.0,,,,1X,2021,Q4,Altered state of consciousness,,2021,Q4,3,F,,20211116.0,20210903,20211116,EXP,,JP-SA-2021SA292048,SANOFI AVENTIS,Tokimaru.. A case developed lactic acidosis following overdose of metformin and insulin in a suicide attempt. a presentation at YIA. Young investigator award.. unk;unknown:61-65,28.0,YR,A,F,Y,,,20211116.0,,HP,JP,JP,2021,Q4,Young Adult
197931924,19793192,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Lethargy,,2021,Q4,4,F,20210820.0,20211008.0,20210906,20211014,EXP,,US-CELGENEUS-USA-20210809054,CELGENE,,74.0,YR,,,Y,,,20211014.0,,MD,US,US,2021,Q4,Elderly
197931924,19793192,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Dehydration,,2021,Q4,4,F,20210820.0,20211008.0,20210906,20211014,EXP,,US-CELGENEUS-USA-20210809054,CELGENE,,74.0,YR,,,Y,,,20211014.0,,MD,US,US,2021,Q4,Elderly
197931924,19793192,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Confusional state,,2021,Q4,4,F,20210820.0,20211008.0,20210906,20211014,EXP,,US-CELGENEUS-USA-20210809054,CELGENE,,74.0,YR,,,Y,,,20211014.0,,MD,US,US,2021,Q4,Elderly
197936682,19793668,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Device failure,,2021,Q4,2,F,20210824.0,20210914.0,20210907,20211004,PER,,US-JNJFOC-20210852549,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,90.8,KG,20211004.0,,HP,US,US,2021,Q4,Elderly
197936682,19793668,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Product dose omission issue,,2021,Q4,2,F,20210824.0,20210914.0,20210907,20211004,PER,,US-JNJFOC-20210852549,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,90.8,KG,20211004.0,,HP,US,US,2021,Q4,Elderly
197942254,19794225,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 iU, UNK",,,U,,,,,15.0,IU,,,2021,Q4,Pancreatic failure,,2021,Q4,4,F,,20211101.0,20210907,20211108,EXP,,US-SA-2021SA293481,SANOFI AVENTIS,,74.0,YR,E,F,Y,103.0,KG,20211108.0,,HP,US,US,2021,Q4,Elderly
197942254,19794225,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 iU, UNK",,,U,,,,,15.0,IU,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,4,F,,20211101.0,20210907,20211108,EXP,,US-SA-2021SA293481,SANOFI AVENTIS,,74.0,YR,E,F,Y,103.0,KG,20211108.0,,HP,US,US,2021,Q4,Elderly
197942254,19794225,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 iU, UNK",,,U,,,,,15.0,IU,,,2021,Q4,Incorrect dose administered by device,,2021,Q4,4,F,,20211101.0,20210907,20211108,EXP,,US-SA-2021SA293481,SANOFI AVENTIS,,74.0,YR,E,F,Y,103.0,KG,20211108.0,,HP,US,US,2021,Q4,Elderly
197942254,19794225,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 iU, UNK",,,U,,,,,15.0,IU,,,2021,Q4,Device delivery system issue,,2021,Q4,4,F,,20211101.0,20210907,20211108,EXP,,US-SA-2021SA293481,SANOFI AVENTIS,,74.0,YR,E,F,Y,103.0,KG,20211108.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit/mL injection 1-2 units nightly,,,U,,,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit/mL injection 1-2 units nightly,,,U,,,,,,,,,2021,Q4,Myositis,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit/mL injection 1-2 units nightly,,,U,,,,,,,,,2021,Q4,Eyelid ptosis,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit/mL injection 1-2 units nightly,,,U,,,,,,,,,2021,Q4,Myasthenia gravis,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 unit/mL injection 1-2 units nightly,,,U,,,,,,,,,2021,Q4,Alanine aminotransferase increased,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/mL injection 1-3 units, 3 times daily",,,U,,,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/mL injection 1-3 units, 3 times daily",,,U,,,,,,,,,2021,Q4,Myositis,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/mL injection 1-3 units, 3 times daily",,,U,,,,,,,,,2021,Q4,Eyelid ptosis,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/mL injection 1-3 units, 3 times daily",,,U,,,,,,,,,2021,Q4,Myasthenia gravis,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198074134,19807413,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 unit/mL injection 1-3 units, 3 times daily",,,U,,,,,,,,,2021,Q4,Alanine aminotransferase increased,,2021,Q4,4,F,20210830.0,20211028.0,20210908,20211103,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-088893,BRISTOL MYERS SQUIBB,,78.0,YR,,M,Y,,,20211103.0,,HP,US,US,2021,Q4,Elderly
198267772,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,2,F,20210802.0,20211029.0,20210914,20211109,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20211109.0,,CN,US,US,2021,Q4,Adult
198267772,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,2,F,20210802.0,20211029.0,20210914,20211109,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20211109.0,,CN,US,US,2021,Q4,Adult
198267772,19826777,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,2,F,20210802.0,20211029.0,20210914,20211109,EXP,,US-INTERCEPT-PM2021002686,INTERCEPT PHARMACEUTICALS,,62.0,YR,,F,Y,,,20211109.0,,CN,US,US,2021,Q4,Adult
198329098,19832909,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,2 IU (International Unit),,,,,,,,2.0,IU,Injection,QD,2021,Q4,Interstitial lung disease,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,2 IU (International Unit),,,,,,,,2.0,IU,Injection,QD,2021,Q4,Embolism,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,2 IU (International Unit),,,,,,,,2.0,IU,Injection,QD,2021,Q4,Respiratory disorder,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,58,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,2 IU (International Unit),,,,,,,,2.0,IU,Injection,QD,2021,Q4,Cardiac failure,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,3 IU (International Unit),,,,,,,,3.0,IU,Injection,QD,2021,Q4,Interstitial lung disease,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,3 IU (International Unit),,,,,,,,3.0,IU,Injection,QD,2021,Q4,Embolism,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,3 IU (International Unit),,,,,,,,3.0,IU,Injection,QD,2021,Q4,Respiratory disorder,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198329098,19832909,59,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous drip,3 IU (International Unit),,,,,,,,3.0,IU,Injection,QD,2021,Q4,Cardiac failure,,2021,Q4,8,F,20210902.0,20211207.0,20210915,20211216,EXP,,US-CELGENEUS-USA-20210902235,CELGENE,,73.0,YR,,F,Y,70.37,KG,20211216.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Encephalopathy,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Opportunistic infection,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Cytomegalovirus viraemia,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Fungaemia,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198651735,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Bacteraemia,,2021,Q4,5,F,20210812.0,20211116.0,20210921,20211122,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20211122.0,,HP,US,US,2021,Q4,Elderly
198737453,19873745,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Dementia,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Dementia,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D355431A,,20563.0,,,Injection,,2021,Q4,Dementia,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D355431A,,20563.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D355431A,,20563.0,,,Injection,,2021,Q4,Dementia,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D355431A,,20563.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,10.0,IU,Injection,TID,2021,Q4,Dementia,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,10.0,IU,Injection,TID,2021,Q4,Incorrect dose administered,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,10.0,IU,Injection,TID,2021,Q4,Dementia,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,10.0,IU,Injection,TID,2021,Q4,Incorrect dose administered,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D371847A,,20563.0,,,Injection,,2021,Q4,Dementia,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D371847A,,20563.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2021,Q4,Dementia,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198737453,19873745,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2021,Q4,Incorrect dose administered,,2021,Q4,3,F,20210301.0,20211206.0,20210922,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202109005713,ELI LILLY AND CO,,66.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
198743552,19874355,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,2,F,,20210917.0,20210923,20211001,EXP,,DE-SA-2021SA312559,SANOFI AVENTIS,,82.0,YR,E,F,Y,,,20211001.0,,CN,DE,DE,2021,Q4,Elderly
198743552,19874355,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Blood glucose abnormal,,2021,Q4,2,F,,20210917.0,20210923,20211001,EXP,,DE-SA-2021SA312559,SANOFI AVENTIS,,82.0,YR,E,F,Y,,,20211001.0,,CN,DE,DE,2021,Q4,Elderly
198814142,19881414,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2021,Q4,Underdose,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2021,Q4,Malaise,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2021,Q4,Dizziness,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2021,Q4,Middle ear disorder,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D222829A,,,,,Solution for injection,,2021,Q4,Underdose,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D222829A,,,,,Solution for injection,,2021,Q4,Malaise,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D222829A,,,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D222829A,,,,,Solution for injection,,2021,Q4,Dizziness,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D222829A,,,,,Solution for injection,,2021,Q4,Middle ear disorder,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D332676C,,,,,Solution for injection,,2021,Q4,Underdose,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D332676C,,,,,Solution for injection,,2021,Q4,Malaise,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D332676C,,,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D332676C,,,,,Solution for injection,,2021,Q4,Dizziness,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198814142,19881414,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D332676C,,,,,Solution for injection,,2021,Q4,Middle ear disorder,,2021,Q4,2,F,20210923.0,20211220.0,20210925,20211221,PER,,US-ELI_LILLY_AND_COMPANY-US202109010059,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Elderly
198830612,19883061,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, tid",,,U,,D261904A,,20563.0,20.0,IU,Injection,TID,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210923.0,20210923.0,20210926,20211005,PER,,US-ELI_LILLY_AND_COMPANY-US202109010069,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211005.0,,CN,US,US,2021,Q4,Elderly
198866152,19886615,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Extra dose administered,,2021,Q4,2,F,20210904.0,20210920.0,20210928,20211102,PER,,US-ELI_LILLY_AND_COMPANY-US202109008186,ELI LILLY AND CO,,54.0,YR,,M,Y,35.8,KG,20211102.0,,HP,US,US,2021,Q4,Adult
198904882,19890488,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Oesophagitis,,2021,Q4,2,F,20210831.0,20211215.0,20210927,20211222,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-095697,BRISTOL MYERS SQUIBB,,56.0,YR,,M,Y,138.0,KG,20211222.0,,HP,US,US,2021,Q4,Adult
198917722,19891772,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,D245042,,,,,,,2021,Q4,Drug delivery system issue,,2021,Q4,2,F,,20211125.0,20210928,20211203,30DAY,DE-BFARM-21008785,DE-NOVOPROD-846973,NOVO NORDISK,,86.0,YR,,F,Y,,,20211203.0,,PH,DE,DE,2021,Q4,Elderly
198917722,19891772,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,D245042,,,,,,,2021,Q4,Syncope,,2021,Q4,2,F,,20211125.0,20210928,20211203,30DAY,DE-BFARM-21008785,DE-NOVOPROD-846973,NOVO NORDISK,,86.0,YR,,F,Y,,,20211203.0,,PH,DE,DE,2021,Q4,Elderly
198939782,19893978,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Normocytic anaemia,,2021,Q4,2,F,20210816.0,20211018.0,20210928,20211026,EXP,IT-MINISAL02-787345,IT-DSJP-DSE-2021-131111,DAIICHI,,85.0,YR,,F,Y,,,20211026.0,,MD,IT,IT,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Chest X-ray abnormal,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Malaise,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199056081,19905608,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,20210926.0,,20211001,20211001,DIR,584537,,FDA-CTU,,87.0,YR,,M,N,78.75,KG,20211001.0,Y,,US,US,2021,Q4,Elderly
199073391,19907339,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Underdose,,2021,Q4,1,I,20210412.0,20210929.0,20211001,20211001,EXP,,JP-OTSUKA-2021_033959,OTSUKA,,73.0,YR,,F,Y,99.4,KG,20211001.0,,PH,JP,JP,2021,Q4,Elderly
199073391,19907339,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Liver disorder,,2021,Q4,1,I,20210412.0,20210929.0,20211001,20211001,EXP,,JP-OTSUKA-2021_033959,OTSUKA,,73.0,YR,,F,Y,99.4,KG,20211001.0,,PH,JP,JP,2021,Q4,Elderly
199073391,19907339,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20210412.0,20210929.0,20211001,20211001,EXP,,JP-OTSUKA-2021_033959,OTSUKA,,73.0,YR,,F,Y,99.4,KG,20211001.0,,PH,JP,JP,2021,Q4,Elderly
199073391,19907339,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Injection,,2021,Q4,Respiratory symptom,,2021,Q4,1,I,20210412.0,20210929.0,20211001,20211001,EXP,,JP-OTSUKA-2021_033959,OTSUKA,,73.0,YR,,F,Y,99.4,KG,20211001.0,,PH,JP,JP,2021,Q4,Elderly
199083761,19908376,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"108 international unit (32IU breakfast, 37IU lunch, 39IU dinner), daily",91152.0,IU,,,,,20563.0,108.0,IU,,QD,2021,Q4,Hyperinsulinaemic hypoglycaemia,,2021,Q4,1,I,20210809.0,20210920.0,20211001,20211001,EXP,IT-MINISAL02-788593,IT-ELI_LILLY_AND_COMPANY-IT202109007673,ELI LILLY AND CO,,69.0,YR,,M,Y,106.0,KG,20211001.0,,CN,IT,IT,2021,Q4,Elderly
199088311,19908831,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 UNIT (8 units before meals),,,,,,,,,,Injection,,2021,Q4,Cardiac failure congestive,,2021,Q4,1,I,,20210920.0,20211002,20211002,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2021-18631,LUPIN,"Yoshida T, Takemoto M. Impaired cardiac and neurological function with mild hypophosphatemia during insulin therapy for diabetic ketoacidosis and marked improvement with phosphate supplementation: A case report. Journal of Diabetes Investigation. 2021;12(3):454-458",52.0,YR,,M,Y,71.4,KG,20211002.0,,HP,JP,JP,2021,Q4,Adult
199088311,19908831,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 UNIT (8 units before meals),,,,,,,,,,Injection,,2021,Q4,Depressed level of consciousness,,2021,Q4,1,I,,20210920.0,20211002,20211002,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2021-18631,LUPIN,"Yoshida T, Takemoto M. Impaired cardiac and neurological function with mild hypophosphatemia during insulin therapy for diabetic ketoacidosis and marked improvement with phosphate supplementation: A case report. Journal of Diabetes Investigation. 2021;12(3):454-458",52.0,YR,,M,Y,71.4,KG,20211002.0,,HP,JP,JP,2021,Q4,Adult
199088311,19908831,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 UNIT (8 units before meals),,,,,,,,,,Injection,,2021,Q4,Electrocardiogram ST segment elevation,,2021,Q4,1,I,,20210920.0,20211002,20211002,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2021-18631,LUPIN,"Yoshida T, Takemoto M. Impaired cardiac and neurological function with mild hypophosphatemia during insulin therapy for diabetic ketoacidosis and marked improvement with phosphate supplementation: A case report. Journal of Diabetes Investigation. 2021;12(3):454-458",52.0,YR,,M,Y,71.4,KG,20211002.0,,HP,JP,JP,2021,Q4,Adult
199088311,19908831,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 UNIT (8 units before meals),,,,,,,,,,Injection,,2021,Q4,Hypophosphataemia,,2021,Q4,1,I,,20210920.0,20211002,20211002,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2021-18631,LUPIN,"Yoshida T, Takemoto M. Impaired cardiac and neurological function with mild hypophosphatemia during insulin therapy for diabetic ketoacidosis and marked improvement with phosphate supplementation: A case report. Journal of Diabetes Investigation. 2021;12(3):454-458",52.0,YR,,M,Y,71.4,KG,20211002.0,,HP,JP,JP,2021,Q4,Adult
199088311,19908831,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 UNIT (8 units before meals),,,,,,,,,,Injection,,2021,Q4,Myocardial injury,,2021,Q4,1,I,,20210920.0,20211002,20211002,EXP,,JP-LUPIN PHARMACEUTICALS INC.-2021-18631,LUPIN,"Yoshida T, Takemoto M. Impaired cardiac and neurological function with mild hypophosphatemia during insulin therapy for diabetic ketoacidosis and marked improvement with phosphate supplementation: A case report. Journal of Diabetes Investigation. 2021;12(3):454-458",52.0,YR,,M,Y,71.4,KG,20211002.0,,HP,JP,JP,2021,Q4,Adult
199118081,19911808,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 dose per 1 D, 8 unit",,,,,UNK,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 dose per 1 D, 8 unit",,,,,UNK,,,,,,,2021,Q4,Pollakiuria,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 dose per 1 D, 8 unit",,,,,UNK,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 dose per 1d, 5 units",,,,,UNK,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 dose per 1d, 5 units",,,,,UNK,,,,,,,2021,Q4,Pollakiuria,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199118081,19911808,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"3 dose per 1d, 5 units",,,,,UNK,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,,20210921.0,20211004,20211004,EXP,,US-AVET LIFESCIENCES LTD-2021-AVET-000027,EMCURE,"Rupp J, Gillespie A.. A Case of Diabetic Hemichorea Hemiballismus Exacerbated by Hypoglycemia. AACE Clinical Case Reports. 2021;7(5):327-329",62.0,YR,,F,Y,,,20211004.0,,MD,US,US,2021,Q4,Adult
199131171,19913117,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,,20210929.0,20211004,20211004,PER,,US-SA-2021SA324196,SANOFI AVENTIS,,60.0,YR,A,F,Y,,,20211004.0,,CN,US,US,2021,Q4,Adult
199143762,19914376,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-21 Units, every six hours",,,,,,,,,,Injection,Q6H,2021,Q4,Lethargy,,2021,Q4,2,F,20210901.0,20210927.0,20211004,20211101,EXP,,US-BAUSCH-BL-2021-033205,BAUSCH AND LOMB,,55.0,YR,,F,Y,73.0,KG,20211101.0,,MD,US,US,2021,Q4,Adult
199143762,19914376,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-21 Units, every six hours",,,,,,,,,,Injection,Q6H,2021,Q4,Hypersomnia,,2021,Q4,2,F,20210901.0,20210927.0,20211004,20211101,EXP,,US-BAUSCH-BL-2021-033205,BAUSCH AND LOMB,,55.0,YR,,F,Y,73.0,KG,20211101.0,,MD,US,US,2021,Q4,Adult
199143762,19914376,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-21 Units, every six hours",,,,,,,,,,Injection,Q6H,2021,Q4,Melaena,,2021,Q4,2,F,20210901.0,20210927.0,20211004,20211101,EXP,,US-BAUSCH-BL-2021-033205,BAUSCH AND LOMB,,55.0,YR,,F,Y,73.0,KG,20211101.0,,MD,US,US,2021,Q4,Adult
199143762,19914376,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1-21 Units, every six hours",,,,,,,,,,Injection,Q6H,2021,Q4,Confusional state,,2021,Q4,2,F,20210901.0,20210927.0,20211004,20211101,EXP,,US-BAUSCH-BL-2021-033205,BAUSCH AND LOMB,,55.0,YR,,F,Y,73.0,KG,20211101.0,,MD,US,US,2021,Q4,Adult
199211831,19921183,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q4,Neurotoxicity,,2021,Q4,1,I,,20210924.0,20211006,20211006,EXP,,US-BAXTER-2021BAX030793,BAXTER,"BEHAL M, THOMAS J, THOMPSON BASTIN M, Mefford B. CEFEPIME INDUCED NEUROTOXICITY FOLLOWING A REGIMEN DOSE-ADJUSTED FOR RENAL FUNCTION: CASE REPORT AND REVIEW OF THE LITERATURE. HOSPITAL PHARMACY. 2021;1-7.",43.0,YR,,F,Y,,,20211006.0,,HP,US,US,2021,Q4,Adult
199211831,19921183,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2021,Q4,Mean arterial pressure increased,,2021,Q4,1,I,,20210924.0,20211006,20211006,EXP,,US-BAXTER-2021BAX030793,BAXTER,"BEHAL M, THOMAS J, THOMPSON BASTIN M, Mefford B. CEFEPIME INDUCED NEUROTOXICITY FOLLOWING A REGIMEN DOSE-ADJUSTED FOR RENAL FUNCTION: CASE REPORT AND REVIEW OF THE LITERATURE. HOSPITAL PHARMACY. 2021;1-7.",43.0,YR,,F,Y,,,20211006.0,,HP,US,US,2021,Q4,Adult
199226511,19922651,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.5U-3U-3U, every 8 hrs",,,Y,,,,20563.0,,,,Q8H,2021,Q4,Anxiety,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.5U-3U-3U, every 8 hrs",,,Y,,,,20563.0,,,,Q8H,2021,Q4,Gait inability,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.5U-3U-3U, every 8 hrs",,,Y,,,,20563.0,,,,Q8H,2021,Q4,Feeding disorder,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.5U-3U-3U, every 8 hrs",,,Y,,,,20563.0,,,,Q8H,2021,Q4,Weight increased,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.5U-3U-3U, every 8 hrs",,,Y,,,,20563.0,,,,Q8H,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.5U-3U-3U, every 8 hrs",,,Y,,,,20563.0,,,,Q8H,2021,Q4,Intentional dose omission,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3.5U-3U-3U, every 8 hrs",,,Y,,,,20563.0,,,,Q8H,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2021,Q4,Anxiety,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2021,Q4,Gait inability,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2021,Q4,Feeding disorder,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2021,Q4,Intentional dose omission,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199226511,19922651,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,20563.0,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210911.0,20210923.0,20211005,20211005,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202109009471,ELI LILLY AND CO,,71.0,YR,,M,Y,65.0,KG,20211005.0,,CN,ES,ES,2021,Q4,Elderly
199242512,19924251,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, qd",,,,,,,,,,,,2021,Q4,Hepatic function abnormal,,2021,Q4,2,F,20210918.0,20211129.0,20211006,20211206,EXP,,JP-SEATTLE GENETICS-2021SGN05091,SEATTLE GENETICS,,72.0,YR,,M,Y,79.6,KG,20211206.0,,PH,JP,JP,2021,Q4,Elderly
199242512,19924251,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, qd",,,,,,,,,,,,2021,Q4,Fluid retention,,2021,Q4,2,F,20210918.0,20211129.0,20211006,20211206,EXP,,JP-SEATTLE GENETICS-2021SGN05091,SEATTLE GENETICS,,72.0,YR,,M,Y,79.6,KG,20211206.0,,PH,JP,JP,2021,Q4,Elderly
199242512,19924251,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, qd",,,,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,2,F,20210918.0,20211129.0,20211006,20211206,EXP,,JP-SEATTLE GENETICS-2021SGN05091,SEATTLE GENETICS,,72.0,YR,,M,Y,79.6,KG,20211206.0,,PH,JP,JP,2021,Q4,Elderly
199264451,19926445,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"Humalog 75/25 mix in a vial, 72 units Before breakfast and before dinner",,,,,,,,72.0,IU,,BID,2021,Q4,Tooth injury,,2021,Q4,1,I,20210101.0,20210818.0,20211006,20211006,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0368,BIODELIVERY SCIENCES INTERNATIONAL,,70.0,YR,E,F,Y,90.8,KG,20211006.0,,CN,US,US,2021,Q4,Elderly
199264451,19926445,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"Humalog 75/25 mix in a vial, 72 units Before breakfast and before dinner",,,,,,,,72.0,IU,,BID,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210101.0,20210818.0,20211006,20211006,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0368,BIODELIVERY SCIENCES INTERNATIONAL,,70.0,YR,E,F,Y,90.8,KG,20211006.0,,CN,US,US,2021,Q4,Elderly
199264451,19926445,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"Humalog 75/25 mix in a vial, 72 units Before breakfast and before dinner",,,,,,,,72.0,IU,,BID,2021,Q4,Cardiovascular insufficiency,,2021,Q4,1,I,20210101.0,20210818.0,20211006,20211006,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0368,BIODELIVERY SCIENCES INTERNATIONAL,,70.0,YR,E,F,Y,90.8,KG,20211006.0,,CN,US,US,2021,Q4,Elderly
199264451,19926445,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"Humalog 75/25 mix in a vial, 72 units Before breakfast and before dinner",,,,,,,,72.0,IU,,BID,2021,Q4,Tooth abscess,,2021,Q4,1,I,20210101.0,20210818.0,20211006,20211006,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0368,BIODELIVERY SCIENCES INTERNATIONAL,,70.0,YR,E,F,Y,90.8,KG,20211006.0,,CN,US,US,2021,Q4,Elderly
199264451,19926445,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"Humalog 75/25 mix in a vial, 72 units Before breakfast and before dinner",,,,,,,,72.0,IU,,BID,2021,Q4,Dental caries,,2021,Q4,1,I,20210101.0,20210818.0,20211006,20211006,PER,,US-BIODELIVERY SCIENCES INTERNATIONAL-2021BDSI0368,BIODELIVERY SCIENCES INTERNATIONAL,,70.0,YR,E,F,Y,90.8,KG,20211006.0,,CN,US,US,2021,Q4,Elderly
199321331,19932133,18,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Pneumonia,,2021,Q4,1,I,20211001.0,,20211007,20211007,DIR,585272,,FDA-CTU,,52.0,YR,,M,N,102.15,KG,20211007.0,Y,,US,US,2021,Q4,Adult
199321331,19932133,18,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,1,I,20211001.0,,20211007,20211007,DIR,585272,,FDA-CTU,,52.0,YR,,M,N,102.15,KG,20211007.0,Y,,US,US,2021,Q4,Adult
199325191,19932519,9,C,Lispro SQ,,2,,,,,,,,,,,,,,2021,Q4,Throat tightness,,2021,Q4,1,I,20210928.0,,20211007,20211007,DIR,585660,,FDA-CTU,,43.0,YR,,F,N,102.0,KG,20211007.0,N,PH,US,US,2021,Q4,Adult
199325191,19932519,9,C,Lispro SQ,,2,,,,,,,,,,,,,,2021,Q4,Peripheral swelling,,2021,Q4,1,I,20210928.0,,20211007,20211007,DIR,585660,,FDA-CTU,,43.0,YR,,F,N,102.0,KG,20211007.0,N,PH,US,US,2021,Q4,Adult
199325191,19932519,9,C,Lispro SQ,,2,,,,,,,,,,,,,,2021,Q4,Feeling abnormal,,2021,Q4,1,I,20210928.0,,20211007,20211007,DIR,585660,,FDA-CTU,,43.0,YR,,F,N,102.0,KG,20211007.0,N,PH,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Memory impairment,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Abdominal pain upper,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Heart rate increased,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Hypertension,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Chest pain,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Secretion discharge,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Vision blurred,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Taste disorder,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Dysgeusia,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199332451,19933245,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,20190101.0,20190503.0,20211008,20211008,EXP,,US-JNJFOC-A-NJ2019-190513,JOHNSON AND JOHNSON,,55.0,YR,A,F,Y,,,20211008.0,,HP,US,US,2021,Q4,Adult
199336321,19933632,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,,20211004.0,20211008,20211008,PER,,US-ELI_LILLY_AND_COMPANY-US202110002466,ELI LILLY AND CO,,81.0,YR,,,Y,,,20211008.0,,CN,US,US,2021,Q4,Elderly
199336321,19933632,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Memory impairment,,2021,Q4,1,I,,20211004.0,20211008,20211008,PER,,US-ELI_LILLY_AND_COMPANY-US202110002466,ELI LILLY AND CO,,81.0,YR,,,Y,,,20211008.0,,CN,US,US,2021,Q4,Elderly
199347102,19934710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Aphasia,,2021,Q4,2,F,,20211011.0,20211008,20211014,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109011163,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211014.0,,CN,CN,CN,2021,Q4,Adult
199347102,19934710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Death,,2021,Q4,2,F,,20211011.0,20211008,20211014,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109011163,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211014.0,,CN,CN,CN,2021,Q4,Adult
199347102,19934710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Cardiac failure,,2021,Q4,2,F,,20211011.0,20211008,20211014,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202109011163,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211014.0,,CN,CN,CN,2021,Q4,Adult
199357481,19935748,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unk,,,U,,,,,,,,,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,,20211004.0,20211008,20211008,PER,,US-SA-2021SA330042,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20211008.0,,CN,US,US,2021,Q4,Adult
199357481,19935748,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unk,,,U,,,,,,,,,2021,Q4,Injection site pain,,2021,Q4,1,I,,20211004.0,20211008,20211008,PER,,US-SA-2021SA330042,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20211008.0,,CN,US,US,2021,Q4,Adult
199371582,19937158,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, prn (with meals)",,,,,D341139A,,20563.0,4.0,IU,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20210701.0,20211005.0,20211010,20211010,PER,,US-ELI_LILLY_AND_COMPANY-US202109011615,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211010.0,,CN,US,US,2021,Q4,Adult
199371582,19937158,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, prn (with meals)",,,,,D341139A,,20563.0,4.0,IU,Injection,,2021,Q4,Blood glucose abnormal,,2021,Q4,2,F,20210701.0,20211005.0,20211010,20211010,PER,,US-ELI_LILLY_AND_COMPANY-US202109011615,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211010.0,,CN,US,US,2021,Q4,Adult
199371582,19937158,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, prn (with meals)",,,,,D341139A,,20563.0,4.0,IU,Injection,,2021,Q4,Peripheral swelling,,2021,Q4,2,F,20210701.0,20211005.0,20211010,20211010,PER,,US-ELI_LILLY_AND_COMPANY-US202109011615,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211010.0,,CN,US,US,2021,Q4,Adult
199371582,19937158,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, prn (with meals)",,,,,D341139A,,20563.0,4.0,IU,Injection,,2021,Q4,Joint swelling,,2021,Q4,2,F,20210701.0,20211005.0,20211010,20211010,PER,,US-ELI_LILLY_AND_COMPANY-US202109011615,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211010.0,,CN,US,US,2021,Q4,Adult
199376461,19937646,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, tid",,,U,,D341139A,,20563.0,3.0,IU,Injection,TID,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210901.0,20211007.0,20211011,20211011,PER,,US-ELI_LILLY_AND_COMPANY-US202110003070,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Adult
199376461,19937646,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, tid",,,U,,D341139A,,20563.0,3.0,IU,Injection,TID,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210901.0,20211007.0,20211011,20211011,PER,,US-ELI_LILLY_AND_COMPANY-US202110003070,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Adult
199376461,19937646,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, tid",,,U,,D341139A,,20563.0,3.0,IU,Injection,TID,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210901.0,20211007.0,20211011,20211011,PER,,US-ELI_LILLY_AND_COMPANY-US202110003070,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Adult
199376461,19937646,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, tid",,,U,,D341139A,,20563.0,3.0,IU,Injection,TID,2021,Q4,Vision blurred,,2021,Q4,1,I,20210901.0,20211007.0,20211011,20211011,PER,,US-ELI_LILLY_AND_COMPANY-US202110003070,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Adult
199388434,19938843,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Pneumonia,,2021,Q4,4,F,20210808.0,20211210.0,20211011,20211216,EXP,,NVSC2021US181359,NOVARTIS,,67.0,YR,,M,Y,96.0,KG,20211216.0,,MD,US,US,2021,Q4,Elderly
199414901,19941490,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Prostatic mass,,2021,Q4,1,I,20210801.0,20211001.0,20211011,20211011,EXP,,US-ELI_LILLY_AND_COMPANY-US202110001146,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
199414901,19941490,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Prostate cancer,,2021,Q4,1,I,20210801.0,20211001.0,20211011,20211011,EXP,,US-ELI_LILLY_AND_COMPANY-US202110001146,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
199414901,19941490,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210801.0,20211001.0,20211011,20211011,EXP,,US-ELI_LILLY_AND_COMPANY-US202110001146,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20211011.0,,CN,US,US,2021,Q4,Elderly
199435611,19943561,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Plan, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435611,19943561,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Plan, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,Dehydration,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435611,19943561,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Plan, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435611,19943561,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Plan, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199435611,19943561,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Plan, Injektions-/Infusionsl?sung",,,,,,,,,,Injection,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070718,MYLAN,,74.0,YR,,M,Y,,,20211012.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2021,Q4,Diarrhoea,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2021,Q4,Night sweats,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2021,Q4,Fatigue,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199436012,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2021,Q4,Medication error,,2021,Q4,2,F,,20211006.0,20211012,20211014,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20211014.0,,MD,DE,DE,2021,Q4,Elderly
199457021,19945702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (45-30-35-0, Injektion solution/Infusion solution)",,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070292,MYLAN,,82.0,YR,,F,Y,,,20211012.0,,PH,DE,DE,2021,Q4,Elderly
199457021,19945702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (45-30-35-0, Injektion solution/Infusion solution)",,,,,,,,,,,,2021,Q4,Fall,,2021,Q4,1,I,,20211006.0,20211012,20211012,EXP,,DE-MYLANLABS-2021M1070292,MYLAN,,82.0,YR,,F,Y,,,20211012.0,,PH,DE,DE,2021,Q4,Elderly
199477162,19947716,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (Demand, solution for injection/infusion)",,,U,U,,,,,,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211029.0,20211012,20211104,EXP,,DE-MYLANLABS-2021M1070540,MYLAN,,82.0,YR,,F,Y,89.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
199477162,19947716,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (Demand, solution for injection/infusion)",,,U,U,,,,,,Solution for injection,,2021,Q4,Medication error,,2021,Q4,2,F,,20211029.0,20211012,20211104,EXP,,DE-MYLANLABS-2021M1070540,MYLAN,,82.0,YR,,F,Y,89.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
199477162,19947716,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (Demand, solution for injection/infusion)",,,U,U,,,,,,Solution for injection,,2021,Q4,Depressed level of consciousness,,2021,Q4,2,F,,20211029.0,20211012,20211104,EXP,,DE-MYLANLABS-2021M1070540,MYLAN,,82.0,YR,,F,Y,89.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
199477162,19947716,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (Demand, solution for injection/infusion)",,,U,U,,,,,,Solution for injection,,2021,Q4,Product prescribing error,,2021,Q4,2,F,,20211029.0,20211012,20211104,EXP,,DE-MYLANLABS-2021M1070540,MYLAN,,82.0,YR,,F,Y,89.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
199477162,19947716,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (Demand, solution for injection/infusion)",,,U,U,,,,,,Solution for injection,,2021,Q4,Product administration error,,2021,Q4,2,F,,20211029.0,20211012,20211104,EXP,,DE-MYLANLABS-2021M1070540,MYLAN,,82.0,YR,,F,Y,89.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
199477561,19947756,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D370635G,,20563.0,,,Injection,,2021,Q4,Blood pressure decreased,,2021,Q4,1,I,,20210930.0,20211012,20211012,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202109012521,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20211012.0,,CN,PL,PL,2021,Q4,Elderly
199477561,19947756,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D370635G,,20563.0,,,Injection,,2021,Q4,Seizure,,2021,Q4,1,I,,20210930.0,20211012,20211012,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202109012521,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20211012.0,,CN,PL,PL,2021,Q4,Elderly
199477561,19947756,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D370635G,,20563.0,,,Injection,,2021,Q4,Hypersensitivity,,2021,Q4,1,I,,20210930.0,20211012,20211012,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202109012521,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20211012.0,,CN,PL,PL,2021,Q4,Elderly
199477561,19947756,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D370635G,,20563.0,,,Injection,,2021,Q4,Asthenia,,2021,Q4,1,I,,20210930.0,20211012,20211012,EXP,,PL-ELI_LILLY_AND_COMPANY-PL202109012521,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20211012.0,,CN,PL,PL,2021,Q4,Elderly
199479151,19947915,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),,,,,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211001.0,20211012,20211012,EXP,,US-B.BRAUN MEDICAL INC.-2120461,B BRAUN,"Sara Kutner, Idarucizumab (PRAXBIND) as a sole reversal agent in an unstable hemorrhagic shock patient on an unknown anticoagulant with elevated protime/international normalized ratio (PT/INR). American Journal of Emergency Medicine 46 (2021) 800.e1-800.e3",85.0,YR,,F,Y,,,20211012.0,,PH,US,US,2021,Q4,Elderly
199490131,19949013,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Propofol infusion syndrome,,2021,Q4,1,I,20211005.0,,20211012,20211012,DIR,586229,,FDA-CTU,,18.0,YR,,F,N,127.0,KG,20211012.0,N,PH,US,US,2021,Q4,Youth
199490131,19949013,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,20211005.0,,20211012,20211012,DIR,586229,,FDA-CTU,,18.0,YR,,F,N,127.0,KG,20211012.0,N,PH,US,US,2021,Q4,Youth
199504221,19950422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Rash vesicular,,2021,Q4,1,I,20210927.0,,20211013,20211013,DIR,586410,,FDA-CTU,,28.0,YR,,M,N,66.5,KG,20211013.0,N,PH,US,US,2021,Q4,Young Adult
199504221,19950422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Eosinophilia,,2021,Q4,1,I,20210927.0,,20211013,20211013,DIR,586410,,FDA-CTU,,28.0,YR,,M,N,66.5,KG,20211013.0,N,PH,US,US,2021,Q4,Young Adult
199504221,19950422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Transaminases increased,,2021,Q4,1,I,20210927.0,,20211013,20211013,DIR,586410,,FDA-CTU,,28.0,YR,,M,N,66.5,KG,20211013.0,N,PH,US,US,2021,Q4,Young Adult
199504221,19950422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Drug reaction with eosinophilia and systemic symptoms,,2021,Q4,1,I,20210927.0,,20211013,20211013,DIR,586410,,FDA-CTU,,28.0,YR,,M,N,66.5,KG,20211013.0,N,PH,US,US,2021,Q4,Young Adult
199504221,19950422,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Rash macular,,2021,Q4,1,I,20210927.0,,20211013,20211013,DIR,586410,,FDA-CTU,,28.0,YR,,M,N,66.5,KG,20211013.0,N,PH,US,US,2021,Q4,Young Adult
199519982,19951998,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pancreatitis,,2021,Q4,2,F,20161001.0,20211011.0,20211013,20211019,EXP,,US-JAZZ-2021-US-019117,JAZZ,,61.0,YR,,M,Y,112.0,KG,20211019.0,,MD,US,US,2021,Q4,Adult
199519982,19951998,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Colonoscopy,,2021,Q4,2,F,20161001.0,20211011.0,20211013,20211019,EXP,,US-JAZZ-2021-US-019117,JAZZ,,61.0,YR,,M,Y,112.0,KG,20211019.0,,MD,US,US,2021,Q4,Adult
199519982,19951998,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Endoscopic ultrasound,,2021,Q4,2,F,20161001.0,20211011.0,20211013,20211019,EXP,,US-JAZZ-2021-US-019117,JAZZ,,61.0,YR,,M,Y,112.0,KG,20211019.0,,MD,US,US,2021,Q4,Adult
199538161,19953816,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"19.9 u, daily",96.0,IU,Y,,D276024,,20563.0,19.9,IU,,QD,2021,Q4,Palpitations,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"19.9 u, daily",96.0,IU,Y,,D276024,,20563.0,19.9,IU,,QD,2021,Q4,Chest discomfort,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"19.9 u, daily",96.0,IU,Y,,D276024,,20563.0,19.9,IU,,QD,2021,Q4,Tremor,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"19.9 u, daily",96.0,IU,Y,,D276024,,20563.0,19.9,IU,,QD,2021,Q4,Discomfort,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"19.9 u, daily",96.0,IU,Y,,D276024,,20563.0,19.9,IU,,QD,2021,Q4,Blood pressure increased,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"19.9 u, daily",96.0,IU,Y,,D276024,,20563.0,19.9,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, daily",96.0,IU,Y,,D276024,,20563.0,24.0,IU,,QD,2021,Q4,Palpitations,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, daily",96.0,IU,Y,,D276024,,20563.0,24.0,IU,,QD,2021,Q4,Chest discomfort,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, daily",96.0,IU,Y,,D276024,,20563.0,24.0,IU,,QD,2021,Q4,Tremor,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, daily",96.0,IU,Y,,D276024,,20563.0,24.0,IU,,QD,2021,Q4,Discomfort,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, daily",96.0,IU,Y,,D276024,,20563.0,24.0,IU,,QD,2021,Q4,Blood pressure increased,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199538161,19953816,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 u, daily",96.0,IU,Y,,D276024,,20563.0,24.0,IU,,QD,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,20210928.0,20211001.0,20211013,20211013,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202110001089,ELI LILLY AND CO,,58.0,YR,,F,Y,82.0,KG,20211013.0,,CN,CN,CN,2021,Q4,Adult
199553981,19955398,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,Unknown,,,,,,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,20210101.0,20211013.0,20211014,20211014,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132437",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,,,20211014.0,,PH,US,US,2021,Q4,Elderly
199553981,19955398,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,Unknown,,,,,,,2021,Q4,Depressed mood,,2021,Q4,1,I,20210101.0,20211013.0,20211014,20211014,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132437",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,,,20211014.0,,PH,US,US,2021,Q4,Elderly
199553981,19955398,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,Unknown,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20210101.0,20211013.0,20211014,20211014,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132437",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,,,20211014.0,,PH,US,US,2021,Q4,Elderly
199553981,19955398,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,Unknown,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,20210101.0,20211013.0,20211014,20211014,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132437",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,,,20211014.0,,PH,US,US,2021,Q4,Elderly
199553981,19955398,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,Unknown,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210101.0,20211013.0,20211014,20211014,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132437",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,,,20211014.0,,PH,US,US,2021,Q4,Elderly
199553981,19955398,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,Unknown,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20210101.0,20211013.0,20211014,20211014,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132437",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,,,20211014.0,,PH,US,US,2021,Q4,Elderly
199553981,19955398,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,Unknown,,,,,,,2021,Q4,Lethargy,,2021,Q4,1,I,20210101.0,20211013.0,20211014,20211014,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132437",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,,,20211014.0,,PH,US,US,2021,Q4,Elderly
199553981,19955398,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,sliding scale as needed,,,,,Unknown,,,,,,,2021,Q4,Hip arthroplasty,,2021,Q4,1,I,20210101.0,20211013.0,20211014,20211014,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-132437",BOEHRINGER INGELHEIM,,80.0,YR,E,F,Y,,,20211014.0,,PH,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Dizziness,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Glaucoma,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Osteoarthritis,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Tunnel vision,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Cataract,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Gait disturbance,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Fall,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Contusion,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Arthritis,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,,,21017.0,20.0,IU,Injection,QD,2021,Q4,Hunger,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Dizziness,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Glaucoma,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Osteoarthritis,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Tunnel vision,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Cataract,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Gait disturbance,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Fall,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Contusion,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Arthritis,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,,,21017.0,18.0,IU,Injection,QD,2021,Q4,Hunger,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Dizziness,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Glaucoma,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Osteoarthritis,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Tunnel vision,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Cataract,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Gait disturbance,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Fall,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Contusion,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Arthritis,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, each morning",,,,,D134925H,,21017.0,20.0,IU,Injection,QD,2021,Q4,Hunger,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Dizziness,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Glaucoma,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Osteoarthritis,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Tunnel vision,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Blindness unilateral,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Cataract,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Gait disturbance,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Fall,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Contusion,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Arthritis,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199555951,19955595,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 u, each evening (night)",,,,,D134925H,,21017.0,18.0,IU,Injection,QD,2021,Q4,Hunger,,2021,Q4,1,I,20150101.0,20211005.0,20211014,20211014,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003287,ELI LILLY AND CO,,70.0,YR,,F,Y,87.0,KG,20211014.0,,CN,US,US,2021,Q4,Elderly
199558162,19955816,3,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Unknown,10-10-10,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210427.0,20211022.0,20211014,20211101,EXP,,JP-AstraZeneca-2021A765456,ASTRAZENECA,,28.0,YR,,M,Y,,,20211101.0,,MD,JP,,2021,Q4,Young Adult
199558162,19955816,4,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Unknown,8-6-6,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210427.0,20211022.0,20211014,20211101,EXP,,JP-AstraZeneca-2021A765456,ASTRAZENECA,,28.0,YR,,M,Y,,,20211101.0,,MD,JP,,2021,Q4,Young Adult
199558162,19955816,5,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Unknown,4-3-3,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210427.0,20211022.0,20211014,20211101,EXP,,JP-AstraZeneca-2021A765456,ASTRAZENECA,,28.0,YR,,M,Y,,,20211101.0,,MD,JP,,2021,Q4,Young Adult
199558162,19955816,7,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Unknown,10-10-10,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210427.0,20211022.0,20211014,20211101,EXP,,JP-AstraZeneca-2021A765456,ASTRAZENECA,,28.0,YR,,M,Y,,,20211101.0,,MD,JP,,2021,Q4,Young Adult
199558162,19955816,8,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Unknown,8-6-6,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210427.0,20211022.0,20211014,20211101,EXP,,JP-AstraZeneca-2021A765456,ASTRAZENECA,,28.0,YR,,M,Y,,,20211101.0,,MD,JP,,2021,Q4,Young Adult
199558162,19955816,9,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Unknown,4-3-3,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210427.0,20211022.0,20211014,20211101,EXP,,JP-AstraZeneca-2021A765456,ASTRAZENECA,,28.0,YR,,M,Y,,,20211101.0,,MD,JP,,2021,Q4,Young Adult
199569771,19956977,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, tid, 1 IU, 3-3-2-0, cylindrical ampoules",,,U,U,,,,1.0,IU,,TID,2021,Q4,Cellulitis,,2021,Q4,1,I,,20211008.0,20211014,20211014,EXP,,DE-MYLANLABS-2021M1071409,MYLAN,,70.0,YR,,M,Y,89.0,KG,20211014.0,,PH,DE,DE,2021,Q4,Elderly
199569771,19956977,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, tid, 1 IU, 3-3-2-0, cylindrical ampoules",,,U,U,,,,1.0,IU,,TID,2021,Q4,Skin ulcer,,2021,Q4,1,I,,20211008.0,20211014,20211014,EXP,,DE-MYLANLABS-2021M1071409,MYLAN,,70.0,YR,,M,Y,89.0,KG,20211014.0,,PH,DE,DE,2021,Q4,Elderly
199569931,19956993,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 units 3 times per day,,,,,,,,,,,TID,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211004.0,20211014,20211014,EXP,,US-BAXTER-2021BAX031647,BAXTER,"SAEED M, GIL G, LOPEZ P, VISCO F, PEKLER G, MUSHIYEV S. CHEST PAIN INDUCED BY INTRAVENOUS NITROGLYCERIN. AMERICAN JOURNAL OF THERAPEUTICS. 2020;27(3):E299-E301.",54.0,YR,,M,Y,,,20211014.0,,MD,US,US,2021,Q4,Adult
199591631,19959163,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions-/Infusionslosung",,,,,,,,,,,,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,,20211009.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071636,MYLAN,,88.0,YR,,F,Y,,,20211015.0,,MD,DE,DE,2021,Q4,Elderly
199591631,19959163,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions-/Infusionslosung",,,,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20211009.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071636,MYLAN,,88.0,YR,,F,Y,,,20211015.0,,MD,DE,DE,2021,Q4,Elderly
199591631,19959163,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions-/Infusionslosung",,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211009.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071636,MYLAN,,88.0,YR,,F,Y,,,20211015.0,,MD,DE,DE,2021,Q4,Elderly
199591631,19959163,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions-/Infusionslosung",,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211009.0,20211015,20211015,EXP,,DE-MYLANLABS-2021M1071636,MYLAN,,88.0,YR,,F,Y,,,20211015.0,,MD,DE,DE,2021,Q4,Elderly
199626613,19962661,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Dizziness,,2021,Q4,3,F,20180101.0,20211207.0,20211018,20211216,EXP,,BR-NOVOPROD-856195,NOVO NORDISK,,69.0,YR,,F,Y,64.0,KG,20211216.0,,MD,BR,BR,2021,Q4,Elderly
199626613,19962661,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,3,F,20180101.0,20211207.0,20211018,20211216,EXP,,BR-NOVOPROD-856195,NOVO NORDISK,,69.0,YR,,F,Y,64.0,KG,20211216.0,,MD,BR,BR,2021,Q4,Elderly
199626613,19962661,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,3,F,20180101.0,20211207.0,20211018,20211216,EXP,,BR-NOVOPROD-856195,NOVO NORDISK,,69.0,YR,,F,Y,64.0,KG,20211216.0,,MD,BR,BR,2021,Q4,Elderly
199626613,19962661,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Extra dose administered,,2021,Q4,3,F,20180101.0,20211207.0,20211018,20211216,EXP,,BR-NOVOPROD-856195,NOVO NORDISK,,69.0,YR,,F,Y,64.0,KG,20211216.0,,MD,BR,BR,2021,Q4,Elderly
199626613,19962661,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unknown,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20180101.0,20211207.0,20211018,20211216,EXP,,BR-NOVOPROD-856195,NOVO NORDISK,,69.0,YR,,F,Y,64.0,KG,20211216.0,,MD,BR,BR,2021,Q4,Elderly
199655841,19965584,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 iU,,,U,,,,,4.0,IU,,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 iU,,,U,,,,,4.0,IU,,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 iU,,,U,,,,,4.0,IU,,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 iU,,,U,,,,,4.0,IU,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 iU,,,U,,,,,5.0,IU,,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 iU,,,U,,,,,5.0,IU,,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 iU,,,U,,,,,5.0,IU,,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 iU,,,U,,,,,5.0,IU,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 iU,,,U,,,,,24.0,IU,,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 iU,,,U,,,,,24.0,IU,,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 iU,,,U,,,,,24.0,IU,,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 iU,,,U,,,,,24.0,IU,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20-0-8 IU to 24-0-14 IU,,,U,,,,,,,,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20-0-8 IU to 24-0-14 IU,,,U,,,,,,,,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20-0-8 IU to 24-0-14 IU,,,U,,,,,,,,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20-0-8 IU to 24-0-14 IU,,,U,,,,,,,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26-0-16 IU,,,U,,,,,,,,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26-0-16 IU,,,U,,,,,,,,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26-0-16 IU,,,U,,,,,,,,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,26-0-16 IU,,,U,,,,,,,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,at lunch time at the dose of 4 IU,,,U,,,,,4.0,IU,,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,at lunch time at the dose of 4 IU,,,U,,,,,4.0,IU,,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,at lunch time at the dose of 4 IU,,,U,,,,,4.0,IU,,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,at lunch time at the dose of 4 IU,,,U,,,,,4.0,IU,,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6-0 IU,,,U,,,,,,,,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6-0 IU,,,U,,,,,,,,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6-0 IU,,,U,,,,,,,,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-6-0 IU,,,U,,,,,,,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-7-0 IU,,,U,,,,,,,,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-7-0 IU,,,U,,,,,,,,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-7-0 IU,,,U,,,,,,,,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199655841,19965584,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,0-7-0 IU,,,U,,,,,,,,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211011.0,20211018,20211018,EXP,,SK-SA-2021SA338452,SANOFI AVENTIS,,66.0,YR,E,M,Y,93.0,KG,20211018.0,,MD,SK,SK,2021,Q4,Elderly
199689941,19968994,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Fungal infection,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Skin haemorrhage,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Skin ulcer,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Mass,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Back pain,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199689941,19968994,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2021,Q4,Trichophytosis,,2021,Q4,1,I,20180101.0,20200804.0,20211019,20211019,EXP,,CZ-MYLANLABS-2020M1070332,MYLAN,"Novakova M, Svobodova K, Hercogova J.. Unusual manifestation of cutaneous mycosis in a patient after heart transplantation.. CESKA DERMATOVENEROLOGIE. 2020;10(2):116-119",65.0,YR,,M,Y,,,20211019.0,,HP,CZ,CZ,2021,Q4,Elderly
199700571,19970057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199700571,19970057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20211006.0,20211007.0,20211019,20211019,EXP,,US-ELI_LILLY_AND_COMPANY-US202110003255,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211019.0,,CN,US,US,2021,Q4,Adult
199735051,19973505,17,C,Insulin lispro kwikpen,,2,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Death,,2021,Q4,1,I,20211005.0,20211011.0,20211020,20211020,EXP,,US-CELGENEUS-USA-20211005177,CELGENE,,72.0,YR,,F,Y,89.4,KG,20211020.0,,PH,US,US,2021,Q4,Elderly
199762011,19976201,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g of carbohydrate with meals and snacks,,,,,,,,,,Unknown,,2021,Q4,Diabetic ketoacidosis,,2021,Q4,1,I,,20211012.0,20211021,20211021,EXP,,CA-JNJFOC-20211035870,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20211021.0,,MD,CA,CA,2021,Q4,Youth
199762011,19976201,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g of carbohydrate with meals and snacks,,,,,,,,,,Unknown,,2021,Q4,Product use issue,,2021,Q4,1,I,,20211012.0,20211021,20211021,EXP,,CA-JNJFOC-20211035870,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20211021.0,,MD,CA,CA,2021,Q4,Youth
199762011,19976201,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g of carbohydrate with meals and snacks,,,,,,,,,,Unknown,,2021,Q4,Off label use,,2021,Q4,1,I,,20211012.0,20211021,20211021,EXP,,CA-JNJFOC-20211035870,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20211021.0,,MD,CA,CA,2021,Q4,Youth
199805153,19980515,11,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,1,Subcutaneous,"26 unit, bid",,,U,,,,,,,,BID,2021,Q4,Renal impairment,,2021,Q4,3,F,20211008.0,20211124.0,20211022,20211129,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-108409,BRISTOL MYERS SQUIBB,,78.0,YR,,F,Y,82.086,KG,20211129.0,,CN,US,US,2021,Q4,Elderly
199805153,19980515,11,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,1,Subcutaneous,"26 unit, bid",,,U,,,,,,,,BID,2021,Q4,Gingival bleeding,,2021,Q4,3,F,20211008.0,20211124.0,20211022,20211129,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-108409,BRISTOL MYERS SQUIBB,,78.0,YR,,F,Y,82.086,KG,20211129.0,,CN,US,US,2021,Q4,Elderly
199805153,19980515,11,C,INSULIN LISPRO;INSULIN LISPRO PROTAMINE SUSPENSION,,1,Subcutaneous,"26 unit, bid",,,U,,,,,,,,BID,2021,Q4,Renal haemorrhage,,2021,Q4,3,F,20211008.0,20211124.0,20211022,20211129,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-108409,BRISTOL MYERS SQUIBB,,78.0,YR,,F,Y,82.086,KG,20211129.0,,CN,US,US,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Feeling hot,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Asthenia,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Feeling abnormal,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Cold sweat,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Nervousness,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Feeling abnormal,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Nervousness,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Hyperhidrosis,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Hyperhidrosis,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199805722,19980572,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (in each meal)",,,U,,,,20563.0,,,,,2021,Q4,Abnormal dreams,,2021,Q4,2,F,20210927.0,20211103.0,20211021,20211110,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202110004586,ELI LILLY AND CO,,77.0,YR,,F,Y,74.4,KG,20211110.0,,CN,ES,ES,2021,Q4,Elderly
199832831,19983283,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Live birth,,2021,Q4,1,I,,20211018.0,20211021,20211021,EXP,,CA-GLAXOSMITHKLINE-CACH2021AMR072931,GLAXOSMITHKLINE,,27.0,YR,,F,Y,,,20211021.0,,PH,CA,CA,2021,Q4,Young Adult
199832831,19983283,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Exposure during pregnancy,,2021,Q4,1,I,,20211018.0,20211021,20211021,EXP,,CA-GLAXOSMITHKLINE-CACH2021AMR072931,GLAXOSMITHKLINE,,27.0,YR,,F,Y,,,20211021.0,,PH,CA,CA,2021,Q4,Young Adult
199832831,19983283,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Heart rate increased,,2021,Q4,1,I,,20211018.0,20211021,20211021,EXP,,CA-GLAXOSMITHKLINE-CACH2021AMR072931,GLAXOSMITHKLINE,,27.0,YR,,F,Y,,,20211021.0,,PH,CA,CA,2021,Q4,Young Adult
199832831,19983283,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Oligohydramnios,,2021,Q4,1,I,,20211018.0,20211021,20211021,EXP,,CA-GLAXOSMITHKLINE-CACH2021AMR072931,GLAXOSMITHKLINE,,27.0,YR,,F,Y,,,20211021.0,,PH,CA,CA,2021,Q4,Young Adult
199841514,19984151,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Cardiac failure,,2021,Q4,4,F,20210617.0,20211213.0,20211022,20211215,PER,,US-CELGENEUS-USA-20211005912,CELGENE,,86.0,YR,,M,Y,,,20211215.0,,MD,US,US,2021,Q4,Elderly
199843941,19984394,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Angioedema,,2021,Q4,1,I,20211003.0,,20211022,20211022,DIR,587641,,FDA-CTU,,58.0,YR,,F,N,137.7,KG,20211022.0,N,PH,US,US,2021,Q4,Adult
199876031,19987603,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D182601C,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211020.0,20211020.0,20211023,20211023,PER,,US-ELI_LILLY_AND_COMPANY-US202110009285,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20211023.0,,CN,US,US,2021,Q4,Elderly
199886791,19988679,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,,,,Injection,,2021,Q4,Myalgia,,2021,Q4,1,I,20211018.0,20211020.0,20211024,20211024,PER,,US-ELI_LILLY_AND_COMPANY-US202110009244,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20211024.0,,CN,US,US,2021,Q4,Elderly
199886791,19988679,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,,,,Injection,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211018.0,20211020.0,20211024,20211024,PER,,US-ELI_LILLY_AND_COMPANY-US202110009244,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20211024.0,,CN,US,US,2021,Q4,Elderly
199886791,19988679,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20211018.0,20211020.0,20211024,20211024,PER,,US-ELI_LILLY_AND_COMPANY-US202110009244,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20211024.0,,CN,US,US,2021,Q4,Elderly
199891941,19989194,17,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,20210101.0,20211020.0,20211025,20211025,PER,,US-AMGEN-USASP2021163629,AMGEN,,76.0,YR,E,M,Y,,,20211024.0,,HP,US,US,2021,Q4,Elderly
199891941,19989194,17,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Nausea,,2021,Q4,1,I,20210101.0,20211020.0,20211025,20211025,PER,,US-AMGEN-USASP2021163629,AMGEN,,76.0,YR,E,M,Y,,,20211024.0,,HP,US,US,2021,Q4,Elderly
199891941,19989194,17,C,INSULIN LISPRO PROTAMINE RECOMBINANT,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20210101.0,20211020.0,20211025,20211025,PER,,US-AMGEN-USASP2021163629,AMGEN,,76.0,YR,E,M,Y,,,20211024.0,,HP,US,US,2021,Q4,Elderly
199902381,19990238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,?          OTHER STRENGTH:100u/mL;OTHER DOSE:95u;,,,,,,,,,,,QD,2021,Q4,Manufacturing issue,,2021,Q4,1,I,20210706.0,,20211022,20211022,DIR,FDA-CDER-CTU-2021-79117,,FDA-CTU,,29.0,YR,,M,N,,,20211022.0,N,MD,US,US,2021,Q4,Young Adult
199902381,19990238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,?          OTHER STRENGTH:100u/mL;OTHER DOSE:95u;,,,,,,,,,,,QD,2021,Q4,Blood glucose fluctuation,,2021,Q4,1,I,20210706.0,,20211022,20211022,DIR,FDA-CDER-CTU-2021-79117,,FDA-CTU,,29.0,YR,,M,N,,,20211022.0,N,MD,US,US,2021,Q4,Young Adult
199902381,19990238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,?          OTHER STRENGTH:100u/mL;OTHER DOSE:95u;,,,,,,,,,,,QD,2021,Q4,Feeling abnormal,,2021,Q4,1,I,20210706.0,,20211022,20211022,DIR,FDA-CDER-CTU-2021-79117,,FDA-CTU,,29.0,YR,,M,N,,,20211022.0,N,MD,US,US,2021,Q4,Young Adult
199902381,19990238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,?          OTHER STRENGTH:100u/mL;OTHER DOSE:95u;,,,,,,,,,,,QD,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210706.0,,20211022,20211022,DIR,FDA-CDER-CTU-2021-79117,,FDA-CTU,,29.0,YR,,M,N,,,20211022.0,N,MD,US,US,2021,Q4,Young Adult
199902381,19990238,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,?          OTHER STRENGTH:100u/mL;OTHER DOSE:95u;,,,,,,,,,,,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210706.0,,20211022,20211022,DIR,FDA-CDER-CTU-2021-79117,,FDA-CTU,,29.0,YR,,M,N,,,20211022.0,N,MD,US,US,2021,Q4,Young Adult
199914802,19991480,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,Injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,Injection,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,Injection,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,Y,U,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose unspecified,,,,,,,,,,Injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose unspecified,,,,,,,,,,Injection,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose unspecified,,,,,,,,,,Injection,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose unspecified,,,,,,,,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose unspecified,,,,,,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,dose unspecified,,,,,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Weight increased,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,total daily insulin dose was 80 units/day (insulin lispro plus glargine),,,,,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 international unit, qd",,,,,,,,15.0,IU,Injection,QD,2021,Q4,Weight increased,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 international unit, qd",,,,,,,,15.0,IU,Injection,QD,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 international unit, qd",,,,,,,,15.0,IU,Injection,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 international unit, qd",,,,,,,,15.0,IU,Injection,QD,2021,Q4,Drug ineffective,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 international unit, qd",,,,,,,,15.0,IU,Injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199914802,19991480,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 international unit, qd",,,,,,,,15.0,IU,Injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,2,F,20160501.0,20211026.0,20211025,20211103,EXP,,SK-MYLANLABS-2021M1046357,MYLAN,"Kollarova D, Martinka E, Urbanova M et al.. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211103.0,,MD,SK,SK,2021,Q4,Adult
199935311,19993531,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,1,I,,20211022.0,20211026,20211026,EXP,,"CA-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2021-BI-134450",BOEHRINGER INGELHEIM,,82.0,YR,E,F,Y,61.0,KG,20211026.0,,PH,CA,CA,2021,Q4,Elderly
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Myalgia,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Oropharyngeal pain,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Feeling abnormal,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Aspartate aminotransferase increased,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Alanine aminotransferase increased,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Pain,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Dysphonia,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Haemoptysis,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199970721,19997072,8,C,insulin lispro and glargine,,2,,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20211021.0,,20211026,20211026,DIR,588185,,FDA-CTU,,58.0,YR,,M,N,145.0,KG,20211026.0,N,PH,US,US,2021,Q4,Adult
199971211,19997121,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning",,,,,D371840A,,20563.0,7.0,IU,Injection,QD,2021,Q4,Accidental underdose,,2021,Q4,1,I,20210923.0,20210927.0,20211026,20211026,PER,,US-ELI_LILLY_AND_COMPANY-US202109011131,ELI LILLY AND CO,,46.0,YR,,M,Y,,,20211026.0,,CN,US,US,2021,Q4,Adult
199971211,19997121,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning",,,,,D371840A,,20563.0,7.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210923.0,20210927.0,20211026,20211026,PER,,US-ELI_LILLY_AND_COMPANY-US202109011131,ELI LILLY AND CO,,46.0,YR,,M,Y,,,20211026.0,,CN,US,US,2021,Q4,Adult
199971211,19997121,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, bid(at lunch and dinner)",,,,,D371840A,,20563.0,5.0,IU,Injection,BID,2021,Q4,Accidental underdose,,2021,Q4,1,I,20210923.0,20210927.0,20211026,20211026,PER,,US-ELI_LILLY_AND_COMPANY-US202109011131,ELI LILLY AND CO,,46.0,YR,,M,Y,,,20211026.0,,CN,US,US,2021,Q4,Adult
199971211,19997121,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, bid(at lunch and dinner)",,,,,D371840A,,20563.0,5.0,IU,Injection,BID,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210923.0,20210927.0,20211026,20211026,PER,,US-ELI_LILLY_AND_COMPANY-US202109011131,ELI LILLY AND CO,,46.0,YR,,M,Y,,,20211026.0,,CN,US,US,2021,Q4,Adult
199976331,19997633,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unk,,,,,,,2021,Q4,Sensory disturbance,,2021,Q4,1,I,,20211017.0,20211026,20211026,EXP,,BR-NOVOPROD-859121,NOVO NORDISK,,63.0,YR,,F,Y,98.0,KG,20211026.0,,MD,BR,BR,2021,Q4,Adult
199976331,19997633,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unk,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211017.0,20211026,20211026,EXP,,BR-NOVOPROD-859121,NOVO NORDISK,,63.0,YR,,F,Y,98.0,KG,20211026.0,,MD,BR,BR,2021,Q4,Adult
199976331,19997633,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unk,,,,,,,2021,Q4,Hunger,,2021,Q4,1,I,,20211017.0,20211026,20211026,EXP,,BR-NOVOPROD-859121,NOVO NORDISK,,63.0,YR,,F,Y,98.0,KG,20211026.0,,MD,BR,BR,2021,Q4,Adult
199976331,19997633,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,unk,,,,,,,2021,Q4,Breast cancer,,2021,Q4,1,I,,20211017.0,20211026,20211026,EXP,,BR-NOVOPROD-859121,NOVO NORDISK,,63.0,YR,,F,Y,98.0,KG,20211026.0,,MD,BR,BR,2021,Q4,Adult
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Glycogen storage disease type VIII,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Overdose,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Abdominal discomfort,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Hepatitis acute,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Abdominal tenderness,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Nausea,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200005582,20000558,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,D,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211027.0,20211026,20211104,EXP,,US-SA-2021SA348218,SANOFI AVENTIS,,16.0,YR,T,M,Y,,,20211104.0,,MD,US,US,2021,Q4,Youth
200008991,20000899,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,D,D,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,1,I,,,20211026,20211026,DIR,FDA-CDER-CTU-2021-79979,,FDA-CTU,,29.0,YR,,F,N,95.89,KG,20211026.0,N,,US,US,2021,Q4,Young Adult
200008991,20000899,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Drug intolerance,,2021,Q4,1,I,,,20211026,20211026,DIR,FDA-CDER-CTU-2021-79979,,FDA-CTU,,29.0,YR,,F,N,95.89,KG,20211026.0,N,,US,US,2021,Q4,Young Adult
200022521,20002252,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"48 IU, qd",,,U,U,Unknown,,,48.0,IU,,QD,2021,Q4,COVID-19,,2021,Q4,1,I,,20211018.0,20211027,20211027,EXP,,JP-NOVOPROD-859511,NOVO NORDISK,,60.0,YR,,M,Y,,,20211027.0,,MD,JP,JP,2021,Q4,Adult
200022521,20002252,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"48 IU, qd",,,U,U,Unknown,,,48.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211018.0,20211027,20211027,EXP,,JP-NOVOPROD-859511,NOVO NORDISK,,60.0,YR,,M,Y,,,20211027.0,,MD,JP,JP,2021,Q4,Adult
200105091,20010509,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Cataract,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Cataract,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Vertigo,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200105091,20010509,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2021,Q4,Eye infarction,,2021,Q4,1,I,20190101.0,20211025.0,20211029,20211029,EXP,,PR-ABBVIE-21K-131-4138119-00,ABBVIE,,63.0,YR,,F,Y,86.26,KG,20211029.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Adult
200115291,20011529,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Product storage error,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Product storage error,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Product storage error,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Product storage error,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200115291,20011529,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341138C,,20563.0,,,Injection,,2021,Q4,Glycosylated haemoglobin increased,,2021,Q4,1,I,20210701.0,20211027.0,20211029,20211029,PER,,US-ELI_LILLY_AND_COMPANY-US202110011682,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211029.0,,CN,US,US,2021,Q4,Elderly
200119413,20011941,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,,1.0,IU,Injection,,2021,Q4,Acute respiratory failure,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,,1.0,IU,Injection,,2021,Q4,Product administration error,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,,1.0,IU,Injection,,2021,Q4,Condition aggravated,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,,1.0,IU,Injection,,2021,Q4,Cough,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,,1.0,IU,Injection,,2021,Q4,Hypoxia,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200119413,20011941,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, NK [presumably not known], prefilled syringes",,,U,U,,,,1.0,IU,Injection,,2021,Q4,Dyspnoea,,2021,Q4,3,F,,20211025.0,20211029,20211104,EXP,,DE-MYLANLABS-2021M1076678,MYLAN,,56.0,YR,,F,Y,105.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Adult
200185892,20018589,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Cholecystitis acute,,2021,Q4,2,F,20211013.0,20211110.0,20211101,20211122,EXP,,US-ROCHE-2940258,ROCHE,,63.0,YR,,M,Y,98.9,KG,20211122.0,,MD,US,,2021,Q4,Adult
200185892,20018589,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,2,F,20211013.0,20211110.0,20211101,20211122,EXP,,US-ROCHE-2940258,ROCHE,,63.0,YR,,M,Y,98.9,KG,20211122.0,,MD,US,,2021,Q4,Adult
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Rash,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Drug hypersensitivity,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Urticaria,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Therapeutic response decreased,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Polyuria,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Dry mouth,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Disease recurrence,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Pruritus,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Polydipsia,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Skin mass,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200208031,20020803,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,U,,,,,,,Solution for injection,,2021,Q4,Injection site nodule,,2021,Q4,1,I,20180101.0,20211026.0,20211101,20211101,EXP,,CN-SA-2021SA357938,SANOFI AVENTIS,"Zhuqing Z, Zelin L, Xiaobo L. Insulin pump combined with flash glucose monitoring for insulin desensitization treatment. Chin J Diabetes. 2021;29(10):781-783",67.0,YR,E,M,Y,,,20211101.0,,HP,CN,CN,2021,Q4,Elderly
200211081,20021108,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,Injection,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20210101.0,20211028.0,20211101,20211101,PER,,US-AMGEN-USASP2021169583,AMGEN,,74.0,YR,E,F,Y,,,20211101.0,,HP,US,US,2021,Q4,Elderly
200227252,20022725,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dose: 1 U,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,2,F,20210304.0,20211103.0,20211102,20211111,EXP,,US-ROCHE-2788394,ROCHE,,56.0,YR,,M,Y,69.0,KG,20211111.0,,MD,US,,2021,Q4,Adult
200227252,20022725,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Dose: 1 U,,,,,,,,,,,,2021,Q4,Device occlusion,,2021,Q4,2,F,20210304.0,20211103.0,20211102,20211111,EXP,,US-ROCHE-2788394,ROCHE,,56.0,YR,,M,Y,69.0,KG,20211111.0,,MD,US,,2021,Q4,Adult
200239302,20023930,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12IE-0-0-0 s.c. Comedication on 15.08.2021,since an unknown date (but before",,,,,,,,,,,,2021,Q4,Pancytopenia,,2021,Q4,2,F,20210815.0,20211021.0,20211102,20211102,EXP,CH-SM-2021-22451,CH-Accord-243878,ACCORD,,69.0,YR,E,M,Y,,,20211102.0,,MD,CH,CH,2021,Q4,Elderly
200239302,20023930,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12IE-0-0-0 s.c. Comedication on 15.08.2021,since an unknown date (but before",,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,2,F,20210815.0,20211021.0,20211102,20211102,EXP,CH-SM-2021-22451,CH-Accord-243878,ACCORD,,69.0,YR,E,M,Y,,,20211102.0,,MD,CH,CH,2021,Q4,Elderly
200250821,20025082,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Leukaemia,,2021,Q4,1,I,20210101.0,20211026.0,20211102,20211102,EXP,,US-ELI_LILLY_AND_COMPANY-US202110010952,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20211102.0,,CN,US,US,2021,Q4,Adult
200250821,20025082,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20210101.0,20211026.0,20211102,20211102,EXP,,US-ELI_LILLY_AND_COMPANY-US202110010952,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20211102.0,,CN,US,US,2021,Q4,Adult
200250821,20025082,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Leukaemia,,2021,Q4,1,I,20210101.0,20211026.0,20211102,20211102,EXP,,US-ELI_LILLY_AND_COMPANY-US202110010952,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20211102.0,,CN,US,US,2021,Q4,Adult
200250821,20025082,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20210101.0,20211026.0,20211102,20211102,EXP,,US-ELI_LILLY_AND_COMPANY-US202110010952,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20211102.0,,CN,US,US,2021,Q4,Adult
200250821,20025082,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,20563.0,,,Injection,,2021,Q4,Leukaemia,,2021,Q4,1,I,20210101.0,20211026.0,20211102,20211102,EXP,,US-ELI_LILLY_AND_COMPANY-US202110010952,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20211102.0,,CN,US,US,2021,Q4,Adult
200250821,20025082,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,20563.0,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20210101.0,20211026.0,20211102,20211102,EXP,,US-ELI_LILLY_AND_COMPANY-US202110010952,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20211102.0,,CN,US,US,2021,Q4,Adult
200250821,20025082,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,20563.0,,,Injection,,2021,Q4,Leukaemia,,2021,Q4,1,I,20210101.0,20211026.0,20211102,20211102,EXP,,US-ELI_LILLY_AND_COMPANY-US202110010952,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20211102.0,,CN,US,US,2021,Q4,Adult
200250821,20025082,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,20563.0,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20210101.0,20211026.0,20211102,20211102,EXP,,US-ELI_LILLY_AND_COMPANY-US202110010952,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20211102.0,,CN,US,US,2021,Q4,Adult
200259391,20025939,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 u, night",,,,,,,20563.0,3.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211018.0,20211019.0,20211102,20211102,PER,,US-ELI_LILLY_AND_COMPANY-US202110008806,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20211102.0,,CN,US,US,2021,Q4,Elderly
200259391,20025939,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 u, night",,,,,,,20563.0,3.0,IU,Injection,QD,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20211018.0,20211019.0,20211102,20211102,PER,,US-ELI_LILLY_AND_COMPANY-US202110008806,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20211102.0,,CN,US,US,2021,Q4,Elderly
200259391,20025939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 u, night",,,,,D341139A,,20563.0,3.0,IU,Injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211018.0,20211019.0,20211102,20211102,PER,,US-ELI_LILLY_AND_COMPANY-US202110008806,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20211102.0,,CN,US,US,2021,Q4,Elderly
200259391,20025939,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 u, night",,,,,D341139A,,20563.0,3.0,IU,Injection,QD,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20211018.0,20211019.0,20211102,20211102,PER,,US-ELI_LILLY_AND_COMPANY-US202110008806,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20211102.0,,CN,US,US,2021,Q4,Elderly
200277501,20027750,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,6.0,IU,,,2021,Q4,Myocardial bridging,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068624,GLENMARK,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S.. Chest Pain Induced by Intravenous Nitroglycerin... American journal of therapeutics. 2020;27(3):e299-301",54.0,YR,,M,Y,,,20211103.0,,MD,US,US,2021,Q4,Adult
200277501,20027750,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,6.0,IU,,,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211025.0,20211103,20211103,EXP,,US-GLENMARK PHARMACEUTICALS-2021GMK068624,GLENMARK,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S.. Chest Pain Induced by Intravenous Nitroglycerin... American journal of therapeutics. 2020;27(3):e299-301",54.0,YR,,M,Y,,,20211103.0,,MD,US,US,2021,Q4,Adult
200281232,20028123,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Cerebrovascular accident,,2021,Q4,2,F,,20211104.0,20211103,20211110,PER,,US-AMGEN-USASP2021169953,AMGEN,,79.0,YR,E,F,Y,,,20211110.0,,MD,US,US,2021,Q4,Elderly
200290211,20029021,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pneumonia,,2021,Q4,1,I,20210930.0,20211022.0,20211103,20211103,EXP,,US-BAUSCH-BL-2021-035439,BAUSCH AND LOMB,,79.0,YR,,M,Y,85.3,KG,20211103.0,,CN,US,US,2021,Q4,Elderly
200297591,20029759,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210501.0,20211006.0,20211103,20211103,PER,,US-ELI_LILLY_AND_COMPANY-US202110003515,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200297591,20029759,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20210501.0,20211006.0,20211103,20211103,PER,,US-ELI_LILLY_AND_COMPANY-US202110003515,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200297591,20029759,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D341139A,,,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20210501.0,20211006.0,20211103,20211103,PER,,US-ELI_LILLY_AND_COMPANY-US202110003515,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200297591,20029759,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D341139A,,,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20210501.0,20211006.0,20211103,20211103,PER,,US-ELI_LILLY_AND_COMPANY-US202110003515,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200303501,20030350,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 u, daily",,,U,U,D277138C,,20563.0,30.0,IU,,QD,2021,Q4,Injection site mass,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 u, daily",,,U,U,D277138C,,20563.0,30.0,IU,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 u, daily",,,U,U,D277138C,,20563.0,30.0,IU,,QD,2021,Q4,Injection site induration,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 u, daily",,,U,U,D277138C,,20563.0,30.0,IU,,QD,2021,Q4,Drug hypersensitivity,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 u, daily",,,U,U,D277138C,,20563.0,30.0,IU,,QD,2021,Q4,Injection site erythema,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 u, daily",,,U,U,D277138C,,20563.0,30.0,IU,,QD,2021,Q4,Injection site injury,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"30 u, daily",,,U,U,D277138C,,20563.0,30.0,IU,,QD,2021,Q4,Injection site pruritus,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2021,Q4,Injection site mass,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2021,Q4,Injection site induration,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2021,Q4,Drug hypersensitivity,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2021,Q4,Injection site erythema,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2021,Q4,Injection site injury,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200303501,20030350,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,20563.0,,,,,2021,Q4,Injection site pruritus,,2021,Q4,1,I,20211010.0,20211023.0,20211103,20211103,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000111,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211103.0,,CN,CN,CN,2021,Q4,Elderly
200312533,20031253,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding Scale,,,,,,,,,,,TID,2021,Q4,Streptococcal bacteraemia,,2021,Q4,3,F,20211026.0,20211122.0,20211103,20211129,EXP,,US-ABBVIE-21P-163-4140208-00,ABBVIE,,78.0,YR,,F,Y,67.5,KG,20211129.0,,MD,COUNTRY NOT SPECIFIED,US,2021,Q4,Elderly
200325361,20032536,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q4,Platelet count decreased,,2021,Q4,1,I,20210819.0,20211028.0,20211103,20211103,EXP,,US-Taiho Oncology  Inc-EU-2021-02375,TAIHO ONCOLOGY INC,,78.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200325361,20032536,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q4,White blood cell count decreased,,2021,Q4,1,I,20210819.0,20211028.0,20211103,20211103,EXP,,US-Taiho Oncology  Inc-EU-2021-02375,TAIHO ONCOLOGY INC,,78.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200325361,20032536,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q4,Lung lobectomy,,2021,Q4,1,I,20210819.0,20211028.0,20211103,20211103,EXP,,US-Taiho Oncology  Inc-EU-2021-02375,TAIHO ONCOLOGY INC,,78.0,YR,,M,Y,,,20211103.0,,CN,US,US,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Cough,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Constipation,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200351081,20035108,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211029.0,20211104,20211104,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211104.0,,PH,DE,DE,2021,Q4,Elderly
200373732,20037373,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2021,Q4,Death,,2021,Q4,2,F,20211011.0,20211115.0,20211105,20211123,EXP,,US-ACORDA-ACO_170751_2021,ACORDA,,54.0,YR,,F,Y,,,20211123.0,,MD,US,US,2021,Q4,Adult
200376723,20037672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,Injection,TID,2021,Q4,Hyponatraemia,,2021,Q4,3,F,20211025.0,20211216.0,20211105,20211222,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20211222.0,,MD,US,,2021,Q4,Elderly
200376723,20037672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,Injection,TID,2021,Q4,Adrenal insufficiency,,2021,Q4,3,F,20211025.0,20211216.0,20211105,20211222,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20211222.0,,MD,US,,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Vertigo,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Fatigue,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Nausea,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Diarrhoea,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Hyperlipidaemia,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Respiratory disorder,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Malaise,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Dysphagia,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200380601,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2021,Q4,Drug intolerance,,2021,Q4,1,I,20180208.0,20211029.0,20211105,20211105,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20211105.0,,CN,US,US,2021,Q4,Elderly
200410862,20041086,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D243920A,,20563.0,,,Injection,,2021,Q4,Palpitations,,2021,Q4,2,F,20211026.0,20211102.0,20211107,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001404,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
200410862,20041086,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D243920A,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20211026.0,20211102.0,20211107,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001404,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
200410862,20041086,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D243920A,,20563.0,,,Injection,,2021,Q4,Initial insomnia,,2021,Q4,2,F,20211026.0,20211102.0,20211107,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001404,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
200410862,20041086,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D243920A,,20563.0,,,Injection,,2021,Q4,Dizziness,,2021,Q4,2,F,20211026.0,20211102.0,20211107,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001404,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
200410862,20041086,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D243920A,,20563.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,2,F,20211026.0,20211102.0,20211107,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001404,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,,,,20.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,,,,20.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,,,,20.0,IU,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,,,,20.0,IU,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,D341138C,,,20.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,D341138C,,,20.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,D341138C,,,20.0,IU,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,D341138C,,,20.0,IU,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,D261904A,,,20.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,D261904A,,,20.0,IU,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,D261904A,,,20.0,IU,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200424562,20042456,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, unknown",,,U,,D261904A,,,20.0,IU,Injection,,2021,Q4,Drug ineffective,,2021,Q4,2,F,20211029.0,20211103.0,20211108,20211111,PER,,US-ELI_LILLY_AND_COMPANY-US202101002391,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20211111.0,,CN,US,US,2021,Q4,Elderly
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Malaise,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Urinary tract infection,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Nephrolithiasis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Chronic hepatitis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Headache,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Amylase increased,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Pyrexia,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Chills,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Cutaneous amyloidosis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Lumbar spinal stenosis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Nausea,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Diarrhoea,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Euglycaemic diabetic ketoacidosis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200426212,20042621,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"TID, morning: 18 units, noon: 15 units, evening: 20 units",,,U,,,,,,,Injection,Q8H,2021,Q4,Hepatic fibrosis,,2021,Q4,2,F,20210714.0,20211118.0,20211108,20211124,EXP,,JP-SA-2021SA347596,SANOFI AVENTIS,,51.0,YR,A,F,Y,61.0,KG,20211124.0,,MD,JP,JP,2021,Q4,Adult
200438081,20043808,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,dose unspecified (Injection),,,U,,,,,,,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,dose unspecified (Injection),,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,dose unspecified (Injection),,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,total daily insulin dose was 80 units/day (insulin lispro plus glargine)(INJECTION),,,U,,,,,,,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,total daily insulin dose was 80 units/day (insulin lispro plus glargine)(INJECTION),,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,total daily insulin dose was 80 units/day (insulin lispro plus glargine)(INJECTION),,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 IU, QD (Injection)",,,U,,,,,15.0,IU,,QD,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 IU, QD (Injection)",,,U,,,,,15.0,IU,,QD,2021,Q4,Weight increased,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 IU, QD (Injection)",,,U,,,,,15.0,IU,,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Diabetic metabolic decompensation,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200438081,20043808,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Drug ineffective,,2021,Q4,1,I,,20211027.0,20211108,20211108,EXP,,NVSC2021SK247838,NOVARTIS,"Kollarova D, Martinka E, Urbanova M. Practical experience confirms the results of the RCT and RWE studies with empagliflosin: case reports. FORUM DIABETOLOGICUM. 2021;10(1):53-61",53.0,YR,,M,Y,,,20211108.0,,HP,SK,SK,2021,Q4,Adult
200442372,20044237,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Cardiac arrest,,2021,Q4,2,F,20211014.0,20211218.0,20211108,20211220,EXP,,NVSC2021US243269,NOVARTIS,,70.0,YR,,F,Y,58.3,KG,20211220.0,,MD,US,US,2021,Q4,Elderly
200453821,20045382,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,20211026.0,20211104.0,20211108,20211108,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-117959,BRISTOL MYERS SQUIBB,,70.0,YR,,F,Y,,,20211108.0,,CN,US,US,2021,Q4,Elderly
200494901,20049490,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 to 4 IU doses ( in meals),,,,,unk,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20160331.0,20211029.0,20211109,20211109,EXP,,BR-NOVOPROD-862710,NOVO NORDISK,,25.0,YR,,F,Y,53.0,KG,20211109.0,,MD,BR,BR,2021,Q4,Young Adult
200494901,20049490,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 to 4 IU doses ( in meals),,,,,unk,,,,,,,2021,Q4,Coronary artery disease,,2021,Q4,1,I,20160331.0,20211029.0,20211109,20211109,EXP,,BR-NOVOPROD-862710,NOVO NORDISK,,25.0,YR,,F,Y,53.0,KG,20211109.0,,MD,BR,BR,2021,Q4,Young Adult
200494901,20049490,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 to 4 IU doses ( in meals),,,,,unk,,,,,,,2021,Q4,Tonsillitis,,2021,Q4,1,I,20160331.0,20211029.0,20211109,20211109,EXP,,BR-NOVOPROD-862710,NOVO NORDISK,,25.0,YR,,F,Y,53.0,KG,20211109.0,,MD,BR,BR,2021,Q4,Young Adult
200494901,20049490,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 to 4 IU doses ( in meals),,,,,unk,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20160331.0,20211029.0,20211109,20211109,EXP,,BR-NOVOPROD-862710,NOVO NORDISK,,25.0,YR,,F,Y,53.0,KG,20211109.0,,MD,BR,BR,2021,Q4,Young Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Lung disorder,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Metabolic acidosis,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Throat irritation,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Thrombocytopenia,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Interleukin level increased,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Infusion related reaction,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,C-reactive protein increased,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Respiratory rate increased,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200500591,20050059,10,C,insulin detemir/insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,1,I,20211104.0,,20211109,20211109,DIR,590212,,FDA-CTU,,43.0,YR,,F,N,74.1,KG,20211109.0,N,PH,US,,2021,Q4,Adult
200529244,20052924,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding scale,,,,,,,,,,Unknown,TID,2021,Q4,Streptococcal bacteraemia,,2021,Q4,4,F,20211026.0,20211129.0,20211110,20211206,PER,,US-CELGENEUS-USA-20211101886,CELGENE,,78.0,YR,,F,Y,67.5,KG,20211206.0,,MD,US,US,2021,Q4,Elderly
200596741,20059674,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, daily",,,Y,,D277139,,20563.0,,,Injection,QD,2021,Q4,Injection site erythema,,2021,Q4,1,I,20211019.0,20211030.0,20211111,20211111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000943,ELI LILLY AND CO,,24.0,YR,,M,Y,43.0,KG,20211111.0,,CN,CN,CN,2021,Q4,Young Adult
200596741,20059674,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, daily",,,Y,,D277139,,20563.0,,,Injection,QD,2021,Q4,Injection site pain,,2021,Q4,1,I,20211019.0,20211030.0,20211111,20211111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000943,ELI LILLY AND CO,,24.0,YR,,M,Y,43.0,KG,20211111.0,,CN,CN,CN,2021,Q4,Young Adult
200596741,20059674,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, daily",,,Y,,D277139,,20563.0,,,Injection,QD,2021,Q4,Injection site induration,,2021,Q4,1,I,20211019.0,20211030.0,20211111,20211111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000943,ELI LILLY AND CO,,24.0,YR,,M,Y,43.0,KG,20211111.0,,CN,CN,CN,2021,Q4,Young Adult
200596741,20059674,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK UNK, daily",,,Y,,D277139,,20563.0,,,Injection,QD,2021,Q4,Injection site swelling,,2021,Q4,1,I,20211019.0,20211030.0,20211111,20211111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111000943,ELI LILLY AND CO,,24.0,YR,,M,Y,43.0,KG,20211111.0,,CN,CN,CN,2021,Q4,Young Adult
200609701,20060970,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, prn",,,U,,,,20563.0,5.0,IU,Injection,,2021,Q4,Inappropriate schedule of product administration,,2021,Q4,1,I,,20211021.0,20211112,20211112,PER,,US-ELI_LILLY_AND_COMPANY-US202110009765,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211112.0,,CN,US,US,2021,Q4,Adult
200609701,20060970,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, prn",,,U,,,,20563.0,5.0,IU,Injection,,2021,Q4,Wrong product administered,,2021,Q4,1,I,,20211021.0,20211112,20211112,PER,,US-ELI_LILLY_AND_COMPANY-US202110009765,ELI LILLY AND CO,,52.0,YR,,M,Y,,,20211112.0,,CN,US,US,2021,Q4,Adult
200625671,20062567,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Vid P-glukos }10 mmol/1 ge enheter/ml 6 E Insulin lispro extra Vid P-glukos }14 mmol/1 ge 8 E Insuli,,,,,,,,,,,,2021,Q4,Confusional state,,2021,Q4,1,I,20210209.0,20211102.0,20211112,20211112,EXP,SE-MPA-2021-091376,SE-ELI_LILLY_AND_COMPANY-SE202111001015,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211112.0,,CN,SE,SE,2021,Q4,Adult
200627101,20062710,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,1,I,20211001.0,,20211111,20211111,DIR,590577,,FDA-CTU,,62.0,YR,,M,N,131.4,KG,20211111.0,N,,US,,2021,Q4,Adult
200646721,20064672,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,30 units,,,,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211101.0,20211112,20211112,EXP,,RU-EMD Serono-9277425,EMD SERONO INC,"Pashkova E, Gezalyan M. It^s time to change stereotypes: a new look at fixed-mixtures insulins. Endokrinologiya: novosti, mneniya, obuchenie [Endocrinology: News, Opinions, Training].. 2021;10(3):59-65. doi:https://doi. org/10.33029/2304-9529-2021-10-3-59-65",60.0,YR,A,M,Y,,,20211112.0,,MD,RU,,2021,Q4,Adult
200668491,20066849,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 IU, qd",,,,U,,,,12.0,IU,,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20160601.0,20211101.0,20211115,20211115,EXP,,BR-NOVOPROD-863887,NOVO NORDISK,,9.0,YR,,F,Y,26.5,KG,20211115.0,,MD,BR,BR,2021,Q4,Child
200668491,20066849,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 IU, qd",,,,U,,,,12.0,IU,,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,20160601.0,20211101.0,20211115,20211115,EXP,,BR-NOVOPROD-863887,NOVO NORDISK,,9.0,YR,,F,Y,26.5,KG,20211115.0,,MD,BR,BR,2021,Q4,Child
200668491,20066849,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 IU, qd",,,,U,,,,12.0,IU,,QD,2021,Q4,Upper limb fracture,,2021,Q4,1,I,20160601.0,20211101.0,20211115,20211115,EXP,,BR-NOVOPROD-863887,NOVO NORDISK,,9.0,YR,,F,Y,26.5,KG,20211115.0,,MD,BR,BR,2021,Q4,Child
200668491,20066849,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 IU, qd",,,,U,,,,12.0,IU,,QD,2021,Q4,Arthritis bacterial,,2021,Q4,1,I,20160601.0,20211101.0,20211115,20211115,EXP,,BR-NOVOPROD-863887,NOVO NORDISK,,9.0,YR,,F,Y,26.5,KG,20211115.0,,MD,BR,BR,2021,Q4,Child
200668491,20066849,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 IU, qd",,,,U,,,,12.0,IU,,QD,2021,Q4,Pneumonia,,2021,Q4,1,I,20160601.0,20211101.0,20211115,20211115,EXP,,BR-NOVOPROD-863887,NOVO NORDISK,,9.0,YR,,F,Y,26.5,KG,20211115.0,,MD,BR,BR,2021,Q4,Child
200668491,20066849,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 IU, qd",,,,U,,,,12.0,IU,,QD,2021,Q4,Osteomyelitis,,2021,Q4,1,I,20160601.0,20211101.0,20211115,20211115,EXP,,BR-NOVOPROD-863887,NOVO NORDISK,,9.0,YR,,F,Y,26.5,KG,20211115.0,,MD,BR,BR,2021,Q4,Child
200699331,20069933,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q4,Completed suicide,,2021,Q4,1,I,20190101.0,20211101.0,20211115,20211115,EXP,,US-NORTHSTAR HEALTHCARE HOLDINGS-US-2021NSR000116,NORTHSTAR,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al.. 2019 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58(12):1360-1541",61.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
200699331,20069933,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2021,Q4,Toxicity to various agents,,2021,Q4,1,I,20190101.0,20211101.0,20211115,20211115,EXP,,US-NORTHSTAR HEALTHCARE HOLDINGS-US-2021NSR000116,NORTHSTAR,"Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Brooks DE, Dibert KW, et al.. 2019 Annual Report of the American Association of Poison Control Centers^ National Poison Data System (NPDS): 37th Annual Report. Clinical Toxicology. 2020;58(12):1360-1541",61.0,YR,,M,Y,,,20211115.0,,MD,US,US,2021,Q4,Adult
200706911,20070691,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,20211109.0,,20211115,20211115,DIR,590891,,FDA-CTU,,72.0,YR,,M,N,73.3,KG,20211115.0,N,PH,US,,2021,Q4,Elderly
200706911,20070691,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Unresponsive to stimuli,,2021,Q4,1,I,20211109.0,,20211115,20211115,DIR,590891,,FDA-CTU,,72.0,YR,,M,N,73.3,KG,20211115.0,N,PH,US,,2021,Q4,Elderly
200706911,20070691,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pulse absent,,2021,Q4,1,I,20211109.0,,20211115,20211115,DIR,590891,,FDA-CTU,,72.0,YR,,M,N,73.3,KG,20211115.0,N,PH,US,,2021,Q4,Elderly
200706911,20070691,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,1,I,20211109.0,,20211115,20211115,DIR,590891,,FDA-CTU,,72.0,YR,,M,N,73.3,KG,20211115.0,N,PH,US,,2021,Q4,Elderly
200706911,20070691,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Liver function test increased,,2021,Q4,1,I,20211109.0,,20211115,20211115,DIR,590891,,FDA-CTU,,72.0,YR,,M,N,73.3,KG,20211115.0,N,PH,US,,2021,Q4,Elderly
200755981,20075598,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Neurotoxicity,,2021,Q4,1,I,20211016.0,,20211116,20211116,DIR,591055,,FDA-CTU,,74.0,YR,,F,N,59.4,KG,20211116.0,N,,US,,2021,Q4,Elderly
200755981,20075598,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,1,I,20211016.0,,20211116,20211116,DIR,591055,,FDA-CTU,,74.0,YR,,F,N,59.4,KG,20211116.0,N,,US,,2021,Q4,Elderly
200818511,20081851,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Cytokine release syndrome,,2021,Q4,1,I,20210921.0,,20211117,20211117,DIR,591206,,FDA-CTU,,73.0,YR,,M,N,116.1,KG,20211117.0,N,,US,,2021,Q4,Elderly
200818511,20081851,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Neurotoxicity,,2021,Q4,1,I,20210921.0,,20211117,20211117,DIR,591206,,FDA-CTU,,73.0,YR,,M,N,116.1,KG,20211117.0,N,,US,,2021,Q4,Elderly
200827783,20082778,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24 United states pharmacopeia unit, 2x/day",,,,,,,,,,,BID,2021,Q4,Respiratory failure,,2021,Q4,3,F,20211109.0,20211214.0,20211117,20211223,EXP,,CN-PFIZER INC-202101578687,PFIZER,,76.0,YR,,M,Y,94.0,KG,20211223.0,,HP,CN,CN,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Musculoskeletal pain,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Sepsis,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829682,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,2,F,,20211111.0,20211117,20211124,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20211124.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Sepsis,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200829711,20082971,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Schema),,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1084344,MYLAN,,69.0,YR,,F,Y,93.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832231,20083223,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (nach Wert),,,U,U,,,,,,Injection,,2021,Q4,Cough,,2021,Q4,1,I,,20211113.0,20211117,20211117,EXP,DE-EMA-DD-20210526-Bisht_p-105858,DE-MYLANLABS-2021M1084721,MYLAN,,83.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832231,20083223,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (nach Wert),,,U,U,,,,,,Injection,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211113.0,20211117,20211117,EXP,DE-EMA-DD-20210526-Bisht_p-105858,DE-MYLANLABS-2021M1084721,MYLAN,,83.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832231,20083223,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (nach Wert),,,U,U,,,,,,Injection,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211113.0,20211117,20211117,EXP,DE-EMA-DD-20210526-Bisht_p-105858,DE-MYLANLABS-2021M1084721,MYLAN,,83.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832231,20083223,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (nach Wert),,,U,U,,,,,,Injection,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211113.0,20211117,20211117,EXP,DE-EMA-DD-20210526-Bisht_p-105858,DE-MYLANLABS-2021M1084721,MYLAN,,83.0,YR,,M,Y,,,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Hypertension,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Systemic infection,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Disorientation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832491,20083249,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083799,MYLAN,,75.0,YR,,M,Y,90.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832841,20083284,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,20210118.0,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083699,MYLAN,,79.0,YR,,M,Y,75.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832841,20083284,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Angina pectoris,,2021,Q4,1,I,20210118.0,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083699,MYLAN,,79.0,YR,,M,Y,75.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832841,20083284,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Bradycardia,,2021,Q4,1,I,20210118.0,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083699,MYLAN,,79.0,YR,,M,Y,75.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832841,20083284,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,20210118.0,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083699,MYLAN,,79.0,YR,,M,Y,75.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832841,20083284,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20210118.0,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083699,MYLAN,,79.0,YR,,M,Y,75.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200832841,20083284,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,20210118.0,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083699,MYLAN,,79.0,YR,,M,Y,75.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24-24-32-0, syringe cartridge",,,,,,,,,,Injection,,2021,Q4,Insomnia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24-24-32-0, syringe cartridge",,,,,,,,,,Injection,,2021,Q4,Tachycardia,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24-24-32-0, syringe cartridge",,,,,,,,,,Injection,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24-24-32-0, syringe cartridge",,,,,,,,,,Injection,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24-24-32-0, syringe cartridge",,,,,,,,,,Injection,,2021,Q4,Dehydration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833351,20083335,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 24-24-32-0, syringe cartridge",,,,,,,,,,Injection,,2021,Q4,Fall,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083879,MYLAN,,77.0,YR,,F,Y,79.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Elderly
200833411,20083341,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, Bedarf, Fertigspritzen)",,,,,,,,,,Injection,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, Bedarf, Fertigspritzen)",,,,,,,,,,Injection,,2021,Q4,Headache,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, Bedarf, Fertigspritzen)",,,,,,,,,,Injection,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, Bedarf, Fertigspritzen)",,,,,,,,,,Injection,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, Bedarf, Fertigspritzen)",,,,,,,,,,Injection,,2021,Q4,Jaundice,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, Bedarf, Fertigspritzen)",,,,,,,,,,Injection,,2021,Q4,Fatigue,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200833411,20083341,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, Bedarf, Fertigspritzen)",,,,,,,,,,Injection,,2021,Q4,Nausea,,2021,Q4,1,I,,20211111.0,20211117,20211117,EXP,,DE-MYLANLABS-2021M1083872,MYLAN,,55.0,YR,,F,Y,62.0,KG,20211117.0,,PH,DE,DE,2021,Q4,Adult
200840581,20084058,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,N,,,,,,,Solution for injection,,2021,Q4,Interstitial lung disease,,2021,Q4,1,I,20200101.0,20211112.0,20211118,20211118,EXP,FR-AFSSAPS-PV20213175,FR-SANOFI US-2021SA380366,SANOFI AVENTIS,,73.0,YR,E,M,Y,99.0,KG,20211118.0,,MD,FR,FR,2021,Q4,Elderly
200840581,20084058,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,N,,,,,,,Solution for injection,,2021,Q4,Pulmonary fibrosis,,2021,Q4,1,I,20200101.0,20211112.0,20211118,20211118,EXP,FR-AFSSAPS-PV20213175,FR-SANOFI US-2021SA380366,SANOFI AVENTIS,,73.0,YR,E,M,Y,99.0,KG,20211118.0,,MD,FR,FR,2021,Q4,Elderly
200870341,20087034,12,C,sliding scale insulin lispro,,2,,,,,,,,,,,,,,2021,Q4,Liver injury,,2021,Q4,1,I,20211111.0,,20211118,20211118,DIR,591406,,FDA-CTU,,56.0,YR,,M,N,80.1,KG,20211118.0,N,PH,US,,2021,Q4,Adult
200871852,20087185,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084108,MYLAN,,73.0,YR,,F,Y,100.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871852,20087185,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084108,MYLAN,,73.0,YR,,F,Y,100.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871852,20087185,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Flank pain,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084108,MYLAN,,73.0,YR,,F,Y,100.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871852,20087185,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Localised infection,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084108,MYLAN,,73.0,YR,,F,Y,100.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871852,20087185,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084108,MYLAN,,73.0,YR,,F,Y,100.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871852,20087185,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084108,MYLAN,,73.0,YR,,F,Y,100.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871852,20087185,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084108,MYLAN,,73.0,YR,,F,Y,100.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871892,20087189,12,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084105,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871892,20087189,12,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084105,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871892,20087189,12,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084105,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871892,20087189,12,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Renal pain,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084105,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871892,20087189,12,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084105,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871892,20087189,12,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Flank pain,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084105,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200871892,20087189,12,C,INSULIN LISPRO W/INSULIN LISPRO PROTAMINE SUS,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,2,F,,20211112.0,20211118,20211122,EXP,,DE-MYLANLABS-2021M1084105,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211122.0,,PH,DE,DE,2021,Q4,Elderly
200893132,20089313,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q4,Dementia,,2021,Q4,2,F,,20211126.0,20211119,20211126,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-139196",BOEHRINGER INGELHEIM,,85.0,YR,E,M,Y,45.0,KG,20211126.0,,MD,JP,JP,2021,Q4,Elderly
200893132,20089313,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2021,Q4,Therapeutic product effect incomplete,,2021,Q4,2,F,,20211126.0,20211119,20211126,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-139196",BOEHRINGER INGELHEIM,,85.0,YR,E,M,Y,45.0,KG,20211126.0,,MD,JP,JP,2021,Q4,Elderly
200898501,20089850,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Daily with each meal,,,,,,,,,,Solution for injection,QD,2021,Q4,Gastrointestinal inflammation,,2021,Q4,1,I,20211028.0,20211117.0,20211119,20211119,EXP,,PR-ABBVIE-21K-131-4168263-00,ABBVIE,,17.0,YR,,M,Y,,,20211119.0,,CN,COUNTRY NOT SPECIFIED,PR,2021,Q4,Youth
200910631,20091063,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,DE-MYLANLABS-2021M1084192,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211119.0,,PH,DE,DE,2021,Q4,Elderly
200910631,20091063,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,DE-MYLANLABS-2021M1084192,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211119.0,,PH,DE,DE,2021,Q4,Elderly
200910631,20091063,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,DE-MYLANLABS-2021M1084192,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211119.0,,PH,DE,DE,2021,Q4,Elderly
200910631,20091063,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Flank pain,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,DE-MYLANLABS-2021M1084192,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211119.0,,PH,DE,DE,2021,Q4,Elderly
200910631,20091063,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IE, 56-0-36-0",,,,,,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,DE-MYLANLABS-2021M1084192,MYLAN,,73.0,YR,,F,Y,95.0,KG,20211119.0,,PH,DE,DE,2021,Q4,Elderly
200912751,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,,,,,8.0,IU,Injection,BID,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,,,,,8.0,IU,Injection,BID,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,,,,,8.0,IU,Injection,BID,2021,Q4,Increased appetite,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,,,,,8.0,IU,Injection,BID,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,,,,,8.0,IU,Injection,BID,2021,Q4,Obesity,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,,,,,8.0,IU,Injection,BID,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,,,,,8.0,IU,Injection,BID,2021,Q4,Metabolic syndrome,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,,,,,15.0,IU,Injection,QD,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,,,,,15.0,IU,Injection,QD,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,,,,,15.0,IU,Injection,QD,2021,Q4,Increased appetite,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,,,,,15.0,IU,Injection,QD,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,,,,,15.0,IU,Injection,QD,2021,Q4,Obesity,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,,,,,15.0,IU,Injection,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,,,,,15.0,IU,Injection,QD,2021,Q4,Metabolic syndrome,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,,,,,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,,,,,,,Injection,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,,,,,,,Injection,,2021,Q4,Increased appetite,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,,,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,,,,,,,Injection,,2021,Q4,Obesity,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,,,,,,,Injection,,2021,Q4,Metabolic syndrome,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,,,,,,,Injection,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,,,,,,,Injection,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,,,,,,,Injection,,2021,Q4,Increased appetite,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,,,,,,,Injection,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,,,,,,,Injection,,2021,Q4,Obesity,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200912751,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,,,,,,,Injection,,2021,Q4,Metabolic syndrome,,2021,Q4,1,I,,20211112.0,20211119,20211119,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20211119.0,,HP,IT,IT,2021,Q4,Elderly
200916453,20091645,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q8h (start date: 17-Aug-2021) 100 unit/ml, 3 ml",,,,,,,,1.0,IU,Injection,Q8H,2021,Q4,Acute kidney injury,,2021,Q4,3,F,20210811.0,20211130.0,20211119,20211206,EXP,,ES-MYLANLABS-2021M1084633,MYLAN,,87.0,YR,,M,Y,72.0,KG,20211206.0,,HP,ES,ES,2021,Q4,Elderly
200916551,20091655,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,35 units in the morning and 25 units at night,,,,,,,,,,Injection,,2021,Q4,Wrong technique in product usage process,,2021,Q4,1,I,20210201.0,20211110.0,20211119,20211119,EXP,,NVSC2021EG259250,NOVARTIS,,46.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200916551,20091655,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,35 units in the morning and 25 units at night,,,,,,,,,,Injection,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,20210201.0,20211110.0,20211119,20211119,EXP,,NVSC2021EG259250,NOVARTIS,,46.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200916551,20091655,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,35 units in the morning and 25 units at night,,,,,,,,,,Injection,,2021,Q4,Blood cholesterol increased,,2021,Q4,1,I,20210201.0,20211110.0,20211119,20211119,EXP,,NVSC2021EG259250,NOVARTIS,,46.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200916551,20091655,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,35 units in the morning and 25 units at night,,,,,,,,,,Injection,,2021,Q4,Fatigue,,2021,Q4,1,I,20210201.0,20211110.0,20211119,20211119,EXP,,NVSC2021EG259250,NOVARTIS,,46.0,YR,,M,Y,,,20211119.0,,CN,EG,EG,2021,Q4,Adult
200921711,20092171,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,,,,,,Injection,TID,2021,Q4,Interstitial lung disease,,2021,Q4,1,I,20210804.0,20211115.0,20211119,20211119,EXP,,JP-MYLANLABS-2021M1081293,MYLAN,,83.0,YR,,M,Y,,,20211119.0,,MD,JP,JP,2021,Q4,Elderly
200921721,20092172,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,20211017.0,,20211119,20211119,DIR,591646,,FDA-CTU,,64.0,YR,,M,N,95.1,KG,20211119.0,N,,US,,2021,Q4,Adult
200921721,20092172,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,20211017.0,,20211119,20211119,DIR,591646,,FDA-CTU,,64.0,YR,,M,N,95.1,KG,20211119.0,N,,US,,2021,Q4,Adult
200921721,20092172,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Abscess,,2021,Q4,1,I,20211017.0,,20211119,20211119,DIR,591646,,FDA-CTU,,64.0,YR,,M,N,95.1,KG,20211119.0,N,,US,,2021,Q4,Adult
200921721,20092172,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Diverticulitis intestinal perforated,,2021,Q4,1,I,20211017.0,,20211119,20211119,DIR,591646,,FDA-CTU,,64.0,YR,,M,N,95.1,KG,20211119.0,N,,US,,2021,Q4,Adult
200921721,20092172,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,1,I,20211017.0,,20211119,20211119,DIR,591646,,FDA-CTU,,64.0,YR,,M,N,95.1,KG,20211119.0,N,,US,,2021,Q4,Adult
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pulmonary oedema,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Lung infiltration,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Oxygen saturation decreased,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Respiratory distress,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Electrocardiogram ST segment depression,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Troponin increased,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Electrocardiogram T wave inversion,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200959661,20095966,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Infusion related reaction,,2021,Q4,1,I,20211119.0,,20211120,20211120,DIR,591802,,FDA-CTU,,65.0,YR,,M,N,78.5,KG,20211120.0,N,PH,US,,2021,Q4,Elderly
200970621,20097062,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2021,Q4,Colitis,,2021,Q4,1,I,20210525.0,20211112.0,20211122,20211122,EXP,,US-CELGENEUS-USA-20211103835,CELGENE,,56.0,YR,,F,Y,,,20211122.0,,HP,US,US,2021,Q4,Adult
200979902,20097990,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 iU,,,Y,,,,,1.0,IU,Solution for injection,,2021,Q4,Abdominal pain,,2021,Q4,2,F,20210905.0,20211115.0,20211122,20211125,EXP,IT-MINISAL02-807518,IT-SA-2021SA381894,SANOFI AVENTIS,,11.0,YR,C,M,Y,,,20211125.0,,PH,IT,IT,2021,Q4,Child
200979902,20097990,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 iU,,,Y,,,,,1.0,IU,Solution for injection,,2021,Q4,Vomiting,,2021,Q4,2,F,20210905.0,20211115.0,20211122,20211125,EXP,IT-MINISAL02-807518,IT-SA-2021SA381894,SANOFI AVENTIS,,11.0,YR,C,M,Y,,,20211125.0,,PH,IT,IT,2021,Q4,Child
200979902,20097990,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 iU,,,Y,,,,,1.0,IU,Solution for injection,,2021,Q4,Hyperinsulinaemic hypoglycaemia,,2021,Q4,2,F,20210905.0,20211115.0,20211122,20211125,EXP,IT-MINISAL02-807518,IT-SA-2021SA381894,SANOFI AVENTIS,,11.0,YR,C,M,Y,,,20211125.0,,PH,IT,IT,2021,Q4,Child
200984491,20098449,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, prn",,,Y,,,,20563.0,1.0,IU,,,2021,Q4,Vomiting,,2021,Q4,1,I,20210905.0,20211110.0,20211122,20211122,EXP,IT-MINISAL02-807518,IT-ELI_LILLY_AND_COMPANY-IT202111004817,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20211122.0,,CN,IT,IT,2021,Q4,Child
200984491,20098449,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, prn",,,Y,,,,20563.0,1.0,IU,,,2021,Q4,Hyperinsulinaemic hypoglycaemia,,2021,Q4,1,I,20210905.0,20211110.0,20211122,20211122,EXP,IT-MINISAL02-807518,IT-ELI_LILLY_AND_COMPANY-IT202111004817,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20211122.0,,CN,IT,IT,2021,Q4,Child
200984491,20098449,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, prn",,,Y,,,,20563.0,1.0,IU,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,20210905.0,20211110.0,20211122,20211122,EXP,IT-MINISAL02-807518,IT-ELI_LILLY_AND_COMPANY-IT202111004817,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20211122.0,,CN,IT,IT,2021,Q4,Child
201105021,20110502,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20210501.0,20210617.0,20211124,20211124,PER,,US-NOVOPROD-823461,NOVO NORDISK,,66.0,YR,,M,Y,128.7,KG,20211124.0,,HP,US,US,2021,Q4,Elderly
201105021,20110502,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Extra dose administered,,2021,Q4,1,I,20210501.0,20210617.0,20211124,20211124,PER,,US-NOVOPROD-823461,NOVO NORDISK,,66.0,YR,,M,Y,128.7,KG,20211124.0,,HP,US,US,2021,Q4,Elderly
201105021,20110502,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,20210501.0,20210617.0,20211124,20211124,PER,,US-NOVOPROD-823461,NOVO NORDISK,,66.0,YR,,M,Y,128.7,KG,20211124.0,,HP,US,US,2021,Q4,Elderly
201118121,20111812,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Abdominal pain,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Thermal burn,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Injection site pain,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Abdominal pain,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Thermal burn,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,,,20563.0,5.0,IU,Injection,TID,2021,Q4,Injection site pain,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Abdominal pain,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Thermal burn,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Injection site pain,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Abdominal pain,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Thermal burn,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201118121,20111812,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, tid",,,U,,D371840A,,20563.0,5.0,IU,Injection,TID,2021,Q4,Injection site pain,,2021,Q4,1,I,20211025.0,20211026.0,20211125,20211125,PER,,US-ELI_LILLY_AND_COMPANY-US202110010946,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20211125.0,,CN,US,US,2021,Q4,Elderly
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Oedema peripheral,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Condition aggravated,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Nausea,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Cough,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Product availability issue,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Decreased appetite,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Haematemesis,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Abdominal distension,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Hepatic encephalopathy,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Urinary tract infection,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Fatigue,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201124322,20112432,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 Units/ml injectable solution, 3 unit , SUB-Q, Before meals",,,,,,,,,,Solution,Q8H,2021,Q4,Vomiting,,2021,Q4,2,F,20210101.0,20211119.0,20211125,20211202,EXP,,US-BAUSCH-BL-2021-038506,BAUSCH AND LOMB,,63.0,YR,,M,Y,102.27,KG,20211202.0,,MD,US,US,2021,Q4,Adult
201138703,20113870,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 DF (20 Units), qd",,,,,,,,,,,QD,2021,Q4,Pneumonia,,2021,Q4,3,F,20201201.0,20211209.0,20211125,20211213,EXP,,IT-GLAXOSMITHKLINE-IT2021GSK224286,GLAXOSMITHKLINE,,70.0,YR,,F,Y,82.0,KG,20211213.0,,MD,IT,IT,2021,Q4,Elderly
201162941,20116294,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D357990A,,20563.0,,,Solution for injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20211101.0,20211115.0,20211126,20211126,PER,,US-ELI_LILLY_AND_COMPANY-US202111007682,ELI LILLY AND CO,,5.0,YR,,,Y,,,20211126.0,,CN,US,US,2021,Q4,Child
201162941,20116294,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D357990A,,20563.0,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211101.0,20211115.0,20211126,20211126,PER,,US-ELI_LILLY_AND_COMPANY-US202111007682,ELI LILLY AND CO,,5.0,YR,,,Y,,,20211126.0,,CN,US,US,2021,Q4,Child
201162941,20116294,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D357990A,,20563.0,,,Solution for injection,,2021,Q4,Nasopharyngitis,,2021,Q4,1,I,20211101.0,20211115.0,20211126,20211126,PER,,US-ELI_LILLY_AND_COMPANY-US202111007682,ELI LILLY AND CO,,5.0,YR,,,Y,,,20211126.0,,CN,US,US,2021,Q4,Child
201162941,20116294,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D357990A,,20563.0,,,Solution for injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20211101.0,20211115.0,20211126,20211126,PER,,US-ELI_LILLY_AND_COMPANY-US202111007682,ELI LILLY AND CO,,5.0,YR,,,Y,,,20211126.0,,CN,US,US,2021,Q4,Child
201162941,20116294,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D357990A,,20563.0,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211101.0,20211115.0,20211126,20211126,PER,,US-ELI_LILLY_AND_COMPANY-US202111007682,ELI LILLY AND CO,,5.0,YR,,,Y,,,20211126.0,,CN,US,US,2021,Q4,Child
201162941,20116294,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D357990A,,20563.0,,,Solution for injection,,2021,Q4,Nasopharyngitis,,2021,Q4,1,I,20211101.0,20211115.0,20211126,20211126,PER,,US-ELI_LILLY_AND_COMPANY-US202111007682,ELI LILLY AND CO,,5.0,YR,,,Y,,,20211126.0,,CN,US,US,2021,Q4,Child
201186801,20118680,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2021,Q4,Death,,2021,Q4,1,I,20211002.0,20211123.0,20211126,20211126,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-126676,BRISTOL MYERS SQUIBB,,74.0,YR,,F,Y,,,20211126.0,,MD,US,US,2021,Q4,Elderly
201216381,20121638,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15-20 units, daily",,,U,,D318637A,,20563.0,,,Solution for injection,QD,2021,Q4,Incorrect product administration duration,,2021,Q4,1,I,20211101.0,20211122.0,20211128,20211128,PER,,US-ELI_LILLY_AND_COMPANY-US202111009722,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20211128.0,,CN,US,US,2021,Q4,Adult
201216381,20121638,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15-20 units, daily",,,U,,D318637A,,20563.0,,,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211101.0,20211122.0,20211128,20211128,PER,,US-ELI_LILLY_AND_COMPANY-US202111009722,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20211128.0,,CN,US,US,2021,Q4,Adult
201232732,20123273,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,unk,,,,,,,2021,Q4,Bacteraemia,,2021,Q4,2,F,20210101.0,20211125.0,20211129,20211206,EXP,,CA-NOVOPROD-867598,NOVO NORDISK,,70.0,YR,,M,Y,117.0,KG,20211206.0,,HP,CA,CA,2021,Q4,Elderly
201232732,20123273,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,unk,,,,,,,2021,Q4,Epigastric discomfort,,2021,Q4,2,F,20210101.0,20211125.0,20211129,20211206,EXP,,CA-NOVOPROD-867598,NOVO NORDISK,,70.0,YR,,M,Y,117.0,KG,20211206.0,,HP,CA,CA,2021,Q4,Elderly
201232732,20123273,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,unk,,,,,,,2021,Q4,Pancreatitis,,2021,Q4,2,F,20210101.0,20211125.0,20211129,20211206,EXP,,CA-NOVOPROD-867598,NOVO NORDISK,,70.0,YR,,M,Y,117.0,KG,20211206.0,,HP,CA,CA,2021,Q4,Elderly
201232732,20123273,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,unk,,,,,,,2021,Q4,Flatulence,,2021,Q4,2,F,20210101.0,20211125.0,20211129,20211206,EXP,,CA-NOVOPROD-867598,NOVO NORDISK,,70.0,YR,,M,Y,117.0,KG,20211206.0,,HP,CA,CA,2021,Q4,Elderly
201232732,20123273,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,unk,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,2,F,20210101.0,20211125.0,20211129,20211206,EXP,,CA-NOVOPROD-867598,NOVO NORDISK,,70.0,YR,,M,Y,117.0,KG,20211206.0,,HP,CA,CA,2021,Q4,Elderly
201232732,20123273,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,unk,,,,,,,2021,Q4,Abdominal distension,,2021,Q4,2,F,20210101.0,20211125.0,20211129,20211206,EXP,,CA-NOVOPROD-867598,NOVO NORDISK,,70.0,YR,,M,Y,117.0,KG,20211206.0,,HP,CA,CA,2021,Q4,Elderly
201247431,20124743,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, with meals",,,U,,,,20563.0,,,,,2021,Q4,Hepatitis acute,,2021,Q4,1,I,,20211116.0,20211129,20211129,EXP,,US-ELI_LILLY_AND_COMPANY-US202111007252,ELI LILLY AND CO,"Sasidharan Pillai S, Quintos J.B, Topor L.S..Acute Hepatitis due to Hepatic Glycogenosis After Insulin Overdose and Oral Glucose Administration in an Adolescent.Journal of the Endocrine Society 2021;5 (11):1-6.DOI:doi.org/10.1210/jendso/bvab142",16.0,YR,,M,Y,,,20211129.0,,MD,US,US,2021,Q4,Youth
201247431,20124743,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, with meals",,,U,,,,20563.0,,,,,2021,Q4,Glycogen storage disease type VIII,,2021,Q4,1,I,,20211116.0,20211129,20211129,EXP,,US-ELI_LILLY_AND_COMPANY-US202111007252,ELI LILLY AND CO,"Sasidharan Pillai S, Quintos J.B, Topor L.S..Acute Hepatitis due to Hepatic Glycogenosis After Insulin Overdose and Oral Glucose Administration in an Adolescent.Journal of the Endocrine Society 2021;5 (11):1-6.DOI:doi.org/10.1210/jendso/bvab142",16.0,YR,,M,Y,,,20211129.0,,MD,US,US,2021,Q4,Youth
201247431,20124743,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, with meals",,,U,,,,20563.0,,,,,2021,Q4,Overdose,,2021,Q4,1,I,,20211116.0,20211129,20211129,EXP,,US-ELI_LILLY_AND_COMPANY-US202111007252,ELI LILLY AND CO,"Sasidharan Pillai S, Quintos J.B, Topor L.S..Acute Hepatitis due to Hepatic Glycogenosis After Insulin Overdose and Oral Glucose Administration in an Adolescent.Journal of the Endocrine Society 2021;5 (11):1-6.DOI:doi.org/10.1210/jendso/bvab142",16.0,YR,,M,Y,,,20211129.0,,MD,US,US,2021,Q4,Youth
201247431,20124743,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, with meals",,,U,,,,20563.0,,,,,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,,20211116.0,20211129,20211129,EXP,,US-ELI_LILLY_AND_COMPANY-US202111007252,ELI LILLY AND CO,"Sasidharan Pillai S, Quintos J.B, Topor L.S..Acute Hepatitis due to Hepatic Glycogenosis After Insulin Overdose and Oral Glucose Administration in an Adolescent.Journal of the Endocrine Society 2021;5 (11):1-6.DOI:doi.org/10.1210/jendso/bvab142",16.0,YR,,M,Y,,,20211129.0,,MD,US,US,2021,Q4,Youth
201304601,20130460,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 dosage form, tid (Dose: 6 units 3 times per day)",,,U,U,,,,,,,TID,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088710,MYLAN,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S. Chest Pain Induced by Intravenous Nitroglycerin. Am-J-Ther 2020;27(3):e299-e301.",54.0,YR,,M,Y,,,20211130.0,,MD,US,US,2021,Q4,Adult
201304601,20130460,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 dosage form, tid (Dose: 6 units 3 times per day)",,,U,U,,,,,,,TID,2021,Q4,Off label use,,2021,Q4,1,I,,20211122.0,20211130,20211130,EXP,,US-MYLANLABS-2021M1088710,MYLAN,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S. Chest Pain Induced by Intravenous Nitroglycerin. Am-J-Ther 2020;27(3):e299-e301.",54.0,YR,,M,Y,,,20211130.0,,MD,US,US,2021,Q4,Adult
201309422,20130942,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2021,Q4,Cellulitis,,2021,Q4,2,F,20211115.0,20211228.0,20211130,20211229,EXP,,US-TAKEDA-2021TUS074817,TAKEDA,,80.0,YR,,M,Y,92.063,KG,20211229.0,,MD,US,US,2021,Q4,Elderly
201329501,20132950,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Heart rate increased,,2021,Q4,1,I,,20211122.0,20211201,20211201,EXP,,CA-TEVA-2021-CA-1981391,TEVA,,27.0,YR,A,F,Y,,,20211201.0,,PH,CA,CA,2021,Q4,Young Adult
201329501,20132950,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Oligohydramnios,,2021,Q4,1,I,,20211122.0,20211201,20211201,EXP,,CA-TEVA-2021-CA-1981391,TEVA,,27.0,YR,A,F,Y,,,20211201.0,,PH,CA,CA,2021,Q4,Young Adult
201329841,20132984,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 u, each morning, sliding scale",,,U,,D261904A,,20563.0,6.0,IU,Injection,QD,2021,Q4,Cataract,,2021,Q4,1,I,20211031.0,20211101.0,20211201,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001260,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
201329841,20132984,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 u, each morning, sliding scale",,,U,,D261904A,,20563.0,6.0,IU,Injection,QD,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211031.0,20211101.0,20211201,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001260,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
201329841,20132984,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 u, each morning, sliding scale",,,U,,D261904A,,20563.0,6.0,IU,Injection,QD,2021,Q4,Visual impairment,,2021,Q4,1,I,20211031.0,20211101.0,20211201,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001260,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
201329841,20132984,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 u, bid, sliding scale",,,U,,D261904A,,20563.0,9.0,IU,Injection,BID,2021,Q4,Cataract,,2021,Q4,1,I,20211031.0,20211101.0,20211201,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001260,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
201329841,20132984,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 u, bid, sliding scale",,,U,,D261904A,,20563.0,9.0,IU,Injection,BID,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211031.0,20211101.0,20211201,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001260,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
201329841,20132984,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 u, bid, sliding scale",,,U,,D261904A,,20563.0,9.0,IU,Injection,BID,2021,Q4,Visual impairment,,2021,Q4,1,I,20211031.0,20211101.0,20211201,20211201,PER,,US-ELI_LILLY_AND_COMPANY-US202111001260,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Elderly
201369031,20136903,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily (qd)",,,,,,,,,,,QD,2021,Q4,Tuberculosis,,2021,Q4,1,I,,20211122.0,20211201,20211201,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111010124,ELI LILLY AND CO,,55.0,YR,,M,Y,60.0,KG,20211201.0,,CN,CN,CN,2021,Q4,Adult
201369031,20136903,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily (qd)",,,,,,,,,,,QD,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211122.0,20211201,20211201,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111010124,ELI LILLY AND CO,,55.0,YR,,M,Y,60.0,KG,20211201.0,,CN,CN,CN,2021,Q4,Adult
201371252,20137125,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,2,F,20211025.0,20211220.0,20211201,20211221,EXP,,US-GILEAD-2021-0555074,GILEAD,,69.0,YR,E,F,Y,,,20211221.0,,HP,US,US,2021,Q4,Elderly
201371252,20137125,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,2,F,20211025.0,20211220.0,20211201,20211221,EXP,,US-GILEAD-2021-0555074,GILEAD,,69.0,YR,E,F,Y,,,20211221.0,,HP,US,US,2021,Q4,Elderly
201371252,20137125,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,2,F,20211025.0,20211220.0,20211201,20211221,EXP,,US-GILEAD-2021-0555074,GILEAD,,69.0,YR,E,F,Y,,,20211221.0,,HP,US,US,2021,Q4,Elderly
201376941,20137694,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D355431A,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211030.0,20211102.0,20211202,20211202,PER,,US-ELI_LILLY_AND_COMPANY-US202111004481,ELI LILLY AND CO,,37.0,YR,,F,Y,,,20211201.0,,CN,US,US,2021,Q4,Adult
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Blood urea increased,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Respiratory failure,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Hypocapnia,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Oral herpes,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Inflammation,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Lymphopenia,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Hyperlactacidaemia,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Pneumonia fungal,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201391261,20139126,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 UI/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Hypercreatinaemia,,2021,Q4,1,I,20191210.0,20211124.0,20211202,20211202,EXP,,FR-Orion Corporation ORION PHARMA-TREX2021-0114,ORION,,83.0,YR,,M,Y,97.0,KG,20211202.0,,HP,FR,,2021,Q4,Elderly
201397531,20139753,5,C,"insulin lispro, 1-21 Units, Q6H",,2,,,,,,,,,,,,,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20211122.0,,20211201,20211201,DIR,593263,,FDA-CTU,,67.0,YR,,F,N,74.5,KG,20211201.0,Y,,US,,2021,Q4,Elderly
201397531,20139753,5,C,"insulin lispro, 1-21 Units, Q6H",,2,,,,,,,,,,,,,,2021,Q4,Liver function test increased,,2021,Q4,1,I,20211122.0,,20211201,20211201,DIR,593263,,FDA-CTU,,67.0,YR,,F,N,74.5,KG,20211201.0,Y,,US,,2021,Q4,Elderly
201397531,20139753,5,C,"insulin lispro, 1-21 Units, Q6H",,2,,,,,,,,,,,,,,2021,Q4,Cord blood transplant therapy,,2021,Q4,1,I,20211122.0,,20211201,20211201,DIR,593263,,FDA-CTU,,67.0,YR,,F,N,74.5,KG,20211201.0,Y,,US,,2021,Q4,Elderly
201397531,20139753,5,C,"insulin lispro, 1-21 Units, Q6H",,2,,,,,,,,,,,,,,2021,Q4,Obstructive airways disorder,,2021,Q4,1,I,20211122.0,,20211201,20211201,DIR,593263,,FDA-CTU,,67.0,YR,,F,N,74.5,KG,20211201.0,Y,,US,,2021,Q4,Elderly
201397531,20139753,5,C,"insulin lispro, 1-21 Units, Q6H",,2,,,,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,1,I,20211122.0,,20211201,20211201,DIR,593263,,FDA-CTU,,67.0,YR,,F,N,74.5,KG,20211201.0,Y,,US,,2021,Q4,Elderly
201397531,20139753,5,C,"insulin lispro, 1-21 Units, Q6H",,2,,,,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,1,I,20211122.0,,20211201,20211201,DIR,593263,,FDA-CTU,,67.0,YR,,F,N,74.5,KG,20211201.0,Y,,US,,2021,Q4,Elderly
201397531,20139753,5,C,"insulin lispro, 1-21 Units, Q6H",,2,,,,,,,,,,,,,,2021,Q4,Blood stem cell transplant failure,,2021,Q4,1,I,20211122.0,,20211201,20211201,DIR,593263,,FDA-CTU,,67.0,YR,,F,N,74.5,KG,20211201.0,Y,,US,,2021,Q4,Elderly
201397531,20139753,5,C,"insulin lispro, 1-21 Units, Q6H",,2,,,,,,,,,,,,,,2021,Q4,Multiple organ dysfunction syndrome,,2021,Q4,1,I,20211122.0,,20211201,20211201,DIR,593263,,FDA-CTU,,67.0,YR,,F,N,74.5,KG,20211201.0,Y,,US,,2021,Q4,Elderly
201418902,20141890,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pneumonia bacterial,,2021,Q4,2,F,20210503.0,20211215.0,20211202,20211221,EXP,,US-GILEAD-2021-0558902,GILEAD,,56.0,YR,A,F,Y,,,20211221.0,,HP,US,US,2021,Q4,Adult
201447921,20144792,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20211201.0,20211202.0,20211203,20211203,PER,,US-ELI_LILLY_AND_COMPANY-US202112001363,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20211203.0,,CN,US,US,2021,Q4,Adult
201447921,20144792,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139A,,20563.0,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20211201.0,20211202.0,20211203,20211203,PER,,US-ELI_LILLY_AND_COMPANY-US202112001363,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20211203.0,,CN,US,US,2021,Q4,Adult
201450481,20145048,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Renal injury,,2021,Q4,1,I,20211021.0,20211123.0,20211203,20211203,EXP,,US-ELI_LILLY_AND_COMPANY-US202111010976,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20211203.0,,CN,US,US,2021,Q4,Elderly
201450481,20145048,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Fall,,2021,Q4,1,I,20211021.0,20211123.0,20211203,20211203,EXP,,US-ELI_LILLY_AND_COMPANY-US202111010976,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20211203.0,,CN,US,US,2021,Q4,Elderly
201450481,20145048,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D395986A,,20563.0,,,Injection,,2021,Q4,Renal injury,,2021,Q4,1,I,20211021.0,20211123.0,20211203,20211203,EXP,,US-ELI_LILLY_AND_COMPANY-US202111010976,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20211203.0,,CN,US,US,2021,Q4,Elderly
201450481,20145048,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D395986A,,20563.0,,,Injection,,2021,Q4,Fall,,2021,Q4,1,I,20211021.0,20211123.0,20211203,20211203,EXP,,US-ELI_LILLY_AND_COMPANY-US202111010976,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20211203.0,,CN,US,US,2021,Q4,Elderly
201459791,20145979,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Flank pain,,2021,Q4,1,I,20211123.0,,20211203,20211203,DIR,FDA-CDER-CTU-2021-91235,,FDA-CTU,,26.0,YR,,F,N,,,20211203.0,N,MD,US,,2021,Q4,Young Adult
201459791,20145979,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211123.0,,20211203,20211203,DIR,FDA-CDER-CTU-2021-91235,,FDA-CTU,,26.0,YR,,F,N,,,20211203.0,N,MD,US,,2021,Q4,Young Adult
201459791,20145979,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Somnolence,,2021,Q4,1,I,20211123.0,,20211203,20211203,DIR,FDA-CDER-CTU-2021-91235,,FDA-CTU,,26.0,YR,,F,N,,,20211203.0,N,MD,US,,2021,Q4,Young Adult
201459791,20145979,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pain in extremity,,2021,Q4,1,I,20211123.0,,20211203,20211203,DIR,FDA-CDER-CTU-2021-91235,,FDA-CTU,,26.0,YR,,F,N,,,20211203.0,N,MD,US,,2021,Q4,Young Adult
201459791,20145979,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211123.0,,20211203,20211203,DIR,FDA-CDER-CTU-2021-91235,,FDA-CTU,,26.0,YR,,F,N,,,20211203.0,N,MD,US,,2021,Q4,Young Adult
201486332,20148633,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,20 kiU,,,Y,,,,,20.0,KIU,Solution for injection,,2021,Q4,Syncope,,2021,Q4,2,F,20211028.0,20211202.0,20211204,20211209,EXP,IT-MINISAL02-813496,IT-SA-2021SA404304,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20211209.0,,MD,IT,IT,2021,Q4,Elderly
201486332,20148633,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,20 kiU,,,Y,,,,,20.0,KIU,Solution for injection,,2021,Q4,Hypoglycaemia,,2021,Q4,2,F,20211028.0,20211202.0,20211204,20211209,EXP,IT-MINISAL02-813496,IT-SA-2021SA404304,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20211209.0,,MD,IT,IT,2021,Q4,Elderly
201495271,20149527,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q4,Localised infection,,2021,Q4,1,I,20210901.0,20211130.0,20211205,20211205,EXP,GB-MHRA-EYC 00267774,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-141255",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,92.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201495271,20149527,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q4,Malaise,,2021,Q4,1,I,20210901.0,20211130.0,20211205,20211205,EXP,GB-MHRA-EYC 00267774,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-141255",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,92.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201495271,20149527,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2021,Q4,Toe amputation,,2021,Q4,1,I,20210901.0,20211130.0,20211205,20211205,EXP,GB-MHRA-EYC 00267774,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-141255",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,92.0,KG,20211206.0,,HP,GB,GB,2021,Q4,Elderly
201524651,20152465,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 0-6-0 IU",,,,,,,,,,Injection,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 0-6-0 IU",,,,,,,,,,Injection,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 0-6-0 IU",,,,,,,,,,Injection,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 0-6-0 IU",,,,,,,,,,Injection,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 international unit,,,,,,,,24.0,IU,Injection,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 international unit,,,,,,,,24.0,IU,Injection,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 international unit,,,,,,,,24.0,IU,Injection,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,24 international unit,,,,,,,,24.0,IU,Injection,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 0-7-0 IU",,,,,,,,,,Injection,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 0-7-0 IU",,,,,,,,,,Injection,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 0-7-0 IU",,,,,,,,,,Injection,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 0-7-0 IU",,,,,,,,,,Injection,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 international unit,,,,,,,,5.0,IU,Injection,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 international unit,,,,,,,,5.0,IU,Injection,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 international unit,,,,,,,,5.0,IU,Injection,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,5 international unit,,,,,,,,5.0,IU,Injection,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 26-0-16 IU",,,,,,,,,,Injection,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 26-0-16 IU",,,,,,,,,,Injection,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 26-0-16 IU",,,,,,,,,,Injection,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 26-0-16 IU",,,,,,,,,,Injection,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 international unit,,,,,,,,4.0,IU,Injection,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 international unit,,,,,,,,4.0,IU,Injection,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 international unit,,,,,,,,4.0,IU,Injection,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 international unit,,,,,,,,4.0,IU,Injection,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 international unit, qd, at lunch time at the dose of 4 IU",,,,,,,,4.0,IU,Injection,QD,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 international unit, qd, at lunch time at the dose of 4 IU",,,,,,,,4.0,IU,Injection,QD,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 international unit, qd, at lunch time at the dose of 4 IU",,,,,,,,4.0,IU,Injection,QD,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 international unit, qd, at lunch time at the dose of 4 IU",,,,,,,,4.0,IU,Injection,QD,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 20-0-8 IU to 24-0-14 IU",,,,,,,,,,Injection,,2021,Q4,Bile duct stone,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 20-0-8 IU to 24-0-14 IU",,,,,,,,,,Injection,,2021,Q4,Balanoposthitis,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 20-0-8 IU to 24-0-14 IU",,,,,,,,,,Injection,,2021,Q4,Diabetic neuropathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201524651,20152465,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, 20-0-8 IU to 24-0-14 IU",,,,,,,,,,Injection,,2021,Q4,Diabetic retinopathy,,2021,Q4,1,I,,20211130.0,20211206,20211206,EXP,,SK-MYLANLABS-2021M1089247,MYLAN,,66.0,YR,,M,Y,93.0,KG,20211206.0,,MD,SK,SK,2021,Q4,Elderly
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Therapeutic product effect variable,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Arteriosclerosis coronary artery,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Adverse event,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Abdominal hernia,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Staphylococcal infection,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Illness,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Pancreatic phlegmon,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Infected dermal cyst,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Diabetes mellitus,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Infusion related reaction,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Fatigue,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Lymphadenopathy mediastinal,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Haemoglobin decreased,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Product dose omission issue,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Malaise,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Immune-mediated dermatitis,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Hilar lymphadenopathy,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Weight decreased,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Renal procedural complication,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Dehydration,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Blood thyroid stimulating hormone increased,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Autoimmune pancreatitis,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Blood iron decreased,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Clostridium difficile colitis,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Malignant neoplasm progression,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Neuropathy peripheral,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Pseudocyst,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Serum ferritin increased,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Bile duct stenosis,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Blood glucose increased,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201534433,20153443,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 units before supper,,,,,,,,,,,,2021,Q4,Cholangitis acute,,2021,Q4,3,F,20180730.0,20211217.0,20211206,20211222,EXP,,US-009507513-2112USA001258,MERCK,,57.0,YR,,M,Y,80.6,KG,20211222.0,,CN,US,US,2021,Q4,Adult
201564641,20156464,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 dosage form,,,N,,,,,,,,,2021,Q4,Ovarian cyst,,2021,Q4,1,I,20150318.0,20211203.0,20211207,20211207,EXP,,US-TAKEDA-US-001763,TAKEDA,,56.0,YR,,F,Y,97.959,KG,20211207.0,,MD,US,US,2021,Q4,Adult
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Pneumonia fungal,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Hyperlactacidaemia,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Lymphopenia,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Inflammation,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Oral herpes,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Hypercreatinaemia,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Off label use,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Respiratory failure,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Blood urea increased,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201569531,20156953,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 IU/ml, according to blood glucose level",,,,,,,,,,,,2021,Q4,Hypocapnia,,2021,Q4,1,I,20191210.0,20211124.0,20211207,20211207,EXP,,FR-PFIZER INC-202101713656,PFIZER,,83.0,YR,,M,Y,97.0,KG,20211207.0,,HP,FR,FR,2021,Q4,Elderly
201570631,20157063,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 units, tid",,,,,,,,,,,,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211130.0,20211207,20211207,EXP,,US-AMERICAN REGENT INC-2021003169,AMERICAN REGENT,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S. Chest Pain Induced by Intravenous Nitroglycerin. American Journal of Therapeutics. 2020;27(3):e299-e301",54.0,YR,,M,Y,,,20211207.0,,MD,US,US,2021,Q4,Adult
201570631,20157063,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 units, tid",,,,,,,,,,,,2021,Q4,Product use in unapproved indication,,2021,Q4,1,I,,20211130.0,20211207,20211207,EXP,,US-AMERICAN REGENT INC-2021003169,AMERICAN REGENT,"Saeed M, Gil GS, Lopez PD, Visco F, Pekler G, Mushiyev S. Chest Pain Induced by Intravenous Nitroglycerin. American Journal of Therapeutics. 2020;27(3):e299-e301",54.0,YR,,M,Y,,,20211207.0,,MD,US,US,2021,Q4,Adult
201574862,20157486,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2021,Q4,Oedema,,2021,Q4,2,F,20211115.0,20211214.0,20211207,20211217,EXP,,US-TAKEDA-2021TUS076261,TAKEDA,,73.0,YR,,M,Y,118.91,KG,20211217.0,,MD,US,US,2021,Q4,Elderly
201609611,20160961,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Insomnia,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown(re-started)",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Drug ineffective,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown(re-started)",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown(re-started)",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Insomnia,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown(re-started)",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Incorrect dose administered,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201609611,20160961,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown(re-started)",,,Y,,D261904A,,20563.0,,,Injection,,2021,Q4,Blood glucose decreased,,2021,Q4,1,I,20211107.0,20211108.0,20211208,20211208,PER,,US-ELI_LILLY_AND_COMPANY-US202111003763,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20211208.0,,CN,US,US,2021,Q4,Adult
201618811,20161881,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",48.0,IU,U,,D312549A,,20563.0,8.0,IU,Injection,TID,2021,Q4,Hypokalaemia,,2021,Q4,1,I,20211101.0,20211125.0,20211208,20211208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111011999,ELI LILLY AND CO,,77.0,YR,,F,Y,70.0,KG,20211208.0,,CN,CN,CN,2021,Q4,Elderly
201618811,20161881,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",48.0,IU,U,,D312549A,,20563.0,8.0,IU,Injection,TID,2021,Q4,Hypoglycaemia,,2021,Q4,1,I,20211101.0,20211125.0,20211208,20211208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111011999,ELI LILLY AND CO,,77.0,YR,,F,Y,70.0,KG,20211208.0,,CN,CN,CN,2021,Q4,Elderly
201618811,20161881,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",48.0,IU,U,,D312549A,,20563.0,8.0,IU,Injection,TID,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211101.0,20211125.0,20211208,20211208,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202111011999,ELI LILLY AND CO,,77.0,YR,,F,Y,70.0,KG,20211208.0,,CN,CN,CN,2021,Q4,Elderly
201643371,20164337,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Diabetes mellitus inadequate control,,2021,Q4,1,I,,20211129.0,20211209,20211209,EXP,,CA-TEVA-2021-CA-1984239,TEVA,,88.0,YR,E,F,Y,,,20211209.0,,PH,CA,CA,2021,Q4,Elderly
201643371,20164337,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211129.0,20211209,20211209,EXP,,CA-TEVA-2021-CA-1984239,TEVA,,88.0,YR,E,F,Y,,,20211209.0,,PH,CA,CA,2021,Q4,Elderly
201671941,20167194,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D371840A,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211206.0,20211207.0,20211209,20211209,PER,,US-ELI_LILLY_AND_COMPANY-US202112004022,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20211209.0,,CN,US,US,2021,Q4,Elderly
201738301,20173830,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12 units Tid,,,U,,,,,,,,,2021,Q4,Infusion related reaction,,2021,Q4,1,I,20211207.0,20211209.0,20211213,20211213,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-134042,BRISTOL MYERS SQUIBB,,61.0,YR,,F,Y,90.3,KG,20211213.0,,HP,US,US,2021,Q4,Adult
201739291,20173929,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Headache,,2021,Q4,1,I,20211207.0,20211208.0,20211213,20211213,PER,,US-ELI_LILLY_AND_COMPANY-US202112004851,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20211213.0,,CN,US,US,2021,Q4,Adult
201739291,20173929,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Malaise,,2021,Q4,1,I,20211207.0,20211208.0,20211213,20211213,PER,,US-ELI_LILLY_AND_COMPANY-US202112004851,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20211213.0,,CN,US,US,2021,Q4,Adult
201739291,20173929,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Stress,,2021,Q4,1,I,20211207.0,20211208.0,20211213,20211213,PER,,US-ELI_LILLY_AND_COMPANY-US202112004851,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20211213.0,,CN,US,US,2021,Q4,Adult
201739291,20173929,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2021,Q4,Gastric disorder,,2021,Q4,1,I,20211207.0,20211208.0,20211213,20211213,PER,,US-ELI_LILLY_AND_COMPANY-US202112004851,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20211213.0,,CN,US,US,2021,Q4,Adult
201741231,20174123,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Protrusion tongue,,2021,Q4,1,I,20210810.0,20211130.0,20211213,20211213,PER,,US-TEVA-2021-US-1984429,TEVA,,66.0,YR,E,F,Y,63.4,KG,20211213.0,,HP,US,US,2021,Q4,Elderly
201741231,20174123,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Dyskinesia,,2021,Q4,1,I,20210810.0,20211130.0,20211213,20211213,PER,,US-TEVA-2021-US-1984429,TEVA,,66.0,YR,E,F,Y,63.4,KG,20211213.0,,HP,US,US,2021,Q4,Elderly
201776731,20177673,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 iU, BID",812.0,IU,Y,,D293492C,,,14.0,IU,Injection,Q12H,2021,Q4,Hypoglycaemic coma,,2021,Q4,1,I,20211029.0,20211204.0,20211213,20211213,EXP,,CN-SA-2021SA409484,SANOFI AVENTIS,,67.0,YR,E,F,Y,51.0,KG,20211213.0,,HP,CN,CN,2021,Q4,Elderly
201776731,20177673,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 iU, BID",812.0,IU,Y,,D293492C,,,14.0,IU,Injection,Q12H,2021,Q4,Urinary incontinence,,2021,Q4,1,I,20211029.0,20211204.0,20211213,20211213,EXP,,CN-SA-2021SA409484,SANOFI AVENTIS,,67.0,YR,E,F,Y,51.0,KG,20211213.0,,HP,CN,CN,2021,Q4,Elderly
201776731,20177673,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 iU, BID",812.0,IU,Y,,D293492C,,,14.0,IU,Injection,Q12H,2021,Q4,Loss of consciousness,,2021,Q4,1,I,20211029.0,20211204.0,20211213,20211213,EXP,,CN-SA-2021SA409484,SANOFI AVENTIS,,67.0,YR,E,F,Y,51.0,KG,20211213.0,,HP,CN,CN,2021,Q4,Elderly
201789111,20178911,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q4,Choking,,2021,Q4,1,I,,20211203.0,20211214,20211214,EXP,RU-RZN-1262105,RU-NOVOPROD-873903,NOVO NORDISK,,80.0,YR,,F,Y,80.0,KG,20211214.0,,MD,RU,RU,2021,Q4,Elderly
201789111,20178911,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q4,Blood pressure increased,,2021,Q4,1,I,,20211203.0,20211214,20211214,EXP,RU-RZN-1262105,RU-NOVOPROD-873903,NOVO NORDISK,,80.0,YR,,F,Y,80.0,KG,20211214.0,,MD,RU,RU,2021,Q4,Elderly
201789111,20178911,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q4,Injection site pruritus,,2021,Q4,1,I,,20211203.0,20211214,20211214,EXP,RU-RZN-1262105,RU-NOVOPROD-873903,NOVO NORDISK,,80.0,YR,,F,Y,80.0,KG,20211214.0,,MD,RU,RU,2021,Q4,Elderly
201789111,20178911,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,U,,,,,,,,2021,Q4,Injection site erythema,,2021,Q4,1,I,,20211203.0,20211214,20211214,EXP,RU-RZN-1262105,RU-NOVOPROD-873903,NOVO NORDISK,,80.0,YR,,F,Y,80.0,KG,20211214.0,,MD,RU,RU,2021,Q4,Elderly
201816481,20181648,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211212.0,20211213.0,20211214,20211214,PER,,US-ELI_LILLY_AND_COMPANY-US202112006026,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20211214.0,,CN,US,US,2021,Q4,Adult
201816481,20181648,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211212.0,20211213.0,20211214,20211214,PER,,US-ELI_LILLY_AND_COMPANY-US202112006026,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20211214.0,,CN,US,US,2021,Q4,Adult
201816481,20181648,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D261904A,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211212.0,20211213.0,20211214,20211214,PER,,US-ELI_LILLY_AND_COMPANY-US202112006026,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20211214.0,,CN,US,US,2021,Q4,Adult
201828582,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,2,F,20211206.0,20211210.0,20211214,20211216,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20211216.0,,MD,US,,2021,Q4,Elderly
201828582,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Ischaemic stroke,,2021,Q4,2,F,20211206.0,20211210.0,20211214,20211216,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20211216.0,,MD,US,,2021,Q4,Elderly
201828582,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pneumonia bacterial,,2021,Q4,2,F,20211206.0,20211210.0,20211214,20211216,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20211216.0,,MD,US,,2021,Q4,Elderly
201828582,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Thrombocytopenia,,2021,Q4,2,F,20211206.0,20211210.0,20211214,20211216,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20211216.0,,MD,US,,2021,Q4,Elderly
201828582,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,2,F,20211206.0,20211210.0,20211214,20211216,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20211216.0,,MD,US,,2021,Q4,Elderly
201828582,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Death,,2021,Q4,2,F,20211206.0,20211210.0,20211214,20211216,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20211216.0,,MD,US,,2021,Q4,Elderly
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Mental status changes,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Syncope,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Hypercapnia,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Haemorrhage intracranial,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pneumonia,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Facial paralysis,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Diverticulum,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Hypoxia,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Sleep apnoea syndrome,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201873371,20187337,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Brain stem haemorrhage,,2021,Q4,1,I,20211109.0,,20211214,20211214,DIR,595015,,FDA-CTU,,58.0,YR,,M,N,151.0,KG,20211214.0,N,PH,US,,2021,Q4,Adult
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945581,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, other",,,U,,,,20563.0,,,,,2021,Q4,Product administration error,,2021,Q4,1,I,,20211209.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Elderly
201945631,20194563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2021,Q4,Cardiac failure congestive,,2021,Q4,1,I,20200501.0,20211209.0,20211216,20211216,EXP,,US-ELI_LILLY_AND_COMPANY-US202112004894,ELI LILLY AND CO,,37.0,YR,,M,Y,,,20211216.0,,CN,US,US,2021,Q4,Adult
201945863,20194586,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 - 18 - 0 /jour,,,N,,,,,,,Solution for injection,,2021,Q4,Vitamin B12 deficiency,,2021,Q4,3,F,20201105.0,20211210.0,20211216,20211223,EXP,FR-AFSSAPS-AM20201369,FR-SA-2021SA417467,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20211223.0,,MD,FR,FR,2021,Q4,Elderly
201947411,20194741,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Productive cough,,2021,Q4,1,I,20211201.0,,20211216,20211216,DIR,595241,,FDA-CTU,,62.0,YR,,M,N,162.45,KG,20211216.0,Y,,US,,2021,Q4,Adult
201947411,20194741,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211201.0,,20211216,20211216,DIR,595241,,FDA-CTU,,62.0,YR,,M,N,162.45,KG,20211216.0,Y,,US,,2021,Q4,Adult
201947411,20194741,4,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2021,Q4,Body temperature increased,,2021,Q4,1,I,20211201.0,,20211216,20211216,DIR,595241,,FDA-CTU,,62.0,YR,,M,N,162.45,KG,20211216.0,Y,,US,,2021,Q4,Adult
201952061,20195206,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNKNOWN,,,,,Injection,,2021,Q4,Febrile neutropenia,,2021,Q4,1,I,,20211206.0,20211216,20211216,EXP,,CA-Fresenius Kabi-FK202113999,FRESENIUS KABI,,60.0,YR,,M,Y,97.0,KG,20211216.0,,HP,CA,CA,2021,Q4,Adult
201952061,20195206,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNKNOWN,,,,,Injection,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211206.0,20211216,20211216,EXP,,CA-Fresenius Kabi-FK202113999,FRESENIUS KABI,,60.0,YR,,M,Y,97.0,KG,20211216.0,,HP,CA,CA,2021,Q4,Adult
201963381,20196338,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201963381,20196338,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, unknown",,,U,,,,20563.0,300.0,IU,,,2021,Q4,Pain,,2021,Q4,1,I,,20211210.0,20211216,20211216,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20211216.0,,CN,DE,DE,2021,Q4,Adult
201985371,20198537,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2115634US,ALLERGAN,,61.0,YR,,M,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985371,20198537,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Hyperhidrosis,,2021,Q4,1,I,,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2115634US,ALLERGAN,,61.0,YR,,M,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985371,20198537,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Product quality issue,,2021,Q4,1,I,,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2115634US,ALLERGAN,,61.0,YR,,M,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
201985371,20198537,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20210426.0,20211217,20211217,PER,,US-ALLERGAN-2115634US,ALLERGAN,,61.0,YR,,M,Y,,,20211217.0,,PH,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Hypotension,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Hypophagia,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Asthenia,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Atrioventricular block,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Syncope,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Faeces discoloured,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Diarrhoea haemorrhagic,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Acute myocardial infarction,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Rectal haemorrhage,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202027691,20202769,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2021,Q4,Lower gastrointestinal haemorrhage,,2021,Q4,1,I,,20211208.0,20211218,20211218,EXP,,US-SA-2021SA419342,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20211218.0,,CN,US,US,2021,Q4,Adult
202040751,20204075,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"0.4-0.6U/h as basic dose, and 4-6U 5 minutes before the three meals",,,,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,CN-BEH-2021139301,CSL BEHRING,,36.0,YR,A,M,Y,,,20211220.0,,HP,CN,CN,2021,Q4,Adult
202040751,20204075,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"0.4-0.6U/h as basic dose, and 4-6U 5 minutes before the three meals",,,,,,,,,,,,2021,Q4,Cardiac failure,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,CN-BEH-2021139301,CSL BEHRING,,36.0,YR,A,M,Y,,,20211220.0,,HP,CN,CN,2021,Q4,Adult
202040751,20204075,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"0.4-0.6U/h as basic dose, and 4-6U 5 minutes before the three meals",,,,,,,,,,,,2021,Q4,Pruritus,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,CN-BEH-2021139301,CSL BEHRING,,36.0,YR,A,M,Y,,,20211220.0,,HP,CN,CN,2021,Q4,Adult
202040751,20204075,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"0.4-0.6U/h as basic dose, and 4-6U 5 minutes before the three meals",,,,,,,,,,,,2021,Q4,Rales,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,CN-BEH-2021139301,CSL BEHRING,,36.0,YR,A,M,Y,,,20211220.0,,HP,CN,CN,2021,Q4,Adult
202040751,20204075,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"0.4-0.6U/h as basic dose, and 4-6U 5 minutes before the three meals",,,,,,,,,,,,2021,Q4,Tachypnoea,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,CN-BEH-2021139301,CSL BEHRING,,36.0,YR,A,M,Y,,,20211220.0,,HP,CN,CN,2021,Q4,Adult
202040751,20204075,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"0.4-0.6U/h as basic dose, and 4-6U 5 minutes before the three meals",,,,,,,,,,,,2021,Q4,Hypersensitivity,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,CN-BEH-2021139301,CSL BEHRING,,36.0,YR,A,M,Y,,,20211220.0,,HP,CN,CN,2021,Q4,Adult
202040751,20204075,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"0.4-0.6U/h as basic dose, and 4-6U 5 minutes before the three meals",,,,,,,,,,,,2021,Q4,Rash,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,CN-BEH-2021139301,CSL BEHRING,,36.0,YR,A,M,Y,,,20211220.0,,HP,CN,CN,2021,Q4,Adult
202048451,20204845,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202048451,20204845,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Scheme),,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-AUROBINDO-AUR-APL-2021-051832,AUROBINDO,,78.0,YR,,F,Y,,,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Product administration error,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Treatment noncompliance,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202057291,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,U,,unknown,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211209.0,20211220,20211220,EXP,,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202059021,20205902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Hypercalcaemia,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059021,20205902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Mycobacterium kansasii infection,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059021,20205902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Pancytopenia,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059021,20205902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059021,20205902,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Acute kidney injury,,2021,Q4,1,I,,20211210.0,20211220,20211220,EXP,,US-Accord-247465,ACCORD,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021 Nov 30;14(11):e245800",6.0,DEC,,M,Y,,,20211220.0,,MD,US,US,2021,Q4,Child
202059841,20205984,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,20211210.0,,20211217,20211217,DIR,595529,,FDA-CTU,,72.0,YR,,M,N,99.0,KG,20211217.0,N,PH,US,,2021,Q4,Elderly
202059841,20205984,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Infusion site extravasation,,2021,Q4,1,I,20211210.0,,20211217,20211217,DIR,595529,,FDA-CTU,,72.0,YR,,M,N,99.0,KG,20211217.0,N,PH,US,,2021,Q4,Elderly
202059841,20205984,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2021,Q4,Infusion site swelling,,2021,Q4,1,I,20211210.0,,20211217,20211217,DIR,595529,,FDA-CTU,,72.0,YR,,M,N,99.0,KG,20211217.0,N,PH,US,,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,Electrocardiogram abnormal,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,Hyperglycaemia,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,Renal impairment,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,Product administration error,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202062631,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211214.0,20211220,20211220,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Elderly
202063091,20206309,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,300.0,IU,Injection/infusion solution,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144923,DR REDDYS,,62.0,YR,A,M,Y,124.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Adult
202063091,20206309,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,300.0,IU,Injection/infusion solution,,2021,Q4,Contraindicated product administered,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144923,DR REDDYS,,62.0,YR,A,M,Y,124.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Adult
202063091,20206309,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,300.0,IU,Injection/infusion solution,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211215.0,20211220,20211220,EXP,,DE-drreddys-SPO/GER/21/0144923,DR REDDYS,,62.0,YR,A,M,Y,124.0,KG,20211220.0,,PH,DE,DE,2021,Q4,Adult
202102691,20210269,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286549,NOVARTIS,,79.0,YR,,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202102691,20210269,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Product monitoring error,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286549,NOVARTIS,,79.0,YR,,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202102691,20210269,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286549,NOVARTIS,,79.0,YR,,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202102691,20210269,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286549,NOVARTIS,,79.0,YR,,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202102691,20210269,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286549,NOVARTIS,,79.0,YR,,M,Y,,,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,Upper gastrointestinal haemorrhage,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,Frequent bowel movements,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,Product monitoring error,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,Product prescribing error,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,Faeces discoloured,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202105441,20210544,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,,Unknown,,,,,,Q8H,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,"DE-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-143179",BOEHRINGER INGELHEIM,,79.0,YR,E,M,Y,90.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Elderly
202108211,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202108211,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2021,Q4,Pain,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202108211,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2021,Q4,Therapeutic drug monitoring analysis not performed,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,Chills,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,Headache,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202122431,20212243,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, unknown",,,,,,,,1.0,IU,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006291,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Adult
202123651,20212365,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286121,NOVARTIS,,62.0,YR,,M,Y,124.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202123651,20212365,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286121,NOVARTIS,,62.0,YR,,M,Y,124.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202123651,20212365,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2021,Q4,Contraindicated product administered,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,NVSC2021DE286121,NOVARTIS,,62.0,YR,,M,Y,124.0,KG,20211221.0,,PH,DE,DE,2021,Q4,Adult
202135391,20213539,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"600|3 IE/ml, 18-24-25-0, Injektions-/Infusionsl?sung",,,U,,,,20563.0,,,,,2021,Q4,Wrong product administered,,2021,Q4,1,I,20210808.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006312,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202135391,20213539,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"600|3 IE/ml, 18-24-25-0, Injektions-/Infusionsl?sung",,,U,,,,20563.0,,,,,2021,Q4,Fear of disease,,2021,Q4,1,I,20210808.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006312,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202135391,20213539,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"600|3 IE/ml, 18-24-25-0, Injektions-/Infusionsl?sung",,,U,,,,20563.0,,,,,2021,Q4,Anxiety,,2021,Q4,1,I,20210808.0,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006312,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202135531,20213553,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D3959346A,,,,,Injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210301.0,20211214.0,20211221,20211221,EXP,,US-ELI_LILLY_AND_COMPANY-US202112006439,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Adult
202135531,20213553,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D3959346A,,,,,Injection,,2021,Q4,Injection site bruising,,2021,Q4,1,I,20210301.0,20211214.0,20211221,20211221,EXP,,US-ELI_LILLY_AND_COMPANY-US202112006439,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Adult
202135531,20213553,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D371847A,,,,,Injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20210301.0,20211214.0,20211221,20211221,EXP,,US-ELI_LILLY_AND_COMPANY-US202112006439,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Adult
202135531,20213553,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D371847A,,,,,Injection,,2021,Q4,Injection site bruising,,2021,Q4,1,I,20210301.0,20211214.0,20211221,20211221,EXP,,US-ELI_LILLY_AND_COMPANY-US202112006439,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20211221.0,,CN,US,US,2021,Q4,Adult
202135611,20213561,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (1 IE, 6-6-8-0, Injektions)",,,U,,,,20563.0,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006308,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202135611,20213561,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (1 IE, 6-6-8-0, Injektions)",,,U,,,,20563.0,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006308,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202135611,20213561,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (1 IE, 6-6-8-0, Injektions)",,,U,,,,20563.0,,,,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006308,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202135611,20213561,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (1 IE, 6-6-8-0, Injektions)",,,U,,,,20563.0,,,,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006308,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202135611,20213561,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (1 IE, 6-6-8-0, Injektions)",,,U,,,,20563.0,,,,,2021,Q4,Product monitoring error,,2021,Q4,1,I,,20211213.0,20211221,20211221,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006308,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20211221.0,,CN,DE,DE,2021,Q4,Elderly
202141601,20214160,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18-24-25 iU,,,D,,,,209196.0,,,,,2021,Q4,Fear of disease,,2021,Q4,1,I,20210808.0,20211216.0,20211221,20211221,EXP,DE-ADRED-07410-01,DE-SA-2021SA423163,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20211221.0,,MD,DE,DE,2021,Q4,Elderly
202141601,20214160,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18-24-25 iU,,,D,,,,209196.0,,,,,2021,Q4,Wrong product administered,,2021,Q4,1,I,20210808.0,20211216.0,20211221,20211221,EXP,DE-ADRED-07410-01,DE-SA-2021SA423163,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20211221.0,,MD,DE,DE,2021,Q4,Elderly
202141601,20214160,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18-24-25 iU,,,D,,,,209196.0,,,,,2021,Q4,Anxiety,,2021,Q4,1,I,20210808.0,20211216.0,20211221,20211221,EXP,DE-ADRED-07410-01,DE-SA-2021SA423163,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20211221.0,,MD,DE,DE,2021,Q4,Elderly
202162071,20216207,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202162071,20216207,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,DE-ADRED-05958-07,NVSC2021DE285445,NOVARTIS,,78.0,YR,,F,Y,,,20211222.0,,PH,DE,DE,2021,Q4,Elderly
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202171391,20217139,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, after solution for injection/infusion",,,,,UNKNOWN,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211213.0,20211222,20211222,EXP,,DE-Fresenius Kabi-FK202114175,FRESENIUS KABI,,64.0,YR,,M,Y,,,20211222.0,,HP,NL,DE,2021,Q4,Adult
202191352,20219135,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,2,F,20211120.0,20211222.0,20211222,20211230,EXP,,US-PFIZER INC-202101806399,PFIZER,,71.0,YR,,F,Y,115.0,KG,20211230.0,,HP,US,US,2021,Q4,Elderly
202191352,20219135,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Respiratory distress,,2021,Q4,2,F,20211120.0,20211222.0,20211222,20211230,EXP,,US-PFIZER INC-202101806399,PFIZER,,71.0,YR,,F,Y,115.0,KG,20211230.0,,HP,US,US,2021,Q4,Elderly
202197241,20219724,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Hordeolum,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Helicobacter gastritis,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Muscle spasms,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Vision blurred,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Pancreatic atrophy,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,D390489A,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Hordeolum,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,D390489A,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Helicobacter gastritis,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,D390489A,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,D390489A,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Muscle spasms,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,D390489A,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,D390489A,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Vision blurred,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,D390489A,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Pancreatic atrophy,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Hordeolum,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Helicobacter gastritis,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Drug ineffective,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Muscle spasms,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Vision blurred,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202197241,20219724,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"65 u, daily",,,,,ASKU,,20563.0,65.0,IU,Solution for injection,QD,2021,Q4,Pancreatic atrophy,,2021,Q4,1,I,20211201.0,20211215.0,20211222,20211222,EXP,,US-ELI_LILLY_AND_COMPANY-US202112009558,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20211222.0,,CN,US,US,2021,Q4,Elderly
202202101,20220210,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,UNKNOWN,,,1.0,IU,Solution for injection/infusion,TID,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145009,DR REDDYS,,79.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202101,20220210,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,UNKNOWN,,,1.0,IU,Solution for injection/infusion,TID,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145009,DR REDDYS,,79.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202101,20220210,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,UNKNOWN,,,1.0,IU,Solution for injection/infusion,TID,2021,Q4,Anaemia,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145009,DR REDDYS,,79.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202101,20220210,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,UNKNOWN,,,1.0,IU,Solution for injection/infusion,TID,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145009,DR REDDYS,,79.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202101,20220210,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,UNKNOWN,,,1.0,IU,Solution for injection/infusion,TID,2021,Q4,Product monitoring error,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145009,DR REDDYS,,79.0,YR,E,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202202151,20220215,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2021,Q4,Injection site haemorrhage,,2021,Q4,1,I,20211201.0,20211201.0,20211223,20211223,PER,,US-ELI_LILLY_AND_COMPANY-US202112001429,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20211223.0,,CN,US,US,2021,Q4,Elderly
202202151,20220215,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2021,Q4,Injection site bruising,,2021,Q4,1,I,20211201.0,20211201.0,20211223,20211223,PER,,US-ELI_LILLY_AND_COMPANY-US202112001429,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20211223.0,,CN,US,US,2021,Q4,Elderly
202202151,20220215,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2021,Q4,Injury associated with device,,2021,Q4,1,I,20211201.0,20211201.0,20211223,20211223,PER,,US-ELI_LILLY_AND_COMPANY-US202112001429,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20211223.0,,CN,US,US,2021,Q4,Elderly
202202151,20220215,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D379507A,,,,,,,2021,Q4,Injection site haemorrhage,,2021,Q4,1,I,20211201.0,20211201.0,20211223,20211223,PER,,US-ELI_LILLY_AND_COMPANY-US202112001429,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20211223.0,,CN,US,US,2021,Q4,Elderly
202202151,20220215,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D379507A,,,,,,,2021,Q4,Injection site bruising,,2021,Q4,1,I,20211201.0,20211201.0,20211223,20211223,PER,,US-ELI_LILLY_AND_COMPANY-US202112001429,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20211223.0,,CN,US,US,2021,Q4,Elderly
202202151,20220215,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D379507A,,,,,,,2021,Q4,Injury associated with device,,2021,Q4,1,I,20211201.0,20211201.0,20211223,20211223,PER,,US-ELI_LILLY_AND_COMPANY-US202112001429,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20211223.0,,CN,US,US,2021,Q4,Elderly
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Headache,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Chills,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202202451,20220245,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211211.0,20211223,20211223,PER,DE-ADRED-06590-05,DE-Shilpa Medicare Limited-SML-DE-2021-01506,SHILPA MEDICARE,,64.0,YR,A,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202205261,20220526,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 milliliter (3 ml, 10-0-8-0, Injektions-/Infusionsl?sung)",,,U,,,,,3.0,ML,Solution for Injection or Infusion,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 milliliter (3 ml, 10-0-8-0, Injektions-/Infusionsl?sung)",,,U,,,,,3.0,ML,Solution for Injection or Infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 milliliter (3 ml, 10-0-8-0, Injektions-/Infusionsl?sung)",,,U,,,,,3.0,ML,Solution for Injection or Infusion,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 milliliter (3 ml, 10-0-8-0, Injektions-/Infusionsl?sung)",,,U,,,,,3.0,ML,Solution for Injection or Infusion,,2021,Q4,Constipation,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 milliliter (3 ml, 10-0-8-0, Injektions-/Infusionsl?sung)",,,U,,,,,3.0,ML,Solution for Injection or Infusion,,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 milliliter (3 ml, 10-0-8-0, Injektions-/Infusionsl?sung)",,,U,,,,,3.0,ML,Solution for Injection or Infusion,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202205261,20220526,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 milliliter (3 ml, 10-0-8-0, Injektions-/Infusionsl?sung)",,,U,,,,,3.0,ML,Solution for Injection or Infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052436,AUROBINDO,,84.0,YR,,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202206641,20220664,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (according to the scheme, injection / infusion solution)",,,,,,,,,,,,2021,Q4,Haematochezia,,2021,Q4,1,I,20200630.0,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052050,AUROBINDO,,67.0,YR,,M,Y,95.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202207891,20220789,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (solution for injection / infusion),,,,,,,,300.0,IU,,,2021,Q4,Contraindicated product administered,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052250,AUROBINDO,,62.0,YR,,M,Y,124.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202207891,20220789,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (solution for injection / infusion),,,,,,,,300.0,IU,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052250,AUROBINDO,,62.0,YR,,M,Y,124.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202207891,20220789,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (solution for injection / infusion),,,,,,,,300.0,IU,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052250,AUROBINDO,,62.0,YR,,M,Y,124.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,Headache,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,Chills,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202213351,20221335,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach BZ, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,NVSC2021DE286459,NOVARTIS,,64.0,YR,,M,Y,,,20211223.0,,PH,DE,DE,2021,Q4,Adult
202216641,20221664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (Solution for injection / infusion),,,U,,,,,300.0,IU,,,2021,Q4,Therapeutic drug monitoring analysis not performed,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202216641,20221664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (Solution for injection / infusion),,,U,,,,,300.0,IU,,,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202216641,20221664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (Solution for injection / infusion),,,U,,,,,300.0,IU,,,2021,Q4,Pain,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Adult
202223731,20222373,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,3.0,ML,,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,3.0,ML,,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,3.0,ML,,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,3.0,ML,,,2021,Q4,Constipation,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,3.0,ML,,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202223731,20222373,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,3.0,ML,,,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211223,20211223,EXP,DE-ADRED-07342-01,DE-TORRENT-00021756,TORRENT,,84.0,YR,E,M,Y,101.0,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225372,20222537,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 units in the morning, 14 units in the evening",,,,,,,,,,Injection,,2021,Q4,Epilepsy,,2021,Q4,2,F,20210710.0,20211222.0,20211223,20211230,EXP,,CN-AstraZeneca-2021A883036,ASTRAZENECA,,14435.0,DY,,M,Y,85.0,KG,20211230.0,,CN,CN,,2021,Q4,Elderly
202225701,20222570,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,,,UNKNOWN,,,,,Solution for injection/infusion,BID,2021,Q4,Constipation,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,,,UNKNOWN,,,,,Solution for injection/infusion,BID,2021,Q4,Dysuria,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,,,UNKNOWN,,,,,Solution for injection/infusion,BID,2021,Q4,Nausea,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,,,UNKNOWN,,,,,Solution for injection/infusion,BID,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,,,UNKNOWN,,,,,Solution for injection/infusion,BID,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,,,UNKNOWN,,,,,Solution for injection/infusion,BID,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202225701,20222570,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,,,UNKNOWN,,,,,Solution for injection/infusion,BID,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,,DE-drreddys-SPO/GER/21/0145031,DR REDDYS,,84.0,YR,E,M,Y,101.4,KG,20211223.0,,PH,DE,DE,2021,Q4,Elderly
202249241,20224924,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,209196.0,,,Solution for injection,,2021,Q4,Maternal exposure during pregnancy,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,FR-AFSSAPS-CN20213885,FR-SA-2021SA423067,SANOFI AVENTIS,,19.0,YR,A,F,Y,33.0,KG,20211223.0,,MD,FR,FR,2021,Q4,Youth
202249241,20224924,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,209196.0,,,Solution for injection,,2021,Q4,Abortion spontaneous,,2021,Q4,1,I,,20211215.0,20211223,20211223,EXP,FR-AFSSAPS-CN20213885,FR-SA-2021SA423067,SANOFI AVENTIS,,19.0,YR,A,F,Y,33.0,KG,20211223.0,,MD,FR,FR,2021,Q4,Youth
202255611,20225561,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, qd (6-6-8-0)",,,U,U,,,,20.0,IU,Solution for injection,QD,2021,Q4,Anaemia,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,ID-DE-BFARM-21011734,DE-NOVOPROD-876119,NOVO NORDISK,,79.0,YR,,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202255611,20225561,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, qd (6-6-8-0)",,,U,U,,,,20.0,IU,Solution for injection,QD,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,ID-DE-BFARM-21011734,DE-NOVOPROD-876119,NOVO NORDISK,,79.0,YR,,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202255611,20225561,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, qd (6-6-8-0)",,,U,U,,,,20.0,IU,Solution for injection,QD,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,ID-DE-BFARM-21011734,DE-NOVOPROD-876119,NOVO NORDISK,,79.0,YR,,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202255611,20225561,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, qd (6-6-8-0)",,,U,U,,,,20.0,IU,Solution for injection,QD,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,ID-DE-BFARM-21011734,DE-NOVOPROD-876119,NOVO NORDISK,,79.0,YR,,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202255611,20225561,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 IU, qd (6-6-8-0)",,,U,U,,,,20.0,IU,Solution for injection,QD,2021,Q4,Product monitoring error,,2021,Q4,1,I,,20211214.0,20211224,20211224,EXP,ID-DE-BFARM-21011734,DE-NOVOPROD-876119,NOVO NORDISK,,79.0,YR,,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202258451,20225845,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211129.0,20211129.0,20211224,20211224,PER,,US-ELI_LILLY_AND_COMPANY-US202111012614,ELI LILLY AND CO,,9.0,YR,,M,Y,,,20211224.0,,CN,US,US,2021,Q4,Child
202258451,20225845,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20211129.0,20211129.0,20211224,20211224,PER,,US-ELI_LILLY_AND_COMPANY-US202111012614,ELI LILLY AND CO,,9.0,YR,,M,Y,,,20211224.0,,CN,US,US,2021,Q4,Child
202258451,20225845,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D385999L,,20563.0,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20211129.0,20211129.0,20211224,20211224,PER,,US-ELI_LILLY_AND_COMPANY-US202111012614,ELI LILLY AND CO,,9.0,YR,,M,Y,,,20211224.0,,CN,US,US,2021,Q4,Child
202258451,20225845,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D385999L,,20563.0,,,Injection,,2021,Q4,Product dose omission issue,,2021,Q4,1,I,20211129.0,20211129.0,20211224,20211224,PER,,US-ELI_LILLY_AND_COMPANY-US202111012614,ELI LILLY AND CO,,9.0,YR,,M,Y,,,20211224.0,,CN,US,US,2021,Q4,Child
202258471,20225847,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,Solution for injection,,2021,Q4,Pneumonia,,2021,Q4,1,I,,20211210.0,20211224,20211224,EXP,,US-SA-2021SA413626,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20211224.0,,CN,US,US,2021,Q4,Elderly
202258471,20225847,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,Solution for injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,,20211210.0,20211224,20211224,EXP,,US-SA-2021SA413626,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20211224.0,,CN,US,US,2021,Q4,Elderly
202258471,20225847,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,209196.0,,,Solution for injection,,2021,Q4,Myasthenia gravis,,2021,Q4,1,I,,20211210.0,20211224,20211224,EXP,,US-SA-2021SA413626,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20211224.0,,CN,US,US,2021,Q4,Elderly
202269631,20226963,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Nausea,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Constipation,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202269631,20226963,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211215.0,20211224,20211224,EXP,,DE-JNJFOC-20211240149,JOHNSON AND JOHNSON,,84.0,YR,E,M,Y,101.4,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202270781,20227078,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0",,,U,,,,,1.0,IU,,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,DE-ADRED-07306-02,DE-TORRENT-00021738,TORRENT,,79.0,YR,E,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202270781,20227078,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0",,,U,,,,,1.0,IU,,,2021,Q4,Product monitoring error,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,DE-ADRED-07306-02,DE-TORRENT-00021738,TORRENT,,79.0,YR,E,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202270781,20227078,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0",,,U,,,,,1.0,IU,,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,DE-ADRED-07306-02,DE-TORRENT-00021738,TORRENT,,79.0,YR,E,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202270781,20227078,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0",,,U,,,,,1.0,IU,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,DE-ADRED-07306-02,DE-TORRENT-00021738,TORRENT,,79.0,YR,E,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202270781,20227078,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0",,,U,,,,,1.0,IU,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,DE-ADRED-07306-02,DE-TORRENT-00021738,TORRENT,,79.0,YR,E,M,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202275351,20227535,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Off label use,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046757,APOTEX,,20.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Youth
202275351,20227535,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2021,Q4,Drug ineffective for unapproved indication,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,CA-APOTEX-2021AP046757,APOTEX,,20.0,YR,,F,Y,,,20211224.0,,HP,CA,CA,2021,Q4,Youth
202275731,20227573,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(Schema),,,U,,,,,,,,,2021,Q4,Urogenital haemorrhage,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021DE285831,NOVARTIS,,69.0,YR,,M,Y,110.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202275731,20227573,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(Schema),,,U,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021DE285831,NOVARTIS,,69.0,YR,,M,Y,110.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202275731,20227573,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(Schema),,,U,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021DE285831,NOVARTIS,,69.0,YR,,M,Y,110.0,KG,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202276841,20227684,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211216.0,20211224,20211224,EXP,,DE-TEVA-2021-DE-1990909,TEVA,,78.0,YR,E,F,Y,,,20211224.0,,PH,DE,DE,2021,Q4,Elderly
202279301,20227930,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL; 12 IU),,,U,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL; 12 IU),,,U,,,,,,,,,2021,Q4,Arrhythmia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL; 12 IU),,,U,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL; 12 IU),,,U,,,,,,,,,2021,Q4,COVID-19 pneumonia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL; 12 IU),,,U,,,,,,,,,2021,Q4,Palpitations,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL; 12 IU),,,U,,,,,,,,,2021,Q4,Pyrexia,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL; 12 IU),,,U,,,,,,,,,2021,Q4,Chronic kidney disease,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202279301,20227930,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL; 12 IU),,,U,,,,,,,,,2021,Q4,COVID-19,,2021,Q4,1,I,,20211213.0,20211224,20211224,EXP,,NVSC2021PT290997,NOVARTIS,,58.0,YR,,M,Y,111.0,KG,20211224.0,,PH,PT,PT,2021,Q4,Adult
202294831,20229483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Nausea,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202294831,20229483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0",,,U,,,,,,,Solution for injection/infusion,,2021,Q4,Constipation,,2021,Q4,1,I,,20211213.0,20211225,20211225,EXP,,NVSC2021DE286198,NOVARTIS,,84.0,YR,,M,Y,101.4,KG,20211225.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Frequent bowel movements,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Upper gastrointestinal haemorrhage,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Muscular weakness,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Product monitoring error,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Haematochezia,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Product prescribing error,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,General physical health deterioration,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Faeces discoloured,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202313552,20231355,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 6-6-8-0, solution for injection / infusion",,,U,,,,,1.0,IU,Solution for injection/infusion,,2021,Q4,Anaemia,,2021,Q4,2,F,,20211222.0,20211227,20211229,EXP,,DE-009507513-2112DEU007899,MERCK,,79.0,YR,,M,Y,90.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Chills,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,Headache,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331831,20233183,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ,",,,,,,,,,,Solution for injection/infusion,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992346,TEVA,,64.0,YR,A,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Adult
202331871,20233187,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0,",,,U,,Unknown,,,,,Solution for injection/infusion,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992756,TEVA,,79.0,YR,E,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Elderly
202331871,20233187,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0,",,,U,,Unknown,,,,,Solution for injection/infusion,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992756,TEVA,,79.0,YR,E,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Elderly
202331871,20233187,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0,",,,U,,Unknown,,,,,Solution for injection/infusion,,2021,Q4,Product monitoring error,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992756,TEVA,,79.0,YR,E,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Elderly
202331871,20233187,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0,",,,U,,Unknown,,,,,Solution for injection/infusion,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992756,TEVA,,79.0,YR,E,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Elderly
202331871,20233187,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0,",,,U,,Unknown,,,,,Solution for injection/infusion,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211220.0,20211227,20211227,EXP,,DE-TEVA-2021-DE-1992756,TEVA,,79.0,YR,E,M,Y,,,20211227.0,,PH,DE,DE,2021,Q4,Elderly
202335751,20233575,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20211203.0,20211203.0,20211227,20211227,PER,,US-ELI_LILLY_AND_COMPANY-US202112002449,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211227.0,,CN,US,US,2021,Q4,Adult
202335751,20233575,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20211203.0,20211203.0,20211227,20211227,PER,,US-ELI_LILLY_AND_COMPANY-US202112002449,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20211227.0,,CN,US,US,2021,Q4,Adult
202371321,20237132,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Septic shock,,2021,Q4,1,I,20211120.0,20211216.0,20211228,20211228,EXP,,US-MYLANLABS-2021M1094624,MYLAN,,71.0,YR,,F,Y,115.0,KG,20211228.0,,HP,US,US,2021,Q4,Elderly
202371321,20237132,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2021,Q4,Respiratory distress,,2021,Q4,1,I,20211120.0,20211216.0,20211228,20211228,EXP,,US-MYLANLABS-2021M1094624,MYLAN,,71.0,YR,,F,Y,115.0,KG,20211228.0,,HP,US,US,2021,Q4,Elderly
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Chills,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Vomiting,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Diarrhoea,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Dizziness,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202378111,20237811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,1.0,IU,Unknown,,2021,Q4,Headache,,2021,Q4,1,I,,20211217.0,20211228,20211228,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-21-56434,HIKMA,,64.0,YR,,M,Y,,,20211228.0,,PH,DE,DE,2021,Q4,Adult
202399061,20239906,6,C,INSULINE LISPRO,,1,Subcutaneous,42 IU,,,U,,,,,42.0,IU,,,2021,Q4,Annular elastolytic giant cell granuloma,,2021,Q4,1,I,20201201.0,20211220.0,20211228,20211228,EXP,FR-AFSSAPS-LY202112666,NVSC2021FR292172,NOVARTIS,,79.0,YR,,F,Y,,,20211228.0,,MD,FR,FR,2021,Q4,Elderly
202463721,20246372,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0, solution for injection / infusion",,,D,,,,209196.0,,,,,2021,Q4,Anaemia,,2021,Q4,1,I,,20211216.0,20211229,20211229,EXP,,DE-SANOFI US-2021SA423261,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202463721,20246372,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0, solution for injection / infusion",,,D,,,,209196.0,,,,,2021,Q4,Muscular weakness,,2021,Q4,1,I,,20211216.0,20211229,20211229,EXP,,DE-SANOFI US-2021SA423261,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202463721,20246372,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0, solution for injection / infusion",,,D,,,,209196.0,,,,,2021,Q4,Product monitoring error,,2021,Q4,1,I,,20211216.0,20211229,20211229,EXP,,DE-SANOFI US-2021SA423261,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202463721,20246372,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0, solution for injection / infusion",,,D,,,,209196.0,,,,,2021,Q4,Haematochezia,,2021,Q4,1,I,,20211216.0,20211229,20211229,EXP,,DE-SANOFI US-2021SA423261,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202463721,20246372,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 6-6-8-0, solution for injection / infusion",,,D,,,,209196.0,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211216.0,20211229,20211229,EXP,,DE-SANOFI US-2021SA423261,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20211229.0,,PH,DE,DE,2021,Q4,Elderly
202474271,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,Unknown,,,300.0,IU,Solution for injection/infusion,TID,2021,Q4,Pain,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202474271,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,Unknown,,,300.0,IU,Solution for injection/infusion,TID,2021,Q4,Therapeutic drug monitoring analysis not performed,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202474271,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,Unknown,,,300.0,IU,Solution for injection/infusion,TID,2021,Q4,Peripheral coldness,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202480841,20248084,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,Solution for injection/infusion,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992534,TEVA,,62.0,YR,A,M,Y,124.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202480841,20248084,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,Solution for injection/infusion,,2021,Q4,Contraindicated product administered,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992534,TEVA,,62.0,YR,A,M,Y,124.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202480841,20248084,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,,,,,,300.0,IU,Solution for injection/infusion,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211219.0,20211229,20211229,EXP,,DE-TEVA-2021-DE-1992534,TEVA,,62.0,YR,A,M,Y,124.0,KG,20211229.0,,PH,DE,DE,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Amnesia,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Movement disorder,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Renal failure,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Staphylococcal infection,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,West Nile viral infection,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Amnesia,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Movement disorder,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Renal failure,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,Staphylococcal infection,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2021,Q4,West Nile viral infection,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Amnesia,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Movement disorder,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Renal failure,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Staphylococcal infection,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,West Nile viral infection,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Accidental underdose,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Amnesia,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Movement disorder,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Cerebrovascular accident,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Visual impairment,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Blood glucose increased,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Cardiac arrest,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Renal failure,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,Staphylococcal infection,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202510261,20251026,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379507A,,,,,Injection,,2021,Q4,West Nile viral infection,,2021,Q4,1,I,20160101.0,20211221.0,20211229,20211229,EXP,,US-ELI_LILLY_AND_COMPANY-US202112010094,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20211229.0,,CN,US,US,2021,Q4,Adult
202548011,20254801,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to the scheme,,,,,,,,,,Solution for injection/infusion,,2021,Q4,Haematochezia,,2021,Q4,1,I,20200630.0,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992419,TEVA,,67.0,YR,E,M,Y,95.0,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion",,,,,,,,3.0,ML,Solution for injection/infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion",,,,,,,,3.0,ML,Solution for injection/infusion,,2021,Q4,Abdominal pain,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion",,,,,,,,3.0,ML,Solution for injection/infusion,,2021,Q4,Constipation,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion",,,,,,,,3.0,ML,Solution for injection/infusion,,2021,Q4,Dysuria,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion",,,,,,,,3.0,ML,Solution for injection/infusion,,2021,Q4,Nausea,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion",,,,,,,,3.0,ML,Solution for injection/infusion,,2021,Q4,Decreased appetite,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202572351,20257235,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion",,,,,,,,3.0,ML,Solution for injection/infusion,,2021,Q4,Abdominal distension,,2021,Q4,1,I,,20211220.0,20211230,20211230,EXP,,DE-TEVA-2021-DE-1992798,TEVA,,84.0,YR,E,M,Y,101.4,KG,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,General physical health deterioration,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Dyspnoea,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Chronic obstructive pulmonary disease,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Condition aggravated,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Acute respiratory failure,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202585411,20258541,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,,,,,,,,2021,Q4,Atrial fibrillation,,2021,Q4,1,I,,20211224.0,20211230,20211230,EXP,,DE-MYLANLABS-2021M1096832,MYLAN,,78.0,YR,,F,Y,,,20211230.0,,PH,DE,DE,2021,Q4,Elderly
202662571,20266257,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU injection-/ solution for infusion,,,,,,,,,,,,2021,Q4,Contraindicated product administered,,2021,Q4,1,I,,20211223.0,20211231,20211231,EXP,,DE-009507513-2112DEU008389,MERCK,,62.0,YR,,M,Y,124.0,KG,20211231.0,,PH,DE,DE,2021,Q4,Adult
202662571,20266257,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU injection-/ solution for infusion,,,,,,,,,,,,2021,Q4,Oedema peripheral,,2021,Q4,1,I,,20211223.0,20211231,20211231,EXP,,DE-009507513-2112DEU008389,MERCK,,62.0,YR,,M,Y,124.0,KG,20211231.0,,PH,DE,DE,2021,Q4,Adult
202662571,20266257,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU injection-/ solution for infusion,,,,,,,,,,,,2021,Q4,Weight increased,,2021,Q4,1,I,,20211223.0,20211231,20211231,EXP,,DE-009507513-2112DEU008389,MERCK,,62.0,YR,,M,Y,124.0,KG,20211231.0,,PH,DE,DE,2021,Q4,Adult
